pericentric heterochromatin organization (GO:0140462),3,3,0.3,+,9.84,3.76E-03
ammonium import across plasma membrane (GO:0140157),3,3,0.3,+,9.84,3.76E-03
pericentric heterochromatin assembly (GO:0031508),3,3,0.3,+,9.84,3.76E-03
response to silver ion (GO:0010272),1,1,0.1,+,9.84,9.67E-02
negative regulation of macrophage antigen processing and presentation (GO:0002617),1,1,0.1,+,9.84,9.67E-02
regulation of macrophage antigen processing and presentation (GO:0002616),1,1,0.1,+,9.84,9.67E-02
positive regulation of L-dopa decarboxylase activity (GO:1903200),1,1,0.1,+,9.84,9.67E-02
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496),1,1,0.1,+,9.84,9.67E-02
cell-cell signaling involved in lung development (GO:0060495),1,1,0.1,+,9.84,9.67E-02
positive regulation of pro-B cell differentiation (GO:2000975),1,1,0.1,+,9.84,9.67E-02
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470),1,1,0.1,+,9.84,9.67E-02
left lung morphogenesis (GO:0060460),1,1,0.1,+,9.84,9.67E-02
signal transduction involved in intra-S DNA damage checkpoint (GO:0072428),1,1,0.1,+,9.84,9.67E-02
left lung development (GO:0060459),2,2,0.2,+,9.84,1.81E-02
bud outgrowth involved in lung branching (GO:0060447),2,2,0.2,+,9.84,1.81E-02
bronchiole morphogenesis (GO:0060436),1,1,0.1,+,9.84,9.67E-02
lung pattern specification process (GO:0060432),1,1,0.1,+,9.84,9.67E-02
positive regulation of chondrocyte development (GO:1902761),1,1,0.1,+,9.84,9.67E-02
D-alanine family amino acid metabolic process (GO:0046144),1,1,0.1,+,9.84,9.67E-02
cell gliding (GO:0071976),1,1,0.1,+,9.84,9.67E-02
toll-like receptor 1 signaling pathway (GO:0034130),1,1,0.1,+,9.84,9.67E-02
formation of animal organ boundary (GO:0010160),1,1,0.1,+,9.84,9.67E-02
regulation of L-dopa decarboxylase activity (GO:1903198),1,1,0.1,+,9.84,9.67E-02
positive regulation of L-dopa biosynthetic process (GO:1903197),1,1,0.1,+,9.84,9.67E-02
regulation of L-dopa biosynthetic process (GO:1903195),1,1,0.1,+,9.84,9.67E-02
glyoxal catabolic process (GO:1903190),1,1,0.1,+,9.84,9.67E-02
glyoxal metabolic process (GO:1903189),1,1,0.1,+,9.84,9.67E-02
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178),1,1,0.1,+,9.84,9.67E-02
regulation of tyrosine 3-monooxygenase activity (GO:1903176),1,1,0.1,+,9.84,9.67E-02
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168),1,1,0.1,+,9.84,9.67E-02
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167),1,1,0.1,+,9.84,9.67E-02
dibenzo-p-dioxin catabolic process (GO:0019341),1,1,0.1,+,9.84,9.67E-02
ventral midline determination (GO:0007371),1,1,0.1,+,9.84,9.67E-02
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122),1,1,0.1,+,9.84,9.67E-02
protein localization to actin cytoskeleton (GO:1903119),1,1,0.1,+,9.84,9.67E-02
regulation of progesterone secretion (GO:2000870),1,1,0.1,+,9.84,9.67E-02
positive regulation of DNA strand elongation (GO:0060383),1,1,0.1,+,9.84,9.67E-02
positive regulation of mast cell differentiation (GO:0060376),1,1,0.1,+,9.84,9.67E-02
negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302),1,1,0.1,+,9.84,9.67E-02
1-aminocyclopropane-1-carboxylate metabolic process (GO:0018871),1,1,0.1,+,9.84,9.67E-02
negative regulation of lipid transporter activity (GO:0110114),1,1,0.1,+,9.84,9.67E-02
positive regulation of lipid transporter activity (GO:0110113),1,1,0.1,+,9.84,9.67E-02
polarity specification of proximal/distal axis (GO:0010085),2,2,0.2,+,9.84,1.81E-02
malonyl-CoA catabolic process (GO:2001294),1,1,0.1,+,9.84,9.67E-02
negative regulation of death-inducing signaling complex assembly (GO:1903073),1,1,0.1,+,9.84,9.67E-02
regulation of death-inducing signaling complex assembly (GO:1903072),1,1,0.1,+,9.84,9.67E-02
neural crest cell migration involved in sympathetic nervous system development (GO:1903045),1,1,0.1,+,9.84,9.67E-02
positive regulation of chondrocyte hypertrophy (GO:1903043),1,1,0.1,+,9.84,9.67E-02
regulation of chondrocyte hypertrophy (GO:1903041),1,1,0.1,+,9.84,9.67E-02
subthalamus development (GO:0021539),1,1,0.1,+,9.84,9.67E-02
mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285),1,1,0.1,+,9.84,9.67E-02
positive regulation of glucosylceramide catabolic process (GO:2000753),1,1,0.1,+,9.84,9.67E-02
regulation of glucosylceramide catabolic process (GO:2000752),1,1,0.1,+,9.84,9.67E-02
negative regulation of cell growth involved in contact inhibition (GO:0060243),1,1,0.1,+,9.84,9.67E-02
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729),2,2,0.2,+,9.84,1.81E-02
vesicle-mediated intercellular transport (GO:0110077),1,1,0.1,+,9.84,9.67E-02
hepatic immune response (GO:0002384),2,2,0.2,+,9.84,1.81E-02
nuclear inner membrane organization (GO:0071765),1,1,0.1,+,9.84,9.67E-02
nicotinamide riboside catabolic process (GO:0006738),1,1,0.1,+,9.84,9.67E-02
B cell cytokine production (GO:0002368),1,1,0.1,+,9.84,9.67E-02
estrogen catabolic process (GO:0006711),1,1,0.1,+,9.84,9.67E-02
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173),1,1,0.1,+,9.84,9.67E-02
regulation of MAPK export from nucleus (GO:0071701),1,1,0.1,+,9.84,9.67E-02
negative regulation of sperm capacitation (GO:1902491),1,1,0.1,+,9.84,9.67E-02
regulation of sperm capacitation (GO:1902490),2,2,0.2,+,9.84,1.81E-02
negative regulation of histone H3-K9 acetylation (GO:2000616),1,1,0.1,+,9.84,9.67E-02
phytosphingosine metabolic process (GO:0006671),1,1,0.1,+,9.84,9.67E-02
mastication (GO:0071626),1,1,0.1,+,9.84,9.67E-02
phytosphingosine biosynthetic process (GO:0071602),1,1,0.1,+,9.84,9.67E-02
positive regulation of cellular glucuronidation (GO:2001031),1,1,0.1,+,9.84,9.67E-02
regulation of cellular glucuronidation (GO:2001029),1,1,0.1,+,9.84,9.67E-02
neutrophil apoptotic process (GO:0001781),1,1,0.1,+,9.84,9.67E-02
female meiosis sister chromatid cohesion (GO:0007066),1,1,0.1,+,9.84,9.67E-02
regulation of mitotic spindle elongation (GO:0032888),1,1,0.1,+,9.84,9.67E-02
regulation of spindle elongation (GO:0032887),1,1,0.1,+,9.84,9.67E-02
mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036),1,1,0.1,+,9.84,9.67E-02
negative regulation of dendritic cell dendrite assembly (GO:2000548),1,1,0.1,+,9.84,9.67E-02
epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168),1,1,0.1,+,9.84,9.67E-02
epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167),1,1,0.1,+,9.84,9.67E-02
positive regulation of myeloid dendritic cell chemotaxis (GO:2000529),1,1,0.1,+,9.84,9.67E-02
regulation of myeloid dendritic cell chemotaxis (GO:2000527),1,1,0.1,+,9.84,9.67E-02
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526),1,1,0.1,+,9.84,9.67E-02
positive regulation of immunological synapse formation (GO:2000522),1,1,0.1,+,9.84,9.67E-02
positive regulation of protein localization to spindle pole body (GO:1902365),1,1,0.1,+,9.84,9.67E-02
regulation of protein localization to spindle pole body (GO:1902363),1,1,0.1,+,9.84,9.67E-02
negative regulation of T-helper 1 cell activation (GO:2000518),1,1,0.1,+,9.84,9.67E-02
regulation of T-helper 1 cell activation (GO:2000517),1,1,0.1,+,9.84,9.67E-02
positive regulation of granzyme A production (GO:2000513),1,1,0.1,+,9.84,9.67E-02
regulation of granzyme A production (GO:2000511),1,1,0.1,+,9.84,9.67E-02
ornithine catabolic process (GO:0006593),1,1,0.1,+,9.84,9.67E-02
negative regulation of chromosome condensation (GO:1902340),1,1,0.1,+,9.84,9.67E-02
chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115),1,1,0.1,+,9.84,9.67E-02
tRNA re-export from nucleus (GO:0071528),1,1,0.1,+,9.84,9.67E-02
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835),1,1,0.1,+,9.84,9.67E-02
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834),1,1,0.1,+,9.84,9.67E-02
negative regulation of CD4 production (GO:0045225),1,1,0.1,+,9.84,9.67E-02
regulation of CD4 production (GO:0045223),1,1,0.1,+,9.84,9.67E-02
subtelomeric heterochromatin organization (GO:0140461),1,1,0.1,+,9.84,9.67E-02
negative regulation of erythrocyte apoptotic process (GO:1902251),1,1,0.1,+,9.84,9.67E-02
regulation of erythrocyte apoptotic process (GO:1902250),1,1,0.1,+,9.84,9.67E-02
negative regulation of T cell extravasation (GO:2000408),1,1,0.1,+,9.84,9.67E-02
negative regulation of positive thymic T cell selection (GO:1902233),1,1,0.1,+,9.84,9.67E-02
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227),2,2,0.2,+,9.84,1.81E-02
negative regulation of acrosome reaction (GO:1902225),1,1,0.1,+,9.84,9.67E-02
endocrine signaling (GO:0038002),1,1,0.1,+,9.84,9.67E-02
peptidyl-glutamic acid poly-ADP-ribosylation (GO:0018424),1,1,0.1,+,9.84,9.67E-02
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215),1,1,0.1,+,9.84,9.67E-02
positive regulation of prolactin signaling pathway (GO:1902213),1,1,0.1,+,9.84,9.67E-02
regulation of prolactin signaling pathway (GO:1902211),1,1,0.1,+,9.84,9.67E-02
cellular hypotonic salinity response (GO:0071477),2,2,0.2,+,9.84,1.81E-02
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206),1,1,0.1,+,9.84,9.67E-02
regulation of interleukin-2-mediated signaling pathway (GO:1902205),1,1,0.1,+,9.84,9.67E-02
"general adaptation syndrome, behavioral process (GO:0051867)",1,1,0.1,+,9.84,9.67E-02
primary miRNA methylation (GO:1990744),1,1,0.1,+,9.84,9.67E-02
primary miRNA modification (GO:1990729),1,1,0.1,+,9.84,9.67E-02
cholangiocyte proliferation (GO:1990705),1,1,0.1,+,9.84,9.67E-02
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581),2,2,0.2,+,9.84,1.81E-02
positive regulation of mesoderm development (GO:2000382),1,1,0.1,+,9.84,9.67E-02
positive regulation of kidney smooth muscle cell differentiation (GO:2000358),1,1,0.1,+,9.84,9.67E-02
negative regulation of kidney smooth muscle cell differentiation (GO:2000357),1,1,0.1,+,9.84,9.67E-02
regulation of kidney smooth muscle cell differentiation (GO:2000356),1,1,0.1,+,9.84,9.67E-02
negative regulation of nuclear receptor transcription coactivator activity (GO:2000326),1,1,0.1,+,9.84,9.67E-02
termination of RNA polymerase III transcription (GO:0006386),1,1,0.1,+,9.84,9.67E-02
enzyme active site formation via L-cysteine sulfinic acid (GO:0018323),1,1,0.1,+,9.84,9.67E-02
cellular response to interleukin-11 (GO:0071348),1,1,0.1,+,9.84,9.67E-02
diphosphate metabolic process (GO:0071344),2,2,0.2,+,9.84,1.81E-02
positive regulation of hair follicle cell proliferation (GO:0071338),1,1,0.1,+,9.84,9.67E-02
regulation of hair follicle cell proliferation (GO:0071336),1,1,0.1,+,9.84,9.67E-02
dibasic protein processing (GO:0090472),1,1,0.1,+,9.84,9.67E-02
endocytic iron import into cell (GO:0140298),1,1,0.1,+,9.84,9.67E-02
positive regulation of cellular amino acid biosynthetic process (GO:2000284),1,1,0.1,+,9.84,9.67E-02
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277),1,1,0.1,+,9.84,9.67E-02
tripeptide import across plasma membrane (GO:0140207),1,1,0.1,+,9.84,9.67E-02
adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate (GO:0140200),1,1,0.1,+,9.84,9.67E-02
protein sulfhydration (GO:0044524),1,1,0.1,+,9.84,9.67E-02
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272),1,1,0.1,+,9.84,9.67E-02
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010),1,1,0.1,+,9.84,9.67E-02
peptidyl-serine trans-autophosphorylation (GO:1990579),1,1,0.1,+,9.84,9.67E-02
cellular response to carbon monoxide (GO:0071245),1,1,0.1,+,9.84,9.67E-02
regulation of cellular response to alcohol (GO:1905957),1,1,0.1,+,9.84,9.67E-02
mitochondrial manganese ion transmembrane transport (GO:1990540),1,1,0.1,+,9.84,9.67E-02
fructose import across plasma membrane (GO:1990539),1,1,0.1,+,9.84,9.67E-02
response to fenofibrate (GO:1901557),1,1,0.1,+,9.84,9.67E-02
response to raffinose (GO:1901545),1,1,0.1,+,9.84,9.67E-02
positive regulation of chylomicron remnant clearance (GO:0090321),1,1,0.1,+,9.84,9.67E-02
regulation of chylomicron remnant clearance (GO:0090320),1,1,0.1,+,9.84,9.67E-02
adenohypophysis morphogenesis (GO:0048855),1,1,0.1,+,9.84,9.67E-02
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289),1,1,0.1,+,9.84,9.67E-02
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288),1,1,0.1,+,9.84,9.67E-02
positive regulation of pro-T cell differentiation (GO:2000176),1,1,0.1,+,9.84,9.67E-02
regulation of pro-T cell differentiation (GO:2000174),1,1,0.1,+,9.84,9.67E-02
"regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)",1,1,0.1,+,9.84,9.67E-02
fructose import (GO:0032445),1,1,0.1,+,9.84,9.67E-02
negative regulation of sodium-dependent phosphate transport (GO:2000119),1,1,0.1,+,9.84,9.67E-02
calcium-dependent activation of synaptic vesicle fusion (GO:0099502),1,1,0.1,+,9.84,9.67E-02
inosine catabolic process (GO:0006148),1,1,0.1,+,9.84,9.67E-02
negative regulation of postsynaptic density organization (GO:1905875),1,1,0.1,+,9.84,9.67E-02
cellular response to pyrimidine ribonucleotide (GO:1905835),1,1,0.1,+,9.84,9.67E-02
response to pyrimidine ribonucleotide (GO:1905834),1,1,0.1,+,9.84,9.67E-02
response to interleukin-11 (GO:0071105),1,1,0.1,+,9.84,9.67E-02
positive regulation of chromatin silencing at telomere (GO:0031940),1,1,0.1,+,9.84,9.67E-02
positive regulation of mitochondrial DNA replication (GO:0090297),1,1,0.1,+,9.84,9.67E-02
positive regulation of osteoclast proliferation (GO:0090290),1,1,0.1,+,9.84,9.67E-02
regulation of response to alcohol (GO:1901419),1,1,0.1,+,9.84,9.67E-02
peptidyl-lysine butyrylation (GO:0140067),1,1,0.1,+,9.84,9.67E-02
peptidyl-lysine crotonylation (GO:0140066),1,1,0.1,+,9.84,9.67E-02
pyridine nucleoside catabolic process (GO:0070638),1,1,0.1,+,9.84,9.67E-02
pyridine nucleoside metabolic process (GO:0070637),1,1,0.1,+,9.84,9.67E-02
cellular detoxification of methylglyoxal (GO:0140041),1,1,0.1,+,9.84,9.67E-02
positive regulation of ureter smooth muscle cell differentiation (GO:2000063),1,1,0.1,+,9.84,9.67E-02
negative regulation of ureter smooth muscle cell differentiation (GO:2000062),1,1,0.1,+,9.84,9.67E-02
regulation of ureter smooth muscle cell differentiation (GO:2000061),1,1,0.1,+,9.84,9.67E-02
positive regulation of cobalamin metabolic process (GO:0106121),1,1,0.1,+,9.84,9.67E-02
cytochrome c-heme linkage (GO:0018063),1,1,0.1,+,9.84,9.67E-02
protein amidation (GO:0018032),1,1,0.1,+,9.84,9.67E-02
CMP-N-acetylneuraminate biosynthetic process (GO:0006055),1,1,0.1,+,9.84,9.67E-02
NMDA selective glutamate receptor signaling pathway (GO:0098989),1,1,0.1,+,9.84,9.67E-02
snoRNA polyadenylation (GO:0071050),1,1,0.1,+,9.84,9.67E-02
monopolar spindle attachment to meiosis I kinetochore (GO:0051455),1,1,0.1,+,9.84,9.67E-02
positive regulation of transforming growth factor beta1 activation (GO:1901394),1,1,0.1,+,9.84,9.67E-02
positive regulation of transforming growth factor beta activation (GO:1901390),1,1,0.1,+,9.84,9.67E-02
hard palate morphogenesis (GO:1905748),1,1,0.1,+,9.84,9.67E-02
negative regulation of saliva secretion (GO:1905747),1,1,0.1,+,9.84,9.67E-02
response to cortisone (GO:0051413),1,1,0.1,+,9.84,9.67E-02
positive regulation of inhibitory synapse assembly (GO:1905704),2,2,0.2,+,9.84,1.81E-02
polarity specification of anterior/posterior axis (GO:0009949),2,2,0.2,+,9.84,1.81E-02
cell-cell adhesion involved in gastrulation (GO:0070586),1,1,0.1,+,9.84,9.67E-02
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138),1,1,0.1,+,9.84,9.67E-02
regulation of cobalamin metabolic process (GO:0106064),1,1,0.1,+,9.84,9.67E-02
spermidine deacetylation (GO:0106048),1,1,0.1,+,9.84,9.67E-02
polyamine deacetylation (GO:0106047),1,1,0.1,+,9.84,9.67E-02
"guanine deglycation, glyoxal removal (GO:0106046)",1,1,0.1,+,9.84,9.67E-02
"guanine deglycation, methylglyoxal removal (GO:0106045)",1,1,0.1,+,9.84,9.67E-02
guanine deglycation (GO:0106044),1,1,0.1,+,9.84,9.67E-02
'de novo' AMP biosynthetic process (GO:0044208),1,1,0.1,+,9.84,9.67E-02
positive regulation of polysome binding (GO:1905698),1,1,0.1,+,9.84,9.67E-02
response to transition metal nanoparticle (GO:1990267),1,1,0.1,+,9.84,9.67E-02
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316),1,1,0.1,+,9.84,9.67E-02
male meiosis chromosome separation (GO:0051308),1,1,0.1,+,9.84,9.67E-02
negative regulation of extracellular matrix assembly (GO:1901202),1,1,0.1,+,9.84,9.67E-02
transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010),1,1,0.1,+,9.84,9.67E-02
glutathione deglycation (GO:0036531),1,1,0.1,+,9.84,9.67E-02
"protein deglycation, methylglyoxal removal (GO:0036530)",1,1,0.1,+,9.84,9.67E-02
"protein deglycation, glyoxal removal (GO:0036529)",1,1,0.1,+,9.84,9.67E-02
peptidyl-lysine deglycation (GO:0036528),1,1,0.1,+,9.84,9.67E-02
peptidyl-arginine deglycation (GO:0036527),1,1,0.1,+,9.84,9.67E-02
peptidyl-cysteine deglycation (GO:0036526),1,1,0.1,+,9.84,9.67E-02
regulation of carbohydrate phosphatase activity (GO:0032113),1,1,0.1,+,9.84,9.67E-02
fibronectin fibril organization (GO:1905590),1,1,0.1,+,9.84,9.67E-02
outer hair cell apoptotic process (GO:1905584),1,1,0.1,+,9.84,9.67E-02
positive regulation of subtelomeric heterochromatin assembly (GO:1905549),1,1,0.1,+,9.84,9.67E-02
regulation of subtelomeric heterochromatin assembly (GO:1905547),1,1,0.1,+,9.84,9.67E-02
positive regulation of abscisic acid-activated signaling pathway (GO:0009789),1,1,0.1,+,9.84,9.67E-02
regulation of abscisic acid-activated signaling pathway (GO:0009787),1,1,0.1,+,9.84,9.67E-02
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630),1,1,0.1,+,9.84,9.67E-02
ncRNA polyadenylation (GO:0043629),1,1,0.1,+,9.84,9.67E-02
positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632),1,1,0.1,+,9.84,9.67E-02
detoxification of mercury ion (GO:0050787),2,2,0.2,+,9.84,1.81E-02
cellular response to glyoxal (GO:0036471),1,1,0.1,+,9.84,9.67E-02
response to copper ion starvation (GO:0120126),1,1,0.1,+,9.84,9.67E-02
T cell meandering migration (GO:0120117),1,1,0.1,+,9.84,9.67E-02
positive regulation of lymphoid progenitor cell differentiation (GO:1905458),2,2,0.2,+,9.84,1.81E-02
ethylene metabolic process (GO:0009692),1,1,0.1,+,9.84,9.67E-02
benzylpenicillin metabolic process (GO:1901086),1,1,0.1,+,9.84,9.67E-02
regulation of dense core granule exocytosis (GO:1905413),1,1,0.1,+,9.84,9.67E-02
subtelomeric heterochromatin assembly (GO:0031509),1,1,0.1,+,9.84,9.67E-02
positive regulation of viral translation (GO:1904973),1,1,0.1,+,9.84,9.67E-02
regulation of viral translation (GO:1904971),1,1,0.1,+,9.84,9.67E-02
positive regulation of urothelial cell proliferation (GO:0050677),1,1,0.1,+,9.84,9.67E-02
regulation of urothelial cell proliferation (GO:0050675),1,1,0.1,+,9.84,9.67E-02
urothelial cell proliferation (GO:0050674),1,1,0.1,+,9.84,9.67E-02
opsin transport (GO:0036372),1,1,0.1,+,9.84,9.67E-02
axial mesodermal cell fate specification (GO:0048327),1,1,0.1,+,9.84,9.67E-02
axial mesodermal cell fate commitment (GO:0048322),1,1,0.1,+,9.84,9.67E-02
axial mesodermal cell differentiation (GO:0048321),1,1,0.1,+,9.84,9.67E-02
platelet maturation (GO:0036345),1,1,0.1,+,9.84,9.67E-02
cellular response to copper ion starvation (GO:0035874),1,1,0.1,+,9.84,9.67E-02
learned vocalization behavior (GO:0098583),1,1,0.1,+,9.84,9.67E-02
negative regulation of calcium-independent cell-cell adhesion (GO:0051042),1,1,0.1,+,9.84,9.67E-02
tracheoesophageal septum formation (GO:1905327),1,1,0.1,+,9.84,9.67E-02
positive regulation of mRNA cleavage (GO:0031439),1,1,0.1,+,9.84,9.67E-02
regulation of mRNA cleavage (GO:0031437),1,1,0.1,+,9.84,9.67E-02
isotype switching to IgG isotypes (GO:0048291),1,1,0.1,+,9.84,9.67E-02
protein trans-autophosphorylation (GO:0036290),1,1,0.1,+,9.84,9.67E-02
regulation of diacylglycerol biosynthetic process (GO:1900480),1,1,0.1,+,9.84,9.67E-02
swimming (GO:0036268),1,1,0.1,+,9.84,9.67E-02
positive regulation of aortic smooth muscle cell differentiation (GO:1904831),1,1,0.1,+,9.84,9.67E-02
response to methylamine (GO:0036255),1,1,0.1,+,9.84,9.67E-02
regulation of aortic smooth muscle cell differentiation (GO:1904829),1,1,0.1,+,9.84,9.67E-02
protein splicing (GO:0030908),1,1,0.1,+,9.84,9.67E-02
mature natural killer cell chemotaxis (GO:0035782),1,1,0.1,+,9.84,9.67E-02
negative regulation of memory T cell differentiation (GO:0043381),2,2,0.2,+,9.84,1.81E-02
nitric oxide storage (GO:0035732),1,1,0.1,+,9.84,9.67E-02
"cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)",2,2,0.2,+,9.84,1.81E-02
glucagon secretion (GO:0070091),1,1,0.1,+,9.84,9.67E-02
protein-tetrapyrrole linkage (GO:0017006),1,1,0.1,+,9.84,9.67E-02
protein-heme linkage (GO:0017003),1,1,0.1,+,9.84,9.67E-02
"mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)",1,1,0.1,+,9.84,9.67E-02
positive regulation of myofibroblast differentiation (GO:1904762),1,1,0.1,+,9.84,9.67E-02
osteoclast maturation (GO:0036179),1,1,0.1,+,9.84,9.67E-02
triglyceride acyl-chain remodeling (GO:0036153),1,1,0.1,+,9.84,9.67E-02
intein-mediated protein splicing (GO:0016539),1,1,0.1,+,9.84,9.67E-02
mitophagy by induced vacuole formation (GO:0035695),1,1,0.1,+,9.84,9.67E-02
peptidyl-lysine propionylation (GO:0061921),1,1,0.1,+,9.84,9.67E-02
positive regulation of phagosome maturation (GO:1905164),1,1,0.1,+,9.84,9.67E-02
enteric smooth muscle cell differentiation (GO:0035645),1,1,0.1,+,9.84,9.67E-02
pseudopodium assembly (GO:0031269),1,1,0.1,+,9.84,9.67E-02
D-serine catabolic process (GO:0036088),1,1,0.1,+,9.84,9.67E-02
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260),1,1,0.1,+,9.84,9.67E-02
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259),1,1,0.1,+,9.84,9.67E-02
regulation of pronephros size (GO:0035565),1,1,0.1,+,9.84,9.67E-02
cardiac jelly development (GO:1905072),1,1,0.1,+,9.84,9.67E-02
D-alanine catabolic process (GO:0055130),1,1,0.1,+,9.84,9.67E-02
positive regulation of antifungal innate immune response (GO:1905036),1,1,0.1,+,9.84,9.67E-02
short-chain fatty acid import (GO:0015913),1,1,0.1,+,9.84,9.67E-02
mating plug formation (GO:0042628),1,1,0.1,+,9.84,9.67E-02
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170),1,1,0.1,+,9.84,9.67E-02
beta-lactam antibiotic metabolic process (GO:0030653),1,1,0.1,+,9.84,9.67E-02
regulation of glucocorticoid mediated signaling pathway (GO:1900169),2,2,0.2,+,9.84,1.81E-02
positive regulation of phospholipid scramblase activity (GO:1900163),1,1,0.1,+,9.84,9.67E-02
regulation of phospholipid scramblase activity (GO:1900161),1,1,0.1,+,9.84,9.67E-02
leukocyte adhesion to arterial endothelial cell (GO:0061757),1,1,0.1,+,9.84,9.67E-02
anastral spindle assembly (GO:0055048),1,1,0.1,+,9.84,9.67E-02
isoleucine transport (GO:0015818),1,1,0.1,+,9.84,9.67E-02
negative regulation of hemoglobin biosynthetic process (GO:0046986),1,1,0.1,+,9.84,9.67E-02
fatty acid primary amide metabolic process (GO:0062126),1,1,0.1,+,9.84,9.67E-02
fatty acid primary amide biosynthetic process (GO:0062112),1,1,0.1,+,9.84,9.67E-02
hypotonic salinity response (GO:0042539),2,2,0.2,+,9.84,1.81E-02
regulation of D-erythro-sphingosine kinase activity (GO:1900022),1,1,0.1,+,9.84,9.67E-02
cellular response to bisphenol A (GO:1903926),1,1,0.1,+,9.84,9.67E-02
response to bisphenol A (GO:1903925),1,1,0.1,+,9.84,9.67E-02
bilirubin transport (GO:0015723),1,1,0.1,+,9.84,9.67E-02
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030),1,1,0.1,+,9.84,9.67E-02
adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024),1,1,0.1,+,9.84,9.67E-02
positive regulation of protein localization to actin cortical patch (GO:1904372),1,1,0.1,+,9.84,9.67E-02
regulation of protein localization to actin cortical patch (GO:1904370),1,1,0.1,+,9.84,9.67E-02
arginine biosynthetic process via ornithine (GO:0042450),2,2,0.2,+,9.84,1.81E-02
colon epithelial cell migration (GO:0061580),1,1,0.1,+,9.84,9.67E-02
DNA-templated viral transcription (GO:0039695),1,1,0.1,+,9.84,9.67E-02
carotene catabolic process (GO:0016121),1,1,0.1,+,9.84,9.67E-02
carotene metabolic process (GO:0016119),1,1,0.1,+,9.84,9.67E-02
fusion of virus membrane with host endosome membrane (GO:0039654),1,1,0.1,+,9.84,9.67E-02
mercury ion transport (GO:0015694),1,1,0.1,+,9.84,9.67E-02
L-isoleucine import across plasma membrane (GO:1903806),1,1,0.1,+,9.84,9.67E-02
positive regulation of arginase activity (GO:0150072),1,1,0.1,+,9.84,9.67E-02
regulation of arginase activity (GO:0150070),1,1,0.1,+,9.84,9.67E-02
positive regulation of Schwann cell chemotaxis (GO:1904268),1,1,0.1,+,9.84,9.67E-02
regulation of Schwann cell chemotaxis (GO:1904266),1,1,0.1,+,9.84,9.67E-02
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246),2,2,0.2,+,9.84,1.81E-02
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240),1,1,0.1,+,9.84,9.67E-02
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239),1,1,0.1,+,9.84,9.67E-02
penicillin metabolic process (GO:0042316),1,1,0.1,+,9.84,9.67E-02
cellular response to raffinose (GO:0097403),1,1,0.1,+,9.84,9.67E-02
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705),2,2,0.2,+,9.84,1.81E-02
protein localization to vacuolar membrane (GO:1903778),1,1,0.1,+,9.84,9.67E-02
isoleucine transmembrane transport (GO:1903714),1,1,0.1,+,9.84,9.67E-02
regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994),1,1,0.1,+,9.84,9.67E-02
lipid tube assembly involved in organelle fusion (GO:0060989),1,1,0.1,+,9.84,9.67E-02
peptidyl-aspartic acid hydroxylation (GO:0042264),1,1,0.1,+,9.84,9.67E-02
negative regulation of microglial cell migration (GO:1904140),1,1,0.1,+,9.84,9.67E-02
1-aminocyclopropane-1-carboxylate biosynthetic process (GO:0042218),1,1,0.1,+,9.84,9.67E-02
protein localization to microvillus (GO:1904106),2,2,0.2,+,9.84,1.81E-02
positive regulation of Schwann cell proliferation (GO:0010625),1,1,0.1,+,9.84,9.67E-02
semicircular canal fusion (GO:0060879),1,1,0.1,+,9.84,9.67E-02
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412),1,1,0.1,+,9.84,9.67E-02
optic cup structural organization (GO:0003409),1,1,0.1,+,9.84,9.67E-02
renal phosphate ion absorption (GO:0097291),1,1,0.1,+,9.84,9.67E-02
positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804),1,1,0.1,+,9.84,9.67E-02
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802),1,1,0.1,+,9.84,9.67E-02
cellular urea homeostasis (GO:0097277),1,1,0.1,+,9.84,9.67E-02
cellular creatinine homeostasis (GO:0097276),1,1,0.1,+,9.84,9.67E-02
cellular ammonium homeostasis (GO:0097275),1,1,0.1,+,9.84,9.67E-02
ammonium homeostasis (GO:0097272),2,2,0.2,+,9.84,1.81E-02
negative regulation of cystathionine beta-synthase activity (GO:1904042),1,1,0.1,+,9.84,9.67E-02
regulation of cystathionine beta-synthase activity (GO:1904041),1,1,0.1,+,9.84,9.67E-02
mitochondrial unfolded protein response (GO:0034514),1,1,0.1,+,9.84,9.67E-02
tRNA N2-guanine methylation (GO:0002940),1,1,0.1,+,9.84,9.67E-02
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296),1,1,0.1,+,9.84,9.67E-02
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295),1,1,0.1,+,9.84,9.67E-02
negative regulation of mesonephros development (GO:0061218),1,1,0.1,+,9.84,9.67E-02
mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783),1,1,0.1,+,9.84,9.67E-02
regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782),1,1,0.1,+,9.84,9.67E-02
lamellipodium assembly involved in ameboidal cell migration (GO:0003363),1,1,0.1,+,9.84,9.67E-02
nicotinamide riboside metabolic process (GO:0046495),1,1,0.1,+,9.84,9.67E-02
cellular response to sodium dodecyl sulfate (GO:0072707),1,1,0.1,+,9.84,9.67E-02
response to sodium dodecyl sulfate (GO:0072706),1,1,0.1,+,9.84,9.67E-02
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734),1,1,0.1,+,9.84,9.67E-02
D-alanine metabolic process (GO:0046436),1,1,0.1,+,9.84,9.67E-02
dentin mineralization (GO:0097188),1,1,0.1,+,9.84,9.67E-02
cellular response to azide (GO:0097185),1,1,0.1,+,9.84,9.67E-02
response to azide (GO:0097184),1,1,0.1,+,9.84,9.67E-02
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843),1,1,0.1,+,9.84,9.67E-02
negative regulation of translational initiation by iron (GO:0045993),1,1,0.1,+,9.84,9.67E-02
regulation of sclerotome development (GO:0061190),1,1,0.1,+,9.84,9.67E-02
positive regulation of sclerotome development (GO:0061189),1,1,0.1,+,9.84,9.67E-02
lung proximal/distal axis specification (GO:0061115),1,1,0.1,+,9.84,9.67E-02
response to lipoic acid (GO:1903442),1,1,0.1,+,9.84,9.67E-02
seminal vesicle epithelium development (GO:0061108),1,1,0.1,+,9.84,9.67E-02
positive regulation of sodium:potassium-exchanging ATPase activity (GO:1903408),2,2,0.2,+,9.84,1.81E-02
regulation of sodium:potassium-exchanging ATPase activity (GO:1903406),2,2,0.2,+,9.84,1.81E-02
negative regulation of cholesterol transporter activity (GO:0060695),1,1,0.1,+,9.84,9.67E-02
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247),1,1,0.1,+,9.84,9.67E-02
CMP-N-acetylneuraminate metabolic process (GO:0046381),1,1,0.1,+,9.84,9.67E-02
plasma membrane selenite transport (GO:0097080),1,1,0.1,+,9.84,9.67E-02
sensory organ boundary specification (GO:0008052),1,1,0.1,+,9.84,9.67E-02
positive regulation of synaptic growth at neuromuscular junction (GO:0045887),1,1,0.1,+,9.84,9.67E-02
maintenance of symbiont-containing vacuole by host (GO:0085018),1,1,0.1,+,9.84,9.67E-02
positive regulation of prostaglandin secretion involved in immune response (GO:0061078),1,1,0.1,+,9.84,9.67E-02
hepatoblast differentiation (GO:0061017),1,1,0.1,+,9.84,9.67E-02
nucleolar fragmentation (GO:0007576),1,1,0.1,+,9.84,9.67E-02
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816),1,1,0.1,+,9.84,9.67E-02
glycolate biosynthetic process (GO:0046295),1,1,0.1,+,9.84,9.67E-02
"positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)",1,1,0.1,+,9.84,9.67E-02
"regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)",1,1,0.1,+,9.84,9.67E-02
"positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)",1,1,0.1,+,9.84,9.67E-02
"regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)",1,1,0.1,+,9.84,9.67E-02
terpene catabolic process (GO:0046247),1,1,0.1,+,9.84,9.67E-02
positive regulation of mitotic spindle elongation (GO:1902846),1,1,0.1,+,9.84,9.67E-02
proximal/distal axis specification (GO:0009946),4,3,0.41,+,7.38,8.28E-03
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738),4,3,0.41,+,7.38,8.28E-03
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023),4,3,0.41,+,7.38,8.28E-03
glycine decarboxylation via glycine cleavage system (GO:0019464),3,2,0.3,+,6.56,3.80E-02
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990),3,2,0.3,+,6.56,3.80E-02
thorax and anterior abdomen determination (GO:0007356),3,2,0.3,+,6.56,3.80E-02
regulation of lipid transporter activity (GO:0110112),3,2,0.3,+,6.56,3.80E-02
tail-anchored membrane protein insertion into ER membrane (GO:0071816),3,2,0.3,+,6.56,3.80E-02
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070),3,2,0.3,+,6.56,3.80E-02
positive regulation of hh target transcription factor activity (GO:0007228),3,2,0.3,+,6.56,3.80E-02
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208),3,2,0.3,+,6.56,3.80E-02
eye pigment biosynthetic process (GO:0006726),3,2,0.3,+,6.56,3.80E-02
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199),3,2,0.3,+,6.56,3.80E-02
maternal process involved in parturition (GO:0060137),6,4,0.61,+,6.56,3.55E-03
positive regulation of mesenchymal stem cell proliferation (GO:1902462),3,2,0.3,+,6.56,3.80E-02
regulation of mesenchymal stem cell proliferation (GO:1902460),3,2,0.3,+,6.56,3.80E-02
cerebrospinal fluid secretion (GO:0033326),3,2,0.3,+,6.56,3.80E-02
male meiosis chromosome segregation (GO:0007060),3,2,0.3,+,6.56,3.80E-02
regulation of dendritic cell dendrite assembly (GO:2000547),3,2,0.3,+,6.56,3.80E-02
glycine catabolic process (GO:0006546),3,2,0.3,+,6.56,3.80E-02
thyroid hormone mediated signaling pathway (GO:0002154),3,2,0.3,+,6.56,3.80E-02
regulation of positive thymic T cell selection (GO:1902232),3,2,0.3,+,6.56,3.80E-02
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226),3,2,0.3,+,6.56,3.80E-02
maintenance of Golgi location (GO:0051684),3,2,0.3,+,6.56,3.80E-02
meiotic DNA double-strand break processing (GO:0000706),3,2,0.3,+,6.56,3.80E-02
cartilage homeostasis (GO:1990079),3,2,0.3,+,6.56,3.80E-02
pigment metabolic process involved in pigmentation (GO:0043474),3,2,0.3,+,6.56,3.80E-02
establishment or maintenance of actin cytoskeleton polarity (GO:0030950),3,2,0.3,+,6.56,3.80E-02
natural killer cell chemotaxis (GO:0035747),3,2,0.3,+,6.56,3.80E-02
"response to 3,3',5-triiodo-L-thyronine (GO:1905242)",3,2,0.3,+,6.56,3.80E-02
pigment metabolic process involved in developmental pigmentation (GO:0043324),3,2,0.3,+,6.56,3.80E-02
positive regulation of intracellular mRNA localization (GO:1904582),3,2,0.3,+,6.56,3.80E-02
regulation of intracellular mRNA localization (GO:1904580),3,2,0.3,+,6.56,3.80E-02
response to 17alpha-ethynylestradiol (GO:1904486),3,2,0.3,+,6.56,3.80E-02
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612),3,2,0.3,+,6.56,3.80E-02
positive regulation of saliva secretion (GO:0046878),3,2,0.3,+,6.56,3.80E-02
regulation of saliva secretion (GO:0046877),6,4,0.61,+,6.56,3.55E-03
eye pigment metabolic process (GO:0042441),3,2,0.3,+,6.56,3.80E-02
regulation of polynucleotide adenylyltransferase activity (GO:1904245),3,2,0.3,+,6.56,3.80E-02
cuticle development (GO:0042335),3,2,0.3,+,6.56,3.80E-02
positive regulation of microglial cell mediated cytotoxicity (GO:1904151),3,2,0.3,+,6.56,3.80E-02
regulation of microglial cell mediated cytotoxicity (GO:1904149),3,2,0.3,+,6.56,3.80E-02
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513),3,2,0.3,+,6.56,3.80E-02
positive regulation of translational fidelity (GO:0045903),3,2,0.3,+,6.56,3.80E-02
secretion by lung epithelial cell involved in lung growth (GO:0061033),3,2,0.3,+,6.56,3.80E-02
specification of axis polarity (GO:0065001),5,3,0.51,+,5.9,1.50E-02
regulation of binding of sperm to zona pellucida (GO:2000359),5,3,0.51,+,5.9,1.50E-02
formation of anatomical boundary (GO:0048859),5,3,0.51,+,5.9,1.50E-02
sensory perception of sour taste (GO:0050915),5,3,0.51,+,5.9,1.50E-02
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736),5,3,0.51,+,5.9,1.50E-02
brush border assembly (GO:1904970),5,3,0.51,+,5.9,1.50E-02
negative regulation of cardiac muscle contraction (GO:0055118),5,3,0.51,+,5.9,1.50E-02
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",7,4,0.71,+,5.62,6.08E-03
"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",6,3,0.61,+,4.92,2.41E-02
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196),6,3,0.61,+,4.92,2.41E-02
regulation of keratinocyte apoptotic process (GO:1902172),6,3,0.61,+,4.92,2.41E-02
tripeptide transport (GO:0042939),6,3,0.61,+,4.92,2.41E-02
determination of left/right asymmetry in lateral mesoderm (GO:0003140),6,3,0.61,+,4.92,2.41E-02
negative regulation of intestinal cholesterol absorption (GO:0045796),2,1,0.2,+,4.92,1.84E-01
positive regulation of calcium:sodium antiporter activity (GO:1903281),2,1,0.2,+,4.92,1.84E-01
D-amino acid catabolic process (GO:0019478),2,1,0.2,+,4.92,1.84E-01
posterior midgut development (GO:0007497),2,1,0.2,+,4.92,1.84E-01
pronephric nephron tubule development (GO:0039020),2,1,0.2,+,4.92,1.84E-01
prevention of polyspermy (GO:0060468),2,1,0.2,+,4.92,1.84E-01
negative regulation of fertilization (GO:0060467),2,1,0.2,+,4.92,1.84E-01
ganglion mother cell fate determination (GO:0007402),2,1,0.2,+,4.92,1.84E-01
right lung development (GO:0060458),2,1,0.2,+,4.92,1.84E-01
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166),2,1,0.2,+,4.92,1.84E-01
negative regulation of sterol import (GO:2000910),2,1,0.2,+,4.92,1.84E-01
positive regulation of lens fiber cell differentiation (GO:1902748),2,1,0.2,+,4.92,1.84E-01
positive regulation of vitamin metabolic process (GO:0046136),4,2,0.41,+,4.92,6.33E-02
negative regulation of chondrocyte proliferation (GO:1902731),4,2,0.41,+,4.92,6.33E-02
response to ozone (GO:0010193),4,2,0.41,+,4.92,6.33E-02
leukotriene production involved in inflammatory response (GO:0002540),2,1,0.2,+,4.92,1.84E-01
arachidonic acid metabolite production involved in inflammatory response (GO:0002538),2,1,0.2,+,4.92,1.84E-01
negative regulation of megakaryocyte differentiation (GO:0045653),4,2,0.41,+,4.92,6.33E-02
positive regulation of dopamine biosynthetic process (GO:1903181),2,1,0.2,+,4.92,1.84E-01
regulation of dopamine biosynthetic process (GO:1903179),2,1,0.2,+,4.92,1.84E-01
fatty alcohol metabolic process (GO:1903173),2,1,0.2,+,4.92,1.84E-01
cysteine biosynthetic process (GO:0019344),2,1,0.2,+,4.92,1.84E-01
cysteine biosynthetic process via cystathionine (GO:0019343),2,1,0.2,+,4.92,1.84E-01
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121),4,2,0.41,+,4.92,6.33E-02
"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",4,2,0.41,+,4.92,6.33E-02
oculomotor nerve formation (GO:0021623),2,1,0.2,+,4.92,1.84E-01
oculomotor nerve morphogenesis (GO:0021622),2,1,0.2,+,4.92,1.84E-01
regulation of DNA strand elongation (GO:0060382),2,1,0.2,+,4.92,1.84E-01
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301),2,1,0.2,+,4.92,1.84E-01
arsonoacetate metabolic process (GO:0018872),2,1,0.2,+,4.92,1.84E-01
cellular cadmium ion homeostasis (GO:0006876),2,1,0.2,+,4.92,1.84E-01
macrophage apoptotic process (GO:0071888),2,1,0.2,+,4.92,1.84E-01
Norrin signaling pathway (GO:0110135),2,1,0.2,+,4.92,1.84E-01
acyl carnitine transmembrane transport (GO:1902616),2,1,0.2,+,4.92,1.84E-01
negative regulation of animal organ morphogenesis (GO:0110111),2,1,0.2,+,4.92,1.84E-01
immune response to tumor cell (GO:0002418),4,2,0.41,+,4.92,6.33E-02
negative regulation of protein K48-linked deubiquitination (GO:1903094),2,1,0.2,+,4.92,1.84E-01
L-methionine salvage from S-adenosylmethionine (GO:0019284),2,1,0.2,+,4.92,1.84E-01
glycine biosynthetic process from serine (GO:0019264),2,1,0.2,+,4.92,1.84E-01
regulation of melanosome organization (GO:1903056),2,1,0.2,+,4.92,1.84E-01
spermatogonial cell division (GO:0007284),2,1,0.2,+,4.92,1.84E-01
positive regulation of opsonization (GO:1903028),2,1,0.2,+,4.92,1.84E-01
thigmotaxis (GO:0001966),2,1,0.2,+,4.92,1.84E-01
xenobiotic glucuronidation (GO:0052697),2,1,0.2,+,4.92,1.84E-01
signal transduction downstream of smoothened (GO:0007227),4,2,0.41,+,4.92,6.33E-02
positive regulation of oocyte development (GO:0060282),2,1,0.2,+,4.92,1.84E-01
positive regulation of sphingomyelin catabolic process (GO:2000755),2,1,0.2,+,4.92,1.84E-01
regulation of sphingomyelin catabolic process (GO:2000754),2,1,0.2,+,4.92,1.84E-01
negative regulation of nuclear cell cycle DNA replication (GO:1902576),2,1,0.2,+,4.92,1.84E-01
positive regulation of hippocampal neuron apoptotic process (GO:0110090),2,1,0.2,+,4.92,1.84E-01
positive regulation of dense core granule biogenesis (GO:2000707),2,1,0.2,+,4.92,1.84E-01
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395),2,1,0.2,+,4.92,1.84E-01
immune response in gut-associated lymphoid tissue (GO:0002387),2,1,0.2,+,4.92,1.84E-01
leukotriene transport (GO:0071716),2,1,0.2,+,4.92,1.84E-01
mesonephric duct formation (GO:0072181),2,1,0.2,+,4.92,1.84E-01
posterior mesonephric tubule development (GO:0072166),2,1,0.2,+,4.92,1.84E-01
nephron tubule epithelial cell differentiation (GO:0072160),2,1,0.2,+,4.92,1.84E-01
trophectodermal cellular morphogenesis (GO:0001831),2,1,0.2,+,4.92,1.84E-01
negative regulation of early endosome to late endosome transport (GO:2000642),2,1,0.2,+,4.92,1.84E-01
pronephros morphogenesis (GO:0072114),2,1,0.2,+,4.92,1.84E-01
somatotropin secreting cell development (GO:0060133),2,1,0.2,+,4.92,1.84E-01
corticotropin hormone secreting cell differentiation (GO:0060128),2,1,0.2,+,4.92,1.84E-01
negative regulation of growth hormone secretion (GO:0060125),2,1,0.2,+,4.92,1.84E-01
positive regulation of activin receptor signaling pathway (GO:0032927),8,4,0.81,+,4.92,9.58E-03
positive regulation of transforming growth factor beta2 production (GO:0032915),2,1,0.2,+,4.92,1.84E-01
nerve growth factor production (GO:0032902),2,1,0.2,+,4.92,1.84E-01
smooth muscle cell chemotaxis (GO:0071670),2,1,0.2,+,4.92,1.84E-01
positive regulation of inward rectifier potassium channel activity (GO:1901980),2,1,0.2,+,4.92,1.84E-01
positive regulation of metanephric ureteric bud development (GO:2001076),2,1,0.2,+,4.92,1.84E-01
regulation of metanephric ureteric bud development (GO:2001074),2,1,0.2,+,4.92,1.84E-01
calcium ion regulated lysosome exocytosis (GO:1990927),2,1,0.2,+,4.92,1.84E-01
short-term synaptic potentiation (GO:1990926),2,1,0.2,+,4.92,1.84E-01
defense response to nematode (GO:0002215),2,1,0.2,+,4.92,1.84E-01
positive regulation of anterograde dense core granule transport (GO:1901953),2,1,0.2,+,4.92,1.84E-01
regulation of anterograde dense core granule transport (GO:1901951),2,1,0.2,+,4.92,1.84E-01
early viral transcription (GO:0019085),2,1,0.2,+,4.92,1.84E-01
regulation of branch elongation involved in ureteric bud branching (GO:0072095),4,2,0.41,+,4.92,6.33E-02
phytol metabolic process (GO:0033306),2,1,0.2,+,4.92,1.84E-01
protein transport into plasma membrane raft (GO:0044861),2,1,0.2,+,4.92,1.84E-01
neurotrophin production (GO:0032898),2,1,0.2,+,4.92,1.84E-01
urokinase plasminogen activator signaling pathway (GO:0038195),2,1,0.2,+,4.92,1.84E-01
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558),2,1,0.2,+,4.92,1.84E-01
regulation of immunoglobulin production in mucosal tissue (GO:2000557),2,1,0.2,+,4.92,1.84E-01
positive regulation of B cell chemotaxis (GO:2000538),2,1,0.2,+,4.92,1.84E-01
regulation of B cell chemotaxis (GO:2000537),2,1,0.2,+,4.92,1.84E-01
negative regulation of tRNA catabolic process (GO:1902371),2,1,0.2,+,4.92,1.84E-01
regulation of tRNA catabolic process (GO:1902370),2,1,0.2,+,4.92,1.84E-01
macrophage colony-stimulating factor signaling pathway (GO:0038145),4,2,0.41,+,4.92,6.33E-02
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)",2,1,0.2,+,4.92,1.84E-01
"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)",2,1,0.2,+,4.92,1.84E-01
negative regulation of natural killer cell chemotaxis (GO:2000502),2,1,0.2,+,4.92,1.84E-01
melanin biosynthetic process from tyrosine (GO:0006583),2,1,0.2,+,4.92,1.84E-01
ethanolamine metabolic process (GO:0006580),2,1,0.2,+,4.92,1.84E-01
toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123),4,2,0.41,+,4.92,6.33E-02
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116),4,2,0.41,+,4.92,6.33E-02
L-serine catabolic process (GO:0006565),4,2,0.41,+,4.92,6.33E-02
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804),2,1,0.2,+,4.92,1.84E-01
arginine biosynthetic process (GO:0006526),4,2,0.41,+,4.92,6.33E-02
positive regulation of relaxation of cardiac muscle (GO:1901899),2,1,0.2,+,4.92,1.84E-01
negative regulation of relaxation of cardiac muscle (GO:1901898),2,1,0.2,+,4.92,1.84E-01
tRNA wobble position uridine thiolation (GO:0002143),4,2,0.41,+,4.92,6.33E-02
glutamate reuptake (GO:0051935),2,1,0.2,+,4.92,1.84E-01
catecholamine uptake involved in synaptic transmission (GO:0051934),4,2,0.41,+,4.92,6.33E-02
amino acid neurotransmitter reuptake (GO:0051933),2,1,0.2,+,4.92,1.84E-01
abortive mitotic cell cycle (GO:0033277),2,1,0.2,+,4.92,1.84E-01
intermicrovillar adhesion (GO:0090675),2,1,0.2,+,4.92,1.84E-01
DNA clamp unloading (GO:0090618),2,1,0.2,+,4.92,1.84E-01
regulation of opioid receptor signaling pathway (GO:2000474),2,1,0.2,+,4.92,1.84E-01
uropod organization (GO:0032796),2,1,0.2,+,4.92,1.84E-01
bile acid secretion (GO:0032782),4,2,0.41,+,4.92,6.33E-02
DNA methylation on adenine (GO:0032775),2,1,0.2,+,4.92,1.84E-01
mast cell cytokine production (GO:0032762),2,1,0.2,+,4.92,1.84E-01
peptidyl-tyrosine sulfation (GO:0006478),2,1,0.2,+,4.92,1.84E-01
cellular response to blue light (GO:0071483),2,1,0.2,+,4.92,1.84E-01
cellular response to salt stress (GO:0071472),8,4,0.81,+,4.92,9.58E-03
cellular response to alkaline pH (GO:0071469),2,1,0.2,+,4.92,1.84E-01
cellular response to cell-matrix adhesion (GO:0071460),2,1,0.2,+,4.92,1.84E-01
extraocular skeletal muscle development (GO:0002074),2,1,0.2,+,4.92,1.84E-01
pigment granule aggregation in cell center (GO:0051877),2,1,0.2,+,4.92,1.84E-01
general adaptation syndrome (GO:0051866),2,1,0.2,+,4.92,1.84E-01
snRNA export from nucleus (GO:0006408),2,1,0.2,+,4.92,1.84E-01
regulation of blood volume by renal aldosterone (GO:0002017),2,1,0.2,+,4.92,1.84E-01
xylulose biosynthetic process (GO:0005999),2,1,0.2,+,4.92,1.84E-01
male anatomical structure morphogenesis (GO:0090598),4,2,0.41,+,4.92,6.33E-02
positive regulation of neutrophil mediated killing of fungus (GO:0070965),2,1,0.2,+,4.92,1.84E-01
regulation of neutrophil mediated killing of fungus (GO:0070953),2,1,0.2,+,4.92,1.84E-01
peptide amidation (GO:0001519),2,1,0.2,+,4.92,1.84E-01
negative regulation of binding of sperm to zona pellucida (GO:2000360),4,2,0.41,+,4.92,6.33E-02
negative regulation of ovarian follicle development (GO:2000355),2,1,0.2,+,4.92,1.84E-01
negative regulation of T-helper 17 cell lineage commitment (GO:2000329),2,1,0.2,+,4.92,1.84E-01
termination of mitochondrial transcription (GO:0006393),2,1,0.2,+,4.92,1.84E-01
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309),2,1,0.2,+,4.92,1.84E-01
protein-pyridoxal-5-phosphate linkage (GO:0018352),2,1,0.2,+,4.92,1.84E-01
interleukin-21 production (GO:0032625),2,1,0.2,+,4.92,1.84E-01
interleukin-12 production (GO:0032615),2,1,0.2,+,4.92,1.84E-01
enzyme active site formation (GO:0018307),2,1,0.2,+,4.92,1.84E-01
histone H3-K9 deacetylation (GO:1990619),2,1,0.2,+,4.92,1.84E-01
positive regulation of presynaptic membrane organization (GO:1901631),2,1,0.2,+,4.92,1.84E-01
regulation of presynaptic membrane organization (GO:1901629),2,1,0.2,+,4.92,1.84E-01
myeloid cell apoptotic process (GO:0033028),4,2,0.41,+,4.92,6.33E-02
oxidative stress-induced premature senescence (GO:0090403),4,2,0.41,+,4.92,6.33E-02
oncogene-induced cell senescence (GO:0090402),2,1,0.2,+,4.92,1.84E-01
hydrogen sulfide biosynthetic process (GO:0070814),2,1,0.2,+,4.92,1.84E-01
regulation of oxidative phosphorylation uncoupler activity (GO:2000275),4,2,0.41,+,4.92,6.33E-02
cellular oligosaccharide catabolic process (GO:0051692),2,1,0.2,+,4.92,1.84E-01
cellular oligosaccharide metabolic process (GO:0051691),2,1,0.2,+,4.92,1.84E-01
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931),2,1,0.2,+,4.92,1.84E-01
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916),2,1,0.2,+,4.92,1.84E-01
regulation of calcium ion export across plasma membrane (GO:1905912),2,1,0.2,+,4.92,1.84E-01
negative regulation of DNA demethylation (GO:1901536),2,1,0.2,+,4.92,1.84E-01
response to biotin (GO:0070781),2,1,0.2,+,4.92,1.84E-01
hypophysis morphogenesis (GO:0048850),2,1,0.2,+,4.92,1.84E-01
age-dependent response to oxidative stress involved in chronological cell aging (GO:0001324),2,1,0.2,+,4.92,1.84E-01
age-dependent general metabolic decline involved in chronological cell aging (GO:0001323),2,1,0.2,+,4.92,1.84E-01
enucleate erythrocyte development (GO:0048822),2,1,0.2,+,4.92,1.84E-01
negative regulation of ubiquitin-specific protease activity (GO:2000157),2,1,0.2,+,4.92,1.84E-01
male genitalia morphogenesis (GO:0048808),4,2,0.41,+,4.92,6.33E-02
interleukin-10-mediated signaling pathway (GO:0140105),2,1,0.2,+,4.92,1.84E-01
peptidyl-aspartic acid modification (GO:0018197),2,1,0.2,+,4.92,1.84E-01
nerve growth factor processing (GO:0032455),4,2,0.41,+,4.92,6.33E-02
regulation of sodium-dependent phosphate transport (GO:2000118),4,2,0.41,+,4.92,6.33E-02
negative regulation of sodium:proton antiporter activity (GO:0032416),2,1,0.2,+,4.92,1.84E-01
dopamine uptake involved in synaptic transmission (GO:0051583),4,2,0.41,+,4.92,6.33E-02
histone H2B acetylation (GO:0043969),4,2,0.41,+,4.92,6.33E-02
positive regulation of lymphangiogenesis (GO:1901492),2,1,0.2,+,4.92,1.84E-01
"adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)",2,1,0.2,+,4.92,1.84E-01
regulation of chromatin silencing at telomere (GO:0031938),2,1,0.2,+,4.92,1.84E-01
negative regulation of mitochondrial DNA replication (GO:0090298),2,1,0.2,+,4.92,1.84E-01
regulation of mitochondrial DNA replication (GO:0090296),4,2,0.41,+,4.92,6.33E-02
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265),2,1,0.2,+,4.92,1.84E-01
intralumenal vesicle formation (GO:0070676),2,1,0.2,+,4.92,1.84E-01
positive regulation of tetrapyrrole metabolic process (GO:1901403),2,1,0.2,+,4.92,1.84E-01
canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335),2,1,0.2,+,4.92,1.84E-01
regulation of transcription involved in anterior/posterior axis specification (GO:0044324),2,1,0.2,+,4.92,1.84E-01
positive regulation of DNA helicase activity (GO:1905776),2,1,0.2,+,4.92,1.84E-01
meiotic DNA recombinase assembly (GO:0000707),2,1,0.2,+,4.92,1.84E-01
regulation of transforming growth factor beta1 activation (GO:1901392),2,1,0.2,+,4.92,1.84E-01
negative regulation of chorionic trophoblast cell proliferation (GO:1901383),2,1,0.2,+,4.92,1.84E-01
organic heteropentacyclic compound catabolic process (GO:1901377),2,1,0.2,+,4.92,1.84E-01
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191),2,1,0.2,+,4.92,1.84E-01
regulation of inhibitory synapse assembly (GO:1905702),4,2,0.41,+,4.92,6.33E-02
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976),2,1,0.2,+,4.92,1.84E-01
vesicle-mediated cholesterol transport (GO:0090119),2,1,0.2,+,4.92,1.84E-01
telomere assembly (GO:0032202),4,2,0.41,+,4.92,6.33E-02
regulation of polysome binding (GO:1905696),2,1,0.2,+,4.92,1.84E-01
cellular response to potassium ion starvation (GO:0051365),2,1,0.2,+,4.92,1.84E-01
proline import across plasma membrane (GO:1905647),2,1,0.2,+,4.92,1.84E-01
positive regulation of DNA methylation (GO:1905643),4,2,0.41,+,4.92,6.33E-02
detection of hypoxia (GO:0070483),2,1,0.2,+,4.92,1.84E-01
thyroid-stimulating hormone secretion (GO:0070460),2,1,0.2,+,4.92,1.84E-01
establishment of animal organ orientation (GO:0048561),2,1,0.2,+,4.92,1.84E-01
antibiotic metabolic process (GO:0016999),2,1,0.2,+,4.92,1.84E-01
hydrocarbon catabolic process (GO:0120253),2,1,0.2,+,4.92,1.84E-01
protein deglycation (GO:0036525),2,1,0.2,+,4.92,1.84E-01
maintenance of unfolded protein (GO:0036506),2,1,0.2,+,4.92,1.84E-01
blue light signaling pathway (GO:0009785),2,1,0.2,+,4.92,1.84E-01
iron ion import across plasma membrane (GO:0098711),2,1,0.2,+,4.92,1.84E-01
telomeric loop formation (GO:0031627),2,1,0.2,+,4.92,1.84E-01
positive regulation of ERK5 cascade (GO:0070378),2,1,0.2,+,4.92,1.84E-01
regulation of ERK5 cascade (GO:0070376),2,1,0.2,+,4.92,1.84E-01
positive regulation of white fat cell proliferation (GO:0070352),2,1,0.2,+,4.92,1.84E-01
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492),2,1,0.2,+,4.92,1.84E-01
tRNA stabilization (GO:0036416),2,1,0.2,+,4.92,1.84E-01
regulation of tRNA stability (GO:0036415),2,1,0.2,+,4.92,1.84E-01
histone H3-R26 citrullination (GO:0036413),2,1,0.2,+,4.92,1.84E-01
box H/ACA snoRNP assembly (GO:0000493),2,1,0.2,+,4.92,1.84E-01
positive regulation of DNA duplex unwinding (GO:1905464),2,1,0.2,+,4.92,1.84E-01
stress-induced mitochondrial fusion (GO:1990046),2,1,0.2,+,4.92,1.84E-01
response to high light intensity (GO:0009644),2,1,0.2,+,4.92,1.84E-01
mesendoderm development (GO:0048382),4,2,0.41,+,4.92,6.33E-02
axial mesoderm formation (GO:0048320),2,1,0.2,+,4.92,1.84E-01
generation of catalytic spliceosome for first transesterification step (GO:0000349),2,1,0.2,+,4.92,1.84E-01
ceramide phosphoethanolamine biosynthetic process (GO:1905373),2,1,0.2,+,4.92,1.84E-01
ceramide phosphoethanolamine metabolic process (GO:1905371),2,1,0.2,+,4.92,1.84E-01
cellular alkene metabolic process (GO:0043449),2,1,0.2,+,4.92,1.84E-01
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",2,1,0.2,+,4.92,1.84E-01
regulation of calcium-independent cell-cell adhesion (GO:0051040),2,1,0.2,+,4.92,1.84E-01
skeletal muscle fiber differentiation (GO:0098528),2,1,0.2,+,4.92,1.84E-01
adrenal cortex formation (GO:0035802),2,1,0.2,+,4.92,1.84E-01
positive regulation of macropinocytosis (GO:1905303),2,1,0.2,+,4.92,1.84E-01
endothelial to hematopoietic transition (GO:0098508),2,1,0.2,+,4.92,1.84E-01
insecticide metabolic process (GO:0017143),2,1,0.2,+,4.92,1.84E-01
D-serine metabolic process (GO:0070178),2,1,0.2,+,4.92,1.84E-01
positive regulation of excitatory synapse assembly (GO:1904891),2,1,0.2,+,4.92,1.84E-01
DNA rewinding (GO:0036292),2,1,0.2,+,4.92,1.84E-01
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),4,2,0.41,+,4.92,6.33E-02
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104),2,1,0.2,+,4.92,1.84E-01
cellular response to menadione (GO:0036245),2,1,0.2,+,4.92,1.84E-01
positive regulation of dense core granule transport (GO:1904811),2,1,0.2,+,4.92,1.84E-01
regulation of dense core granule transport (GO:1904809),2,1,0.2,+,4.92,1.84E-01
"nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)",2,1,0.2,+,4.92,1.84E-01
mycotoxin catabolic process (GO:0043387),2,1,0.2,+,4.92,1.84E-01
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274),4,2,0.41,+,4.92,6.33E-02
mesangial cell-matrix adhesion (GO:0035759),2,1,0.2,+,4.92,1.84E-01
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259),2,1,0.2,+,4.92,1.84E-01
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258),2,1,0.2,+,4.92,1.84E-01
atrioventricular canal morphogenesis (GO:1905222),2,1,0.2,+,4.92,1.84E-01
memory T cell activation (GO:0035709),2,1,0.2,+,4.92,1.84E-01
negative regulation of neutrophil degranulation (GO:0043314),2,1,0.2,+,4.92,1.84E-01
toxin catabolic process (GO:0009407),2,1,0.2,+,4.92,1.84E-01
tear secretion (GO:0070075),2,1,0.2,+,4.92,1.84E-01
negative regulation of protein localization to centrosome (GO:1904780),2,1,0.2,+,4.92,1.84E-01
negative regulation of intestinal lipid absorption (GO:1904730),2,1,0.2,+,4.92,1.84E-01
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669),2,1,0.2,+,4.92,1.84E-01
TRAM-dependent toll-like receptor signaling pathway (GO:0035668),2,1,0.2,+,4.92,1.84E-01
intrahepatic bile duct development (GO:0035622),2,1,0.2,+,4.92,1.84E-01
pseudopodium organization (GO:0031268),2,1,0.2,+,4.92,1.84E-01
protein side chain deglutamylation (GO:0035610),4,2,0.41,+,4.92,6.33E-02
eye pigmentation (GO:0048069),4,2,0.41,+,4.92,6.33E-02
uterine wall breakdown (GO:0042704),2,1,0.2,+,4.92,1.84E-01
negative regulation of phenotypic switching (GO:1900240),2,1,0.2,+,4.92,1.84E-01
regulation of astrocyte activation (GO:0061888),2,1,0.2,+,4.92,1.84E-01
positive regulation of mini excitatory postsynaptic potential (GO:0061885),2,1,0.2,+,4.92,1.84E-01
regulation of mini excitatory postsynaptic potential (GO:0061884),2,1,0.2,+,4.92,1.84E-01
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224),2,1,0.2,+,4.92,1.84E-01
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220),2,1,0.2,+,4.92,1.84E-01
positive regulation of cardiolipin metabolic process (GO:1900210),2,1,0.2,+,4.92,1.84E-01
oxidative single-stranded DNA demethylation (GO:0035552),2,1,0.2,+,4.92,1.84E-01
peptide modification (GO:0031179),2,1,0.2,+,4.92,1.84E-01
regulation of antifungal innate immune response (GO:1905034),2,1,0.2,+,4.92,1.84E-01
positive regulation of myosin light chain kinase activity (GO:0035505),2,1,0.2,+,4.92,1.84E-01
regulation of myosin light chain kinase activity (GO:0035504),2,1,0.2,+,4.92,1.84E-01
10-formyltetrahydrofolate catabolic process (GO:0009258),2,1,0.2,+,4.92,1.84E-01
short-chain fatty acid transport (GO:0015912),2,1,0.2,+,4.92,1.84E-01
positive regulation of cell fate specification (GO:0042660),2,1,0.2,+,4.92,1.84E-01
L-proline transmembrane transport (GO:1904555),2,1,0.2,+,4.92,1.84E-01
regulation of defense response to fungus (GO:1900150),4,2,0.41,+,4.92,6.33E-02
positive regulation of Schwann cell migration (GO:1900149),2,1,0.2,+,4.92,1.84E-01
regulation of Schwann cell migration (GO:1900147),2,1,0.2,+,4.92,1.84E-01
negative regulation of arachidonic acid secretion (GO:1900139),2,1,0.2,+,4.92,1.84E-01
negative regulation of phospholipase A2 activity (GO:1900138),2,1,0.2,+,4.92,1.84E-01
negative regulation of histone H3-K9 dimethylation (GO:1900110),2,1,0.2,+,4.92,1.84E-01
FAD transport (GO:0015883),2,1,0.2,+,4.92,1.84E-01
coenzyme A transport (GO:0015880),2,1,0.2,+,4.92,1.84E-01
maintenance of rDNA (GO:0043007),2,1,0.2,+,4.92,1.84E-01
negative regulation of matrix metallopeptidase secretion (GO:1904465),2,1,0.2,+,4.92,1.84E-01
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998),4,2,0.41,+,4.92,6.33E-02
positive regulation of iron ion import across plasma membrane (GO:1904440),2,1,0.2,+,4.92,1.84E-01
regulation of L-arginine import (GO:0010963),2,1,0.2,+,4.92,1.84E-01
"O-glycan processing, core 1 (GO:0016267)",2,1,0.2,+,4.92,1.84E-01
embryonic genitalia morphogenesis (GO:0030538),2,1,0.2,+,4.92,1.84E-01
negative regulation of intestinal phytosterol absorption (GO:0010949),2,1,0.2,+,4.92,1.84E-01
carbon dioxide transmembrane transport (GO:0035378),2,1,0.2,+,4.92,1.84E-01
UDP-glucose transmembrane transport (GO:0015786),2,1,0.2,+,4.92,1.84E-01
primary palate development (GO:1903929),2,1,0.2,+,4.92,1.84E-01
FAD transmembrane transport (GO:0035350),2,1,0.2,+,4.92,1.84E-01
coenzyme A transmembrane transport (GO:0035349),2,1,0.2,+,4.92,1.84E-01
leucine biosynthetic process (GO:0009098),2,1,0.2,+,4.92,1.84E-01
detection of triacyl bacterial lipopeptide (GO:0042495),2,1,0.2,+,4.92,1.84E-01
positive regulation of neuromuscular junction development (GO:1904398),2,1,0.2,+,4.92,1.84E-01
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489),2,1,0.2,+,4.92,1.84E-01
negative regulation of odontogenesis (GO:0042483),2,1,0.2,+,4.92,1.84E-01
negative regulation of eye photoreceptor cell development (GO:0042480),2,1,0.2,+,4.92,1.84E-01
regulation of eye photoreceptor cell development (GO:0042478),2,1,0.2,+,4.92,1.84E-01
maintenance of unfolded protein involved in ERAD pathway (GO:1904378),2,1,0.2,+,4.92,1.84E-01
response to kainic acid (GO:1904373),2,1,0.2,+,4.92,1.84E-01
positive regulation of mitotic sister chromatid segregation (GO:0062033),2,1,0.2,+,4.92,1.84E-01
positive regulation of stress granule assembly (GO:0062029),2,1,0.2,+,4.92,1.84E-01
synaptic vesicle to endosome fusion (GO:0016189),2,1,0.2,+,4.92,1.84E-01
thymus epithelium morphogenesis (GO:0097536),2,1,0.2,+,4.92,1.84E-01
lymphoid lineage cell migration into thymus (GO:0097535),2,1,0.2,+,4.92,1.84E-01
lymphoid lineage cell migration (GO:0097534),2,1,0.2,+,4.92,1.84E-01
cholesterol storage (GO:0010878),2,1,0.2,+,4.92,1.84E-01
execution phase of necroptosis (GO:0097528),2,1,0.2,+,4.92,1.84E-01
regulation of chromatin disassembly (GO:0010848),2,1,0.2,+,4.92,1.84E-01
intestinal epithelial cell migration (GO:0061582),2,1,0.2,+,4.92,1.84E-01
xanthophyll metabolic process (GO:0016122),2,1,0.2,+,4.92,1.84E-01
carotenoid metabolic process (GO:0016116),2,1,0.2,+,4.92,1.84E-01
negative regulation of ATF6-mediated unfolded protein response (GO:1903892),2,1,0.2,+,4.92,1.84E-01
tetraterpenoid metabolic process (GO:0016108),2,1,0.2,+,4.92,1.84E-01
early endosome to recycling endosome transport (GO:0061502),2,1,0.2,+,4.92,1.84E-01
glycine import across plasma membrane (GO:1903804),2,1,0.2,+,4.92,1.84E-01
positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074),2,1,0.2,+,4.92,1.84E-01
regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073),2,1,0.2,+,4.92,1.84E-01
positive regulation of iron ion transmembrane transport (GO:0034761),2,1,0.2,+,4.92,1.84E-01
L-proline import across plasma membrane (GO:1904271),2,1,0.2,+,4.92,1.84E-01
positive regulation of iron ion transport (GO:0034758),2,1,0.2,+,4.92,1.84E-01
retinal cone cell apoptotic process (GO:0097474),2,1,0.2,+,4.92,1.84E-01
fructosamine metabolic process (GO:0030389),2,1,0.2,+,4.92,1.84E-01
regulation of DNA double-strand break processing (GO:1903775),2,1,0.2,+,4.92,1.84E-01
mesenchymal cell differentiation involved in lung development (GO:0060915),2,1,0.2,+,4.92,1.84E-01
drug export (GO:0046618),2,1,0.2,+,4.92,1.84E-01
terpene metabolic process (GO:0042214),2,1,0.2,+,4.92,1.84E-01
positive regulation of protein O-linked glycosylation (GO:1904100),2,1,0.2,+,4.92,1.84E-01
inferior colliculus development (GO:0061379),2,1,0.2,+,4.92,1.84E-01
corpora quadrigemina development (GO:0061378),2,1,0.2,+,4.92,1.84E-01
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317),2,1,0.2,+,4.92,1.84E-01
positive regulation of chaperone-mediated protein folding (GO:1903646),2,1,0.2,+,4.92,1.84E-01
smooth muscle cell-matrix adhesion (GO:0061302),2,1,0.2,+,4.92,1.84E-01
negative regulation of protein tyrosine phosphatase activity (GO:1903614),2,1,0.2,+,4.92,1.84E-01
leading edge cell differentiation (GO:0035026),2,1,0.2,+,4.92,1.84E-01
semicircular canal formation (GO:0060876),2,1,0.2,+,4.92,1.84E-01
optic vesicle morphogenesis (GO:0003404),2,1,0.2,+,4.92,1.84E-01
regulation of protein O-linked glycosylation (GO:1904098),2,1,0.2,+,4.92,1.84E-01
urea homeostasis (GO:0097274),2,1,0.2,+,4.92,1.84E-01
creatinine homeostasis (GO:0097273),2,1,0.2,+,4.92,1.84E-01
nitric oxide transport (GO:0030185),2,1,0.2,+,4.92,1.84E-01
cellular response to methylglyoxal (GO:0097238),2,1,0.2,+,4.92,1.84E-01
negative regulation of collagen fibril organization (GO:1904027),2,1,0.2,+,4.92,1.84E-01
cellular response to Thyroglobulin triiodothyronine (GO:1904017),2,1,0.2,+,4.92,1.84E-01
response to Thyroglobulin triiodothyronine (GO:1904016),4,2,0.41,+,4.92,6.33E-02
negative regulation of membrane tubulation (GO:1903526),2,1,0.2,+,4.92,1.84E-01
positive regulation of single strand break repair (GO:1903518),2,1,0.2,+,4.92,1.84E-01
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366),2,1,0.2,+,4.92,1.84E-01
septum transversum development (GO:0003343),2,1,0.2,+,4.92,1.84E-01
proepicardium development (GO:0003342),2,1,0.2,+,4.92,1.84E-01
epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738),2,1,0.2,+,4.92,1.84E-01
positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876),2,1,0.2,+,4.92,1.84E-01
urate biosynthetic process (GO:0034418),2,1,0.2,+,4.92,1.84E-01
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),4,2,0.41,+,4.92,6.33E-02
cellular manganese ion homeostasis (GO:0030026),2,1,0.2,+,4.92,1.84E-01
taste bud development (GO:0061193),2,1,0.2,+,4.92,1.84E-01
negative regulation of mitotic cell cycle DNA replication (GO:1903464),2,1,0.2,+,4.92,1.84E-01
corticospinal neuron axon guidance (GO:0021966),2,1,0.2,+,4.92,1.84E-01
regulation of cholesterol transporter activity (GO:0060694),2,1,0.2,+,4.92,1.84E-01
negative regulation of female receptivity (GO:0007621),4,2,0.41,+,4.92,6.33E-02
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252),2,1,0.2,+,4.92,1.84E-01
branch elongation involved in salivary gland morphogenesis (GO:0060667),2,1,0.2,+,4.92,1.84E-01
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665),4,2,0.41,+,4.92,6.33E-02
submandibular salivary gland formation (GO:0060661),2,1,0.2,+,4.92,1.84E-01
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245),2,1,0.2,+,4.92,1.84E-01
cardiac atrium formation (GO:0003210),2,1,0.2,+,4.92,1.84E-01
negative regulation of cholesterol import (GO:0060621),2,1,0.2,+,4.92,1.84E-01
mammary gland bud formation (GO:0060615),2,1,0.2,+,4.92,1.84E-01
regulation of melanosome transport (GO:1902908),2,1,0.2,+,4.92,1.84E-01
dendritic cell dendrite assembly (GO:0097026),2,1,0.2,+,4.92,1.84E-01
primary alcohol biosynthetic process (GO:0034309),4,2,0.41,+,4.92,6.33E-02
lymphocyte migration into lymph node (GO:0097022),2,1,0.2,+,4.92,1.84E-01
female courtship behavior (GO:0008050),2,1,0.2,+,4.92,1.84E-01
eukaryotic translation initiation factor 4F complex assembly (GO:0097010),2,1,0.2,+,4.92,1.84E-01
regulation of phospholipid translocation (GO:0061091),4,2,0.41,+,4.92,6.33E-02
ciliary body morphogenesis (GO:0061073),4,2,0.41,+,4.92,6.33E-02
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384),2,1,0.2,+,4.92,1.84E-01
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383),2,1,0.2,+,4.92,1.84E-01
forebrain astrocyte development (GO:0021897),2,1,0.2,+,4.92,1.84E-01
forebrain astrocyte differentiation (GO:0021896),2,1,0.2,+,4.92,1.84E-01
visceral serous pericardium development (GO:0061032),2,1,0.2,+,4.92,1.84E-01
glutamate catabolic process to 2-oxoglutarate (GO:0019551),2,1,0.2,+,4.92,1.84E-01
glutamate catabolic process to aspartate (GO:0019550),2,1,0.2,+,4.92,1.84E-01
arginine catabolic process to ornithine (GO:0019547),2,1,0.2,+,4.92,1.84E-01
positive regulation of protein folding (GO:1903334),4,2,0.41,+,4.92,6.33E-02
negative regulation of tRNA metabolic process (GO:1903327),2,1,0.2,+,4.92,1.84E-01
regulation of tRNA metabolic process (GO:1903326),2,1,0.2,+,4.92,1.84E-01
L-methionine salvage from methylthioadenosine (GO:0019509),4,2,0.41,+,4.92,6.33E-02
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595),2,1,0.2,+,4.92,1.84E-01
Purkinje myocyte development (GO:0003165),2,1,0.2,+,4.92,1.84E-01
gonadal mesoderm development (GO:0007506),2,1,0.2,+,4.92,1.84E-01
positive regulation of vitamin D biosynthetic process (GO:0060557),2,1,0.2,+,4.92,1.84E-01
AMP transport (GO:0080121),2,1,0.2,+,4.92,1.84E-01
primary prostatic bud elongation (GO:0060516),2,1,0.2,+,4.92,1.84E-01
aflatoxin catabolic process (GO:0046223),2,1,0.2,+,4.92,1.84E-01
snoRNA splicing (GO:0034247),2,1,0.2,+,4.92,1.84E-01
spermidine catabolic process (GO:0046203),2,1,0.2,+,4.92,1.84E-01
enkephalin processing (GO:0034230),2,1,0.2,+,4.92,1.84E-01
natural killer cell mediated cytotoxicity (GO:0042267),20,9,2.03,+,4.43,2.64E-04
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),9,4,0.91,+,4.37,1.42E-02
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),7,3,0.71,+,4.22,3.55E-02
regulation of natural killer cell chemotaxis (GO:2000501),7,3,0.71,+,4.22,3.55E-02
response to methylmercury (GO:0051597),7,3,0.71,+,4.22,3.55E-02
regulation of cortisol biosynthetic process (GO:2000064),7,3,0.71,+,4.22,3.55E-02
regulation of voltage-gated sodium channel activity (GO:1905150),7,3,0.71,+,4.22,3.55E-02
cobalamin transport (GO:0015889),7,3,0.71,+,4.22,3.55E-02
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103),7,3,0.71,+,4.22,3.55E-02
vascular endothelial growth factor production (GO:0010573),7,3,0.71,+,4.22,3.55E-02
positive regulation of nuclear cell cycle DNA replication (GO:0010571),7,3,0.71,+,4.22,3.55E-02
dentinogenesis (GO:0097187),7,3,0.71,+,4.22,3.55E-02
forebrain radial glial cell differentiation (GO:0021861),7,3,0.71,+,4.22,3.55E-02
methylguanosine-cap decapping (GO:0110156),12,5,1.22,+,4.1,8.25E-03
natural killer cell mediated immunity (GO:0002228),22,9,2.24,+,4.02,5.21E-04
protein homotrimerization (GO:0070207),15,6,1.52,+,3.93,4.79E-03
ammonium transmembrane transport (GO:0072488),10,4,1.02,+,3.93,2.00E-02
ventral midline development (GO:0007418),5,2,0.51,+,3.93,9.27E-02
acrosomal vesicle exocytosis (GO:0060478),5,2,0.51,+,3.93,9.27E-02
toll-like receptor 7 signaling pathway (GO:0034154),5,2,0.51,+,3.93,9.27E-02
inflammatory cell apoptotic process (GO:0006925),5,2,0.51,+,3.93,9.27E-02
egg activation (GO:0007343),5,2,0.51,+,3.93,9.27E-02
oligopeptide transport (GO:0006857),10,4,1.02,+,3.93,2.00E-02
negative regulation of apoptotic process in bone marrow cell (GO:0071866),5,2,0.51,+,3.93,9.27E-02
regulation of apoptotic process in bone marrow cell (GO:0071865),5,2,0.51,+,3.93,9.27E-02
response to L-ascorbic acid (GO:0033591),5,2,0.51,+,3.93,9.27E-02
regulation of histone H2B ubiquitination (GO:2001166),5,2,0.51,+,3.93,9.27E-02
xenobiotic transport across blood-brain barrier (GO:1990962),5,2,0.51,+,3.93,9.27E-02
polyamine catabolic process (GO:0006598),5,2,0.51,+,3.93,9.27E-02
positive regulation of natural killer cell chemotaxis (GO:2000503),5,2,0.51,+,3.93,9.27E-02
cellular response to temperature stimulus (GO:0071502),5,2,0.51,+,3.93,9.27E-02
positive regulation of high voltage-gated calcium channel activity (GO:1901843),5,2,0.51,+,3.93,9.27E-02
inhibition of neuroepithelial cell differentiation (GO:0002085),5,2,0.51,+,3.93,9.27E-02
CRD-mediated mRNA stabilization (GO:0070934),5,2,0.51,+,3.93,9.27E-02
regulation of mesoderm development (GO:2000380),5,2,0.51,+,3.93,9.27E-02
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),5,2,0.51,+,3.93,9.27E-02
dipeptide import across plasma membrane (GO:0140206),5,2,0.51,+,3.93,9.27E-02
oligopeptide import across plasma membrane (GO:0140205),5,2,0.51,+,3.93,9.27E-02
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534),5,2,0.51,+,3.93,9.27E-02
citrate metabolic process (GO:0006101),5,2,0.51,+,3.93,9.27E-02
microtubule nucleation by interphase microtubule organizing center (GO:0051415),5,2,0.51,+,3.93,9.27E-02
negative regulation of macrophage migration (GO:1905522),10,4,1.02,+,3.93,2.00E-02
regulation of bile acid secretion (GO:0120188),5,2,0.51,+,3.93,9.27E-02
anterograde neuronal dense core vesicle transport (GO:1990048),5,2,0.51,+,3.93,9.27E-02
negative regulation of relaxation of muscle (GO:1901078),5,2,0.51,+,3.93,9.27E-02
mitochondrial DNA repair (GO:0043504),5,2,0.51,+,3.93,9.27E-02
response to blue light (GO:0009637),5,2,0.51,+,3.93,9.27E-02
positive regulation of helicase activity (GO:0051096),5,2,0.51,+,3.93,9.27E-02
dipeptide transport (GO:0042938),5,2,0.51,+,3.93,9.27E-02
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175),5,2,0.51,+,3.93,9.27E-02
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145),5,2,0.51,+,3.93,9.27E-02
tripeptide transmembrane transport (GO:0035443),5,2,0.51,+,3.93,9.27E-02
dipeptide transmembrane transport (GO:0035442),5,2,0.51,+,3.93,9.27E-02
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),5,2,0.51,+,3.93,9.27E-02
habituation (GO:0046959),5,2,0.51,+,3.93,9.27E-02
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972),5,2,0.51,+,3.93,9.27E-02
regulation of response to macrophage colony-stimulating factor (GO:1903969),5,2,0.51,+,3.93,9.27E-02
branched-chain amino acid biosynthetic process (GO:0009082),5,2,0.51,+,3.93,9.27E-02
sialic acid transport (GO:0015739),5,2,0.51,+,3.93,9.27E-02
regulation of synaptic growth at neuromuscular junction (GO:0008582),5,2,0.51,+,3.93,9.27E-02
trigeminal ganglion development (GO:0061551),5,2,0.51,+,3.93,9.27E-02
ammonium transport (GO:0015696),10,4,1.02,+,3.93,2.00E-02
negative regulation of TORC1 signaling (GO:1904262),10,4,1.02,+,3.93,2.00E-02
glutathione transport (GO:0034635),5,2,0.51,+,3.93,9.27E-02
regulation of phosphatidylinositol biosynthetic process (GO:0010511),5,2,0.51,+,3.93,9.27E-02
regulation of mesonephros development (GO:0061217),5,2,0.51,+,3.93,9.27E-02
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770),5,2,0.51,+,3.93,9.27E-02
regulation of T cell mediated immune response to tumor cell (GO:0002840),5,2,0.51,+,3.93,9.27E-02
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938),5,2,0.51,+,3.93,9.27E-02
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664),5,2,0.51,+,3.93,9.27E-02
tRNA thio-modification (GO:0034227),5,2,0.51,+,3.93,9.27E-02
RNA decapping (GO:0110154),13,5,1.32,+,3.78,1.13E-02
serine family amino acid catabolic process (GO:0009071),13,5,1.32,+,3.78,1.13E-02
ornithine metabolic process (GO:0006591),8,3,0.81,+,3.69,4.93E-02
p38MAPK cascade (GO:0038066),8,3,0.81,+,3.69,4.93E-02
negative regulation of interleukin-5 production (GO:0032714),8,3,0.81,+,3.69,4.93E-02
regulation of glucocorticoid biosynthetic process (GO:0031946),8,3,0.81,+,3.69,4.93E-02
regulation of lymphoid progenitor cell differentiation (GO:1905456),8,3,0.81,+,3.69,4.93E-02
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),8,3,0.81,+,3.69,4.93E-02
response to macrophage colony-stimulating factor (GO:0036005),8,3,0.81,+,3.69,4.93E-02
spermidine metabolic process (GO:0008216),8,3,0.81,+,3.69,4.93E-02
negative regulation of striated muscle contraction (GO:0045988),8,3,0.81,+,3.69,4.93E-02
negative regulation of T-helper 17 type immune response (GO:2000317),11,4,1.12,+,3.58,2.71E-02
positive regulation of astrocyte differentiation (GO:0048711),11,4,1.12,+,3.58,2.71E-02
SCF complex assembly (GO:0010265),6,2,0.61,+,3.28,1.25E-01
regulation of calcium:sodium antiporter activity (GO:1903279),3,1,0.3,+,3.28,2.63E-01
pronephric nephron development (GO:0039019),3,1,0.3,+,3.28,2.63E-01
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),6,2,0.61,+,3.28,1.25E-01
regulation of hydrogen peroxide-induced neuron death (GO:1903207),6,2,0.61,+,3.28,1.25E-01
negative regulation of forebrain neuron differentiation (GO:2000978),3,1,0.3,+,3.28,2.63E-01
negative regulation of pro-B cell differentiation (GO:2000974),3,1,0.3,+,3.28,2.63E-01
angiotensin-mediated drinking behavior (GO:0003051),3,1,0.3,+,3.28,2.63E-01
lung growth (GO:0060437),6,2,0.61,+,3.28,1.25E-01
bronchiole development (GO:0060435),3,1,0.3,+,3.28,2.63E-01
regulation of sterol import (GO:2000909),3,1,0.3,+,3.28,2.63E-01
nitrobenzene metabolic process (GO:0018916),3,1,0.3,+,3.28,2.63E-01
recycling endosome to Golgi transport (GO:0071955),3,1,0.3,+,3.28,2.63E-01
glucuronoside catabolic process (GO:0019391),3,1,0.3,+,3.28,2.63E-01
glucuronoside metabolic process (GO:0019389),3,1,0.3,+,3.28,2.63E-01
cell-cell adhesion mediated by integrin (GO:0033631),6,2,0.61,+,3.28,1.25E-01
negative regulation of integrin activation (GO:0033624),3,1,0.3,+,3.28,2.63E-01
vestibulocochlear nerve formation (GO:0021650),3,1,0.3,+,3.28,2.63E-01
rescue of stalled ribosome (GO:0072344),3,1,0.3,+,3.28,2.63E-01
pole plasm assembly (GO:0007315),3,1,0.3,+,3.28,2.63E-01
regulation of mast cell differentiation (GO:0060375),3,1,0.3,+,3.28,2.63E-01
oocyte anterior/posterior axis specification (GO:0007314),3,1,0.3,+,3.28,2.63E-01
cellular lactam metabolic process (GO:0072338),3,1,0.3,+,3.28,2.63E-01
negative regulation of glucocorticoid secretion (GO:2000850),3,1,0.3,+,3.28,2.63E-01
oocyte axis specification (GO:0007309),3,1,0.3,+,3.28,2.63E-01
oocyte construction (GO:0007308),3,1,0.3,+,3.28,2.63E-01
negative regulation of corticosteroid hormone secretion (GO:2000847),3,1,0.3,+,3.28,2.63E-01
dibenzo-p-dioxin metabolic process (GO:0018894),3,1,0.3,+,3.28,2.63E-01
negative regulation of steroid hormone secretion (GO:2000832),3,1,0.3,+,3.28,2.63E-01
positive regulation of glucose mediated signaling pathway (GO:1902661),3,1,0.3,+,3.28,2.63E-01
maintenance of mitotic sister chromatid cohesion (GO:0034088),3,1,0.3,+,3.28,2.63E-01
maintenance of sister chromatid cohesion (GO:0034086),3,1,0.3,+,3.28,2.63E-01
regulation of glucose mediated signaling pathway (GO:1902659),3,1,0.3,+,3.28,2.63E-01
tertiary alcohol biosynthetic process (GO:1902645),3,1,0.3,+,3.28,2.63E-01
negative regulation of blood vessel remodeling (GO:0060313),3,1,0.3,+,3.28,2.63E-01
elastin catabolic process (GO:0060309),3,1,0.3,+,3.28,2.63E-01
odontoblast differentiation (GO:0071895),3,1,0.3,+,3.28,2.63E-01
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),6,2,0.61,+,3.28,1.25E-01
acyl carnitine transport (GO:0006844),3,1,0.3,+,3.28,2.63E-01
tricarboxylic acid transport (GO:0006842),3,1,0.3,+,3.28,2.63E-01
response to silicon dioxide (GO:0034021),3,1,0.3,+,3.28,2.63E-01
mRNA alternative polyadenylation (GO:0110104),3,1,0.3,+,3.28,2.63E-01
cobalt ion transport (GO:0006824),6,2,0.61,+,3.28,1.25E-01
malonyl-CoA metabolic process (GO:2001293),3,1,0.3,+,3.28,2.63E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),6,2,0.61,+,3.28,1.25E-01
myeloid dendritic cell chemotaxis (GO:0002408),3,1,0.3,+,3.28,2.63E-01
regulation of protein K48-linked deubiquitination (GO:1903093),3,1,0.3,+,3.28,2.63E-01
oculomotor nerve development (GO:0021557),3,1,0.3,+,3.28,2.63E-01
lactate biosynthetic process (GO:0019249),3,1,0.3,+,3.28,2.63E-01
floor plate morphogenesis (GO:0033505),3,1,0.3,+,3.28,2.63E-01
regulation of oocyte development (GO:0060281),3,1,0.3,+,3.28,2.63E-01
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768),3,1,0.3,+,3.28,2.63E-01
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),3,1,0.3,+,3.28,2.63E-01
regulation of dense core granule biogenesis (GO:2000705),3,1,0.3,+,3.28,2.63E-01
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212),3,1,0.3,+,3.28,2.63E-01
positive regulation of cardiac muscle myoblast proliferation (GO:0110024),3,1,0.3,+,3.28,2.63E-01
regulation of cardiac muscle myoblast proliferation (GO:0110022),3,1,0.3,+,3.28,2.63E-01
cellular response to triacyl bacterial lipopeptide (GO:0071727),3,1,0.3,+,3.28,2.63E-01
response to triacyl bacterial lipopeptide (GO:0071725),3,1,0.3,+,3.28,2.63E-01
negative regulation of ATP biosynthetic process (GO:2001170),3,1,0.3,+,3.28,2.63E-01
plasma cell differentiation (GO:0002317),3,1,0.3,+,3.28,2.63E-01
germinal center B cell differentiation (GO:0002314),6,2,0.61,+,3.28,1.25E-01
nitric oxide homeostasis (GO:0033484),3,1,0.3,+,3.28,2.63E-01
transforming growth factor beta receptor complex assembly (GO:0007181),3,1,0.3,+,3.28,2.63E-01
ureter smooth muscle cell differentiation (GO:0072193),3,1,0.3,+,3.28,2.63E-01
ureter smooth muscle development (GO:0072191),3,1,0.3,+,3.28,2.63E-01
distal tubule morphogenesis (GO:0072156),3,1,0.3,+,3.28,2.63E-01
glomerular parietal epithelial cell differentiation (GO:0072139),3,1,0.3,+,3.28,2.63E-01
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138),3,1,0.3,+,3.28,2.63E-01
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136),3,1,0.3,+,3.28,2.63E-01
kidney mesenchymal cell proliferation (GO:0072135),3,1,0.3,+,3.28,2.63E-01
olfactory pit development (GO:0060166),3,1,0.3,+,3.28,2.63E-01
negative regulation of receptor catabolic process (GO:2000645),3,1,0.3,+,3.28,2.63E-01
negative regulation of glomerular mesangial cell proliferation (GO:0072125),3,1,0.3,+,3.28,2.63E-01
negative regulation of collagen biosynthetic process (GO:0032966),12,4,1.22,+,3.28,3.55E-02
negative regulation of primary miRNA processing (GO:2000635),3,1,0.3,+,3.28,2.63E-01
regulation of primary miRNA processing (GO:2000634),3,1,0.3,+,3.28,2.63E-01
positive regulation of miRNA catabolic process (GO:2000627),3,1,0.3,+,3.28,2.63E-01
regulation of miRNA catabolic process (GO:2000625),3,1,0.3,+,3.28,2.63E-01
glomerular capillary formation (GO:0072104),6,2,0.61,+,3.28,1.25E-01
glomerulus vasculature morphogenesis (GO:0072103),6,2,0.61,+,3.28,1.25E-01
protein localization to cell leading edge (GO:1902463),3,1,0.3,+,3.28,2.63E-01
negative regulation of histone H4-K16 acetylation (GO:2000619),3,1,0.3,+,3.28,2.63E-01
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129),3,1,0.3,+,3.28,2.63E-01
somatotropin secreting cell differentiation (GO:0060126),3,1,0.3,+,3.28,2.63E-01
negative regulation of transforming growth factor beta1 production (GO:0032911),6,2,0.61,+,3.28,1.25E-01
olfactory placode morphogenesis (GO:0071699),3,1,0.3,+,3.28,2.63E-01
olfactory placode development (GO:0071698),3,1,0.3,+,3.28,2.63E-01
microglial cell activation involved in immune response (GO:0002282),3,1,0.3,+,3.28,2.63E-01
positive regulation of granzyme B production (GO:0071663),3,1,0.3,+,3.28,2.63E-01
regulation of granzyme B production (GO:0071661),3,1,0.3,+,3.28,2.63E-01
S-adenosylmethionine cycle (GO:0033353),6,2,0.61,+,3.28,1.25E-01
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013),3,1,0.3,+,3.28,2.63E-01
release from viral latency (GO:0019046),3,1,0.3,+,3.28,2.63E-01
latent virus replication (GO:0019045),3,1,0.3,+,3.28,2.63E-01
smooth muscle contraction involved in micturition (GO:0060083),3,1,0.3,+,3.28,2.63E-01
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058),3,1,0.3,+,3.28,2.63E-01
erythropoietin-mediated signaling pathway (GO:0038162),3,1,0.3,+,3.28,2.63E-01
positive regulation of T cell costimulation (GO:2000525),3,1,0.3,+,3.28,2.63E-01
interleukin-11-mediated signaling pathway (GO:0038154),3,1,0.3,+,3.28,2.63E-01
negative regulation of T cell costimulation (GO:2000524),3,1,0.3,+,3.28,2.63E-01
regulation of T cell costimulation (GO:2000523),6,2,0.61,+,3.28,1.25E-01
regulation of immunological synapse formation (GO:2000520),3,1,0.3,+,3.28,2.63E-01
regulation of synaptic activity (GO:0060025),3,1,0.3,+,3.28,2.63E-01
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",3,1,0.3,+,3.28,2.63E-01
"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)",3,1,0.3,+,3.28,2.63E-01
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107),3,1,0.3,+,3.28,2.63E-01
aspartate biosynthetic process (GO:0006532),3,1,0.3,+,3.28,2.63E-01
response to endothelin (GO:1990839),3,1,0.3,+,3.28,2.63E-01
response to heparin (GO:0071503),6,2,0.61,+,3.28,1.25E-01
extracellular polysaccharide biosynthetic process (GO:0045226),3,1,0.3,+,3.28,2.63E-01
establishment of neuroblast polarity (GO:0045200),3,1,0.3,+,3.28,2.63E-01
HRI-mediated signaling (GO:0140468),3,1,0.3,+,3.28,2.63E-01
positive regulation of thymocyte migration (GO:2000412),3,1,0.3,+,3.28,2.63E-01
negative regulation of T cell migration (GO:2000405),6,2,0.61,+,3.28,1.25E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231),6,2,0.61,+,3.28,1.25E-01
regulation of interleukin-4-mediated signaling pathway (GO:1902214),3,1,0.3,+,3.28,2.63E-01
regulation of translational initiation by iron (GO:0006447),3,1,0.3,+,3.28,2.63E-01
negative regulation of neuron maturation (GO:0014043),3,1,0.3,+,3.28,2.63E-01
histidyl-tRNA aminoacylation (GO:0006427),3,1,0.3,+,3.28,2.63E-01
asparaginyl-tRNA aminoacylation (GO:0006421),3,1,0.3,+,3.28,2.63E-01
establishment or maintenance of neuroblast polarity (GO:0045196),3,1,0.3,+,3.28,2.63E-01
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961),3,1,0.3,+,3.28,2.63E-01
positive regulation of neutrophil mediated cytotoxicity (GO:0070960),3,1,0.3,+,3.28,2.63E-01
regulation of cell growth by extracellular stimulus (GO:0001560),3,1,0.3,+,3.28,2.63E-01
regulation of neutrophil mediated cytotoxicity (GO:0070948),6,2,0.61,+,3.28,1.25E-01
neutrophil-mediated killing of gram-negative bacterium (GO:0070945),3,1,0.3,+,3.28,2.63E-01
oocyte growth (GO:0001555),3,1,0.3,+,3.28,2.63E-01
preantral ovarian follicle growth (GO:0001546),3,1,0.3,+,3.28,2.63E-01
positive regulation of keratinocyte apoptotic process (GO:1902174),3,1,0.3,+,3.28,2.63E-01
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),6,2,0.61,+,3.28,1.25E-01
regulation of kainate selective glutamate receptor activity (GO:2000312),3,1,0.3,+,3.28,2.63E-01
regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307),3,1,0.3,+,3.28,2.63E-01
cellular response to jasmonic acid stimulus (GO:0071395),3,1,0.3,+,3.28,2.63E-01
peptidyl-serine ADP-ribosylation (GO:0018312),3,1,0.3,+,3.28,2.63E-01
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771),3,1,0.3,+,3.28,2.63E-01
meiotic gene conversion (GO:0006311),3,1,0.3,+,3.28,2.63E-01
response to iron ion starvation (GO:1990641),3,1,0.3,+,3.28,2.63E-01
constitutive secretory pathway (GO:0045054),3,1,0.3,+,3.28,2.63E-01
protein import into mitochondrial intermembrane space (GO:0045041),3,1,0.3,+,3.28,2.63E-01
negative regulation of lymphocyte chemotaxis (GO:1901624),3,1,0.3,+,3.28,2.63E-01
positive regulation of vesicle transport along microtubule (GO:1901610),3,1,0.3,+,3.28,2.63E-01
negative regulation of synapse maturation (GO:2000297),3,1,0.3,+,3.28,2.63E-01
regulation of cellular amino acid biosynthetic process (GO:2000282),3,1,0.3,+,3.28,2.63E-01
hydrogen sulfide metabolic process (GO:0070813),3,1,0.3,+,3.28,2.63E-01
regulation of microvillus length (GO:0032532),6,2,0.61,+,3.28,1.25E-01
"base-excision repair, DNA ligation (GO:0006288)",3,1,0.3,+,3.28,2.63E-01
cellular response to mercury ion (GO:0071288),3,1,0.3,+,3.28,2.63E-01
L-methionine salvage (GO:0071267),6,2,0.61,+,3.28,1.25E-01
L-methionine biosynthetic process (GO:0071265),6,2,0.61,+,3.28,1.25E-01
mitochondrial L-ornithine transmembrane transport (GO:1990575),3,1,0.3,+,3.28,2.63E-01
cellular response to molecule of fungal origin (GO:0071226),3,1,0.3,+,3.28,2.63E-01
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930),3,1,0.3,+,3.28,2.63E-01
norepinephrine uptake (GO:0051620),6,2,0.61,+,3.28,1.25E-01
regulation of cell differentiation involved in phenotypic switching (GO:1905915),3,1,0.3,+,3.28,2.63E-01
histamine uptake (GO:0051615),3,1,0.3,+,3.28,2.63E-01
dense core granule maturation (GO:1990502),3,1,0.3,+,3.28,2.63E-01
stem cell fate determination (GO:0048867),3,1,0.3,+,3.28,2.63E-01
diencephalon morphogenesis (GO:0048852),3,1,0.3,+,3.28,2.63E-01
negative regulation of female gonad development (GO:2000195),3,1,0.3,+,3.28,2.63E-01
regulation of female gonad development (GO:2000194),6,2,0.61,+,3.28,1.25E-01
female genitalia morphogenesis (GO:0048807),3,1,0.3,+,3.28,2.63E-01
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470),3,1,0.3,+,3.28,2.63E-01
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137),3,1,0.3,+,3.28,2.63E-01
positive regulation of mismatch repair (GO:0032425),3,1,0.3,+,3.28,2.63E-01
response to methylglyoxal (GO:0051595),3,1,0.3,+,3.28,2.63E-01
regulation of oogenesis (GO:1905879),3,1,0.3,+,3.28,2.63E-01
NADH oxidation (GO:0006116),3,1,0.3,+,3.28,2.63E-01
positive regulation of transcription factor catabolic process (GO:1901485),3,1,0.3,+,3.28,2.63E-01
regulation of transcription factor catabolic process (GO:1901483),3,1,0.3,+,3.28,2.63E-01
miRNA transport (GO:1990428),3,1,0.3,+,3.28,2.63E-01
positive regulation of chromatin silencing (GO:0031937),3,1,0.3,+,3.28,2.63E-01
nuclear matrix anchoring at nuclear membrane (GO:0090292),3,1,0.3,+,3.28,2.63E-01
regulation of osteoclast proliferation (GO:0090289),3,1,0.3,+,3.28,2.63E-01
regulation of immune complex clearance by monocytes and macrophages (GO:0090264),3,1,0.3,+,3.28,2.63E-01
positive regulation of histone H4 acetylation (GO:0090240),6,2,0.61,+,3.28,1.25E-01
regulation of centromere complex assembly (GO:0090230),3,1,0.3,+,3.28,2.63E-01
protein localization to nuclear pore (GO:0090204),3,1,0.3,+,3.28,2.63E-01
regulation of peroxisome size (GO:0044375),3,1,0.3,+,3.28,2.63E-01
N-terminal peptidyl-lysine acetylation (GO:0018076),3,1,0.3,+,3.28,2.63E-01
aldosterone biosynthetic process (GO:0032342),3,1,0.3,+,3.28,2.63E-01
aldosterone metabolic process (GO:0032341),3,1,0.3,+,3.28,2.63E-01
RNA 3' uridylation (GO:0071076),3,1,0.3,+,3.28,2.63E-01
negative regulation of filopodium assembly (GO:0051490),3,1,0.3,+,3.28,2.63E-01
double-strand break repair via break-induced replication (GO:0000727),12,4,1.22,+,3.28,3.55E-02
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967),3,1,0.3,+,3.28,2.63E-01
organic heteropentacyclic compound metabolic process (GO:1901376),3,1,0.3,+,3.28,2.63E-01
protection from non-homologous end joining at telomere (GO:0031848),6,2,0.61,+,3.28,1.25E-01
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176),3,1,0.3,+,3.28,2.63E-01
vitamin D receptor signaling pathway (GO:0070561),3,1,0.3,+,3.28,2.63E-01
sensory perception of touch (GO:0050975),3,1,0.3,+,3.28,2.63E-01
protein kinase C signaling (GO:0070528),15,5,1.52,+,3.28,1.97E-02
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636),3,1,0.3,+,3.28,2.63E-01
positive regulation of miRNA mediated inhibition of translation (GO:1905618),6,2,0.61,+,3.28,1.25E-01
regulation of miRNA mediated inhibition of translation (GO:1905616),6,2,0.61,+,3.28,1.25E-01
G2 phase (GO:0051319),3,1,0.3,+,3.28,2.63E-01
establishment of anatomical structure orientation (GO:0048560),3,1,0.3,+,3.28,2.63E-01
regulation of timing of cell differentiation (GO:0048505),12,4,1.22,+,3.28,3.55E-02
regulation of blastocyst development (GO:0120222),3,1,0.3,+,3.28,2.63E-01
positive regulation blood vessel branching (GO:1905555),3,1,0.3,+,3.28,2.63E-01
messenger ribonucleoprotein complex assembly (GO:1990120),3,1,0.3,+,3.28,2.63E-01
response to jasmonic acid (GO:0009753),3,1,0.3,+,3.28,2.63E-01
cellular amide catabolic process (GO:0043605),3,1,0.3,+,3.28,2.63E-01
regulation of white fat cell proliferation (GO:0070350),3,1,0.3,+,3.28,2.63E-01
mucociliary clearance (GO:0120197),3,1,0.3,+,3.28,2.63E-01
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491),3,1,0.3,+,3.28,2.63E-01
detection of bacterial lipopeptide (GO:0070340),3,1,0.3,+,3.28,2.63E-01
postsynaptic intermediate filament cytoskeleton organization (GO:0099185),3,1,0.3,+,3.28,2.63E-01
positive regulation of G0 to G1 transition (GO:0070318),3,1,0.3,+,3.28,2.63E-01
olefin metabolic process (GO:1900673),3,1,0.3,+,3.28,2.63E-01
regulation of modification of postsynaptic structure (GO:0099159),6,2,0.61,+,3.28,1.25E-01
acetate ester biosynthetic process (GO:1900620),3,1,0.3,+,3.28,2.63E-01
snoRNA guided rRNA pseudouridine synthesis (GO:0000454),3,1,0.3,+,3.28,2.63E-01
senescence-associated heterochromatin focus assembly (GO:0035986),3,1,0.3,+,3.28,2.63E-01
nuclear matrix organization (GO:0043578),3,1,0.3,+,3.28,2.63E-01
"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)",6,2,0.61,+,3.28,1.25E-01
activation of phospholipase D activity (GO:0031584),6,2,0.61,+,3.28,1.25E-01
negative regulation of lymphoid progenitor cell differentiation (GO:1905457),3,1,0.3,+,3.28,2.63E-01
positive regulation of autophagosome maturation (GO:1901098),6,2,0.61,+,3.28,1.25E-01
positive regulation of relaxation of muscle (GO:1901079),3,1,0.3,+,3.28,2.63E-01
cold acclimation (GO:0009631),3,1,0.3,+,3.28,2.63E-01
response to nematode (GO:0009624),3,1,0.3,+,3.28,2.63E-01
positive regulation of mucus secretion (GO:0070257),6,2,0.61,+,3.28,1.25E-01
axial mesoderm morphogenesis (GO:0048319),3,1,0.3,+,3.28,2.63E-01
tRNA-type intron splice site recognition and cleavage (GO:0000379),3,1,0.3,+,3.28,2.63E-01
regulation of pentose-phosphate shunt (GO:0043456),3,1,0.3,+,3.28,2.63E-01
positive regulation of aggrephagy (GO:1905337),3,1,0.3,+,3.28,2.63E-01
regulation of aggrephagy (GO:1905335),3,1,0.3,+,3.28,2.63E-01
homocysteine catabolic process (GO:0043418),3,1,0.3,+,3.28,2.63E-01
chiasma assembly (GO:0051026),6,2,0.61,+,3.28,1.25E-01
adrenal cortex development (GO:0035801),3,1,0.3,+,3.28,2.63E-01
regulation of macropinocytosis (GO:1905301),3,1,0.3,+,3.28,2.63E-01
negative regulation of Golgi to plasma membrane protein transport (GO:0042997),6,2,0.61,+,3.28,1.25E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952),6,2,0.61,+,3.28,1.25E-01
positive regulation of long-term synaptic depression (GO:1900454),6,2,0.61,+,3.28,1.25E-01
olfactory placode formation (GO:0030910),3,1,0.3,+,3.28,2.63E-01
mycotoxin metabolic process (GO:0043385),3,1,0.3,+,3.28,2.63E-01
negative regulation of aspartic-type peptidase activity (GO:1905246),3,1,0.3,+,3.28,2.63E-01
putrescine catabolic process (GO:0009447),3,1,0.3,+,3.28,2.63E-01
glycolate metabolic process (GO:0009441),3,1,0.3,+,3.28,2.63E-01
positive regulation of protein localization to cell cortex (GO:1904778),6,2,0.61,+,3.28,1.25E-01
multi-layer follicle stage (GO:0048162),3,1,0.3,+,3.28,2.63E-01
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),6,2,0.61,+,3.28,1.25E-01
"protein import into peroxisome matrix, translocation (GO:0016561)",3,1,0.3,+,3.28,2.63E-01
positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903),3,1,0.3,+,3.28,2.63E-01
regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901),3,1,0.3,+,3.28,2.63E-01
regulation of phagosome maturation (GO:1905162),3,1,0.3,+,3.28,2.63E-01
sulfate assimilation (GO:0000103),3,1,0.3,+,3.28,2.63E-01
folic acid-containing compound catabolic process (GO:0009397),3,1,0.3,+,3.28,2.63E-01
C-terminal protein deglutamylation (GO:0035609),3,1,0.3,+,3.28,2.63E-01
protein deglutamylation (GO:0035608),6,2,0.61,+,3.28,1.25E-01
tRNA 3'-trailer cleavage (GO:0042779),3,1,0.3,+,3.28,2.63E-01
response to methionine (GO:1904640),3,1,0.3,+,3.28,2.63E-01
positive regulation of glomerular visceral epithelial cell apoptotic process (GO:1904635),3,1,0.3,+,3.28,2.63E-01
regulation of glomerular visceral epithelial cell apoptotic process (GO:1904633),3,1,0.3,+,3.28,2.63E-01
embryonic skeletal limb joint morphogenesis (GO:0036023),3,1,0.3,+,3.28,2.63E-01
limb joint morphogenesis (GO:0036022),3,1,0.3,+,3.28,2.63E-01
regulation of phenotypic switching (GO:1900239),3,1,0.3,+,3.28,2.63E-01
cellular response to erythropoietin (GO:0036018),6,2,0.61,+,3.28,1.25E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212),3,1,0.3,+,3.28,2.63E-01
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211),3,1,0.3,+,3.28,2.63E-01
mitotic G2 phase (GO:0000085),3,1,0.3,+,3.28,2.63E-01
urea cycle (GO:0000050),12,4,1.22,+,3.28,3.55E-02
positive regulation of tight junction disassembly (GO:1905075),3,1,0.3,+,3.28,2.63E-01
regulation of tight junction disassembly (GO:1905073),3,1,0.3,+,3.28,2.63E-01
oxidative single-stranded RNA demethylation (GO:0035553),3,1,0.3,+,3.28,2.63E-01
NAD transport (GO:0043132),3,1,0.3,+,3.28,2.63E-01
amino acid salvage (GO:0043102),6,2,0.61,+,3.28,1.25E-01
protein lipoylation (GO:0009249),6,2,0.61,+,3.28,1.25E-01
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164),3,1,0.3,+,3.28,2.63E-01
"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)",3,1,0.3,+,3.28,2.63E-01
regulation of nodal signaling pathway (GO:1900107),6,2,0.61,+,3.28,1.25E-01
positive regulation of hyaluranon cable assembly (GO:1900106),3,1,0.3,+,3.28,2.63E-01
regulation of hyaluranon cable assembly (GO:1900104),3,1,0.3,+,3.28,2.63E-01
cadmium ion homeostasis (GO:0055073),3,1,0.3,+,3.28,2.63E-01
manganese ion homeostasis (GO:0055071),3,1,0.3,+,3.28,2.63E-01
penile erection (GO:0043084),3,1,0.3,+,3.28,2.63E-01
creatine transmembrane transport (GO:0015881),3,1,0.3,+,3.28,2.63E-01
amino-acid betaine transport (GO:0015838),6,2,0.61,+,3.28,1.25E-01
peptidoglycan transport (GO:0015835),3,1,0.3,+,3.28,2.63E-01
double-strand break repair via alternative nonhomologous end joining (GO:0097681),3,1,0.3,+,3.28,2.63E-01
negative regulation of intestinal absorption (GO:1904479),3,1,0.3,+,3.28,2.63E-01
pteridine-containing compound catabolic process (GO:0042560),3,1,0.3,+,3.28,2.63E-01
DNA ADP-ribosylation (GO:0030592),3,1,0.3,+,3.28,2.63E-01
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094),3,1,0.3,+,3.28,2.63E-01
Cajal body organization (GO:0030576),3,1,0.3,+,3.28,2.63E-01
regulation of iron ion import across plasma membrane (GO:1904438),3,1,0.3,+,3.28,2.63E-01
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980),3,1,0.3,+,3.28,2.63E-01
regulation of vitamin D 24-hydroxylase activity (GO:0010979),3,1,0.3,+,3.28,2.63E-01
detoxification of inorganic compound (GO:0061687),15,5,1.52,+,3.28,1.97E-02
negative regulation of ruffle assembly (GO:1900028),6,2,0.61,+,3.28,1.25E-01
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984),3,1,0.3,+,3.28,2.63E-01
negative regulation of glial cell migration (GO:1903976),3,1,0.3,+,3.28,2.63E-01
transepithelial water transport (GO:0035377),3,1,0.3,+,3.28,2.63E-01
NAD transmembrane transport (GO:0035352),3,1,0.3,+,3.28,2.63E-01
valine biosynthetic process (GO:0009099),3,1,0.3,+,3.28,2.63E-01
isoleucine biosynthetic process (GO:0009097),3,1,0.3,+,3.28,2.63E-01
citrate transport (GO:0015746),3,1,0.3,+,3.28,2.63E-01
membrane depolarization during bundle of His cell action potential (GO:0086048),3,1,0.3,+,3.28,2.63E-01
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047),3,1,0.3,+,3.28,2.63E-01
Purkinje myocyte action potential (GO:0086017),3,1,0.3,+,3.28,2.63E-01
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395),3,1,0.3,+,3.28,2.63E-01
negative regulation of dopaminergic neuron differentiation (GO:1904339),3,1,0.3,+,3.28,2.63E-01
serotonin biosynthetic process (GO:0042427),3,1,0.3,+,3.28,2.63E-01
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577),3,1,0.3,+,3.28,2.63E-01
cranial ganglion development (GO:0061550),6,2,0.61,+,3.28,1.25E-01
basal dendrite arborization (GO:0150020),3,1,0.3,+,3.28,2.63E-01
negative regulation of ERAD pathway (GO:1904293),6,2,0.61,+,3.28,1.25E-01
basal dendrite morphogenesis (GO:0150019),3,1,0.3,+,3.28,2.63E-01
basal dendrite development (GO:0150018),3,1,0.3,+,3.28,2.63E-01
polyprenol biosynthetic process (GO:0016094),3,1,0.3,+,3.28,2.63E-01
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751),3,1,0.3,+,3.28,2.63E-01
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750),3,1,0.3,+,3.28,2.63E-01
cardiac muscle cell fate commitment (GO:0060923),6,2,0.61,+,3.28,1.25E-01
mesenchymal cell proliferation involved in lung development (GO:0060916),3,1,0.3,+,3.28,2.63E-01
interneuron axon guidance (GO:0097376),3,1,0.3,+,3.28,2.63E-01
cortisol biosynthetic process (GO:0034651),3,1,0.3,+,3.28,2.63E-01
"positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)",3,1,0.3,+,3.28,2.63E-01
positive regulation of mitotic centrosome separation (GO:0046604),3,1,0.3,+,3.28,2.63E-01
negative regulation of alkaline phosphatase activity (GO:0010693),3,1,0.3,+,3.28,2.63E-01
response to clozapine (GO:0097338),3,1,0.3,+,3.28,2.63E-01
growth hormone secretion (GO:0030252),6,2,0.61,+,3.28,1.25E-01
"maternal determination of anterior/posterior axis, embryo (GO:0008358)",3,1,0.3,+,3.28,2.63E-01
positive regulation of cap-independent translational initiation (GO:1903679),3,1,0.3,+,3.28,2.63E-01
regulation of cap-independent translational initiation (GO:1903677),3,1,0.3,+,3.28,2.63E-01
negative regulation of cytoplasmic transport (GO:1903650),3,1,0.3,+,3.28,2.63E-01
canonical Wnt signaling pathway involved in heart development (GO:0061316),3,1,0.3,+,3.28,2.63E-01
embryonic heart tube anterior/posterior pattern specification (GO:0035054),3,1,0.3,+,3.28,2.63E-01
positive regulation of Rac protein signal transduction (GO:0035022),6,2,0.61,+,3.28,1.25E-01
termination of signal transduction (GO:0023021),3,1,0.3,+,3.28,2.63E-01
spermidine biosynthetic process (GO:0008295),3,1,0.3,+,3.28,2.63E-01
acetylcholine biosynthetic process (GO:0008292),3,1,0.3,+,3.28,2.63E-01
cell proliferation involved in mesonephros development (GO:0061209),3,1,0.3,+,3.28,2.63E-01
regulation of membrane tubulation (GO:1903525),6,2,0.61,+,3.28,1.25E-01
regulation of single strand break repair (GO:1903516),3,1,0.3,+,3.28,2.63E-01
establishment of cell polarity involved in ameboidal cell migration (GO:0003365),3,1,0.3,+,3.28,2.63E-01
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769),3,1,0.3,+,3.28,2.63E-01
mammary gland branching involved in pregnancy (GO:0060745),6,2,0.61,+,3.28,1.25E-01
late endosome to Golgi transport (GO:0034499),6,2,0.61,+,3.28,1.25E-01
histone H3-K36 trimethylation (GO:0097198),3,1,0.3,+,3.28,2.63E-01
pilomotor reflex (GO:0097195),3,1,0.3,+,3.28,2.63E-01
D-amino acid metabolic process (GO:0046416),3,1,0.3,+,3.28,2.63E-01
positive regulation of skeletal muscle cell proliferation (GO:0014858),3,1,0.3,+,3.28,2.63E-01
post-translational protein acetylation (GO:0034421),3,1,0.3,+,3.28,2.63E-01
regulation of chronic inflammatory response to antigenic stimulus (GO:0002874),3,1,0.3,+,3.28,2.63E-01
vein smooth muscle contraction (GO:0014826),3,1,0.3,+,3.28,2.63E-01
response to alkaline pH (GO:0010446),3,1,0.3,+,3.28,2.63E-01
negative regulation of growth rate (GO:0045967),3,1,0.3,+,3.28,2.63E-01
positive regulation of dopamine metabolic process (GO:0045964),6,2,0.61,+,3.28,1.25E-01
positive regulation of catecholamine metabolic process (GO:0045915),6,2,0.61,+,3.28,1.25E-01
seminal vesicle development (GO:0061107),3,1,0.3,+,3.28,2.63E-01
negative regulation of cell maturation (GO:1903430),6,2,0.61,+,3.28,1.25E-01
negative regulation of synaptic vesicle recycling (GO:1903422),3,1,0.3,+,3.28,2.63E-01
osteoclast fusion (GO:0072675),6,2,0.61,+,3.28,1.25E-01
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910),3,1,0.3,+,3.28,2.63E-01
positive regulation of phospholipid catabolic process (GO:0060697),3,1,0.3,+,3.28,2.63E-01
epithelial-mesenchymal cell signaling (GO:0060684),6,2,0.61,+,3.28,1.25E-01
courtship behavior (GO:0007619),3,1,0.3,+,3.28,2.63E-01
epithelial cell morphogenesis involved in placental branching (GO:0060672),3,1,0.3,+,3.28,2.63E-01
epithelial cell differentiation involved in embryonic placenta development (GO:0060671),3,1,0.3,+,3.28,2.63E-01
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250),3,1,0.3,+,3.28,2.63E-01
extracellular polysaccharide metabolic process (GO:0046379),3,1,0.3,+,3.28,2.63E-01
mammary gland bud morphogenesis (GO:0060648),3,1,0.3,+,3.28,2.63E-01
"positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)",3,1,0.3,+,3.28,2.63E-01
regulation of cholesterol import (GO:0060620),3,1,0.3,+,3.28,2.63E-01
diacylglycerol catabolic process (GO:0046340),3,1,0.3,+,3.28,2.63E-01
negative regulation of tau-protein kinase activity (GO:1902948),3,1,0.3,+,3.28,2.63E-01
L-kynurenine catabolic process (GO:0097053),3,1,0.3,+,3.28,2.63E-01
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051),3,1,0.3,+,3.28,2.63E-01
protein linear polyubiquitination (GO:0097039),3,1,0.3,+,3.28,2.63E-01
branchiomeric skeletal muscle development (GO:0014707),3,1,0.3,+,3.28,2.63E-01
positive regulation of phospholipid translocation (GO:0061092),3,1,0.3,+,3.28,2.63E-01
sclerotome development (GO:0061056),3,1,0.3,+,3.28,2.63E-01
myotome development (GO:0061055),3,1,0.3,+,3.28,2.63E-01
facioacoustic ganglion development (GO:1903375),3,1,0.3,+,3.28,2.63E-01
hypothalamic tangential migration using cell-axon interactions (GO:0021856),3,1,0.3,+,3.28,2.63E-01
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828),3,1,0.3,+,3.28,2.63E-01
mammary gland specification (GO:0060594),3,1,0.3,+,3.28,2.63E-01
formaldehyde catabolic process (GO:0046294),3,1,0.3,+,3.28,2.63E-01
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559),3,1,0.3,+,3.28,2.63E-01
endodermal-mesodermal cell signaling involved in heart induction (GO:0003134),3,1,0.3,+,3.28,2.63E-01
endodermal-mesodermal cell signaling (GO:0003133),3,1,0.3,+,3.28,2.63E-01
BMP signaling pathway involved in heart induction (GO:0003130),3,1,0.3,+,3.28,2.63E-01
heart induction (GO:0003129),3,1,0.3,+,3.28,2.63E-01
negative regulation of non-motile cilium assembly (GO:1902856),3,1,0.3,+,3.28,2.63E-01
prostate epithelial cord elongation (GO:0060523),3,1,0.3,+,3.28,2.63E-01
aflatoxin metabolic process (GO:0046222),3,1,0.3,+,3.28,2.63E-01
trigeminal nerve development (GO:0021559),9,3,0.91,+,3.28,6.53E-02
androgen biosynthetic process (GO:0006702),9,3,0.91,+,3.28,6.53E-02
glomerulus morphogenesis (GO:0072102),9,3,0.91,+,3.28,6.53E-02
aggressive behavior (GO:0002118),9,3,0.91,+,3.28,6.53E-02
dopamine uptake (GO:0090494),9,3,0.91,+,3.28,6.53E-02
catecholamine uptake (GO:0090493),9,3,0.91,+,3.28,6.53E-02
mitochondrial DNA metabolic process (GO:0032042),9,3,0.91,+,3.28,6.53E-02
protein trimerization (GO:0070206),18,6,1.83,+,3.28,1.11E-02
oligopeptide transmembrane transport (GO:0035672),9,3,0.91,+,3.28,6.53E-02
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),9,3,0.91,+,3.28,6.53E-02
regulation of DNA-directed DNA polymerase activity (GO:1900262),9,3,0.91,+,3.28,6.53E-02
cobalamin metabolic process (GO:0009235),18,6,1.83,+,3.28,1.11E-02
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768),9,3,0.91,+,3.28,6.53E-02
negative regulation of cellular extravasation (GO:0002692),9,3,0.91,+,3.28,6.53E-02
leukocyte mediated cytotoxicity (GO:0001909),34,11,3.46,+,3.18,9.09E-04
arginine metabolic process (GO:0006525),16,5,1.63,+,3.07,2.51E-02
potassium ion homeostasis (GO:0055075),29,9,2.95,+,3.05,3.37E-03
detoxification of copper ion (GO:0010273),13,4,1.32,+,3.03,4.52E-02
nitrogen cycle metabolic process (GO:0071941),13,4,1.32,+,3.03,4.52E-02
radial glial cell differentiation (GO:0060019),13,4,1.32,+,3.03,4.52E-02
G protein-coupled receptor internalization (GO:0002031),13,4,1.32,+,3.03,4.52E-02
cellular response to vitamin D (GO:0071305),13,4,1.32,+,3.03,4.52E-02
positive regulation of DNA-dependent DNA replication (GO:2000105),13,4,1.32,+,3.03,4.52E-02
"regulation of development, heterochronic (GO:0040034)",13,4,1.32,+,3.03,4.52E-02
negative regulation by host of viral transcription (GO:0043922),13,4,1.32,+,3.03,4.52E-02
positive regulation of voltage-gated calcium channel activity (GO:1901387),13,4,1.32,+,3.03,4.52E-02
mRNA cleavage involved in mRNA processing (GO:0098787),13,4,1.32,+,3.03,4.52E-02
stress response to copper ion (GO:1990169),13,4,1.32,+,3.03,4.52E-02
macrophage chemotaxis (GO:0048246),13,4,1.32,+,3.03,4.52E-02
maternal behavior (GO:0042711),13,4,1.32,+,3.03,4.52E-02
positive regulation of T cell chemotaxis (GO:0010820),13,4,1.32,+,3.03,4.52E-02
negative regulation of collagen metabolic process (GO:0010713),13,4,1.32,+,3.03,4.52E-02
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",13,4,1.32,+,3.03,4.52E-02
parental behavior (GO:0060746),13,4,1.32,+,3.03,4.52E-02
urea metabolic process (GO:0019627),13,4,1.32,+,3.03,4.52E-02
regulation of activin receptor signaling pathway (GO:0032925),23,7,2.34,+,2.99,1.01E-02
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),10,3,1.02,+,2.95,8.33E-02
locomotor rhythm (GO:0045475),10,3,1.02,+,2.95,8.33E-02
negative regulation of T-helper 17 cell differentiation (GO:2000320),10,3,1.02,+,2.95,8.33E-02
maintenance of organelle location (GO:0051657),10,3,1.02,+,2.95,8.33E-02
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),10,3,1.02,+,2.95,8.33E-02
regulation of glucocorticoid metabolic process (GO:0031943),10,3,1.02,+,2.95,8.33E-02
plasminogen activation (GO:0031639),10,3,1.02,+,2.95,8.33E-02
thyroid hormone transport (GO:0070327),10,3,1.02,+,2.95,8.33E-02
small nucleolar ribonucleoprotein complex assembly (GO:0000491),10,3,1.02,+,2.95,8.33E-02
drinking behavior (GO:0042756),10,3,1.02,+,2.95,8.33E-02
positive regulation of histone exchange (GO:1900051),10,3,1.02,+,2.95,8.33E-02
regulation of histone exchange (GO:1900049),10,3,1.02,+,2.95,8.33E-02
quaternary ammonium group transport (GO:0015697),10,3,1.02,+,2.95,8.33E-02
regulation of plasma membrane organization (GO:1903729),10,3,1.02,+,2.95,8.33E-02
lipid glycosylation (GO:0030259),10,3,1.02,+,2.95,8.33E-02
xenobiotic catabolic process (GO:0042178),10,3,1.02,+,2.95,8.33E-02
negative regulation of T cell cytokine production (GO:0002725),10,3,1.02,+,2.95,8.33E-02
mononuclear cell differentiation (GO:1903131),17,5,1.73,+,2.89,3.14E-02
fucosylation (GO:0036065),17,5,1.73,+,2.89,3.14E-02
chloride ion homeostasis (GO:0055064),17,5,1.73,+,2.89,3.14E-02
monocyte differentiation (GO:0030224),17,5,1.73,+,2.89,3.14E-02
3'-UTR-mediated mRNA destabilization (GO:0061158),17,5,1.73,+,2.89,3.14E-02
positive regulation of dendritic cell antigen processing and presentation (GO:0002606),7,2,0.71,+,2.81,1.60E-01
renal sodium ion transport (GO:0003096),7,2,0.71,+,2.81,1.60E-01
regulation of pro-B cell differentiation (GO:2000973),7,2,0.71,+,2.81,1.60E-01
cranial nerve formation (GO:0021603),7,2,0.71,+,2.81,1.60E-01
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),7,2,0.71,+,2.81,1.60E-01
negative regulation of response to interferon-gamma (GO:0060331),7,2,0.71,+,2.81,1.60E-01
neuronal action potential propagation (GO:0019227),7,2,0.71,+,2.81,1.60E-01
tetrahydrobiopterin biosynthetic process (GO:0006729),7,2,0.71,+,2.81,1.60E-01
negative regulation of dendritic cell apoptotic process (GO:2000669),7,2,0.71,+,2.81,1.60E-01
ganglioside catabolic process (GO:0006689),7,2,0.71,+,2.81,1.60E-01
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961),7,2,0.71,+,2.81,1.60E-01
double-strand break repair involved in meiotic recombination (GO:1990918),7,2,0.71,+,2.81,1.60E-01
S-shaped body morphogenesis (GO:0072050),7,2,0.71,+,2.81,1.60E-01
bile acid signaling pathway (GO:0038183),14,4,1.42,+,2.81,5.63E-02
positive regulation of T-helper 2 cell cytokine production (GO:2000553),7,2,0.71,+,2.81,1.60E-01
positive regulation of protein glycosylation (GO:0060050),7,2,0.71,+,2.81,1.60E-01
positive regulation of natural killer cell differentiation (GO:0032825),7,2,0.71,+,2.81,1.60E-01
valine metabolic process (GO:0006573),7,2,0.71,+,2.81,1.60E-01
glutamate catabolic process (GO:0006538),7,2,0.71,+,2.81,1.60E-01
regulation of relaxation of cardiac muscle (GO:1901897),7,2,0.71,+,2.81,1.60E-01
regulation of nuclear cell cycle DNA replication (GO:0033262),14,4,1.42,+,2.81,5.63E-02
iron import into cell (GO:0033212),7,2,0.71,+,2.81,1.60E-01
adiponectin-activated signaling pathway (GO:0033211),7,2,0.71,+,2.81,1.60E-01
negative regulation of interleukin-13 production (GO:0032696),7,2,0.71,+,2.81,1.60E-01
postsynaptic endocytosis (GO:0140239),7,2,0.71,+,2.81,1.60E-01
cellular response to salt (GO:1902075),7,2,0.71,+,2.81,1.60E-01
positive regulation of anoikis (GO:2000210),7,2,0.71,+,2.81,1.60E-01
establishment of Golgi localization (GO:0051683),7,2,0.71,+,2.81,1.60E-01
UTP biosynthetic process (GO:0006228),7,2,0.71,+,2.81,1.60E-01
positive regulation of gonad development (GO:1905941),7,2,0.71,+,2.81,1.60E-01
locomotion involved in locomotory behavior (GO:0031987),7,2,0.71,+,2.81,1.60E-01
positive regulation of arachidonic acid secretion (GO:0090238),7,2,0.71,+,2.81,1.60E-01
positive regulation of male gonad development (GO:2000020),7,2,0.71,+,2.81,1.60E-01
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388),7,2,0.71,+,2.81,1.60E-01
postsynaptic neurotransmitter receptor internalization (GO:0098884),7,2,0.71,+,2.81,1.60E-01
action potential propagation (GO:0098870),7,2,0.71,+,2.81,1.60E-01
positive regulation of extracellular matrix disassembly (GO:0090091),7,2,0.71,+,2.81,1.60E-01
foam cell differentiation (GO:0090077),7,2,0.71,+,2.81,1.60E-01
rRNA base methylation (GO:0070475),7,2,0.71,+,2.81,1.60E-01
negative regulation of myelination (GO:0031642),7,2,0.71,+,2.81,1.60E-01
negative regulation of translation in response to stress (GO:0032055),7,2,0.71,+,2.81,1.60E-01
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696),7,2,0.71,+,2.81,1.60E-01
response to herbicide (GO:0009635),7,2,0.71,+,2.81,1.60E-01
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),14,4,1.42,+,2.81,5.63E-02
positive regulation of prostaglandin biosynthetic process (GO:0031394),7,2,0.71,+,2.81,1.60E-01
positive regulation of NMDA glutamate receptor activity (GO:1904783),7,2,0.71,+,2.81,1.60E-01
response to erythropoietin (GO:0036017),7,2,0.71,+,2.81,1.60E-01
sulfur amino acid biosynthetic process (GO:0000097),14,4,1.42,+,2.81,5.63E-02
citrulline metabolic process (GO:0000052),7,2,0.71,+,2.81,1.60E-01
monovalent inorganic anion homeostasis (GO:0055083),28,8,2.85,+,2.81,8.85E-03
norepinephrine transport (GO:0015874),7,2,0.71,+,2.81,1.60E-01
choline transport (GO:0015871),7,2,0.71,+,2.81,1.60E-01
nonassociative learning (GO:0046958),7,2,0.71,+,2.81,1.60E-01
regulation of phosphate transport (GO:0010966),7,2,0.71,+,2.81,1.60E-01
bile acid and bile salt transport (GO:0015721),28,8,2.85,+,2.81,8.85E-03
regulation of neuromuscular junction development (GO:1904396),7,2,0.71,+,2.81,1.60E-01
positive regulation of RNA export from nucleus (GO:0046833),7,2,0.71,+,2.81,1.60E-01
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),7,2,0.71,+,2.81,1.60E-01
negative regulation of keratinocyte proliferation (GO:0010839),14,4,1.42,+,2.81,5.63E-02
regulation of T cell chemotaxis (GO:0010819),14,4,1.42,+,2.81,5.63E-02
negative regulation of macrophage chemotaxis (GO:0010760),7,2,0.71,+,2.81,1.60E-01
macrophage derived foam cell differentiation (GO:0010742),7,2,0.71,+,2.81,1.60E-01
protein localization to cytoplasmic stress granule (GO:1903608),7,2,0.71,+,2.81,1.60E-01
positive regulation of activation of Janus kinase activity (GO:0010536),7,2,0.71,+,2.81,1.60E-01
regulation of skeletal muscle cell proliferation (GO:0014857),14,4,1.42,+,2.81,5.63E-02
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866),7,2,0.71,+,2.81,1.60E-01
glyceraldehyde-3-phosphate metabolic process (GO:0019682),7,2,0.71,+,2.81,1.60E-01
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937),7,2,0.71,+,2.81,1.60E-01
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),7,2,0.71,+,2.81,1.60E-01
epithelial cell proliferation involved in liver morphogenesis (GO:0072575),7,2,0.71,+,2.81,1.60E-01
hepatocyte proliferation (GO:0072574),7,2,0.71,+,2.81,1.60E-01
T-helper 17 cell lineage commitment (GO:0072540),7,2,0.71,+,2.81,1.60E-01
regulation of calcidiol 1-monooxygenase activity (GO:0060558),7,2,0.71,+,2.81,1.60E-01
NADH regeneration (GO:0006735),25,7,2.54,+,2.75,1.53E-02
regulation of astrocyte differentiation (GO:0048710),25,7,2.54,+,2.75,1.53E-02
glucose catabolic process to pyruvate (GO:0061718),25,7,2.54,+,2.75,1.53E-02
canonical glycolysis (GO:0061621),25,7,2.54,+,2.75,1.53E-02
polyamine metabolic process (GO:0006595),18,5,1.83,+,2.73,3.85E-02
"base-excision repair, AP site formation (GO:0006285)",18,5,1.83,+,2.73,3.85E-02
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),29,8,2.95,+,2.71,1.08E-02
regulation of dendritic cell antigen processing and presentation (GO:0002604),11,3,1.12,+,2.68,1.03E-01
regulation of toll-like receptor 2 signaling pathway (GO:0034135),11,3,1.12,+,2.68,1.03E-01
positive regulation of cellular senescence (GO:2000774),11,3,1.12,+,2.68,1.03E-01
regulation of T-helper 2 cell cytokine production (GO:2000551),11,3,1.12,+,2.68,1.03E-01
glomerular basement membrane development (GO:0032836),11,3,1.12,+,2.68,1.03E-01
cellular response to acidic pH (GO:0071468),11,3,1.12,+,2.68,1.03E-01
depurination (GO:0045007),11,3,1.12,+,2.68,1.03E-01
regulation of gonad development (GO:1905939),11,3,1.12,+,2.68,1.03E-01
secretory granule localization (GO:0032252),11,3,1.12,+,2.68,1.03E-01
regulation of steroid hormone biosynthetic process (GO:0090030),11,3,1.12,+,2.68,1.03E-01
regulation of excretion (GO:0044062),22,6,2.24,+,2.68,2.66E-02
response to salt stress (GO:0009651),22,6,2.24,+,2.68,2.66E-02
positive regulation of mRNA 3'-end processing (GO:0031442),11,3,1.12,+,2.68,1.03E-01
response to insecticide (GO:0017085),11,3,1.12,+,2.68,1.03E-01
phosphate ion homeostasis (GO:0055062),11,3,1.12,+,2.68,1.03E-01
negative regulation of transcription by competitive promoter binding (GO:0010944),11,3,1.12,+,2.68,1.03E-01
positive regulation of mitochondrial membrane potential (GO:0010918),11,3,1.12,+,2.68,1.03E-01
methionine biosynthetic process (GO:0009086),11,3,1.12,+,2.68,1.03E-01
bone trabecula morphogenesis (GO:0061430),11,3,1.12,+,2.68,1.03E-01
genitalia morphogenesis (GO:0035112),11,3,1.12,+,2.68,1.03E-01
response to mercury ion (GO:0046689),11,3,1.12,+,2.68,1.03E-01
positive regulation of inflammatory response to antigenic stimulus (GO:0002863),11,3,1.12,+,2.68,1.03E-01
telencephalon regionalization (GO:0021978),11,3,1.12,+,2.68,1.03E-01
trivalent inorganic anion homeostasis (GO:0072506),11,3,1.12,+,2.68,1.03E-01
divalent inorganic anion homeostasis (GO:0072505),11,3,1.12,+,2.68,1.03E-01
glycolytic process through glucose-6-phosphate (GO:0061620),26,7,2.64,+,2.65,1.85E-02
glycolytic process through fructose-6-phosphate (GO:0061615),26,7,2.64,+,2.65,1.85E-02
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),15,4,1.52,+,2.62,6.87E-02
macrophage activation involved in immune response (GO:0002281),15,4,1.52,+,2.62,6.87E-02
glycine metabolic process (GO:0006544),15,4,1.52,+,2.62,6.87E-02
induction of positive chemotaxis (GO:0050930),15,4,1.52,+,2.62,6.87E-02
toxin metabolic process (GO:0009404),15,4,1.52,+,2.62,6.87E-02
sodium-independent organic anion transport (GO:0043252),15,4,1.52,+,2.62,6.87E-02
telomere capping (GO:0016233),15,4,1.52,+,2.62,6.87E-02
stress response to metal ion (GO:0097501),15,4,1.52,+,2.62,6.87E-02
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),15,4,1.52,+,2.62,6.87E-02
activation of cysteine-type endopeptidase activity (GO:0097202),15,4,1.52,+,2.62,6.87E-02
parturition (GO:0007567),15,4,1.52,+,2.62,6.87E-02
regulation of keratinocyte proliferation (GO:0010837),34,9,3.46,+,2.6,9.08E-03
mature B cell differentiation involved in immune response (GO:0002313),19,5,1.93,+,2.59,4.66E-02
mRNA cleavage (GO:0006379),19,5,1.93,+,2.59,4.66E-02
DNA strand elongation involved in DNA replication (GO:0006271),19,5,1.93,+,2.59,4.66E-02
regulation of ARF protein signal transduction (GO:0032012),19,5,1.93,+,2.59,4.66E-02
rRNA methylation (GO:0031167),19,5,1.93,+,2.59,4.66E-02
positive regulation of glycoprotein metabolic process (GO:1903020),23,6,2.34,+,2.57,3.20E-02
histone mRNA metabolic process (GO:0008334),23,6,2.34,+,2.57,3.20E-02
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),27,7,2.74,+,2.55,2.21E-02
face morphogenesis (GO:0060325),31,8,3.15,+,2.54,1.54E-02
mRNA destabilization (GO:0061157),31,8,3.15,+,2.54,1.54E-02
cell adhesion mediated by integrin (GO:0033627),24,6,2.44,+,2.46,3.80E-02
tertiary alcohol metabolic process (GO:1902644),12,3,1.22,+,2.46,1.25E-01
glucocorticoid biosynthetic process (GO:0006704),12,3,1.22,+,2.46,1.25E-01
immunological synapse formation (GO:0001771),12,3,1.22,+,2.46,1.25E-01
nerve growth factor signaling pathway (GO:0038180),12,3,1.22,+,2.46,1.25E-01
regulation of histone ubiquitination (GO:0033182),12,3,1.22,+,2.46,1.25E-01
positive regulation of killing of cells of other organism (GO:0051712),12,3,1.22,+,2.46,1.25E-01
negative regulation of platelet aggregation (GO:0090331),12,3,1.22,+,2.46,1.25E-01
pentose-phosphate shunt (GO:0006098),12,3,1.22,+,2.46,1.25E-01
positive regulation of heterochromatin organization (GO:0120263),12,3,1.22,+,2.46,1.25E-01
pre-mRNA cleavage required for polyadenylation (GO:0098789),12,3,1.22,+,2.46,1.25E-01
ruffle organization (GO:0031529),24,6,2.44,+,2.46,3.80E-02
lateral mesoderm development (GO:0048368),12,3,1.22,+,2.46,1.25E-01
positive regulation of heterochromatin assembly (GO:0031453),12,3,1.22,+,2.46,1.25E-01
enamel mineralization (GO:0070166),12,3,1.22,+,2.46,1.25E-01
dopamine transport (GO:0015872),12,3,1.22,+,2.46,1.25E-01
keratan sulfate catabolic process (GO:0042340),12,3,1.22,+,2.46,1.25E-01
fibroblast migration (GO:0010761),12,3,1.22,+,2.46,1.25E-01
DNA strand elongation (GO:0022616),24,6,2.44,+,2.46,3.80E-02
adenohypophysis development (GO:0021984),12,3,1.22,+,2.46,1.25E-01
pyramidal neuron differentiation (GO:0021859),12,3,1.22,+,2.46,1.25E-01
positive regulation of chronic inflammatory response (GO:0002678),4,1,0.41,+,2.46,3.34E-01
heat acclimation (GO:0010286),4,1,0.41,+,2.46,3.34E-01
negative regulation of bone resorption (GO:0045779),16,4,1.63,+,2.46,8.24E-02
positive regulation of cellular amino acid metabolic process (GO:0045764),4,1,0.41,+,2.46,3.34E-01
negative regulation of dendritic cell antigen processing and presentation (GO:0002605),4,1,0.41,+,2.46,3.34E-01
positive regulation of sodium ion export across plasma membrane (GO:1903278),4,1,0.41,+,2.46,3.34E-01
regulation of sodium ion export across plasma membrane (GO:1903276),4,1,0.41,+,2.46,3.34E-01
negative regulation of leukocyte tethering or rolling (GO:1903237),4,1,0.41,+,2.46,3.34E-01
sulfide oxidation (GO:0019418),4,1,0.41,+,2.46,3.34E-01
negative regulation of inner ear receptor cell differentiation (GO:2000981),4,1,0.41,+,2.46,3.34E-01
lung-associated mesenchyme development (GO:0060484),8,2,0.81,+,2.46,1.96E-01
aldehyde biosynthetic process (GO:0046184),8,2,0.81,+,2.46,1.96E-01
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723),4,1,0.41,+,2.46,3.34E-01
inosine metabolic process (GO:0046102),4,1,0.41,+,2.46,3.34E-01
osteoblast proliferation (GO:0033687),4,1,0.41,+,2.46,3.34E-01
negative regulation of mechanoreceptor differentiation (GO:0045632),4,1,0.41,+,2.46,3.34E-01
galactose catabolic process (GO:0019388),8,2,0.81,+,2.46,1.96E-01
negative regulation of inner ear auditory receptor cell differentiation (GO:0045608),4,1,0.41,+,2.46,3.34E-01
integrin activation (GO:0033622),8,2,0.81,+,2.46,1.96E-01
transsulfuration (GO:0019346),4,1,0.41,+,2.46,3.34E-01
pentose biosynthetic process (GO:0019322),4,1,0.41,+,2.46,3.34E-01
UDP-galactose transmembrane transport (GO:0072334),4,1,0.41,+,2.46,3.34E-01
frontal suture morphogenesis (GO:0060364),4,1,0.41,+,2.46,3.34E-01
positive regulation of receptor localization to synapse (GO:1902685),4,1,0.41,+,2.46,3.34E-01
cGMP catabolic process (GO:0046069),4,1,0.41,+,2.46,3.34E-01
positive regulation of androgen receptor activity (GO:2000825),4,1,0.41,+,2.46,3.34E-01
UTP metabolic process (GO:0046051),8,2,0.81,+,2.46,1.96E-01
"positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)",4,1,0.41,+,2.46,3.34E-01
drug transmembrane transport (GO:0006855),8,2,0.81,+,2.46,1.96E-01
carnitine transmembrane transport (GO:1902603),4,1,0.41,+,2.46,3.34E-01
TNFSF11-mediated signaling pathway (GO:0071847),4,1,0.41,+,2.46,3.34E-01
response to hydroxyisoflavone (GO:0033594),4,1,0.41,+,2.46,3.34E-01
positive regulation of protein lipidation (GO:1903061),4,1,0.41,+,2.46,3.34E-01
vestibulocochlear nerve development (GO:0021562),8,2,0.81,+,2.46,1.96E-01
citrulline biosynthetic process (GO:0019240),4,1,0.41,+,2.46,3.34E-01
regulation of opsonization (GO:1903027),4,1,0.41,+,2.46,3.34E-01
cellular detoxification of aldehyde (GO:0110095),8,2,0.81,+,2.46,1.96E-01
regulation of hippocampal neuron apoptotic process (GO:0110089),4,1,0.41,+,2.46,3.34E-01
polyphosphate catabolic process (GO:0006798),4,1,0.41,+,2.46,3.34E-01
endoplasmic reticulum tubular network formation (GO:0071787),4,1,0.41,+,2.46,3.34E-01
positive regulation of apoptotic DNA fragmentation (GO:1902512),4,1,0.41,+,2.46,3.34E-01
immune response in mucosal-associated lymphoid tissue (GO:0002386),4,1,0.41,+,2.46,3.34E-01
defense response to tumor cell (GO:0002357),4,1,0.41,+,2.46,3.34E-01
progesterone biosynthetic process (GO:0006701),4,1,0.41,+,2.46,3.34E-01
positive regulation of histone H2B ubiquitination (GO:2001168),4,1,0.41,+,2.46,3.34E-01
marginal zone B cell differentiation (GO:0002315),8,2,0.81,+,2.46,1.96E-01
Mullerian duct regression (GO:0001880),4,1,0.41,+,2.46,3.34E-01
NK T cell differentiation (GO:0001865),4,1,0.41,+,2.46,3.34E-01
mesonephric duct morphogenesis (GO:0072180),4,1,0.41,+,2.46,3.34E-01
mesonephric tubule formation (GO:0072172),8,2,0.81,+,2.46,1.96E-01
positive regulation of type B pancreatic cell apoptotic process (GO:2000676),4,1,0.41,+,2.46,3.34E-01
regulation of genetic imprinting (GO:2000653),4,1,0.41,+,2.46,3.34E-01
regulation of muscle filament sliding (GO:0032971),4,1,0.41,+,2.46,3.34E-01
positive regulation of ureteric bud formation (GO:0072107),4,1,0.41,+,2.46,3.34E-01
regulation of ureteric bud formation (GO:0072106),4,1,0.41,+,2.46,3.34E-01
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291),4,1,0.41,+,2.46,3.34E-01
negative regulation of smooth muscle cell chemotaxis (GO:0071672),4,1,0.41,+,2.46,3.34E-01
ATP generation from poly-ADP-D-ribose (GO:1990966),4,1,0.41,+,2.46,3.34E-01
response to molecule of fungal origin (GO:0002238),4,1,0.41,+,2.46,3.34E-01
protein localization to secretory granule (GO:0033366),4,1,0.41,+,2.46,3.34E-01
late viral transcription (GO:0019086),4,1,0.41,+,2.46,3.34E-01
establishment of T cell polarity (GO:0001768),8,2,0.81,+,2.46,1.96E-01
metanephric renal vesicle formation (GO:0072093),4,1,0.41,+,2.46,3.34E-01
specification of loop of Henle identity (GO:0072086),4,1,0.41,+,2.46,3.34E-01
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),4,1,0.41,+,2.46,3.34E-01
formation of translation preinitiation complex (GO:0001731),8,2,0.81,+,2.46,1.96E-01
protein localization to plasma membrane raft (GO:0044860),4,1,0.41,+,2.46,3.34E-01
"positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)",4,1,0.41,+,2.46,3.34E-01
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040),4,1,0.41,+,2.46,3.34E-01
"regulation of vacuole fusion, non-autophagic (GO:0032889)",4,1,0.41,+,2.46,3.34E-01
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039),4,1,0.41,+,2.46,3.34E-01
negative regulation of T-helper 2 cell cytokine production (GO:2000552),4,1,0.41,+,2.46,3.34E-01
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546),4,1,0.41,+,2.46,3.34E-01
neurofilament cytoskeleton organization (GO:0060052),8,2,0.81,+,2.46,1.96E-01
positive regulation of dendritic cell chemotaxis (GO:2000510),8,2,0.81,+,2.46,1.96E-01
valine catabolic process (GO:0006574),4,1,0.41,+,2.46,3.34E-01
threonine catabolic process (GO:0006567),4,1,0.41,+,2.46,3.34E-01
proline catabolic process (GO:0006562),4,1,0.41,+,2.46,3.34E-01
leucine metabolic process (GO:0006551),8,2,0.81,+,2.46,1.96E-01
glycine biosynthetic process (GO:0006545),4,1,0.41,+,2.46,3.34E-01
aspartate catabolic process (GO:0006533),4,1,0.41,+,2.46,3.34E-01
osteoclast proliferation (GO:0002158),4,1,0.41,+,2.46,3.34E-01
gamma-aminobutyric acid import (GO:0051939),4,1,0.41,+,2.46,3.34E-01
maternal aggressive behavior (GO:0002125),4,1,0.41,+,2.46,3.34E-01
telomerase RNA stabilization (GO:0090669),4,1,0.41,+,2.46,3.34E-01
cerebrospinal fluid circulation (GO:0090660),4,1,0.41,+,2.46,3.34E-01
negative regulation of protein sumoylation (GO:0033234),8,2,0.81,+,2.46,1.96E-01
positive regulation of interleukin-18 production (GO:0032741),4,1,0.41,+,2.46,3.34E-01
regulation of thymocyte migration (GO:2000410),4,1,0.41,+,2.46,3.34E-01
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),4,1,0.41,+,2.46,3.34E-01
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202),4,1,0.41,+,2.46,3.34E-01
gamma-aminobutyric acid secretion (GO:0014051),4,1,0.41,+,2.46,3.34E-01
neural crest cell fate commitment (GO:0014034),4,1,0.41,+,2.46,3.34E-01
cellular response to histamine (GO:0071420),8,2,0.81,+,2.46,1.96E-01
desensitization of G protein-coupled receptor signaling pathway (GO:0002029),16,4,1.63,+,2.46,8.24E-02
renin-angiotensin regulation of aldosterone production (GO:0002018),4,1,0.41,+,2.46,3.34E-01
response to vitamin A (GO:0033189),20,5,2.03,+,2.46,5.56E-02
xylulose metabolic process (GO:0005997),4,1,0.41,+,2.46,3.34E-01
"nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)",4,1,0.41,+,2.46,3.34E-01
regulation of neutrophil mediated killing of symbiont cell (GO:0070949),4,1,0.41,+,2.46,3.34E-01
luteinization (GO:0001553),8,2,0.81,+,2.46,1.96E-01
regulation of glucocorticoid receptor signaling pathway (GO:2000322),8,2,0.81,+,2.46,1.96E-01
transcription initiation from mitochondrial promoter (GO:0006391),4,1,0.41,+,2.46,3.34E-01
adenosine to inosine editing (GO:0006382),8,2,0.81,+,2.46,1.96E-01
interleukin-10 production (GO:0032613),4,1,0.41,+,2.46,3.34E-01
negative regulation of hair follicle development (GO:0051799),4,1,0.41,+,2.46,3.34E-01
"meiotic sister chromatid cohesion, centromeric (GO:0051754)",4,1,0.41,+,2.46,3.34E-01
positive regulation of superoxide dismutase activity (GO:1901671),4,1,0.41,+,2.46,3.34E-01
regulation of superoxide dismutase activity (GO:1901668),4,1,0.41,+,2.46,3.34E-01
positive regulation of immature T cell proliferation in thymus (GO:0033092),4,1,0.41,+,2.46,3.34E-01
protein de-ADP-ribosylation (GO:0051725),4,1,0.41,+,2.46,3.34E-01
protein insertion into mitochondrial outer membrane (GO:0045040),4,1,0.41,+,2.46,3.34E-01
depyrimidination (GO:0045008),8,2,0.81,+,2.46,1.96E-01
regulation of vesicle transport along microtubule (GO:1901608),4,1,0.41,+,2.46,3.34E-01
doxorubicin metabolic process (GO:0044598),8,2,0.81,+,2.46,1.96E-01
daunorubicin metabolic process (GO:0044597),8,2,0.81,+,2.46,1.96E-01
stress-induced premature senescence (GO:0090400),8,2,0.81,+,2.46,1.96E-01
[2Fe-2S] cluster assembly (GO:0044571),4,1,0.41,+,2.46,3.34E-01
response to vitamin K (GO:0032571),4,1,0.41,+,2.46,3.34E-01
lagging strand elongation (GO:0006273),4,1,0.41,+,2.46,3.34E-01
cellular response to cobalt ion (GO:0071279),4,1,0.41,+,2.46,3.34E-01
protein K69-linked ufmylation (GO:1990592),4,1,0.41,+,2.46,3.34E-01
protein polyufmylation (GO:1990564),4,1,0.41,+,2.46,3.34E-01
negative regulation of gonad development (GO:1905940),4,1,0.41,+,2.46,3.34E-01
bone regeneration (GO:1990523),4,1,0.41,+,2.46,3.34E-01
piRNA biosynthetic process (GO:1990511),4,1,0.41,+,2.46,3.34E-01
regulation of progesterone biosynthetic process (GO:2000182),4,1,0.41,+,2.46,3.34E-01
age-dependent response to oxidative stress (GO:0001306),4,1,0.41,+,2.46,3.34E-01
chronological cell aging (GO:0001300),4,1,0.41,+,2.46,3.34E-01
otolith morphogenesis (GO:0032474),4,1,0.41,+,2.46,3.34E-01
synaptic vesicle endosomal processing (GO:0099532),8,2,0.81,+,2.46,1.96E-01
peptidyl-cysteine oxidation (GO:0018171),4,1,0.41,+,2.46,3.34E-01
protein urmylation (GO:0032447),4,1,0.41,+,2.46,3.34E-01
GTP biosynthetic process (GO:0006183),8,2,0.81,+,2.46,1.96E-01
regulation of mismatch repair (GO:0032423),4,1,0.41,+,2.46,3.34E-01
melanosome transport (GO:0032402),20,5,2.03,+,2.46,5.56E-02
methylglyoxal catabolic process (GO:0051596),4,1,0.41,+,2.46,3.34E-01
establishment of protein localization to chromatin (GO:0071169),4,1,0.41,+,2.46,3.34E-01
protein citrullination (GO:0018101),4,1,0.41,+,2.46,3.34E-01
epididymis development (GO:1905867),4,1,0.41,+,2.46,3.34E-01
oxaloacetate metabolic process (GO:0006107),8,2,0.81,+,2.46,1.96E-01
fumarate metabolic process (GO:0006106),4,1,0.41,+,2.46,3.34E-01
succinate metabolic process (GO:0006105),4,1,0.41,+,2.46,3.34E-01
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),4,1,0.41,+,2.46,3.34E-01
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441),4,1,0.41,+,2.46,3.34E-01
pyruvate transmembrane transport (GO:1901475),4,1,0.41,+,2.46,3.34E-01
regulation of tetrapyrrole metabolic process (GO:1901401),4,1,0.41,+,2.46,3.34E-01
negative regulation of cortisol biosynthetic process (GO:2000065),4,1,0.41,+,2.46,3.34E-01
negative regulation of aldosterone biosynthetic process (GO:0032348),4,1,0.41,+,2.46,3.34E-01
negative regulation of aldosterone metabolic process (GO:0032345),4,1,0.41,+,2.46,3.34E-01
regulation of male gonad development (GO:2000018),8,2,0.81,+,2.46,1.96E-01
negative regulation of DNA damage checkpoint (GO:2000002),4,1,0.41,+,2.46,3.34E-01
regulation of DNA helicase activity (GO:1905774),4,1,0.41,+,2.46,3.34E-01
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),4,1,0.41,+,2.46,3.34E-01
meiotic mismatch repair (GO:0000710),4,1,0.41,+,2.46,3.34E-01
mannose metabolic process (GO:0006013),8,2,0.81,+,2.46,1.96E-01
glucose catabolic process (GO:0006007),28,7,2.85,+,2.46,2.62E-02
fucose metabolic process (GO:0006004),16,4,1.63,+,2.46,8.24E-02
fructose catabolic process (GO:0006001),4,1,0.41,+,2.46,3.34E-01
negative regulation of ubiquitin-protein transferase activity (GO:0051444),16,4,1.63,+,2.46,8.24E-02
telomeric 3' overhang formation (GO:0031860),4,1,0.41,+,2.46,3.34E-01
detoxification of nitrogen compound (GO:0051410),4,1,0.41,+,2.46,3.34E-01
sensory perception of umami taste (GO:0050917),4,1,0.41,+,2.46,3.34E-01
protein maturation by [4Fe-4S] cluster transfer (GO:0106035),4,1,0.41,+,2.46,3.34E-01
positive regulation of nucleobase-containing compound transport (GO:0032241),8,2,0.81,+,2.46,1.96E-01
activation of store-operated calcium channel activity (GO:0032237),4,1,0.41,+,2.46,3.34E-01
"positive regulation of synaptic transmission, cholinergic (GO:0032224)",4,1,0.41,+,2.46,3.34E-01
negative regulation of protein deubiquitination (GO:0090086),4,1,0.41,+,2.46,3.34E-01
cellular detoxification of nitrogen compound (GO:0070458),4,1,0.41,+,2.46,3.34E-01
positive regulation of response to nutrient levels (GO:0032109),4,1,0.41,+,2.46,3.34E-01
positive regulation of response to extracellular stimulus (GO:0032106),4,1,0.41,+,2.46,3.34E-01
positive regulation of appetite (GO:0032100),4,1,0.41,+,2.46,3.34E-01
xenophagy (GO:0098792),4,1,0.41,+,2.46,3.34E-01
regulation of blood vessel branching (GO:1905553),4,1,0.41,+,2.46,3.34E-01
dicarboxylic acid catabolic process (GO:0043649),16,4,1.63,+,2.46,8.24E-02
primary amino compound biosynthetic process (GO:1901162),4,1,0.41,+,2.46,3.34E-01
positive regulation of fertilization (GO:1905516),4,1,0.41,+,2.46,3.34E-01
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630),4,1,0.41,+,2.46,3.34E-01
Harderian gland development (GO:0070384),4,1,0.41,+,2.46,3.34E-01
cellular heat acclimation (GO:0070370),4,1,0.41,+,2.46,3.34E-01
positive regulation of fat cell proliferation (GO:0070346),4,1,0.41,+,2.46,3.34E-01
regulation of translation in response to endoplasmic reticulum stress (GO:0036490),8,2,0.81,+,2.46,1.96E-01
ventral trunk neural crest cell migration (GO:0036486),4,1,0.41,+,2.46,3.34E-01
trunk neural crest cell migration (GO:0036484),4,1,0.41,+,2.46,3.34E-01
positive regulation of response to food (GO:0032097),4,1,0.41,+,2.46,3.34E-01
positive regulation of endodeoxyribonuclease activity (GO:0032079),4,1,0.41,+,2.46,3.34E-01
histone citrullination (GO:0036414),4,1,0.41,+,2.46,3.34E-01
negative regulation of translational initiation in response to stress (GO:0032057),4,1,0.41,+,2.46,3.34E-01
box C/D snoRNP assembly (GO:0000492),8,2,0.81,+,2.46,1.96E-01
cardiolipin acyl-chain remodeling (GO:0035965),8,2,0.81,+,2.46,1.96E-01
"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)",4,1,0.41,+,2.46,3.34E-01
negative regulation of actin nucleation (GO:0051126),8,2,0.81,+,2.46,1.96E-01
hepoxilin biosynthetic process (GO:0051122),8,2,0.81,+,2.46,1.96E-01
hepoxilin metabolic process (GO:0051121),8,2,0.81,+,2.46,1.96E-01
response to isolation stress (GO:0035900),8,2,0.81,+,2.46,1.96E-01
skeletal muscle fiber adaptation (GO:0043503),4,1,0.41,+,2.46,3.34E-01
retinal cell apoptotic process (GO:1990009),4,1,0.41,+,2.46,3.34E-01
negative regulation of retinoic acid receptor signaling pathway (GO:0048387),8,2,0.81,+,2.46,1.96E-01
"sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)",4,1,0.41,+,2.46,3.34E-01
protein poly-ADP-ribosylation (GO:0070212),8,2,0.81,+,2.46,1.96E-01
negative regulation of membrane protein ectodomain proteolysis (GO:0051045),8,2,0.81,+,2.46,1.96E-01
gene conversion (GO:0035822),4,1,0.41,+,2.46,3.34E-01
regulation of gastric motility (GO:1905333),4,1,0.41,+,2.46,3.34E-01
negative regulation of renal sodium excretion (GO:0035814),4,1,0.41,+,2.46,3.34E-01
snRNA transport (GO:0051030),4,1,0.41,+,2.46,3.34E-01
telomerase holoenzyme complex assembly (GO:1905323),4,1,0.41,+,2.46,3.34E-01
response to methotrexate (GO:0031427),4,1,0.41,+,2.46,3.34E-01
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986),4,1,0.41,+,2.46,3.34E-01
negative regulation of adiponectin secretion (GO:0070164),4,1,0.41,+,2.46,3.34E-01
snoRNA localization (GO:0048254),4,1,0.41,+,2.46,3.34E-01
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849),4,1,0.41,+,2.46,3.34E-01
regulation of interleukin-6-mediated signaling pathway (GO:0070103),4,1,0.41,+,2.46,3.34E-01
9-cis-retinoic acid metabolic process (GO:0042905),4,1,0.41,+,2.46,3.34E-01
9-cis-retinoic acid biosynthetic process (GO:0042904),4,1,0.41,+,2.46,3.34E-01
regulation of corticotropin-releasing hormone secretion (GO:0043397),4,1,0.41,+,2.46,3.34E-01
positive regulation of epithelial tube formation (GO:1905278),8,2,0.81,+,2.46,1.96E-01
regulation of epithelial tube formation (GO:1905276),8,2,0.81,+,2.46,1.96E-01
natural killer cell degranulation (GO:0043320),4,1,0.41,+,2.46,3.34E-01
T-helper 1 cell activation (GO:0035711),4,1,0.41,+,2.46,3.34E-01
regulation of neutrophil degranulation (GO:0043313),8,2,0.81,+,2.46,1.96E-01
putrescine metabolic process (GO:0009445),8,2,0.81,+,2.46,1.96E-01
regulation of protein localization to cell cortex (GO:1904776),8,2,0.81,+,2.46,1.96E-01
pyruvate biosynthetic process (GO:0042866),4,1,0.41,+,2.46,3.34E-01
regulation of myofibroblast differentiation (GO:1904760),4,1,0.41,+,2.46,3.34E-01
nucleosome positioning (GO:0016584),8,2,0.81,+,2.46,1.96E-01
positive regulation of mRNA polyadenylation (GO:1900365),4,1,0.41,+,2.46,3.34E-01
regulation of chaperone-mediated autophagy (GO:1904714),8,2,0.81,+,2.46,1.96E-01
mitochondrial protein catabolic process (GO:0035694),4,1,0.41,+,2.46,3.34E-01
B cell costimulation (GO:0031296),4,1,0.41,+,2.46,3.34E-01
positive regulation of cytoplasmic translational initiation (GO:1904690),4,1,0.41,+,2.46,3.34E-01
negative regulation of metalloendopeptidase activity (GO:1904684),4,1,0.41,+,2.46,3.34E-01
negative regulation of somatic stem cell population maintenance (GO:1904673),4,1,0.41,+,2.46,3.34E-01
nucleosome mobilization (GO:0042766),4,1,0.41,+,2.46,3.34E-01
regulation of cardiolipin metabolic process (GO:1900208),4,1,0.41,+,2.46,3.34E-01
GDP-mannose biosynthetic process (GO:0009298),4,1,0.41,+,2.46,3.34E-01
long-chain fatty acid import into peroxisome (GO:0015910),4,1,0.41,+,2.46,3.34E-01
follicle-stimulating hormone signaling pathway (GO:0042699),4,1,0.41,+,2.46,3.34E-01
polyketide metabolic process (GO:0030638),8,2,0.81,+,2.46,1.96E-01
secretory granule maturation (GO:0061792),4,1,0.41,+,2.46,3.34E-01
regulation of histone H3-K9 dimethylation (GO:1900109),4,1,0.41,+,2.46,3.34E-01
methylglyoxal catabolic process to lactate (GO:0061727),4,1,0.41,+,2.46,3.34E-01
carnitine transport (GO:0015879),4,1,0.41,+,2.46,3.34E-01
extracellular matrix-cell signaling (GO:0035426),4,1,0.41,+,2.46,3.34E-01
ketone body catabolic process (GO:0046952),4,1,0.41,+,2.46,3.34E-01
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903),4,1,0.41,+,2.46,3.34E-01
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),4,1,0.41,+,2.46,3.34E-01
homoserine metabolic process (GO:0009092),4,1,0.41,+,2.46,3.34E-01
positive regulation of hippo signaling (GO:0035332),4,1,0.41,+,2.46,3.34E-01
fructose transmembrane transport (GO:0015755),4,1,0.41,+,2.46,3.34E-01
alpha-ketoglutarate transport (GO:0015742),4,1,0.41,+,2.46,3.34E-01
canalicular bile acid transport (GO:0015722),4,1,0.41,+,2.46,3.34E-01
"pentose-phosphate shunt, oxidative branch (GO:0009051)",4,1,0.41,+,2.46,3.34E-01
positive regulation of odontogenesis (GO:0042482),4,1,0.41,+,2.46,3.34E-01
regulation of transepithelial transport (GO:0150111),4,1,0.41,+,2.46,3.34E-01
indole-containing compound biosynthetic process (GO:0042435),4,1,0.41,+,2.46,3.34E-01
targeting of mRNA for destruction involved in RNA interference (GO:0030423),4,1,0.41,+,2.46,3.34E-01
positive regulation of PERK-mediated unfolded protein response (GO:1903899),4,1,0.41,+,2.46,3.34E-01
regulation of ATF6-mediated unfolded protein response (GO:1903891),4,1,0.41,+,2.46,3.34E-01
diterpenoid catabolic process (GO:0016103),4,1,0.41,+,2.46,3.34E-01
trunk segmentation (GO:0035290),4,1,0.41,+,2.46,3.34E-01
glutathione transmembrane transport (GO:0034775),4,1,0.41,+,2.46,3.34E-01
sympathetic neuron projection guidance (GO:0097491),4,1,0.41,+,2.46,3.34E-01
sympathetic neuron projection extension (GO:0097490),4,1,0.41,+,2.46,3.34E-01
clathrin-dependent synaptic vesicle endocytosis (GO:0150007),4,1,0.41,+,2.46,3.34E-01
polyprenol metabolic process (GO:0016093),8,2,0.81,+,2.46,1.96E-01
kidney vasculature morphogenesis (GO:0061439),8,2,0.81,+,2.46,1.96E-01
renal system vasculature morphogenesis (GO:0061438),8,2,0.81,+,2.46,1.96E-01
positive regulation of phospholipid metabolic process (GO:1903727),16,4,1.63,+,2.46,8.24E-02
lipid tube assembly (GO:0060988),4,1,0.41,+,2.46,3.34E-01
operant conditioning (GO:0035106),4,1,0.41,+,2.46,3.34E-01
response to pyrethroid (GO:0046684),4,1,0.41,+,2.46,3.34E-01
retinoic acid catabolic process (GO:0034653),4,1,0.41,+,2.46,3.34E-01
cortisol metabolic process (GO:0034650),4,1,0.41,+,2.46,3.34E-01
regulation of alkaline phosphatase activity (GO:0010692),8,2,0.81,+,2.46,1.96E-01
protein to membrane docking (GO:0022615),4,1,0.41,+,2.46,3.34E-01
isoprenoid catabolic process (GO:0008300),8,2,0.81,+,2.46,1.96E-01
"positive regulation of wound healing, spreading of epidermal cells (GO:1903691)",4,1,0.41,+,2.46,3.34E-01
adaptation of signaling pathway (GO:0023058),16,4,1.63,+,2.46,8.24E-02
retinal pigment epithelium development (GO:0003406),4,1,0.41,+,2.46,3.34E-01
hematopoietic stem cell migration to bone marrow (GO:0097241),4,1,0.41,+,2.46,3.34E-01
regulation of lung blood pressure (GO:0014916),4,1,0.41,+,2.46,3.34E-01
negative regulation of mature B cell apoptotic process (GO:0002906),4,1,0.41,+,2.46,3.34E-01
regulation of mature B cell apoptotic process (GO:0002905),4,1,0.41,+,2.46,3.34E-01
androgen metabolic process (GO:0008209),28,7,2.85,+,2.46,2.62E-02
positive regulation of histamine secretion by mast cell (GO:1903595),4,1,0.41,+,2.46,3.34E-01
regulation of histamine secretion by mast cell (GO:1903593),4,1,0.41,+,2.46,3.34E-01
positive regulation of membrane tubulation (GO:1903527),4,1,0.41,+,2.46,3.34E-01
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),8,2,0.81,+,2.46,1.96E-01
dynamin family protein polymerization involved in membrane fission (GO:0003373),8,2,0.81,+,2.46,1.96E-01
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750),4,1,0.41,+,2.46,3.34E-01
positive regulation of extracellular matrix constituent secretion (GO:0003331),4,1,0.41,+,2.46,3.34E-01
prostate gland morphogenetic growth (GO:0060737),4,1,0.41,+,2.46,3.34E-01
Wnt signaling pathway involved in heart development (GO:0003306),4,1,0.41,+,2.46,3.34E-01
response to carbon monoxide (GO:0034465),4,1,0.41,+,2.46,3.34E-01
epithelial fluid transport (GO:0042045),8,2,0.81,+,2.46,1.96E-01
glycoprotein transport (GO:0034436),4,1,0.41,+,2.46,3.34E-01
cholesterol esterification (GO:0034435),4,1,0.41,+,2.46,3.34E-01
sterol esterification (GO:0034434),4,1,0.41,+,2.46,3.34E-01
steroid esterification (GO:0034433),4,1,0.41,+,2.46,3.34E-01
negative regulation of skeletal muscle cell proliferation (GO:0014859),4,1,0.41,+,2.46,3.34E-01
intestine smooth muscle contraction (GO:0014827),4,1,0.41,+,2.46,3.34E-01
negative adaptation of signaling pathway (GO:0022401),16,4,1.63,+,2.46,8.24E-02
regulation of chondrocyte development (GO:0061181),4,1,0.41,+,2.46,3.34E-01
regulation of female receptivity (GO:0045924),8,2,0.81,+,2.46,1.96E-01
GDP-mannose metabolic process (GO:0019673),8,2,0.81,+,2.46,1.96E-01
regulation of mitotic cell cycle DNA replication (GO:1903463),4,1,0.41,+,2.46,3.34E-01
pancreas morphogenesis (GO:0061113),4,1,0.41,+,2.46,3.34E-01
eosinophil migration (GO:0072677),16,4,1.63,+,2.46,8.24E-02
multinuclear osteoclast differentiation (GO:0072674),8,2,0.81,+,2.46,1.96E-01
growth involved in heart morphogenesis (GO:0003241),4,1,0.41,+,2.46,3.34E-01
mesenchymal-epithelial cell signaling (GO:0060638),8,2,0.81,+,2.46,1.96E-01
regulation of chromosome condensation (GO:0060623),4,1,0.41,+,2.46,3.34E-01
Fc receptor mediated inhibitory signaling pathway (GO:0002774),4,1,0.41,+,2.46,3.34E-01
mature conventional dendritic cell differentiation (GO:0097029),4,1,0.41,+,2.46,3.34E-01
establishment of blood-nerve barrier (GO:0008065),4,1,0.41,+,2.46,3.34E-01
myeloid leukocyte cytokine production (GO:0061082),4,1,0.41,+,2.46,3.34E-01
positive regulation of membrane potential (GO:0045838),16,4,1.63,+,2.46,8.24E-02
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),4,1,0.41,+,2.46,3.34E-01
vascular wound healing (GO:0061042),8,2,0.81,+,2.46,1.96E-01
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888),4,1,0.41,+,2.46,3.34E-01
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886),4,1,0.41,+,2.46,3.34E-01
hypothalamus cell migration (GO:0021855),4,1,0.41,+,2.46,3.34E-01
age-dependent general metabolic decline (GO:0007571),4,1,0.41,+,2.46,3.34E-01
L-threonine catabolic process to glycine (GO:0019518),4,1,0.41,+,2.46,3.34E-01
endothelial cell apoptotic process (GO:0072577),8,2,0.81,+,2.46,1.96E-01
liver morphogenesis (GO:0072576),8,2,0.81,+,2.46,1.96E-01
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815),4,1,0.41,+,2.46,3.34E-01
chondroblast differentiation (GO:0060591),4,1,0.41,+,2.46,3.34E-01
regulation of fertilization (GO:0080154),8,2,0.81,+,2.46,1.96E-01
formaldehyde metabolic process (GO:0046292),4,1,0.41,+,2.46,3.34E-01
pyridine-containing compound catabolic process (GO:0072526),4,1,0.41,+,2.46,3.34E-01
positive regulation of secondary heart field cardioblast proliferation (GO:0072513),4,1,0.41,+,2.46,3.34E-01
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528),4,1,0.41,+,2.46,3.34E-01
prostatic bud formation (GO:0060513),4,1,0.41,+,2.46,3.34E-01
negative regulation of netrin-activated signaling pathway (GO:1902842),4,1,0.41,+,2.46,3.34E-01
regulation of netrin-activated signaling pathway (GO:1902841),4,1,0.41,+,2.46,3.34E-01
indolalkylamine biosynthetic process (GO:0046219),4,1,0.41,+,2.46,3.34E-01
positive regulation of macrophage fusion (GO:0034241),4,1,0.41,+,2.46,3.34E-01
regulation of macrophage fusion (GO:0034239),4,1,0.41,+,2.46,3.34E-01
cellular response to glucose starvation (GO:0042149),45,11,4.57,+,2.4,7.40E-03
transferrin transport (GO:0033572),33,8,3.35,+,2.38,2.14E-02
reproductive behavior (GO:0019098),29,7,2.95,+,2.37,3.08E-02
response to immobilization stress (GO:0035902),29,7,2.95,+,2.37,3.08E-02
pigment granule transport (GO:0051904),21,5,2.13,+,2.34,6.55E-02
cellular response to pH (GO:0071467),21,5,2.13,+,2.34,6.55E-02
regulation of T-helper 17 type immune response (GO:2000316),21,5,2.13,+,2.34,6.55E-02
regulation of lymphocyte chemotaxis (GO:1901623),21,5,2.13,+,2.34,6.55E-02
establishment of melanosome localization (GO:0032401),21,5,2.13,+,2.34,6.55E-02
olefinic compound biosynthetic process (GO:0120255),21,5,2.13,+,2.34,6.55E-02
positive regulation of glycoprotein biosynthetic process (GO:0010560),21,5,2.13,+,2.34,6.55E-02
branching involved in salivary gland morphogenesis (GO:0060445),17,4,1.73,+,2.31,9.74E-02
blastoderm segmentation (GO:0007350),17,4,1.73,+,2.31,9.74E-02
dendritic cell chemotaxis (GO:0002407),17,4,1.73,+,2.31,9.74E-02
positive regulation of lymphocyte chemotaxis (GO:0140131),17,4,1.73,+,2.31,9.74E-02
neurotransmitter reuptake (GO:0098810),17,4,1.73,+,2.31,9.74E-02
RNA destabilization (GO:0050779),34,8,3.46,+,2.31,2.50E-02
"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)",17,4,1.73,+,2.31,9.74E-02
cellular response to thyroid hormone stimulus (GO:0097067),17,4,1.73,+,2.31,9.74E-02
hexose catabolic process (GO:0019320),47,11,4.78,+,2.3,9.99E-03
cellular response to dexamethasone stimulus (GO:0071549),30,7,3.05,+,2.3,3.59E-02
rRNA modification (GO:0000154),30,7,3.05,+,2.3,3.59E-02
regulation of TORC1 signaling (GO:1903432),30,7,3.05,+,2.3,3.59E-02
positive regulation of chromatin assembly or disassembly (GO:0045799),13,3,1.32,+,2.27,1.48E-01
midgut development (GO:0007494),13,3,1.32,+,2.27,1.48E-01
tripartite regional subdivision (GO:0007351),13,3,1.32,+,2.27,1.48E-01
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),13,3,1.32,+,2.27,1.48E-01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),13,3,1.32,+,2.27,1.48E-01
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),13,3,1.32,+,2.27,1.48E-01
positive regulation of gene silencing by miRNA (GO:2000637),26,6,2.64,+,2.27,5.21E-02
positive regulation of protein sumoylation (GO:0033235),13,3,1.32,+,2.27,1.48E-01
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),13,3,1.32,+,2.27,1.48E-01
negative regulation of cilium assembly (GO:1902018),13,3,1.32,+,2.27,1.48E-01
cellular response to copper ion (GO:0071280),26,6,2.64,+,2.27,5.21E-02
Golgi localization (GO:0051645),13,3,1.32,+,2.27,1.48E-01
positive regulation of cell aging (GO:0090343),13,3,1.32,+,2.27,1.48E-01
protein oxidation (GO:0018158),13,3,1.32,+,2.27,1.48E-01
regulation of relaxation of muscle (GO:1901077),13,3,1.32,+,2.27,1.48E-01
"CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)",13,3,1.32,+,2.27,1.48E-01
G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589),13,3,1.32,+,2.27,1.48E-01
snoRNA processing (GO:0043144),13,3,1.32,+,2.27,1.48E-01
progesterone metabolic process (GO:0042448),13,3,1.32,+,2.27,1.48E-01
"anterior/posterior axis specification, embryo (GO:0008595)",13,3,1.32,+,2.27,1.48E-01
regulation of skeletal muscle satellite cell proliferation (GO:0014842),13,3,1.32,+,2.27,1.48E-01
P-body assembly (GO:0033962),13,3,1.32,+,2.27,1.48E-01
eyelid development in camera-type eye (GO:0061029),13,3,1.32,+,2.27,1.48E-01
heterotypic cell-cell adhesion (GO:0034113),35,8,3.56,+,2.25,2.89E-02
establishment of pigment granule localization (GO:0051905),22,5,2.24,+,2.24,7.64E-02
positive regulation of mRNA processing (GO:0050685),31,7,3.15,+,2.22,4.16E-02
positive regulation of posttranscriptional gene silencing (GO:0060148),27,6,2.74,+,2.19,6.02E-02
neurotransmitter uptake (GO:0001504),27,6,2.74,+,2.19,6.02E-02
homeostasis of number of cells within a tissue (GO:0048873),27,6,2.74,+,2.19,6.02E-02
hair follicle morphogenesis (GO:0031069),27,6,2.74,+,2.19,6.02E-02
myotube cell development (GO:0014904),27,6,2.74,+,2.19,6.02E-02
positive regulation of antigen processing and presentation (GO:0002579),9,2,0.91,+,2.19,2.33E-01
negative regulation of antigen processing and presentation (GO:0002578),9,2,0.91,+,2.19,2.33E-01
negative regulation of erythrocyte differentiation (GO:0045647),9,2,0.91,+,2.19,2.33E-01
cerebellar granular layer morphogenesis (GO:0021683),9,2,0.91,+,2.19,2.33E-01
negative regulation of cell adhesion mediated by integrin (GO:0033629),9,2,0.91,+,2.19,2.33E-01
fucose catabolic process (GO:0019317),9,2,0.91,+,2.19,2.33E-01
regulation of heart morphogenesis (GO:2000826),9,2,0.91,+,2.19,2.33E-01
head morphogenesis (GO:0060323),36,8,3.66,+,2.19,3.32E-02
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),9,2,0.91,+,2.19,2.33E-01
positive regulation of autophagosome assembly (GO:2000786),9,2,0.91,+,2.19,2.33E-01
detection of cell density (GO:0060245),9,2,0.91,+,2.19,2.33E-01
contact inhibition (GO:0060242),9,2,0.91,+,2.19,2.33E-01
"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",9,2,0.91,+,2.19,2.33E-01
female mating behavior (GO:0060180),9,2,0.91,+,2.19,2.33E-01
regulation of glomerular mesangial cell proliferation (GO:0072124),9,2,0.91,+,2.19,2.33E-01
regulation of histone H3-K9 acetylation (GO:2000615),9,2,0.91,+,2.19,2.33E-01
positive regulation of transforming growth factor beta production (GO:0071636),18,4,1.83,+,2.19,1.13E-01
dense core granule transport (GO:1901950),9,2,0.91,+,2.19,2.33E-01
establishment of lymphocyte polarity (GO:0001767),9,2,0.91,+,2.19,2.33E-01
thyroid hormone generation (GO:0006590),18,4,1.83,+,2.19,1.13E-01
regulation of dendritic cell chemotaxis (GO:2000508),9,2,0.91,+,2.19,2.33E-01
arginine catabolic process (GO:0006527),9,2,0.91,+,2.19,2.33E-01
nodal signaling pathway (GO:0038092),9,2,0.91,+,2.19,2.33E-01
cellular hypotonic response (GO:0071476),9,2,0.91,+,2.19,2.33E-01
osteoblast development (GO:0002076),18,4,1.83,+,2.19,1.13E-01
meiotic sister chromatid segregation (GO:0045144),9,2,0.91,+,2.19,2.33E-01
antiviral innate immune response (GO:0140374),9,2,0.91,+,2.19,2.33E-01
fatty acid alpha-oxidation (GO:0001561),9,2,0.91,+,2.19,2.33E-01
regulation of T-helper 17 cell differentiation (GO:2000319),18,4,1.83,+,2.19,1.13E-01
interleukin-4 production (GO:0032633),9,2,0.91,+,2.19,2.33E-01
DNA replication-dependent nucleosome assembly (GO:0006335),9,2,0.91,+,2.19,2.33E-01
stem cell fate commitment (GO:0048865),9,2,0.91,+,2.19,2.33E-01
dense core granule cytoskeletal transport (GO:0099519),9,2,0.91,+,2.19,2.33E-01
regulation of arachidonic acid secretion (GO:0090237),9,2,0.91,+,2.19,2.33E-01
cardiac muscle fiber development (GO:0048739),9,2,0.91,+,2.19,2.33E-01
ethanol catabolic process (GO:0006068),9,2,0.91,+,2.19,2.33E-01
microtubule nucleation by microtubule organizing center (GO:0051418),9,2,0.91,+,2.19,2.33E-01
dense core granule localization (GO:0032253),9,2,0.91,+,2.19,2.33E-01
cellular response to leucine starvation (GO:1990253),9,2,0.91,+,2.19,2.33E-01
hydrocarbon metabolic process (GO:0120252),9,2,0.91,+,2.19,2.33E-01
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),9,2,0.91,+,2.19,2.33E-01
macrophage migration (GO:1905517),18,4,1.83,+,2.19,1.13E-01
tongue morphogenesis (GO:0043587),9,2,0.91,+,2.19,2.33E-01
meiotic sister chromatid cohesion (GO:0051177),9,2,0.91,+,2.19,2.33E-01
response to light intensity (GO:0009642),9,2,0.91,+,2.19,2.33E-01
DNA ligation involved in DNA repair (GO:0051103),9,2,0.91,+,2.19,2.33E-01
response to gravity (GO:0009629),9,2,0.91,+,2.19,2.33E-01
regulation of mucus secretion (GO:0070255),9,2,0.91,+,2.19,2.33E-01
synaptic vesicle budding (GO:0070142),9,2,0.91,+,2.19,2.33E-01
regulation of glucagon secretion (GO:0070092),9,2,0.91,+,2.19,2.33E-01
telomere maintenance in response to DNA damage (GO:0043247),9,2,0.91,+,2.19,2.33E-01
regulation of somatic stem cell population maintenance (GO:1904672),9,2,0.91,+,2.19,2.33E-01
negative regulation of amyloid-beta clearance (GO:1900222),9,2,0.91,+,2.19,2.33E-01
mitochondrial genome maintenance (GO:0000002),18,4,1.83,+,2.19,1.13E-01
aminoglycoside antibiotic metabolic process (GO:0030647),9,2,0.91,+,2.19,2.33E-01
positive regulation of execution phase of apoptosis (GO:1900119),9,2,0.91,+,2.19,2.33E-01
negative regulation of bone remodeling (GO:0046851),18,4,1.83,+,2.19,1.13E-01
glycoside catabolic process (GO:0016139),9,2,0.91,+,2.19,2.33E-01
L-fucose catabolic process (GO:0042355),9,2,0.91,+,2.19,2.33E-01
L-fucose metabolic process (GO:0042354),9,2,0.91,+,2.19,2.33E-01
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",9,2,0.91,+,2.19,2.33E-01
DNA replication-dependent nucleosome organization (GO:0034723),9,2,0.91,+,2.19,2.33E-01
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",9,2,0.91,+,2.19,2.33E-01
regulation of activation of Janus kinase activity (GO:0010533),9,2,0.91,+,2.19,2.33E-01
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940),9,2,0.91,+,2.19,2.33E-01
regulation of branching involved in salivary gland morphogenesis (GO:0060693),9,2,0.91,+,2.19,2.33E-01
chylomicron remodeling (GO:0034371),9,2,0.91,+,2.19,2.33E-01
T-helper 17 cell differentiation (GO:0072539),9,2,0.91,+,2.19,2.33E-01
diaphragm development (GO:0060539),9,2,0.91,+,2.19,2.33E-01
regulation of collagen biosynthetic process (GO:0032965),32,7,3.25,+,2.15,4.78E-02
monosaccharide catabolic process (GO:0046365),55,12,5.59,+,2.15,1.22E-02
negative regulation of tissue remodeling (GO:0034104),23,5,2.34,+,2.14,8.81E-02
T cell lineage commitment (GO:0002360),23,5,2.34,+,2.14,8.81E-02
peptidyl-glutamic acid modification (GO:0018200),23,5,2.34,+,2.14,8.81E-02
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),23,5,2.34,+,2.14,8.81E-02
melanosome localization (GO:0032400),23,5,2.34,+,2.14,8.81E-02
skeletal muscle fiber development (GO:0048741),23,5,2.34,+,2.14,8.81E-02
heterochromatin assembly (GO:0031507),23,5,2.34,+,2.14,8.81E-02
male genitalia development (GO:0030539),23,5,2.34,+,2.14,8.81E-02
response to acidic pH (GO:0010447),23,5,2.34,+,2.14,8.81E-02
positive regulation of mRNA metabolic process (GO:1903313),79,17,8.03,+,2.12,3.77E-03
positive chemotaxis (GO:0050918),42,9,4.27,+,2.11,3.03E-02
response to pH (GO:0009268),42,9,4.27,+,2.11,3.03E-02
thalamus development (GO:0021794),14,3,1.42,+,2.11,1.72E-01
regulation of leukocyte tethering or rolling (GO:1903236),14,3,1.42,+,2.11,1.72E-01
atrial septum morphogenesis (GO:0060413),14,3,1.42,+,2.11,1.72E-01
positive regulation of keratinocyte differentiation (GO:0045618),14,3,1.42,+,2.11,1.72E-01
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),14,3,1.42,+,2.11,1.72E-01
NADPH regeneration (GO:0006740),14,3,1.42,+,2.11,1.72E-01
inner cell mass cell proliferation (GO:0001833),14,3,1.42,+,2.11,1.72E-01
metanephric mesenchyme development (GO:0072075),14,3,1.42,+,2.11,1.72E-01
negative regulation of sodium ion transmembrane transport (GO:1902306),14,3,1.42,+,2.11,1.72E-01
catecholamine transport (GO:0051937),14,3,1.42,+,2.11,1.72E-01
regulation of high voltage-gated calcium channel activity (GO:1901841),14,3,1.42,+,2.11,1.72E-01
negative regulation of lymphocyte migration (GO:2000402),14,3,1.42,+,2.11,1.72E-01
negative regulation of cholesterol transport (GO:0032375),14,3,1.42,+,2.11,1.72E-01
negative regulation of sterol transport (GO:0032372),14,3,1.42,+,2.11,1.72E-01
regulation of long-term synaptic depression (GO:1900452),14,3,1.42,+,2.11,1.72E-01
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),14,3,1.42,+,2.11,1.72E-01
sulfur amino acid catabolic process (GO:0000098),14,3,1.42,+,2.11,1.72E-01
muscle cell fate commitment (GO:0042693),14,3,1.42,+,2.11,1.72E-01
positive regulation of keratinocyte proliferation (GO:0010838),14,3,1.42,+,2.11,1.72E-01
cell migration involved in gastrulation (GO:0042074),14,3,1.42,+,2.11,1.72E-01
negative regulation of type 2 immune response (GO:0002829),14,3,1.42,+,2.11,1.72E-01
regulation of DNA-dependent DNA replication (GO:0090329),47,10,4.78,+,2.09,2.43E-02
termination of RNA polymerase II transcription (GO:0006369),33,7,3.35,+,2.09,5.45E-02
purine ribonucleoside bisphosphate metabolic process (GO:0034035),19,4,1.93,+,2.07,1.31E-01
glomerular visceral epithelial cell differentiation (GO:0072112),19,4,1.93,+,2.07,1.31E-01
glutathione derivative biosynthetic process (GO:1901687),19,4,1.93,+,2.07,1.31E-01
glutathione derivative metabolic process (GO:1901685),19,4,1.93,+,2.07,1.31E-01
positive regulation of multi-organism process (GO:0043902),19,4,1.93,+,2.07,1.31E-01
platelet morphogenesis (GO:0036344),19,4,1.93,+,2.07,1.31E-01
regulation of renal sodium excretion (GO:0035813),19,4,1.93,+,2.07,1.31E-01
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),19,4,1.93,+,2.07,1.31E-01
glycoside metabolic process (GO:0016137),19,4,1.93,+,2.07,1.31E-01
negative regulation of sodium ion transport (GO:0010766),19,4,1.93,+,2.07,1.31E-01
negative regulation of gene silencing by miRNA (GO:0060965),19,4,1.93,+,2.07,1.31E-01
response to copper ion (GO:0046688),38,8,3.86,+,2.07,4.32E-02
renal filtration cell differentiation (GO:0061318),19,4,1.93,+,2.07,1.31E-01
negative regulation of platelet activation (GO:0010544),19,4,1.93,+,2.07,1.31E-01
negative regulation of T cell differentiation (GO:0045581),43,9,4.37,+,2.06,3.44E-02
pigment granule localization (GO:0051875),24,5,2.44,+,2.05,1.01E-01
glutamine family amino acid catabolic process (GO:0009065),24,5,2.44,+,2.05,1.01E-01
negative regulation of alpha-beta T cell differentiation (GO:0046639),24,5,2.44,+,2.05,1.01E-01
positive regulation of ATPase activity (GO:0032781),53,11,5.39,+,2.04,2.20E-02
behavioral defense response (GO:0002209),29,6,2.95,+,2.04,7.86E-02
chromatin remodeling at centromere (GO:0031055),29,6,2.95,+,2.04,7.86E-02
NADH metabolic process (GO:0006734),34,7,3.46,+,2.03,6.18E-02
"DNA-templated transcription, termination (GO:0006353)",68,14,6.91,+,2.03,1.15E-02
negative regulation of TOR signaling (GO:0032007),34,7,3.46,+,2.03,6.18E-02
response to arsenic-containing substance (GO:0046685),34,7,3.46,+,2.03,6.18E-02
centromere complex assembly (GO:0034508),34,7,3.46,+,2.03,6.18E-02
response to dexamethasone (GO:0071548),39,8,3.96,+,2.02,4.89E-02
body morphogenesis (GO:0010171),44,9,4.47,+,2.01,3.88E-02
zymogen activation (GO:0031638),44,9,4.47,+,2.01,3.88E-02
positive regulation of mRNA catabolic process (GO:0061014),49,10,4.98,+,2.01,3.09E-02
alpha-amino acid biosynthetic process (GO:1901607),59,12,6,+,2,1.98E-02
preganglionic parasympathetic fiber development (GO:0021783),15,3,1.52,+,1.97,1.97E-01
positive regulation of systemic arterial blood pressure (GO:0003084),15,3,1.52,+,1.97,1.97E-01
negative regulation of homotypic cell-cell adhesion (GO:0034111),15,3,1.52,+,1.97,1.97E-01
glycolipid catabolic process (GO:0019377),15,3,1.52,+,1.97,1.97E-01
regulation of receptor localization to synapse (GO:1902683),15,3,1.52,+,1.97,1.97E-01
G protein-coupled glutamate receptor signaling pathway (GO:0007216),15,3,1.52,+,1.97,1.97E-01
positive regulation of glial cell proliferation (GO:0060252),15,3,1.52,+,1.97,1.97E-01
alpha-beta T cell lineage commitment (GO:0002363),15,3,1.52,+,1.97,1.97E-01
phagolysosome assembly (GO:0001845),15,3,1.52,+,1.97,1.97E-01
regulation of acrosome reaction (GO:0060046),15,3,1.52,+,1.97,1.97E-01
methionine metabolic process (GO:0006555),15,3,1.52,+,1.97,1.97E-01
tRNA wobble uridine modification (GO:0002098),15,3,1.52,+,1.97,1.97E-01
regulation of killing of cells of other organism (GO:0051709),15,3,1.52,+,1.97,1.97E-01
negative regulation of myeloid cell apoptotic process (GO:0033033),15,3,1.52,+,1.97,1.97E-01
protein N-linked glycosylation via asparagine (GO:0018279),30,6,3.05,+,1.97,8.88E-02
neurotransmitter receptor internalization (GO:0099590),15,3,1.52,+,1.97,1.97E-01
peptidyl-asparagine modification (GO:0018196),30,6,3.05,+,1.97,8.88E-02
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),30,6,3.05,+,1.97,8.88E-02
epidermis morphogenesis (GO:0048730),30,6,3.05,+,1.97,8.88E-02
membrane fission (GO:0090148),15,3,1.52,+,1.97,1.97E-01
intra-S DNA damage checkpoint (GO:0031573),15,3,1.52,+,1.97,1.97E-01
pyroptosis (GO:0070269),15,3,1.52,+,1.97,1.97E-01
peptidyl-serine dephosphorylation (GO:0070262),15,3,1.52,+,1.97,1.97E-01
eosinophil chemotaxis (GO:0048245),15,3,1.52,+,1.97,1.97E-01
positive regulation of circadian rhythm (GO:0042753),15,3,1.52,+,1.97,1.97E-01
relaxation of cardiac muscle (GO:0055119),15,3,1.52,+,1.97,1.97E-01
vitamin D metabolic process (GO:0042359),15,3,1.52,+,1.97,1.97E-01
snoRNA metabolic process (GO:0016074),15,3,1.52,+,1.97,1.97E-01
tooth mineralization (GO:0034505),15,3,1.52,+,1.97,1.97E-01
glucocorticoid metabolic process (GO:0008211),15,3,1.52,+,1.97,1.97E-01
mesenchymal cell proliferation (GO:0010463),15,3,1.52,+,1.97,1.97E-01
copulation (GO:0007620),15,3,1.52,+,1.97,1.97E-01
low-density lipoprotein particle remodeling (GO:0034374),15,3,1.52,+,1.97,1.97E-01
protein N-linked glycosylation (GO:0006487),70,14,7.12,+,1.97,1.43E-02
proximal/distal pattern formation (GO:0009954),35,7,3.56,+,1.97,6.97E-02
axon extension (GO:0048675),35,7,3.56,+,1.97,6.97E-02
positive regulation of smoothened signaling pathway (GO:0045880),35,7,3.56,+,1.97,6.97E-02
regulation of cellular extravasation (GO:0002691),35,7,3.56,+,1.97,6.97E-02
regulation of chronic inflammatory response (GO:0002676),10,2,1.02,+,1.97,2.70E-01
response to selenium ion (GO:0010269),10,2,1.02,+,1.97,2.70E-01
negative regulation of protein targeting to mitochondrion (GO:1903215),5,1,0.51,+,1.97,3.99E-01
renal water transport (GO:0003097),5,1,0.51,+,1.97,3.99E-01
regulation of forebrain neuron differentiation (GO:2000977),5,1,0.51,+,1.97,3.99E-01
detection of oxygen (GO:0003032),5,1,0.51,+,1.97,3.99E-01
positive regulation of penile erection (GO:0060406),5,1,0.51,+,1.97,3.99E-01
positive regulation of chondrocyte proliferation (GO:1902732),5,1,0.51,+,1.97,3.99E-01
hypotonic response (GO:0006971),10,2,1.02,+,1.97,2.70E-01
acute-phase response (GO:0006953),40,8,4.07,+,1.97,5.50E-02
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),5,1,0.51,+,1.97,3.99E-01
toll-like receptor 2 signaling pathway (GO:0034134),5,1,0.51,+,1.97,3.99E-01
regulation of antigen processing and presentation (GO:0002577),20,4,2.03,+,1.97,1.49E-01
mast cell chemotaxis (GO:0002551),5,1,0.51,+,1.97,3.99E-01
dolichol metabolic process (GO:0019348),5,1,0.51,+,1.97,3.99E-01
vestibulocochlear nerve morphogenesis (GO:0021648),5,1,0.51,+,1.97,3.99E-01
trigeminal nerve structural organization (GO:0021637),5,1,0.51,+,1.97,3.99E-01
trigeminal nerve morphogenesis (GO:0021636),5,1,0.51,+,1.97,3.99E-01
glomerular epithelial cell differentiation (GO:0072311),20,4,2.03,+,1.97,1.49E-01
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335),5,1,0.51,+,1.97,3.99E-01
positive regulation of response to interferon-gamma (GO:0060332),5,1,0.51,+,1.97,3.99E-01
CTP metabolic process (GO:0046036),10,2,1.02,+,1.97,2.70E-01
protein localization to adherens junction (GO:0071896),5,1,0.51,+,1.97,3.99E-01
purine nucleoside bisphosphate catabolic process (GO:0034034),5,1,0.51,+,1.97,3.99E-01
ribonucleoside bisphosphate catabolic process (GO:0034031),5,1,0.51,+,1.97,3.99E-01
pyruvate transport (GO:0006848),5,1,0.51,+,1.97,3.99E-01
negative regulation of regulatory T cell differentiation (GO:0045590),5,1,0.51,+,1.97,3.99E-01
response to iron(III) ion (GO:0010041),5,1,0.51,+,1.97,3.99E-01
regulation of systemic arterial blood pressure by vasopressin (GO:0001992),5,1,0.51,+,1.97,3.99E-01
positive regulation of osteoclast development (GO:2001206),5,1,0.51,+,1.97,3.99E-01
histone H2B ubiquitination (GO:0033523),10,2,1.02,+,1.97,2.70E-01
corpus callosum morphogenesis (GO:0021540),5,1,0.51,+,1.97,3.99E-01
metanephric S-shaped body morphogenesis (GO:0072284),5,1,0.51,+,1.97,3.99E-01
activation of JNKK activity (GO:0007256),10,2,1.02,+,1.97,2.70E-01
T cell mediated cytotoxicity (GO:0001913),10,2,1.02,+,1.97,2.70E-01
cellular response to aldehyde (GO:0110096),10,2,1.02,+,1.97,2.70E-01
negative regulation of serine-type peptidase activity (GO:1902572),5,1,0.51,+,1.97,3.99E-01
negative regulation of neutrophil activation (GO:1902564),5,1,0.51,+,1.97,3.99E-01
delamination (GO:0060232),5,1,0.51,+,1.97,3.99E-01
polyphosphate metabolic process (GO:0006797),5,1,0.51,+,1.97,3.99E-01
mature B cell differentiation (GO:0002335),25,5,2.54,+,1.97,1.14E-01
regulation of endocytic recycling (GO:2001135),10,2,1.02,+,1.97,2.70E-01
nephric duct formation (GO:0072179),5,1,0.51,+,1.97,3.99E-01
meiosis II (GO:0007135),10,2,1.02,+,1.97,2.70E-01
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660),5,1,0.51,+,1.97,3.99E-01
cell proliferation involved in kidney development (GO:0072111),10,2,1.02,+,1.97,2.70E-01
negative regulation of posttranscriptional gene silencing (GO:0060149),20,4,2.03,+,1.97,1.49E-01
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),10,2,1.02,+,1.97,2.70E-01
T-helper cell lineage commitment (GO:0002295),10,2,1.02,+,1.97,2.70E-01
negative regulation of monocyte chemotactic protein-1 production (GO:0071638),5,1,0.51,+,1.97,3.99E-01
regulation of inward rectifier potassium channel activity (GO:1901979),5,1,0.51,+,1.97,3.99E-01
negative regulation of cell cycle checkpoint (GO:1901977),5,1,0.51,+,1.97,3.99E-01
negative regulation of mesenchymal cell apoptotic process (GO:2001054),10,2,1.02,+,1.97,2.70E-01
carnitine biosynthetic process (GO:0045329),5,1,0.51,+,1.97,3.99E-01
establishment of viral latency (GO:0019043),10,2,1.02,+,1.97,2.70E-01
somite specification (GO:0001757),5,1,0.51,+,1.97,3.99E-01
specification of nephron tubule identity (GO:0072081),5,1,0.51,+,1.97,3.99E-01
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583),5,1,0.51,+,1.97,3.99E-01
comma-shaped body morphogenesis (GO:0072049),5,1,0.51,+,1.97,3.99E-01
proximal/distal pattern formation involved in nephron development (GO:0072047),5,1,0.51,+,1.97,3.99E-01
"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",5,1,0.51,+,1.97,3.99E-01
positive regulation of T-helper 1 cell cytokine production (GO:2000556),5,1,0.51,+,1.97,3.99E-01
regulation of T-helper 1 cell cytokine production (GO:2000554),5,1,0.51,+,1.97,3.99E-01
somatostatin signaling pathway (GO:0038170),5,1,0.51,+,1.97,3.99E-01
mammary gland involution (GO:0060056),5,1,0.51,+,1.97,3.99E-01
somatostatin receptor signaling pathway (GO:0038169),5,1,0.51,+,1.97,3.99E-01
proximal tubule development (GO:0072014),5,1,0.51,+,1.97,3.99E-01
positive regulation of cellular pH reduction (GO:0032849),5,1,0.51,+,1.97,3.99E-01
convergent extension involved in axis elongation (GO:0060028),5,1,0.51,+,1.97,3.99E-01
Bergmann glial cell differentiation (GO:0060020),10,2,1.02,+,1.97,2.70E-01
Sertoli cell proliferation (GO:0060011),5,1,0.51,+,1.97,3.99E-01
tyrosine catabolic process (GO:0006572),5,1,0.51,+,1.97,3.99E-01
lymphocyte aggregation (GO:0071593),5,1,0.51,+,1.97,3.99E-01
threonine metabolic process (GO:0006566),5,1,0.51,+,1.97,3.99E-01
L-serine metabolic process (GO:0006563),10,2,1.02,+,1.97,2.70E-01
protein ufmylation (GO:0071569),5,1,0.51,+,1.97,3.99E-01
glutamate biosynthetic process (GO:0006537),5,1,0.51,+,1.97,3.99E-01
alanine catabolic process (GO:0006524),5,1,0.51,+,1.97,3.99E-01
alanine metabolic process (GO:0006522),5,1,0.51,+,1.97,3.99E-01
cellular response to heparin (GO:0071504),5,1,0.51,+,1.97,3.99E-01
positive regulation of cellular amine metabolic process (GO:0033240),10,2,1.02,+,1.97,2.70E-01
positive regulation of interleukin-23 production (GO:0032747),5,1,0.51,+,1.97,3.99E-01
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),20,4,2.03,+,1.97,1.49E-01
regulation of T cell extravasation (GO:2000407),5,1,0.51,+,1.97,3.99E-01
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031),5,1,0.51,+,1.97,3.99E-01
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),20,4,2.03,+,1.97,1.49E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219),5,1,0.51,+,1.97,3.99E-01
negative regulation of glutamate secretion (GO:0014050),5,1,0.51,+,1.97,3.99E-01
succinate transmembrane transport (GO:0071422),5,1,0.51,+,1.97,3.99E-01
manganese ion transmembrane transport (GO:0071421),10,2,1.02,+,1.97,2.70E-01
protein sialylation (GO:1990743),5,1,0.51,+,1.97,3.99E-01
brain renin-angiotensin system (GO:0002035),5,1,0.51,+,1.97,3.99E-01
regulation of blood volume by renin-angiotensin (GO:0002016),10,2,1.02,+,1.97,2.70E-01
positive regulation of histone ubiquitination (GO:0033184),5,1,0.51,+,1.97,3.99E-01
negative regulation of cell proliferation involved in kidney development (GO:1901723),5,1,0.51,+,1.97,3.99E-01
glomerular visceral epithelial cell migration (GO:0090521),5,1,0.51,+,1.97,3.99E-01
neutrophil-mediated killing of bacterium (GO:0070944),5,1,0.51,+,1.97,3.99E-01
neutrophil-mediated killing of symbiont cell (GO:0070943),5,1,0.51,+,1.97,3.99E-01
neutrophil mediated cytotoxicity (GO:0070942),5,1,0.51,+,1.97,3.99E-01
positive regulation of clathrin-dependent endocytosis (GO:2000370),5,1,0.51,+,1.97,3.99E-01
regulation of ovarian follicle development (GO:2000354),5,1,0.51,+,1.97,3.99E-01
regulation of nuclear receptor transcription coactivator activity (GO:2000325),5,1,0.51,+,1.97,3.99E-01
peptidyl-glutamine methylation (GO:0018364),5,1,0.51,+,1.97,3.99E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301),5,1,0.51,+,1.97,3.99E-01
interleukin-2 production (GO:0032623),10,2,1.02,+,1.97,2.70E-01
DNA methylation-dependent heterochromatin assembly (GO:0006346),5,1,0.51,+,1.97,3.99E-01
cellular response to fructose stimulus (GO:0071332),5,1,0.51,+,1.97,3.99E-01
cellular response to isoquinoline alkaloid (GO:0071317),5,1,0.51,+,1.97,3.99E-01
cellular response to morphine (GO:0071315),5,1,0.51,+,1.97,3.99E-01
positive regulation of immature T cell proliferation (GO:0033091),5,1,0.51,+,1.97,3.99E-01
protein retention in Golgi apparatus (GO:0045053),5,1,0.51,+,1.97,3.99E-01
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),10,2,1.02,+,1.97,2.70E-01
hexose import across plasma membrane (GO:0140271),5,1,0.51,+,1.97,3.99E-01
protein transport into membrane raft (GO:0032596),5,1,0.51,+,1.97,3.99E-01
"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",5,1,0.51,+,1.97,3.99E-01
negative regulation of hematopoietic stem cell differentiation (GO:1902037),5,1,0.51,+,1.97,3.99E-01
regulation of NADP metabolic process (GO:1902031),5,1,0.51,+,1.97,3.99E-01
cellular response to vitamin (GO:0071295),20,4,2.03,+,1.97,1.49E-01
rRNA 5'-end processing (GO:0000967),5,1,0.51,+,1.97,3.99E-01
cellular response to iron ion (GO:0071281),10,2,1.02,+,1.97,2.70E-01
CTP biosynthetic process (GO:0006241),10,2,1.02,+,1.97,2.70E-01
cellular response to leucine (GO:0071233),10,2,1.02,+,1.97,2.70E-01
mitochondrial ATP transmembrane transport (GO:1990544),5,1,0.51,+,1.97,3.99E-01
negative regulation of protein targeting to membrane (GO:0090315),5,1,0.51,+,1.97,3.99E-01
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),10,2,1.02,+,1.97,2.70E-01
regulation of ubiquitin-specific protease activity (GO:2000152),5,1,0.51,+,1.97,3.99E-01
negative regulation of macrophage apoptotic process (GO:2000110),5,1,0.51,+,1.97,3.99E-01
vesicle fusion to plasma membrane (GO:0099500),10,2,1.02,+,1.97,2.70E-01
AMP biosynthetic process (GO:0006167),5,1,0.51,+,1.97,3.99E-01
embryonic cleavage (GO:0040016),5,1,0.51,+,1.97,3.99E-01
viral translational termination-reinitiation (GO:0075525),5,1,0.51,+,1.97,3.99E-01
mRNA pseudouridine synthesis (GO:1990481),5,1,0.51,+,1.97,3.99E-01
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),5,1,0.51,+,1.97,3.99E-01
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),5,1,0.51,+,1.97,3.99E-01
glycerol biosynthetic process (GO:0006114),5,1,0.51,+,1.97,3.99E-01
succinyl-CoA metabolic process (GO:0006104),5,1,0.51,+,1.97,3.99E-01
regulation of lymphangiogenesis (GO:1901490),5,1,0.51,+,1.97,3.99E-01
ossification involved in bone remodeling (GO:0043932),5,1,0.51,+,1.97,3.99E-01
positive regulation of spindle assembly (GO:1905832),5,1,0.51,+,1.97,3.99E-01
negative regulation of glucocorticoid biosynthetic process (GO:0031947),5,1,0.51,+,1.97,3.99E-01
negative regulation of glucocorticoid metabolic process (GO:0031944),5,1,0.51,+,1.97,3.99E-01
mitochondrial ADP transmembrane transport (GO:0140021),5,1,0.51,+,1.97,3.99E-01
peptidyl-lysine oxidation (GO:0018057),5,1,0.51,+,1.97,3.99E-01
glucuronate catabolic process (GO:0006064),5,1,0.51,+,1.97,3.99E-01
negative regulation of icosanoid secretion (GO:0032304),5,1,0.51,+,1.97,3.99E-01
histone mRNA catabolic process (GO:0071044),10,2,1.02,+,1.97,2.70E-01
regulation of chorionic trophoblast cell proliferation (GO:1901382),5,1,0.51,+,1.97,3.99E-01
protein localization to microtubule end (GO:1905725),5,1,0.51,+,1.97,3.99E-01
regulation of neuronal action potential (GO:0098908),5,1,0.51,+,1.97,3.99E-01
positive regulation of store-operated calcium channel activity (GO:1901341),5,1,0.51,+,1.97,3.99E-01
negative regulation of kidney development (GO:0090185),5,1,0.51,+,1.97,3.99E-01
cadmium ion transmembrane transport (GO:0070574),5,1,0.51,+,1.97,3.99E-01
mesenchyme migration (GO:0090131),5,1,0.51,+,1.97,3.99E-01
myoblast fate commitment (GO:0048625),5,1,0.51,+,1.97,3.99E-01
intestinal hexose absorption (GO:0106001),5,1,0.51,+,1.97,3.99E-01
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299),5,1,0.51,+,1.97,3.99E-01
positive regulation of blood-brain barrier permeability (GO:1905605),5,1,0.51,+,1.97,3.99E-01
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080),5,1,0.51,+,1.97,3.99E-01
positive regulation of microtubule nucleation (GO:0090063),5,1,0.51,+,1.97,3.99E-01
flavonoid metabolic process (GO:0009812),5,1,0.51,+,1.97,3.99E-01
coumarin metabolic process (GO:0009804),5,1,0.51,+,1.97,3.99E-01
negative regulation of steroid hormone biosynthetic process (GO:0090032),5,1,0.51,+,1.97,3.99E-01
B cell receptor signaling pathway (GO:0050853),40,8,4.07,+,1.97,5.50E-02
neural crest cell migration involved in autonomic nervous system development (GO:1901166),5,1,0.51,+,1.97,3.99E-01
positive regulation of trophoblast cell migration (GO:1901165),5,1,0.51,+,1.97,3.99E-01
xylulose 5-phosphate biosynthetic process (GO:1901159),5,1,0.51,+,1.97,3.99E-01
carbohydrate import across plasma membrane (GO:0098704),5,1,0.51,+,1.97,3.99E-01
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),10,2,1.02,+,1.97,2.70E-01
maintenance of animal organ identity (GO:0048496),5,1,0.51,+,1.97,3.99E-01
negative regulation of fat cell proliferation (GO:0070345),5,1,0.51,+,1.97,3.99E-01
regulation of fat cell proliferation (GO:0070344),10,2,1.02,+,1.97,2.70E-01
positive regulation of lipoprotein metabolic process (GO:0050747),5,1,0.51,+,1.97,3.99E-01
positive regulation of deoxyribonuclease activity (GO:0032077),5,1,0.51,+,1.97,3.99E-01
acetate ester metabolic process (GO:1900619),5,1,0.51,+,1.97,3.99E-01
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",5,1,0.51,+,1.97,3.99E-01
endodermal cell differentiation (GO:0035987),40,8,4.07,+,1.97,5.50E-02
regulation of synaptic vesicle cycle (GO:0098693),5,1,0.51,+,1.97,3.99E-01
regulation of DNA duplex unwinding (GO:1905462),5,1,0.51,+,1.97,3.99E-01
regulation of translational initiation in response to stress (GO:0043558),10,2,1.02,+,1.97,2.70E-01
xylulose 5-phosphate metabolic process (GO:0051167),5,1,0.51,+,1.97,3.99E-01
phenylpropanoid metabolic process (GO:0009698),5,1,0.51,+,1.97,3.99E-01
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451),5,1,0.51,+,1.97,3.99E-01
retrograde neuronal dense core vesicle transport (GO:1990049),5,1,0.51,+,1.97,3.99E-01
guanosine-containing compound biosynthetic process (GO:1901070),10,2,1.02,+,1.97,2.70E-01
synaptic growth at neuromuscular junction (GO:0051124),5,1,0.51,+,1.97,3.99E-01
RNA polymerase II preinitiation complex assembly (GO:0051123),10,2,1.02,+,1.97,2.70E-01
renal sodium ion absorption (GO:0070294),5,1,0.51,+,1.97,3.99E-01
N-acylethanolamine metabolic process (GO:0070291),5,1,0.51,+,1.97,3.99E-01
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),5,1,0.51,+,1.97,3.99E-01
homocysteine metabolic process (GO:0050667),10,2,1.02,+,1.97,2.70E-01
hydrogen peroxide biosynthetic process (GO:0050665),10,2,1.02,+,1.97,2.70E-01
positive regulation of macrophage proliferation (GO:0120041),5,1,0.51,+,1.97,3.99E-01
spliceosomal conformational changes to generate catalytic conformation (GO:0000393),5,1,0.51,+,1.97,3.99E-01
regulation of helicase activity (GO:0051095),10,2,1.02,+,1.97,2.70E-01
regulation of membrane protein ectodomain proteolysis (GO:0051043),25,5,2.54,+,1.97,1.14E-01
negative regulation of urine volume (GO:0035811),5,1,0.51,+,1.97,3.99E-01
regulation of Golgi to plasma membrane protein transport (GO:0042996),10,2,1.02,+,1.97,2.70E-01
positive regulation of receptor signaling pathway via STAT (GO:1904894),40,8,4.07,+,1.97,5.50E-02
positive regulation of tooth mineralization (GO:0070172),5,1,0.51,+,1.97,3.99E-01
regulation of adiponectin secretion (GO:0070163),5,1,0.51,+,1.97,3.99E-01
protein localization to microtubule plus-end (GO:1904825),5,1,0.51,+,1.97,3.99E-01
regulation of memory T cell differentiation (GO:0043380),10,2,1.02,+,1.97,2.70E-01
"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",5,1,0.51,+,1.97,3.99E-01
regulation of prostaglandin biosynthetic process (GO:0031392),10,2,1.02,+,1.97,2.70E-01
regulation of modification of synaptic structure (GO:1905244),10,2,1.02,+,1.97,2.70E-01
negative regulation of purine nucleotide biosynthetic process (GO:1900372),5,1,0.51,+,1.97,3.99E-01
inner dynein arm assembly (GO:0036159),10,2,1.02,+,1.97,2.70E-01
acylglycerol acyl-chain remodeling (GO:0036155),5,1,0.51,+,1.97,3.99E-01
regulation of intestinal lipid absorption (GO:1904729),10,2,1.02,+,1.97,2.70E-01
peroxisome fission (GO:0016559),10,2,1.02,+,1.97,2.70E-01
meiosis II cell cycle process (GO:0061983),10,2,1.02,+,1.97,2.70E-01
negative regulation of nucleotide biosynthetic process (GO:0030809),5,1,0.51,+,1.97,3.99E-01
rDNA heterochromatin assembly (GO:0000183),10,2,1.02,+,1.97,2.70E-01
regulation of cytoplasmic translational initiation (GO:1904688),5,1,0.51,+,1.97,3.99E-01
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091),5,1,0.51,+,1.97,3.99E-01
protein O-linked fucosylation (GO:0036066),5,1,0.51,+,1.97,3.99E-01
cellular response to ionomycin (GO:1904637),5,1,0.51,+,1.97,3.99E-01
response to ionomycin (GO:1904636),5,1,0.51,+,1.97,3.99E-01
cellular response to phorbol 13-acetate 12-myristate (GO:1904628),5,1,0.51,+,1.97,3.99E-01
response to phorbol 13-acetate 12-myristate (GO:1904627),5,1,0.51,+,1.97,3.99E-01
regulation of kidney size (GO:0035564),5,1,0.51,+,1.97,3.99E-01
oxidative RNA demethylation (GO:0035513),5,1,0.51,+,1.97,3.99E-01
10-formyltetrahydrofolate metabolic process (GO:0009256),5,1,0.51,+,1.97,3.99E-01
tRNA pseudouridine synthesis (GO:0031119),5,1,0.51,+,1.97,3.99E-01
thelarche (GO:0042695),5,1,0.51,+,1.97,3.99E-01
retinal cone cell differentiation (GO:0042670),10,2,1.02,+,1.97,2.70E-01
regulation of vitamin metabolic process (GO:0030656),10,2,1.02,+,1.97,2.70E-01
positive regulation of lipophagy (GO:1904504),5,1,0.51,+,1.97,3.99E-01
regulation of lipophagy (GO:1904502),5,1,0.51,+,1.97,3.99E-01
negative regulation of histone H3-K9 trimethylation (GO:1900113),5,1,0.51,+,1.97,3.99E-01
drug transport (GO:0015893),10,2,1.02,+,1.97,2.70E-01
regulation of hemoglobin biosynthetic process (GO:0046984),5,1,0.51,+,1.97,3.99E-01
cellular ketone body metabolic process (GO:0046950),10,2,1.02,+,1.97,2.70E-01
free ubiquitin chain polymerization (GO:0010994),5,1,0.51,+,1.97,3.99E-01
positive regulation of lipoprotein particle clearance (GO:0010986),5,1,0.51,+,1.97,3.99E-01
L-arginine import across plasma membrane (GO:0097638),5,1,0.51,+,1.97,3.99E-01
negative regulation of macrophage cytokine production (GO:0010936),5,1,0.51,+,1.97,3.99E-01
negative regulation of cytokine production involved in inflammatory response (GO:1900016),20,4,2.03,+,1.97,1.49E-01
negative regulation of serine-type endopeptidase activity (GO:1900004),5,1,0.51,+,1.97,3.99E-01
cellular response to sodium arsenite (GO:1903936),5,1,0.51,+,1.97,3.99E-01
pyruvate family amino acid catabolic process (GO:0009080),5,1,0.51,+,1.97,3.99E-01
succinate transport (GO:0015744),5,1,0.51,+,1.97,3.99E-01
pyruvate family amino acid metabolic process (GO:0009078),5,1,0.51,+,1.97,3.99E-01
aspartate family amino acid biosynthetic process (GO:0009067),20,4,2.03,+,1.97,1.49E-01
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",5,1,0.51,+,1.97,3.99E-01
bundle of His cell action potential (GO:0086043),5,1,0.51,+,1.97,3.99E-01
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029),5,1,0.51,+,1.97,3.99E-01
bundle of His cell to Purkinje myocyte signaling (GO:0086028),5,1,0.51,+,1.97,3.99E-01
detection of bacterial lipoprotein (GO:0042494),5,1,0.51,+,1.97,3.99E-01
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393),5,1,0.51,+,1.97,3.99E-01
regulation of odontogenesis of dentin-containing tooth (GO:0042487),10,2,1.02,+,1.97,2.70E-01
response to L-phenylalanine derivative (GO:1904386),5,1,0.51,+,1.97,3.99E-01
regulation of stress granule assembly (GO:0062028),5,1,0.51,+,1.97,3.99E-01
negative regulation of triglyceride catabolic process (GO:0010897),5,1,0.51,+,1.97,3.99E-01
negative regulation of sequestering of triglyceride (GO:0010891),5,1,0.51,+,1.97,3.99E-01
regulation of dopaminergic neuron differentiation (GO:1904338),10,2,1.02,+,1.97,2.70E-01
dopamine biosynthetic process (GO:0042416),10,2,1.02,+,1.97,2.70E-01
cadmium ion transport (GO:0015691),5,1,0.51,+,1.97,3.99E-01
carbon dioxide transport (GO:0015670),5,1,0.51,+,1.97,3.99E-01
histone H4-K20 trimethylation (GO:0034773),5,1,0.51,+,1.97,3.99E-01
regulation of iron ion transmembrane transport (GO:0034759),5,1,0.51,+,1.97,3.99E-01
transepithelial chloride transport (GO:0030321),5,1,0.51,+,1.97,3.99E-01
hematopoietic stem cell homeostasis (GO:0061484),5,1,0.51,+,1.97,3.99E-01
regulation of intestinal cholesterol absorption (GO:0030300),10,2,1.02,+,1.97,2.70E-01
negative regulation of gene silencing by RNA (GO:0060967),20,4,2.03,+,1.97,1.49E-01
response to prostaglandin E (GO:0034695),25,5,2.54,+,1.97,1.14E-01
gamma-delta T cell activation (GO:0046629),10,2,1.02,+,1.97,2.70E-01
positive regulation of alkaline phosphatase activity (GO:0010694),5,1,0.51,+,1.97,3.99E-01
response to antineoplastic agent (GO:0097327),5,1,0.51,+,1.97,3.99E-01
cell adhesion involved in heart morphogenesis (GO:0061343),5,1,0.51,+,1.97,3.99E-01
regulation of chaperone-mediated protein folding (GO:1903644),5,1,0.51,+,1.97,3.99E-01
positive regulation of DNA catabolic process (GO:1903626),5,1,0.51,+,1.97,3.99E-01
regulation of protein tyrosine phosphatase activity (GO:1903613),5,1,0.51,+,1.97,3.99E-01
retinal cone cell development (GO:0046549),10,2,1.02,+,1.97,2.70E-01
acetylcholine metabolic process (GO:0008291),5,1,0.51,+,1.97,3.99E-01
response to aldosterone (GO:1904044),5,1,0.51,+,1.97,3.99E-01
regulation of collagen fibril organization (GO:1904026),5,1,0.51,+,1.97,3.99E-01
tRNA dihydrouridine synthesis (GO:0002943),5,1,0.51,+,1.97,3.99E-01
retina vasculature morphogenesis in camera-type eye (GO:0061299),10,2,1.02,+,1.97,2.70E-01
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925),5,1,0.51,+,1.97,3.99E-01
cornified envelope assembly (GO:1903575),5,1,0.51,+,1.97,3.99E-01
regulation of androgen receptor signaling pathway (GO:0060765),25,5,2.54,+,1.97,1.14E-01
positive regulation of mast cell chemotaxis (GO:0060754),5,1,0.51,+,1.97,3.99E-01
branch elongation involved in mammary gland duct branching (GO:0060751),5,1,0.51,+,1.97,3.99E-01
mammary gland branching involved in thelarche (GO:0060744),5,1,0.51,+,1.97,3.99E-01
chorionic trophoblast cell differentiation (GO:0060718),5,1,0.51,+,1.97,3.99E-01
positive regulation of hypersensitivity (GO:0002885),5,1,0.51,+,1.97,3.99E-01
microspike assembly (GO:0030035),5,1,0.51,+,1.97,3.99E-01
fungiform papilla morphogenesis (GO:0061197),5,1,0.51,+,1.97,3.99E-01
fatty acid omega-oxidation (GO:0010430),5,1,0.51,+,1.97,3.99E-01
"positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)",5,1,0.51,+,1.97,3.99E-01
anterior commissure morphogenesis (GO:0021960),5,1,0.51,+,1.97,3.99E-01
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),5,1,0.51,+,1.97,3.99E-01
response to glycoside (GO:1903416),5,1,0.51,+,1.97,3.99E-01
cellular response to bile acid (GO:1903413),5,1,0.51,+,1.97,3.99E-01
response to bile acid (GO:1903412),5,1,0.51,+,1.97,3.99E-01
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666),5,1,0.51,+,1.97,3.99E-01
salivary gland cavitation (GO:0060662),5,1,0.51,+,1.97,3.99E-01
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),5,1,0.51,+,1.97,3.99E-01
high-density lipoprotein particle clearance (GO:0034384),10,2,1.02,+,1.97,2.70E-01
"regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)",5,1,0.51,+,1.97,3.99E-01
tube lumen cavitation (GO:0060605),5,1,0.51,+,1.97,3.99E-01
ductus arteriosus closure (GO:0097070),5,1,0.51,+,1.97,3.99E-01
nucleoside bisphosphate catabolic process (GO:0033869),5,1,0.51,+,1.97,3.99E-01
common bile duct development (GO:0061009),5,1,0.51,+,1.97,3.99E-01
response to phenylpropanoid (GO:0080184),5,1,0.51,+,1.97,3.99E-01
tricuspid valve morphogenesis (GO:0003186),5,1,0.51,+,1.97,3.99E-01
His-Purkinje system development (GO:0003164),5,1,0.51,+,1.97,3.99E-01
T-helper 17 type immune response (GO:0072538),10,2,1.02,+,1.97,2.70E-01
type II pneumocyte differentiation (GO:0060510),5,1,0.51,+,1.97,3.99E-01
type I pneumocyte differentiation (GO:0060509),5,1,0.51,+,1.97,3.99E-01
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501),5,1,0.51,+,1.97,3.99E-01
base-excision repair (GO:0006284),46,9,4.68,+,1.92,4.88E-02
positive regulation of DNA replication (GO:0045740),36,7,3.66,+,1.91,7.81E-02
regulation of keratinocyte differentiation (GO:0045616),36,7,3.66,+,1.91,7.81E-02
ATP generation from ADP (GO:0006757),36,7,3.66,+,1.91,7.81E-02
glycolytic process (GO:0006096),36,7,3.66,+,1.91,7.81E-02
regulation of collagen metabolic process (GO:0010712),36,7,3.66,+,1.91,7.81E-02
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),36,7,3.66,+,1.91,7.81E-02
cell volume homeostasis (GO:0006884),31,6,3.15,+,1.9,9.98E-02
positive regulation of filopodium assembly (GO:0051491),31,6,3.15,+,1.9,9.98E-02
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),31,6,3.15,+,1.9,9.98E-02
positive regulation of epidermis development (GO:0045684),26,5,2.64,+,1.89,1.29E-01
cellular response to glucocorticoid stimulus (GO:0071385),52,10,5.29,+,1.89,4.32E-02
regulation of protein exit from endoplasmic reticulum (GO:0070861),26,5,2.64,+,1.89,1.29E-01
cell-cell fusion (GO:0140253),26,5,2.64,+,1.89,1.29E-01
phagosome acidification (GO:0090383),26,5,2.64,+,1.89,1.29E-01
cellular aldehyde metabolic process (GO:0006081),52,10,5.29,+,1.89,4.32E-02
syncytium formation by plasma membrane fusion (GO:0000768),26,5,2.64,+,1.89,1.29E-01
positive regulation of p38MAPK cascade (GO:1900745),26,5,2.64,+,1.89,1.29E-01
negative regulation of gene silencing (GO:0060969),26,5,2.64,+,1.89,1.29E-01
negative regulation of cytokine production involved in immune response (GO:0002719),26,5,2.64,+,1.89,1.29E-01
phosphatidylinositol-mediated signaling (GO:0048015),73,14,7.42,+,1.89,1.97E-02
cellular response to amino acid starvation (GO:0034198),68,13,6.91,+,1.88,2.45E-02
hyperosmotic response (GO:0006972),21,4,2.13,+,1.87,1.68E-01
regulation of proton transport (GO:0010155),21,4,2.13,+,1.87,1.68E-01
acrosome reaction (GO:0007340),21,4,2.13,+,1.87,1.68E-01
positive regulation of extracellular matrix organization (GO:1903055),21,4,2.13,+,1.87,1.68E-01
nitric oxide mediated signal transduction (GO:0007263),21,4,2.13,+,1.87,1.68E-01
regulation of myelination (GO:0031641),42,8,4.27,+,1.87,6.86E-02
tongue development (GO:0043586),21,4,2.13,+,1.87,1.68E-01
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",21,4,2.13,+,1.87,1.68E-01
polarized epithelial cell differentiation (GO:0030859),21,4,2.13,+,1.87,1.68E-01
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",21,4,2.13,+,1.87,1.68E-01
cGMP-mediated signaling (GO:0019934),21,4,2.13,+,1.87,1.68E-01
megakaryocyte differentiation (GO:0030219),21,4,2.13,+,1.87,1.68E-01
secondary metabolic process (GO:0019748),42,8,4.27,+,1.87,6.86E-02
amelogenesis (GO:0097186),21,4,2.13,+,1.87,1.68E-01
mating behavior (GO:0007617),21,4,2.13,+,1.87,1.68E-01
negative regulation of T cell mediated immunity (GO:0002710),21,4,2.13,+,1.87,1.68E-01
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),37,7,3.76,+,1.86,8.71E-02
negative regulation of lymphocyte differentiation (GO:0045620),53,10,5.39,+,1.86,4.79E-02
nucleoside diphosphate phosphorylation (GO:0006165),48,9,4.88,+,1.84,6.02E-02
positive regulation of heterotypic cell-cell adhesion (GO:0034116),16,3,1.63,+,1.84,2.23E-01
lipoxygenase pathway (GO:0019372),16,3,1.63,+,1.84,2.23E-01
positive regulation of SMAD protein signal transduction (GO:0060391),16,3,1.63,+,1.84,2.23E-01
manganese ion transport (GO:0006828),16,3,1.63,+,1.84,2.23E-01
secretion by tissue (GO:0032941),16,3,1.63,+,1.84,2.23E-01
mast cell activation involved in immune response (GO:0002279),16,3,1.63,+,1.84,2.23E-01
organ induction (GO:0001759),16,3,1.63,+,1.84,2.23E-01
positive regulation of telomerase activity (GO:0051973),32,6,3.25,+,1.84,1.11E-01
regulation of transmission of nerve impulse (GO:0051969),16,3,1.63,+,1.84,2.23E-01
positive regulation of monooxygenase activity (GO:0032770),32,6,3.25,+,1.84,1.11E-01
establishment of epithelial cell apical/basal polarity (GO:0045198),16,3,1.63,+,1.84,2.23E-01
3'-UTR-mediated mRNA stabilization (GO:0070935),16,3,1.63,+,1.84,2.23E-01
negative regulation of DNA-dependent DNA replication (GO:2000104),16,3,1.63,+,1.84,2.23E-01
positive regulation by host of viral transcription (GO:0043923),16,3,1.63,+,1.84,2.23E-01
parasympathetic nervous system development (GO:0048486),16,3,1.63,+,1.84,2.23E-01
renal absorption (GO:0070293),16,3,1.63,+,1.84,2.23E-01
megakaryocyte development (GO:0035855),16,3,1.63,+,1.84,2.23E-01
mast cell degranulation (GO:0043303),16,3,1.63,+,1.84,2.23E-01
stress fiber assembly (GO:0043149),16,3,1.63,+,1.84,2.23E-01
coenzyme A metabolic process (GO:0015936),16,3,1.63,+,1.84,2.23E-01
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",16,3,1.63,+,1.84,2.23E-01
regulation of hippo signaling (GO:0035330),16,3,1.63,+,1.84,2.23E-01
glutamine family amino acid biosynthetic process (GO:0009084),16,3,1.63,+,1.84,2.23E-01
regulation of odontogenesis (GO:0042481),16,3,1.63,+,1.84,2.23E-01
positive regulation of telomere capping (GO:1904355),16,3,1.63,+,1.84,2.23E-01
organic cation transport (GO:0015695),32,6,3.25,+,1.84,1.11E-01
ceramide catabolic process (GO:0046514),16,3,1.63,+,1.84,2.23E-01
contractile actin filament bundle assembly (GO:0030038),16,3,1.63,+,1.84,2.23E-01
branch elongation of an epithelium (GO:0060602),16,3,1.63,+,1.84,2.23E-01
cellular amino acid biosynthetic process (GO:0008652),75,14,7.62,+,1.84,2.40E-02
regulation of glycoprotein metabolic process (GO:1903018),43,8,4.37,+,1.83,7.61E-02
B cell activation involved in immune response (GO:0002312),43,8,4.37,+,1.83,7.61E-02
phagosome maturation (GO:0090382),43,8,4.37,+,1.83,7.61E-02
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),43,8,4.37,+,1.83,7.61E-02
positive regulation of protein import into nucleus (GO:0042307),43,8,4.37,+,1.83,7.61E-02
positive regulation of acute inflammatory response (GO:0002675),27,5,2.74,+,1.82,1.44E-01
syncytium formation (GO:0006949),27,5,2.74,+,1.82,1.44E-01
modified amino acid transport (GO:0072337),27,5,2.74,+,1.82,1.44E-01
regulation of sodium ion transmembrane transporter activity (GO:2000649),54,10,5.49,+,1.82,5.29E-02
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",27,5,2.74,+,1.82,1.44E-01
mRNA polyadenylation (GO:0006378),27,5,2.74,+,1.82,1.44E-01
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),27,5,2.74,+,1.82,1.44E-01
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),27,5,2.74,+,1.82,1.44E-01
ERK1 and ERK2 cascade (GO:0070371),27,5,2.74,+,1.82,1.44E-01
regulation of mRNA 3'-end processing (GO:0031440),27,5,2.74,+,1.82,1.44E-01
epithelial cell apoptotic process (GO:1904019),27,5,2.74,+,1.82,1.44E-01
regulation of animal organ formation (GO:0003156),27,5,2.74,+,1.82,1.44E-01
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),65,12,6.61,+,1.82,3.73E-02
blastocyst formation (GO:0001825),38,7,3.86,+,1.81,9.67E-02
regulation of digestive system process (GO:0044058),38,7,3.86,+,1.81,9.67E-02
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),76,14,7.73,+,1.81,2.64E-02
regulation of glycoprotein biosynthetic process (GO:0010559),38,7,3.86,+,1.81,9.67E-02
positive regulation of protein localization to nucleus (GO:1900182),87,16,8.84,+,1.81,1.89E-02
RNA stabilization (GO:0043489),49,9,4.98,+,1.81,6.66E-02
response to amino acid starvation (GO:1990928),71,13,7.22,+,1.8,3.29E-02
positive regulation of cell division (GO:0051781),82,15,8.34,+,1.8,2.34E-02
aldehyde catabolic process (GO:0046185),11,2,1.12,+,1.79,3.08E-01
pinocytosis (GO:0006907),11,2,1.12,+,1.79,3.08E-01
positive regulation of monocyte differentiation (GO:0045657),11,2,1.12,+,1.79,3.08E-01
positive regulation of epidermal cell differentiation (GO:0045606),22,4,2.24,+,1.79,1.88E-01
positive regulation of integrin activation (GO:0033625),11,2,1.12,+,1.79,3.08E-01
facial nerve morphogenesis (GO:0021610),11,2,1.12,+,1.79,3.08E-01
negative regulation of neuron migration (GO:2001223),11,2,1.12,+,1.79,3.08E-01
negative regulation of extracellular matrix organization (GO:1903054),11,2,1.12,+,1.79,3.08E-01
facial nerve development (GO:0021561),11,2,1.12,+,1.79,3.08E-01
positive regulation of cytoplasmic translation (GO:2000767),11,2,1.12,+,1.79,3.08E-01
response to tumor cell (GO:0002347),11,2,1.12,+,1.79,3.08E-01
regulation of phospholipid transport (GO:2001138),11,2,1.12,+,1.79,3.08E-01
regulation of dendritic cell apoptotic process (GO:2000668),11,2,1.12,+,1.79,3.08E-01
limb bud formation (GO:0060174),11,2,1.12,+,1.79,3.08E-01
negative regulation of protein acetylation (GO:1901984),22,4,2.24,+,1.79,1.88E-01
neutrophil homeostasis (GO:0001780),11,2,1.12,+,1.79,3.08E-01
Leydig cell differentiation (GO:0033327),11,2,1.12,+,1.79,3.08E-01
plasma membrane repair (GO:0001778),11,2,1.12,+,1.79,3.08E-01
vacuolar acidification (GO:0007035),22,4,2.24,+,1.79,1.88E-01
glomerular visceral epithelial cell development (GO:0072015),11,2,1.12,+,1.79,3.08E-01
regulation of protein glycosylation (GO:0060049),11,2,1.12,+,1.79,3.08E-01
tyrosine metabolic process (GO:0006570),11,2,1.12,+,1.79,3.08E-01
L-phenylalanine catabolic process (GO:0006559),11,2,1.12,+,1.79,3.08E-01
L-phenylalanine metabolic process (GO:0006558),11,2,1.12,+,1.79,3.08E-01
ketone body metabolic process (GO:1902224),11,2,1.12,+,1.79,3.08E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),11,2,1.12,+,1.79,3.08E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),11,2,1.12,+,1.79,3.08E-01
signal peptide processing (GO:0006465),11,2,1.12,+,1.79,3.08E-01
phosphatidylinositol 3-kinase signaling (GO:0014065),33,6,3.35,+,1.79,1.24E-01
cellular hyperosmotic response (GO:0071474),11,2,1.12,+,1.79,3.08E-01
neural crest formation (GO:0014029),11,2,1.12,+,1.79,3.08E-01
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),11,2,1.12,+,1.79,3.08E-01
regulation of interleukin-5 production (GO:0032674),22,4,2.24,+,1.79,1.88E-01
positive regulation of acrosome reaction (GO:2000344),11,2,1.12,+,1.79,3.08E-01
cellular response to corticosteroid stimulus (GO:0071384),55,10,5.59,+,1.79,5.83E-02
regulation of T cell differentiation in thymus (GO:0033081),22,4,2.24,+,1.79,1.88E-01
regulation of cell projection size (GO:0032536),11,2,1.12,+,1.79,3.08E-01
regulation of microvillus organization (GO:0032530),11,2,1.12,+,1.79,3.08E-01
cellular response to zinc ion (GO:0071294),22,4,2.24,+,1.79,1.88E-01
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),22,4,2.24,+,1.79,1.88E-01
peptidyl-L-cysteine S-palmitoylation (GO:0018230),22,4,2.24,+,1.79,1.88E-01
phagosome-lysosome fusion (GO:0090385),11,2,1.12,+,1.79,3.08E-01
interleukin-35-mediated signaling pathway (GO:0070757),11,2,1.12,+,1.79,3.08E-01
"negative regulation of translation, ncRNA-mediated (GO:0040033)",11,2,1.12,+,1.79,3.08E-01
negative regulation of cell cycle arrest (GO:0071157),22,4,2.24,+,1.79,1.88E-01
regulation of chromatin silencing (GO:0031935),11,2,1.12,+,1.79,3.08E-01
negative regulation of astrocyte differentiation (GO:0048712),11,2,1.12,+,1.79,3.08E-01
protein polyglutamylation (GO:0018095),11,2,1.12,+,1.79,3.08E-01
positive regulation of prostaglandin secretion (GO:0032308),11,2,1.12,+,1.79,3.08E-01
positive regulation of phospholipid biosynthetic process (GO:0071073),11,2,1.12,+,1.79,3.08E-01
negative regulation of NIK/NF-kappaB signaling (GO:1901223),22,4,2.24,+,1.79,1.88E-01
leukocyte aggregation (GO:0070486),11,2,1.12,+,1.79,3.08E-01
regulation of trophoblast cell migration (GO:1901163),11,2,1.12,+,1.79,3.08E-01
positive regulation of vacuole organization (GO:0044090),11,2,1.12,+,1.79,3.08E-01
peptidyl-threonine dephosphorylation (GO:0035970),22,4,2.24,+,1.79,1.88E-01
dendritic cell migration (GO:0036336),22,4,2.24,+,1.79,1.88E-01
positive regulation of urine volume (GO:0035810),11,2,1.12,+,1.79,3.08E-01
positive regulation of immunoglobulin secretion (GO:0051024),11,2,1.12,+,1.79,3.08E-01
establishment of protein localization to chromosome (GO:0070199),11,2,1.12,+,1.79,3.08E-01
regulation of excitatory synapse assembly (GO:1904889),11,2,1.12,+,1.79,3.08E-01
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),11,2,1.12,+,1.79,3.08E-01
xenobiotic transport (GO:0042908),33,6,3.35,+,1.79,1.24E-01
mRNA transcription by RNA polymerase II (GO:0042789),11,2,1.12,+,1.79,3.08E-01
peptide hormone processing (GO:0016486),33,6,3.35,+,1.79,1.24E-01
inositol lipid-mediated signaling (GO:0048017),77,14,7.83,+,1.79,2.90E-02
coenzyme A biosynthetic process (GO:0015937),11,2,1.12,+,1.79,3.08E-01
snoRNA 3'-end processing (GO:0031126),11,2,1.12,+,1.79,3.08E-01
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209),11,2,1.12,+,1.79,3.08E-01
glycine transport (GO:0015816),11,2,1.12,+,1.79,3.08E-01
gamma-aminobutyric acid transport (GO:0015812),11,2,1.12,+,1.79,3.08E-01
negative regulation of neurotransmitter secretion (GO:0046929),11,2,1.12,+,1.79,3.08E-01
negative regulation of hippo signaling (GO:0035331),11,2,1.12,+,1.79,3.08E-01
thyroid hormone metabolic process (GO:0042403),22,4,2.24,+,1.79,1.88E-01
retina layer formation (GO:0010842),22,4,2.24,+,1.79,1.88E-01
miRNA mediated inhibition of translation (GO:0035278),11,2,1.12,+,1.79,3.08E-01
response to histamine (GO:0034776),11,2,1.12,+,1.79,3.08E-01
dendrite extension (GO:0097484),11,2,1.12,+,1.79,3.08E-01
keratan sulfate metabolic process (GO:0042339),33,6,3.35,+,1.79,1.24E-01
protein maturation by iron-sulfur cluster transfer (GO:0097428),11,2,1.12,+,1.79,3.08E-01
cardiac cell fate commitment (GO:0060911),11,2,1.12,+,1.79,3.08E-01
hepatocyte apoptotic process (GO:0097284),11,2,1.12,+,1.79,3.08E-01
negative regulation of glycoprotein biosynthetic process (GO:0010561),11,2,1.12,+,1.79,3.08E-01
antifungal humoral response (GO:0019732),11,2,1.12,+,1.79,3.08E-01
presynaptic membrane assembly (GO:0097105),11,2,1.12,+,1.79,3.08E-01
"regulation of translation, ncRNA-mediated (GO:0045974)",11,2,1.12,+,1.79,3.08E-01
regulation of cerebellar granule cell precursor proliferation (GO:0021936),11,2,1.12,+,1.79,3.08E-01
short-term memory (GO:0007614),11,2,1.12,+,1.79,3.08E-01
diacylglycerol metabolic process (GO:0046339),22,4,2.24,+,1.79,1.88E-01
response to granulocyte macrophage colony-stimulating factor (GO:0097012),11,2,1.12,+,1.79,3.08E-01
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),11,2,1.12,+,1.79,3.08E-01
pyramidal neuron development (GO:0021860),11,2,1.12,+,1.79,3.08E-01
body fluid secretion (GO:0007589),66,12,6.71,+,1.79,4.10E-02
nucleotide phosphorylation (GO:0046939),50,9,5.08,+,1.77,7.33E-02
toxin transport (GO:1901998),39,7,3.96,+,1.77,1.07E-01
positive regulation of bone mineralization (GO:0030501),39,7,3.96,+,1.77,1.07E-01
response to vitamin D (GO:0033280),28,5,2.85,+,1.76,1.59E-01
behavioral fear response (GO:0001662),28,5,2.85,+,1.76,1.59E-01
negative regulation of peptidyl-serine phosphorylation (GO:0033137),28,5,2.85,+,1.76,1.59E-01
keratan sulfate biosynthetic process (GO:0018146),28,5,2.85,+,1.76,1.59E-01
RNA polyadenylation (GO:0043631),28,5,2.85,+,1.76,1.59E-01
axonemal dynein complex assembly (GO:0070286),28,5,2.85,+,1.76,1.59E-01
amino acid import across plasma membrane (GO:0089718),28,5,2.85,+,1.76,1.59E-01
myotube differentiation (GO:0014902),56,10,5.69,+,1.76,6.41E-02
oligodendrocyte development (GO:0014003),45,8,4.57,+,1.75,9.26E-02
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823),45,8,4.57,+,1.75,9.26E-02
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),79,14,8.03,+,1.74,3.48E-02
negative regulation of reproductive process (GO:2000242),51,9,5.18,+,1.74,8.05E-02
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),17,3,1.73,+,1.74,2.50E-01
monocyte chemotaxis (GO:0002548),34,6,3.46,+,1.74,1.36E-01
negative regulation of T-helper cell differentiation (GO:0045623),17,3,1.73,+,1.74,2.50E-01
regulation of integrin activation (GO:0033623),17,3,1.73,+,1.74,2.50E-01
calcium ion import into cytosol (GO:1902656),17,3,1.73,+,1.74,2.50E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),17,3,1.73,+,1.74,2.50E-01
somatic diversification of immunoglobulins involved in immune response (GO:0002208),17,3,1.73,+,1.74,2.50E-01
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),17,3,1.73,+,1.74,2.50E-01
kidney mesenchyme development (GO:0072074),17,3,1.73,+,1.74,2.50E-01
signaling receptor ligand precursor processing (GO:0140448),34,6,3.46,+,1.74,1.36E-01
isotype switching (GO:0045190),17,3,1.73,+,1.74,2.50E-01
glial cell proliferation (GO:0014009),17,3,1.73,+,1.74,2.50E-01
interferon-gamma production (GO:0032609),17,3,1.73,+,1.74,2.50E-01
embryonic digestive tract morphogenesis (GO:0048557),17,3,1.73,+,1.74,2.50E-01
negative regulation of nervous system process (GO:0031645),17,3,1.73,+,1.74,2.50E-01
negative regulation of response to reactive oxygen species (GO:1901032),17,3,1.73,+,1.74,2.50E-01
epithelial cell differentiation involved in kidney development (GO:0035850),34,6,3.46,+,1.74,1.36E-01
positive regulation of membrane protein ectodomain proteolysis (GO:0051044),17,3,1.73,+,1.74,2.50E-01
phosphatidylglycerol acyl-chain remodeling (GO:0036148),17,3,1.73,+,1.74,2.50E-01
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),17,3,1.73,+,1.74,2.50E-01
regulation of Rac protein signal transduction (GO:0035020),17,3,1.73,+,1.74,2.50E-01
regulation of ketone biosynthetic process (GO:0010566),17,3,1.73,+,1.74,2.50E-01
retina vasculature development in camera-type eye (GO:0061298),17,3,1.73,+,1.74,2.50E-01
phasic smooth muscle contraction (GO:0014821),17,3,1.73,+,1.74,2.50E-01
mating (GO:0007618),34,6,3.46,+,1.74,1.36E-01
regulation of monooxygenase activity (GO:0032768),57,10,5.79,+,1.73,7.02E-02
lymphocyte chemotaxis (GO:0048247),40,7,4.07,+,1.72,1.17E-01
positive regulation of transcription regulatory region DNA binding (GO:2000679),23,4,2.34,+,1.71,2.08E-01
glomerular epithelium development (GO:0072010),23,4,2.34,+,1.71,2.08E-01
regulation of protein sumoylation (GO:0033233),23,4,2.34,+,1.71,2.08E-01
ganglioside metabolic process (GO:0001573),23,4,2.34,+,1.71,2.08E-01
bone cell development (GO:0098751),23,4,2.34,+,1.71,2.08E-01
positive regulation of protein import (GO:1904591),46,8,4.68,+,1.71,1.02E-01
negative regulation of heart contraction (GO:0045822),23,4,2.34,+,1.71,2.08E-01
response to estrogen (GO:0043627),75,13,7.62,+,1.71,4.70E-02
response to vitamin (GO:0033273),81,14,8.23,+,1.7,4.12E-02
regulation of gene silencing by miRNA (GO:0060964),87,15,8.84,+,1.7,3.62E-02
negative regulation of viral transcription (GO:0032897),29,5,2.95,+,1.7,1.76E-01
negative regulation of endothelial cell apoptotic process (GO:2000352),29,5,2.95,+,1.7,1.76E-01
peroxisomal membrane transport (GO:0015919),29,5,2.95,+,1.7,1.76E-01
regulation of microtubule depolymerization (GO:0031114),29,5,2.95,+,1.7,1.76E-01
cytolysis (GO:0019835),29,5,2.95,+,1.7,1.76E-01
estrogen metabolic process (GO:0008210),29,5,2.95,+,1.7,1.76E-01
cell killing (GO:0001906),105,18,10.67,+,1.69,2.47E-02
response to isoquinoline alkaloid (GO:0014072),35,6,3.56,+,1.69,1.50E-01
cellular response to interleukin-6 (GO:0071354),35,6,3.56,+,1.69,1.50E-01
heterochromatin organization (GO:0070828),35,6,3.56,+,1.69,1.50E-01
response to morphine (GO:0043278),35,6,3.56,+,1.69,1.50E-01
amino acid import (GO:0043090),35,6,3.56,+,1.69,1.50E-01
serine family amino acid metabolic process (GO:0009069),35,6,3.56,+,1.69,1.50E-01
negative regulation of alpha-beta T cell activation (GO:0046636),35,6,3.56,+,1.69,1.50E-01
nephron tubule development (GO:0072080),76,13,7.73,+,1.68,5.11E-02
translational elongation (GO:0006414),117,20,11.89,+,1.68,1.92E-02
positive regulation of axon extension (GO:0045773),41,7,4.17,+,1.68,1.29E-01
release of sequestered calcium ion into cytosol (GO:0051209),41,7,4.17,+,1.68,1.29E-01
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),41,7,4.17,+,1.68,1.29E-01
roof of mouth development (GO:0060021),88,15,8.95,+,1.68,3.93E-02
"regulation of DNA-templated transcription, initiation (GO:2000142)",88,15,8.95,+,1.68,3.93E-02
negative regulation of lipid localization (GO:1905953),47,8,4.78,+,1.67,1.11E-01
negative regulation of leukocyte migration (GO:0002686),47,8,4.78,+,1.67,1.11E-01
substrate adhesion-dependent cell spreading (GO:0034446),53,9,5.39,+,1.67,9.60E-02
positive regulation of osteoblast differentiation (GO:0045669),59,10,6,+,1.67,8.34E-02
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),59,10,6,+,1.67,8.34E-02
negative regulation of RNA catabolic process (GO:1902369),59,10,6,+,1.67,8.34E-02
anion homeostasis (GO:0055081),59,10,6,+,1.67,8.34E-02
nephron epithelium morphogenesis (GO:0072088),65,11,6.61,+,1.66,7.26E-02
primary alcohol metabolic process (GO:0034308),77,13,7.83,+,1.66,5.54E-02
regulation of posttranscriptional gene silencing (GO:0060147),89,15,9.05,+,1.66,4.26E-02
respiratory burst involved in defense response (GO:0002679),6,1,0.61,+,1.64,4.57E-01
regulation of acute inflammatory response (GO:0002673),48,8,4.88,+,1.64,1.21E-01
cerebral cortex regionalization (GO:0021796),6,1,0.61,+,1.64,4.57E-01
branchiomotor neuron axon guidance (GO:0021785),6,1,0.61,+,1.64,4.57E-01
positive regulation of behavioral fear response (GO:2000987),6,1,0.61,+,1.64,4.57E-01
alditol biosynthetic process (GO:0019401),6,1,0.61,+,1.64,4.57E-01
salivary gland morphogenesis (GO:0007435),30,5,3.05,+,1.64,1.93E-01
regulation of heart rate by chemical signal (GO:0003062),6,1,0.61,+,1.64,4.57E-01
positive regulation of cardiac muscle contraction (GO:0060452),6,1,0.61,+,1.64,4.57E-01
epithelial tube branching involved in lung morphogenesis (GO:0060441),24,4,2.44,+,1.64,2.30E-01
cellular defense response (GO:0006968),48,8,4.88,+,1.64,1.21E-01
embryonic body morphogenesis (GO:0010172),6,1,0.61,+,1.64,4.57E-01
galactolipid biosynthetic process (GO:0019375),6,1,0.61,+,1.64,4.57E-01
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),6,1,0.61,+,1.64,4.57E-01
axonogenesis involved in innervation (GO:0060385),6,1,0.61,+,1.64,4.57E-01
insemination (GO:0007320),12,2,1.22,+,1.64,3.45E-01
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),6,1,0.61,+,1.64,4.57E-01
regulation of aldosterone secretion (GO:2000858),6,1,0.61,+,1.64,4.57E-01
regulation of mineralocorticoid secretion (GO:2000855),6,1,0.61,+,1.64,4.57E-01
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368),12,2,1.22,+,1.64,3.45E-01
glomerular epithelial cell development (GO:0072310),12,2,1.22,+,1.64,3.45E-01
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),24,4,2.44,+,1.64,2.30E-01
regulation of response to interferon-gamma (GO:0060330),24,4,2.44,+,1.64,2.30E-01
regulation of regulatory T cell differentiation (GO:0045589),30,5,3.05,+,1.64,1.93E-01
regulation of unsaturated fatty acid biosynthetic process (GO:2001279),12,2,1.22,+,1.64,3.45E-01
anterior/posterior axon guidance (GO:0033564),6,1,0.61,+,1.64,4.57E-01
regulation of neuron migration (GO:2001222),42,7,4.27,+,1.64,1.40E-01
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),6,1,0.61,+,1.64,4.57E-01
regulation of osteoclast development (GO:2001204),12,2,1.22,+,1.64,3.45E-01
sperm axoneme assembly (GO:0007288),12,2,1.22,+,1.64,3.45E-01
intramembranous ossification (GO:0001957),6,1,0.61,+,1.64,4.57E-01
lymphangiogenesis (GO:0001946),12,2,1.22,+,1.64,3.45E-01
positive regulation of protein deubiquitination (GO:1903003),6,1,0.61,+,1.64,4.57E-01
regulation of sarcomere organization (GO:0060297),6,1,0.61,+,1.64,4.57E-01
regulation of metanephros development (GO:0072215),6,1,0.61,+,1.64,4.57E-01
regulation of serine-type peptidase activity (GO:1902571),6,1,0.61,+,1.64,4.57E-01
Mo-molybdopterin cofactor biosynthetic process (GO:0006777),6,1,0.61,+,1.64,4.57E-01
mineralocorticoid biosynthetic process (GO:0006705),6,1,0.61,+,1.64,4.57E-01
myeloid progenitor cell differentiation (GO:0002318),6,1,0.61,+,1.64,4.57E-01
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),6,1,0.61,+,1.64,4.57E-01
positive regulation of glomerular mesangial cell proliferation (GO:0072126),6,1,0.61,+,1.64,4.57E-01
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962),6,1,0.61,+,1.64,4.57E-01
positive regulation of miRNA metabolic process (GO:2000630),6,1,0.61,+,1.64,4.57E-01
regulation of histone H4-K16 acetylation (GO:2000618),6,1,0.61,+,1.64,4.57E-01
regulation of growth hormone secretion (GO:0060123),12,2,1.22,+,1.64,3.45E-01
inner ear receptor cell stereocilium organization (GO:0060122),30,5,3.05,+,1.64,1.93E-01
inner ear receptor cell differentiation (GO:0060113),54,9,5.49,+,1.64,1.04E-01
sphingomyelin biosynthetic process (GO:0006686),6,1,0.61,+,1.64,4.57E-01
galactosylceramide biosynthetic process (GO:0006682),6,1,0.61,+,1.64,4.57E-01
"positive regulation of phagocytosis, engulfment (GO:0060100)",12,2,1.22,+,1.64,3.45E-01
regulation of transforming growth factor beta1 production (GO:0032908),12,2,1.22,+,1.64,3.45E-01
organ or tissue specific immune response (GO:0002251),30,5,3.05,+,1.64,1.93E-01
regulation of mesenchymal cell apoptotic process (GO:2001053),12,2,1.22,+,1.64,3.45E-01
negative regulation of MHC class II biosynthetic process (GO:0045347),6,1,0.61,+,1.64,4.57E-01
positive regulation of MHC class I biosynthetic process (GO:0045345),6,1,0.61,+,1.64,4.57E-01
positive regulation of skeletal muscle cell differentiation (GO:2001016),6,1,0.61,+,1.64,4.57E-01
viral latency (GO:0019042),12,2,1.22,+,1.64,3.45E-01
DNA repair complex assembly (GO:0090735),6,1,0.61,+,1.64,4.57E-01
"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",6,1,0.61,+,1.64,4.57E-01
endodermal cell fate specification (GO:0001714),6,1,0.61,+,1.64,4.57E-01
renal vesicle formation (GO:0072033),6,1,0.61,+,1.64,4.57E-01
outer mitochondrial membrane organization (GO:0007008),6,1,0.61,+,1.64,4.57E-01
distal tubule development (GO:0072017),12,2,1.22,+,1.64,3.45E-01
"synaptic transmission, glycinergic (GO:0060012)",6,1,0.61,+,1.64,4.57E-01
regulation of natural killer cell differentiation (GO:0032823),12,2,1.22,+,1.64,3.45E-01
positive regulation of apoptotic process involved in morphogenesis (GO:1902339),6,1,0.61,+,1.64,4.57E-01
negative regulation of apoptotic process involved in morphogenesis (GO:1902338),6,1,0.61,+,1.64,4.57E-01
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803),6,1,0.61,+,1.64,4.57E-01
leucine catabolic process (GO:0006552),6,1,0.61,+,1.64,4.57E-01
aspartate metabolic process (GO:0006531),6,1,0.61,+,1.64,4.57E-01
negative regulation of transmission of nerve impulse (GO:0051970),6,1,0.61,+,1.64,4.57E-01
positive regulation of cellular respiration (GO:1901857),6,1,0.61,+,1.64,4.57E-01
negative regulation of high voltage-gated calcium channel activity (GO:1901842),6,1,0.61,+,1.64,4.57E-01
negative regulation of mitochondrial depolarization (GO:0051902),6,1,0.61,+,1.64,4.57E-01
regulation of glycogen (starch) synthase activity (GO:2000465),6,1,0.61,+,1.64,4.57E-01
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030),6,1,0.61,+,1.64,4.57E-01
paracrine signaling (GO:0038001),6,1,0.61,+,1.64,4.57E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218),6,1,0.61,+,1.64,4.57E-01
tooth eruption (GO:0044691),6,1,0.61,+,1.64,4.57E-01
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),6,1,0.61,+,1.64,4.57E-01
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),6,1,0.61,+,1.64,4.57E-01
regulation of CD40 signaling pathway (GO:2000348),6,1,0.61,+,1.64,4.57E-01
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177),6,1,0.61,+,1.64,4.57E-01
regulation of T-helper 17 cell lineage commitment (GO:2000328),6,1,0.61,+,1.64,4.57E-01
transcription by RNA polymerase III (GO:0006383),30,5,3.05,+,1.64,1.93E-01
positive regulation of hair follicle development (GO:0051798),12,2,1.22,+,1.64,3.45E-01
negative thymic T cell selection (GO:0045060),12,2,1.22,+,1.64,3.45E-01
"regulation of blood coagulation, intrinsic pathway (GO:2000266)",6,1,0.61,+,1.64,4.57E-01
"base-excision repair, gap-filling (GO:0006287)",6,1,0.61,+,1.64,4.57E-01
potassium ion import across plasma membrane (GO:1990573),42,7,4.27,+,1.64,1.40E-01
maintenance of centrosome location (GO:0051661),6,1,0.61,+,1.64,4.57E-01
cellular response to bacterial lipopeptide (GO:0071221),6,1,0.61,+,1.64,4.57E-01
cellular response to bacterial lipoprotein (GO:0071220),6,1,0.61,+,1.64,4.57E-01
changes to DNA methylation involved in embryo development (GO:1901538),6,1,0.61,+,1.64,4.57E-01
regulation of DNA demethylation (GO:1901535),6,1,0.61,+,1.64,4.57E-01
negative regulation of cholesterol efflux (GO:0090370),6,1,0.61,+,1.64,4.57E-01
forebrain morphogenesis (GO:0048853),12,2,1.22,+,1.64,3.45E-01
Cdc42 protein signal transduction (GO:0032488),6,1,0.61,+,1.64,4.57E-01
"negative regulation of DNA-templated transcription, initiation (GO:2000143)",6,1,0.61,+,1.64,4.57E-01
'de novo' IMP biosynthetic process (GO:0006189),6,1,0.61,+,1.64,4.57E-01
regulation of sodium:proton antiporter activity (GO:0032415),6,1,0.61,+,1.64,4.57E-01
isocitrate metabolic process (GO:0006102),6,1,0.61,+,1.64,4.57E-01
positive regulation of keratinocyte migration (GO:0051549),12,2,1.22,+,1.64,3.45E-01
elastin metabolic process (GO:0051541),6,1,0.61,+,1.64,4.57E-01
negative regulation of chromatin silencing (GO:0031936),6,1,0.61,+,1.64,4.57E-01
negative regulation of histone H4 acetylation (GO:0090241),6,1,0.61,+,1.64,4.57E-01
regulation of histone H4 acetylation (GO:0090239),12,2,1.22,+,1.64,3.45E-01
dendrite arborization (GO:0140059),6,1,0.61,+,1.64,4.57E-01
centromeric sister chromatid cohesion (GO:0070601),6,1,0.61,+,1.64,4.57E-01
negative regulation of non-canonical Wnt signaling pathway (GO:2000051),6,1,0.61,+,1.64,4.57E-01
molybdopterin cofactor biosynthetic process (GO:0032324),6,1,0.61,+,1.64,4.57E-01
DNA recombinase assembly (GO:0000730),6,1,0.61,+,1.64,4.57E-01
myoblast migration (GO:0051451),12,2,1.22,+,1.64,3.45E-01
anterograde dendritic transport (GO:0098937),6,1,0.61,+,1.64,4.57E-01
positive regulation of collateral sprouting (GO:0048672),12,2,1.22,+,1.64,3.45E-01
equilibrioception (GO:0050957),6,1,0.61,+,1.64,4.57E-01
modulation of inhibitory postsynaptic potential (GO:0098828),6,1,0.61,+,1.64,4.57E-01
regulation of protein deubiquitination (GO:0090085),12,2,1.22,+,1.64,3.45E-01
negative regulation of sequestering of calcium ion (GO:0051283),42,7,4.27,+,1.64,1.40E-01
negative regulation of trophoblast cell migration (GO:1901164),6,1,0.61,+,1.64,4.57E-01
primary amino compound metabolic process (GO:1901160),12,2,1.22,+,1.64,3.45E-01
hepatocyte differentiation (GO:0070365),12,2,1.22,+,1.64,3.45E-01
response to bacterial lipopeptide (GO:0070339),6,1,0.61,+,1.64,4.57E-01
synaptic vesicle recycling via endosome (GO:0036466),6,1,0.61,+,1.64,4.57E-01
TRAIL-activated apoptotic signaling pathway (GO:0036462),6,1,0.61,+,1.64,4.57E-01
presynaptic modulation of chemical synaptic transmission (GO:0099171),6,1,0.61,+,1.64,4.57E-01
prosthetic group metabolic process (GO:0051189),6,1,0.61,+,1.64,4.57E-01
maintenance of DNA repeat elements (GO:0043570),6,1,0.61,+,1.64,4.57E-01
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),6,1,0.61,+,1.64,4.57E-01
hemidesmosome assembly (GO:0031581),12,2,1.22,+,1.64,3.45E-01
glucose 6-phosphate metabolic process (GO:0051156),24,4,2.44,+,1.64,2.30E-01
molybdopterin cofactor metabolic process (GO:0043545),6,1,0.61,+,1.64,4.57E-01
positive regulation of smooth muscle cell differentiation (GO:0051152),12,2,1.22,+,1.64,3.45E-01
positive regulation of exit from mitosis (GO:0031536),6,1,0.61,+,1.64,4.57E-01
regulation of response to reactive oxygen species (GO:1901031),30,5,3.05,+,1.64,1.93E-01
axial mesoderm development (GO:0048318),6,1,0.61,+,1.64,4.57E-01
regulation of macrophage proliferation (GO:0120040),6,1,0.61,+,1.64,4.57E-01
modulation by symbiont of host autophagy (GO:0075071),6,1,0.61,+,1.64,4.57E-01
positive regulation by symbiont of host autophagy (GO:0075044),6,1,0.61,+,1.64,4.57E-01
proton-transporting ATP synthase complex assembly (GO:0043461),6,1,0.61,+,1.64,4.57E-01
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),6,1,0.61,+,1.64,4.57E-01
peptidyl-diphthamide metabolic process (GO:0017182),6,1,0.61,+,1.64,4.57E-01
positive regulation of renal sodium excretion (GO:0035815),12,2,1.22,+,1.64,3.45E-01
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),6,1,0.61,+,1.64,4.57E-01
mRNA stabilization (GO:0048255),42,7,4.27,+,1.64,1.40E-01
negative T cell selection (GO:0043383),12,2,1.22,+,1.64,3.45E-01
common myeloid progenitor cell proliferation (GO:0035726),6,1,0.61,+,1.64,4.57E-01
hematopoietic stem cell migration (GO:0035701),6,1,0.61,+,1.64,4.57E-01
methylglyoxal metabolic process (GO:0009438),6,1,0.61,+,1.64,4.57E-01
carnitine metabolic process (GO:0009437),12,2,1.22,+,1.64,3.45E-01
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),6,1,0.61,+,1.64,4.57E-01
regulation of myeloid dendritic cell activation (GO:0030885),6,1,0.61,+,1.64,4.57E-01
thyroid gland development (GO:0030878),24,4,2.44,+,1.64,2.30E-01
positive regulation of apoptotic process involved in development (GO:1904747),6,1,0.61,+,1.64,4.57E-01
negative regulation of apoptotic process involved in development (GO:1904746),6,1,0.61,+,1.64,4.57E-01
histone dephosphorylation (GO:0016576),6,1,0.61,+,1.64,4.57E-01
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),48,8,4.88,+,1.64,1.21E-01
positive regulation of double-strand break repair via homologous recombination (GO:1905168),12,2,1.22,+,1.64,3.45E-01
positive regulation of membrane invagination (GO:1905155),12,2,1.22,+,1.64,3.45E-01
bone mineralization involved in bone maturation (GO:0035630),6,1,0.61,+,1.64,4.57E-01
positive regulation of pseudopodium assembly (GO:0031274),12,2,1.22,+,1.64,3.45E-01
oligosaccharide catabolic process (GO:0009313),12,2,1.22,+,1.64,3.45E-01
oligosaccharide biosynthetic process (GO:0009312),30,5,3.05,+,1.64,1.93E-01
5S class rRNA transcription by RNA polymerase III (GO:0042791),6,1,0.61,+,1.64,4.57E-01
regulation of metalloendopeptidase activity (GO:1904683),6,1,0.61,+,1.64,4.57E-01
mitochondrial ATP synthesis coupled proton transport (GO:0042776),12,2,1.22,+,1.64,3.45E-01
very long-chain fatty acid catabolic process (GO:0042760),6,1,0.61,+,1.64,4.57E-01
cleavage furrow formation (GO:0036089),6,1,0.61,+,1.64,4.57E-01
direct ossification (GO:0036072),6,1,0.61,+,1.64,4.57E-01
sperm ejaculation (GO:0042713),6,1,0.61,+,1.64,4.57E-01
cellular response to interleukin-3 (GO:0036016),6,1,0.61,+,1.64,4.57E-01
response to interleukin-3 (GO:0036015),6,1,0.61,+,1.64,4.57E-01
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),6,1,0.61,+,1.64,4.57E-01
telomeric D-loop disassembly (GO:0061820),6,1,0.61,+,1.64,4.57E-01
endoplasmic reticulum-plasma membrane tethering (GO:0061817),6,1,0.61,+,1.64,4.57E-01
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),6,1,0.61,+,1.64,4.57E-01
induction of bacterial agglutination (GO:0043152),6,1,0.61,+,1.64,4.57E-01
oxidative DNA demethylation (GO:0035511),6,1,0.61,+,1.64,4.57E-01
pyrimidine deoxyribonucleotide catabolic process (GO:0009223),12,2,1.22,+,1.64,3.45E-01
neuron projection regeneration (GO:0031102),30,5,3.05,+,1.64,1.93E-01
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208),12,2,1.22,+,1.64,3.45E-01
positive regulation of microtubule binding (GO:1904528),6,1,0.61,+,1.64,4.57E-01
motor learning (GO:0061743),6,1,0.61,+,1.64,4.57E-01
asymmetric neuroblast division (GO:0055059),6,1,0.61,+,1.64,4.57E-01
DNA methylation involved in embryo development (GO:0043045),6,1,0.61,+,1.64,4.57E-01
endothelin receptor signaling pathway (GO:0086100),6,1,0.61,+,1.64,4.57E-01
double-strand break repair via classical nonhomologous end joining (GO:0097680),6,1,0.61,+,1.64,4.57E-01
regulation of intestinal absorption (GO:1904478),12,2,1.22,+,1.64,3.45E-01
regulation of matrix metallopeptidase secretion (GO:1904464),6,1,0.61,+,1.64,4.57E-01
hemoglobin biosynthetic process (GO:0042541),6,1,0.61,+,1.64,4.57E-01
regulation of SMAD protein complex assembly (GO:0010990),6,1,0.61,+,1.64,4.57E-01
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),12,2,1.22,+,1.64,3.45E-01
spontaneous neurotransmitter secretion (GO:0061669),6,1,0.61,+,1.64,4.57E-01
mitochondrial ribosome assembly (GO:0061668),6,1,0.61,+,1.64,4.57E-01
regulation of serine-type endopeptidase activity (GO:1900003),6,1,0.61,+,1.64,4.57E-01
regulation of very-low-density lipoprotein particle remodeling (GO:0010901),6,1,0.61,+,1.64,4.57E-01
positive regulation of microglial cell activation (GO:1903980),6,1,0.61,+,1.64,4.57E-01
chemorepulsion of axon (GO:0061643),6,1,0.61,+,1.64,4.57E-01
response to sodium arsenite (GO:1903935),6,1,0.61,+,1.64,4.57E-01
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),6,1,0.61,+,1.64,4.57E-01
urate transport (GO:0015747),6,1,0.61,+,1.64,4.57E-01
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068),6,1,0.61,+,1.64,4.57E-01
prostaglandin transport (GO:0015732),6,1,0.61,+,1.64,4.57E-01
mechanoreceptor differentiation (GO:0042490),60,10,6.1,+,1.64,9.06E-02
odontogenesis (GO:0042476),114,19,11.59,+,1.64,2.75E-02
negative regulation of protein export from nucleus (GO:0046826),6,1,0.61,+,1.64,4.57E-01
hormone biosynthetic process (GO:0042446),48,8,4.88,+,1.64,1.21E-01
mast cell migration (GO:0097531),6,1,0.61,+,1.64,4.57E-01
terpenoid catabolic process (GO:0016115),6,1,0.61,+,1.64,4.57E-01
positive regulation of oxidative phosphorylation (GO:1903862),6,1,0.61,+,1.64,4.57E-01
microglial cell proliferation (GO:0061518),6,1,0.61,+,1.64,4.57E-01
macrophage proliferation (GO:0061517),6,1,0.61,+,1.64,4.57E-01
positive regulation of neuroinflammatory response (GO:0150078),12,2,1.22,+,1.64,3.45E-01
negative regulation of plasminogen activation (GO:0010757),6,1,0.61,+,1.64,4.57E-01
positive regulation of plasminogen activation (GO:0010756),6,1,0.61,+,1.64,4.57E-01
regulation of plasminogen activation (GO:0010755),12,2,1.22,+,1.64,3.45E-01
CDP-diacylglycerol biosynthetic process (GO:0016024),12,2,1.22,+,1.64,3.45E-01
T follicular helper cell differentiation (GO:0061470),6,1,0.61,+,1.64,4.57E-01
RIG-I signaling pathway (GO:0039529),6,1,0.61,+,1.64,4.57E-01
regulation of gene silencing (GO:0060968),102,17,10.37,+,1.64,3.55E-02
regulation of gene silencing by RNA (GO:0060966),90,15,9.15,+,1.64,4.60E-02
response to prostaglandin (GO:0034694),30,5,3.05,+,1.64,1.93E-01
mature ribosome assembly (GO:0042256),6,1,0.61,+,1.64,4.57E-01
skeletal muscle thin filament assembly (GO:0030240),6,1,0.61,+,1.64,4.57E-01
regulation of Schwann cell proliferation (GO:0010624),6,1,0.61,+,1.64,4.57E-01
testosterone biosynthetic process (GO:0061370),6,1,0.61,+,1.64,4.57E-01
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800),6,1,0.61,+,1.64,4.57E-01
axis elongation (GO:0003401),24,4,2.44,+,1.64,2.30E-01
development of secondary female sexual characteristics (GO:0046543),6,1,0.61,+,1.64,4.57E-01
mitochondrial respirasome assembly (GO:0097250),6,1,0.61,+,1.64,4.57E-01
miRNA catabolic process (GO:0010587),6,1,0.61,+,1.64,4.57E-01
pancreatic juice secretion (GO:0030157),6,1,0.61,+,1.64,4.57E-01
cellular response to gonadotropin-releasing hormone (GO:0097211),6,1,0.61,+,1.64,4.57E-01
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),12,2,1.22,+,1.64,3.45E-01
lipid hydroxylation (GO:0002933),6,1,0.61,+,1.64,4.57E-01
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923),12,2,1.22,+,1.64,3.45E-01
mineralocorticoid metabolic process (GO:0008212),6,1,0.61,+,1.64,4.57E-01
negative regulation of phospholipase activity (GO:0010519),6,1,0.61,+,1.64,4.57E-01
RNA secondary structure unwinding (GO:0010501),6,1,0.61,+,1.64,4.57E-01
Mo-molybdopterin cofactor metabolic process (GO:0019720),6,1,0.61,+,1.64,4.57E-01
brainstem development (GO:0003360),6,1,0.61,+,1.64,4.57E-01
chorio-allantoic fusion (GO:0060710),6,1,0.61,+,1.64,4.57E-01
positive regulation of inhibitory postsynaptic potential (GO:0097151),6,1,0.61,+,1.64,4.57E-01
gastro-intestinal system smooth muscle contraction (GO:0014831),6,1,0.61,+,1.64,4.57E-01
regulation of somitogenesis (GO:0014807),6,1,0.61,+,1.64,4.57E-01
fungiform papilla development (GO:0061196),6,1,0.61,+,1.64,4.57E-01
negative regulation of vasoconstriction (GO:0045906),6,1,0.61,+,1.64,4.57E-01
regulation of synaptic vesicle recycling (GO:1903421),24,4,2.44,+,1.64,2.30E-01
neutrophil extravasation (GO:0072672),6,1,0.61,+,1.64,4.57E-01
regulation of prostatic bud formation (GO:0060685),6,1,0.61,+,1.64,4.57E-01
ureteric bud elongation (GO:0060677),6,1,0.61,+,1.64,4.57E-01
negative regulation of smooth muscle cell apoptotic process (GO:0034392),6,1,0.61,+,1.64,4.57E-01
presynaptic membrane organization (GO:0097090),12,2,1.22,+,1.64,3.45E-01
triglyceride-rich lipoprotein particle remodeling (GO:0034370),12,2,1.22,+,1.64,3.45E-01
negative regulation of glucose import (GO:0046325),12,2,1.22,+,1.64,3.45E-01
response to thyroid hormone (GO:0097066),24,4,2.44,+,1.64,2.30E-01
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),6,1,0.61,+,1.64,4.57E-01
primary alcohol catabolic process (GO:0034310),12,2,1.22,+,1.64,3.45E-01
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),6,1,0.61,+,1.64,4.57E-01
lymphocyte migration into lymphoid organs (GO:0097021),6,1,0.61,+,1.64,4.57E-01
positive regulation of natural killer cell cytokine production (GO:0002729),6,1,0.61,+,1.64,4.57E-01
positive regulation of NAD(P)H oxidase activity (GO:0033864),6,1,0.61,+,1.64,4.57E-01
positive regulation of fear response (GO:1903367),6,1,0.61,+,1.64,4.57E-01
L-ornithine transmembrane transport (GO:1903352),6,1,0.61,+,1.64,4.57E-01
lactation (GO:0007595),42,7,4.27,+,1.64,1.40E-01
regulation of protein folding (GO:1903332),12,2,1.22,+,1.64,3.45E-01
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814),6,1,0.61,+,1.64,4.57E-01
tricuspid valve development (GO:0003175),6,1,0.61,+,1.64,4.57E-01
mesodermal cell fate specification (GO:0007501),6,1,0.61,+,1.64,4.57E-01
toll-like receptor 4 signaling pathway (GO:0034142),18,3,1.83,+,1.64,2.77E-01
mast cell mediated immunity (GO:0002448),18,3,1.83,+,1.64,2.77E-01
nephron tubule formation (GO:0072079),18,3,1.83,+,1.64,2.77E-01
nephron morphogenesis (GO:0072028),66,11,6.71,+,1.64,7.88E-02
adaptive thermogenesis (GO:1990845),18,3,1.83,+,1.64,2.77E-01
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),18,3,1.83,+,1.64,2.77E-01
tRNA wobble base modification (GO:0002097),18,3,1.83,+,1.64,2.77E-01
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),18,3,1.83,+,1.64,2.77E-01
regulation of hair follicle development (GO:0051797),18,3,1.83,+,1.64,2.77E-01
ethanol metabolic process (GO:0006067),18,3,1.83,+,1.64,2.77E-01
positive regulation of icosanoid secretion (GO:0032305),18,3,1.83,+,1.64,2.77E-01
detection of light stimulus involved in sensory perception (GO:0050962),18,3,1.83,+,1.64,2.77E-01
detection of light stimulus involved in visual perception (GO:0050908),18,3,1.83,+,1.64,2.77E-01
response to glucocorticoid (GO:0051384),138,23,14.03,+,1.64,1.67E-02
kinetochore organization (GO:0051383),18,3,1.83,+,1.64,2.77E-01
steroid hormone biosynthetic process (GO:0120178),36,6,3.66,+,1.64,1.64E-01
mitochondrial fission (GO:0000266),18,3,1.83,+,1.64,2.77E-01
negative regulation of B cell proliferation (GO:0030889),18,3,1.83,+,1.64,2.77E-01
protein O-linked mannosylation (GO:0035269),18,3,1.83,+,1.64,2.77E-01
positive regulation of macrophage derived foam cell differentiation (GO:0010744),18,3,1.83,+,1.64,2.77E-01
platelet formation (GO:0030220),18,3,1.83,+,1.64,2.77E-01
renal tubule morphogenesis (GO:0061333),66,11,6.71,+,1.64,7.88E-02
positive regulation of autophagy of mitochondrion (GO:1903599),18,3,1.83,+,1.64,2.77E-01
diol biosynthetic process (GO:0034312),18,3,1.83,+,1.64,2.77E-01
nephron epithelium development (GO:0072009),97,16,9.86,+,1.62,4.36E-02
odontogenesis of dentin-containing tooth (GO:0042475),79,13,8.03,+,1.62,6.48E-02
renal tubule development (GO:0061326),79,13,8.03,+,1.62,6.48E-02
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),73,12,7.42,+,1.62,7.43E-02
glycosaminoglycan catabolic process (GO:0006027),61,10,6.2,+,1.61,9.81E-02
cell-substrate adhesion (GO:0031589),177,29,17.99,+,1.61,9.88E-03
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),55,9,5.59,+,1.61,1.13E-01
positive regulation of ossification (GO:0045778),49,8,4.98,+,1.61,1.31E-01
face development (GO:0060324),49,8,4.98,+,1.61,1.31E-01
sulfur compound catabolic process (GO:0044273),49,8,4.98,+,1.61,1.31E-01
positive regulation of fibroblast proliferation (GO:0048146),49,8,4.98,+,1.61,1.31E-01
regulation of protein localization to nucleus (GO:1900180),135,22,13.72,+,1.6,2.34E-02
inner ear receptor cell development (GO:0060119),43,7,4.37,+,1.6,1.53E-01
microtubule bundle formation (GO:0001578),86,14,8.74,+,1.6,6.11E-02
cellular response to epidermal growth factor stimulus (GO:0071364),43,7,4.37,+,1.6,1.53E-01
negative regulation of response to endoplasmic reticulum stress (GO:1903573),43,7,4.37,+,1.6,1.53E-01
NAD metabolic process (GO:0019674),43,7,4.37,+,1.6,1.53E-01
negative regulation of T cell activation (GO:0050868),111,18,11.28,+,1.6,3.89E-02
regulation of ATPase activity (GO:0043462),74,12,7.52,+,1.6,8.01E-02
lamellipodium assembly (GO:0030032),37,6,3.76,+,1.6,1.79E-01
activation of GTPase activity (GO:0090630),99,16,10.06,+,1.59,5.05E-02
regulation of epidermis development (GO:0045682),62,10,6.3,+,1.59,1.06E-01
cellular zinc ion homeostasis (GO:0006882),31,5,3.15,+,1.59,2.11E-01
response to iron ion (GO:0010039),31,5,3.15,+,1.59,2.11E-01
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),31,5,3.15,+,1.59,2.11E-01
tetrapyrrole metabolic process (GO:0033013),62,10,6.3,+,1.59,1.06E-01
negative regulation of lipid transport (GO:0032369),31,5,3.15,+,1.59,2.11E-01
establishment of epithelial cell polarity (GO:0090162),31,5,3.15,+,1.59,2.11E-01
regulation of type 2 immune response (GO:0002828),31,5,3.15,+,1.59,2.11E-01
mammary gland duct morphogenesis (GO:0060603),31,5,3.15,+,1.59,2.11E-01
regulation of epidermal cell differentiation (GO:0045604),56,9,5.69,+,1.58,1.22E-01
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),56,9,5.69,+,1.58,1.22E-01
immunoglobulin production (GO:0002377),56,9,5.69,+,1.58,1.22E-01
spindle assembly (GO:0051225),81,13,8.23,+,1.58,7.52E-02
DNA duplex unwinding (GO:0032508),106,17,10.78,+,1.58,4.76E-02
innervation (GO:0060384),25,4,2.54,+,1.57,2.51E-01
immunoglobulin production involved in immunoglobulin mediated immune response (GO:0002381),25,4,2.54,+,1.57,2.51E-01
negative regulation of microtubule depolymerization (GO:0007026),25,4,2.54,+,1.57,2.51E-01
endoderm formation (GO:0001706),50,8,5.08,+,1.57,1.42E-01
nephron development (GO:0072006),125,20,12.71,+,1.57,3.47E-02
positive regulation of mesenchymal cell proliferation (GO:0002053),25,4,2.54,+,1.57,2.51E-01
intermediate filament organization (GO:0045109),25,4,2.54,+,1.57,2.51E-01
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920),25,4,2.54,+,1.57,2.51E-01
transepithelial transport (GO:0070633),25,4,2.54,+,1.57,2.51E-01
muscle fiber development (GO:0048747),50,8,5.08,+,1.57,1.42E-01
positive regulation of positive chemotaxis (GO:0050927),25,4,2.54,+,1.57,2.51E-01
positive regulation of cytokine secretion (GO:0050715),25,4,2.54,+,1.57,2.51E-01
inactivation of MAPK activity (GO:0000188),25,4,2.54,+,1.57,2.51E-01
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),25,4,2.54,+,1.57,2.51E-01
branched-chain amino acid metabolic process (GO:0009081),25,4,2.54,+,1.57,2.51E-01
chromatin organization involved in negative regulation of transcription (GO:0097549),50,8,5.08,+,1.57,1.42E-01
ionotropic glutamate receptor signaling pathway (GO:0035235),25,4,2.54,+,1.57,2.51E-01
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),25,4,2.54,+,1.57,2.51E-01
positive regulation of lamellipodium assembly (GO:0010592),25,4,2.54,+,1.57,2.51E-01
negative regulation of blood circulation (GO:1903523),25,4,2.54,+,1.57,2.51E-01
phosphatidic acid metabolic process (GO:0046473),50,8,5.08,+,1.57,1.42E-01
negative regulation of adaptive immune response (GO:0002820),50,8,5.08,+,1.57,1.42E-01
protein localization to cell surface (GO:0034394),25,4,2.54,+,1.57,2.51E-01
RNA methylation (GO:0001510),69,11,7.01,+,1.57,9.91E-02
ADP metabolic process (GO:0046031),44,7,4.47,+,1.56,1.65E-01
gluconeogenesis (GO:0006094),44,7,4.47,+,1.56,1.65E-01
negative regulation of lymphocyte mediated immunity (GO:0002707),44,7,4.47,+,1.56,1.65E-01
cell differentiation involved in kidney development (GO:0061005),44,7,4.47,+,1.56,1.65E-01
nephron tubule morphogenesis (GO:0072078),63,10,6.4,+,1.56,1.14E-01
amine metabolic process (GO:0009308),63,10,6.4,+,1.56,1.14E-01
regulation of protein import into nucleus (GO:0042306),63,10,6.4,+,1.56,1.14E-01
lymphocyte migration (GO:0072676),63,10,6.4,+,1.56,1.14E-01
cell-matrix adhesion (GO:0007160),120,19,12.2,+,1.56,4.22E-02
regulation of steroid hormone secretion (GO:2000831),19,3,1.93,+,1.55,3.05E-01
spinal cord dorsal/ventral patterning (GO:0021513),19,3,1.93,+,1.55,3.05E-01
response to nitric oxide (GO:0071731),19,3,1.93,+,1.55,3.05E-01
blastocyst growth (GO:0001832),19,3,1.93,+,1.55,3.05E-01
regulation of skeletal muscle cell differentiation (GO:2001014),19,3,1.93,+,1.55,3.05E-01
regulation of exit from mitosis (GO:0007096),19,3,1.93,+,1.55,3.05E-01
pericardium development (GO:0060039),19,3,1.93,+,1.55,3.05E-01
"mRNA cis splicing, via spliceosome (GO:0045292)",19,3,1.93,+,1.55,3.05E-01
response to interleukin-6 (GO:0070741),38,6,3.86,+,1.55,1.94E-01
regulation of heterochromatin organization (GO:0120261),19,3,1.93,+,1.55,3.05E-01
cellular amine metabolic process (GO:0044106),57,9,5.79,+,1.55,1.32E-01
regulation of heterochromatin assembly (GO:0031445),19,3,1.93,+,1.55,3.05E-01
regulation of lipoprotein particle clearance (GO:0010984),19,3,1.93,+,1.55,3.05E-01
middle ear morphogenesis (GO:0042474),19,3,1.93,+,1.55,3.05E-01
sialylation (GO:0097503),19,3,1.93,+,1.55,3.05E-01
regulation of ERAD pathway (GO:1904292),19,3,1.93,+,1.55,3.05E-01
acid secretion (GO:0046717),19,3,1.93,+,1.55,3.05E-01
folic acid metabolic process (GO:0046655),19,3,1.93,+,1.55,3.05E-01
positive regulation of sprouting angiogenesis (GO:1903672),19,3,1.93,+,1.55,3.05E-01
positive regulation of humoral immune response (GO:0002922),19,3,1.93,+,1.55,3.05E-01
regulation of catecholamine metabolic process (GO:0042069),19,3,1.93,+,1.55,3.05E-01
regulation of dopamine metabolic process (GO:0042053),19,3,1.93,+,1.55,3.05E-01
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),19,3,1.93,+,1.55,3.05E-01
embryo implantation (GO:0007566),38,6,3.86,+,1.55,1.94E-01
negative regulation of response to oxidative stress (GO:1902883),19,3,1.93,+,1.55,3.05E-01
negative regulation of leukocyte chemotaxis (GO:0002689),19,3,1.93,+,1.55,3.05E-01
chromatin assembly (GO:0031497),95,15,9.66,+,1.55,6.63E-02
detoxification (GO:0098754),121,19,12.3,+,1.54,4.51E-02
negative regulation of mRNA catabolic process (GO:1902373),51,8,5.18,+,1.54,1.53E-01
response to axon injury (GO:0048678),51,8,5.18,+,1.54,1.53E-01
positive regulation of fat cell differentiation (GO:0045600),64,10,6.51,+,1.54,1.23E-01
regulation of sodium ion transmembrane transport (GO:1902305),64,10,6.51,+,1.54,1.23E-01
fear response (GO:0042596),32,5,3.25,+,1.54,2.29E-01
embryonic forelimb morphogenesis (GO:0035115),32,5,3.25,+,1.54,2.29E-01
membrane lipid catabolic process (GO:0046466),32,5,3.25,+,1.54,2.29E-01
positive regulation of vasoconstriction (GO:0045907),32,5,3.25,+,1.54,2.29E-01
protein-DNA complex assembly (GO:0065004),141,22,14.33,+,1.53,3.51E-02
response to corticosteroid (GO:0031960),154,24,15.66,+,1.53,2.92E-02
negative regulation of leukocyte cell-cell adhesion (GO:1903038),122,19,12.4,+,1.53,4.81E-02
positive regulation of biomineralization (GO:0110151),45,7,4.57,+,1.53,1.78E-01
protein-DNA complex subunit organization (GO:0071824),180,28,18.3,+,1.53,2.02E-02
glutamate receptor signaling pathway (GO:0007215),45,7,4.57,+,1.53,1.78E-01
regulation of bone resorption (GO:0045124),45,7,4.57,+,1.53,1.78E-01
genitalia development (GO:0048806),45,7,4.57,+,1.53,1.78E-01
positive regulation of biomineral tissue development (GO:0070169),45,7,4.57,+,1.53,1.78E-01
interleukin-12-mediated signaling pathway (GO:0035722),45,7,4.57,+,1.53,1.78E-01
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",58,9,5.9,+,1.53,1.42E-01
regulation of receptor signaling pathway via STAT (GO:1904892),71,11,7.22,+,1.52,1.14E-01
positive regulation of Ras protein signal transduction (GO:0046579),71,11,7.22,+,1.52,1.14E-01
regulation of smoothened signaling pathway (GO:0008589),84,13,8.54,+,1.52,9.28E-02
mononuclear cell migration (GO:0071674),39,6,3.96,+,1.51,2.09E-01
viral protein processing (GO:0019082),39,6,3.96,+,1.51,2.09E-01
positive regulation of lipid kinase activity (GO:0090218),39,6,3.96,+,1.51,2.09E-01
translesion synthesis (GO:0019985),39,6,3.96,+,1.51,2.09E-01
forelimb morphogenesis (GO:0035136),39,6,3.96,+,1.51,2.09E-01
cellular amino acid catabolic process (GO:0009063),117,18,11.89,+,1.51,5.83E-02
negative regulation of digestive system process (GO:0060457),13,2,1.32,+,1.51,3.81E-01
tetrahydrobiopterin metabolic process (GO:0046146),13,2,1.32,+,1.51,3.81E-01
cerebellar granular layer development (GO:0021681),13,2,1.32,+,1.51,3.81E-01
lateral ventricle development (GO:0021670),13,2,1.32,+,1.51,3.81E-01
pathway-restricted SMAD protein phosphorylation (GO:0060389),13,2,1.32,+,1.51,3.81E-01
regulation of neutrophil activation (GO:1902563),13,2,1.32,+,1.51,3.81E-01
camera-type eye photoreceptor cell differentiation (GO:0060219),26,4,2.64,+,1.51,2.73E-01
negative regulation of transforming growth factor beta production (GO:0071635),13,2,1.32,+,1.51,3.81E-01
positive regulation of DNA biosynthetic process (GO:2000573),65,10,6.61,+,1.51,1.32E-01
auditory receptor cell stereocilium organization (GO:0060088),13,2,1.32,+,1.51,3.81E-01
endodermal cell fate commitment (GO:0001711),13,2,1.32,+,1.51,3.81E-01
regulation of apoptotic process involved in morphogenesis (GO:1902337),13,2,1.32,+,1.51,3.81E-01
cytoplasmic translational initiation (GO:0002183),26,4,2.64,+,1.51,2.73E-01
cytoplasmic translation (GO:0002181),65,10,6.61,+,1.51,1.32E-01
regulation of chromatin assembly or disassembly (GO:0001672),26,4,2.64,+,1.51,2.73E-01
regulation of cell proliferation involved in kidney development (GO:1901722),13,2,1.32,+,1.51,3.81E-01
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),13,2,1.32,+,1.51,3.81E-01
left/right axis specification (GO:0070986),13,2,1.32,+,1.51,3.81E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),13,2,1.32,+,1.51,3.81E-01
mitochondrial transcription (GO:0006390),13,2,1.32,+,1.51,3.81E-01
transcription elongation from RNA polymerase I promoter (GO:0006362),26,4,2.64,+,1.51,2.73E-01
double-strand break repair via nonhomologous end joining (GO:0006303),52,8,5.29,+,1.51,1.65E-01
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),13,2,1.32,+,1.51,3.81E-01
DNA ligation (GO:0006266),13,2,1.32,+,1.51,3.81E-01
replicative senescence (GO:0090399),13,2,1.32,+,1.51,3.81E-01
endoplasmic reticulum calcium ion homeostasis (GO:0032469),26,4,2.64,+,1.51,2.73E-01
regulation of postsynaptic density organization (GO:1905874),13,2,1.32,+,1.51,3.81E-01
ossification involved in bone maturation (GO:0043931),13,2,1.32,+,1.51,3.81E-01
negative regulation of protein autophosphorylation (GO:0031953),13,2,1.32,+,1.51,3.81E-01
regulation of DNA damage checkpoint (GO:2000001),13,2,1.32,+,1.51,3.81E-01
acetyl-CoA biosynthetic process (GO:0006085),13,2,1.32,+,1.51,3.81E-01
regulation of prostaglandin secretion (GO:0032306),13,2,1.32,+,1.51,3.81E-01
galactose metabolic process (GO:0006012),13,2,1.32,+,1.51,3.81E-01
regulation of positive chemotaxis (GO:0050926),26,4,2.64,+,1.51,2.73E-01
"positive regulation of synaptic transmission, GABAergic (GO:0032230)",13,2,1.32,+,1.51,3.81E-01
kinetochore assembly (GO:0051382),13,2,1.32,+,1.51,3.81E-01
dicarboxylic acid biosynthetic process (GO:0043650),13,2,1.32,+,1.51,3.81E-01
maturation of LSU-rRNA (GO:0000470),26,4,2.64,+,1.51,2.73E-01
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",13,2,1.32,+,1.51,3.81E-01
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),13,2,1.32,+,1.51,3.81E-01
G protein-coupled serotonin receptor signaling pathway (GO:0098664),26,4,2.64,+,1.51,2.73E-01
regulation of autophagosome maturation (GO:1901096),13,2,1.32,+,1.51,3.81E-01
actin filament bundle assembly (GO:0051017),52,8,5.29,+,1.51,1.65E-01
regulation of amyloid precursor protein biosynthetic process (GO:0042984),13,2,1.32,+,1.51,3.81E-01
clathrin coat assembly (GO:0048268),13,2,1.32,+,1.51,3.81E-01
proton-transporting two-sector ATPase complex assembly (GO:0070071),13,2,1.32,+,1.51,3.81E-01
regulation of apoptotic process involved in development (GO:1904748),13,2,1.32,+,1.51,3.81E-01
protein import into peroxisome matrix (GO:0016558),13,2,1.32,+,1.51,3.81E-01
alpha-linolenic acid metabolic process (GO:0036109),13,2,1.32,+,1.51,3.81E-01
regulation of pseudopodium assembly (GO:0031272),13,2,1.32,+,1.51,3.81E-01
response to leucine (GO:0043201),13,2,1.32,+,1.51,3.81E-01
somatic hypermutation of immunoglobulin genes (GO:0016446),13,2,1.32,+,1.51,3.81E-01
cyclic nucleotide catabolic process (GO:0009214),13,2,1.32,+,1.51,3.81E-01
regulation of hair cycle (GO:0042634),26,4,2.64,+,1.51,2.73E-01
retinal metabolic process (GO:0042574),13,2,1.32,+,1.51,3.81E-01
regulation of low-density lipoprotein particle clearance (GO:0010988),13,2,1.32,+,1.51,3.81E-01
bundle of His cell to Purkinje myocyte communication (GO:0086069),13,2,1.32,+,1.51,3.81E-01
regulation of bone remodeling (GO:0046850),52,8,5.29,+,1.51,1.65E-01
T cell chemotaxis (GO:0010818),13,2,1.32,+,1.51,3.81E-01
synaptic vesicle priming (GO:0016082),13,2,1.32,+,1.51,3.81E-01
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),13,2,1.32,+,1.51,3.81E-01
ketone catabolic process (GO:0042182),13,2,1.32,+,1.51,3.81E-01
glycosphingolipid catabolic process (GO:0046479),13,2,1.32,+,1.51,3.81E-01
urate metabolic process (GO:0046415),13,2,1.32,+,1.51,3.81E-01
positive regulation of immune response to tumor cell (GO:0002839),13,2,1.32,+,1.51,3.81E-01
positive regulation of response to tumor cell (GO:0002836),13,2,1.32,+,1.51,3.81E-01
endothelial tube morphogenesis (GO:0061154),13,2,1.32,+,1.51,3.81E-01
ureteric bud morphogenesis (GO:0060675),52,8,5.29,+,1.51,1.65E-01
positive regulation of smooth muscle cell apoptotic process (GO:0034393),13,2,1.32,+,1.51,3.81E-01
CDP-diacylglycerol metabolic process (GO:0046341),13,2,1.32,+,1.51,3.81E-01
adherens junction assembly (GO:0034333),13,2,1.32,+,1.51,3.81E-01
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),13,2,1.32,+,1.51,3.81E-01
positive regulation of protein maturation (GO:1903319),26,4,2.64,+,1.51,2.73E-01
morphogenesis of an endothelium (GO:0003159),13,2,1.32,+,1.51,3.81E-01
seminiferous tubule development (GO:0072520),13,2,1.32,+,1.51,3.81E-01
mitochondrial translational elongation (GO:0070125),85,13,8.64,+,1.5,9.91E-02
negative regulation of lymphocyte activation (GO:0051250),144,22,14.64,+,1.5,4.24E-02
modulation by host of symbiont process (GO:0051851),59,9,6,+,1.5,1.52E-01
embryonic pattern specification (GO:0009880),59,9,6,+,1.5,1.52E-01
positive regulation of macroautophagy (GO:0016239),59,9,6,+,1.5,1.52E-01
myeloid leukocyte migration (GO:0097529),118,18,12,+,1.5,6.21E-02
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),105,16,10.67,+,1.5,7.56E-02
regulation of cell aging (GO:0090342),46,7,4.68,+,1.5,1.92E-01
response to cAMP (GO:0051591),92,14,9.35,+,1.5,9.24E-02
regulation of multi-organism process (GO:0043900),46,7,4.68,+,1.5,1.92E-01
regulation of filopodium assembly (GO:0051489),46,7,4.68,+,1.5,1.92E-01
regulation of nitric-oxide synthase activity (GO:0050999),46,7,4.68,+,1.5,1.92E-01
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),46,7,4.68,+,1.5,1.92E-01
DNA geometric change (GO:0032392),112,17,11.39,+,1.49,7.07E-02
cellular hormone metabolic process (GO:0034754),112,17,11.39,+,1.49,7.07E-02
negative regulation of neuron apoptotic process (GO:0043524),145,22,14.74,+,1.49,4.50E-02
alpha-amino acid catabolic process (GO:1901606),99,15,10.06,+,1.49,8.62E-02
salivary gland development (GO:0007431),33,5,3.35,+,1.49,2.47E-01
positive regulation of cation channel activity (GO:2001259),66,10,6.71,+,1.49,1.41E-01
transcription initiation from RNA polymerase I promoter (GO:0006361),33,5,3.35,+,1.49,2.47E-01
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),33,5,3.35,+,1.49,2.47E-01
regulation of kidney development (GO:0090183),33,5,3.35,+,1.49,2.47E-01
positive regulation of telomere maintenance via telomerase (GO:0032212),33,5,3.35,+,1.49,2.47E-01
embryonic digestive tract development (GO:0048566),33,5,3.35,+,1.49,2.47E-01
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),33,5,3.35,+,1.49,2.47E-01
sulfur amino acid metabolic process (GO:0000096),33,5,3.35,+,1.49,2.47E-01
zinc ion homeostasis (GO:0055069),33,5,3.35,+,1.49,2.47E-01
positive regulation of Rho protein signal transduction (GO:0035025),33,5,3.35,+,1.49,2.47E-01
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),66,10,6.71,+,1.49,1.41E-01
negative regulation of smoothened signaling pathway (GO:0045879),33,5,3.35,+,1.49,2.47E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374),192,29,19.52,+,1.49,2.57E-02
response to zinc ion (GO:0010043),53,8,5.39,+,1.48,1.77E-01
mesonephric tubule morphogenesis (GO:0072171),53,8,5.39,+,1.48,1.77E-01
glomerulus development (GO:0032835),53,8,5.39,+,1.48,1.77E-01
cellular response to cAMP (GO:0071320),53,8,5.39,+,1.48,1.77E-01
regulation of macrophage activation (GO:0043030),53,8,5.39,+,1.48,1.77E-01
actin filament bundle organization (GO:0061572),53,8,5.39,+,1.48,1.77E-01
monosaccharide biosynthetic process (GO:0046364),53,8,5.39,+,1.48,1.77E-01
negative regulation of cell-cell adhesion (GO:0022408),173,26,17.59,+,1.48,3.48E-02
negative regulation of cell activation (GO:0050866),193,29,19.62,+,1.48,2.72E-02
positive regulation of gliogenesis (GO:0014015),60,9,6.1,+,1.48,1.63E-01
calcium ion transmembrane import into cytosol (GO:0097553),60,9,6.1,+,1.48,1.63E-01
positive regulation of phospholipase activity (GO:0010518),60,9,6.1,+,1.48,1.63E-01
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686),20,3,2.03,+,1.48,3.32E-01
water transport (GO:0006833),20,3,2.03,+,1.48,3.32E-01
central nervous system myelination (GO:0022010),20,3,2.03,+,1.48,3.32E-01
spinal cord patterning (GO:0021511),20,3,2.03,+,1.48,3.32E-01
regulation of cellular senescence (GO:2000772),40,6,4.07,+,1.48,2.25E-01
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),20,3,2.03,+,1.48,3.32E-01
negative regulation of peptidyl-lysine acetylation (GO:2000757),20,3,2.03,+,1.48,3.32E-01
establishment of tissue polarity (GO:0007164),20,3,2.03,+,1.48,3.32E-01
positive regulation of collagen biosynthetic process (GO:0032967),20,3,2.03,+,1.48,3.32E-01
positive regulation of superoxide anion generation (GO:0032930),20,3,2.03,+,1.48,3.32E-01
establishment of planar polarity (GO:0001736),20,3,2.03,+,1.48,3.32E-01
positive regulation of natural killer cell activation (GO:0032816),20,3,2.03,+,1.48,3.32E-01
regulation of T cell migration (GO:2000404),40,6,4.07,+,1.48,2.25E-01
positive regulation of signal transduction by p53 class mediator (GO:1901798),20,3,2.03,+,1.48,3.32E-01
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",20,3,2.03,+,1.48,3.32E-01
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",20,3,2.03,+,1.48,3.32E-01
regulation of DNA replication (GO:0006275),100,15,10.17,+,1.48,9.17E-02
negative regulation of intracellular protein transport (GO:0090317),40,6,4.07,+,1.48,2.25E-01
axon ensheathment in central nervous system (GO:0032291),20,3,2.03,+,1.48,3.32E-01
linoleic acid metabolic process (GO:0043651),20,3,2.03,+,1.48,3.32E-01
sympathetic nervous system development (GO:0048485),20,3,2.03,+,1.48,3.32E-01
regulation of DNA methylation (GO:0044030),20,3,2.03,+,1.48,3.32E-01
regulation of translation in response to stress (GO:0043555),20,3,2.03,+,1.48,3.32E-01
regulation of urine volume (GO:0035809),20,3,2.03,+,1.48,3.32E-01
fibrinolysis (GO:0042730),20,3,2.03,+,1.48,3.32E-01
neurotrophin TRK receptor signaling pathway (GO:0048011),20,3,2.03,+,1.48,3.32E-01
monoamine transport (GO:0015844),20,3,2.03,+,1.48,3.32E-01
L-glutamate transmembrane transport (GO:0015813),20,3,2.03,+,1.48,3.32E-01
bicarbonate transport (GO:0015701),40,6,4.07,+,1.48,2.25E-01
negative regulation of lipid storage (GO:0010888),20,3,2.03,+,1.48,3.32E-01
error-prone translesion synthesis (GO:0042276),20,3,2.03,+,1.48,3.32E-01
mammary gland lobule development (GO:0061377),20,3,2.03,+,1.48,3.32E-01
mammary gland alveolus development (GO:0060749),20,3,2.03,+,1.48,3.32E-01
regulation of cell maturation (GO:1903429),20,3,2.03,+,1.48,3.32E-01
atrial septum development (GO:0003283),20,3,2.03,+,1.48,3.32E-01
deoxyribose phosphate catabolic process (GO:0046386),20,3,2.03,+,1.48,3.32E-01
regulation of smooth muscle cell apoptotic process (GO:0034391),20,3,2.03,+,1.48,3.32E-01
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),20,3,2.03,+,1.48,3.32E-01
myoblast fusion (GO:0007520),20,3,2.03,+,1.48,3.32E-01
aminoglycan catabolic process (GO:0006026),67,10,6.81,+,1.47,1.50E-01
regulation of protein import (GO:1904589),67,10,6.81,+,1.47,1.50E-01
positive regulation of nucleocytoplasmic transport (GO:0046824),67,10,6.81,+,1.47,1.50E-01
hexose biosynthetic process (GO:0019319),47,7,4.78,+,1.47,2.06E-01
phosphatidic acid biosynthetic process (GO:0006654),47,7,4.78,+,1.47,2.06E-01
cellular response to interleukin-12 (GO:0071349),47,7,4.78,+,1.47,2.06E-01
DNA modification (GO:0006304),94,14,9.56,+,1.47,1.05E-01
cellular pigmentation (GO:0033059),47,7,4.78,+,1.47,2.06E-01
response to epidermal growth factor (GO:0070849),47,7,4.78,+,1.47,2.06E-01
anterior/posterior axis specification (GO:0009948),47,7,4.78,+,1.47,2.06E-01
endoderm development (GO:0007492),74,11,7.52,+,1.46,1.39E-01
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),27,4,2.74,+,1.46,2.96E-01
"blood coagulation, fibrin clot formation (GO:0072378)",27,4,2.74,+,1.46,2.96E-01
protein activation cascade (GO:0072376),27,4,2.74,+,1.46,2.96E-01
termination of RNA polymerase I transcription (GO:0006363),27,4,2.74,+,1.46,2.96E-01
positive regulation of membrane permeability (GO:1905710),27,4,2.74,+,1.46,2.96E-01
positive regulation of lipid catabolic process (GO:0050996),27,4,2.74,+,1.46,2.96E-01
sphingolipid catabolic process (GO:0030149),27,4,2.74,+,1.46,2.96E-01
inner ear morphogenesis (GO:0042472),95,14,9.66,+,1.45,1.11E-01
negative regulation of translation (GO:0017148),129,19,13.11,+,1.45,7.37E-02
calcium ion transport into cytosol (GO:0060402),68,10,6.91,+,1.45,1.60E-01
iron ion transport (GO:0006826),68,10,6.91,+,1.45,1.60E-01
activation of phospholipase C activity (GO:0007202),34,5,3.46,+,1.45,2.66E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),34,5,3.46,+,1.45,2.66E-01
positive regulation of RNA splicing (GO:0033120),34,5,3.46,+,1.45,2.66E-01
negative regulation of blood vessel diameter (GO:0097756),34,5,3.46,+,1.45,2.66E-01
T cell homeostasis (GO:0043029),34,5,3.46,+,1.45,2.66E-01
monocarboxylic acid transport (GO:0015718),136,20,13.83,+,1.45,6.88E-02
microtubule polymerization (GO:0046785),34,5,3.46,+,1.45,2.66E-01
positive regulation of glial cell differentiation (GO:0045687),41,6,4.17,+,1.44,2.41E-01
cell-substrate junction assembly (GO:0007044),41,6,4.17,+,1.44,2.41E-01
negative regulation of proteasomal protein catabolic process (GO:1901799),41,6,4.17,+,1.44,2.41E-01
interaction with symbiont (GO:0051702),82,12,8.34,+,1.44,1.37E-01
kidney morphogenesis (GO:0060993),82,12,8.34,+,1.44,1.37E-01
response to organophosphorus (GO:0046683),130,19,13.22,+,1.44,7.79E-02
rRNA processing (GO:0006364),233,34,23.69,+,1.44,2.60E-02
glycosylation (GO:0070085),233,34,23.69,+,1.44,2.60E-02
transforming growth factor beta receptor signaling pathway (GO:0007179),96,14,9.76,+,1.43,1.18E-01
response to amine (GO:0014075),48,7,4.88,+,1.43,2.20E-01
response to interleukin-12 (GO:0070671),48,7,4.88,+,1.43,2.20E-01
neuron apoptotic process (GO:0051402),48,7,4.88,+,1.43,2.20E-01
nucleosome organization (GO:0034728),103,15,10.47,+,1.43,1.10E-01
positive regulation of stress fiber assembly (GO:0051496),55,8,5.59,+,1.43,2.02E-01
lymphocyte costimulation (GO:0031294),55,8,5.59,+,1.43,2.02E-01
negative regulation of leukocyte mediated immunity (GO:0002704),55,8,5.59,+,1.43,2.02E-01
chromatin organization involved in regulation of transcription (GO:0034401),62,9,6.3,+,1.43,1.85E-01
monovalent inorganic cation homeostasis (GO:0055067),138,20,14.03,+,1.43,7.68E-02
regulation of phospholipase activity (GO:0010517),69,10,7.01,+,1.43,1.71E-01
potassium ion transmembrane transport (GO:0071805),145,21,14.74,+,1.42,7.17E-02
ceramide metabolic process (GO:0006672),76,11,7.73,+,1.42,1.57E-01
protein polymerization (GO:0051258),90,13,9.15,+,1.42,1.35E-01
protein glycosylation (GO:0006486),222,32,22.57,+,1.42,3.44E-02
macromolecule glycosylation (GO:0043413),222,32,22.57,+,1.42,3.44E-02
amino acid transport (GO:0006865),125,18,12.71,+,1.42,9.34E-02
regulation of ERK1 and ERK2 cascade (GO:0070372),271,39,27.55,+,1.42,2.20E-02
hormone metabolic process (GO:0042445),181,26,18.4,+,1.41,5.38E-02
regulation of small GTPase mediated signal transduction (GO:0051056),307,44,31.21,+,1.41,1.68E-02
substantia nigra development (GO:0021762),42,6,4.27,+,1.41,2.58E-01
mammary gland morphogenesis (GO:0060443),42,6,4.27,+,1.41,2.58E-01
positive regulation of cell adhesion mediated by integrin (GO:0033630),21,3,2.13,+,1.41,3.60E-01
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),21,3,2.13,+,1.41,3.60E-01
mast cell activation (GO:0045576),21,3,2.13,+,1.41,3.60E-01
metanephric nephron morphogenesis (GO:0072273),21,3,2.13,+,1.41,3.60E-01
nuclear migration (GO:0007097),21,3,2.13,+,1.41,3.60E-01
branching involved in ureteric bud morphogenesis (GO:0001658),42,6,4.27,+,1.41,2.58E-01
multi-multicellular organism process (GO:0044706),203,29,20.64,+,1.41,4.64E-02
protein insertion into ER membrane (GO:0045048),21,3,2.13,+,1.41,3.60E-01
regulation of platelet aggregation (GO:0090330),21,3,2.13,+,1.41,3.60E-01
positive regulation of fatty acid transport (GO:2000193),21,3,2.13,+,1.41,3.60E-01
smooth muscle tissue development (GO:0048745),21,3,2.13,+,1.41,3.60E-01
negative regulation of neuron death (GO:1901215),203,29,20.64,+,1.41,4.64E-02
import across plasma membrane (GO:0098739),126,18,12.81,+,1.41,9.85E-02
response to muscle stretch (GO:0035994),21,3,2.13,+,1.41,3.60E-01
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),21,3,2.13,+,1.41,3.60E-01
lung alveolus development (GO:0048286),42,6,4.27,+,1.41,2.58E-01
negative regulation of DNA recombination at telomere (GO:0048239),21,3,2.13,+,1.41,3.60E-01
arachidonic acid secretion (GO:0050482),21,3,2.13,+,1.41,3.60E-01
protein autoprocessing (GO:0016540),21,3,2.13,+,1.41,3.60E-01
negative regulation of axon extension (GO:0030517),42,6,4.27,+,1.41,2.58E-01
arachidonate transport (GO:1903963),21,3,2.13,+,1.41,3.60E-01
glutamine family amino acid metabolic process (GO:0009064),63,9,6.4,+,1.41,1.97E-01
cell-substrate junction organization (GO:0150115),42,6,4.27,+,1.41,2.58E-01
regulation of chromatin assembly (GO:0010847),21,3,2.13,+,1.41,3.60E-01
carbohydrate catabolic process (GO:0016052),105,15,10.67,+,1.41,1.23E-01
osteoclast differentiation (GO:0030316),42,6,4.27,+,1.41,2.58E-01
positive regulation of collagen metabolic process (GO:0010714),21,3,2.13,+,1.41,3.60E-01
embryonic hemopoiesis (GO:0035162),21,3,2.13,+,1.41,3.60E-01
establishment of apical/basal cell polarity (GO:0035089),21,3,2.13,+,1.41,3.60E-01
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),21,3,2.13,+,1.41,3.60E-01
muscle cell migration (GO:0014812),21,3,2.13,+,1.41,3.60E-01
regulation of DNA recombination at telomere (GO:0072695),21,3,2.13,+,1.41,3.60E-01
forebrain regionalization (GO:0021871),21,3,2.13,+,1.41,3.60E-01
sex determination (GO:0007530),21,3,2.13,+,1.41,3.60E-01
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248),14,2,1.42,+,1.41,4.16E-01
positive regulation of action potential (GO:0045760),7,1,0.71,+,1.41,5.09E-01
maintenance of DNA methylation (GO:0010216),7,1,0.71,+,1.41,5.09E-01
positive regulation of potassium ion import across plasma membrane (GO:1903288),7,1,0.71,+,1.41,5.09E-01
positive regulation of gluconeogenesis (GO:0045722),14,2,1.42,+,1.41,4.16E-01
embryonic skeletal joint development (GO:0072498),14,2,1.42,+,1.41,4.16E-01
hindgut morphogenesis (GO:0007442),7,1,0.71,+,1.41,5.09E-01
cerebellar granule cell differentiation (GO:0021707),7,1,0.71,+,1.41,5.09E-01
negative regulation of neuroblast proliferation (GO:0007406),7,1,0.71,+,1.41,5.09E-01
lung lobe morphogenesis (GO:0060463),7,1,0.71,+,1.41,5.09E-01
lung lobe development (GO:0060462),7,1,0.71,+,1.41,5.09E-01
bud elongation involved in lung branching (GO:0060449),7,1,0.71,+,1.41,5.09E-01
mRNA methylation (GO:0080009),14,2,1.42,+,1.41,4.16E-01
positive regulation of cell cycle G2/M phase transition (GO:1902751),28,4,2.85,+,1.41,3.18E-01
pigment catabolic process (GO:0046149),14,2,1.42,+,1.41,4.16E-01
regulation of penile erection (GO:0060405),7,1,0.71,+,1.41,5.09E-01
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",14,2,1.42,+,1.41,4.16E-01
somatic diversification of immune receptors via somatic mutation (GO:0002566),14,2,1.42,+,1.41,4.16E-01
negative regulation of macrophage differentiation (GO:0045650),7,1,0.71,+,1.41,5.09E-01
cerebellar granular layer formation (GO:0021684),7,1,0.71,+,1.41,5.09E-01
leukotriene biosynthetic process (GO:0019370),14,2,1.42,+,1.41,4.16E-01
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",7,1,0.71,+,1.41,5.09E-01
"fatty acid elongation, saturated fatty acid (GO:0019367)",7,1,0.71,+,1.41,5.09E-01
lipoxin biosynthetic process (GO:2001301),7,1,0.71,+,1.41,5.09E-01
penetration of zona pellucida (GO:0007341),7,1,0.71,+,1.41,5.09E-01
cranial nerve morphogenesis (GO:0021602),28,4,2.85,+,1.41,3.18E-01
tricarboxylic acid metabolic process (GO:0072350),14,2,1.42,+,1.41,4.16E-01
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),7,1,0.71,+,1.41,5.09E-01
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369),7,1,0.71,+,1.41,5.09E-01
positive regulation of cell proliferation in bone marrow (GO:0071864),7,1,0.71,+,1.41,5.09E-01
regulation of cell proliferation in bone marrow (GO:0071863),7,1,0.71,+,1.41,5.09E-01
meiotic chromosome condensation (GO:0010032),7,1,0.71,+,1.41,5.09E-01
positive regulation of neuron migration (GO:2001224),14,2,1.42,+,1.41,4.16E-01
regulation of protein lipidation (GO:1903059),7,1,0.71,+,1.41,5.09E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),56,8,5.69,+,1.41,2.15E-01
response to amphetamine (GO:0001975),35,5,3.56,+,1.41,2.85E-01
G protein-coupled adenosine receptor signaling pathway (GO:0001973),7,1,0.71,+,1.41,5.09E-01
"synaptic transmission, dopaminergic (GO:0001963)",14,2,1.42,+,1.41,4.16E-01
negative regulation of glycoprotein metabolic process (GO:1903019),14,2,1.42,+,1.41,4.16E-01
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794),7,1,0.71,+,1.41,5.09E-01
regulation of cilium beat frequency involved in ciliary motility (GO:0060296),7,1,0.71,+,1.41,5.09E-01
transdifferentiation (GO:0060290),7,1,0.71,+,1.41,5.09E-01
negative regulation of T cell mediated cytotoxicity (GO:0001915),7,1,0.71,+,1.41,5.09E-01
negative regulation of cardiac muscle cell differentiation (GO:2000726),7,1,0.71,+,1.41,5.09E-01
cell proliferation involved in metanephros development (GO:0072203),7,1,0.71,+,1.41,5.09E-01
porphyrin-containing compound catabolic process (GO:0006787),14,2,1.42,+,1.41,4.16E-01
endoplasmic reticulum tubular network organization (GO:0071786),14,2,1.42,+,1.41,4.16E-01
NADP metabolic process (GO:0006739),28,4,2.85,+,1.41,3.18E-01
response to ether (GO:0045472),14,2,1.42,+,1.41,4.16E-01
basement membrane organization (GO:0071711),28,4,2.85,+,1.41,3.18E-01
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),7,1,0.71,+,1.41,5.09E-01
inner cell mass cell differentiation (GO:0001826),7,1,0.71,+,1.41,5.09E-01
male mating behavior (GO:0060179),7,1,0.71,+,1.41,5.09E-01
collagen biosynthetic process (GO:0032964),7,1,0.71,+,1.41,5.09E-01
regulation of inositol trisphosphate biosynthetic process (GO:0032960),7,1,0.71,+,1.41,5.09E-01
embryonic process involved in female pregnancy (GO:0060136),7,1,0.71,+,1.41,5.09E-01
positive regulation of histone H3-K9 acetylation (GO:2000617),7,1,0.71,+,1.41,5.09E-01
negative regulation of stem cell population maintenance (GO:1902455),7,1,0.71,+,1.41,5.09E-01
positive regulation of transforming growth factor beta1 production (GO:0032914),7,1,0.71,+,1.41,5.09E-01
TORC2 signaling (GO:0038203),7,1,0.71,+,1.41,5.09E-01
regulation of smooth muscle cell chemotaxis (GO:0071671),7,1,0.71,+,1.41,5.09E-01
positive regulation of integrin-mediated signaling pathway (GO:2001046),7,1,0.71,+,1.41,5.09E-01
receptor-mediated endocytosis of virus by host cell (GO:0019065),7,1,0.71,+,1.41,5.09E-01
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),7,1,0.71,+,1.41,5.09E-01
"regulation of phagocytosis, engulfment (GO:0060099)",14,2,1.42,+,1.41,4.16E-01
collecting duct development (GO:0072044),14,2,1.42,+,1.41,4.16E-01
neurotrophin signaling pathway (GO:0038179),28,4,2.85,+,1.41,3.18E-01
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),7,1,0.71,+,1.41,5.09E-01
granzyme-mediated programmed cell death signaling pathway (GO:0140507),7,1,0.71,+,1.41,5.09E-01
negative regulation by host of viral genome replication (GO:0044828),7,1,0.71,+,1.41,5.09E-01
regulation of cellular pH reduction (GO:0032847),7,1,0.71,+,1.41,5.09E-01
G-quadruplex DNA unwinding (GO:0044806),7,1,0.71,+,1.41,5.09E-01
multi-organism membrane fusion (GO:0044800),7,1,0.71,+,1.41,5.09E-01
amino-acid betaine biosynthetic process (GO:0006578),7,1,0.71,+,1.41,5.09E-01
cellular biogenic amine metabolic process (GO:0006576),56,8,5.69,+,1.41,2.15E-01
otic vesicle development (GO:0071599),14,2,1.42,+,1.41,4.16E-01
L-serine biosynthetic process (GO:0006564),7,1,0.71,+,1.41,5.09E-01
lacrimal gland development (GO:0032808),7,1,0.71,+,1.41,5.09E-01
zinc ion import across plasma membrane (GO:0071578),7,1,0.71,+,1.41,5.09E-01
isoleucine metabolic process (GO:0006549),7,1,0.71,+,1.41,5.09E-01
T-tubule organization (GO:0033292),7,1,0.71,+,1.41,5.09E-01
cell-cell junction maintenance (GO:0045217),14,2,1.42,+,1.41,4.16E-01
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299),7,1,0.71,+,1.41,5.09E-01
positive regulation of T cell migration (GO:2000406),28,4,2.85,+,1.41,3.18E-01
dolichyl diphosphate biosynthetic process (GO:0006489),7,1,0.71,+,1.41,5.09E-01
negative regulation of interleukin-4 production (GO:0032713),7,1,0.71,+,1.41,5.09E-01
auditory receptor cell morphogenesis (GO:0002093),14,2,1.42,+,1.41,4.16E-01
"regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)",7,1,0.71,+,1.41,5.09E-01
clustering of voltage-gated sodium channels (GO:0045162),7,1,0.71,+,1.41,5.09E-01
ganglioside biosynthetic process (GO:0001574),14,2,1.42,+,1.41,4.16E-01
regulation of interleukin-18 production (GO:0032661),7,1,0.71,+,1.41,5.09E-01
chromatin assembly or disassembly (GO:0006333),112,16,11.39,+,1.41,1.14E-01
negative regulation of cell division (GO:0051782),14,2,1.42,+,1.41,4.16E-01
actin crosslink formation (GO:0051764),14,2,1.42,+,1.41,4.16E-01
negative regulation of T cell differentiation in thymus (GO:0033085),7,1,0.71,+,1.41,5.09E-01
regulation of immature T cell proliferation in thymus (GO:0033084),7,1,0.71,+,1.41,5.09E-01
tetrapyrrole catabolic process (GO:0033015),14,2,1.42,+,1.41,4.16E-01
negative regulation of fibroblast apoptotic process (GO:2000270),7,1,0.71,+,1.41,5.09E-01
protein transport within lipid bilayer (GO:0032594),7,1,0.71,+,1.41,5.09E-01
regulation of reproductive process (GO:2000241),147,21,14.94,+,1.41,7.97E-02
protein O-linked glycosylation via serine (GO:0018242),7,1,0.71,+,1.41,5.09E-01
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),7,1,0.71,+,1.41,5.09E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,1,0.71,+,1.41,5.09E-01
pyrimidine nucleotide catabolic process (GO:0006244),14,2,1.42,+,1.41,4.16E-01
serotonin uptake (GO:0051610),7,1,0.71,+,1.41,5.09E-01
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),14,2,1.42,+,1.41,4.16E-01
positive regulation of axon extension involved in axon guidance (GO:0048842),7,1,0.71,+,1.41,5.09E-01
otolith development (GO:0048840),7,1,0.71,+,1.41,5.09E-01
negative regulation of neurotransmitter transport (GO:0051589),14,2,1.42,+,1.41,4.16E-01
endocytosis involved in viral entry into host cell (GO:0075509),7,1,0.71,+,1.41,5.09E-01
regulation of keratinocyte migration (GO:0051547),14,2,1.42,+,1.41,4.16E-01
regulation of metaphase plate congression (GO:0090235),7,1,0.71,+,1.41,5.09E-01
semicircular canal morphogenesis (GO:0048752),7,1,0.71,+,1.41,5.09E-01
macropinocytosis (GO:0044351),7,1,0.71,+,1.41,5.09E-01
regulation of aldosterone biosynthetic process (GO:0032347),7,1,0.71,+,1.41,5.09E-01
regulation of aldosterone metabolic process (GO:0032344),7,1,0.71,+,1.41,5.09E-01
uronic acid metabolic process (GO:0006063),14,2,1.42,+,1.41,4.16E-01
peptidyl-lysine monomethylation (GO:0018026),7,1,0.71,+,1.41,5.09E-01
DNA strand renaturation (GO:0000733),7,1,0.71,+,1.41,5.09E-01
hyaloid vascular plexus regression (GO:1990384),7,1,0.71,+,1.41,5.09E-01
non-recombinational repair (GO:0000726),56,8,5.69,+,1.41,2.15E-01
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),7,1,0.71,+,1.41,5.09E-01
regulation of membrane repolarization during action potential (GO:0098903),7,1,0.71,+,1.41,5.09E-01
regulation of store-operated calcium channel activity (GO:1901339),7,1,0.71,+,1.41,5.09E-01
hormone transport (GO:0009914),77,11,7.83,+,1.41,1.67E-01
regulation of vitamin D receptor signaling pathway (GO:0070562),7,1,0.71,+,1.41,5.09E-01
epithelial cell-cell adhesion (GO:0090136),14,2,1.42,+,1.41,4.16E-01
detection of calcium ion (GO:0005513),14,2,1.42,+,1.41,4.16E-01
"regulation of synaptic transmission, cholinergic (GO:0032222)",7,1,0.71,+,1.41,5.09E-01
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),14,2,1.42,+,1.41,4.16E-01
spontaneous synaptic transmission (GO:0098814),7,1,0.71,+,1.41,5.09E-01
regulation of extracellular matrix assembly (GO:1901201),14,2,1.42,+,1.41,4.16E-01
white fat cell differentiation (GO:0050872),14,2,1.42,+,1.41,4.16E-01
protein desumoylation (GO:0016926),7,1,0.71,+,1.41,5.09E-01
cellular response to interleukin-7 (GO:0098761),28,4,2.85,+,1.41,3.18E-01
response to interleukin-7 (GO:0098760),28,4,2.85,+,1.41,3.18E-01
polyadenylation-dependent ncRNA catabolic process (GO:0043634),7,1,0.71,+,1.41,5.09E-01
insulin metabolic process (GO:1901142),7,1,0.71,+,1.41,5.09E-01
response to cGMP (GO:0070305),7,1,0.71,+,1.41,5.09E-01
negative regulation of nuclease activity (GO:0032074),7,1,0.71,+,1.41,5.09E-01
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",7,1,0.71,+,1.41,5.09E-01
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),7,1,0.71,+,1.41,5.09E-01
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),35,5,3.56,+,1.41,2.85E-01
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),7,1,0.71,+,1.41,5.09E-01
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",14,2,1.42,+,1.41,4.16E-01
N-acylphosphatidylethanolamine metabolic process (GO:0070292),7,1,0.71,+,1.41,5.09E-01
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),28,4,2.85,+,1.41,3.18E-01
pre-replicative complex assembly (GO:0036388),7,1,0.71,+,1.41,5.09E-01
sodium ion export across plasma membrane (GO:0036376),14,2,1.42,+,1.41,4.16E-01
establishment of protein localization to telomere (GO:0070200),7,1,0.71,+,1.41,5.09E-01
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",14,2,1.42,+,1.41,4.16E-01
nail development (GO:0035878),7,1,0.71,+,1.41,5.09E-01
lactate transmembrane transport (GO:0035873),7,1,0.71,+,1.41,5.09E-01
tRNA transport (GO:0051031),35,5,3.56,+,1.41,2.85E-01
negative regulation of nitric-oxide synthase activity (GO:0051001),7,1,0.71,+,1.41,5.09E-01
behavioral response to pain (GO:0048266),14,2,1.42,+,1.41,4.16E-01
response to pain (GO:0048265),28,4,2.85,+,1.41,3.18E-01
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847),7,1,0.71,+,1.41,5.09E-01
negative regulation of chemokine-mediated signaling pathway (GO:0070100),7,1,0.71,+,1.41,5.09E-01
regulation of glutamate receptor signaling pathway (GO:1900449),7,1,0.71,+,1.41,5.09E-01
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",35,5,3.56,+,1.41,2.85E-01
"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",7,1,0.71,+,1.41,5.09E-01
positive T cell selection (GO:0043368),28,4,2.85,+,1.41,3.18E-01
enucleate erythrocyte differentiation (GO:0043353),7,1,0.71,+,1.41,5.09E-01
positive regulation of core promoter binding (GO:1904798),7,1,0.71,+,1.41,5.09E-01
proton-transporting V-type ATPase complex assembly (GO:0070070),7,1,0.71,+,1.41,5.09E-01
positive regulation of secondary metabolite biosynthetic process (GO:1900378),7,1,0.71,+,1.41,5.09E-01
autophagic cell death (GO:0048102),7,1,0.71,+,1.41,5.09E-01
locomotory exploration behavior (GO:0035641),14,2,1.42,+,1.41,4.16E-01
tRNA transcription by RNA polymerase III (GO:0042797),7,1,0.71,+,1.41,5.09E-01
positive regulation of melanin biosynthetic process (GO:0048023),7,1,0.71,+,1.41,5.09E-01
osteoclast development (GO:0036035),7,1,0.71,+,1.41,5.09E-01
G protein-coupled purinergic receptor signaling pathway (GO:0035588),7,1,0.71,+,1.41,5.09E-01
regulation of vascular associated smooth muscle cell differentiation (GO:1905063),14,2,1.42,+,1.41,4.16E-01
negative regulation of metallopeptidase activity (GO:1905049),7,1,0.71,+,1.41,5.09E-01
pantothenate metabolic process (GO:0015939),7,1,0.71,+,1.41,5.09E-01
regulation of myosin-light-chain-phosphatase activity (GO:0035507),7,1,0.71,+,1.41,5.09E-01
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",14,2,1.42,+,1.41,4.16E-01
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),14,2,1.42,+,1.41,4.16E-01
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),28,4,2.85,+,1.41,3.18E-01
ADP transport (GO:0015866),7,1,0.71,+,1.41,5.09E-01
organic hydroxy compound transport (GO:0015850),140,20,14.23,+,1.41,8.55E-02
ornithine transport (GO:0015822),7,1,0.71,+,1.41,5.09E-01
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148),14,2,1.42,+,1.41,4.16E-01
pteridine-containing compound biosynthetic process (GO:0042559),14,2,1.42,+,1.41,4.16E-01
hyperosmotic salinity response (GO:0042538),7,1,0.71,+,1.41,5.09E-01
negative regulation of low-density lipoprotein particle clearance (GO:0010989),7,1,0.71,+,1.41,5.09E-01
regulation of microtubule nucleation (GO:0010968),7,1,0.71,+,1.41,5.09E-01
negative regulation of cellular response to hypoxia (GO:1900038),7,1,0.71,+,1.41,5.09E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),7,1,0.71,+,1.41,5.09E-01
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),28,4,2.85,+,1.41,3.18E-01
positive regulation of protein kinase C activity (GO:1900020),7,1,0.71,+,1.41,5.09E-01
regulation of protein kinase C activity (GO:1900019),7,1,0.71,+,1.41,5.09E-01
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),7,1,0.71,+,1.41,5.09E-01
glycerol transport (GO:0015793),7,1,0.71,+,1.41,5.09E-01
peroxisome proliferator activated receptor signaling pathway (GO:0035357),7,1,0.71,+,1.41,5.09E-01
positive regulation of receptor clustering (GO:1903911),7,1,0.71,+,1.41,5.09E-01
lactate transport (GO:0015727),7,1,0.71,+,1.41,5.09E-01
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),7,1,0.71,+,1.41,5.09E-01
inner ear auditory receptor cell differentiation (GO:0042491),28,4,2.85,+,1.41,3.18E-01
regulation of RNA export from nucleus (GO:0046831),14,2,1.42,+,1.41,4.16E-01
regulation of triglyceride catabolic process (GO:0010896),14,2,1.42,+,1.41,4.16E-01
regulation of sequestering of triglyceride (GO:0010889),14,2,1.42,+,1.41,4.16E-01
membrane fusion involved in viral entry into host cell (GO:0039663),7,1,0.71,+,1.41,5.09E-01
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),28,4,2.85,+,1.41,3.18E-01
arginine transmembrane transport (GO:1903826),7,1,0.71,+,1.41,5.09E-01
amyloid-beta clearance by cellular catabolic process (GO:0150094),7,1,0.71,+,1.41,5.09E-01
amyloid-beta clearance by transcytosis (GO:0150093),7,1,0.71,+,1.41,5.09E-01
histone H4-K20 methylation (GO:0034770),7,1,0.71,+,1.41,5.09E-01
positive regulation of fibroblast migration (GO:0010763),14,2,1.42,+,1.41,4.16E-01
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),56,8,5.69,+,1.41,2.15E-01
negative regulation of establishment of protein localization to mitochondrion (GO:1903748),7,1,0.71,+,1.41,5.09E-01
regulation of aerobic respiration (GO:1903715),7,1,0.71,+,1.41,5.09E-01
negative regulation of membrane depolarization (GO:1904180),7,1,0.71,+,1.41,5.09E-01
bone mineralization (GO:0030282),49,7,4.98,+,1.41,2.35E-01
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",7,1,0.71,+,1.41,5.09E-01
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",7,1,0.71,+,1.41,5.09E-01
mammalian oogenesis stage (GO:0022605),7,1,0.71,+,1.41,5.09E-01
hyaluronan biosynthetic process (GO:0030213),7,1,0.71,+,1.41,5.09E-01
BMP signaling pathway involved in heart development (GO:0061312),7,1,0.71,+,1.41,5.09E-01
lymphatic endothelial cell differentiation (GO:0060836),7,1,0.71,+,1.41,5.09E-01
regulation of photoreceptor cell differentiation (GO:0046532),7,1,0.71,+,1.41,5.09E-01
heme catabolic process (GO:0042167),14,2,1.42,+,1.41,4.16E-01
S-adenosylmethionine metabolic process (GO:0046500),14,2,1.42,+,1.41,4.16E-01
response to gonadotropin-releasing hormone (GO:0097210),7,1,0.71,+,1.41,5.09E-01
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),7,1,0.71,+,1.41,5.09E-01
regulation of mast cell chemotaxis (GO:0060753),7,1,0.71,+,1.41,5.09E-01
metanephros morphogenesis (GO:0003338),28,4,2.85,+,1.41,3.18E-01
glycosylceramide biosynthetic process (GO:0046476),7,1,0.71,+,1.41,5.09E-01
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321),7,1,0.71,+,1.41,5.09E-01
dolichyl diphosphate metabolic process (GO:0046465),7,1,0.71,+,1.41,5.09E-01
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308),7,1,0.71,+,1.41,5.09E-01
chorion development (GO:0060717),7,1,0.71,+,1.41,5.09E-01
protein repair (GO:0030091),7,1,0.71,+,1.41,5.09E-01
fluid transport (GO:0042044),28,4,2.85,+,1.41,3.18E-01
peptide hormone secretion (GO:0030072),56,8,5.69,+,1.41,2.15E-01
intercellular transport (GO:0010496),7,1,0.71,+,1.41,5.09E-01
urinary bladder smooth muscle contraction (GO:0014832),7,1,0.71,+,1.41,5.09E-01
parallel actin filament bundle assembly (GO:0030046),7,1,0.71,+,1.41,5.09E-01
positive regulation of cell fate commitment (GO:0010455),7,1,0.71,+,1.41,5.09E-01
positive regulation of T-helper 1 type immune response (GO:0002827),14,2,1.42,+,1.41,4.16E-01
negative regulation of T-helper 1 type immune response (GO:0002826),7,1,0.71,+,1.41,5.09E-01
cellular potassium ion homeostasis (GO:0030007),14,2,1.42,+,1.41,4.16E-01
negative regulation of calcium ion-dependent exocytosis (GO:0045955),7,1,0.71,+,1.41,5.09E-01
hypothalamus cell differentiation (GO:0021979),7,1,0.71,+,1.41,5.09E-01
protein localization to ciliary membrane (GO:1903441),7,1,0.71,+,1.41,5.09E-01
corticospinal tract morphogenesis (GO:0021957),7,1,0.71,+,1.41,5.09E-01
neuroendocrine cell differentiation (GO:0061101),7,1,0.71,+,1.41,5.09E-01
cerebellar granule cell precursor proliferation (GO:0021930),7,1,0.71,+,1.41,5.09E-01
cell proliferation in external granule layer (GO:0021924),7,1,0.71,+,1.41,5.09E-01
L-arginine transmembrane transport (GO:1903400),7,1,0.71,+,1.41,5.09E-01
regulation of phospholipid catabolic process (GO:0060696),7,1,0.71,+,1.41,5.09E-01
long-term memory (GO:0007616),35,5,3.56,+,1.41,2.85E-01
negative regulation of glial cell apoptotic process (GO:0034351),7,1,0.71,+,1.41,5.09E-01
L-kynurenine metabolic process (GO:0097052),7,1,0.71,+,1.41,5.09E-01
adherens junction maintenance (GO:0034334),7,1,0.71,+,1.41,5.09E-01
positive regulation of dendritic cell cytokine production (GO:0002732),7,1,0.71,+,1.41,5.09E-01
regulation of natural killer cell cytokine production (GO:0002727),7,1,0.71,+,1.41,5.09E-01
glucuronate metabolic process (GO:0019585),14,2,1.42,+,1.41,4.16E-01
protein localization to basolateral plasma membrane (GO:1903361),7,1,0.71,+,1.41,5.09E-01
mammary gland formation (GO:0060592),7,1,0.71,+,1.41,5.09E-01
morphogenesis of an epithelial bud (GO:0060572),7,1,0.71,+,1.41,5.09E-01
regulation of vitamin D biosynthetic process (GO:0060556),7,1,0.71,+,1.41,5.09E-01
monovalent inorganic cation transport (GO:0015672),372,53,37.82,+,1.4,1.05E-02
inner ear development (GO:0048839),183,26,18.6,+,1.4,5.96E-02
potassium ion transport (GO:0006813),155,22,15.76,+,1.4,7.83E-02
rRNA metabolic process (GO:0016072),240,34,24.4,+,1.39,3.68E-02
ear morphogenesis (GO:0042471),113,16,11.49,+,1.39,1.20E-01
regulation of ossification (GO:0030278),113,16,11.49,+,1.39,1.20E-01
gland morphogenesis (GO:0022612),99,14,10.06,+,1.39,1.40E-01
cellular response to leukemia inhibitory factor (GO:1990830),92,13,9.35,+,1.39,1.51E-01
biomineralization (GO:0110148),85,12,8.64,+,1.39,1.63E-01
pigmentation (GO:0043473),85,12,8.64,+,1.39,1.63E-01
biomineral tissue development (GO:0031214),85,12,8.64,+,1.39,1.63E-01
sodium ion transport (GO:0006814),163,23,16.57,+,1.39,7.68E-02
oligodendrocyte differentiation (GO:0048709),71,10,7.22,+,1.39,1.92E-01
extracellular matrix organization (GO:0030198),348,49,35.38,+,1.39,1.62E-02
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433),64,9,6.51,+,1.38,2.09E-01
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),64,9,6.51,+,1.38,2.09E-01
neuron projection extension (GO:1990138),64,9,6.51,+,1.38,2.09E-01
actin cytoskeleton reorganization (GO:0031532),64,9,6.51,+,1.38,2.09E-01
establishment or maintenance of cell polarity (GO:0007163),185,26,18.81,+,1.38,6.57E-02
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),185,26,18.81,+,1.38,6.57E-02
extracellular structure organization (GO:0043062),349,49,35.48,+,1.38,1.70E-02
Rho protein signal transduction (GO:0007266),57,8,5.79,+,1.38,2.28E-01
retina morphogenesis in camera-type eye (GO:0060042),57,8,5.79,+,1.38,2.28E-01
regulation of lymphocyte migration (GO:2000401),57,8,5.79,+,1.38,2.28E-01
positive regulation of myeloid leukocyte differentiation (GO:0002763),57,8,5.79,+,1.38,2.28E-01
ameboidal-type cell migration (GO:0001667),171,24,17.38,+,1.38,7.53E-02
regulation of neuron apoptotic process (GO:0043523),207,29,21.04,+,1.38,5.63E-02
regulation of megakaryocyte differentiation (GO:0045652),50,7,5.08,+,1.38,2.50E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),150,21,15.25,+,1.38,9.28E-02
interstrand cross-link repair (GO:0036297),50,7,5.08,+,1.38,2.50E-01
protein import (GO:0017038),143,20,14.54,+,1.38,9.96E-02
integrin-mediated signaling pathway (GO:0007229),93,13,9.45,+,1.38,1.59E-01
regulation of lipase activity (GO:0060191),93,13,9.45,+,1.38,1.59E-01
response to leukemia inhibitory factor (GO:1990823),93,13,9.45,+,1.38,1.59E-01
platelet activation (GO:0030168),129,18,13.11,+,1.37,1.15E-01
protein import into nucleus (GO:0006606),86,12,8.74,+,1.37,1.72E-01
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),86,12,8.74,+,1.37,1.72E-01
"RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",43,6,4.37,+,1.37,2.75E-01
regulation of macrophage migration (GO:1905521),43,6,4.37,+,1.37,2.75E-01
mitochondrial translational termination (GO:0070126),86,12,8.74,+,1.37,1.72E-01
vesicle transport along microtubule (GO:0047496),43,6,4.37,+,1.37,2.75E-01
ovulation cycle process (GO:0022602),43,6,4.37,+,1.37,2.75E-01
negative regulation of leukocyte activation (GO:0002695),172,24,17.49,+,1.37,7.91E-02
mRNA catabolic process (GO:0006402),201,28,20.43,+,1.37,6.32E-02
regulation of response to endoplasmic reticulum stress (GO:1905897),79,11,8.03,+,1.37,1.87E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057),79,11,8.03,+,1.37,1.87E-01
regulation of fibroblast proliferation (GO:0048145),79,11,8.03,+,1.37,1.87E-01
response to transforming growth factor beta (GO:0071559),151,21,15.35,+,1.37,9.75E-02
acute inflammatory response (GO:0002526),72,10,7.32,+,1.37,2.03E-01
activation of JUN kinase activity (GO:0007257),36,5,3.66,+,1.37,3.05E-01
cellular response to transforming growth factor beta stimulus (GO:0071560),144,20,14.64,+,1.37,1.05E-01
cellular response to osmotic stress (GO:0071470),36,5,3.66,+,1.37,3.05E-01
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",36,5,3.66,+,1.37,3.05E-01
regulation of voltage-gated calcium channel activity (GO:1901385),36,5,3.66,+,1.37,3.05E-01
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),36,5,3.66,+,1.37,3.05E-01
cellular response to virus (GO:0098586),36,5,3.66,+,1.37,3.05E-01
regulation of bone mineralization (GO:0030500),72,10,7.32,+,1.37,2.03E-01
hair cell differentiation (GO:0035315),36,5,3.66,+,1.37,3.05E-01
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),36,5,3.66,+,1.37,3.05E-01
ncRNA export from nucleus (GO:0097064),36,5,3.66,+,1.37,3.05E-01
regulation of hormone levels (GO:0010817),497,69,50.53,+,1.37,6.94E-03
carboxylic acid transport (GO:0046942),281,39,28.57,+,1.37,3.52E-02
cellular response to drug (GO:0035690),65,9,6.61,+,1.36,2.21E-01
cell aging (GO:0007569),65,9,6.61,+,1.36,2.21E-01
regulation of cell division (GO:0051302),159,22,16.16,+,1.36,9.53E-02
organic acid transport (GO:0015849),282,39,28.67,+,1.36,3.67E-02
translational termination (GO:0006415),94,13,9.56,+,1.36,1.68E-01
icosanoid transport (GO:0071715),29,4,2.95,+,1.36,3.41E-01
fatty acid derivative transport (GO:1901571),29,4,2.95,+,1.36,3.41E-01
response to increased oxygen levels (GO:0036296),29,4,2.95,+,1.36,3.41E-01
somatic diversification of immunoglobulins (GO:0016445),29,4,2.95,+,1.36,3.41E-01
"synaptic transmission, glutamatergic (GO:0035249)",29,4,2.95,+,1.36,3.41E-01
vasoconstriction (GO:0042310),29,4,2.95,+,1.36,3.41E-01
embryonic hindlimb morphogenesis (GO:0035116),29,4,2.95,+,1.36,3.41E-01
establishment of cell polarity (GO:0030010),116,16,11.79,+,1.36,1.40E-01
T cell migration (GO:0072678),29,4,2.95,+,1.36,3.41E-01
cardiac atrium morphogenesis (GO:0003209),29,4,2.95,+,1.36,3.41E-01
production of molecular mediator of immune response (GO:0002440),80,11,8.13,+,1.35,1.97E-01
L-alpha-amino acid transmembrane transport (GO:1902475),51,7,5.18,+,1.35,2.65E-01
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),51,7,5.18,+,1.35,2.65E-01
positive regulation of epithelial cell differentiation (GO:0030858),51,7,5.18,+,1.35,2.65E-01
posttranscriptional gene silencing (GO:0016441),51,7,5.18,+,1.35,2.65E-01
diterpenoid metabolic process (GO:0016101),102,14,10.37,+,1.35,1.63E-01
negative regulation of blood coagulation (GO:0030195),51,7,5.18,+,1.35,2.65E-01
nerve development (GO:0021675),73,10,7.42,+,1.35,2.14E-01
regulation of leukocyte mediated cytotoxicity (GO:0001910),73,10,7.42,+,1.35,2.14E-01
positive regulation of lipase activity (GO:0060193),73,10,7.42,+,1.35,2.14E-01
RNA modification (GO:0009451),146,20,14.84,+,1.35,1.15E-01
regulation of axon extension (GO:0030516),95,13,9.66,+,1.35,1.77E-01
regulation of osteoblast differentiation (GO:0045667),117,16,11.89,+,1.35,1.47E-01
translation (GO:0006412),344,47,34.97,+,1.34,2.85E-02
response to ketone (GO:1901654),198,27,20.13,+,1.34,8.11E-02
regulation of hydrogen peroxide-induced cell death (GO:1903205),22,3,2.24,+,1.34,3.87E-01
heparan sulfate proteoglycan biosynthetic process (GO:0015012),22,3,2.24,+,1.34,3.87E-01
regulation of osteoclast differentiation (GO:0045670),66,9,6.71,+,1.34,2.34E-01
regulation of macrophage differentiation (GO:0045649),22,3,2.24,+,1.34,3.87E-01
GTP metabolic process (GO:0046039),22,3,2.24,+,1.34,3.87E-01
unsaturated fatty acid biosynthetic process (GO:0006636),44,6,4.47,+,1.34,2.92E-01
glycoprotein catabolic process (GO:0006516),22,3,2.24,+,1.34,3.87E-01
positive regulation of neuroblast proliferation (GO:0002052),22,3,2.24,+,1.34,3.87E-01
nucleosome assembly (GO:0006334),66,9,6.71,+,1.34,2.34E-01
protein import into peroxisome membrane (GO:0045046),22,3,2.24,+,1.34,3.87E-01
transcription preinitiation complex assembly (GO:0070897),22,3,2.24,+,1.34,3.87E-01
regulation of icosanoid secretion (GO:0032303),22,3,2.24,+,1.34,3.87E-01
intracellular pH reduction (GO:0051452),44,6,4.47,+,1.34,2.92E-01
regulation of branching involved in ureteric bud morphogenesis (GO:0090189),22,3,2.24,+,1.34,3.87E-01
negative regulation of lyase activity (GO:0051350),22,3,2.24,+,1.34,3.87E-01
developmental cell growth (GO:0048588),88,12,8.95,+,1.34,1.91E-01
circadian behavior (GO:0048512),22,3,2.24,+,1.34,3.87E-01
negative regulation of phagocytosis (GO:0050765),22,3,2.24,+,1.34,3.87E-01
negative regulation of defense response to virus (GO:0050687),22,3,2.24,+,1.34,3.87E-01
negative regulation of receptor signaling pathway via STAT (GO:1904893),22,3,2.24,+,1.34,3.87E-01
"CD4-positive, alpha-beta T cell activation (GO:0035710)",44,6,4.47,+,1.34,2.92E-01
mRNA modification (GO:0016556),22,3,2.24,+,1.34,3.87E-01
amine catabolic process (GO:0009310),22,3,2.24,+,1.34,3.87E-01
somatic recombination of immunoglobulin gene segments (GO:0016447),22,3,2.24,+,1.34,3.87E-01
mitochondrion transport along microtubule (GO:0047497),22,3,2.24,+,1.34,3.87E-01
response to hyperoxia (GO:0055093),22,3,2.24,+,1.34,3.87E-01
leukocyte chemotaxis (GO:0030595),132,18,13.42,+,1.34,1.33E-01
branched-chain amino acid catabolic process (GO:0009083),22,3,2.24,+,1.34,3.87E-01
regulation of hormone biosynthetic process (GO:0046885),22,3,2.24,+,1.34,3.87E-01
lamellipodium organization (GO:0097581),44,6,4.47,+,1.34,2.92E-01
cellular biogenic amine catabolic process (GO:0042402),22,3,2.24,+,1.34,3.87E-01
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",22,3,2.24,+,1.34,3.87E-01
positive regulation of transcription by RNA polymerase I (GO:0045943),22,3,2.24,+,1.34,3.87E-01
negative regulation of muscle contraction (GO:0045932),22,3,2.24,+,1.34,3.87E-01
positive regulation of leukocyte mediated immunity (GO:0002705),110,15,11.18,+,1.34,1.59E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),235,32,23.89,+,1.34,6.33E-02
glycolipid metabolic process (GO:0006664),103,14,10.47,+,1.34,1.72E-01
amino acid transmembrane transport (GO:0003333),81,11,8.23,+,1.34,2.08E-01
myeloid leukocyte differentiation (GO:0002573),118,16,12,+,1.33,1.55E-01
negative regulation of cytokine-mediated signaling pathway (GO:0001960),59,8,6,+,1.33,2.55E-01
negative regulation of chemotaxis (GO:0050922),59,8,6,+,1.33,2.55E-01
oligosaccharide metabolic process (GO:0009311),59,8,6,+,1.33,2.55E-01
retinoid metabolic process (GO:0001523),96,13,9.76,+,1.33,1.86E-01
glycoprotein biosynthetic process (GO:0009101),281,38,28.57,+,1.33,5.07E-02
renal water homeostasis (GO:0003091),37,5,3.76,+,1.33,3.25E-01
"nucleotide-excision repair, DNA incision (GO:0033683)",37,5,3.76,+,1.33,3.25E-01
transcription by RNA polymerase I (GO:0006360),37,5,3.76,+,1.33,3.25E-01
positive regulation of type I interferon production (GO:0032481),74,10,7.52,+,1.33,2.26E-01
telomere maintenance via semi-conservative replication (GO:0032201),37,5,3.76,+,1.33,3.25E-01
synaptic vesicle transport (GO:0048489),37,5,3.76,+,1.33,3.25E-01
positive regulation of dendrite morphogenesis (GO:0050775),37,5,3.76,+,1.33,3.25E-01
negative regulation of microtubule polymerization or depolymerization (GO:0031111),37,5,3.76,+,1.33,3.25E-01
hindlimb morphogenesis (GO:0035137),37,5,3.76,+,1.33,3.25E-01
lipid storage (GO:0019915),37,5,3.76,+,1.33,3.25E-01
"DNA-templated transcription, initiation (GO:0006352)",200,27,20.33,+,1.33,8.85E-02
positive regulation of GTPase activity (GO:0043547),363,49,36.9,+,1.33,3.09E-02
transcription initiation from RNA polymerase II promoter (GO:0006367),163,22,16.57,+,1.33,1.15E-01
skeletal muscle organ development (GO:0060538),126,17,12.81,+,1.33,1.50E-01
mesonephros development (GO:0001823),89,12,9.05,+,1.33,2.01E-01
regulation of phagocytosis (GO:0050764),89,12,9.05,+,1.33,2.01E-01
lymphocyte homeostasis (GO:0002260),52,7,5.29,+,1.32,2.81E-01
neural crest cell migration (GO:0001755),52,7,5.29,+,1.32,2.81E-01
acidic amino acid transport (GO:0015800),52,7,5.29,+,1.32,2.81E-01
negative regulation of hemostasis (GO:1900047),52,7,5.29,+,1.32,2.81E-01
liposaccharide metabolic process (GO:1903509),104,14,10.57,+,1.32,1.80E-01
nuclear-transcribed mRNA catabolic process (GO:0000956),186,25,18.91,+,1.32,1.02E-01
Fc receptor mediated stimulatory signaling pathway (GO:0002431),67,9,6.81,+,1.32,2.46E-01
Fc-gamma receptor signaling pathway (GO:0038094),67,9,6.81,+,1.32,2.46E-01
ovulation cycle (GO:0042698),67,9,6.81,+,1.32,2.46E-01
ribosomal large subunit biogenesis (GO:0042273),67,9,6.81,+,1.32,2.46E-01
negative regulation of cellular protein catabolic process (GO:1903363),67,9,6.81,+,1.32,2.46E-01
regulation of protein maturation (GO:1903317),67,9,6.81,+,1.32,2.46E-01
lipid oxidation (GO:0034440),82,11,8.34,+,1.32,2.18E-01
response to fibroblast growth factor (GO:0071774),112,15,11.39,+,1.32,1.75E-01
positive regulation of digestive system process (GO:0060456),15,2,1.52,+,1.31,4.51E-01
respiratory system process (GO:0003016),15,2,1.52,+,1.31,4.51E-01
regulation of homotypic cell-cell adhesion (GO:0034110),30,4,3.05,+,1.31,3.64E-01
positive regulation of macrophage differentiation (GO:0045651),15,2,1.52,+,1.31,4.51E-01
regulation of cell adhesion mediated by integrin (GO:0033628),45,6,4.57,+,1.31,3.10E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),30,4,3.05,+,1.31,3.64E-01
mesenchymal to epithelial transition (GO:0060231),15,2,1.52,+,1.31,4.51E-01
cellular response to nitric oxide (GO:0071732),15,2,1.52,+,1.31,4.51E-01
negative regulation of lipase activity (GO:0060192),15,2,1.52,+,1.31,4.51E-01
morphogenesis of a polarized epithelium (GO:0001738),45,6,4.57,+,1.31,3.10E-01
integrated stress response signaling (GO:0140467),15,2,1.52,+,1.31,4.51E-01
negative regulation of interleukin-17 production (GO:0032700),15,2,1.52,+,1.31,4.51E-01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),120,16,12.2,+,1.31,1.70E-01
regulation of glutamate secretion (GO:0014048),15,2,1.52,+,1.31,4.51E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),15,2,1.52,+,1.31,4.51E-01
protein palmitoylation (GO:0018345),30,4,3.05,+,1.31,3.64E-01
nucleosome disassembly (GO:0006337),15,2,1.52,+,1.31,4.51E-01
DNA methylation (GO:0006306),45,6,4.57,+,1.31,3.10E-01
DNA alkylation (GO:0006305),45,6,4.57,+,1.31,3.10E-01
response to salt (GO:1902074),15,2,1.52,+,1.31,4.51E-01
cellular senescence (GO:0090398),30,4,3.05,+,1.31,3.64E-01
synaptic vesicle transport along microtubule (GO:0099517),15,2,1.52,+,1.31,4.51E-01
synaptic vesicle cytoskeletal transport (GO:0099514),15,2,1.52,+,1.31,4.51E-01
positive regulation of transporter activity (GO:0032411),105,14,10.67,+,1.31,1.89E-01
prophase (GO:0051324),15,2,1.52,+,1.31,4.51E-01
regulation of neutrophil chemotaxis (GO:0090022),30,4,3.05,+,1.31,3.64E-01
positive regulation of T cell receptor signaling pathway (GO:0050862),15,2,1.52,+,1.31,4.51E-01
positive regulation of vascular endothelial cell proliferation (GO:1905564),15,2,1.52,+,1.31,4.51E-01
anterograde synaptic vesicle transport (GO:0048490),15,2,1.52,+,1.31,4.51E-01
autonomic nervous system development (GO:0048483),45,6,4.57,+,1.31,3.10E-01
cardiolipin metabolic process (GO:0032048),15,2,1.52,+,1.31,4.51E-01
nose development (GO:0043584),15,2,1.52,+,1.31,4.51E-01
import into nucleus (GO:0051170),105,14,10.67,+,1.31,1.89E-01
regulation of actin nucleation (GO:0051125),30,4,3.05,+,1.31,3.64E-01
regulation of retinoic acid receptor signaling pathway (GO:0048385),15,2,1.52,+,1.31,4.51E-01
"alternative mRNA splicing, via spliceosome (GO:0000380)",15,2,1.52,+,1.31,4.51E-01
chromatin disassembly (GO:0031498),15,2,1.52,+,1.31,4.51E-01
actin filament severing (GO:0051014),15,2,1.52,+,1.31,4.51E-01
cellular response to hepatocyte growth factor stimulus (GO:0035729),15,2,1.52,+,1.31,4.51E-01
regulation of membrane invagination (GO:1905153),15,2,1.52,+,1.31,4.51E-01
erythrocyte maturation (GO:0043249),15,2,1.52,+,1.31,4.51E-01
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",15,2,1.52,+,1.31,4.51E-01
negative regulation of circadian rhythm (GO:0042754),15,2,1.52,+,1.31,4.51E-01
mitotic prophase (GO:0000088),15,2,1.52,+,1.31,4.51E-01
ATP synthesis coupled proton transport (GO:0015986),15,2,1.52,+,1.31,4.51E-01
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",15,2,1.52,+,1.31,4.51E-01
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),15,2,1.52,+,1.31,4.51E-01
negative regulation of protein processing (GO:0010955),30,4,3.05,+,1.31,3.64E-01
regulation of microglial cell activation (GO:1903978),15,2,1.52,+,1.31,4.51E-01
regulation of glial cell migration (GO:1903975),15,2,1.52,+,1.31,4.51E-01
positive regulation of protein targeting to mitochondrion (GO:1903955),30,4,3.05,+,1.31,3.64E-01
serine family amino acid biosynthetic process (GO:0009070),15,2,1.52,+,1.31,4.51E-01
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),15,2,1.52,+,1.31,4.51E-01
ganglion development (GO:0061548),15,2,1.52,+,1.31,4.51E-01
positive regulation of TORC1 signaling (GO:1904263),15,2,1.52,+,1.31,4.51E-01
regulation of macrophage chemotaxis (GO:0010758),30,4,3.05,+,1.31,3.64E-01
cell growth (GO:0016049),90,12,9.15,+,1.31,2.11E-01
regulation of extracellular matrix disassembly (GO:0010715),15,2,1.52,+,1.31,4.51E-01
response to laminar fluid shear stress (GO:0034616),15,2,1.52,+,1.31,4.51E-01
regulation of cell communication by electrical coupling (GO:0010649),15,2,1.52,+,1.31,4.51E-01
venous blood vessel development (GO:0060841),15,2,1.52,+,1.31,4.51E-01
C21-steroid hormone metabolic process (GO:0008207),30,4,3.05,+,1.31,3.64E-01
negative regulation of androgen receptor signaling pathway (GO:0060766),15,2,1.52,+,1.31,4.51E-01
regulation of acute inflammatory response to antigenic stimulus (GO:0002864),15,2,1.52,+,1.31,4.51E-01
vascular associated smooth muscle contraction (GO:0014829),15,2,1.52,+,1.31,4.51E-01
plasma lipoprotein particle remodeling (GO:0034369),30,4,3.05,+,1.31,3.64E-01
protein-lipid complex remodeling (GO:0034368),30,4,3.05,+,1.31,3.64E-01
mitochondrial fusion (GO:0008053),15,2,1.52,+,1.31,4.51E-01
positive regulation of cartilage development (GO:0061036),30,4,3.05,+,1.31,3.64E-01
negative regulation of protein maturation (GO:1903318),30,4,3.05,+,1.31,3.64E-01
positive regulation of cellular extravasation (GO:0002693),15,2,1.52,+,1.31,4.51E-01
positive regulation of reproductive process (GO:2000243),75,10,7.62,+,1.31,2.38E-01
glycoprotein metabolic process (GO:0009100),345,46,35.07,+,1.31,4.19E-02
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),248,33,25.21,+,1.31,7.61E-02
import into cell (GO:0098657),173,23,17.59,+,1.31,1.22E-01
lymphocyte mediated immunity (GO:0002449),128,17,13.01,+,1.31,1.65E-01
positive regulation of response to DNA damage stimulus (GO:2001022),98,13,9.96,+,1.3,2.04E-01
regulation of hematopoietic progenitor cell differentiation (GO:1901532),83,11,8.44,+,1.3,2.29E-01
regulation of TOR signaling (GO:0032006),83,11,8.44,+,1.3,2.29E-01
multicellular organism growth (GO:0035264),83,11,8.44,+,1.3,2.29E-01
multicellular organismal response to stress (GO:0033555),68,9,6.91,+,1.3,2.59E-01
regulation of mitochondrial membrane potential (GO:0051881),68,9,6.91,+,1.3,2.59E-01
regulation of establishment of protein localization to mitochondrion (GO:1903747),68,9,6.91,+,1.3,2.59E-01
stem cell population maintenance (GO:0019827),136,18,13.83,+,1.3,1.60E-01
fatty acid beta-oxidation (GO:0006635),53,7,5.39,+,1.3,2.96E-01
protein targeting to mitochondrion (GO:0006626),53,7,5.39,+,1.3,2.96E-01
cellular response to fibroblast growth factor stimulus (GO:0044344),106,14,10.78,+,1.3,1.98E-01
T cell costimulation (GO:0031295),53,7,5.39,+,1.3,2.96E-01
response to nutrient (GO:0007584),159,21,16.16,+,1.3,1.40E-01
kidney epithelium development (GO:0072073),129,17,13.11,+,1.3,1.72E-01
limb development (GO:0060173),167,22,16.98,+,1.3,1.36E-01
appendage development (GO:0048736),167,22,16.98,+,1.3,1.36E-01
regulation of nucleocytoplasmic transport (GO:0046822),114,15,11.59,+,1.29,1.91E-01
positive regulation of immunoglobulin production (GO:0002639),38,5,3.86,+,1.29,3.44E-01
regulation of tissue remodeling (GO:0034103),76,10,7.73,+,1.29,2.50E-01
regulation of transforming growth factor beta production (GO:0071634),38,5,3.86,+,1.29,3.44E-01
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",38,5,3.86,+,1.29,3.44E-01
peptidyl-cysteine modification (GO:0018198),38,5,3.86,+,1.29,3.44E-01
endocytic recycling (GO:0032456),38,5,3.86,+,1.29,3.44E-01
regulation of p38MAPK cascade (GO:1900744),38,5,3.86,+,1.29,3.44E-01
positive regulation of viral transcription (GO:0050434),38,5,3.86,+,1.29,3.44E-01
peptide biosynthetic process (GO:0043043),365,48,37.11,+,1.29,4.64E-02
positive regulation of neurogenesis (GO:0050769),221,29,22.47,+,1.29,1.03E-01
forebrain generation of neurons (GO:0021872),61,8,6.2,+,1.29,2.84E-01
peptide metabolic process (GO:0006518),473,62,48.09,+,1.29,2.83E-02
hexose metabolic process (GO:0019318),145,19,14.74,+,1.29,1.62E-01
negative regulation of cellular amide metabolic process (GO:0034249),145,19,14.74,+,1.29,1.62E-01
positive regulation of smooth muscle cell proliferation (GO:0048661),84,11,8.54,+,1.29,2.41E-01
positive regulation of axonogenesis (GO:0050772),84,11,8.54,+,1.29,2.41E-01
mitochondrial translation (GO:0032543),107,14,10.88,+,1.29,2.07E-01
female pregnancy (GO:0007565),176,23,17.89,+,1.29,1.38E-01
ncRNA processing (GO:0034470),375,49,38.12,+,1.29,4.87E-02
cellular response to nutrient levels (GO:0031669),222,29,22.57,+,1.28,1.07E-01
regulation of glial cell differentiation (GO:0045685),69,9,7.01,+,1.28,2.73E-01
adrenergic receptor signaling pathway (GO:0071875),23,3,2.34,+,1.28,4.14E-01
hair follicle development (GO:0001942),69,9,7.01,+,1.28,2.73E-01
cytokine production involved in immune response (GO:0002367),23,3,2.34,+,1.28,4.14E-01
male meiosis I (GO:0007141),23,3,2.34,+,1.28,4.14E-01
regulation of superoxide anion generation (GO:0032928),23,3,2.34,+,1.28,4.14E-01
cholesterol efflux (GO:0033344),23,3,2.34,+,1.28,4.14E-01
leukocyte homeostasis (GO:0001776),69,9,7.01,+,1.28,2.73E-01
microtubule nucleation (GO:0007020),23,3,2.34,+,1.28,4.14E-01
regulation of telomerase activity (GO:0051972),46,6,4.68,+,1.28,3.27E-01
alpha-amino acid metabolic process (GO:1901605),184,24,18.71,+,1.28,1.34E-01
"nucleotide-excision repair, DNA gap filling (GO:0006297)",23,3,2.34,+,1.28,4.14E-01
negative regulation of neural precursor cell proliferation (GO:2000178),23,3,2.34,+,1.28,4.14E-01
melanosome organization (GO:0032438),23,3,2.34,+,1.28,4.14E-01
negative regulation of leukocyte apoptotic process (GO:2000107),46,6,4.68,+,1.28,3.27E-01
vesicle-mediated transport between endosomal compartments (GO:0098927),23,3,2.34,+,1.28,4.14E-01
negative chemotaxis (GO:0050919),46,6,4.68,+,1.28,3.27E-01
positive regulation of telomere maintenance (GO:0032206),46,6,4.68,+,1.28,3.27E-01
relaxation of muscle (GO:0090075),23,3,2.34,+,1.28,4.14E-01
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),23,3,2.34,+,1.28,4.14E-01
maintenance of cell number (GO:0098727),138,18,14.03,+,1.28,1.74E-01
ear development (GO:0043583),207,27,21.04,+,1.28,1.18E-01
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),46,6,4.68,+,1.28,3.27E-01
positive regulation of nitric-oxide synthase activity (GO:0051000),23,3,2.34,+,1.28,4.14E-01
positive regulation of mitochondrial membrane permeability (GO:0035794),23,3,2.34,+,1.28,4.14E-01
axon regeneration (GO:0031103),23,3,2.34,+,1.28,4.14E-01
photoreceptor cell development (GO:0042461),46,6,4.68,+,1.28,3.27E-01
granulocyte migration (GO:0097530),92,12,9.35,+,1.28,2.32E-01
positive regulation of phospholipase C activity (GO:0010863),46,6,4.68,+,1.28,3.27E-01
protein mannosylation (GO:0035268),23,3,2.34,+,1.28,4.14E-01
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),23,3,2.34,+,1.28,4.14E-01
establishment or maintenance of monopolar cell polarity (GO:0061339),23,3,2.34,+,1.28,4.14E-01
positive regulation of activated T cell proliferation (GO:0042104),23,3,2.34,+,1.28,4.14E-01
establishment of monopolar cell polarity (GO:0061162),23,3,2.34,+,1.28,4.14E-01
rhythmic behavior (GO:0007622),23,3,2.34,+,1.28,4.14E-01
neuroepithelial cell differentiation (GO:0060563),46,6,4.68,+,1.28,3.27E-01
developmental growth involved in morphogenesis (GO:0060560),115,15,11.69,+,1.28,2.00E-01
positive regulation of cell-substrate adhesion (GO:0010811),123,16,12.5,+,1.28,1.94E-01
nucleotide-excision repair (GO:0006289),100,13,10.17,+,1.28,2.24E-01
glycosaminoglycan biosynthetic process (GO:0006024),100,13,10.17,+,1.28,2.24E-01
amide biosynthetic process (GO:0043604),477,62,48.49,+,1.28,3.26E-02
positive regulation of hydrolase activity (GO:0051345),708,92,71.98,+,1.28,1.13E-02
"DNA-templated transcription, elongation (GO:0006354)",77,10,7.83,+,1.28,2.62E-01
gene silencing by RNA (GO:0031047),77,10,7.83,+,1.28,2.62E-01
fibroblast growth factor receptor signaling pathway (GO:0008543),77,10,7.83,+,1.28,2.62E-01
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),77,10,7.83,+,1.28,2.62E-01
regulation of peptide hormone secretion (GO:0090276),208,27,21.15,+,1.28,1.23E-01
translational initiation (GO:0006413),131,17,13.32,+,1.28,1.87E-01
negative regulation of intracellular transport (GO:0032387),54,7,5.49,+,1.28,3.12E-01
negative regulation of protein catabolic process (GO:0042177),108,14,10.98,+,1.28,2.16E-01
negative regulation of leukocyte proliferation (GO:0070664),85,11,8.64,+,1.27,2.52E-01
regulation of T cell activation (GO:0050863),317,41,32.23,+,1.27,7.45E-02
telomere organization (GO:0032200),93,12,9.45,+,1.27,2.43E-01
regulation of neuroblast proliferation (GO:1902692),31,4,3.15,+,1.27,3.87E-01
serotonin receptor signaling pathway (GO:0007210),31,4,3.15,+,1.27,3.87E-01
neurotransmitter receptor transport (GO:0099637),31,4,3.15,+,1.27,3.87E-01
pyruvate metabolic process (GO:0006090),62,8,6.3,+,1.27,2.98E-01
positive regulation of phagocytosis (GO:0050766),62,8,6.3,+,1.27,2.98E-01
negative regulation of protein localization to membrane (GO:1905476),31,4,3.15,+,1.27,3.87E-01
smooth muscle cell differentiation (GO:0051145),31,4,3.15,+,1.27,3.87E-01
glycolipid biosynthetic process (GO:0009247),62,8,6.3,+,1.27,2.98E-01
cellular metabolic compound salvage (GO:0043094),31,4,3.15,+,1.27,3.87E-01
response to cadmium ion (GO:0046686),62,8,6.3,+,1.27,2.98E-01
regulation of alpha-beta T cell differentiation (GO:0046637),62,8,6.3,+,1.27,2.98E-01
phosphatidylglycerol metabolic process (GO:0046471),31,4,3.15,+,1.27,3.87E-01
negative regulation of DNA replication (GO:0008156),31,4,3.15,+,1.27,3.87E-01
adherens junction organization (GO:0034332),62,8,6.3,+,1.27,2.98E-01
negative regulation of mitotic nuclear division (GO:0045839),31,4,3.15,+,1.27,3.87E-01
carbohydrate biosynthetic process (GO:0016051),132,17,13.42,+,1.27,1.95E-01
cellular detoxification (GO:1990748),101,13,10.27,+,1.27,2.34E-01
stress-activated MAPK cascade (GO:0051403),101,13,10.27,+,1.27,2.34E-01
response to steroid hormone (GO:0048545),272,35,27.65,+,1.27,9.77E-02
transcription-coupled nucleotide-excision repair (GO:0006283),70,9,7.12,+,1.26,2.86E-01
positive regulation of calcium ion transmembrane transport (GO:1904427),70,9,7.12,+,1.26,2.86E-01
"transcription, DNA-templated (GO:0006351)",498,64,50.63,+,1.26,3.67E-02
DNA conformation change (GO:0071103),249,32,25.31,+,1.26,1.10E-01
regulation of extent of cell growth (GO:0061387),109,14,11.08,+,1.26,2.26E-01
positive regulation of DNA metabolic process (GO:0051054),187,24,19.01,+,1.26,1.50E-01
nucleic acid-templated transcription (GO:0097659),499,64,50.73,+,1.26,3.79E-02
positive regulation of blood pressure (GO:0045777),39,5,3.96,+,1.26,3.64E-01
fatty acid oxidation (GO:0019395),78,10,7.93,+,1.26,2.74E-01
response to testosterone (GO:0033574),39,5,3.96,+,1.26,3.64E-01
negative regulation of lymphocyte proliferation (GO:0050672),78,10,7.93,+,1.26,2.74E-01
gene silencing (GO:0016458),117,15,11.89,+,1.26,2.18E-01
endocrine pancreas development (GO:0031018),39,5,3.96,+,1.26,3.64E-01
pteridine-containing compound metabolic process (GO:0042558),39,5,3.96,+,1.26,3.64E-01
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),39,5,3.96,+,1.26,3.64E-01
regulation of double-strand break repair via homologous recombination (GO:0010569),39,5,3.96,+,1.26,3.64E-01
negative regulation of production of molecular mediator of immune response (GO:0002701),39,5,3.96,+,1.26,3.64E-01
viral gene expression (GO:0019080),164,21,16.67,+,1.26,1.71E-01
negative regulation of immune effector process (GO:0002698),125,16,12.71,+,1.26,2.10E-01
regulation of striated muscle contraction (GO:0006942),86,11,8.74,+,1.26,2.64E-01
negative regulation of cell migration (GO:0030336),258,33,26.23,+,1.26,1.11E-01
small molecule catabolic process (GO:0044282),399,51,40.56,+,1.26,6.09E-02
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044),47,6,4.78,+,1.26,3.45E-01
cranial nerve development (GO:0021545),47,6,4.78,+,1.26,3.45E-01
regulation of granulocyte chemotaxis (GO:0071622),47,6,4.78,+,1.26,3.45E-01
cellular response to ketone (GO:1901655),94,12,9.56,+,1.26,2.54E-01
thymus development (GO:0048538),47,6,4.78,+,1.26,3.45E-01
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",47,6,4.78,+,1.26,3.45E-01
pH reduction (GO:0045851),47,6,4.78,+,1.26,3.45E-01
positive regulation of cell development (GO:0010720),290,37,29.48,+,1.26,9.91E-02
endoplasmic reticulum unfolded protein response (GO:0030968),102,13,10.37,+,1.25,2.44E-01
proton transmembrane transport (GO:1902600),110,14,11.18,+,1.25,2.35E-01
Ras protein signal transduction (GO:0007265),165,21,16.77,+,1.25,1.78E-01
viral transcription (GO:0019083),110,14,11.18,+,1.25,2.35E-01
axoneme assembly (GO:0035082),55,7,5.59,+,1.25,3.28E-01
RNA catabolic process (GO:0006401),228,29,23.18,+,1.25,1.34E-01
ribosome biogenesis (GO:0042254),299,38,30.4,+,1.25,9.97E-02
regulation of neuron death (GO:1901214),307,39,31.21,+,1.25,9.69E-02
transcription elongation from RNA polymerase II promoter (GO:0006368),63,8,6.4,+,1.25,3.13E-01
positive regulation of actin filament bundle assembly (GO:0032233),63,8,6.4,+,1.25,3.13E-01
negative regulation of response to cytokine stimulus (GO:0060761),63,8,6.4,+,1.25,3.13E-01
regulation of hormone secretion (GO:0046883),260,33,26.43,+,1.25,1.19E-01
homeostasis of number of cells (GO:0048872),205,26,20.84,+,1.25,1.52E-01
skin epidermis development (GO:0098773),71,9,7.22,+,1.25,3.00E-01
limb morphogenesis (GO:0035108),142,18,14.44,+,1.25,2.04E-01
appendage morphogenesis (GO:0035107),142,18,14.44,+,1.25,2.04E-01
cytosolic calcium ion transport (GO:0060401),79,10,8.03,+,1.25,2.87E-01
negative regulation of mononuclear cell proliferation (GO:0032945),79,10,8.03,+,1.25,2.87E-01
regulation of interleukin-1 beta production (GO:0032651),79,10,8.03,+,1.25,2.87E-01
regulation of lymphocyte differentiation (GO:0045619),174,22,17.69,+,1.24,1.79E-01
monosaccharide metabolic process (GO:0005996),174,22,17.69,+,1.24,1.79E-01
regulation of lymphocyte activation (GO:0051249),420,53,42.7,+,1.24,6.79E-02
regulation of myeloid leukocyte differentiation (GO:0002761),119,15,12.1,+,1.24,2.36E-01
transcription by RNA polymerase II (GO:0006366),365,46,37.11,+,1.24,8.50E-02
RNA biosynthetic process (GO:0032774),508,64,51.64,+,1.24,5.04E-02
negative regulation of cell motility (GO:2000146),270,34,27.45,+,1.24,1.24E-01
mitochondrial gene expression (GO:0140053),135,17,13.72,+,1.24,2.20E-01
regulation of T cell differentiation (GO:0045580),143,18,14.54,+,1.24,2.12E-01
metal ion transport (GO:0030001),596,75,60.59,+,1.24,3.76E-02
glycosaminoglycan metabolic process (GO:0030203),151,19,15.35,+,1.24,2.05E-01
protein localization to nucleus (GO:0034504),151,19,15.35,+,1.24,2.05E-01
protein homooligomerization (GO:0051260),175,22,17.79,+,1.24,1.86E-01
carbohydrate derivative catabolic process (GO:1901136),183,23,18.6,+,1.24,1.80E-01
kidney development (GO:0001822),279,35,28.36,+,1.23,1.24E-01
macromolecule biosynthetic process (GO:0009059),1500,188,152.49,+,1.23,1.91E-03
response to lead ion (GO:0010288),24,3,2.44,+,1.23,4.41E-01
negative regulation of protein localization to plasma membrane (GO:1903077),24,3,2.44,+,1.23,4.41E-01
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),24,3,2.44,+,1.23,4.41E-01
regulation of protein localization to synapse (GO:1902473),24,3,2.44,+,1.23,4.41E-01
activin receptor signaling pathway (GO:0032924),24,3,2.44,+,1.23,4.41E-01
negative regulation of interleukin-1 beta production (GO:0032691),24,3,2.44,+,1.23,4.41E-01
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),24,3,2.44,+,1.23,4.41E-01
postreplication repair (GO:0006301),48,6,4.88,+,1.23,3.63E-01
pigment granule organization (GO:0048753),24,3,2.44,+,1.23,4.41E-01
icosanoid secretion (GO:0032309),24,3,2.44,+,1.23,4.41E-01
positive regulation of neutrophil chemotaxis (GO:0090023),24,3,2.44,+,1.23,4.41E-01
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),24,3,2.44,+,1.23,4.41E-01
cell-cell adhesion (GO:0098609),480,60,48.8,+,1.23,6.34E-02
homologous recombination (GO:0035825),48,6,4.88,+,1.23,3.63E-01
negative regulation of cell killing (GO:0031342),24,3,2.44,+,1.23,4.41E-01
regulation of phospholipase C activity (GO:1900274),48,6,4.88,+,1.23,3.63E-01
positive regulation of protein processing (GO:0010954),24,3,2.44,+,1.23,4.41E-01
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),24,3,2.44,+,1.23,4.41E-01
snRNA processing (GO:0016180),24,3,2.44,+,1.23,4.41E-01
macrophage differentiation (GO:0030225),24,3,2.44,+,1.23,4.41E-01
endosome to lysosome transport (GO:0008333),48,6,4.88,+,1.23,3.63E-01
cell surface receptor signaling pathway involved in heart development (GO:0061311),24,3,2.44,+,1.23,4.41E-01
embryonic placenta morphogenesis (GO:0060669),24,3,2.44,+,1.23,4.41E-01
"positive regulation of gene expression, epigenetic (GO:0045815)",48,6,4.88,+,1.23,3.63E-01
digestion (GO:0007586),96,12,9.76,+,1.23,2.76E-01
positive regulation of T cell tolerance induction (GO:0002666),8,1,0.81,+,1.23,5.57E-01
regulation of potassium ion import (GO:1903286),8,1,0.81,+,1.23,5.57E-01
regulation of protein targeting to mitochondrion (GO:1903214),40,5,4.07,+,1.23,3.84E-01
positive regulation of AMPA receptor activity (GO:2000969),8,1,0.81,+,1.23,5.57E-01
phenol-containing compound biosynthetic process (GO:0046189),32,4,3.25,+,1.23,4.09E-01
purine ribonucleoside catabolic process (GO:0046130),8,1,0.81,+,1.23,5.57E-01
DNA damage induced protein phosphorylation (GO:0006975),8,1,0.81,+,1.23,5.57E-01
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),8,1,0.81,+,1.23,5.57E-01
cerebellar cortex morphogenesis (GO:0021696),32,4,3.25,+,1.23,4.09E-01
lipoxin metabolic process (GO:2001300),8,1,0.81,+,1.23,5.57E-01
segment specification (GO:0007379),16,2,1.63,+,1.23,4.84E-01
plus-end-directed vesicle transport along microtubule (GO:0072383),8,1,0.81,+,1.23,5.57E-01
bone trabecula formation (GO:0060346),8,1,0.81,+,1.23,5.57E-01
regulation of blood vessel remodeling (GO:0060312),8,1,0.81,+,1.23,5.57E-01
response to epinephrine (GO:0071871),16,2,1.63,+,1.23,4.84E-01
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",8,1,0.81,+,1.23,5.57E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),8,1,0.81,+,1.23,5.57E-01
corpus callosum development (GO:0022038),16,2,1.63,+,1.23,4.84E-01
positive regulation of regulatory T cell differentiation (GO:0045591),16,2,1.63,+,1.23,4.84E-01
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),8,1,0.81,+,1.23,5.57E-01
regulation of extracellular matrix organization (GO:1903053),40,5,4.07,+,1.23,3.84E-01
cell proliferation in hindbrain (GO:0021534),8,1,0.81,+,1.23,5.57E-01
metanephric nephron tubule morphogenesis (GO:0072282),8,1,0.81,+,1.23,5.57E-01
blood vessel maturation (GO:0001955),8,1,0.81,+,1.23,5.57E-01
activation of NF-kappaB-inducing kinase activity (GO:0007250),16,2,1.63,+,1.23,4.84E-01
tachykinin receptor signaling pathway (GO:0007217),8,1,0.81,+,1.23,5.57E-01
metanephric nephron development (GO:0072210),32,4,3.25,+,1.23,4.09E-01
terpenoid metabolic process (GO:0006721),112,14,11.39,+,1.23,2.55E-01
C21-steroid hormone biosynthetic process (GO:0006700),16,2,1.63,+,1.23,4.84E-01
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),8,1,0.81,+,1.23,5.57E-01
receptor recycling (GO:0001881),8,1,0.81,+,1.23,5.57E-01
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",224,28,22.77,+,1.23,1.59E-01
neural fold formation (GO:0001842),8,1,0.81,+,1.23,5.57E-01
trophectodermal cell differentiation (GO:0001829),16,2,1.63,+,1.23,4.84E-01
regulation of interleukin-1-mediated signaling pathway (GO:2000659),8,1,0.81,+,1.23,5.57E-01
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),16,2,1.63,+,1.23,4.84E-01
positive regulation of stem cell proliferation (GO:2000648),40,5,4.07,+,1.23,3.84E-01
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),8,1,0.81,+,1.23,5.57E-01
positive regulation of growth hormone secretion (GO:0060124),8,1,0.81,+,1.23,5.57E-01
regulation of transforming growth factor beta2 production (GO:0032909),8,1,0.81,+,1.23,5.57E-01
diacylglycerol biosynthetic process (GO:0006651),8,1,0.81,+,1.23,5.57E-01
membrane lipid metabolic process (GO:0006643),184,23,18.71,+,1.23,1.86E-01
granulocyte chemotaxis (GO:0071621),80,10,8.13,+,1.23,3.00E-01
innate immune response in mucosa (GO:0002227),16,2,1.63,+,1.23,4.84E-01
regulation of MHC class I biosynthetic process (GO:0045343),8,1,0.81,+,1.23,5.57E-01
mitotic sister chromatid cohesion (GO:0007064),16,2,1.63,+,1.23,4.84E-01
sister chromatid cohesion (GO:0007062),40,5,4.07,+,1.23,3.84E-01
protein catabolic process in the vacuole (GO:0007039),8,1,0.81,+,1.23,5.57E-01
"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",8,1,0.81,+,1.23,5.57E-01
micturition (GO:0060073),8,1,0.81,+,1.23,5.57E-01
nucleolus organization (GO:0007000),8,1,0.81,+,1.23,5.57E-01
anatomical structure regression (GO:0060033),16,2,1.63,+,1.23,4.84E-01
indolalkylamine metabolic process (GO:0006586),16,2,1.63,+,1.23,4.84E-01
amino-acid betaine metabolic process (GO:0006577),16,2,1.63,+,1.23,4.84E-01
retinoic acid biosynthetic process (GO:0002138),8,1,0.81,+,1.23,5.57E-01
sulfation (GO:0051923),16,2,1.63,+,1.23,4.84E-01
store-operated calcium entry (GO:0002115),8,1,0.81,+,1.23,5.57E-01
telomeric loop disassembly (GO:0090657),8,1,0.81,+,1.23,5.57E-01
acrosome assembly (GO:0001675),16,2,1.63,+,1.23,4.84E-01
sequestering of BMP from receptor via BMP binding (GO:0038098),8,1,0.81,+,1.23,5.57E-01
neuron projection extension involved in neuron projection guidance (GO:1902284),8,1,0.81,+,1.23,5.57E-01
protein sulfation (GO:0006477),8,1,0.81,+,1.23,5.57E-01
netrin-activated signaling pathway (GO:0038007),8,1,0.81,+,1.23,5.57E-01
translational readthrough (GO:0006451),8,1,0.81,+,1.23,5.57E-01
regulation of translational fidelity (GO:0006450),16,2,1.63,+,1.23,4.84E-01
optic cup morphogenesis involved in camera-type eye development (GO:0002072),8,1,0.81,+,1.23,5.57E-01
cellular response to hydroperoxide (GO:0071447),8,1,0.81,+,1.23,5.57E-01
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),32,4,3.25,+,1.23,4.09E-01
tRNA export from nucleus (GO:0006409),32,4,3.25,+,1.23,4.09E-01
tRNA modification (GO:0006400),80,10,8.13,+,1.23,3.00E-01
regulation of sodium ion transport (GO:0002028),88,11,8.95,+,1.23,2.87E-01
development of secondary sexual characteristics (GO:0045136),8,1,0.81,+,1.23,5.57E-01
positive regulation of cell proliferation involved in kidney development (GO:1901724),8,1,0.81,+,1.23,5.57E-01
bone maturation (GO:0070977),16,2,1.63,+,1.23,4.84E-01
protein localization to endoplasmic reticulum exit site (GO:0070973),8,1,0.81,+,1.23,5.57E-01
small RNA loading onto RISC (GO:0070922),8,1,0.81,+,1.23,5.57E-01
mitochondrial tRNA modification (GO:0070900),8,1,0.81,+,1.23,5.57E-01
selenocysteine incorporation (GO:0001514),8,1,0.81,+,1.23,5.57E-01
regulation of interleukin-23 production (GO:0032667),8,1,0.81,+,1.23,5.57E-01
positive regulation of T-helper 17 cell differentiation (GO:2000321),8,1,0.81,+,1.23,5.57E-01
interleukin-8 production (GO:0032637),8,1,0.81,+,1.23,5.57E-01
transcription initiation from RNA polymerase III promoter (GO:0006384),8,1,0.81,+,1.23,5.57E-01
type I interferon production (GO:0032606),8,1,0.81,+,1.23,5.57E-01
chromatin silencing (GO:0006342),32,4,3.25,+,1.23,4.09E-01
cellular response to ether (GO:0071362),8,1,0.81,+,1.23,5.57E-01
establishment of integrated proviral latency (GO:0075713),8,1,0.81,+,1.23,5.57E-01
skeletal muscle acetylcholine-gated channel clustering (GO:0071340),8,1,0.81,+,1.23,5.57E-01
T-helper 1 cell differentiation (GO:0045063),8,1,0.81,+,1.23,5.57E-01
positive regulation of T cell differentiation in thymus (GO:0033089),8,1,0.81,+,1.23,5.57E-01
positive regulation of fibroblast apoptotic process (GO:2000271),8,1,0.81,+,1.23,5.57E-01
protein O-linked glycosylation via threonine (GO:0018243),8,1,0.81,+,1.23,5.57E-01
L-arginine transport (GO:1902023),8,1,0.81,+,1.23,5.57E-01
DNA unwinding involved in DNA replication (GO:0006268),16,2,1.63,+,1.23,4.84E-01
mitochondrial DNA replication (GO:0006264),8,1,0.81,+,1.23,5.57E-01
peptidyl-histidine modification (GO:0018202),8,1,0.81,+,1.23,5.57E-01
membrane disruption in other organism (GO:0051673),8,1,0.81,+,1.23,5.57E-01
cellular response to molecule of bacterial origin (GO:0071219),184,23,18.71,+,1.23,1.86E-01
histamine transport (GO:0051608),8,1,0.81,+,1.23,5.57E-01
positive regulation of mitophagy (GO:1901526),8,1,0.81,+,1.23,5.57E-01
axon extension involved in axon guidance (GO:0048846),8,1,0.81,+,1.23,5.57E-01
mitotic spindle assembly (GO:0090307),40,5,4.07,+,1.23,3.84E-01
regulation of axon extension involved in axon guidance (GO:0048841),32,4,3.25,+,1.23,4.09E-01
response to bacterial lipoprotein (GO:0032493),8,1,0.81,+,1.23,5.57E-01
modification of synaptic structure (GO:0099563),8,1,0.81,+,1.23,5.57E-01
regulation of growth rate (GO:0040009),8,1,0.81,+,1.23,5.57E-01
purine nucleoside catabolic process (GO:0006152),8,1,0.81,+,1.23,5.57E-01
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",16,2,1.63,+,1.23,4.84E-01
positive regulation of mitochondrial calcium ion concentration (GO:0051561),8,1,0.81,+,1.23,5.57E-01
pronephros development (GO:0048793),8,1,0.81,+,1.23,5.57E-01
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),16,2,1.63,+,1.23,4.84E-01
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),8,1,0.81,+,1.23,5.57E-01
regulation of protein processing (GO:0070613),64,8,6.51,+,1.23,3.28E-01
regulation of type B pancreatic cell development (GO:2000074),8,1,0.81,+,1.23,5.57E-01
cell-cell adhesion mediated by cadherin (GO:0044331),8,1,0.81,+,1.23,5.57E-01
intracellular cholesterol transport (GO:0032367),16,2,1.63,+,1.23,4.84E-01
regulation of stem cell population maintenance (GO:2000036),32,4,3.25,+,1.23,4.09E-01
"DNA catabolic process, exonucleolytic (GO:0000738)",8,1,0.81,+,1.23,5.57E-01
cellular water homeostasis (GO:0009992),8,1,0.81,+,1.23,5.57E-01
regulation of transforming growth factor beta activation (GO:1901388),8,1,0.81,+,1.23,5.57E-01
platelet aggregation (GO:0070527),40,5,4.07,+,1.23,3.84E-01
mitochondrial RNA modification (GO:1900864),8,1,0.81,+,1.23,5.57E-01
regulation of blood-brain barrier permeability (GO:1905603),8,1,0.81,+,1.23,5.57E-01
positive regulation of uterine smooth muscle contraction (GO:0070474),8,1,0.81,+,1.23,5.57E-01
positive regulation of B cell receptor signaling pathway (GO:0050861),8,1,0.81,+,1.23,5.57E-01
positive regulation of pinocytosis (GO:0048549),8,1,0.81,+,1.23,5.57E-01
negative regulation of coagulation (GO:0050819),56,7,5.69,+,1.23,3.44E-01
cellular response to nutrient (GO:0031670),32,4,3.25,+,1.23,4.09E-01
polyadenylation-dependent RNA catabolic process (GO:0043633),8,1,0.81,+,1.23,5.57E-01
L-glutamate import across plasma membrane (GO:0098712),8,1,0.81,+,1.23,5.57E-01
response to sucrose (GO:0009744),8,1,0.81,+,1.23,5.57E-01
calcium ion import across plasma membrane (GO:0098703),16,2,1.63,+,1.23,4.84E-01
neurotransmitter loading into synaptic vesicle (GO:0098700),8,1,0.81,+,1.23,5.57E-01
replication fork protection (GO:0048478),8,1,0.81,+,1.23,5.57E-01
positive regulation of nuclease activity (GO:0032075),8,1,0.81,+,1.23,5.57E-01
regulation of endodeoxyribonuclease activity (GO:0032071),8,1,0.81,+,1.23,5.57E-01
chondrocyte proliferation (GO:0035988),8,1,0.81,+,1.23,5.57E-01
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",8,1,0.81,+,1.23,5.57E-01
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),8,1,0.81,+,1.23,5.57E-01
negative regulation of smooth muscle cell differentiation (GO:0051151),16,2,1.63,+,1.23,4.84E-01
positive regulation of actin nucleation (GO:0051127),16,2,1.63,+,1.23,4.84E-01
epithelial cell proliferation (GO:0050673),88,11,8.95,+,1.23,2.87E-01
negative regulation of thymocyte apoptotic process (GO:0070244),8,1,0.81,+,1.23,5.57E-01
histone H2A-K119 monoubiquitination (GO:0036353),8,1,0.81,+,1.23,5.57E-01
learned vocalization behavior or vocal learning (GO:0098598),8,1,0.81,+,1.23,5.57E-01
negative regulation of morphogenesis of an epithelium (GO:1905331),8,1,0.81,+,1.23,5.57E-01
elastic fiber assembly (GO:0048251),8,1,0.81,+,1.23,5.57E-01
midbrain-hindbrain boundary development (GO:0030917),8,1,0.81,+,1.23,5.57E-01
otic vesicle formation (GO:0030916),8,1,0.81,+,1.23,5.57E-01
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),8,1,0.81,+,1.23,5.57E-01
response to hepatocyte growth factor (GO:0035728),16,2,1.63,+,1.23,4.84E-01
respiratory chain complex III assembly (GO:0017062),8,1,0.81,+,1.23,5.57E-01
chemokine-mediated signaling pathway (GO:0070098),72,9,7.32,+,1.23,3.13E-01
regulation of protein localization to nucleolus (GO:1904749),8,1,0.81,+,1.23,5.57E-01
positive regulation of granulocyte differentiation (GO:0030854),8,1,0.81,+,1.23,5.57E-01
negative regulation of mRNA polyadenylation (GO:1900364),8,1,0.81,+,1.23,5.57E-01
regulation of mRNA polyadenylation (GO:1900363),16,2,1.63,+,1.23,4.84E-01
tRNA transcription (GO:0009304),8,1,0.81,+,1.23,5.57E-01
tRNA 3'-end processing (GO:0042780),8,1,0.81,+,1.23,5.57E-01
hydrogen peroxide metabolic process (GO:0042743),40,5,4.07,+,1.23,3.84E-01
regulation of cytoplasmic translational elongation (GO:1900247),8,1,0.81,+,1.23,5.57E-01
positive regulation of synaptic vesicle endocytosis (GO:1900244),8,1,0.81,+,1.23,5.57E-01
regulation of synaptic vesicle endocytosis (GO:1900242),16,2,1.63,+,1.23,4.84E-01
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),8,1,0.81,+,1.23,5.57E-01
regulation of cardiac muscle contraction (GO:0055117),72,9,7.32,+,1.23,3.13E-01
regulation of metallopeptidase activity (GO:1905048),16,2,1.63,+,1.23,4.84E-01
proline transmembrane transport (GO:0035524),8,1,0.81,+,1.23,5.57E-01
cellular response to starvation (GO:0009267),176,22,17.89,+,1.23,1.92E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),32,4,3.25,+,1.23,4.09E-01
cellular chloride ion homeostasis (GO:0030644),8,1,0.81,+,1.23,5.57E-01
cellular phosphate ion homeostasis (GO:0030643),8,1,0.81,+,1.23,5.57E-01
negative regulation of macrophage activation (GO:0043031),16,2,1.63,+,1.23,4.84E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179),56,7,5.69,+,1.23,3.44E-01
amine transport (GO:0015837),8,1,0.81,+,1.23,5.57E-01
purine nucleoside diphosphate metabolic process (GO:0009135),56,7,5.69,+,1.23,3.44E-01
ketone body biosynthetic process (GO:0046951),8,1,0.81,+,1.23,5.57E-01
peptidyl-lysine deacetylation (GO:0034983),8,1,0.81,+,1.23,5.57E-01
ubiquitin recycling (GO:0010992),8,1,0.81,+,1.23,5.57E-01
regulation of cellular response to insulin stimulus (GO:1900076),56,7,5.69,+,1.23,3.44E-01
positive regulation of neuron projection development (GO:0010976),144,18,14.64,+,1.23,2.21E-01
gap junction assembly (GO:0016264),8,1,0.81,+,1.23,5.57E-01
intracellular estrogen receptor signaling pathway (GO:0030520),16,2,1.63,+,1.23,4.84E-01
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),16,2,1.63,+,1.23,4.84E-01
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),8,1,0.81,+,1.23,5.57E-01
pharyngeal arch artery morphogenesis (GO:0061626),8,1,0.81,+,1.23,5.57E-01
cell communication involved in cardiac conduction (GO:0086065),40,5,4.07,+,1.23,3.84E-01
membrane depolarization during cardiac muscle cell action potential (GO:0086012),16,2,1.63,+,1.23,4.84E-01
ethanolamine-containing compound metabolic process (GO:0042439),8,1,0.81,+,1.23,5.57E-01
necroptotic signaling pathway (GO:0097527),8,1,0.81,+,1.23,5.57E-01
regulation of protein ADP-ribosylation (GO:0010835),8,1,0.81,+,1.23,5.57E-01
diterpenoid biosynthetic process (GO:0016102),8,1,0.81,+,1.23,5.57E-01
sympathetic ganglion development (GO:0061549),8,1,0.81,+,1.23,5.57E-01
hindgut development (GO:0061525),8,1,0.81,+,1.23,5.57E-01
regulation of viral transcription (GO:0046782),64,8,6.51,+,1.23,3.28E-01
regulation of iron ion transport (GO:0034756),8,1,0.81,+,1.23,5.57E-01
organic acid catabolic process (GO:0016054),248,31,25.21,+,1.23,1.45E-01
cellular monovalent inorganic anion homeostasis (GO:0030320),16,2,1.63,+,1.23,4.84E-01
cellular macromolecule biosynthetic process (GO:0034645),1456,182,148.02,+,1.23,2.51E-03
regulation of mitotic centrosome separation (GO:0046602),8,1,0.81,+,1.23,5.57E-01
mitochondrial outer membrane permeabilization (GO:0097345),16,2,1.63,+,1.23,4.84E-01
regulation of microglial cell migration (GO:1904139),8,1,0.81,+,1.23,5.57E-01
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",8,1,0.81,+,1.23,5.57E-01
negative regulation of histone acetylation (GO:0035067),16,2,1.63,+,1.23,4.84E-01
regulation of Ras protein signal transduction (GO:0046578),184,23,18.71,+,1.23,1.86E-01
blood vessel endothelial cell differentiation (GO:0060837),8,1,0.81,+,1.23,5.57E-01
mitochondrial respiratory chain complex III assembly (GO:0034551),8,1,0.81,+,1.23,5.57E-01
neurotransmitter biosynthetic process (GO:0042136),16,2,1.63,+,1.23,4.84E-01
macrophage activation (GO:0042116),56,7,5.69,+,1.23,3.44E-01
B cell activation (GO:0042113),152,19,15.45,+,1.23,2.13E-01
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),8,1,0.81,+,1.23,5.57E-01
epithelial cell morphogenesis (GO:0003382),32,4,3.25,+,1.23,4.09E-01
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),8,1,0.81,+,1.23,5.57E-01
regulation of extracellular matrix constituent secretion (GO:0003330),8,1,0.81,+,1.23,5.57E-01
physiological cardiac muscle hypertrophy (GO:0003301),8,1,0.81,+,1.23,5.57E-01
U4 snRNA 3'-end processing (GO:0034475),8,1,0.81,+,1.23,5.57E-01
skeletal myofibril assembly (GO:0014866),8,1,0.81,+,1.23,5.57E-01
positive regulation of immunoglobulin mediated immune response (GO:0002891),32,4,3.25,+,1.23,4.09E-01
regulation of immune response to tumor cell (GO:0002837),16,2,1.63,+,1.23,4.84E-01
regulation of response to tumor cell (GO:0002834),16,2,1.63,+,1.23,4.84E-01
positive regulation of type 2 immune response (GO:0002830),16,2,1.63,+,1.23,4.84E-01
hair cycle process (GO:0022405),72,9,7.32,+,1.23,3.13E-01
molting cycle process (GO:0022404),72,9,7.32,+,1.23,3.13E-01
cellular anion homeostasis (GO:0030002),16,2,1.63,+,1.23,4.84E-01
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179),8,1,0.81,+,1.23,5.57E-01
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),16,2,1.63,+,1.23,4.84E-01
negative regulation of translational initiation (GO:0045947),16,2,1.63,+,1.23,4.84E-01
aerobic electron transport chain (GO:0019646),16,2,1.63,+,1.23,4.84E-01
physiological muscle hypertrophy (GO:0003298),8,1,0.81,+,1.23,5.57E-01
regulation of morphogenesis of a branching structure (GO:0060688),56,7,5.69,+,1.23,3.44E-01
carboxylic acid catabolic process (GO:0046395),248,31,25.21,+,1.23,1.45E-01
craniofacial suture morphogenesis (GO:0097094),16,2,1.63,+,1.23,4.84E-01
protein-containing complex remodeling (GO:0034367),32,4,3.25,+,1.23,4.09E-01
lateral sprouting from an epithelium (GO:0060601),8,1,0.81,+,1.23,5.57E-01
immune response-inhibiting signal transduction (GO:0002765),8,1,0.81,+,1.23,5.57E-01
positive regulation of protein tyrosine kinase activity (GO:0061098),56,7,5.69,+,1.23,3.44E-01
regulation of T cell cytokine production (GO:0002724),32,4,3.25,+,1.23,4.09E-01
positive regulation of B cell mediated immunity (GO:0002714),32,4,3.25,+,1.23,4.09E-01
iris morphogenesis (GO:0061072),8,1,0.81,+,1.23,5.57E-01
cell growth involved in cardiac muscle cell development (GO:0061049),8,1,0.81,+,1.23,5.57E-01
cellular trivalent inorganic anion homeostasis (GO:0072502),8,1,0.81,+,1.23,5.57E-01
cellular divalent inorganic anion homeostasis (GO:0072501),8,1,0.81,+,1.23,5.57E-01
response to disaccharide (GO:0034285),8,1,0.81,+,1.23,5.57E-01
protein complex oligomerization (GO:0051259),225,28,22.87,+,1.22,1.64E-01
cellular response to lipopolysaccharide (GO:0071222),177,22,17.99,+,1.22,1.99E-01
positive regulation of MAPK cascade (GO:0043410),491,61,49.92,+,1.22,6.74E-02
immune response-activating cell surface receptor signaling pathway (GO:0002429),290,36,29.48,+,1.22,1.33E-01
response to purine-containing compound (GO:0014074),145,18,14.74,+,1.22,2.29E-01
immune response-activating signal transduction (GO:0002757),290,36,29.48,+,1.22,1.33E-01
anion transmembrane transport (GO:0098656),282,35,28.67,+,1.22,1.37E-01
cellular amide metabolic process (GO:0043603),718,89,72.99,+,1.22,3.47E-02
negative regulation of peptidase activity (GO:0010466),234,29,23.79,+,1.22,1.64E-01
response to xenobiotic stimulus (GO:0009410),113,14,11.49,+,1.22,2.65E-01
negative regulation of endopeptidase activity (GO:0010951),226,28,22.98,+,1.22,1.70E-01
response to starvation (GO:0042594),218,27,22.16,+,1.22,1.75E-01
regulation of DNA biosynthetic process (GO:2000278),105,13,10.67,+,1.22,2.76E-01
regulation of chemotaxis (GO:0050920),210,26,21.35,+,1.22,1.81E-01
response to lipopolysaccharide (GO:0032496),299,37,30.4,+,1.22,1.33E-01
positive regulation of peptide hormone secretion (GO:0090277),97,12,9.86,+,1.22,2.87E-01
cellular oxidant detoxification (GO:0098869),89,11,9.05,+,1.22,2.99E-01
cellular response to chemokine (GO:1990869),81,10,8.23,+,1.21,3.13E-01
response to chemokine (GO:1990868),81,10,8.23,+,1.21,3.13E-01
axis specification (GO:0009798),81,10,8.23,+,1.21,3.13E-01
second-messenger-mediated signaling (GO:0019932),324,40,32.94,+,1.21,1.26E-01
nucleoside diphosphate metabolic process (GO:0009132),73,9,7.42,+,1.21,3.27E-01
neutrophil chemotaxis (GO:0030593),73,9,7.42,+,1.21,3.27E-01
calcium-mediated signaling (GO:0019722),138,17,14.03,+,1.21,2.46E-01
regulation of leukocyte migration (GO:0002685),203,25,20.64,+,1.21,1.93E-01
positive regulation of nervous system development (GO:0051962),268,33,27.25,+,1.21,1.55E-01
snRNA transcription (GO:0009301),65,8,6.61,+,1.21,3.43E-01
carboxylic acid transmembrane transport (GO:1905039),130,16,13.22,+,1.21,2.55E-01
immune response-regulating cell surface receptor signaling pathway (GO:0002768),325,40,33.04,+,1.21,1.29E-01
cellular response to extracellular stimulus (GO:0031668),252,31,25.62,+,1.21,1.65E-01
vacuole organization (GO:0007033),122,15,12.4,+,1.21,2.65E-01
digestive tract development (GO:0048565),122,15,12.4,+,1.21,2.65E-01
mammary gland development (GO:0030879),122,15,12.4,+,1.21,2.65E-01
negative regulation of locomotion (GO:0040013),301,37,30.6,+,1.21,1.42E-01
purine nucleoside bisphosphate biosynthetic process (GO:0034033),57,7,5.79,+,1.21,3.61E-01
ribonucleoside bisphosphate biosynthetic process (GO:0034030),57,7,5.79,+,1.21,3.61E-01
positive regulation of wound healing (GO:0090303),57,7,5.79,+,1.21,3.61E-01
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",114,14,11.59,+,1.21,2.75E-01
regulation of telomere maintenance via telomere lengthening (GO:1904356),57,7,5.79,+,1.21,3.61E-01
photoreceptor cell differentiation (GO:0046530),57,7,5.79,+,1.21,3.61E-01
regulation of myeloid leukocyte mediated immunity (GO:0002886),57,7,5.79,+,1.21,3.61E-01
nucleoside bisphosphate biosynthetic process (GO:0033866),57,7,5.79,+,1.21,3.61E-01
regulation of leukocyte chemotaxis (GO:0002688),114,14,11.59,+,1.21,2.75E-01
cellular response to xenobiotic stimulus (GO:0071466),106,13,10.78,+,1.21,2.87E-01
smooth muscle contraction (GO:0006939),49,6,4.98,+,1.2,3.81E-01
cerebellar cortex development (GO:0021695),49,6,4.98,+,1.2,3.81E-01
neuropeptide signaling pathway (GO:0007218),98,12,9.96,+,1.2,2.99E-01
intermediate filament cytoskeleton organization (GO:0045104),49,6,4.98,+,1.2,3.81E-01
positive regulation of ion transmembrane transporter activity (GO:0032414),98,12,9.96,+,1.2,2.99E-01
DNA synthesis involved in DNA repair (GO:0000731),49,6,4.98,+,1.2,3.81E-01
detection of mechanical stimulus (GO:0050982),49,6,4.98,+,1.2,3.81E-01
synaptic vesicle exocytosis (GO:0016079),49,6,4.98,+,1.2,3.81E-01
post-transcriptional gene silencing by RNA (GO:0035194),49,6,4.98,+,1.2,3.81E-01
regulation of immunoglobulin mediated immune response (GO:0002889),49,6,4.98,+,1.2,3.81E-01
cell chemotaxis (GO:0060326),188,23,19.11,+,1.2,2.13E-01
regulation of gliogenesis (GO:0014013),90,11,9.15,+,1.2,3.12E-01
regulation of leukocyte cell-cell adhesion (GO:1903037),311,38,31.62,+,1.2,1.46E-01
cell adhesion (GO:0007155),876,107,89.06,+,1.2,3.13E-02
isoprenoid metabolic process (GO:0006720),131,16,13.32,+,1.2,2.65E-01
cellular amino acid metabolic process (GO:0006520),262,32,26.64,+,1.2,1.70E-01
organic acid transmembrane transport (GO:1903825),131,16,13.32,+,1.2,2.65E-01
organonitrogen compound biosynthetic process (GO:1901566),1245,152,126.57,+,1.2,1.21E-02
cellular response to biotic stimulus (GO:0071216),205,25,20.84,+,1.2,2.06E-01
lung morphogenesis (GO:0060425),41,5,4.17,+,1.2,4.04E-01
renal system development (GO:0072001),287,35,29.18,+,1.2,1.60E-01
T cell selection (GO:0045058),41,5,4.17,+,1.2,4.04E-01
inorganic ion import across plasma membrane (GO:0099587),82,10,8.34,+,1.2,3.26E-01
inorganic cation import across plasma membrane (GO:0098659),82,10,8.34,+,1.2,3.26E-01
calcium-ion regulated exocytosis (GO:0017156),41,5,4.17,+,1.2,4.04E-01
synaptic vesicle localization (GO:0097479),41,5,4.17,+,1.2,4.04E-01
gene silencing by miRNA (GO:0035195),41,5,4.17,+,1.2,4.04E-01
feeding behavior (GO:0007631),82,10,8.34,+,1.2,3.26E-01
immune response-regulating signaling pathway (GO:0002764),328,40,33.34,+,1.2,1.41E-01
negative regulation of cellular component movement (GO:0051271),279,34,28.36,+,1.2,1.65E-01
membrane lipid biosynthetic process (GO:0046467),115,14,11.69,+,1.2,2.86E-01
respiratory system development (GO:0060541),189,23,19.21,+,1.2,2.20E-01
response to osmotic stress (GO:0006970),74,9,7.52,+,1.2,3.41E-01
organelle transport along microtubule (GO:0072384),74,9,7.52,+,1.2,3.41E-01
protein maturation (GO:0051604),222,27,22.57,+,1.2,1.99E-01
defense response to Gram-negative bacterium (GO:0050829),74,9,7.52,+,1.2,3.41E-01
negative regulation of wound healing (GO:0061045),74,9,7.52,+,1.2,3.41E-01
negative regulation of mRNA metabolic process (GO:1903312),74,9,7.52,+,1.2,3.41E-01
aminoglycan biosynthetic process (GO:0006023),107,13,10.88,+,1.2,2.98E-01
B cell differentiation (GO:0030183),107,13,10.88,+,1.2,2.98E-01
cellular response to toxic substance (GO:0097237),107,13,10.88,+,1.2,2.98E-01
response to bacterium (GO:0009617),560,68,56.93,+,1.19,7.98E-02
response to molecule of bacterial origin (GO:0002237),313,38,31.82,+,1.19,1.55E-01
biological adhesion (GO:0022610),882,107,89.67,+,1.19,3.64E-02
regulation of actomyosin structure organization (GO:0110020),99,12,10.06,+,1.19,3.10E-01
regulation of cell killing (GO:0031341),99,12,10.06,+,1.19,3.10E-01
positive regulation of lamellipodium organization (GO:1902745),33,4,3.35,+,1.19,4.32E-01
secretory granule organization (GO:0033363),33,4,3.35,+,1.19,4.32E-01
regulation of natural killer cell activation (GO:0032814),33,4,3.35,+,1.19,4.32E-01
protein transmembrane import into intracellular organelle (GO:0044743),33,4,3.35,+,1.19,4.32E-01
response to ATP (GO:0033198),33,4,3.35,+,1.19,4.32E-01
regulation of smooth muscle cell proliferation (GO:0048660),132,16,13.42,+,1.19,2.74E-01
regulation of renal system process (GO:0098801),33,4,3.35,+,1.19,4.32E-01
negative regulation of protein transport (GO:0051224),132,16,13.42,+,1.19,2.74E-01
negative regulation of protein localization to nucleus (GO:1900181),33,4,3.35,+,1.19,4.32E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145),33,4,3.35,+,1.19,4.32E-01
negative regulation of cellular response to insulin stimulus (GO:1900077),33,4,3.35,+,1.19,4.32E-01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),33,4,3.35,+,1.19,4.32E-01
eye photoreceptor cell development (GO:0042462),33,4,3.35,+,1.19,4.32E-01
regulation of mesenchymal cell proliferation (GO:0010464),33,4,3.35,+,1.19,4.32E-01
actin cytoskeleton organization (GO:0030036),495,60,50.32,+,1.19,9.69E-02
myeloid cell differentiation (GO:0030099),223,27,22.67,+,1.19,2.05E-01
cellular response to unfolded protein (GO:0034620),124,15,12.61,+,1.19,2.85E-01
positive regulation of autophagy (GO:0010508),124,15,12.61,+,1.19,2.85E-01
regulation of cell activation (GO:0050865),546,66,55.51,+,1.19,8.88E-02
regulation of stress fiber assembly (GO:0051492),91,11,9.25,+,1.19,3.24E-01
telomere maintenance (GO:0000723),91,11,9.25,+,1.19,3.24E-01
regulation of leukocyte activation (GO:0002694),505,61,51.34,+,1.19,9.93E-02
"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",58,7,5.9,+,1.19,3.77E-01
neuron death (GO:0070997),58,7,5.9,+,1.19,3.77E-01
transition metal ion transport (GO:0000041),116,14,11.79,+,1.19,2.96E-01
negative regulation of innate immune response (GO:0045824),58,7,5.9,+,1.19,3.77E-01
skeletal muscle tissue development (GO:0007519),116,14,11.79,+,1.19,2.96E-01
peroxisome organization (GO:0007031),83,10,8.44,+,1.19,3.39E-01
regulation of intracellular protein transport (GO:0033157),249,30,25.31,+,1.19,1.98E-01
sulfur compound biosynthetic process (GO:0044272),166,20,16.88,+,1.19,2.53E-01
cyclic-nucleotide-mediated signaling (GO:0019935),166,20,16.88,+,1.19,2.53E-01
regulation of epithelial cell apoptotic process (GO:1904035),83,10,8.44,+,1.19,3.39E-01
neurotransmitter transport (GO:0006836),133,16,13.52,+,1.18,2.84E-01
positive regulation of chemotaxis (GO:0050921),133,16,13.52,+,1.18,2.84E-01
ncRNA metabolic process (GO:0034660),449,54,45.65,+,1.18,1.21E-01
response to nutrient levels (GO:0031667),466,56,47.37,+,1.18,1.17E-01
actin filament-based process (GO:0030029),566,68,57.54,+,1.18,9.31E-02
positive regulation of toll-like receptor signaling pathway (GO:0034123),25,3,2.54,+,1.18,4.67E-01
regulation of heterotypic cell-cell adhesion (GO:0034114),25,3,2.54,+,1.18,4.67E-01
positive regulation of osteoclast differentiation (GO:0045672),25,3,2.54,+,1.18,4.67E-01
diencephalon development (GO:0021536),75,9,7.62,+,1.18,3.55E-01
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),50,6,5.08,+,1.18,3.99E-01
liver development (GO:0001889),125,15,12.71,+,1.18,2.95E-01
cytokine production (GO:0001816),150,18,15.25,+,1.18,2.72E-01
glycosphingolipid biosynthetic process (GO:0006688),25,3,2.54,+,1.18,4.67E-01
regulation of oxidative phosphorylation (GO:0002082),25,3,2.54,+,1.18,4.67E-01
intermediate filament-based process (GO:0045103),50,6,5.08,+,1.18,3.99E-01
negative regulation of leukocyte differentiation (GO:1902106),100,12,10.17,+,1.18,3.22E-01
regulation of anoikis (GO:2000209),25,3,2.54,+,1.18,4.67E-01
regulation of lipid localization (GO:1905952),150,18,15.25,+,1.18,2.72E-01
positive regulation of behavior (GO:0048520),25,3,2.54,+,1.18,4.67E-01
olefinic compound metabolic process (GO:0120254),100,12,10.17,+,1.18,3.22E-01
regulation of mitochondrial translation (GO:0070129),25,3,2.54,+,1.18,4.67E-01
regulation of ubiquitin protein ligase activity (GO:1904666),25,3,2.54,+,1.18,4.67E-01
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),25,3,2.54,+,1.18,4.67E-01
microtubule polymerization or depolymerization (GO:0031109),50,6,5.08,+,1.18,3.99E-01
cardiac muscle tissue growth (GO:0055017),25,3,2.54,+,1.18,4.67E-01
regulation of cytokine production involved in inflammatory response (GO:1900015),50,6,5.08,+,1.18,3.99E-01
regulation of telomere capping (GO:1904353),25,3,2.54,+,1.18,4.67E-01
cellular ketone metabolic process (GO:0042180),75,9,7.62,+,1.18,3.55E-01
central nervous system projection neuron axonogenesis (GO:0021952),25,3,2.54,+,1.18,4.67E-01
lipid droplet organization (GO:0034389),25,3,2.54,+,1.18,4.67E-01
positive regulation of natural killer cell mediated immunity (GO:0002717),25,3,2.54,+,1.18,4.67E-01
regulation of B cell mediated immunity (GO:0002712),50,6,5.08,+,1.18,3.99E-01
regulation of leukocyte mediated immunity (GO:0002703),200,24,20.33,+,1.18,2.34E-01
positive regulation of epithelial cell proliferation (GO:0050679),192,23,19.52,+,1.18,2.42E-01
double-strand break repair (GO:0006302),167,20,16.98,+,1.18,2.61E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056),142,17,14.44,+,1.18,2.82E-01
positive regulation of myeloid cell differentiation (GO:0045639),92,11,9.35,+,1.18,3.36E-01
regulation of cell morphogenesis involved in differentiation (GO:0010769),92,11,9.35,+,1.18,3.36E-01
positive regulation of lymphocyte mediated immunity (GO:0002708),92,11,9.35,+,1.18,3.36E-01
positive regulation of DNA repair (GO:0045739),67,8,6.81,+,1.17,3.73E-01
positive regulation of interferon-gamma production (GO:0032729),67,8,6.81,+,1.17,3.73E-01
vasculogenesis (GO:0001570),67,8,6.81,+,1.17,3.73E-01
negative regulation of axonogenesis (GO:0050771),67,8,6.81,+,1.17,3.73E-01
cellular response to dopamine (GO:1903351),67,8,6.81,+,1.17,3.73E-01
response to dopamine (GO:1903350),67,8,6.81,+,1.17,3.73E-01
regulation of cell size (GO:0008361),176,21,17.89,+,1.17,2.60E-01
glial cell development (GO:0021782),109,13,11.08,+,1.17,3.20E-01
regulation of anion transport (GO:0044070),109,13,11.08,+,1.17,3.20E-01
nucleic acid phosphodiester bond hydrolysis (GO:0090305),260,31,26.43,+,1.17,2.09E-01
positive regulation of lipid metabolic process (GO:0045834),151,18,15.35,+,1.17,2.81E-01
inorganic cation transmembrane transport (GO:0098662),512,61,52.05,+,1.17,1.19E-01
regulation of erythrocyte differentiation (GO:0045646),42,5,4.27,+,1.17,4.24E-01
regulation of gluconeogenesis (GO:0006111),42,5,4.27,+,1.17,4.24E-01
positive regulation of developmental growth (GO:0048639),168,20,17.08,+,1.17,2.69E-01
detection of visible light (GO:0009584),42,5,4.27,+,1.17,4.24E-01
negative regulation of cell projection organization (GO:0031345),168,20,17.08,+,1.17,2.69E-01
bone remodeling (GO:0046849),42,5,4.27,+,1.17,4.24E-01
pituitary gland development (GO:0021983),42,5,4.27,+,1.17,4.24E-01
regulation of membrane depolarization (GO:0003254),42,5,4.27,+,1.17,4.24E-01
excretion (GO:0007588),42,5,4.27,+,1.17,4.24E-01
respiratory gaseous exchange by respiratory system (GO:0007585),42,5,4.27,+,1.17,4.24E-01
platelet degranulation (GO:0002576),126,15,12.81,+,1.17,3.05E-01
negative regulation of proteolysis (GO:0045861),311,37,31.62,+,1.17,1.88E-01
regulation of RNA stability (GO:0043487),185,22,18.81,+,1.17,2.59E-01
protein autophosphorylation (GO:0046777),185,22,18.81,+,1.17,2.59E-01
regulated exocytosis (GO:0045055),648,77,65.88,+,1.17,9.30E-02
positive regulation of protein serine/threonine kinase activity (GO:0071902),303,36,30.8,+,1.17,1.94E-01
chloride transport (GO:0006821),101,12,10.27,+,1.17,3.34E-01
xenobiotic metabolic process (GO:0006805),101,12,10.27,+,1.17,3.34E-01
sensory perception of light stimulus (GO:0050953),202,24,20.54,+,1.17,2.49E-01
negative regulation of hemopoiesis (GO:1903707),101,12,10.27,+,1.17,3.34E-01
urogenital system development (GO:0001655),320,38,32.53,+,1.17,1.88E-01
regulation of myeloid cell differentiation (GO:0045637),219,26,22.26,+,1.17,2.39E-01
response to extracellular stimulus (GO:0009991),497,59,50.53,+,1.17,1.28E-01
regulation of leukocyte differentiation (GO:1902105),278,33,28.26,+,1.17,2.07E-01
ribonucleoside diphosphate metabolic process (GO:0009185),59,7,6,+,1.17,3.93E-01
regulation of cell migration (GO:0030334),844,100,85.8,+,1.17,6.69E-02
dicarboxylic acid transport (GO:0006835),76,9,7.73,+,1.16,3.69E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242),152,18,15.45,+,1.16,2.90E-01
ribonucleoprotein complex biogenesis (GO:0022613),414,49,42.09,+,1.16,1.58E-01
regulation of cell-cell adhesion (GO:0022407),414,49,42.09,+,1.16,1.58E-01
peptidyl-lysine modification (GO:0018205),262,31,26.64,+,1.16,2.21E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599),110,13,11.18,+,1.16,3.31E-01
regulation of lymphocyte mediated immunity (GO:0002706),144,17,14.64,+,1.16,3.01E-01
cellular biosynthetic process (GO:0044249),2406,284,244.6,+,1.16,4.05E-03
positive regulation of protein secretion (GO:0050714),161,19,16.37,+,1.16,2.88E-01
protein-lipid complex subunit organization (GO:0071825),51,6,5.18,+,1.16,4.16E-01
lymphocyte activation involved in immune response (GO:0002285),102,12,10.37,+,1.16,3.46E-01
positive regulation of interleukin-1 beta production (GO:0032731),51,6,5.18,+,1.16,4.16E-01
cellular response to external stimulus (GO:0071496),323,38,32.84,+,1.16,2.03E-01
regulation of telomere maintenance via telomerase (GO:0032210),51,6,5.18,+,1.16,4.16E-01
response to toxic substance (GO:0009636),221,26,22.47,+,1.16,2.53E-01
aspartate family amino acid metabolic process (GO:0009066),51,6,5.18,+,1.16,4.16E-01
organic anion transport (GO:0015711),442,52,44.93,+,1.16,1.60E-01
respiratory burst (GO:0045730),17,2,1.73,+,1.16,5.16E-01
negative regulation of neuron differentiation (GO:0045665),68,8,6.91,+,1.16,3.88E-01
regulation of corticosteroid hormone secretion (GO:2000846),17,2,1.73,+,1.16,5.16E-01
regulation of type I interferon-mediated signaling pathway (GO:0060338),34,4,3.46,+,1.16,4.54E-01
cellular sodium ion homeostasis (GO:0006883),17,2,1.73,+,1.16,5.16E-01
mitochondrial calcium ion transmembrane transport (GO:0006851),17,2,1.73,+,1.16,5.16E-01
regulation of cation channel activity (GO:2001257),170,20,17.28,+,1.16,2.86E-01
positive regulation of transcription of Notch receptor target (GO:0007221),17,2,1.73,+,1.16,5.16E-01
protein-DNA complex disassembly (GO:0032986),17,2,1.73,+,1.16,5.16E-01
regulation of MHC class II biosynthetic process (GO:0045346),17,2,1.73,+,1.16,5.16E-01
angiogenesis involved in wound healing (GO:0060055),17,2,1.73,+,1.16,5.16E-01
modulation by host of viral genome replication (GO:0044827),17,2,1.73,+,1.16,5.16E-01
interleukin-7-mediated signaling pathway (GO:0038111),17,2,1.73,+,1.16,5.16E-01
N-glycan processing (GO:0006491),17,2,1.73,+,1.16,5.16E-01
positive regulation of lymphocyte migration (GO:2000403),34,4,3.46,+,1.16,4.54E-01
pseudouridine synthesis (GO:0001522),17,2,1.73,+,1.16,5.16E-01
negative regulation of interleukin-12 production (GO:0032695),17,2,1.73,+,1.16,5.16E-01
cellular response to prostaglandin E stimulus (GO:0071380),17,2,1.73,+,1.16,5.16E-01
positive regulation of signaling receptor activity (GO:2000273),34,4,3.46,+,1.16,4.54E-01
regulation of fibroblast apoptotic process (GO:2000269),17,2,1.73,+,1.16,5.16E-01
fatty acid transmembrane transport (GO:1902001),17,2,1.73,+,1.16,5.16E-01
intracellular sterol transport (GO:0032366),17,2,1.73,+,1.16,5.16E-01
intracellular lipid transport (GO:0032365),34,4,3.46,+,1.16,4.54E-01
regulation of nucleobase-containing compound transport (GO:0032239),17,2,1.73,+,1.16,5.16E-01
"regulation of synaptic transmission, GABAergic (GO:0032228)",34,4,3.46,+,1.16,4.54E-01
anatomical structure arrangement (GO:0048532),17,2,1.73,+,1.16,5.16E-01
negative regulation of ERK1 and ERK2 cascade (GO:0070373),68,8,6.91,+,1.16,3.88E-01
cellular response to hydrogen peroxide (GO:0070301),68,8,6.91,+,1.16,3.88E-01
negative regulation of establishment of protein localization (GO:1904950),136,16,13.83,+,1.16,3.13E-01
mitochondrion distribution (GO:0048311),17,2,1.73,+,1.16,5.16E-01
lymph vessel morphogenesis (GO:0036303),17,2,1.73,+,1.16,5.16E-01
detection of biotic stimulus (GO:0009595),34,4,3.46,+,1.16,4.54E-01
regulation of morphogenesis of an epithelium (GO:1905330),68,8,6.91,+,1.16,3.88E-01
regulation of immunoglobulin secretion (GO:0051023),17,2,1.73,+,1.16,5.16E-01
midbrain development (GO:0030901),85,10,8.64,+,1.16,3.65E-01
positive regulation of cell killing (GO:0031343),68,8,6.91,+,1.16,3.88E-01
astrocyte activation (GO:0048143),17,2,1.73,+,1.16,5.16E-01
positive regulation of vascular permeability (GO:0043117),17,2,1.73,+,1.16,5.16E-01
negative regulation of vascular permeability (GO:0043116),17,2,1.73,+,1.16,5.16E-01
pyrimidine deoxyribonucleotide metabolic process (GO:0009219),17,2,1.73,+,1.16,5.16E-01
regulation of execution phase of apoptosis (GO:1900117),17,2,1.73,+,1.16,5.16E-01
pyrimidine nucleoside triphosphate metabolic process (GO:0009147),17,2,1.73,+,1.16,5.16E-01
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),34,4,3.46,+,1.16,4.54E-01
hormone secretion (GO:0046879),68,8,6.91,+,1.16,3.88E-01
mannosylation (GO:0097502),34,4,3.46,+,1.16,4.54E-01
negative regulation of glucose transmembrane transport (GO:0010829),17,2,1.73,+,1.16,5.16E-01
gas transport (GO:0015669),17,2,1.73,+,1.16,5.16E-01
positive regulation of sodium ion transport (GO:0010765),34,4,3.46,+,1.16,4.54E-01
regulation of fibroblast migration (GO:0010762),34,4,3.46,+,1.16,4.54E-01
detection of bacterium (GO:0016045),17,2,1.73,+,1.16,5.16E-01
regulation of sprouting angiogenesis (GO:1903670),34,4,3.46,+,1.16,4.54E-01
miRNA metabolic process (GO:0010586),17,2,1.73,+,1.16,5.16E-01
maintenance of cell polarity (GO:0030011),17,2,1.73,+,1.16,5.16E-01
cardiac atrium development (GO:0003230),34,4,3.46,+,1.16,4.54E-01
high-density lipoprotein particle remodeling (GO:0034375),17,2,1.73,+,1.16,5.16E-01
negative regulation of natural killer cell mediated immunity (GO:0002716),17,2,1.73,+,1.16,5.16E-01
"blood coagulation, intrinsic pathway (GO:0007597)",17,2,1.73,+,1.16,5.16E-01
gene expression (GO:0010467),1854,218,188.48,+,1.16,1.36E-02
positive regulation of protein phosphorylation (GO:0001934),954,112,96.99,+,1.15,6.67E-02
regulation of insulin secretion (GO:0050796),179,21,18.2,+,1.15,2.84E-01
hepaticobiliary system development (GO:0061008),128,15,13.01,+,1.15,3.26E-01
positive regulation of leukocyte migration (GO:0002687),128,15,13.01,+,1.15,3.26E-01
cellular protein-containing complex assembly (GO:0034622),683,80,69.43,+,1.15,1.10E-01
renal system process (GO:0003014),111,13,11.28,+,1.15,3.43E-01
regulation of cell motility (GO:2000145),897,105,91.19,+,1.15,7.80E-02
chloride transmembrane transport (GO:1902476),94,11,9.56,+,1.15,3.61E-01
positive regulation of cell cycle phase transition (GO:1901989),94,11,9.56,+,1.15,3.61E-01
regulation of interleukin-1 production (GO:0032652),94,11,9.56,+,1.15,3.61E-01
organic substance biosynthetic process (GO:1901576),2497,292,253.85,+,1.15,5.74E-03
regulation of cytokine-mediated signaling pathway (GO:0001959),154,18,15.66,+,1.15,3.08E-01
peroxisomal transport (GO:0043574),77,9,7.83,+,1.15,3.83E-01
positive regulation of JNK cascade (GO:0046330),77,9,7.83,+,1.15,3.83E-01
cation transport (GO:0006812),753,88,76.55,+,1.15,1.02E-01
lymphocyte activation (GO:0046649),368,43,37.41,+,1.15,1.98E-01
retina development in camera-type eye (GO:0060041),137,16,13.93,+,1.15,3.23E-01
RNA phosphodiester bond hydrolysis (GO:0090501),137,16,13.93,+,1.15,3.23E-01
biosynthetic process (GO:0009058),2552,298,259.44,+,1.15,5.65E-03
anion transport (GO:0006820),557,65,56.63,+,1.15,1.44E-01
positive regulation of interleukin-1 production (GO:0032732),60,7,6.1,+,1.15,4.10E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),240,28,24.4,+,1.15,2.57E-01
protein sumoylation (GO:0016925),60,7,6.1,+,1.15,4.10E-01
myeloid cell development (GO:0061515),60,7,6.1,+,1.15,4.10E-01
negative regulation of cell adhesion (GO:0007162),266,31,27.04,+,1.15,2.46E-01
response to lipid (GO:0033993),798,93,81.13,+,1.15,9.95E-02
regulation of locomotion (GO:0040012),936,109,95.16,+,1.15,8.15E-02
cellular nitrogen compound biosynthetic process (GO:0044271),1383,161,140.6,+,1.15,4.17E-02
secretion (GO:0046903),1006,117,102.27,+,1.14,7.53E-02
ATP metabolic process (GO:0046034),172,20,17.49,+,1.14,3.04E-01
response to catecholamine (GO:0071869),86,10,8.74,+,1.14,3.79E-01
response to monoamine (GO:0071867),86,10,8.74,+,1.14,3.79E-01
glutathione metabolic process (GO:0006749),43,5,4.37,+,1.14,4.43E-01
male meiotic nuclear division (GO:0007140),43,5,4.37,+,1.14,4.43E-01
camera-type eye development (GO:0043010),301,35,30.6,+,1.14,2.34E-01
exocrine system development (GO:0035272),43,5,4.37,+,1.14,4.43E-01
ceramide biosynthetic process (GO:0046513),43,5,4.37,+,1.14,4.43E-01
regulation of wound healing (GO:0061041),129,15,13.11,+,1.14,3.36E-01
regulation of cellular response to growth factor stimulus (GO:0090287),284,33,28.87,+,1.14,2.43E-01
positive regulation of protein kinase activity (GO:0045860),508,59,51.64,+,1.14,1.66E-01
regulation of sequestering of calcium ion (GO:0051282),112,13,11.39,+,1.14,3.54E-01
regulation of GTPase activity (GO:0043087),431,50,43.82,+,1.14,1.90E-01
DNA packaging (GO:0006323),138,16,14.03,+,1.14,3.33E-01
fatty acid transport (GO:0015908),69,8,7.01,+,1.14,4.03E-01
lung development (GO:0030324),164,19,16.67,+,1.14,3.15E-01
regulation of response to cytokine stimulus (GO:0060759),164,19,16.67,+,1.14,3.15E-01
embryonic limb morphogenesis (GO:0030326),121,14,12.3,+,1.14,3.50E-01
embryonic appendage morphogenesis (GO:0035113),121,14,12.3,+,1.14,3.50E-01
positive regulation of leukocyte proliferation (GO:0070665),147,17,14.94,+,1.14,3.30E-01
cation transmembrane transport (GO:0098655),571,66,58.05,+,1.14,1.60E-01
leukocyte migration (GO:0050900),303,35,30.8,+,1.14,2.46E-01
JNK cascade (GO:0007254),78,9,7.93,+,1.13,3.98E-01
water-soluble vitamin metabolic process (GO:0006767),78,9,7.93,+,1.13,3.98E-01
sphingolipid biosynthetic process (GO:0030148),78,9,7.93,+,1.13,3.98E-01
regulation of oxidative stress-induced neuron death (GO:1903203),26,3,2.64,+,1.13,4.92E-01
heart growth (GO:0060419),26,3,2.64,+,1.13,4.92E-01
cerebellar Purkinje cell layer development (GO:0021680),26,3,2.64,+,1.13,4.92E-01
CENP-A containing nucleosome assembly (GO:0034080),26,3,2.64,+,1.13,4.92E-01
mucosal immune response (GO:0002385),26,3,2.64,+,1.13,4.92E-01
positive regulation of granulocyte chemotaxis (GO:0071624),26,3,2.64,+,1.13,4.92E-01
receptor catabolic process (GO:0032801),26,3,2.64,+,1.13,4.92E-01
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),26,3,2.64,+,1.13,4.92E-01
positive regulation of focal adhesion assembly (GO:0051894),26,3,2.64,+,1.13,4.92E-01
regulation of interferon-gamma production (GO:0032649),104,12,10.57,+,1.13,3.70E-01
regulation of AMPA receptor activity (GO:2000311),26,3,2.64,+,1.13,4.92E-01
bicellular tight junction assembly (GO:0070830),52,6,5.29,+,1.13,4.34E-01
establishment of mitochondrion localization (GO:0051654),26,3,2.64,+,1.13,4.92E-01
negative regulation of axon extension involved in axon guidance (GO:0048843),26,3,2.64,+,1.13,4.92E-01
regulation of non-canonical Wnt signaling pathway (GO:2000050),26,3,2.64,+,1.13,4.92E-01
regulation of ubiquitin-protein transferase activity (GO:0051438),52,6,5.29,+,1.13,4.34E-01
regulation of potassium ion transmembrane transporter activity (GO:1901016),52,6,5.29,+,1.13,4.34E-01
retinoic acid metabolic process (GO:0042573),26,3,2.64,+,1.13,4.92E-01
CENP-A containing chromatin organization (GO:0061641),26,3,2.64,+,1.13,4.92E-01
negative regulation of protein localization to cell periphery (GO:1904376),26,3,2.64,+,1.13,4.92E-01
positive regulation of peptide secretion (GO:0002793),182,21,18.5,+,1.13,3.10E-01
"negative regulation of gene expression, epigenetic (GO:0045814)",52,6,5.29,+,1.13,4.34E-01
heterocycle catabolic process (GO:0046700),399,46,40.56,+,1.13,2.13E-01
response to metal ion (GO:0010038),356,41,36.19,+,1.13,2.31E-01
cellular modified amino acid metabolic process (GO:0006575),165,19,16.77,+,1.13,3.24E-01
aminoglycan metabolic process (GO:0006022),165,19,16.77,+,1.13,3.24E-01
regulation of hemopoiesis (GO:1903706),374,43,38.02,+,1.13,2.28E-01
positive regulation of leukocyte chemotaxis (GO:0002690),87,10,8.84,+,1.13,3.92E-01
response to hormone (GO:0009725),766,88,77.87,+,1.13,1.33E-01
inorganic anion transport (GO:0015698),148,17,15.05,+,1.13,3.40E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204),270,31,27.45,+,1.13,2.72E-01
maternal process involved in female pregnancy (GO:0060135),61,7,6.2,+,1.13,4.26E-01
glycosphingolipid metabolic process (GO:0006687),61,7,6.2,+,1.13,4.26E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),122,14,12.4,+,1.13,3.61E-01
carbohydrate derivative biosynthetic process (GO:1901137),549,63,55.81,+,1.13,1.80E-01
L-amino acid transport (GO:0015807),61,7,6.2,+,1.13,4.26E-01
positive regulation of catalytic activity (GO:0043085),1360,156,138.26,+,1.13,6.47E-02
sensory organ development (GO:0007423),524,60,53.27,+,1.13,1.91E-01
macroautophagy (GO:0016236),166,19,16.88,+,1.13,3.33E-01
exocytosis (GO:0006887),734,84,74.62,+,1.13,1.47E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),201,23,20.43,+,1.13,3.13E-01
visual perception (GO:0007601),201,23,20.43,+,1.13,3.13E-01
regulation of cell development (GO:0060284),472,54,47.98,+,1.13,2.07E-01
regulation of translation (GO:0006417),341,39,34.67,+,1.13,2.50E-01
negative regulation of transcription by RNA polymerase II (GO:0000122),857,98,87.12,+,1.12,1.28E-01
regulation of T-helper cell differentiation (GO:0045622),35,4,3.56,+,1.12,4.76E-01
DNA replication-independent nucleosome assembly (GO:0006336),35,4,3.56,+,1.12,4.76E-01
cellular response to cadmium ion (GO:0071276),35,4,3.56,+,1.12,4.76E-01
positive regulation of cytokinesis (GO:0032467),35,4,3.56,+,1.12,4.76E-01
positive regulation of multicellular organism growth (GO:0040018),35,4,3.56,+,1.12,4.76E-01
glucose metabolic process (GO:0006006),105,12,10.67,+,1.12,3.82E-01
positive regulation of lymphocyte activation (GO:0051251),280,32,28.47,+,1.12,2.76E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072),35,4,3.56,+,1.12,4.76E-01
regulation of DNA recombination (GO:0000018),105,12,10.67,+,1.12,3.82E-01
sodium ion homeostasis (GO:0055078),35,4,3.56,+,1.12,4.76E-01
regulation of blood coagulation (GO:0030193),70,8,7.12,+,1.12,4.19E-01
regulation of lamellipodium assembly (GO:0010591),35,4,3.56,+,1.12,4.76E-01
RNA processing (GO:0006396),797,91,81.02,+,1.12,1.41E-01
regulation of MAPK cascade (GO:0043408),657,75,66.79,+,1.12,1.67E-01
regulation of peptide transport (GO:0090087),622,71,63.23,+,1.12,1.75E-01
regulation of neuron differentiation (GO:0045664),184,21,18.71,+,1.12,3.27E-01
muscle cell differentiation (GO:0042692),228,26,23.18,+,1.12,3.05E-01
negative regulation of cellular protein localization (GO:1903828),114,13,11.59,+,1.12,3.77E-01
regulation of intracellular transport (GO:0032386),342,39,34.77,+,1.12,2.56E-01
DNA repair (GO:0006281),465,53,47.27,+,1.12,2.17E-01
regulation of hydrolase activity (GO:0051336),1176,134,119.55,+,1.12,9.43E-02
negative regulation of myeloid cell differentiation (GO:0045638),79,9,8.03,+,1.12,4.12E-01
positive regulation of mitotic cell cycle phase transition (GO:1901992),79,9,8.03,+,1.12,4.12E-01
regulation of microtubule polymerization or depolymerization (GO:0031110),79,9,8.03,+,1.12,4.12E-01
cellular response to growth factor stimulus (GO:0071363),483,55,49.1,+,1.12,2.14E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),123,14,12.5,+,1.12,3.72E-01
regulation of epithelial cell proliferation (GO:0050678),334,38,33.95,+,1.12,2.64E-01
positive regulation of cell projection organization (GO:0031346),334,38,33.95,+,1.12,2.64E-01
cell activation (GO:0001775),1012,115,102.88,+,1.12,1.19E-01
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),44,5,4.47,+,1.12,4.63E-01
polyol biosynthetic process (GO:0046173),44,5,4.47,+,1.12,4.63E-01
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),44,5,4.47,+,1.12,4.63E-01
calcium ion transmembrane transport (GO:0070588),176,20,17.89,+,1.12,3.39E-01
response to carbohydrate (GO:0009743),176,20,17.89,+,1.12,3.39E-01
regulation of mRNA stability (GO:0043488),176,20,17.89,+,1.12,3.39E-01
digestive system development (GO:0055123),132,15,13.42,+,1.12,3.68E-01
retinol metabolic process (GO:0042572),44,5,4.47,+,1.12,4.63E-01
negative regulation of cell growth (GO:0030308),176,20,17.89,+,1.12,3.39E-01
negative regulation of epithelial cell apoptotic process (GO:1904036),44,5,4.47,+,1.12,4.63E-01
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),88,10,8.95,+,1.12,4.05E-01
regulation of peptide secretion (GO:0002791),352,40,35.78,+,1.12,2.60E-01
leukocyte activation involved in immune response (GO:0002366),581,66,59.07,+,1.12,1.95E-01
regulation of systemic arterial blood pressure (GO:0003073),97,11,9.86,+,1.12,4.00E-01
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),97,11,9.86,+,1.12,4.00E-01
regulation of protein transport (GO:0051223),591,67,60.08,+,1.12,1.98E-01
inorganic ion transmembrane transport (GO:0098660),600,68,61,+,1.11,1.96E-01
mesenchyme development (GO:0060485),203,23,20.64,+,1.11,3.29E-01
DNA replication (GO:0006260),203,23,20.64,+,1.11,3.29E-01
protein targeting to ER (GO:0045047),106,12,10.78,+,1.11,3.94E-01
positive regulation of T cell activation (GO:0050870),212,24,21.55,+,1.11,3.26E-01
positive regulation of DNA binding (GO:0043388),53,6,5.39,+,1.11,4.52E-01
cellular monovalent inorganic cation homeostasis (GO:0030004),106,12,10.78,+,1.11,3.94E-01
myeloid cell activation involved in immune response (GO:0002275),486,55,49.41,+,1.11,2.28E-01
cellular divalent inorganic cation homeostasis (GO:0072503),433,49,44.02,+,1.11,2.43E-01
leukocyte differentiation (GO:0002521),336,38,34.16,+,1.11,2.76E-01
respiratory tube development (GO:0030323),168,19,17.08,+,1.11,3.52E-01
negative regulation of macromolecule biosynthetic process (GO:0010558),1371,155,139.38,+,1.11,9.18E-02
stress-activated protein kinase signaling cascade (GO:0031098),115,13,11.69,+,1.11,3.89E-01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1327,150,134.9,+,1.11,9.63E-02
negative regulation of growth (GO:0045926),239,27,24.3,+,1.11,3.17E-01
positive regulation of phosphorylation (GO:0042327),1027,116,104.41,+,1.11,1.32E-01
negative regulation of T cell proliferation (GO:0042130),62,7,6.3,+,1.11,4.42E-01
cell activation involved in immune response (GO:0002263),585,66,59.47,+,1.11,2.11E-01
regulation of transporter activity (GO:0032409),266,30,27.04,+,1.11,3.08E-01
regulation of neurogenesis (GO:0050767),346,39,35.17,+,1.11,2.79E-01
calcium ion homeostasis (GO:0055074),417,47,42.39,+,1.11,2.57E-01
smoothened signaling pathway (GO:0007224),71,8,7.22,+,1.11,4.34E-01
regulation of hemostasis (GO:1900046),71,8,7.22,+,1.11,4.34E-01
myeloid leukocyte mediated immunity (GO:0002444),480,54,48.8,+,1.11,2.43E-01
regulation of neuron projection development (GO:0010975),418,47,42.49,+,1.11,2.62E-01
response to wounding (GO:0009611),507,57,51.54,+,1.11,2.38E-01
negative regulation of transferase activity (GO:0051348),267,30,27.14,+,1.11,3.15E-01
regulation of biomineral tissue development (GO:0070167),89,10,9.05,+,1.11,4.19E-01
divalent inorganic cation homeostasis (GO:0072507),454,51,46.15,+,1.1,2.54E-01
regulation of cellular component movement (GO:0051270),971,109,98.71,+,1.1,1.55E-01
response to other organism (GO:0051707),1167,131,118.64,+,1.1,1.30E-01
protein dephosphorylation (GO:0006470),196,22,19.93,+,1.1,3.49E-01
positive regulation of stress-activated MAPK cascade (GO:0032874),107,12,10.88,+,1.1,4.06E-01
leukocyte activation (GO:0045321),874,98,88.85,+,1.1,1.72E-01
positive regulation of protein modification process (GO:0031401),1160,130,117.93,+,1.1,1.35E-01
nucleobase-containing compound catabolic process (GO:0034655),348,39,35.38,+,1.1,2.91E-01
sodium ion transmembrane transport (GO:0035725),116,13,11.79,+,1.1,4.00E-01
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),116,13,11.79,+,1.1,4.00E-01
response to external biotic stimulus (GO:0043207),1169,131,118.84,+,1.1,1.34E-01
growth (GO:0040007),366,41,37.21,+,1.1,2.86E-01
regulation of fat cell differentiation (GO:0045598),125,14,12.71,+,1.1,3.95E-01
positive regulation of hormone secretion (GO:0046887),125,14,12.71,+,1.1,3.95E-01
regulation of endopeptidase activity (GO:0052548),384,43,39.04,+,1.1,2.82E-01
secretion by cell (GO:0032940),902,101,91.7,+,1.1,1.72E-01
negative regulation of cellular protein metabolic process (GO:0032269),956,107,97.19,+,1.1,1.65E-01
positive regulation of cytokine production (GO:0001819),429,48,43.61,+,1.1,2.70E-01
negative regulation of protein metabolic process (GO:0051248),1010,113,102.68,+,1.1,1.58E-01
positive regulation of cell growth (GO:0030307),152,17,15.45,+,1.1,3.80E-01
response to biotic stimulus (GO:0009607),1199,134,121.89,+,1.1,1.38E-01
negative regulation of RNA metabolic process (GO:0051253),1262,141,128.3,+,1.1,1.32E-01
positive regulation of immune response (GO:0050778),546,61,55.51,+,1.1,2.44E-01
carbohydrate homeostasis (GO:0033500),188,21,19.11,+,1.1,3.62E-01
cellular calcium ion homeostasis (GO:0006874),403,45,40.97,+,1.1,2.82E-01
regulation of nervous system development (GO:0051960),421,47,42.8,+,1.1,2.78E-01
response to growth factor (GO:0070848),511,57,51.95,+,1.1,2.56E-01
response to organic cyclic compound (GO:0014070),834,93,84.79,+,1.1,1.94E-01
positive regulation of cellular protein localization (GO:1903829),287,32,29.18,+,1.1,3.23E-01
adaptive immune response (GO:0002250),296,33,30.09,+,1.1,3.20E-01
regulation of protein secretion (GO:0050708),323,36,32.84,+,1.1,3.12E-01
leukocyte mediated immunity (GO:0002443),593,66,60.29,+,1.09,2.44E-01
positive regulation of cell differentiation (GO:0045597),800,89,81.33,+,1.09,2.06E-01
regulation of catalytic activity (GO:0050790),2167,241,220.3,+,1.09,7.32E-02
RNA metabolic process (GO:0016070),1394,155,141.72,+,1.09,1.31E-01
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),27,3,2.74,+,1.09,5.17E-01
positive regulation of erythrocyte differentiation (GO:0045648),27,3,2.74,+,1.09,5.17E-01
regulation of biomineralization (GO:0110149),90,10,9.15,+,1.09,4.32E-01
DNA biosynthetic process (GO:0071897),99,11,10.06,+,1.09,4.25E-01
folic acid-containing compound metabolic process (GO:0006760),27,3,2.74,+,1.09,5.17E-01
regulation of response to DNA damage stimulus (GO:2001020),198,22,20.13,+,1.09,3.67E-01
eye photoreceptor cell differentiation (GO:0001754),45,5,4.57,+,1.09,4.82E-01
nuclear DNA replication (GO:0033260),54,6,5.49,+,1.09,4.69E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),27,3,2.74,+,1.09,5.17E-01
negative regulation of interleukin-6 production (GO:0032715),45,5,4.57,+,1.09,4.82E-01
negative regulation of interleukin-2 production (GO:0032703),27,3,2.74,+,1.09,5.17E-01
regulation of interleukin-10 production (GO:0032653),54,6,5.49,+,1.09,4.69E-01
cellular response to interleukin-4 (GO:0071353),27,3,2.74,+,1.09,5.17E-01
nucleus localization (GO:0051647),27,3,2.74,+,1.09,5.17E-01
astrocyte differentiation (GO:0048708),54,6,5.49,+,1.09,4.69E-01
regulation of intracellular pH (GO:0051453),81,9,8.23,+,1.09,4.40E-01
positive regulation of oxidoreductase activity (GO:0051353),54,6,5.49,+,1.09,4.69E-01
developmental growth (GO:0048589),360,40,36.6,+,1.09,3.07E-01
tight junction assembly (GO:0120192),54,6,5.49,+,1.09,4.69E-01
regulation of vacuole organization (GO:0044088),45,5,4.57,+,1.09,4.82E-01
regulation of calcium ion transmembrane transporter activity (GO:1901019),81,9,8.23,+,1.09,4.40E-01
exploration behavior (GO:0035640),27,3,2.74,+,1.09,5.17E-01
hydrogen peroxide catabolic process (GO:0042744),27,3,2.74,+,1.09,5.17E-01
regulation of vascular permeability (GO:0043114),45,5,4.57,+,1.09,4.82E-01
regulation of ruffle assembly (GO:1900027),27,3,2.74,+,1.09,5.17E-01
regulation of substrate adhesion-dependent cell spreading (GO:1900024),54,6,5.49,+,1.09,4.69E-01
regulation of protein kinase A signaling (GO:0010738),27,3,2.74,+,1.09,5.17E-01
positive regulation of alpha-beta T cell differentiation (GO:0046638),45,5,4.57,+,1.09,4.82E-01
regulation of Rho protein signal transduction (GO:0035023),81,9,8.23,+,1.09,4.40E-01
cell fate commitment involved in formation of primary germ layer (GO:0060795),27,3,2.74,+,1.09,5.17E-01
negative regulation of response to biotic stimulus (GO:0002832),90,10,9.15,+,1.09,4.32E-01
positive regulation of translational initiation (GO:0045948),27,3,2.74,+,1.09,5.17E-01
regulation of glucose import (GO:0046324),54,6,5.49,+,1.09,4.69E-01
forebrain neuron development (GO:0021884),27,3,2.74,+,1.09,5.17E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808),45,5,4.57,+,1.09,4.82E-01
positive regulation of leukocyte tethering or rolling (GO:1903238),9,1,0.91,+,1.09,6.00E-01
negative regulation of oxidative stress-induced neuron death (GO:1903204),18,2,1.83,+,1.09,5.46E-01
regulation of inner ear receptor cell differentiation (GO:2000980),9,1,0.91,+,1.09,6.00E-01
branching involved in prostate gland morphogenesis (GO:0060442),9,1,0.91,+,1.09,6.00E-01
lung saccule development (GO:0060430),9,1,0.91,+,1.09,6.00E-01
regulation of lens fiber cell differentiation (GO:1902746),9,1,0.91,+,1.09,6.00E-01
"substrate-dependent cell migration, cell extension (GO:0006930)",9,1,0.91,+,1.09,6.00E-01
positive regulation of homotypic cell-cell adhesion (GO:0034112),9,1,0.91,+,1.09,6.00E-01
autophagy (GO:0006914),279,31,28.36,+,1.09,3.34E-01
positive regulation of megakaryocyte differentiation (GO:0045654),9,1,0.91,+,1.09,6.00E-01
regulation of mechanoreceptor differentiation (GO:0045631),9,1,0.91,+,1.09,6.00E-01
regulation of inner ear auditory receptor cell differentiation (GO:0045607),9,1,0.91,+,1.09,6.00E-01
plus-end-directed organelle transport along microtubule (GO:0072386),9,1,0.91,+,1.09,6.00E-01
facial nerve structural organization (GO:0021612),9,1,0.91,+,1.09,6.00E-01
cranial suture morphogenesis (GO:0060363),9,1,0.91,+,1.09,6.00E-01
regulation of behavioral fear response (GO:2000822),9,1,0.91,+,1.09,6.00E-01
regulation of synaptic vesicle clustering (GO:2000807),9,1,0.91,+,1.09,6.00E-01
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),9,1,0.91,+,1.09,6.00E-01
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),18,2,1.83,+,1.09,5.46E-01
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",9,1,0.91,+,1.09,6.00E-01
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993),9,1,0.91,+,1.09,6.00E-01
protein localization to membrane raft (GO:1903044),9,1,0.91,+,1.09,6.00E-01
cellular glucuronidation (GO:0052695),9,1,0.91,+,1.09,6.00E-01
regulation of autophagosome assembly (GO:2000785),36,4,3.66,+,1.09,4.98E-01
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),18,2,1.83,+,1.09,5.46E-01
positive regulation of stem cell differentiation (GO:2000738),18,2,1.83,+,1.09,5.46E-01
protoporphyrinogen IX biosynthetic process (GO:0006782),9,1,0.91,+,1.09,6.00E-01
regulation of organelle transport along microtubule (GO:1902513),9,1,0.91,+,1.09,6.00E-01
regulation of apoptotic DNA fragmentation (GO:1902510),9,1,0.91,+,1.09,6.00E-01
negative regulation of adenylate cyclase activity (GO:0007194),18,2,1.83,+,1.09,5.46E-01
mesonephric duct development (GO:0072177),9,1,0.91,+,1.09,6.00E-01
regulation of type B pancreatic cell apoptotic process (GO:2000674),9,1,0.91,+,1.09,6.00E-01
regulation of miRNA metabolic process (GO:2000628),9,1,0.91,+,1.09,6.00E-01
galactosylceramide metabolic process (GO:0006681),9,1,0.91,+,1.09,6.00E-01
vocalization behavior (GO:0071625),18,2,1.83,+,1.09,5.46E-01
otic vesicle morphogenesis (GO:0071600),9,1,0.91,+,1.09,6.00E-01
telomere maintenance via telomere trimming (GO:0090737),9,1,0.91,+,1.09,6.00E-01
membrane hyperpolarization (GO:0060081),9,1,0.91,+,1.09,6.00E-01
renal system pattern specification (GO:0072048),9,1,0.91,+,1.09,6.00E-01
"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",9,1,0.91,+,1.09,6.00E-01
regulation of resting membrane potential (GO:0060075),9,1,0.91,+,1.09,6.00E-01
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),9,1,0.91,+,1.09,6.00E-01
negative regulation of natural killer cell activation (GO:0032815),9,1,0.91,+,1.09,6.00E-01
proline metabolic process (GO:0006560),9,1,0.91,+,1.09,6.00E-01
cysteine metabolic process (GO:0006534),9,1,0.91,+,1.09,6.00E-01
L-glutamate import (GO:0051938),9,1,0.91,+,1.09,6.00E-01
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),9,1,0.91,+,1.09,6.00E-01
positive regulation of mitochondrial depolarization (GO:0051901),9,1,0.91,+,1.09,6.00E-01
t-circle formation (GO:0090656),9,1,0.91,+,1.09,6.00E-01
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),9,1,0.91,+,1.09,6.00E-01
peptidyl-tyrosine autophosphorylation (GO:0038083),36,4,3.66,+,1.09,4.98E-01
DNA methylation or demethylation (GO:0044728),63,7,6.4,+,1.09,4.59E-01
regulation of delayed rectifier potassium channel activity (GO:1902259),18,2,1.83,+,1.09,5.46E-01
positive regulation of interleukin-10 production (GO:0032733),36,4,3.66,+,1.09,4.98E-01
cellular response to UV-A (GO:0071492),9,1,0.91,+,1.09,6.00E-01
positive regulation of glutamate secretion (GO:0014049),9,1,0.91,+,1.09,6.00E-01
killing by host of symbiont cells (GO:0051873),18,2,1.83,+,1.09,5.46E-01
astrocyte development (GO:0014002),36,4,3.66,+,1.09,4.98E-01
meiotic chromosome segregation (GO:0045132),72,8,7.32,+,1.09,4.49E-01
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),36,4,3.66,+,1.09,4.98E-01
actin filament reorganization (GO:0090527),9,1,0.91,+,1.09,6.00E-01
cellular response to reactive nitrogen species (GO:1902170),18,2,1.83,+,1.09,5.46E-01
cellular response to cholesterol (GO:0071397),18,2,1.83,+,1.09,5.46E-01
chromatin silencing at telomere (GO:0006348),9,1,0.91,+,1.09,6.00E-01
negative regulation of nuclear division (GO:0051784),36,4,3.66,+,1.09,4.98E-01
cellular response to hexose stimulus (GO:0071331),72,8,7.32,+,1.09,4.49E-01
regulation of immature T cell proliferation (GO:0033083),9,1,0.91,+,1.09,6.00E-01
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),9,1,0.91,+,1.09,6.00E-01
protein localization to nuclear envelope (GO:0090435),9,1,0.91,+,1.09,6.00E-01
positive regulation of myoblast proliferation (GO:2000288),9,1,0.91,+,1.09,6.00E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),9,1,0.91,+,1.09,6.00E-01
pyrimidine dimer repair (GO:0006290),9,1,0.91,+,1.09,6.00E-01
establishment of centrosome localization (GO:0051660),9,1,0.91,+,1.09,6.00E-01
endoplasmic reticulum localization (GO:0051643),9,1,0.91,+,1.09,6.00E-01
actin filament network formation (GO:0051639),9,1,0.91,+,1.09,6.00E-01
venous blood vessel morphogenesis (GO:0048845),9,1,0.91,+,1.09,6.00E-01
formation of extrachromosomal circular DNA (GO:0001325),9,1,0.91,+,1.09,6.00E-01
erythrocyte development (GO:0048821),36,4,3.66,+,1.09,4.98E-01
Rap protein signal transduction (GO:0032486),9,1,0.91,+,1.09,6.00E-01
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),9,1,0.91,+,1.09,6.00E-01
trans-synaptic signaling by trans-synaptic complex (GO:0099545),9,1,0.91,+,1.09,6.00E-01
regulation of cell proliferation involved in heart morphogenesis (GO:2000136),18,2,1.83,+,1.09,5.46E-01
cAMP catabolic process (GO:0006198),9,1,0.91,+,1.09,6.00E-01
regulation of macrophage apoptotic process (GO:2000109),9,1,0.91,+,1.09,6.00E-01
"regulation of gene expression, epigenetic (GO:0040029)",135,15,13.72,+,1.09,4.00E-01
"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",9,1,0.91,+,1.09,6.00E-01
negative regulation of triglyceride metabolic process (GO:0090209),9,1,0.91,+,1.09,6.00E-01
lipid droplet formation (GO:0140042),9,1,0.91,+,1.09,6.00E-01
embryonic neurocranium morphogenesis (GO:0048702),9,1,0.91,+,1.09,6.00E-01
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),9,1,0.91,+,1.09,6.00E-01
regulation of phospholipid biosynthetic process (GO:0071071),18,2,1.83,+,1.09,5.46E-01
cell-cell recognition (GO:0009988),72,8,7.32,+,1.09,4.49E-01
dendritic transport (GO:0098935),9,1,0.91,+,1.09,6.00E-01
RNA polymerase I preinitiation complex assembly (GO:0001188),9,1,0.91,+,1.09,6.00E-01
embryonic foregut morphogenesis (GO:0048617),9,1,0.91,+,1.09,6.00E-01
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298),9,1,0.91,+,1.09,6.00E-01
meiotic chromosome separation (GO:0051307),18,2,1.83,+,1.09,5.46E-01
thrombin-activated receptor signaling pathway (GO:0070493),9,1,0.91,+,1.09,6.00E-01
positive regulation of deacetylase activity (GO:0090045),9,1,0.91,+,1.09,6.00E-01
positive regulation of monocyte chemotaxis (GO:0090026),18,2,1.83,+,1.09,5.46E-01
cellular response to cold (GO:0070417),9,1,0.91,+,1.09,6.00E-01
regulation of acyl-CoA biosynthetic process (GO:0050812),9,1,0.91,+,1.09,6.00E-01
ATF6-mediated unfolded protein response (GO:0036500),9,1,0.91,+,1.09,6.00E-01
nuclear pore complex assembly (GO:0051292),9,1,0.91,+,1.09,6.00E-01
cellular protein complex disassembly (GO:0043624),135,15,13.72,+,1.09,4.00E-01
positive regulation of myelination (GO:0031643),18,2,1.83,+,1.09,5.46E-01
response to fructose (GO:0009750),9,1,0.91,+,1.09,6.00E-01
regulation of fever generation (GO:0031620),9,1,0.91,+,1.09,6.00E-01
regulation of postsynaptic density assembly (GO:0099151),9,1,0.91,+,1.09,6.00E-01
regulation of postsynaptic specialization assembly (GO:0099150),9,1,0.91,+,1.09,6.00E-01
intracellular distribution of mitochondria (GO:0048312),9,1,0.91,+,1.09,6.00E-01
spliceosomal snRNP assembly (GO:0000387),36,4,3.66,+,1.09,4.98E-01
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),9,1,0.91,+,1.09,6.00E-01
positive regulation of morphogenesis of an epithelium (GO:1905332),36,4,3.66,+,1.09,4.98E-01
macromolecule methylation (GO:0043414),207,23,21.04,+,1.09,3.63E-01
negative regulation of mRNA 3'-end processing (GO:0031441),9,1,0.91,+,1.09,6.00E-01
regulation of tooth mineralization (GO:0070170),9,1,0.91,+,1.09,6.00E-01
peptidyl-serine autophosphorylation (GO:0036289),9,1,0.91,+,1.09,6.00E-01
interleukin-6-mediated signaling pathway (GO:0070102),18,2,1.83,+,1.09,5.46E-01
positive regulation of vesicle fusion (GO:0031340),9,1,0.91,+,1.09,6.00E-01
regulation of chemokine-mediated signaling pathway (GO:0070099),9,1,0.91,+,1.09,6.00E-01
regulation of core promoter binding (GO:1904796),9,1,0.91,+,1.09,6.00E-01
regulation of epithelial cell differentiation (GO:0030856),135,15,13.72,+,1.09,4.00E-01
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),18,2,1.83,+,1.09,5.46E-01
process utilizing autophagic mechanism (GO:0061919),279,31,28.36,+,1.09,3.34E-01
positive regulation of guanylate cyclase activity (GO:0031284),9,1,0.91,+,1.09,6.00E-01
negative regulation of ubiquitin protein ligase activity (GO:1904667),9,1,0.91,+,1.09,6.00E-01
regulation of SNARE complex assembly (GO:0035542),9,1,0.91,+,1.09,6.00E-01
mRNA transcription (GO:0009299),18,2,1.83,+,1.09,5.46E-01
positive regulation of metallopeptidase activity (GO:1905050),9,1,0.91,+,1.09,6.00E-01
rRNA pseudouridine synthesis (GO:0031118),9,1,0.91,+,1.09,6.00E-01
pyrimidine ribonucleotide biosynthetic process (GO:0009220),18,2,1.83,+,1.09,5.46E-01
reticulophagy (GO:0061709),9,1,0.91,+,1.09,6.00E-01
heme transport (GO:0015886),9,1,0.91,+,1.09,6.00E-01
primary miRNA processing (GO:0031053),9,1,0.91,+,1.09,6.00E-01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),18,2,1.83,+,1.09,5.46E-01
myeloid dendritic cell differentiation (GO:0043011),18,2,1.83,+,1.09,5.46E-01
arginine transport (GO:0015809),9,1,0.91,+,1.09,6.00E-01
purine nucleobase biosynthetic process (GO:0009113),9,1,0.91,+,1.09,6.00E-01
positive regulation of BMP signaling pathway (GO:0030513),36,4,3.66,+,1.09,4.98E-01
positive regulation of isomerase activity (GO:0010912),9,1,0.91,+,1.09,6.00E-01
regulation of isomerase activity (GO:0010911),9,1,0.91,+,1.09,6.00E-01
attachment of spindle microtubules to kinetochore (GO:0008608),18,2,1.83,+,1.09,5.46E-01
regulation of heart rate by cardiac conduction (GO:0086091),36,4,3.66,+,1.09,4.98E-01
filopodium assembly (GO:0046847),18,2,1.83,+,1.09,5.46E-01
regulation of protein localization to cell periphery (GO:1904375),117,13,11.89,+,1.09,4.12E-01
tRNA methylation (GO:0030488),36,4,3.66,+,1.09,4.98E-01
hormone catabolic process (GO:0042447),9,1,0.91,+,1.09,6.00E-01
positive regulation of triglyceride catabolic process (GO:0010898),9,1,0.91,+,1.09,6.00E-01
positive regulation of steroid biosynthetic process (GO:0010893),18,2,1.83,+,1.09,5.46E-01
positive regulation of sequestering of triglyceride (GO:0010890),9,1,0.91,+,1.09,6.00E-01
serotonin metabolic process (GO:0042428),9,1,0.91,+,1.09,6.00E-01
positive regulation of cholesterol esterification (GO:0010873),9,1,0.91,+,1.09,6.00E-01
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),18,2,1.83,+,1.09,5.46E-01
extraembryonic membrane development (GO:1903867),9,1,0.91,+,1.09,6.00E-01
DNA replication-independent nucleosome organization (GO:0034724),36,4,3.66,+,1.09,4.98E-01
synaptic vesicle docking (GO:0016081),9,1,0.91,+,1.09,6.00E-01
negative regulation of fibroblast migration (GO:0010764),9,1,0.91,+,1.09,6.00E-01
positive regulation of macrophage chemotaxis (GO:0010759),18,2,1.83,+,1.09,5.46E-01
regulation of nitric oxide mediated signal transduction (GO:0010749),9,1,0.91,+,1.09,6.00E-01
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),9,1,0.91,+,1.09,6.00E-01
tetrahydrofolate metabolic process (GO:0046653),18,2,1.83,+,1.09,5.46E-01
negative regulation of alpha-beta T cell proliferation (GO:0046642),9,1,0.91,+,1.09,6.00E-01
determination of adult lifespan (GO:0008340),18,2,1.83,+,1.09,5.46E-01
CD40 signaling pathway (GO:0023035),9,1,0.91,+,1.09,6.00E-01
semicircular canal development (GO:0060872),9,1,0.91,+,1.09,6.00E-01
omega-hydroxylase P450 pathway (GO:0097267),9,1,0.91,+,1.09,6.00E-01
smooth muscle cell migration (GO:0014909),9,1,0.91,+,1.09,6.00E-01
regulation of platelet activation (GO:0010543),36,4,3.66,+,1.09,4.98E-01
glyoxylate metabolic process (GO:0046487),9,1,0.91,+,1.09,6.00E-01
regulation of Wnt signaling pathway involved in heart development (GO:0003307),9,1,0.91,+,1.09,6.00E-01
regulation of hypersensitivity (GO:0002883),9,1,0.91,+,1.09,6.00E-01
urinary tract smooth muscle contraction (GO:0014848),9,1,0.91,+,1.09,6.00E-01
microvillus assembly (GO:0030033),9,1,0.91,+,1.09,6.00E-01
histone H3-K36 methylation (GO:0010452),9,1,0.91,+,1.09,6.00E-01
lung secretory cell differentiation (GO:0061140),9,1,0.91,+,1.09,6.00E-01
dorsal/ventral neural tube patterning (GO:0021904),18,2,1.83,+,1.09,5.46E-01
dichotomous subdivision of an epithelial terminal unit (GO:0060600),9,1,0.91,+,1.09,6.00E-01
regulation of glial cell apoptotic process (GO:0034350),9,1,0.91,+,1.09,6.00E-01
regulation of NAD(P)H oxidase activity (GO:0033860),9,1,0.91,+,1.09,6.00E-01
regulation of fear response (GO:1903365),9,1,0.91,+,1.09,6.00E-01
pattern specification involved in kidney development (GO:0061004),9,1,0.91,+,1.09,6.00E-01
regulation of non-motile cilium assembly (GO:1902855),9,1,0.91,+,1.09,6.00E-01
export from cell (GO:0140352),946,105,96.17,+,1.09,1.90E-01
regulation of establishment of protein localization (GO:0070201),613,68,62.32,+,1.09,2.48E-01
negative regulation of biosynthetic process (GO:0009890),1453,161,147.71,+,1.09,1.36E-01
carbohydrate derivative metabolic process (GO:1901135),912,101,92.72,+,1.09,2.01E-01
negative regulation of gene expression (GO:0010629),1834,203,186.45,+,1.09,1.07E-01
leukocyte degranulation (GO:0043299),470,52,47.78,+,1.09,2.87E-01
lymphocyte differentiation (GO:0030098),235,26,23.89,+,1.09,3.59E-01
neutrophil mediated immunity (GO:0002446),461,51,46.87,+,1.09,2.89E-01
calcium ion transport (GO:0006816),226,25,22.98,+,1.09,3.63E-01
positive regulation of MAP kinase activity (GO:0043406),226,25,22.98,+,1.09,3.63E-01
striated muscle cell differentiation (GO:0051146),190,21,19.32,+,1.09,3.80E-01
sensory system development (GO:0048880),353,39,35.89,+,1.09,3.22E-01
cell migration (GO:0016477),851,94,86.51,+,1.09,2.18E-01
regulation of cytosolic calcium ion concentration (GO:0051480),308,34,31.31,+,1.09,3.38E-01
regulation of body fluid levels (GO:0050878),462,51,46.97,+,1.09,2.95E-01
positive regulation of lymphocyte proliferation (GO:0050671),136,15,13.83,+,1.08,4.11E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277),136,15,13.83,+,1.08,4.11E-01
cellular nitrogen compound catabolic process (GO:0044270),399,44,40.56,+,1.08,3.13E-01
regulation of mRNA processing (GO:0050684),127,14,12.91,+,1.08,4.17E-01
positive regulation of immune system process (GO:0002684),844,93,85.8,+,1.08,2.27E-01
eye development (GO:0001654),345,38,35.07,+,1.08,3.31E-01
cytoskeleton organization (GO:0007010),1108,122,112.64,+,1.08,1.93E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),109,12,11.08,+,1.08,4.30E-01
mucopolysaccharide metabolic process (GO:1903510),109,12,11.08,+,1.08,4.30E-01
positive regulation of T cell proliferation (GO:0042102),100,11,10.17,+,1.08,4.38E-01
erythrocyte homeostasis (GO:0034101),91,10,9.25,+,1.08,4.46E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),91,10,9.25,+,1.08,4.46E-01
negative regulation of immune response (GO:0050777),273,30,27.75,+,1.08,3.59E-01
negative regulation of cell development (GO:0010721),173,19,17.59,+,1.08,3.99E-01
regulation of transmembrane transporter activity (GO:0022898),255,28,25.92,+,1.08,3.67E-01
positive regulation of cellular protein metabolic process (GO:0032270),1512,166,153.71,+,1.08,1.59E-01
neutrophil migration (GO:1990266),82,9,8.34,+,1.08,4.54E-01
positive regulation of transferase activity (GO:0051347),656,72,66.69,+,1.08,2.70E-01
fertilization (GO:0009566),164,18,16.67,+,1.08,4.04E-01
erythrocyte differentiation (GO:0030218),82,9,8.34,+,1.08,4.54E-01
blood vessel morphogenesis (GO:0048514),392,43,39.85,+,1.08,3.28E-01
negative regulation of nitrogen compound metabolic process (GO:0051172),2179,239,221.52,+,1.08,1.11E-01
regulation of protein kinase activity (GO:0045859),748,82,76.04,+,1.08,2.57E-01
regulation of organic acid transport (GO:0032890),73,8,7.42,+,1.08,4.64E-01
regulation of translational initiation (GO:0006446),73,8,7.42,+,1.08,4.64E-01
cellular response to monosaccharide stimulus (GO:0071326),73,8,7.42,+,1.08,4.64E-01
regulation of mitochondrial membrane permeability (GO:0046902),73,8,7.42,+,1.08,4.64E-01
cAMP-mediated signaling (GO:0019933),146,16,14.84,+,1.08,4.16E-01
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),146,16,14.84,+,1.08,4.16E-01
regulation of T cell mediated immunity (GO:0002709),73,8,7.42,+,1.08,4.64E-01
posttranscriptional regulation of gene expression (GO:0010608),502,55,51.03,+,1.08,3.05E-01
positive regulation of cell adhesion (GO:0045785),420,46,42.7,+,1.08,3.25E-01
inflammatory response (GO:0006954),484,53,49.2,+,1.08,3.10E-01
cellular nitrogen compound metabolic process (GO:0034641),2950,323,299.9,+,1.08,7.56E-02
protein-containing complex subunit organization (GO:0043933),1370,150,139.28,+,1.08,1.82E-01
positive regulation of mononuclear cell proliferation (GO:0032946),137,15,13.93,+,1.08,4.22E-01
circadian rhythm (GO:0007623),137,15,13.93,+,1.08,4.22E-01
"negative regulation of transcription, DNA-templated (GO:0045892)",1142,125,116.1,+,1.08,2.08E-01
nucleic acid metabolic process (GO:0090304),1929,211,196.11,+,1.08,1.37E-01
positive regulation of JUN kinase activity (GO:0043507),64,7,6.51,+,1.08,4.75E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),128,14,13.01,+,1.08,4.28E-01
snRNA transcription by RNA polymerase II (GO:0042795),64,7,6.51,+,1.08,4.75E-01
neural retina development (GO:0003407),64,7,6.51,+,1.08,4.75E-01
myeloid leukocyte activation (GO:0002274),549,60,55.81,+,1.08,3.02E-01
cellular response to metal ion (GO:0071248),183,20,18.6,+,1.08,4.03E-01
establishment of protein localization to organelle (GO:0072594),421,46,42.8,+,1.07,3.31E-01
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),119,13,12.1,+,1.07,4.35E-01
regulation of peptidase activity (GO:0052547),412,45,41.88,+,1.07,3.34E-01
taxis (GO:0042330),522,57,53.07,+,1.07,3.10E-01
G protein-coupled receptor signaling pathway (GO:0007186),907,99,92.21,+,1.07,2.47E-01
homotypic cell-cell adhesion (GO:0034109),55,6,5.59,+,1.07,4.87E-01
leukocyte cell-cell adhesion (GO:0007159),55,6,5.59,+,1.07,4.87E-01
myeloid cell homeostasis (GO:0002262),110,12,11.18,+,1.07,4.43E-01
cell cycle DNA replication (GO:0044786),55,6,5.59,+,1.07,4.87E-01
regulation of protein stability (GO:0031647),275,30,27.96,+,1.07,3.74E-01
positive regulation of cell-cell adhesion (GO:0022409),275,30,27.96,+,1.07,3.74E-01
positive regulation of cell population proliferation (GO:0008284),871,95,88.55,+,1.07,2.55E-01
aromatic compound catabolic process (GO:0019439),413,45,41.99,+,1.07,3.40E-01
negative regulation of nucleic acid-templated transcription (GO:1903507),1175,128,119.45,+,1.07,2.21E-01
regulation of actin filament bundle assembly (GO:0032231),101,11,10.27,+,1.07,4.51E-01
visual system development (GO:0150063),349,38,35.48,+,1.07,3.57E-01
peptidyl-amino acid modification (GO:0018193),790,86,80.31,+,1.07,2.73E-01
positive regulation of phosphorus metabolic process (GO:0010562),1094,119,111.22,+,1.07,2.35E-01
positive regulation of phosphate metabolic process (GO:0045937),1094,119,111.22,+,1.07,2.35E-01
cognition (GO:0050890),285,31,28.97,+,1.07,3.77E-01
negative regulation of RNA biosynthetic process (GO:1902679),1177,128,119.66,+,1.07,2.26E-01
negative regulation of macromolecule metabolic process (GO:0010605),2603,283,264.62,+,1.07,1.16E-01
long-term synaptic potentiation (GO:0060291),46,5,4.68,+,1.07,5.01E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),184,20,18.71,+,1.07,4.12E-01
reciprocal meiotic recombination (GO:0007131),46,5,4.68,+,1.07,5.01E-01
hematopoietic progenitor cell differentiation (GO:0002244),92,10,9.35,+,1.07,4.59E-01
reciprocal homologous recombination (GO:0140527),46,5,4.68,+,1.07,5.01E-01
cellular lipid catabolic process (GO:0044242),184,20,18.71,+,1.07,4.12E-01
digestive tract morphogenesis (GO:0048546),46,5,4.68,+,1.07,5.01E-01
positive regulation of protein-containing complex assembly (GO:0031334),230,25,23.38,+,1.07,3.96E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088),46,5,4.68,+,1.07,5.01E-01
establishment or maintenance of bipolar cell polarity (GO:0061245),46,5,4.68,+,1.07,5.01E-01
positive regulation of leukocyte activation (GO:0002696),322,35,32.74,+,1.07,3.68E-01
protein-containing complex assembly (GO:0065003),1141,124,116,+,1.07,2.33E-01
lipid localization (GO:0010876),313,34,31.82,+,1.07,3.72E-01
aging (GO:0007568),267,29,27.14,+,1.07,3.85E-01
positive regulation of molecular function (GO:0044093),1685,183,171.3,+,1.07,1.82E-01
negative regulation of cell population proliferation (GO:0008285),654,71,66.49,+,1.07,3.03E-01
negative regulation of catalytic activity (GO:0043086),737,80,74.92,+,1.07,2.90E-01
regulation of immune effector process (GO:0002697),387,42,39.34,+,1.07,3.56E-01
cellular response to catecholamine stimulus (GO:0071870),83,9,8.44,+,1.07,4.68E-01
cellular response to monoamine stimulus (GO:0071868),83,9,8.44,+,1.07,4.68E-01
cellular response to carbohydrate stimulus (GO:0071322),83,9,8.44,+,1.07,4.68E-01
regulation of protein metabolic process (GO:0051246),2573,279,261.58,+,1.07,1.27E-01
BMP signaling pathway (GO:0030509),83,9,8.44,+,1.07,4.68E-01
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),1356,147,137.85,+,1.07,2.19E-01
cellular component biogenesis (GO:0044085),2344,254,238.29,+,1.07,1.44E-01
regulation of cellular amide metabolic process (GO:0034248),397,43,40.36,+,1.07,3.58E-01
response to cytokine (GO:0034097),1062,115,107.96,+,1.07,2.55E-01
neutrophil activation (GO:0042119),462,50,46.97,+,1.06,3.46E-01
regulation of protein phosphorylation (GO:0001932),1368,148,139.07,+,1.06,2.26E-01
modulation of process of other organism involved in symbiotic interaction (GO:0051817),111,12,11.28,+,1.06,4.55E-01
regulation of systemic arterial blood pressure by hormone (GO:0001990),37,4,3.76,+,1.06,5.19E-01
fat-soluble vitamin metabolic process (GO:0006775),37,4,3.76,+,1.06,5.19E-01
actin-myosin filament sliding (GO:0033275),37,4,3.76,+,1.06,5.19E-01
negative regulation of DNA biosynthetic process (GO:2000279),37,4,3.76,+,1.06,5.19E-01
ncRNA 3'-end processing (GO:0043628),37,4,3.76,+,1.06,5.19E-01
killing of cells of other organism (GO:0031640),74,8,7.52,+,1.06,4.79E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201),37,4,3.76,+,1.06,5.19E-01
regulation of phospholipid metabolic process (GO:1903725),37,4,3.76,+,1.06,5.19E-01
insulin secretion (GO:0030073),37,4,3.76,+,1.06,5.19E-01
muscle filament sliding (GO:0030049),37,4,3.76,+,1.06,5.19E-01
response to monosaccharide (GO:0034284),148,16,15.05,+,1.06,4.37E-01
cell morphogenesis involved in differentiation (GO:0000904),537,58,54.59,+,1.06,3.38E-01
lipid modification (GO:0030258),213,23,21.65,+,1.06,4.14E-01
positive regulation of multicellular organismal process (GO:0051240),1343,145,136.53,+,1.06,2.36E-01
protein stabilization (GO:0050821),176,19,17.89,+,1.06,4.28E-01
sphingolipid metabolic process (GO:0006665),139,15,14.13,+,1.06,4.43E-01
regulation of peptidyl-serine phosphorylation (GO:0033135),139,15,14.13,+,1.06,4.43E-01
organic cyclic compound catabolic process (GO:1901361),445,48,45.24,+,1.06,3.59E-01
regulation of synapse structure or activity (GO:0050803),204,22,20.74,+,1.06,4.20E-01
response to endogenous stimulus (GO:0009719),1326,143,134.8,+,1.06,2.42E-01
regulation of intracellular signal transduction (GO:1902531),1651,178,167.84,+,1.06,2.15E-01
regulation of cellular protein metabolic process (GO:0032268),2440,263,248.05,+,1.06,1.60E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039),232,25,23.59,+,1.06,4.12E-01
neutrophil activation involved in immune response (GO:0002283),455,49,46.26,+,1.06,3.61E-01
chemotaxis (GO:0006935),520,56,52.86,+,1.06,3.49E-01
response to inorganic substance (GO:0010035),520,56,52.86,+,1.06,3.49E-01
regulation of stem cell proliferation (GO:0072091),65,7,6.61,+,1.06,4.91E-01
regulation of dendrite morphogenesis (GO:0048814),65,7,6.61,+,1.06,4.91E-01
regulation of lipid kinase activity (GO:0043550),65,7,6.61,+,1.06,4.91E-01
positive regulation of protein metabolic process (GO:0051247),1588,171,161.44,+,1.06,2.25E-01
gliogenesis (GO:0042063),223,24,22.67,+,1.06,4.17E-01
learning or memory (GO:0007611),251,27,25.52,+,1.06,4.10E-01
organic substance catabolic process (GO:1901575),1590,171,161.64,+,1.06,2.30E-01
positive regulation of adaptive immune response (GO:0002821),93,10,9.45,+,1.06,4.72E-01
carboxylic acid biosynthetic process (GO:0046394),279,30,28.36,+,1.06,4.04E-01
positive regulation of intracellular transport (GO:0032388),214,23,21.76,+,1.06,4.23E-01
oxoacid metabolic process (GO:0043436),884,95,89.87,+,1.06,3.03E-01
negative regulation of cellular biosynthetic process (GO:0031327),1424,153,144.77,+,1.06,2.48E-01
regulation of lipid transport (GO:0032368),121,13,12.3,+,1.06,4.59E-01
memory (GO:0007613),121,13,12.3,+,1.06,4.59E-01
activation of immune response (GO:0002253),354,38,35.99,+,1.06,3.90E-01
cell-cell junction organization (GO:0045216),177,19,17.99,+,1.06,4.37E-01
positive regulation of immune effector process (GO:0002699),205,22,20.84,+,1.06,4.28E-01
inorganic ion homeostasis (GO:0098771),671,72,68.21,+,1.06,3.37E-01
organic acid metabolic process (GO:0006082),904,97,91.9,+,1.06,3.07E-01
regulation of leukocyte proliferation (GO:0070663),233,25,23.69,+,1.06,4.20E-01
nuclear transport (GO:0051169),233,25,23.69,+,1.06,4.20E-01
granulocyte activation (GO:0036230),466,50,47.37,+,1.06,3.69E-01
regulation of phosphorylation (GO:0042325),1529,164,155.44,+,1.06,2.47E-01
regulation of transferase activity (GO:0051338),951,102,96.68,+,1.06,3.03E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),84,9,8.54,+,1.05,4.83E-01
ureteric bud development (GO:0001657),84,9,8.54,+,1.05,4.83E-01
proteoglycan metabolic process (GO:0006029),84,9,8.54,+,1.05,4.83E-01
dicarboxylic acid metabolic process (GO:0043648),84,9,8.54,+,1.05,4.83E-01
hair cycle (GO:0042633),84,9,8.54,+,1.05,4.83E-01
molting cycle (GO:0042303),84,9,8.54,+,1.05,4.83E-01
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),28,3,2.85,+,1.05,5.42E-01
regulation of SMAD protein signal transduction (GO:0060390),28,3,2.85,+,1.05,5.42E-01
protein localization to Golgi apparatus (GO:0034067),28,3,2.85,+,1.05,5.42E-01
protein transmembrane transport (GO:0071806),56,6,5.69,+,1.05,5.04E-01
dopamine receptor signaling pathway (GO:0007212),28,3,2.85,+,1.05,5.42E-01
"CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)",28,3,2.85,+,1.05,5.42E-01
protein ADP-ribosylation (GO:0006471),28,3,2.85,+,1.05,5.42E-01
regulation of myeloid cell apoptotic process (GO:0033032),28,3,2.85,+,1.05,5.42E-01
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",28,3,2.85,+,1.05,5.42E-01
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),56,6,5.69,+,1.05,5.04E-01
tight junction organization (GO:0120193),56,6,5.69,+,1.05,5.04E-01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),56,6,5.69,+,1.05,5.04E-01
positive regulation of neuron apoptotic process (GO:0043525),56,6,5.69,+,1.05,5.04E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035),588,63,59.78,+,1.05,3.53E-01
chromosome organization involved in meiotic cell cycle (GO:0070192),56,6,5.69,+,1.05,5.04E-01
neuron cellular homeostasis (GO:0070050),28,3,2.85,+,1.05,5.42E-01
negative regulation of fibroblast proliferation (GO:0048147),28,3,2.85,+,1.05,5.42E-01
establishment of mitotic spindle orientation (GO:0000132),28,3,2.85,+,1.05,5.42E-01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),28,3,2.85,+,1.05,5.42E-01
developmental induction (GO:0031128),28,3,2.85,+,1.05,5.42E-01
organic acid biosynthetic process (GO:0016053),280,30,28.47,+,1.05,4.11E-01
heparan sulfate proteoglycan metabolic process (GO:0030201),28,3,2.85,+,1.05,5.42E-01
ketone biosynthetic process (GO:0042181),28,3,2.85,+,1.05,5.42E-01
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),28,3,2.85,+,1.05,5.42E-01
T-helper cell differentiation (GO:0042093),28,3,2.85,+,1.05,5.42E-01
cardiac muscle hypertrophy (GO:0003300),28,3,2.85,+,1.05,5.42E-01
regulation of mRNA metabolic process (GO:1903311),308,33,31.31,+,1.05,4.04E-01
glucose homeostasis (GO:0042593),187,20,19.01,+,1.05,4.40E-01
sensory perception of mechanical stimulus (GO:0050954),159,17,16.16,+,1.05,4.50E-01
positive regulation of cellular metabolic process (GO:0031325),3115,333,316.68,+,1.05,1.61E-01
nucleobase-containing compound biosynthetic process (GO:0034654),889,95,90.38,+,1.05,3.23E-01
positive regulation of cellular component biogenesis (GO:0044089),496,53,50.42,+,1.05,3.76E-01
defense response (GO:0006952),1189,127,120.88,+,1.05,2.94E-01
mitochondrial transport (GO:0006839),206,22,20.94,+,1.05,4.37E-01
regulation of oxidoreductase activity (GO:0051341),103,11,10.47,+,1.05,4.76E-01
aromatic compound biosynthetic process (GO:0019438),965,103,98.1,+,1.05,3.19E-01
positive regulation of kinase activity (GO:0033674),581,62,59.07,+,1.05,3.67E-01
regulation of muscle contraction (GO:0006937),150,16,15.25,+,1.05,4.58E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),150,16,15.25,+,1.05,4.58E-01
regulation of telomere maintenance (GO:0032204),75,8,7.62,+,1.05,4.94E-01
positive regulation of insulin secretion (GO:0032024),75,8,7.62,+,1.05,4.94E-01
organ growth (GO:0035265),75,8,7.62,+,1.05,4.94E-01
positive regulation of programmed cell death (GO:0043068),544,58,55.3,+,1.05,3.75E-01
regulation of mRNA catabolic process (GO:0061013),197,21,20.03,+,1.05,4.43E-01
locomotion (GO:0040011),1192,127,121.18,+,1.05,3.04E-01
neutrophil degranulation (GO:0043312),451,48,45.85,+,1.05,3.94E-01
cellular response to topologically incorrect protein (GO:0035967),141,15,14.33,+,1.05,4.65E-01
T cell differentiation (GO:0030217),141,15,14.33,+,1.05,4.65E-01
regulation of pH (GO:0006885),94,10,9.56,+,1.05,4.86E-01
plasma lipoprotein particle organization (GO:0071827),47,5,4.78,+,1.05,5.20E-01
mitochondrion localization (GO:0051646),47,5,4.78,+,1.05,5.20E-01
regulation of lyase activity (GO:0051339),47,5,4.78,+,1.05,5.20E-01
meiosis I cell cycle process (GO:0061982),94,10,9.56,+,1.05,4.86E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205),47,5,4.78,+,1.05,5.20E-01
collagen fibril organization (GO:0030199),47,5,4.78,+,1.05,5.20E-01
positive regulation of apoptotic process (GO:0043065),536,57,54.49,+,1.05,3.83E-01
regulation of cellular protein localization (GO:1903827),536,57,54.49,+,1.05,3.83E-01
ion transmembrane transport (GO:0034220),837,89,85.09,+,1.05,3.47E-01
regulation of secretion (GO:0051046),649,69,65.98,+,1.05,3.69E-01
positive regulation of intracellular signal transduction (GO:1902533),950,101,96.58,+,1.05,3.36E-01
regulation of axonogenesis (GO:0050770),160,17,16.27,+,1.05,4.61E-01
response to external stimulus (GO:0009605),2203,234,223.96,+,1.04,2.45E-01
inorganic anion transmembrane transport (GO:0098661),113,12,11.49,+,1.04,4.79E-01
regulation of ATP metabolic process (GO:1903578),113,12,11.49,+,1.04,4.79E-01
metal ion homeostasis (GO:0055065),584,62,59.37,+,1.04,3.82E-01
cellular response to organic cyclic compound (GO:0071407),471,50,47.88,+,1.04,3.98E-01
regulation of localization (GO:0032879),2600,276,264.32,+,1.04,2.26E-01
negative regulation of transport (GO:0051051),424,45,43.1,+,1.04,4.06E-01
regulation of cell adhesion (GO:0030155),688,73,69.94,+,1.04,3.71E-01
vesicle cytoskeletal trafficking (GO:0099518),66,7,6.71,+,1.04,5.06E-01
mRNA 3'-end processing (GO:0031124),66,7,6.71,+,1.04,5.06E-01
alpha-beta T cell activation (GO:0046631),66,7,6.71,+,1.04,5.06E-01
muscle organ development (GO:0007517),264,28,26.84,+,1.04,4.37E-01
localization of cell (GO:0051674),962,102,97.8,+,1.04,3.45E-01
cell motility (GO:0048870),962,102,97.8,+,1.04,3.45E-01
regulation of supramolecular fiber organization (GO:1902903),349,37,35.48,+,1.04,4.21E-01
vasculature development (GO:0001944),500,53,50.83,+,1.04,3.98E-01
mesonephric tubule development (GO:0072164),85,9,8.64,+,1.04,4.96E-01
mesonephric epithelium development (GO:0072163),85,9,8.64,+,1.04,4.96E-01
positive regulation of interleukin-6 production (GO:0032755),85,9,8.64,+,1.04,4.96E-01
neural crest cell differentiation (GO:0014033),85,9,8.64,+,1.04,4.96E-01
regulation of membrane permeability (GO:0090559),85,9,8.64,+,1.04,4.96E-01
cell morphogenesis (GO:0000902),680,72,69.13,+,1.04,3.79E-01
mitochondrial transmembrane transport (GO:1990542),85,9,8.64,+,1.04,4.96E-01
positive regulation of cell motility (GO:2000147),510,54,51.85,+,1.04,4.00E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),85,9,8.64,+,1.04,4.96E-01
transport across blood-brain barrier (GO:0150104),85,9,8.64,+,1.04,4.96E-01
gland development (GO:0048732),397,42,40.36,+,1.04,4.18E-01
cellular aromatic compound metabolic process (GO:0006725),2581,273,262.39,+,1.04,2.47E-01
fat cell differentiation (GO:0045444),104,11,10.57,+,1.04,4.88E-01
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),104,11,10.57,+,1.04,4.88E-01
heterocycle biosynthetic process (GO:0018130),955,101,97.09,+,1.04,3.56E-01
hemopoiesis (GO:0030097),558,59,56.73,+,1.04,3.98E-01
cellular response to tumor necrosis factor (GO:0071356),227,24,23.08,+,1.04,4.51E-01
regulation of ion transmembrane transporter activity (GO:0032412),246,26,25.01,+,1.04,4.48E-01
positive regulation of cell migration (GO:0030335),492,52,50.02,+,1.04,4.07E-01
cellular component assembly (GO:0022607),2110,223,214.51,+,1.04,2.77E-01
chemical homeostasis (GO:0048878),1060,112,107.76,+,1.04,3.50E-01
rhythmic process (GO:0048511),265,28,26.94,+,1.04,4.44E-01
striated muscle tissue development (GO:0014706),265,28,26.94,+,1.04,4.44E-01
sensory perception of sound (GO:0007605),142,15,14.44,+,1.04,4.76E-01
protein processing (GO:0016485),161,17,16.37,+,1.04,4.71E-01
regulation of adaptive immune response (GO:0002819),161,17,16.37,+,1.04,4.71E-01
positive regulation of protein transport (GO:0051222),341,36,34.67,+,1.04,4.33E-01
positive regulation of macromolecule metabolic process (GO:0010604),3269,345,332.33,+,1.04,2.27E-01
defense response to bacterium (GO:0042742),218,23,22.16,+,1.04,4.57E-01
catabolic process (GO:0009056),1877,198,190.82,+,1.04,3.01E-01
negative regulation of immune system process (GO:0002683),493,52,50.12,+,1.04,4.13E-01
positive regulation of cell activation (GO:0050867),332,35,33.75,+,1.04,4.37E-01
positive regulation of metabolic process (GO:0009893),3539,373,359.78,+,1.04,2.23E-01
positive regulation of cellular component movement (GO:0051272),522,55,53.07,+,1.04,4.13E-01
negative regulation of cell differentiation (GO:0045596),598,63,60.79,+,1.04,4.04E-01
purine ribonucleoside biosynthetic process (GO:0046129),19,2,1.93,+,1.04,5.75E-01
regulation of toll-like receptor 4 signaling pathway (GO:0034143),19,2,1.93,+,1.04,5.75E-01
production of molecular mediator involved in inflammatory response (GO:0002532),19,2,1.93,+,1.04,5.75E-01
Notch signaling pathway (GO:0007219),114,12,11.59,+,1.04,4.91E-01
vitamin metabolic process (GO:0006766),114,12,11.59,+,1.04,4.91E-01
"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",19,2,1.93,+,1.04,5.75E-01
blastocyst development (GO:0001824),95,10,9.66,+,1.04,4.99E-01
auditory receptor cell development (GO:0060117),19,2,1.93,+,1.04,5.75E-01
protein targeting to peroxisome (GO:0006625),76,8,7.73,+,1.04,5.08E-01
glomerulus vasculature development (GO:0072012),19,2,1.93,+,1.04,5.75E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),19,2,1.93,+,1.04,5.75E-01
positive regulation of interleukin-12 production (GO:0032735),38,4,3.86,+,1.04,5.40E-01
neural crest cell development (GO:0014032),76,8,7.73,+,1.04,5.08E-01
sensory organ morphogenesis (GO:0090596),247,26,25.11,+,1.04,4.56E-01
carbohydrate metabolic process (GO:0005975),437,46,44.43,+,1.04,4.26E-01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),38,4,3.86,+,1.04,5.40E-01
histone H3 deacetylation (GO:0070932),19,2,1.93,+,1.04,5.75E-01
negative regulation of interleukin-10 production (GO:0032693),19,2,1.93,+,1.04,5.75E-01
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),19,2,1.93,+,1.04,5.75E-01
positive regulation of actin cytoskeleton reorganization (GO:2000251),19,2,1.93,+,1.04,5.75E-01
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),38,4,3.86,+,1.04,5.40E-01
regulation of DNA repair (GO:0006282),114,12,11.59,+,1.04,4.91E-01
synaptic membrane adhesion (GO:0099560),19,2,1.93,+,1.04,5.75E-01
negative regulation of transporter activity (GO:0032410),76,8,7.73,+,1.04,5.08E-01
negative regulation of multi-organism process (GO:0043901),19,2,1.93,+,1.04,5.75E-01
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),19,2,1.93,+,1.04,5.75E-01
protein localization to mitochondrion (GO:0070585),76,8,7.73,+,1.04,5.08E-01
regulation of lipid catabolic process (GO:0050994),57,6,5.79,+,1.04,5.21E-01
negative regulation of telomere maintenance via telomerase (GO:0032211),19,2,1.93,+,1.04,5.75E-01
regulation of coagulation (GO:0050818),76,8,7.73,+,1.04,5.08E-01
catechol-containing compound biosynthetic process (GO:0009713),19,2,1.93,+,1.04,5.75E-01
negative regulation of T cell apoptotic process (GO:0070233),19,2,1.93,+,1.04,5.75E-01
negative regulation of purine nucleotide metabolic process (GO:1900543),19,2,1.93,+,1.04,5.75E-01
detection of other organism (GO:0098543),19,2,1.93,+,1.04,5.75E-01
semi-lunar valve development (GO:1905314),38,4,3.86,+,1.04,5.40E-01
"CD4-positive, alpha-beta T cell differentiation (GO:0043367)",38,4,3.86,+,1.04,5.40E-01
intraciliary transport involved in cilium assembly (GO:0035735),38,4,3.86,+,1.04,5.40E-01
response to water (GO:0009415),19,2,1.93,+,1.04,5.75E-01
phosphatidylserine acyl-chain remodeling (GO:0036150),19,2,1.93,+,1.04,5.75E-01
base conversion or substitution editing (GO:0016553),19,2,1.93,+,1.04,5.75E-01
glial cell activation (GO:0061900),38,4,3.86,+,1.04,5.40E-01
"DNA damage response, detection of DNA damage (GO:0042769)",38,4,3.86,+,1.04,5.40E-01
regulation of amyloid-beta clearance (GO:1900221),19,2,1.93,+,1.04,5.75E-01
deoxyribonucleotide catabolic process (GO:0009264),19,2,1.93,+,1.04,5.75E-01
vesicle cargo loading (GO:0035459),19,2,1.93,+,1.04,5.75E-01
aromatic amino acid family metabolic process (GO:0009072),38,4,3.86,+,1.04,5.40E-01
negative regulation of protein dephosphorylation (GO:0035308),57,6,5.79,+,1.04,5.21E-01
ribonucleoside biosynthetic process (GO:0042455),19,2,1.93,+,1.04,5.75E-01
purine nucleoside biosynthetic process (GO:0042451),19,2,1.93,+,1.04,5.75E-01
catecholamine biosynthetic process (GO:0042423),19,2,1.93,+,1.04,5.75E-01
regulation of insulin receptor signaling pathway (GO:0046626),57,6,5.79,+,1.04,5.21E-01
positive regulation of smooth muscle cell migration (GO:0014911),38,4,3.86,+,1.04,5.40E-01
extrinsic apoptotic signaling pathway (GO:0097191),95,10,9.66,+,1.04,4.99E-01
actin polymerization or depolymerization (GO:0008154),57,6,5.79,+,1.04,5.21E-01
positive regulation of growth (GO:0045927),247,26,25.11,+,1.04,4.56E-01
positive regulation of DNA recombination (GO:0045911),38,4,3.86,+,1.04,5.40E-01
establishment of protein localization to peroxisome (GO:0072663),76,8,7.73,+,1.04,5.08E-01
protein localization to peroxisome (GO:0072662),76,8,7.73,+,1.04,5.08E-01
positive regulation of T cell cytokine production (GO:0002726),19,2,1.93,+,1.04,5.75E-01
morphogenesis of an epithelial fold (GO:0060571),19,2,1.93,+,1.04,5.75E-01
purine-containing compound transmembrane transport (GO:0072530),19,2,1.93,+,1.04,5.75E-01
response to organic substance (GO:0010033),2804,295,285.06,+,1.03,2.68E-01
regulation of immune system process (GO:0002682),1445,152,146.9,+,1.03,3.42E-01
regulation of protein serine/threonine kinase activity (GO:0071900),466,49,47.37,+,1.03,4.25E-01
regulation of protein modification process (GO:0031399),1731,182,175.98,+,1.03,3.27E-01
positive regulation of cellular component organization (GO:0051130),1075,113,109.29,+,1.03,3.70E-01
epithelial cell differentiation (GO:0030855),590,62,59.98,+,1.03,4.13E-01
cellular response to organic substance (GO:0071310),2199,231,223.55,+,1.03,3.06E-01
positive regulation of gene expression (GO:0010628),2123,223,215.83,+,1.03,3.11E-01
oxidation-reduction process (GO:0055114),857,90,87.12,+,1.03,3.91E-01
nucleobase-containing compound metabolic process (GO:0006139),2362,248,240.12,+,1.03,3.01E-01
lipid metabolic process (GO:0006629),1105,116,112.34,+,1.03,3.74E-01
positive regulation of locomotion (GO:0040017),524,55,53.27,+,1.03,4.24E-01
transmembrane transport (GO:0055085),1172,123,119.15,+,1.03,3.70E-01
positive regulation of nitrogen compound metabolic process (GO:0051173),2945,309,299.39,+,1.03,2.79E-01
regulation of calcium ion transmembrane transport (GO:1903169),143,15,14.54,+,1.03,4.87E-01
regulation of immune response (GO:0050776),925,97,94.04,+,1.03,3.91E-01
positive regulation of cellular catabolic process (GO:0031331),372,39,37.82,+,1.03,4.45E-01
small GTPase mediated signal transduction (GO:0007264),248,26,25.21,+,1.03,4.64E-01
DNA-dependent DNA replication (GO:0006261),124,13,12.61,+,1.03,4.93E-01
endocrine system development (GO:0035270),124,13,12.61,+,1.03,4.93E-01
negative regulation of cellular catabolic process (GO:0031330),229,24,23.28,+,1.03,4.68E-01
immune response (GO:0006955),1479,155,150.36,+,1.03,3.58E-01
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),1737,182,176.59,+,1.03,3.45E-01
heterocycle metabolic process (GO:0046483),2539,266,258.12,+,1.03,3.06E-01
response to retinoic acid (GO:0032526),105,11,10.67,+,1.03,5.01E-01
ion transport (GO:0006811),1222,128,124.23,+,1.03,3.76E-01
DNA recombination (GO:0006310),191,20,19.42,+,1.03,4.78E-01
hemostasis (GO:0007599),277,29,28.16,+,1.03,4.62E-01
vascular transport (GO:0010232),86,9,8.74,+,1.03,5.10E-01
negative regulation of response to wounding (GO:1903035),86,9,8.74,+,1.03,5.10E-01
leukocyte proliferation (GO:0070661),86,9,8.74,+,1.03,5.10E-01
ncRNA transcription (GO:0098781),86,9,8.74,+,1.03,5.10E-01
regulation of cytokine production involved in immune response (GO:0002718),86,9,8.74,+,1.03,5.10E-01
regulation of cell growth (GO:0001558),392,41,39.85,+,1.03,4.49E-01
morphogenesis of a branching epithelium (GO:0061138),153,16,15.55,+,1.03,4.89E-01
negative regulation of cellular metabolic process (GO:0031324),2362,247,240.12,+,1.03,3.26E-01
cation homeostasis (GO:0055080),660,69,67.1,+,1.03,4.23E-01
single fertilization (GO:0007338),134,14,13.62,+,1.03,4.95E-01
positive regulation of response to wounding (GO:1903036),67,7,6.81,+,1.03,5.22E-01
regulation of interleukin-6 production (GO:0032675),134,14,13.62,+,1.03,4.95E-01
cellular response to steroid hormone stimulus (GO:0071383),134,14,13.62,+,1.03,4.95E-01
response to estradiol (GO:0032355),134,14,13.62,+,1.03,4.95E-01
positive regulation of protein localization to cell periphery (GO:1904377),67,7,6.81,+,1.03,5.22E-01
digestive system process (GO:0022600),67,7,6.81,+,1.03,5.22E-01
regulation of cell population proliferation (GO:0042127),1541,161,156.66,+,1.03,3.70E-01
multi-organism reproductive process (GO:0044703),900,94,91.5,+,1.03,4.09E-01
actin filament organization (GO:0007015),249,26,25.31,+,1.03,4.72E-01
nucleocytoplasmic transport (GO:0006913),230,24,23.38,+,1.03,4.77E-01
ion homeostasis (GO:0050801),738,77,75.03,+,1.03,4.24E-01
cellular catabolic process (GO:0044248),1639,171,166.62,+,1.03,3.72E-01
hematopoietic or lymphoid organ development (GO:0048534),604,63,61.4,+,1.03,4.36E-01
regulation of cell projection organization (GO:0031344),604,63,61.4,+,1.03,4.36E-01
cellular response to cytokine stimulus (GO:0071345),978,102,99.42,+,1.03,4.09E-01
cellular lipid metabolic process (GO:0044255),873,91,88.75,+,1.03,4.18E-01
cellular component organization or biogenesis (GO:0071840),5201,542,528.74,+,1.03,2.50E-01
organic cyclic compound biosynthetic process (GO:1901362),1094,114,111.22,+,1.03,4.06E-01
positive regulation of biological process (GO:0048518),5614,585,570.73,+,1.03,2.38E-01
chemical synaptic transmission (GO:0007268),384,40,39.04,+,1.02,4.60E-01
intracellular protein transmembrane transport (GO:0065002),48,5,4.88,+,1.02,5.38E-01
response to progesterone (GO:0032570),48,5,4.88,+,1.02,5.38E-01
export across plasma membrane (GO:0140115),48,5,4.88,+,1.02,5.38E-01
anterograde trans-synaptic signaling (GO:0098916),384,40,39.04,+,1.02,4.60E-01
endocrine process (GO:0050886),48,5,4.88,+,1.02,5.38E-01
neuromuscular process controlling balance (GO:0050885),48,5,4.88,+,1.02,5.38E-01
antigen receptor-mediated signaling pathway (GO:0050851),192,20,19.52,+,1.02,4.87E-01
establishment of spindle localization (GO:0051293),48,5,4.88,+,1.02,5.38E-01
regulation of cytokine secretion (GO:0050707),48,5,4.88,+,1.02,5.38E-01
positive regulation of epithelial to mesenchymal transition (GO:0010718),48,5,4.88,+,1.02,5.38E-01
regulation of proteolysis (GO:0030162),672,70,68.32,+,1.02,4.35E-01
positive regulation of T cell mediated immunity (GO:0002711),48,5,4.88,+,1.02,5.38E-01
negative regulation of protein phosphorylation (GO:0001933),394,41,40.05,+,1.02,4.62E-01
regulation of transport (GO:0051049),1701,177,172.93,+,1.02,3.83E-01
cellular metal ion homeostasis (GO:0006875),519,54,52.76,+,1.02,4.50E-01
glial cell differentiation (GO:0010001),173,18,17.59,+,1.02,4.93E-01
striated muscle cell development (GO:0055002),125,13,12.71,+,1.02,5.05E-01
response to tumor necrosis factor (GO:0034612),250,26,25.42,+,1.02,4.80E-01
cellular ion homeostasis (GO:0006873),606,63,61.61,+,1.02,4.46E-01
immune system development (GO:0002520),635,66,64.56,+,1.02,4.45E-01
nitrogen compound metabolic process (GO:0006807),6168,641,627.05,+,1.02,2.47E-01
positive regulation of response to stimulus (GO:0048584),1992,207,202.51,+,1.02,3.79E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),77,8,7.83,+,1.02,5.23E-01
regulation of glycolytic process (GO:0006110),77,8,7.83,+,1.02,5.23E-01
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),77,8,7.83,+,1.02,5.23E-01
regulation of phosphorus metabolic process (GO:0051174),1704,177,173.23,+,1.02,3.93E-01
regulation of biological quality (GO:0065008),3717,386,377.88,+,1.02,3.26E-01
cellular homeostasis (GO:0019725),838,87,85.19,+,1.02,4.36E-01
cellular response to chemical stimulus (GO:0070887),2718,282,276.32,+,1.02,3.64E-01
negative regulation of neurogenesis (GO:0050768),135,14,13.72,+,1.02,5.06E-01
positive regulation of cation transmembrane transport (GO:1904064),135,14,13.72,+,1.02,5.06E-01
positive regulation of cellular process (GO:0048522),5131,532,521.63,+,1.02,3.00E-01
regulation of signal transduction by p53 class mediator (GO:1901796),164,17,16.67,+,1.02,5.01E-01
positive regulation of endopeptidase activity (GO:0010950),164,17,16.67,+,1.02,5.01E-01
regulation of cell cycle G1/S phase transition (GO:1902806),164,17,16.67,+,1.02,5.01E-01
anatomical structure morphogenesis (GO:0009653),2036,211,206.98,+,1.02,3.94E-01
regulation of nitrogen compound metabolic process (GO:0051171),5202,539,528.84,+,1.02,3.04E-01
cellular macromolecule metabolic process (GO:0044260),4483,464,455.75,+,1.02,3.34E-01
bone development (GO:0060348),174,18,17.69,+,1.02,5.02E-01
cell maturation (GO:0048469),145,15,14.74,+,1.02,5.08E-01
actin-mediated cell contraction (GO:0070252),87,9,8.84,+,1.02,5.24E-01
regulation of cellular pH (GO:0030641),87,9,8.84,+,1.02,5.24E-01
positive regulation of epithelial cell migration (GO:0010634),145,15,14.74,+,1.02,5.08E-01
regulation of vasoconstriction (GO:0019229),58,6,5.9,+,1.02,5.38E-01
regulation of glial cell proliferation (GO:0060251),29,3,2.95,+,1.02,5.65E-01
alpha-beta T cell differentiation involved in immune response (GO:0002293),29,3,2.95,+,1.02,5.65E-01
alpha-beta T cell activation involved in immune response (GO:0002287),29,3,2.95,+,1.02,5.65E-01
positive regulation of calcium ion transport (GO:0051928),116,12,11.79,+,1.02,5.15E-01
modulation by host of viral process (GO:0044788),29,3,2.95,+,1.02,5.65E-01
regulation of transcription by RNA polymerase I (GO:0006356),29,3,2.95,+,1.02,5.65E-01
response to interleukin-4 (GO:0070670),29,3,2.95,+,1.02,5.65E-01
negative regulation of lymphocyte apoptotic process (GO:0070229),29,3,2.95,+,1.02,5.65E-01
purine ribonucleotide catabolic process (GO:0009154),29,3,2.95,+,1.02,5.65E-01
regulation of mitochondrial gene expression (GO:0062125),29,3,2.95,+,1.02,5.65E-01
regulation of neuroinflammatory response (GO:0150077),29,3,2.95,+,1.02,5.65E-01
liver regeneration (GO:0097421),29,3,2.95,+,1.02,5.65E-01
positive regulation of vascular endothelial growth factor production (GO:0010575),29,3,2.95,+,1.02,5.65E-01
striated muscle hypertrophy (GO:0014897),29,3,2.95,+,1.02,5.65E-01
actin filament-based movement (GO:0030048),116,12,11.79,+,1.02,5.15E-01
mammary gland epithelium development (GO:0061180),58,6,5.9,+,1.02,5.38E-01
positive regulation of steroid metabolic process (GO:0045940),29,3,2.95,+,1.02,5.65E-01
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),29,3,2.95,+,1.02,5.65E-01
phosphatidylethanolamine metabolic process (GO:0046337),29,3,2.95,+,1.02,5.65E-01
histone monoubiquitination (GO:0010390),29,3,2.95,+,1.02,5.65E-01
diol metabolic process (GO:0034311),29,3,2.95,+,1.02,5.65E-01
clathrin-dependent endocytosis (GO:0072583),29,3,2.95,+,1.02,5.65E-01
cellular response to DNA damage stimulus (GO:0006974),706,73,71.77,+,1.02,4.58E-01
regulation of phosphate metabolic process (GO:0019220),1703,176,173.13,+,1.02,4.21E-01
negative regulation of metabolic process (GO:0009892),2826,292,287.3,+,1.02,3.90E-01
lipid biosynthetic process (GO:0008610),552,57,56.12,+,1.02,4.71E-01
cellular cation homeostasis (GO:0030003),591,61,60.08,+,1.02,4.70E-01
establishment of localization in cell (GO:0051649),2151,222,218.67,+,1.02,4.15E-01
lipid transport (GO:0006869),281,29,28.57,+,1.02,4.93E-01
negative regulation of catabolic process (GO:0009895),281,29,28.57,+,1.02,4.93E-01
branching morphogenesis of an epithelial tube (GO:0048754),126,13,12.81,+,1.01,5.16E-01
organic cyclic compound metabolic process (GO:1901360),2802,289,284.86,+,1.01,4.04E-01
regulation of cysteine-type endopeptidase activity (GO:2000116),223,23,22.67,+,1.01,5.01E-01
negative regulation of hydrolase activity (GO:0051346),417,43,42.39,+,1.01,4.84E-01
cellular metabolic process (GO:0044237),6769,698,688.15,+,1.01,3.20E-01
regulation of protein localization (GO:0032880),902,93,91.7,+,1.01,4.59E-01
cellular response to BMP stimulus (GO:0071773),97,10,9.86,+,1.01,5.25E-01
response to BMP (GO:0071772),97,10,9.86,+,1.01,5.25E-01
neuromuscular process (GO:0050905),97,10,9.86,+,1.01,5.25E-01
positive regulation of cellular biosynthetic process (GO:0031328),1815,187,184.52,+,1.01,4.35E-01
ribonucleoprotein complex assembly (GO:0022618),165,17,16.77,+,1.01,5.11E-01
response to stimulus (GO:0050896),7154,737,727.29,+,1.01,3.24E-01
cellular response to stimulus (GO:0051716),5767,594,586.28,+,1.01,3.54E-01
regulation of MAP kinase activity (GO:0043405),301,31,30.6,+,1.01,4.96E-01
regulation of growth (GO:0040008),641,66,65.17,+,1.01,4.75E-01
positive regulation of signal transduction (GO:0009967),1457,150,148.12,+,1.01,4.48E-01
protein localization to endoplasmic reticulum (GO:0070972),136,14,13.83,+,1.01,5.17E-01
negative regulation of ion transmembrane transporter activity (GO:0032413),68,7,6.91,+,1.01,5.38E-01
establishment of protein localization to membrane (GO:0090150),272,28,27.65,+,1.01,4.99E-01
pancreas development (GO:0031016),68,7,6.91,+,1.01,5.38E-01
regulation of molecular function (GO:0065009),2779,286,282.52,+,1.01,4.20E-01
cellular response to endogenous stimulus (GO:0071495),1069,110,108.68,+,1.01,4.62E-01
regulation of apoptotic process (GO:0042981),1361,140,138.36,+,1.01,4.55E-01
cellular response to hormone stimulus (GO:0032870),496,51,50.42,+,1.01,4.87E-01
response to calcium ion (GO:0051592),146,15,14.84,+,1.01,5.19E-01
transport along microtubule (GO:0010970),146,15,14.84,+,1.01,5.19E-01
positive regulation of RNA metabolic process (GO:0051254),1587,163,161.34,+,1.01,4.57E-01
cellular component organization (GO:0016043),5005,514,508.82,+,1.01,4.00E-01
primary metabolic process (GO:0044238),6575,675,668.42,+,1.01,3.80E-01
regulation of programmed cell death (GO:0043067),1393,143,141.61,+,1.01,4.64E-01
organic substance metabolic process (GO:0071704),6967,715,708.28,+,1.01,3.78E-01
regulation of primary metabolic process (GO:0080090),5371,551,546.02,+,1.01,4.06E-01
negative regulation of cellular process (GO:0048523),4465,458,453.92,+,1.01,4.20E-01
regulation of activated T cell proliferation (GO:0046006),39,4,3.96,+,1.01,5.60E-01
cerebellum morphogenesis (GO:0021587),39,4,3.96,+,1.01,5.60E-01
negative regulation of cytokine production (GO:0001818),273,28,27.75,+,1.01,5.07E-01
glycosyl compound catabolic process (GO:1901658),39,4,3.96,+,1.01,5.60E-01
camera-type eye morphogenesis (GO:0048593),117,12,11.89,+,1.01,5.27E-01
vitamin transport (GO:0051180),39,4,3.96,+,1.01,5.60E-01
regulation of JUN kinase activity (GO:0043506),78,8,7.93,+,1.01,5.37E-01
negative regulation of defense response (GO:0031348),312,32,31.72,+,1.01,5.04E-01
histone ubiquitination (GO:0016574),39,4,3.96,+,1.01,5.60E-01
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",78,8,7.93,+,1.01,5.37E-01
regulation of natural killer cell mediated cytotoxicity (GO:0042269),39,4,3.96,+,1.01,5.60E-01
divalent inorganic cation transport (GO:0072511),273,28,27.75,+,1.01,5.07E-01
anterior/posterior pattern specification (GO:0009952),195,20,19.82,+,1.01,5.14E-01
homeostatic process (GO:0042592),1560,160,158.59,+,1.01,4.65E-01
positive regulation of biosynthetic process (GO:0009891),1843,189,187.36,+,1.01,4.61E-01
establishment of localization (GO:0051234),4136,424,420.47,+,1.01,4.30E-01
regulation of macromolecule metabolic process (GO:0060255),5728,587,582.32,+,1.01,4.14E-01
macromolecule metabolic process (GO:0043170),5505,564,559.65,+,1.01,4.20E-01
cellular protein metabolic process (GO:0044267),3340,342,339.55,+,1.01,4.50E-01
modulation of process of other organism (GO:0035821),127,13,12.91,+,1.01,5.27E-01
cytosolic transport (GO:0016482),127,13,12.91,+,1.01,5.27E-01
positive regulation of cell communication (GO:0010647),1612,165,163.88,+,1.01,4.75E-01
supramolecular fiber organization (GO:0097435),469,48,47.68,+,1.01,5.01E-01
regulation of lymphocyte proliferation (GO:0050670),215,22,21.86,+,1.01,5.17E-01
regulation of cellular metabolic process (GO:0031323),5561,569,565.34,+,1.01,4.34E-01
response to chemical (GO:0042221),3773,386,383.57,+,1.01,4.53E-01
response to fatty acid (GO:0070542),88,9,8.95,+,1.01,5.38E-01
RNA splicing (GO:0008380),352,36,35.78,+,1.01,5.08E-01
DNA metabolic process (GO:0006259),665,68,67.6,+,1.01,4.98E-01
macromolecule modification (GO:0043412),2973,304,302.24,+,1.01,4.65E-01
trans-synaptic signaling (GO:0099537),401,41,40.77,+,1.01,5.07E-01
regulation of kinase activity (GO:0043549),851,87,86.51,+,1.01,4.94E-01
positive regulation of response to biotic stimulus (GO:0002833),225,23,22.87,+,1.01,5.18E-01
transport (GO:0006810),4013,410,407.97,+,1,4.63E-01
regulation of protein localization to membrane (GO:1905475),186,19,18.91,+,1,5.23E-01
regulation of cellular localization (GO:0060341),793,81,80.62,+,1,4.98E-01
movement of cell or subcellular component (GO:0006928),1420,145,144.36,+,1,4.90E-01
apoptotic process (GO:0006915),852,87,86.62,+,1,4.99E-01
regulation of DNA metabolic process (GO:0051052),333,34,33.85,+,1,5.13E-01
animal organ morphogenesis (GO:0009887),921,94,93.63,+,1,4.99E-01
columnar/cuboidal epithelial cell differentiation (GO:0002065),98,10,9.96,+,1,5.38E-01
positive regulation of reactive oxygen species metabolic process (GO:2000379),98,10,9.96,+,1,5.38E-01
peptidyl-tyrosine modification (GO:0018212),147,15,14.94,+,1,5.29E-01
autophagosome assembly (GO:0000045),49,5,4.98,+,1,5.57E-01
regulation of cell morphogenesis (GO:0022604),294,30,29.89,+,1,5.17E-01
antibacterial humoral response (GO:0019731),49,5,4.98,+,1,5.57E-01
positive regulation of response to cytokine stimulus (GO:0060760),49,5,4.98,+,1,5.57E-01
negative regulation of DNA recombination (GO:0045910),49,5,4.98,+,1,5.57E-01
forebrain neuron differentiation (GO:0021879),49,5,4.98,+,1,5.57E-01
positive regulation of signaling (GO:0023056),1618,165,164.49,+,1,4.95E-01
wound healing (GO:0042060),412,42,41.88,+,1,5.14E-01
regulation of metabolic process (GO:0019222),6210,633,631.32,+,1,4.75E-01
regulation of cellular component size (GO:0032535),363,37,36.9,+,1,5.16E-01
regulation of cell differentiation (GO:0045595),1472,150,149.65,+,1,5.00E-01
interspecies interaction between organisms (GO:0044419),1826,186,185.63,+,1,5.00E-01
Golgi organization (GO:0007030),108,11,10.98,+,1,5.38E-01
intracellular signal transduction (GO:0035556),1571,160,159.71,+,1,5.03E-01
negative regulation of biological process (GO:0048519),4998,509,508.1,+,1,4.90E-01
muscle structure development (GO:0061061),442,45,44.93,+,1,5.17E-01
positive regulation of protein kinase B signaling (GO:0051897),167,17,16.98,+,1,5.31E-01
biological_process (GO:0008150),14865,1513,1511.2,+,1,4.59E-01
cellular developmental process (GO:0048869),3253,331,330.7,+,1,5.03E-01
SMAD protein signal transduction (GO:0060395),59,6,6,+,1,5.54E-01
positive regulation of apoptotic signaling pathway (GO:2001235),118,12,12,+,1,5.38E-01
positive regulation of intracellular protein transport (GO:0090316),177,18,17.99,+,1,5.31E-01
positive regulation of macromolecule biosynthetic process (GO:0010557),1711,174,173.94,+,1,5.10E-01
metabolic process (GO:0008152),7456,758,757.99,+,1,5.09E-01
multi-organism process (GO:0051704),964,98,98,-,1,5.27E-01
negative regulation of apoptotic process (GO:0043066),827,84,84.07,-,1,5.26E-01
negative regulation of neuron projection development (GO:0010977),128,13,13.01,-,1,5.72E-01
cell differentiation (GO:0030154),3201,325,325.42,-,1,5.05E-01
regulation of multicellular organismal process (GO:0051239),2522,256,256.39,-,1,5.06E-01
reproductive process (GO:0022414),1301,132,132.26,-,1,5.14E-01
sterol transport (GO:0015918),69,7,7.01,-,1,5.97E-01
antimicrobial humoral response (GO:0019730),138,14,14.03,-,1,5.67E-01
response to activity (GO:0014823),69,7,7.01,-,1,5.97E-01
membrane fusion (GO:0061025),138,14,14.03,-,1,5.67E-01
positive regulation of establishment of protein localization (GO:1904951),355,36,36.09,-,1,5.38E-01
regulation of mononuclear cell proliferation (GO:0032944),217,22,22.06,-,1,5.51E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045),148,15,15.05,-,1,5.63E-01
activation of MAPK activity (GO:0000187),148,15,15.05,-,1,5.63E-01
regulation of cell shape (GO:0008360),148,15,15.05,-,1,5.63E-01
regulation of signal transduction (GO:0009966),2833,287,288.01,-,1,4.90E-01
reproduction (GO:0000003),1303,132,132.46,-,1,5.06E-01
biological regulation (GO:0065007),10703,1084,1088.08,-,1,4.25E-01
phenol-containing compound metabolic process (GO:0018958),79,8,8.03,-,1,5.88E-01
cellular response to lipid (GO:0071396),474,48,48.19,-,1,5.27E-01
water homeostasis (GO:0030104),79,8,8.03,-,1,5.88E-01
organonitrogen compound metabolic process (GO:1901564),4770,483,484.93,-,1,4.71E-01
sulfur compound metabolic process (GO:0006790),326,33,33.14,-,1,5.36E-01
immune effector process (GO:0002252),899,91,91.39,-,1,5.11E-01
regulation of apoptotic signaling pathway (GO:2001233),336,34,34.16,-,1,5.35E-01
post-translational protein modification (GO:0043687),336,34,34.16,-,1,5.35E-01
regulation of plasma membrane bounded cell projection assembly (GO:0120032),168,17,17.08,-,1,5.56E-01
defense response to Gram-positive bacterium (GO:0050830),89,9,9.05,-,0.99,5.81E-01
locomotory behavior (GO:0007626),188,19,19.11,-,0.99,5.50E-01
regulation of cellular process (GO:0050794),9638,974,979.81,-,0.99,3.95E-01
regulation of protein localization to plasma membrane (GO:1903076),99,10,10.06,-,0.99,5.75E-01
negative regulation of angiogenesis (GO:0016525),99,10,10.06,-,0.99,5.75E-01
regulation of BMP signaling pathway (GO:0030510),99,10,10.06,-,0.99,5.75E-01
cellular process (GO:0009987),13152,1328,1337.05,-,0.99,2.95E-01
regulation of actin cytoskeleton organization (GO:0032956),337,34,34.26,-,0.99,5.28E-01
T cell activation (GO:0042110),228,23,23.18,-,0.99,5.40E-01
negative regulation of response to external stimulus (GO:0032102),466,47,47.37,-,0.99,5.17E-01
cellular chemical homeostasis (GO:0055082),704,71,71.57,-,0.99,5.04E-01
osteoblast differentiation (GO:0001649),119,12,12.1,-,0.99,5.65E-01
tRNA processing (GO:0008033),119,12,12.1,-,0.99,5.65E-01
regulation of actin filament-based process (GO:0032970),377,38,38.33,-,0.99,5.22E-01
lipid catabolic process (GO:0016042),268,27,27.25,-,0.99,5.32E-01
behavior (GO:0007610),546,55,55.51,-,0.99,5.08E-01
muscle tissue development (GO:0060537),278,28,28.26,-,0.99,5.30E-01
regulation of response to stimulus (GO:0048583),3795,382,385.81,-,0.99,4.26E-01
blood vessel development (GO:0001568),477,48,48.49,-,0.99,5.10E-01
macromolecule catabolic process (GO:0009057),954,96,96.99,-,0.99,4.86E-01
response to unfolded protein (GO:0006986),159,16,16.16,-,0.99,5.50E-01
regulation of cation transmembrane transport (GO:1904062),328,33,33.34,-,0.99,5.22E-01
positive regulation of developmental process (GO:0051094),1203,121,122.3,-,0.99,4.75E-01
cellular response to stress (GO:0033554),1621,163,164.79,-,0.99,4.62E-01
regulation of biological process (GO:0050789),10130,1018,1029.83,-,0.99,2.82E-01
regulation of multicellular organismal development (GO:2000026),1254,126,127.48,-,0.99,4.69E-01
negative regulation of programmed cell death (GO:0043069),846,85,86.01,-,0.99,4.84E-01
regulation of cellular macromolecule biosynthetic process (GO:2000112),3444,346,350.12,-,0.99,4.16E-01
negative regulation of apoptotic signaling pathway (GO:2001234),219,22,22.26,-,0.99,5.34E-01
Unclassified (UNCLASSIFIED),1385,139,140.8,-,0.99,4.59E-01
protein metabolic process (GO:0019538),3851,386,391.5,-,0.99,3.88E-01
regulation of cell communication (GO:0010646),3173,318,322.57,-,0.99,4.03E-01
carboxylic acid metabolic process (GO:0019752),799,80,81.23,-,0.98,4.74E-01
programmed cell death (GO:0012501),969,97,98.51,-,0.98,4.64E-01
regulation of cell death (GO:0010941),1519,152,154.42,-,0.98,4.40E-01
response to stress (GO:0006950),3229,323,328.27,-,0.98,3.87E-01
regulation of immunoglobulin production (GO:0002637),60,6,6.1,-,0.98,5.90E-01
cerebral cortex radially oriented cell migration (GO:0021799),30,3,3.05,-,0.98,6.36E-01
lung epithelium development (GO:0060428),30,3,3.05,-,0.98,6.36E-01
positive regulation of neutrophil migration (GO:1902624),30,3,3.05,-,0.98,6.36E-01
positive regulation of animal organ morphogenesis (GO:0110110),30,3,3.05,-,0.98,6.36E-01
positive regulation of protein localization to plasma membrane (GO:1903078),60,6,6.1,-,0.98,5.90E-01
neurotransmitter secretion (GO:0007269),90,9,9.15,-,0.98,5.68E-01
regulation of peptidyl-lysine acetylation (GO:2000756),60,6,6.1,-,0.98,5.90E-01
phosphatidylserine metabolic process (GO:0006658),30,3,3.05,-,0.98,6.36E-01
spindle organization (GO:0007051),210,21,21.35,-,0.98,5.27E-01
glutamate secretion (GO:0014047),30,3,3.05,-,0.98,6.36E-01
negative regulation of interleukin-1 production (GO:0032692),30,3,3.05,-,0.98,6.36E-01
signal release from synapse (GO:0099643),90,9,9.15,-,0.98,5.68E-01
cellular response to inorganic substance (GO:0071241),210,21,21.35,-,0.98,5.27E-01
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),30,3,3.05,-,0.98,6.36E-01
anatomical structure formation involved in morphogenesis (GO:0048646),840,84,85.4,-,0.98,4.67E-01
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",30,3,3.05,-,0.98,6.36E-01
long-chain fatty acid biosynthetic process (GO:0042759),30,3,3.05,-,0.98,6.36E-01
very long-chain fatty acid metabolic process (GO:0000038),30,3,3.05,-,0.98,6.36E-01
positive regulation of microtubule polymerization (GO:0031116),30,3,3.05,-,0.98,6.36E-01
ATP transport (GO:0015867),30,3,3.05,-,0.98,6.36E-01
positive regulation of alpha-beta T cell activation (GO:0046635),60,6,6.1,-,0.98,5.90E-01
proteoglycan biosynthetic process (GO:0030166),60,6,6.1,-,0.98,5.90E-01
deoxyribose phosphate metabolic process (GO:0019692),30,3,3.05,-,0.98,6.36E-01
motor neuron axon guidance (GO:0008045),30,3,3.05,-,0.98,6.36E-01
regulation of protein acetylation (GO:1901983),70,7,7.12,-,0.98,5.81E-01
negative regulation of nervous system development (GO:0051961),140,14,14.23,-,0.98,5.46E-01
cellular response to glucose stimulus (GO:0071333),70,7,7.12,-,0.98,5.81E-01
regulation of hematopoietic stem cell differentiation (GO:1902036),70,7,7.12,-,0.98,5.81E-01
multicellular organismal water homeostasis (GO:0050891),70,7,7.12,-,0.98,5.81E-01
regulation of glucose transmembrane transport (GO:0010827),70,7,7.12,-,0.98,5.81E-01
foregut morphogenesis (GO:0007440),10,1,1.02,-,0.98,7.30E-01
regulation of cell projection assembly (GO:0060491),170,17,17.28,-,0.98,5.37E-01
lung epithelial cell differentiation (GO:0060487),20,2,2.03,-,0.98,6.68E-01
positive regulation of osteoblast proliferation (GO:0033690),10,1,1.02,-,0.98,7.30E-01
regulation of monocyte differentiation (GO:0045655),20,2,2.03,-,0.98,6.68E-01
galactolipid metabolic process (GO:0019374),10,1,1.02,-,0.98,7.30E-01
ectoderm development (GO:0007398),20,2,2.03,-,0.98,6.68E-01
regulation of cell-cell adhesion mediated by integrin (GO:0033632),10,1,1.02,-,0.98,7.30E-01
positive regulation of mammary gland epithelial cell proliferation (GO:0033601),10,1,1.02,-,0.98,7.30E-01
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342),20,2,2.03,-,0.98,6.68E-01
carnitine shuttle (GO:0006853),10,1,1.02,-,0.98,7.30E-01
serotonin transport (GO:0006837),10,1,1.02,-,0.98,7.30E-01
ribonucleoprotein complex subunit organization (GO:0071826),170,17,17.28,-,0.98,5.37E-01
floor plate development (GO:0033504),10,1,1.02,-,0.98,7.30E-01
regulation of cytoplasmic translation (GO:2000765),20,2,2.03,-,0.98,6.68E-01
metanephric collecting duct development (GO:0072205),10,1,1.02,-,0.98,7.30E-01
immature B cell differentiation (GO:0002327),10,1,1.02,-,0.98,7.30E-01
gas homeostasis (GO:0033483),10,1,1.02,-,0.98,7.30E-01
positive regulation of phospholipid transport (GO:2001140),10,1,1.02,-,0.98,7.30E-01
response to yeast (GO:0001878),10,1,1.02,-,0.98,7.30E-01
protein targeting to membrane (GO:0006612),170,17,17.28,-,0.98,5.37E-01
somatic diversification of immune receptors (GO:0002200),40,4,4.07,-,0.98,6.16E-01
lysosomal transport (GO:0007041),100,10,10.17,-,0.98,5.62E-01
endoplasmic reticulum organization (GO:0007029),80,8,8.13,-,0.98,5.74E-01
cytoplasm organization (GO:0007028),10,1,1.02,-,0.98,7.30E-01
positive regulation of organic acid transport (GO:0032892),40,4,4.07,-,0.98,6.16E-01
multi-organism membrane organization (GO:0044803),10,1,1.02,-,0.98,7.30E-01
tryptophan catabolic process (GO:0006569),10,1,1.02,-,0.98,7.30E-01
"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",10,1,1.02,-,0.98,7.30E-01
positive regulation of cell junction assembly (GO:1901890),100,10,10.17,-,0.98,5.62E-01
negative regulation of fibrinolysis (GO:0051918),10,1,1.02,-,0.98,7.30E-01
regulation of mitochondrial depolarization (GO:0051900),20,2,2.03,-,0.98,6.68E-01
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),10,1,1.02,-,0.98,7.30E-01
regulation of cAMP-dependent protein kinase activity (GO:2000479),20,2,2.03,-,0.98,6.68E-01
negative regulation of delayed rectifier potassium channel activity (GO:1902260),10,1,1.02,-,0.98,7.30E-01
cellular response to X-ray (GO:0071481),10,1,1.02,-,0.98,7.30E-01
regulation of neuron maturation (GO:0014041),10,1,1.02,-,0.98,7.30E-01
killing of cells in other organism involved in symbiotic interaction (GO:0051883),20,2,2.03,-,0.98,6.68E-01
mesenchymal cell development (GO:0014031),80,8,8.13,-,0.98,5.74E-01
maintenance of epithelial cell apical/basal polarity (GO:0045199),10,1,1.02,-,0.98,7.30E-01
cytolysis by host of symbiont cells (GO:0051838),10,1,1.02,-,0.98,7.30E-01
response to vitamin E (GO:0033197),10,1,1.02,-,0.98,7.30E-01
cytolysis in other organism involved in symbiotic interaction (GO:0051801),10,1,1.02,-,0.98,7.30E-01
glycogen biosynthetic process (GO:0005978),20,2,2.03,-,0.98,6.68E-01
negative regulation of chemokine production (GO:0032682),20,2,2.03,-,0.98,6.68E-01
regulation of endothelial cell apoptotic process (GO:2000351),50,5,5.08,-,0.98,6.01E-01
skeletal system development (GO:0001501),460,46,46.76,-,0.98,4.94E-01
positive regulation of hepatocyte proliferation (GO:2000347),10,1,1.02,-,0.98,7.30E-01
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),10,1,1.02,-,0.98,7.30E-01
positive regulation of T-helper 17 type immune response (GO:2000318),10,1,1.02,-,0.98,7.30E-01
DNA dealkylation involved in DNA repair (GO:0006307),10,1,1.02,-,0.98,7.30E-01
thymic T cell selection (GO:0045061),20,2,2.03,-,0.98,6.68E-01
negative regulation of protein activation cascade (GO:2000258),10,1,1.02,-,0.98,7.30E-01
positive regulation of feeding behavior (GO:2000253),10,1,1.02,-,0.98,7.30E-01
positive regulation of flagellated sperm motility (GO:1902093),10,1,1.02,-,0.98,7.30E-01
stem cell development (GO:0048864),80,8,8.13,-,0.98,5.74E-01
negative regulation of fatty acid transport (GO:2000192),10,1,1.02,-,0.98,7.30E-01
negative regulation of blood vessel morphogenesis (GO:2000181),100,10,10.17,-,0.98,5.62E-01
detection of molecule of bacterial origin (GO:0032490),10,1,1.02,-,0.98,7.30E-01
positive regulation of cilium-dependent cell motility (GO:2000155),10,1,1.02,-,0.98,7.30E-01
IMP biosynthetic process (GO:0006188),10,1,1.02,-,0.98,7.30E-01
regulation of phospholipase A2 activity (GO:0032429),10,1,1.02,-,0.98,7.30E-01
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",10,1,1.02,-,0.98,7.30E-01
animal organ maturation (GO:0048799),20,2,2.03,-,0.98,6.68E-01
response to interleukin-18 (GO:0070673),10,1,1.02,-,0.98,7.30E-01
negative regulation of hormone biosynthetic process (GO:0032353),10,1,1.02,-,0.98,7.30E-01
positive regulation of chondrocyte differentiation (GO:0032332),20,2,2.03,-,0.98,6.68E-01
glycerol metabolic process (GO:0006071),20,2,2.03,-,0.98,6.68E-01
DNA double-strand break processing (GO:0000729),20,2,2.03,-,0.98,6.68E-01
regulation of collateral sprouting (GO:0048670),20,2,2.03,-,0.98,6.68E-01
regulation of cellular response to osmotic stress (GO:0106049),10,1,1.02,-,0.98,7.30E-01
negative regulation of inclusion body assembly (GO:0090084),10,1,1.02,-,0.98,7.30E-01
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),20,2,2.03,-,0.98,6.68E-01
regulation of uterine smooth muscle contraction (GO:0070472),10,1,1.02,-,0.98,7.30E-01
positive regulation of extracellular matrix assembly (GO:1901203),10,1,1.02,-,0.98,7.30E-01
primitive streak formation (GO:0090009),10,1,1.02,-,0.98,7.30E-01
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),10,1,1.02,-,0.98,7.30E-01
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),20,2,2.03,-,0.98,6.68E-01
regulation of vascular endothelial cell proliferation (GO:1905562),20,2,2.03,-,0.98,6.68E-01
regulation of DNA-templated transcription in response to stress (GO:0043620),110,11,11.18,-,0.98,5.57E-01
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),10,1,1.02,-,0.98,7.30E-01
asymmetric stem cell division (GO:0098722),10,1,1.02,-,0.98,7.30E-01
membrane biogenesis (GO:0044091),40,4,4.07,-,0.98,6.16E-01
regulation of deoxyribonuclease activity (GO:0032070),10,1,1.02,-,0.98,7.30E-01
response to cobalt ion (GO:0032025),10,1,1.02,-,0.98,7.30E-01
tetrahydrofolate interconversion (GO:0035999),10,1,1.02,-,0.98,7.30E-01
mRNA transport (GO:0051028),130,13,13.22,-,0.98,5.49E-01
positive regulation of lipoprotein lipase activity (GO:0051006),10,1,1.02,-,0.98,7.30E-01
regulation of lipoprotein lipase activity (GO:0051004),20,2,2.03,-,0.98,6.68E-01
regulation of protein localization to centrosome (GO:1904779),10,1,1.02,-,0.98,7.30E-01
negative regulation of epithelial cell differentiation (GO:0030857),40,4,4.07,-,0.98,6.16E-01
negative regulation of cyclase activity (GO:0031280),20,2,2.03,-,0.98,6.68E-01
signal transduction in response to DNA damage (GO:0042770),100,10,10.17,-,0.98,5.62E-01
protein localization to endosome (GO:0036010),10,1,1.02,-,0.98,7.30E-01
regulation of NLRP3 inflammasome complex assembly (GO:1900225),10,1,1.02,-,0.98,7.30E-01
glucan biosynthetic process (GO:0009250),20,2,2.03,-,0.98,6.68E-01
regulation of microtubule binding (GO:1904526),10,1,1.02,-,0.98,7.30E-01
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),20,2,2.03,-,0.98,6.68E-01
regulation of histone H3-K9 trimethylation (GO:1900112),10,1,1.02,-,0.98,7.30E-01
pyrimidine nucleoside salvage (GO:0043097),10,1,1.02,-,0.98,7.30E-01
cellular response to interferon-beta (GO:0035458),20,2,2.03,-,0.98,6.68E-01
proline transport (GO:0015824),10,1,1.02,-,0.98,7.30E-01
branched-chain amino acid transport (GO:0015803),10,1,1.02,-,0.98,7.30E-01
purine nucleoside monophosphate biosynthetic process (GO:0009127),20,2,2.03,-,0.98,6.68E-01
negative regulation of lipoprotein particle clearance (GO:0010985),10,1,1.02,-,0.98,7.30E-01
pyrimidine-containing compound salvage (GO:0008655),10,1,1.02,-,0.98,7.30E-01
RNA interference (GO:0016246),10,1,1.02,-,0.98,7.30E-01
regulation of macroautophagy (GO:0016241),150,15,15.25,-,0.98,5.42E-01
histone H3-K9 modification (GO:0061647),20,2,2.03,-,0.98,6.68E-01
"wound healing, spreading of epidermal cells (GO:0035313)",10,1,1.02,-,0.98,7.30E-01
cardiac muscle cell contraction (GO:0086003),40,4,4.07,-,0.98,6.16E-01
response to drug (GO:0042493),370,37,37.61,-,0.98,5.03E-01
indole-containing compound catabolic process (GO:0042436),10,1,1.02,-,0.98,7.30E-01
peristalsis (GO:0030432),10,1,1.02,-,0.98,7.30E-01
epidermis development (GO:0008544),340,34,34.56,-,0.98,5.07E-01
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),10,1,1.02,-,0.98,7.30E-01
intestinal cholesterol absorption (GO:0030299),10,1,1.02,-,0.98,7.30E-01
maintenance of gastrointestinal epithelium (GO:0030277),20,2,2.03,-,0.98,6.68E-01
cellular protein-containing complex localization (GO:0034629),20,2,2.03,-,0.98,6.68E-01
adult feeding behavior (GO:0008343),10,1,1.02,-,0.98,7.30E-01
cell communication by electrical coupling (GO:0010644),20,2,2.03,-,0.98,6.68E-01
programmed cell death involved in cell development (GO:0010623),10,1,1.02,-,0.98,7.30E-01
maintenance of apical/basal cell polarity (GO:0035090),10,1,1.02,-,0.98,7.30E-01
negative regulation of Rho protein signal transduction (GO:0035024),20,2,2.03,-,0.98,6.68E-01
protoporphyrinogen IX metabolic process (GO:0046501),10,1,1.02,-,0.98,7.30E-01
desmosome organization (GO:0002934),10,1,1.02,-,0.98,7.30E-01
snRNA 3'-end processing (GO:0034472),20,2,2.03,-,0.98,6.68E-01
labyrinthine layer morphogenesis (GO:0060713),20,2,2.03,-,0.98,6.68E-01
intraciliary transport (GO:0042073),50,5,5.08,-,0.98,6.01E-01
positive regulation of striated muscle contraction (GO:0045989),10,1,1.02,-,0.98,7.30E-01
negative regulation of nucleotide metabolic process (GO:0045980),20,2,2.03,-,0.98,6.68E-01
positive regulation of synaptic vesicle recycling (GO:1903423),10,1,1.02,-,0.98,7.30E-01
visual behavior (GO:0007632),50,5,5.08,-,0.98,6.01E-01
regulation of secondary heart field cardioblast proliferation (GO:0003266),10,1,1.02,-,0.98,7.30E-01
chylomicron assembly (GO:0034378),10,1,1.02,-,0.98,7.30E-01
peptide secretion (GO:0002790),130,13,13.22,-,0.98,5.49E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),10,1,1.02,-,0.98,7.30E-01
hypothalamus development (GO:0021854),20,2,2.03,-,0.98,6.68E-01
positive regulation of dendritic spine morphogenesis (GO:0061003),20,2,2.03,-,0.98,6.68E-01
oxalate transport (GO:0019532),10,1,1.02,-,0.98,7.30E-01
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),80,8,8.13,-,0.98,5.74E-01
mitral valve morphogenesis (GO:0003183),10,1,1.02,-,0.98,7.30E-01
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),40,4,4.07,-,0.98,6.16E-01
indolalkylamine catabolic process (GO:0046218),10,1,1.02,-,0.98,7.30E-01
signaling (GO:0023052),4631,463,470.79,-,0.98,3.47E-01
cell communication (GO:0007154),4706,470,478.42,-,0.98,3.35E-01
positive regulation of response to external stimulus (GO:0032103),471,47,47.88,-,0.98,4.87E-01
negative regulation of cell death (GO:0060548),932,93,94.75,-,0.98,4.54E-01
signal transduction (GO:0007165),4300,429,437.14,-,0.98,3.36E-01
synaptic signaling (GO:0099536),421,42,42.8,-,0.98,4.91E-01
defense response to other organism (GO:0098542),822,82,83.57,-,0.98,4.59E-01
regulation of signaling (GO:0023051),3208,320,326.13,-,0.98,3.66E-01
cell development (GO:0048468),1535,153,156.05,-,0.98,4.19E-01
positive regulation of cell death (GO:0010942),602,60,61.2,-,0.98,4.72E-01
cell population proliferation (GO:0008283),462,46,46.97,-,0.98,4.82E-01
cell surface receptor signaling pathway (GO:0007166),2180,217,221.62,-,0.98,3.86E-01
response to oxygen-containing compound (GO:1901700),1488,148,151.27,-,0.98,4.11E-01
regulation of macromolecule biosynthetic process (GO:0010556),3529,351,358.76,-,0.98,3.34E-01
nervous system process (GO:0050877),976,97,99.22,-,0.98,4.35E-01
morphogenesis of a branching structure (GO:0001763),161,16,16.37,-,0.98,5.29E-01
multicellular organism reproduction (GO:0032504),755,75,76.75,-,0.98,4.49E-01
cellular protein modification process (GO:0006464),2779,276,282.52,-,0.98,3.49E-01
protein modification process (GO:0036211),2779,276,282.52,-,0.98,3.49E-01
sensory perception (GO:0007600),584,58,59.37,-,0.98,4.62E-01
negative regulation of phosphorylation (GO:0042326),433,43,44.02,-,0.98,4.78E-01
blood coagulation (GO:0007596),272,27,27.65,-,0.98,5.01E-01
mitochondrion organization (GO:0007005),403,40,40.97,-,0.98,4.80E-01
ossification (GO:0001503),252,25,25.62,-,0.98,5.03E-01
methylation (GO:0032259),252,25,25.62,-,0.98,5.03E-01
steroid biosynthetic process (GO:0006694),121,12,12.3,-,0.98,5.41E-01
cell-cell junction assembly (GO:0007043),121,12,12.3,-,0.98,5.41E-01
developmental process (GO:0032502),5215,517,530.16,-,0.98,2.53E-01
negative regulation of protein modification process (GO:0031400),565,56,57.44,-,0.97,4.58E-01
formation of primary germ layer (GO:0001704),111,11,11.28,-,0.97,5.45E-01
negative regulation of protein kinase activity (GO:0006469),222,22,22.57,-,0.97,5.08E-01
regulation of purine nucleotide metabolic process (GO:1900542),111,11,11.28,-,0.97,5.45E-01
regulation of system process (GO:0044057),545,54,55.41,-,0.97,4.59E-01
innate immune response (GO:0045087),646,64,65.67,-,0.97,4.49E-01
small molecule biosynthetic process (GO:0044283),535,53,54.39,-,0.97,4.60E-01
multicellular organismal reproductive process (GO:0048609),737,73,74.92,-,0.97,4.40E-01
negative regulation of developmental process (GO:0051093),828,82,84.18,-,0.97,4.32E-01
regulation of gene expression (GO:0010468),4322,428,439.38,-,0.97,2.73E-01
positive regulation of cytoskeleton organization (GO:0051495),202,20,20.54,-,0.97,5.11E-01
negative regulation of vasculature development (GO:1901343),101,10,10.27,-,0.97,5.49E-01
response to mechanical stimulus (GO:0009612),202,20,20.54,-,0.97,5.11E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),202,20,20.54,-,0.97,5.11E-01
positive regulation of endocytosis (GO:0045807),101,10,10.27,-,0.97,5.49E-01
localization (GO:0051179),5165,511,525.08,-,0.97,2.37E-01
multicellular organismal process (GO:0032501),6025,596,612.51,-,0.97,2.08E-01
coagulation (GO:0050817),273,27,27.75,-,0.97,4.93E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),91,9,9.25,-,0.97,5.54E-01
positive regulation of endothelial cell proliferation (GO:0001938),91,9,9.25,-,0.97,5.54E-01
regulation of alpha-beta T cell activation (GO:0046634),91,9,9.25,-,0.97,5.54E-01
positive regulation of transport (GO:0051050),890,88,90.48,-,0.97,4.21E-01
organonitrogen compound catabolic process (GO:1901565),971,96,98.71,-,0.97,4.15E-01
cell death (GO:0008219),1002,99,101.86,-,0.97,4.10E-01
immune system process (GO:0002376),2318,229,235.65,-,0.97,3.35E-01
tube development (GO:0035295),820,81,83.36,-,0.97,4.23E-01
metanephros development (GO:0001656),81,8,8.23,-,0.97,5.60E-01
epidermal cell differentiation (GO:0009913),243,24,24.7,-,0.97,4.97E-01
regulation of cellular biosynthetic process (GO:0031326),3676,363,373.71,-,0.97,2.75E-01
embryonic morphogenesis (GO:0048598),547,54,55.61,-,0.97,4.48E-01
angiogenesis (GO:0001525),304,30,30.91,-,0.97,4.82E-01
positive regulation of ion transmembrane transport (GO:0034767),152,15,15.45,-,0.97,5.22E-01
negative regulation of multicellular organismal process (GO:0051241),973,96,98.92,-,0.97,4.07E-01
organelle organization (GO:0006996),3132,309,318.4,-,0.97,2.91E-01
regulation of epithelial cell migration (GO:0010632),223,22,22.67,-,0.97,4.99E-01
nuclear export (GO:0051168),142,14,14.44,-,0.97,5.24E-01
negative regulation of protein ubiquitination (GO:0031397),71,7,7.22,-,0.97,5.66E-01
ATP-dependent chromatin remodeling (GO:0043044),71,7,7.22,-,0.97,5.66E-01
establishment of protein localization to mitochondrion (GO:0072655),71,7,7.22,-,0.97,5.66E-01
vesicle-mediated transport (GO:0016192),1684,166,171.2,-,0.97,3.56E-01
positive regulation of synapse assembly (GO:0051965),61,6,6.2,-,0.97,5.74E-01
cellular response to amino acid stimulus (GO:0071230),61,6,6.2,-,0.97,5.74E-01
neural nucleus development (GO:0048857),61,6,6.2,-,0.97,5.74E-01
apical junction assembly (GO:0043297),61,6,6.2,-,0.97,5.74E-01
cardiac muscle tissue morphogenesis (GO:0055008),61,6,6.2,-,0.97,5.74E-01
negative regulation of hormone secretion (GO:0046888),61,6,6.2,-,0.97,5.74E-01
mRNA metabolic process (GO:0016071),610,60,62.01,-,0.97,4.30E-01
regulation of protein-containing complex assembly (GO:0043254),417,41,42.39,-,0.97,4.54E-01
regulation of inflammatory response (GO:0050727),458,45,46.56,-,0.97,4.46E-01
regulation of blood circulation (GO:1903522),275,27,27.96,-,0.97,4.77E-01
positive regulation of catabolic process (GO:0009896),438,43,44.53,-,0.97,4.47E-01
regulation of T cell proliferation (GO:0042129),163,16,16.57,-,0.97,5.09E-01
small molecule metabolic process (GO:0044281),1560,153,158.59,-,0.96,3.39E-01
regulation of lipid storage (GO:0010883),51,5,5.18,-,0.96,5.84E-01
response to endoplasmic reticulum stress (GO:0034976),245,24,24.91,-,0.96,4.80E-01
cellular macromolecule catabolic process (GO:0044265),827,81,84.07,-,0.96,3.93E-01
system development (GO:0048731),3952,387,401.77,-,0.96,2.07E-01
response to hexose (GO:0009746),143,14,14.54,-,0.96,5.13E-01
meiosis I (GO:0007127),92,9,9.35,-,0.96,5.41E-01
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),92,9,9.35,-,0.96,5.41E-01
protein O-linked glycosylation (GO:0006493),92,9,9.35,-,0.96,5.41E-01
regulation of innate immune response (GO:0045088),276,27,28.06,-,0.96,4.70E-01
positive regulation of peptidase activity (GO:0010952),184,18,18.71,-,0.96,4.96E-01
regulation of biosynthetic process (GO:0009889),3752,367,381.43,-,0.96,2.08E-01
phosphorylation (GO:0016310),1189,116,120.88,-,0.96,3.44E-01
positive regulation of translation (GO:0045727),123,12,12.5,-,0.96,5.18E-01
positive regulation of protein localization to membrane (GO:1905477),123,12,12.5,-,0.96,5.18E-01
regulation of neutrophil migration (GO:1902622),41,4,4.17,-,0.96,5.96E-01
photoreceptor cell maintenance (GO:0045494),41,4,4.17,-,0.96,5.96E-01
cellular response to insulin stimulus (GO:0032869),164,16,16.67,-,0.96,4.99E-01
"regulation of DNA-templated transcription, elongation (GO:0032784)",41,4,4.17,-,0.96,5.96E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),41,4,4.17,-,0.96,5.96E-01
regulation of actin cytoskeleton reorganization (GO:2000249),41,4,4.17,-,0.96,5.96E-01
cellular response to calcium ion (GO:0071277),82,8,8.34,-,0.96,5.46E-01
protein K63-linked ubiquitination (GO:0070534),41,4,4.17,-,0.96,5.96E-01
histone exchange (GO:0043486),41,4,4.17,-,0.96,5.96E-01
neuroinflammatory response (GO:0150076),41,4,4.17,-,0.96,5.96E-01
response to nicotine (GO:0035094),41,4,4.17,-,0.96,5.96E-01
regulation of natural killer cell mediated immunity (GO:0002715),41,4,4.17,-,0.96,5.96E-01
regulation of RNA metabolic process (GO:0051252),3322,324,337.72,-,0.96,2.11E-01
generation of precursor metabolites and energy (GO:0006091),359,35,36.5,-,0.96,4.44E-01
cellular localization (GO:0051641),2708,264,275.3,-,0.96,2.39E-01
regulation of developmental growth (GO:0048638),318,31,32.33,-,0.96,4.53E-01
regulation of cellular response to stress (GO:0080135),636,62,64.66,-,0.96,3.99E-01
"positive regulation of transcription, DNA-templated (GO:0045893)",1426,139,144.97,-,0.96,3.21E-01
response to virus (GO:0009615),277,27,28.16,-,0.96,4.62E-01
positive regulation of nucleic acid-templated transcription (GO:1903508),1498,146,152.29,-,0.96,3.14E-01
vesicle localization (GO:0051648),195,19,19.82,-,0.96,4.86E-01
positive regulation of leukocyte differentiation (GO:1902107),154,15,15.66,-,0.96,5.01E-01
positive regulation of hemopoiesis (GO:1903708),154,15,15.66,-,0.96,5.01E-01
male sex differentiation (GO:0046661),154,15,15.66,-,0.96,5.01E-01
positive regulation of RNA biosynthetic process (GO:1902680),1499,146,152.39,-,0.96,3.11E-01
cellular response to oxygen-containing compound (GO:1901701),996,97,101.25,-,0.96,3.55E-01
divalent metal ion transport (GO:0070838),267,26,27.14,-,0.96,4.63E-01
nitrogen compound transport (GO:0071705),1674,163,170.18,-,0.96,2.97E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219),3554,346,361.31,-,0.96,1.89E-01
regulation of nucleotide metabolic process (GO:0006140),113,11,11.49,-,0.96,5.21E-01
positive regulation of supramolecular fiber organization (GO:1902905),185,18,18.81,-,0.96,4.87E-01
positive regulation of secretion (GO:0051047),329,32,33.45,-,0.96,4.45E-01
regulation of double-strand break repair (GO:2000779),72,7,7.32,-,0.96,5.51E-01
fatty acid metabolic process (GO:0006631),288,28,29.28,-,0.96,4.54E-01
peptidyl-tyrosine phosphorylation (GO:0018108),144,14,14.64,-,0.96,5.03E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775),72,7,7.32,-,0.96,5.51E-01
learning (GO:0007612),144,14,14.64,-,0.96,5.03E-01
regulation of transcription by RNA polymerase II (GO:0006357),2335,227,237.38,-,0.96,2.46E-01
phospholipid biosynthetic process (GO:0008654),247,24,25.11,-,0.96,4.64E-01
morphogenesis of an epithelium (GO:0002009),422,41,42.9,-,0.96,4.23E-01
protein targeting (GO:0006605),350,34,35.58,-,0.96,4.38E-01
microtubule-based transport (GO:0099111),175,17,17.79,-,0.96,4.88E-01
"regulation of transcription, DNA-templated (GO:0006355)",3028,294,307.83,-,0.96,2.00E-01
negative regulation of viral process (GO:0048525),103,10,10.47,-,0.96,5.24E-01
response to amino acid (GO:0043200),103,10,10.47,-,0.96,5.24E-01
purine ribonucleotide metabolic process (GO:0009150),268,26,27.25,-,0.95,4.55E-01
anatomical structure development (GO:0048856),4804,466,488.38,-,0.95,1.19E-01
alcohol biosynthetic process (GO:0046165),93,9,9.45,-,0.95,5.28E-01
oxidative phosphorylation (GO:0006119),93,9,9.45,-,0.95,5.28E-01
tissue remodeling (GO:0048771),93,9,9.45,-,0.95,5.28E-01
olfactory bulb development (GO:0021772),31,3,3.15,-,0.95,6.13E-01
neuroblast proliferation (GO:0007405),31,3,3.15,-,0.95,6.13E-01
regulation of response to wounding (GO:1903034),155,15,15.76,-,0.95,4.91E-01
protein-lipid complex assembly (GO:0065005),31,3,3.15,-,0.95,6.13E-01
protein deglycosylation (GO:0006517),31,3,3.15,-,0.95,6.13E-01
regulation of isotype switching (GO:0045191),31,3,3.15,-,0.95,6.13E-01
regulation of interleukin-17 production (GO:0032660),31,3,3.15,-,0.95,6.13E-01
7-methylguanosine mRNA capping (GO:0006370),31,3,3.15,-,0.95,6.13E-01
quinone metabolic process (GO:1901661),31,3,3.15,-,0.95,6.13E-01
regulation of superoxide metabolic process (GO:0090322),31,3,3.15,-,0.95,6.13E-01
detection of mechanical stimulus involved in sensory perception (GO:0050974),31,3,3.15,-,0.95,6.13E-01
response to acid chemical (GO:0001101),124,12,12.61,-,0.95,5.07E-01
intestinal absorption (GO:0050892),31,3,3.15,-,0.95,6.13E-01
hormone-mediated signaling pathway (GO:0009755),124,12,12.61,-,0.95,5.07E-01
regulation of smooth muscle cell differentiation (GO:0051150),31,3,3.15,-,0.95,6.13E-01
ribonucleotide catabolic process (GO:0009261),31,3,3.15,-,0.95,6.13E-01
positive regulation of cell-substrate junction organization (GO:0150117),31,3,3.15,-,0.95,6.13E-01
regulation of macrophage derived foam cell differentiation (GO:0010743),31,3,3.15,-,0.95,6.13E-01
negative regulation of insulin receptor signaling pathway (GO:0046627),31,3,3.15,-,0.95,6.13E-01
extracellular matrix disassembly (GO:0022617),62,6,6.3,-,0.95,5.58E-01
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),31,3,3.15,-,0.95,6.13E-01
regulation of smooth muscle cell migration (GO:0014910),62,6,6.3,-,0.95,5.58E-01
muscle hypertrophy (GO:0014896),31,3,3.15,-,0.95,6.13E-01
actin filament polymerization (GO:0030041),31,3,3.15,-,0.95,6.13E-01
reactive oxygen species biosynthetic process (GO:1903409),31,3,3.15,-,0.95,6.13E-01
regulation of response to stress (GO:0080134),1396,135,141.92,-,0.95,2.89E-01
protein phosphorylation (GO:0006468),910,88,92.51,-,0.95,3.39E-01
regulation of nucleic acid-templated transcription (GO:1903506),3082,298,313.32,-,0.95,1.76E-01
enzyme linked receptor protein signaling pathway (GO:0007167),693,67,70.45,-,0.95,3.66E-01
cellular response to oxidative stress (GO:0034599),238,23,24.2,-,0.95,4.56E-01
negative regulation of ion transport (GO:0043271),145,14,14.74,-,0.95,4.92E-01
organic substance transport (GO:0071702),1999,193,203.22,-,0.95,2.35E-01
regulation of RNA biosynthetic process (GO:2001141),3087,298,313.83,-,0.95,1.68E-01
positive regulation of transmembrane transport (GO:0034764),197,19,20.03,-,0.95,4.67E-01
organic hydroxy compound biosynthetic process (GO:1901617),166,16,16.88,-,0.95,4.79E-01
positive regulation of transcription by RNA polymerase II (GO:0045944),1131,109,114.98,-,0.95,3.02E-01
intracellular transport (GO:0046907),1350,130,137.24,-,0.95,2.77E-01
regulation of cytokine production (GO:0001817),696,67,70.76,-,0.95,3.52E-01
negative regulation of kinase activity (GO:0033673),239,23,24.3,-,0.95,4.48E-01
steroid metabolic process (GO:0008202),239,23,24.3,-,0.95,4.48E-01
protein localization to organelle (GO:0033365),717,69,72.89,-,0.95,3.48E-01
protein insertion into membrane (GO:0051205),52,5,5.29,-,0.95,5.66E-01
selective autophagy (GO:0061912),52,5,5.29,-,0.95,5.66E-01
autophagosome organization (GO:1905037),52,5,5.29,-,0.95,5.66E-01
ribonucleoside triphosphate metabolic process (GO:0009199),52,5,5.29,-,0.95,5.66E-01
multicellular organism development (GO:0007275),4477,430,455.14,-,0.94,8.68E-02
detection of abiotic stimulus (GO:0009582),125,12,12.71,-,0.94,4.95E-01
ATP synthesis coupled electron transport (GO:0042773),73,7,7.42,-,0.94,5.36E-01
lymphocyte proliferation (GO:0046651),73,7,7.42,-,0.94,5.36E-01
system process (GO:0003008),1607,154,163.37,-,0.94,2.34E-01
regulation of defense response (GO:0031347),741,71,75.33,-,0.94,3.31E-01
regulation of secretion by cell (GO:1903530),595,57,60.49,-,0.94,3.54E-01
anatomical structure maturation (GO:0071695),188,18,19.11,-,0.94,4.59E-01
establishment of vesicle localization (GO:0051650),188,18,19.11,-,0.94,4.59E-01
regulation of cellular catabolic process (GO:0031329),794,76,80.72,-,0.94,3.20E-01
protein-containing complex disassembly (GO:0032984),209,20,21.25,-,0.94,4.49E-01
purine nucleoside bisphosphate metabolic process (GO:0034032),115,11,11.69,-,0.94,4.97E-01
fatty acid biosynthetic process (GO:0006633),115,11,11.69,-,0.94,4.97E-01
ribonucleoside bisphosphate metabolic process (GO:0033875),115,11,11.69,-,0.94,4.97E-01
nucleoside bisphosphate metabolic process (GO:0033865),115,11,11.69,-,0.94,4.97E-01
regulation of developmental process (GO:0050793),2291,219,232.91,-,0.94,1.72E-01
response to light stimulus (GO:0009416),293,28,29.79,-,0.94,4.17E-01
regulation of autophagy (GO:0010506),314,30,31.92,-,0.94,4.10E-01
endosomal transport (GO:0016197),199,19,20.23,-,0.94,4.49E-01
negative regulation of inflammatory response (GO:0050728),241,23,24.5,-,0.94,4.32E-01
cell-cell signaling (GO:0007267),1048,100,106.54,-,0.94,2.76E-01
regulation of actin filament organization (GO:0110053),262,25,26.64,-,0.94,4.24E-01
regulation of anatomical structure size (GO:0090066),493,47,50.12,-,0.94,3.61E-01
negative regulation of molecular function (GO:0044092),1049,100,106.64,-,0.94,2.72E-01
negative regulation of phosphate metabolic process (GO:0045936),535,51,54.39,-,0.94,3.52E-01
nervous system development (GO:0007399),2057,196,209.12,-,0.94,1.76E-01
positive regulation of fatty acid biosynthetic process (GO:0045723),21,2,2.13,-,0.94,6.40E-01
lung cell differentiation (GO:0060479),21,2,2.13,-,0.94,6.40E-01
axonal fasciculation (GO:0007413),21,2,2.13,-,0.94,6.40E-01
negative regulation of cation channel activity (GO:2001258),42,4,4.27,-,0.94,5.76E-01
hindbrain morphogenesis (GO:0021575),42,4,4.27,-,0.94,5.76E-01
negative regulation of stem cell differentiation (GO:2000737),21,2,2.13,-,0.94,6.40E-01
metanephric epithelium development (GO:0072207),21,2,2.13,-,0.94,6.40E-01
circadian regulation of gene expression (GO:0032922),63,6,6.4,-,0.94,5.41E-01
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),21,2,2.13,-,0.94,6.40E-01
mitotic spindle assembly checkpoint (GO:0007094),21,2,2.13,-,0.94,6.40E-01
positive regulation of sodium ion transmembrane transport (GO:1902307),21,2,2.13,-,0.94,6.40E-01
tRNA aminoacylation for protein translation (GO:0006418),42,4,4.27,-,0.94,5.76E-01
error-free translesion synthesis (GO:0070987),21,2,2.13,-,0.94,6.40E-01
positive regulation of peptidyl-serine phosphorylation (GO:0033138),105,10,10.67,-,0.94,4.99E-01
regulation of interleukin-13 production (GO:0032656),21,2,2.13,-,0.94,6.40E-01
cellular response to prostaglandin stimulus (GO:0071379),21,2,2.13,-,0.94,6.40E-01
transcytosis (GO:0045056),21,2,2.13,-,0.94,6.40E-01
early endosome to late endosome transport (GO:0045022),21,2,2.13,-,0.94,6.40E-01
positive regulation of mast cell activation (GO:0033005),21,2,2.13,-,0.94,6.40E-01
regulation of cardiac muscle cell membrane repolarization (GO:0099623),21,2,2.13,-,0.94,6.40E-01
pyrimidine nucleotide metabolic process (GO:0006220),42,4,4.27,-,0.94,5.76E-01
cellular response to arsenic-containing substance (GO:0071243),21,2,2.13,-,0.94,6.40E-01
purine nucleotide catabolic process (GO:0006195),42,4,4.27,-,0.94,5.76E-01
mitotic spindle checkpoint (GO:0071174),21,2,2.13,-,0.94,6.40E-01
spindle assembly checkpoint (GO:0071173),21,2,2.13,-,0.94,6.40E-01
negative regulation of peptide hormone secretion (GO:0090278),42,4,4.27,-,0.94,5.76E-01
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",21,2,2.13,-,0.94,6.40E-01
negative regulation of lipid catabolic process (GO:0050995),21,2,2.13,-,0.94,6.40E-01
neuron projection fasciculation (GO:0106030),21,2,2.13,-,0.94,6.40E-01
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),42,4,4.27,-,0.94,5.76E-01
spindle checkpoint (GO:0031577),21,2,2.13,-,0.94,6.40E-01
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),21,2,2.13,-,0.94,6.40E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),21,2,2.13,-,0.94,6.40E-01
amine biosynthetic process (GO:0009309),21,2,2.13,-,0.94,6.40E-01
calcium-mediated signaling using intracellular calcium source (GO:0035584),21,2,2.13,-,0.94,6.40E-01
metallo-sulfur cluster assembly (GO:0031163),21,2,2.13,-,0.94,6.40E-01
RNA 3'-end processing (GO:0031123),105,10,10.67,-,0.94,4.99E-01
pyrimidine ribonucleotide metabolic process (GO:0009218),21,2,2.13,-,0.94,6.40E-01
leukocyte adhesion to vascular endothelial cell (GO:0061756),21,2,2.13,-,0.94,6.40E-01
nucleotide catabolic process (GO:0009166),63,6,6.4,-,0.94,5.41E-01
androgen receptor signaling pathway (GO:0030521),21,2,2.13,-,0.94,6.40E-01
iron-sulfur cluster assembly (GO:0016226),21,2,2.13,-,0.94,6.40E-01
aspartate family amino acid catabolic process (GO:0009068),21,2,2.13,-,0.94,6.40E-01
negative regulation of nucleocytoplasmic transport (GO:0046823),21,2,2.13,-,0.94,6.40E-01
cellular biogenic amine biosynthetic process (GO:0042401),21,2,2.13,-,0.94,6.40E-01
positive regulation of glucose transmembrane transport (GO:0010828),42,4,4.27,-,0.94,5.76E-01
positive regulation of dendrite extension (GO:1903861),21,2,2.13,-,0.94,6.40E-01
kidney vasculature development (GO:0061440),21,2,2.13,-,0.94,6.40E-01
renal system vasculature development (GO:0061437),21,2,2.13,-,0.94,6.40E-01
prostate gland epithelium morphogenesis (GO:0060740),21,2,2.13,-,0.94,6.40E-01
positive regulation of isotype switching (GO:0045830),21,2,2.13,-,0.94,6.40E-01
pulmonary valve development (GO:0003177),21,2,2.13,-,0.94,6.40E-01
regulation of chromatin organization (GO:1902275),189,18,19.21,-,0.94,4.49E-01
regulation of response to biotic stimulus (GO:0002831),378,36,38.43,-,0.94,3.85E-01
sexual reproduction (GO:0019953),746,71,75.84,-,0.94,3.10E-01
cell cycle (GO:0007049),1240,118,126.06,-,0.94,2.44E-01
negative regulation of phosphorus metabolic process (GO:0010563),536,51,54.49,-,0.94,3.47E-01
microtubule cytoskeleton organization (GO:0000226),515,49,52.36,-,0.94,3.51E-01
positive regulation of proteolysis (GO:0045862),347,33,35.28,-,0.94,3.91E-01
dephosphorylation (GO:0016311),284,27,28.87,-,0.94,4.09E-01
cellular response to chemical stress (GO:0062197),284,27,28.87,-,0.94,4.09E-01
regulation of cellular component organization (GO:0051128),2178,207,221.42,-,0.93,1.57E-01
cell fate commitment (GO:0045165),242,23,24.6,-,0.93,4.24E-01
neurogenesis (GO:0022008),1316,125,133.79,-,0.93,2.29E-01
animal organ development (GO:0048513),2959,281,300.82,-,0.93,1.08E-01
response to glucose (GO:0009749),137,13,13.93,-,0.93,4.72E-01
muscle cell development (GO:0055001),137,13,13.93,-,0.93,4.72E-01
signal transduction by p53 class mediator (GO:0072331),116,11,11.79,-,0.93,4.85E-01
alcohol metabolic process (GO:0006066),306,29,31.11,-,0.93,3.96E-01
phagocytosis (GO:0006909),190,18,19.32,-,0.93,4.40E-01
toll-like receptor signaling pathway (GO:0002224),95,9,9.66,-,0.93,5.01E-01
organelle fusion (GO:0048284),95,9,9.66,-,0.93,5.01E-01
epithelium development (GO:0060429),1003,95,101.97,-,0.93,2.57E-01
tRNA metabolic process (GO:0006399),169,16,17.18,-,0.93,4.50E-01
mesenchymal cell differentiation (GO:0048762),148,14,15.05,-,0.93,4.60E-01
negative regulation of MAP kinase activity (GO:0043407),74,7,7.52,-,0.93,5.21E-01
regulation of inflammatory response to antigenic stimulus (GO:0002861),148,14,15.05,-,0.93,4.60E-01
keratinocyte differentiation (GO:0030216),201,19,20.43,-,0.93,4.31E-01
embryonic skeletal system development (GO:0048706),127,12,12.91,-,0.93,4.73E-01
tube morphogenesis (GO:0035239),635,60,64.56,-,0.93,3.08E-01
transmission of nerve impulse (GO:0019226),53,5,5.39,-,0.93,5.48E-01
negative regulation of phosphoprotein phosphatase activity (GO:0032515),53,5,5.39,-,0.93,5.48E-01
spindle localization (GO:0051653),53,5,5.39,-,0.93,5.48E-01
synaptic vesicle cycle (GO:0099504),106,10,10.78,-,0.93,4.87E-01
keratinization (GO:0031424),159,15,16.16,-,0.93,4.50E-01
regulation of histone acetylation (GO:0035065),53,5,5.39,-,0.93,5.48E-01
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),53,5,5.39,-,0.93,5.48E-01
positive regulation of innate immune response (GO:0045089),191,18,19.42,-,0.93,4.31E-01
spermatogenesis (GO:0007283),467,44,47.48,-,0.93,3.37E-01
monocarboxylic acid metabolic process (GO:0032787),478,45,48.59,-,0.93,3.33E-01
regulation of catabolic process (GO:0009894),946,89,96.17,-,0.93,2.44E-01
embryonic organ morphogenesis (GO:0048562),287,27,29.18,-,0.93,3.88E-01
regulation of ion transport (GO:0043269),670,63,68.11,-,0.92,2.88E-01
regulation of lipid metabolic process (GO:0019216),383,36,38.94,-,0.92,3.55E-01
regeneration (GO:0031099),149,14,15.15,-,0.92,4.50E-01
purine-containing compound biosynthetic process (GO:0072522),149,14,15.15,-,0.92,4.50E-01
peptide transport (GO:0015833),1384,130,140.7,-,0.92,1.85E-01
glycerophospholipid biosynthetic process (GO:0046474),213,20,21.65,-,0.92,4.14E-01
apoptotic signaling pathway (GO:0097190),277,26,28.16,-,0.92,3.87E-01
phosphate-containing compound metabolic process (GO:0006796),1973,185,200.58,-,0.92,1.27E-01
unsaturated fatty acid metabolic process (GO:0033559),96,9,9.76,-,0.92,4.88E-01
cotranslational protein targeting to membrane (GO:0006613),96,9,9.76,-,0.92,4.88E-01
regulation of synapse assembly (GO:0051963),96,9,9.76,-,0.92,4.88E-01
embryonic skeletal system morphogenesis (GO:0048704),96,9,9.76,-,0.92,4.88E-01
positive regulation of neuron death (GO:1901216),96,9,9.76,-,0.92,4.88E-01
histone acetylation (GO:0016573),96,9,9.76,-,0.92,4.88E-01
multicellular organism aging (GO:0010259),32,3,3.25,-,0.92,5.91E-01
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562),32,3,3.25,-,0.92,5.91E-01
negative regulation of protein serine/threonine kinase activity (GO:0071901),128,12,13.01,-,0.92,4.61E-01
T cell differentiation involved in immune response (GO:0002292),32,3,3.25,-,0.92,5.91E-01
leukocyte activation involved in inflammatory response (GO:0002269),32,3,3.25,-,0.92,5.91E-01
microglial cell activation (GO:0001774),32,3,3.25,-,0.92,5.91E-01
centrosome localization (GO:0051642),32,3,3.25,-,0.92,5.91E-01
regulation of fatty acid transport (GO:2000191),32,3,3.25,-,0.92,5.91E-01
negative regulation of telomere maintenance (GO:0032205),32,3,3.25,-,0.92,5.91E-01
maturation of 5.8S rRNA (GO:0000460),32,3,3.25,-,0.92,5.91E-01
RNA capping (GO:0036260),32,3,3.25,-,0.92,5.91E-01
7-methylguanosine RNA capping (GO:0009452),32,3,3.25,-,0.92,5.91E-01
cytochrome complex assembly (GO:0017004),32,3,3.25,-,0.92,5.91E-01
somatic cell DNA recombination (GO:0016444),32,3,3.25,-,0.92,5.91E-01
histone lysine methylation (GO:0034968),64,6,6.51,-,0.92,5.25E-01
positive regulation of phosphatase activity (GO:0010922),32,3,3.25,-,0.92,5.91E-01
pigment metabolic process (GO:0042440),64,6,6.51,-,0.92,5.25E-01
telomere maintenance via telomere lengthening (GO:0010833),32,3,3.25,-,0.92,5.91E-01
negative regulation of anion transport (GO:1903792),32,3,3.25,-,0.92,5.91E-01
regulation of protein kinase B signaling (GO:0051896),224,21,22.77,-,0.92,4.07E-01
mitotic prometaphase (GO:0000236),160,15,16.27,-,0.92,4.40E-01
tissue development (GO:0009888),1601,150,162.76,-,0.92,1.56E-01
establishment of protein localization (GO:0045184),1432,134,145.58,-,0.92,1.68E-01
phosphorus metabolic process (GO:0006793),1999,187,203.22,-,0.92,1.19E-01
positive regulation of mitotic cell cycle (GO:0045931),107,10,10.88,-,0.92,4.74E-01
circulatory system development (GO:0072359),824,77,83.77,-,0.92,2.44E-01
microtubule-based process (GO:0007017),728,68,74.01,-,0.92,2.59E-01
cytoskeleton-dependent intracellular transport (GO:0030705),182,17,18.5,-,0.92,4.22E-01
cell projection assembly (GO:0030031),407,38,41.38,-,0.92,3.33E-01
mononuclear cell proliferation (GO:0032943),75,7,7.62,-,0.92,5.06E-01
"retrograde transport, endosome to Golgi (GO:0042147)",75,7,7.62,-,0.92,5.06E-01
positive regulation of ion transport (GO:0043270),268,25,27.25,-,0.92,3.79E-01
cell junction assembly (GO:0034329),268,25,27.25,-,0.92,3.79E-01
meiotic cell cycle (GO:0051321),193,18,19.62,-,0.92,4.13E-01
regulation of synapse organization (GO:0050807),193,18,19.62,-,0.92,4.13E-01
regulation of calcium ion transport (GO:0051924),236,22,23.99,-,0.92,3.91E-01
positive regulation of chromosome organization (GO:2001252),161,15,16.37,-,0.92,4.30E-01
tissue morphogenesis (GO:0048729),526,49,53.47,-,0.92,2.96E-01
regulation of neurotransmitter levels (GO:0001505),204,19,20.74,-,0.92,4.05E-01
positive regulation of defense response (GO:0031349),333,31,33.85,-,0.92,3.50E-01
activation of innate immune response (GO:0002218),129,12,13.11,-,0.92,4.50E-01
purine ribonucleotide biosynthetic process (GO:0009152),129,12,13.11,-,0.92,4.50E-01
positive regulation of cytokine-mediated signaling pathway (GO:0001961),43,4,4.37,-,0.92,5.57E-01
positive regulation of nitric oxide biosynthetic process (GO:0045429),43,4,4.37,-,0.92,5.57E-01
double-strand break repair via homologous recombination (GO:0000724),86,8,8.74,-,0.92,4.90E-01
intermembrane lipid transfer (GO:0120009),43,4,4.37,-,0.92,5.57E-01
detection of chemical stimulus (GO:0009593),172,16,17.49,-,0.92,4.21E-01
regulation of long-term synaptic potentiation (GO:1900271),43,4,4.37,-,0.92,5.57E-01
anterograde axonal transport (GO:0008089),43,4,4.37,-,0.92,5.57E-01
neuromuscular junction development (GO:0007528),43,4,4.37,-,0.92,5.57E-01
male gamete generation (GO:0048232),484,45,49.2,-,0.91,3.02E-01
detection of stimulus (GO:0051606),355,33,36.09,-,0.91,3.39E-01
glycerophospholipid metabolic process (GO:0006650),312,29,31.72,-,0.91,3.54E-01
regulation of response to external stimulus (GO:0032101),1066,99,108.37,-,0.91,1.90E-01
purine nucleotide metabolic process (GO:0006163),291,27,29.58,-,0.91,3.59E-01
macromolecule localization (GO:0033036),2285,212,232.3,-,0.91,7.93E-02
positive regulation of secretion by cell (GO:1903532),302,28,30.7,-,0.91,3.53E-01
endocytosis (GO:0006897),410,38,41.68,-,0.91,3.16E-01
negative regulation of response to stimulus (GO:0048585),1640,152,166.72,-,0.91,1.22E-01
regulation of stem cell differentiation (GO:2000736),108,10,10.98,-,0.91,4.62E-01
phosphatidylinositol biosynthetic process (GO:0006661),108,10,10.98,-,0.91,4.62E-01
Fc receptor signaling pathway (GO:0038093),162,15,16.47,-,0.91,4.20E-01
positive regulation of chemokine production (GO:0032722),54,5,5.49,-,0.91,5.31E-01
positive regulation of receptor-mediated endocytosis (GO:0048260),54,5,5.49,-,0.91,5.31E-01
dendrite development (GO:0016358),108,10,10.98,-,0.91,4.62E-01
purine nucleoside triphosphate metabolic process (GO:0009144),54,5,5.49,-,0.91,5.31E-01
O-glycan processing (GO:0016266),54,5,5.49,-,0.91,5.31E-01
cholesterol transport (GO:0030301),54,5,5.49,-,0.91,5.31E-01
alpha-beta T cell differentiation (GO:0046632),54,5,5.49,-,0.91,5.31E-01
glycerolipid catabolic process (GO:0046503),54,5,5.49,-,0.91,5.31E-01
reactive oxygen species metabolic process (GO:0072593),108,10,10.98,-,0.91,4.62E-01
"RNA splicing, via transesterification reactions (GO:0000375)",270,25,27.45,-,0.91,3.64E-01
anatomical structure homeostasis (GO:0060249),346,32,35.17,-,0.91,3.32E-01
establishment of organelle localization (GO:0051656),368,34,37.41,-,0.91,3.22E-01
regulation of metal ion transport (GO:0010959),368,34,37.41,-,0.91,3.22E-01
lysosome organization (GO:0007040),65,6,6.61,-,0.91,5.09E-01
peptidyl-lysine methylation (GO:0018022),65,6,6.61,-,0.91,5.09E-01
regulation of defense response to virus (GO:0050688),65,6,6.61,-,0.91,5.09E-01
plasma membrane bounded cell projection assembly (GO:0120031),390,36,39.65,-,0.91,3.13E-01
lytic vacuole organization (GO:0080171),65,6,6.61,-,0.91,5.09E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),499,46,50.73,-,0.91,2.78E-01
ribose phosphate metabolic process (GO:0019693),293,27,29.79,-,0.91,3.45E-01
phospholipid metabolic process (GO:0006644),369,34,37.51,-,0.91,3.16E-01
regulation of release of sequestered calcium ion into cytosol (GO:0051279),76,7,7.73,-,0.91,4.92E-01
electron transport chain (GO:0022900),152,14,15.45,-,0.91,4.19E-01
positive regulation of cellular amide metabolic process (GO:0034250),152,14,15.45,-,0.91,4.19E-01
negative regulation of intracellular signal transduction (GO:1902532),467,43,47.48,-,0.91,2.84E-01
regulation of cell cycle phase transition (GO:1901987),424,39,43.1,-,0.9,2.95E-01
positive regulation of neuron differentiation (GO:0045666),87,8,8.84,-,0.9,4.76E-01
cilium-dependent cell motility (GO:0060285),87,8,8.84,-,0.9,4.76E-01
cilium or flagellum-dependent cell motility (GO:0001539),87,8,8.84,-,0.9,4.76E-01
negative regulation of cysteine-type endopeptidase activity (GO:2000117),87,8,8.84,-,0.9,4.76E-01
regulation of carbohydrate catabolic process (GO:0043470),87,8,8.84,-,0.9,4.76E-01
positive regulation of exocytosis (GO:0045921),87,8,8.84,-,0.9,4.76E-01
amide transport (GO:0042886),1414,130,143.75,-,0.9,1.23E-01
organic hydroxy compound metabolic process (GO:1901615),446,41,45.34,-,0.9,2.87E-01
ribonucleotide metabolic process (GO:0009259),283,26,28.77,-,0.9,3.44E-01
generation of neurons (GO:0048699),1198,110,121.79,-,0.9,1.43E-01
regulation of cell-substrate adhesion (GO:0010810),207,19,21.04,-,0.9,3.80E-01
protein localization (GO:0008104),1972,181,200.48,-,0.9,7.49E-02
glycerolipid biosynthetic process (GO:0045017),229,21,23.28,-,0.9,3.66E-01
neuron projection morphogenesis (GO:0048812),480,44,48.8,-,0.9,2.71E-01
regulation of type I interferon production (GO:0032479),120,11,12.2,-,0.9,4.38E-01
regulation of B cell activation (GO:0050864),120,11,12.2,-,0.9,4.38E-01
regulation of DNA binding (GO:0051101),120,11,12.2,-,0.9,4.38E-01
protein export from nucleus (GO:0006611),131,12,13.32,-,0.9,4.28E-01
male gonad development (GO:0008584),131,12,13.32,-,0.9,4.28E-01
negative regulation of mitotic cell cycle (GO:0045930),284,26,28.87,-,0.9,3.37E-01
regulation of production of molecular mediator of immune response (GO:0002700),142,13,14.44,-,0.9,4.18E-01
cell division (GO:0051301),448,41,45.54,-,0.9,2.77E-01
microtubule-based movement (GO:0007018),306,28,31.11,-,0.9,3.27E-01
stem cell differentiation (GO:0048863),153,14,15.55,-,0.9,4.09E-01
cardiac muscle tissue development (GO:0048738),153,14,15.55,-,0.9,4.09E-01
regulation of ion transmembrane transport (GO:0034765),459,42,46.66,-,0.9,2.73E-01
organelle assembly (GO:0070925),667,61,67.81,-,0.9,2.19E-01
protein transport (GO:0015031),1357,124,137.95,-,0.9,1.15E-01
peptidyl-serine modification (GO:0018209),197,18,20.03,-,0.9,3.78E-01
regulation of heart contraction (GO:0008016),230,21,23.38,-,0.9,3.58E-01
regulation of transmembrane transport (GO:0034762),537,49,54.59,-,0.9,2.45E-01
skin development (GO:0043588),307,28,31.21,-,0.9,3.20E-01
regulation of mitotic cell cycle phase transition (GO:1901990),395,36,40.16,-,0.9,2.85E-01
axon development (GO:0061564),406,37,41.27,-,0.9,2.81E-01
axonogenesis (GO:0007409),374,34,38.02,-,0.89,2.88E-01
heart process (GO:0003015),99,9,10.06,-,0.89,4.49E-01
cerebellum development (GO:0021549),99,9,10.06,-,0.89,4.49E-01
response to reactive oxygen species (GO:0000302),187,17,19.01,-,0.89,3.76E-01
receptor metabolic process (GO:0043112),99,9,10.06,-,0.89,4.49E-01
positive regulation of tolerance induction (GO:0002645),11,1,1.12,-,0.89,6.92E-01
negative regulation of cell cycle (GO:0045786),528,48,53.68,-,0.89,2.39E-01
mesoderm development (GO:0007498),110,10,11.18,-,0.89,4.38E-01
glomerular filtration (GO:0003094),11,1,1.12,-,0.89,6.92E-01
branching involved in mammary gland duct morphogenesis (GO:0060444),22,2,2.24,-,0.89,6.13E-01
trachea morphogenesis (GO:0060439),11,1,1.12,-,0.89,6.92E-01
toll-like receptor 3 signaling pathway (GO:0034138),11,1,1.12,-,0.89,6.92E-01
pentose metabolic process (GO:0019321),11,1,1.12,-,0.89,6.92E-01
cranial nerve structural organization (GO:0021604),11,1,1.12,-,0.89,6.92E-01
regulation of glucocorticoid secretion (GO:2000849),11,1,1.12,-,0.89,6.92E-01
chaperone-mediated protein transport (GO:0072321),11,1,1.12,-,0.89,6.92E-01
IMP metabolic process (GO:0046040),11,1,1.12,-,0.89,6.92E-01
complement receptor mediated signaling pathway (GO:0002430),11,1,1.12,-,0.89,6.92E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),11,1,1.12,-,0.89,6.92E-01
pons development (GO:0021548),11,1,1.12,-,0.89,6.92E-01
cell differentiation in hindbrain (GO:0021533),22,2,2.24,-,0.89,6.13E-01
metanephric renal vesicle morphogenesis (GO:0072283),11,1,1.12,-,0.89,6.92E-01
regulation of cilium movement involved in cell motility (GO:0060295),22,2,2.24,-,0.89,6.13E-01
embryonic skeletal joint morphogenesis (GO:0060272),11,1,1.12,-,0.89,6.92E-01
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),22,2,2.24,-,0.89,6.13E-01
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),11,1,1.12,-,0.89,6.92E-01
nuclear membrane organization (GO:0071763),11,1,1.12,-,0.89,6.92E-01
estrogen biosynthetic process (GO:0006703),11,1,1.12,-,0.89,6.92E-01
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),11,1,1.12,-,0.89,6.92E-01
metanephric tubule morphogenesis (GO:0072173),11,1,1.12,-,0.89,6.92E-01
release of cytochrome c from mitochondria (GO:0001836),22,2,2.24,-,0.89,6.13E-01
positive regulation of protein localization to synapse (GO:1902474),11,1,1.12,-,0.89,6.92E-01
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),22,2,2.24,-,0.89,6.13E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),11,1,1.12,-,0.89,6.92E-01
loop of Henle development (GO:0072070),11,1,1.12,-,0.89,6.92E-01
positive regulation of chromosome segregation (GO:0051984),11,1,1.12,-,0.89,6.92E-01
negative regulation of telomerase activity (GO:0051974),11,1,1.12,-,0.89,6.92E-01
proteolysis (GO:0006508),1133,103,115.18,-,0.89,1.29E-01
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),11,1,1.12,-,0.89,6.92E-01
negative regulation of monooxygenase activity (GO:0032769),11,1,1.12,-,0.89,6.92E-01
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),11,1,1.12,-,0.89,6.92E-01
diet induced thermogenesis (GO:0002024),11,1,1.12,-,0.89,6.92E-01
histone H3-K9 demethylation (GO:0033169),11,1,1.12,-,0.89,6.92E-01
positive regulation of ceramide biosynthetic process (GO:2000304),11,1,1.12,-,0.89,6.92E-01
negative regulation of viral genome replication (GO:0045071),55,5,5.59,-,0.89,5.13E-01
positive thymic T cell selection (GO:0045059),11,1,1.12,-,0.89,6.92E-01
cytolysis in other organism (GO:0051715),11,1,1.12,-,0.89,6.92E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),11,1,1.12,-,0.89,6.92E-01
plasma membrane fusion (GO:0045026),22,2,2.24,-,0.89,6.13E-01
regulation of protein activation cascade (GO:2000257),11,1,1.12,-,0.89,6.92E-01
axo-dendritic protein transport (GO:0099640),11,1,1.12,-,0.89,6.92E-01
protein localization to axon (GO:0099612),11,1,1.12,-,0.89,6.92E-01
microvillus organization (GO:0032528),11,1,1.12,-,0.89,6.92E-01
regulation of cilium-dependent cell motility (GO:1902019),22,2,2.24,-,0.89,6.13E-01
peptidyl-methionine modification (GO:0018206),11,1,1.12,-,0.89,6.92E-01
cellular response to mechanical stimulus (GO:0071260),77,7,7.83,-,0.89,4.77E-01
regulation of protein deacetylation (GO:0090311),44,4,4.47,-,0.89,5.37E-01
establishment of mitotic spindle localization (GO:0040001),33,3,3.35,-,0.89,5.68E-01
response to folic acid (GO:0051593),11,1,1.12,-,0.89,6.92E-01
negative regulation of histone H3-K9 methylation (GO:0051573),11,1,1.12,-,0.89,6.92E-01
regulation of histone H3-K9 methylation (GO:0051570),22,2,2.24,-,0.89,6.13E-01
neuron projection arborization (GO:0140058),11,1,1.12,-,0.89,6.92E-01
negative regulation of hormone metabolic process (GO:0032351),11,1,1.12,-,0.89,6.92E-01
recombinational repair (GO:0000725),88,8,8.95,-,0.89,4.62E-01
postsynaptic actin cytoskeleton organization (GO:0098974),11,1,1.12,-,0.89,6.92E-01
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),11,1,1.12,-,0.89,6.92E-01
positive regulation of sphingolipid biosynthetic process (GO:0090154),11,1,1.12,-,0.89,6.92E-01
cochlea morphogenesis (GO:0090103),22,2,2.24,-,0.89,6.13E-01
calcium ion import (GO:0070509),44,4,4.47,-,0.89,5.37E-01
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),33,3,3.35,-,0.89,5.68E-01
neurotransmitter receptor transport to plasma membrane (GO:0098877),11,1,1.12,-,0.89,6.92E-01
carbohydrate derivative transport (GO:1901264),88,8,8.95,-,0.89,4.62E-01
regulation of tubulin deacetylation (GO:0090043),11,1,1.12,-,0.89,6.92E-01
regulation of T cell receptor signaling pathway (GO:0050856),44,4,4.47,-,0.89,5.37E-01
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),11,1,1.12,-,0.89,6.92E-01
embryonic axis specification (GO:0000578),33,3,3.35,-,0.89,5.68E-01
engulfment of apoptotic cell (GO:0043652),11,1,1.12,-,0.89,6.92E-01
cell death in response to oxidative stress (GO:0036473),22,2,2.24,-,0.89,6.13E-01
regulation of appetite (GO:0032098),22,2,2.24,-,0.89,6.13E-01
regulation of nuclease activity (GO:0032069),22,2,2.24,-,0.89,6.13E-01
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",22,2,2.24,-,0.89,6.13E-01
hemoglobin metabolic process (GO:0020027),11,1,1.12,-,0.89,6.92E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654),44,4,4.47,-,0.89,5.37E-01
protein auto-ADP-ribosylation (GO:0070213),11,1,1.12,-,0.89,6.92E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039),484,44,49.2,-,0.89,2.52E-01
cellular response to potassium ion (GO:0035865),11,1,1.12,-,0.89,6.92E-01
detection of external biotic stimulus (GO:0098581),22,2,2.24,-,0.89,6.13E-01
regulation of cellular carbohydrate catabolic process (GO:0043471),11,1,1.12,-,0.89,6.92E-01
regulation of cellular respiration (GO:0043457),22,2,2.24,-,0.89,6.13E-01
regulation of secondary metabolic process (GO:0043455),11,1,1.12,-,0.89,6.92E-01
nuclear envelope reassembly (GO:0031468),11,1,1.12,-,0.89,6.92E-01
microtubule severing (GO:0051013),11,1,1.12,-,0.89,6.92E-01
kynurenine metabolic process (GO:0070189),11,1,1.12,-,0.89,6.92E-01
astral microtubule organization (GO:0030953),11,1,1.12,-,0.89,6.92E-01
interleukin-27-mediated signaling pathway (GO:0070106),11,1,1.12,-,0.89,6.92E-01
Rac protein signal transduction (GO:0016601),22,2,2.24,-,0.89,6.13E-01
spliceosomal tri-snRNP complex assembly (GO:0000244),11,1,1.12,-,0.89,6.92E-01
endothelial cell chemotaxis (GO:0035767),11,1,1.12,-,0.89,6.92E-01
negative regulation of cardiocyte differentiation (GO:1905208),11,1,1.12,-,0.89,6.92E-01
response to water deprivation (GO:0009414),11,1,1.12,-,0.89,6.92E-01
defense response to protozoan (GO:0042832),22,2,2.24,-,0.89,6.13E-01
regulation of secondary metabolite biosynthetic process (GO:1900376),11,1,1.12,-,0.89,6.92E-01
regulation of guanylate cyclase activity (GO:0031282),11,1,1.12,-,0.89,6.92E-01
multicellular organismal signaling (GO:0035637),132,12,13.42,-,0.89,4.17E-01
auditory behavior (GO:0031223),11,1,1.12,-,0.89,6.92E-01
very long-chain fatty acid biosynthetic process (GO:0042761),11,1,1.12,-,0.89,6.92E-01
regulation of melanin biosynthetic process (GO:0048021),11,1,1.12,-,0.89,6.92E-01
microtubule organizing center localization (GO:0061842),33,3,3.35,-,0.89,5.68E-01
purinergic nucleotide receptor signaling pathway (GO:0035590),44,4,4.47,-,0.89,5.37E-01
nucleotide-sugar biosynthetic process (GO:0009226),22,2,2.24,-,0.89,6.13E-01
SNARE complex assembly (GO:0035493),11,1,1.12,-,0.89,6.92E-01
tRNA aminoacylation (GO:0043039),44,4,4.47,-,0.89,5.37E-01
mitochondrial protein processing (GO:0034982),11,1,1.12,-,0.89,6.92E-01
positive regulation of cellular response to insulin stimulus (GO:1900078),22,2,2.24,-,0.89,6.13E-01
magnesium ion homeostasis (GO:0010960),11,1,1.12,-,0.89,6.92E-01
positive regulation of nitric oxide metabolic process (GO:1904407),44,4,4.47,-,0.89,5.37E-01
positive regulation of cytokine production involved in inflammatory response (GO:1900017),22,2,2.24,-,0.89,6.13E-01
positive regulation of glial cell migration (GO:1903977),11,1,1.12,-,0.89,6.92E-01
positive regulation of dephosphorylation (GO:0035306),55,5,5.59,-,0.89,5.13E-01
fatty acid elongation (GO:0030497),11,1,1.12,-,0.89,6.92E-01
melanin biosynthetic process (GO:0042438),11,1,1.12,-,0.89,6.92E-01
indole-containing compound metabolic process (GO:0042430),22,2,2.24,-,0.89,6.13E-01
regulation of cholesterol esterification (GO:0010872),11,1,1.12,-,0.89,6.92E-01
visual learning (GO:0008542),44,4,4.47,-,0.89,5.37E-01
positive regulation of mitochondrion organization (GO:0010822),88,8,8.95,-,0.89,4.62E-01
regulation of PERK-mediated unfolded protein response (GO:1903897),11,1,1.12,-,0.89,6.92E-01
regulation of dendrite extension (GO:1903859),22,2,2.24,-,0.89,6.13E-01
negative regulation of voltage-gated potassium channel activity (GO:1903817),11,1,1.12,-,0.89,6.92E-01
negative regulation of neuroinflammatory response (GO:0150079),11,1,1.12,-,0.89,6.92E-01
fat-soluble vitamin catabolic process (GO:0042363),11,1,1.12,-,0.89,6.92E-01
snRNA metabolic process (GO:0016073),33,3,3.35,-,0.89,5.68E-01
rhodopsin mediated signaling pathway (GO:0016056),11,1,1.12,-,0.89,6.92E-01
establishment of skin barrier (GO:0061436),22,2,2.24,-,0.89,6.13E-01
left/right pattern formation (GO:0060972),22,2,2.24,-,0.89,6.13E-01
positive regulation of membrane depolarization (GO:1904181),11,1,1.12,-,0.89,6.92E-01
phosphatidylcholine catabolic process (GO:0034638),11,1,1.12,-,0.89,6.92E-01
cellular modified amino acid catabolic process (GO:0042219),22,2,2.24,-,0.89,6.13E-01
heparin biosynthetic process (GO:0030210),11,1,1.12,-,0.89,6.92E-01
associative learning (GO:0008306),77,7,7.83,-,0.89,4.77E-01
positive regulation of triglyceride lipase activity (GO:0061365),11,1,1.12,-,0.89,6.92E-01
negative regulation of sprouting angiogenesis (GO:1903671),11,1,1.12,-,0.89,6.92E-01
positive regulation of cytoplasmic transport (GO:1903651),11,1,1.12,-,0.89,6.92E-01
Notch signaling involved in heart development (GO:0061314),11,1,1.12,-,0.89,6.92E-01
cornea development in camera-type eye (GO:0061303),11,1,1.12,-,0.89,6.92E-01
regulation of DNA catabolic process (GO:1903624),11,1,1.12,-,0.89,6.92E-01
retinal rod cell development (GO:0046548),11,1,1.12,-,0.89,6.92E-01
development of primary male sexual characteristics (GO:0046546),132,12,13.42,-,0.89,4.17E-01
sphingoid biosynthetic process (GO:0046520),11,1,1.12,-,0.89,6.92E-01
sphingosine biosynthetic process (GO:0046512),11,1,1.12,-,0.89,6.92E-01
amyloid-beta clearance (GO:0097242),22,2,2.24,-,0.89,6.13E-01
regulation of vascular endothelial growth factor production (GO:0010574),33,3,3.35,-,0.89,5.68E-01
negative regulation of B cell apoptotic process (GO:0002903),11,1,1.12,-,0.89,6.92E-01
establishment of protein localization to postsynaptic membrane (GO:1903540),11,1,1.12,-,0.89,6.92E-01
positive regulation of cilium movement (GO:0003353),11,1,1.12,-,0.89,6.92E-01
epithelial cell differentiation involved in prostate gland development (GO:0060742),11,1,1.12,-,0.89,6.92E-01
acylglycerol catabolic process (GO:0046464),33,3,3.35,-,0.89,5.68E-01
neutral lipid catabolic process (GO:0046461),33,3,3.35,-,0.89,5.68E-01
protein localization to phagophore assembly site (GO:0034497),11,1,1.12,-,0.89,6.92E-01
prostate gland growth (GO:0060736),11,1,1.12,-,0.89,6.92E-01
T cell proliferation (GO:0042098),33,3,3.35,-,0.89,5.68E-01
negative regulation of myeloid leukocyte mediated immunity (GO:0002887),11,1,1.12,-,0.89,6.92E-01
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",11,1,1.12,-,0.89,6.92E-01
negative regulation of cell fate commitment (GO:0010454),11,1,1.12,-,0.89,6.92E-01
postsynaptic membrane assembly (GO:0097104),11,1,1.12,-,0.89,6.92E-01
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),22,2,2.24,-,0.89,6.13E-01
olfactory lobe development (GO:0021988),33,3,3.35,-,0.89,5.68E-01
central nervous system neuron axonogenesis (GO:0021955),33,3,3.35,-,0.89,5.68E-01
rostrocaudal neural tube patterning (GO:0021903),11,1,1.12,-,0.89,6.92E-01
regulation of cardioblast proliferation (GO:0003264),11,1,1.12,-,0.89,6.92E-01
negative regulation of fatty acid oxidation (GO:0046322),11,1,1.12,-,0.89,6.92E-01
positive regulation of protein polyubiquitination (GO:1902916),11,1,1.12,-,0.89,6.92E-01
dendritic cell differentiation (GO:0097028),33,3,3.35,-,0.89,5.68E-01
regulation of protein tyrosine kinase activity (GO:0061097),88,8,8.95,-,0.89,4.62E-01
regulation of dendritic cell cytokine production (GO:0002730),11,1,1.12,-,0.89,6.92E-01
positive regulation of cytokine production involved in immune response (GO:0002720),55,5,5.59,-,0.89,5.13E-01
olfactory bulb interneuron differentiation (GO:0021889),11,1,1.12,-,0.89,6.92E-01
aortic valve development (GO:0003176),33,3,3.35,-,0.89,5.68E-01
mitral valve development (GO:0003174),11,1,1.12,-,0.89,6.92E-01
intestinal epithelial cell differentiation (GO:0060575),22,2,2.24,-,0.89,6.13E-01
prostate glandular acinus development (GO:0060525),11,1,1.12,-,0.89,6.92E-01
positive regulation of organelle organization (GO:0010638),551,50,56.02,-,0.89,2.29E-01
cell cycle process (GO:0022402),948,86,96.38,-,0.89,1.50E-01
response to organonitrogen compound (GO:0010243),926,84,94.14,-,0.89,1.53E-01
intracellular protein transport (GO:0006886),893,81,90.78,-,0.89,1.58E-01
embryonic organ development (GO:0048568),430,39,43.71,-,0.89,2.64E-01
purine-containing compound metabolic process (GO:0072521),320,29,32.53,-,0.89,3.03E-01
embryo development (GO:0009790),927,84,94.24,-,0.89,1.50E-01
regionalization (GO:0003002),309,28,31.41,-,0.89,3.07E-01
vascular process in circulatory system (GO:0003018),254,23,25.82,-,0.89,3.32E-01
protein modification by small protein conjugation or removal (GO:0070647),895,81,90.99,-,0.89,1.53E-01
cytokine-mediated signaling pathway (GO:0019221),663,60,67.4,-,0.89,1.97E-01
detection of stimulus involved in sensory perception (GO:0050906),199,18,20.23,-,0.89,3.61E-01
signal release (GO:0023061),177,16,17.99,-,0.89,3.75E-01
epithelial tube morphogenesis (GO:0060562),299,27,30.4,-,0.89,3.05E-01
protein modification by small protein conjugation (GO:0032446),720,65,73.2,-,0.89,1.79E-01
cell projection morphogenesis (GO:0048858),488,44,49.61,-,0.89,2.34E-01
protein localization to membrane (GO:0072657),488,44,49.61,-,0.89,2.34E-01
regulation of mitotic cell cycle (GO:0007346),555,50,56.42,-,0.89,2.13E-01
monocarboxylic acid catabolic process (GO:0072329),111,10,11.28,-,0.89,4.26E-01
in utero embryonic development (GO:0001701),333,30,33.85,-,0.89,2.86E-01
vesicle-mediated transport in synapse (GO:0099003),111,10,11.28,-,0.89,4.26E-01
positive regulation of chromatin organization (GO:1905269),111,10,11.28,-,0.89,4.26E-01
tissue homeostasis (GO:0001894),211,19,21.45,-,0.89,3.47E-01
internal peptidyl-lysine acetylation (GO:0018393),100,9,10.17,-,0.89,4.37E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),100,9,10.17,-,0.89,4.37E-01
response to topologically incorrect protein (GO:0035966),178,16,18.1,-,0.88,3.66E-01
"mRNA splicing, via spliceosome (GO:0000398)",267,24,27.14,-,0.88,3.13E-01
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",267,24,27.14,-,0.88,3.13E-01
fatty acid catabolic process (GO:0009062),89,8,9.05,-,0.88,4.49E-01
cell morphogenesis involved in neuron differentiation (GO:0048667),434,39,44.12,-,0.88,2.44E-01
RNA transport (GO:0050658),167,15,16.98,-,0.88,3.73E-01
nucleic acid transport (GO:0050657),167,15,16.98,-,0.88,3.73E-01
regulation of neurotransmitter receptor activity (GO:0099601),78,7,7.93,-,0.88,4.63E-01
maintenance of location (GO:0051235),156,14,15.86,-,0.88,3.80E-01
muscle contraction (GO:0006936),234,21,23.79,-,0.88,3.28E-01
developmental maturation (GO:0021700),223,20,22.67,-,0.88,3.33E-01
response to insulin (GO:0032868),223,20,22.67,-,0.88,3.33E-01
epithelial to mesenchymal transition (GO:0001837),67,6,6.81,-,0.88,4.78E-01
chondrocyte differentiation (GO:0002062),67,6,6.81,-,0.88,4.78E-01
regulation of antigen receptor-mediated signaling pathway (GO:0050854),67,6,6.81,-,0.88,4.78E-01
mitotic cytokinesis (GO:0000281),67,6,6.81,-,0.88,4.78E-01
negative regulation of epithelial cell migration (GO:0010633),67,6,6.81,-,0.88,4.78E-01
cell junction organization (GO:0034330),469,42,47.68,-,0.88,2.26E-01
protein ubiquitination (GO:0016567),648,58,65.88,-,0.88,1.77E-01
detection of external stimulus (GO:0009581),123,11,12.5,-,0.88,4.05E-01
monocarboxylic acid biosynthetic process (GO:0072330),179,16,18.2,-,0.88,3.57E-01
regulation of synaptic plasticity (GO:0048167),179,16,18.2,-,0.88,3.57E-01
mRNA processing (GO:0006397),414,37,42.09,-,0.88,2.41E-01
positive regulation of cell-matrix adhesion (GO:0001954),56,5,5.69,-,0.88,4.96E-01
long-chain fatty acid transport (GO:0015909),56,5,5.69,-,0.88,4.96E-01
response to hydrogen peroxide (GO:0042542),112,10,11.39,-,0.88,4.14E-01
apoptotic mitochondrial changes (GO:0008637),56,5,5.69,-,0.88,4.96E-01
positive regulation of anion transport (GO:1903793),56,5,5.69,-,0.88,4.96E-01
regulation of embryonic development (GO:0045995),56,5,5.69,-,0.88,4.96E-01
response to oxidative stress (GO:0006979),381,34,38.73,-,0.88,2.50E-01
MAPK cascade (GO:0000165),381,34,38.73,-,0.88,2.50E-01
protein acylation (GO:0043543),157,14,15.96,-,0.88,3.70E-01
stimulatory C-type lectin receptor signaling pathway (GO:0002223),101,9,10.27,-,0.88,4.24E-01
internal protein amino acid acetylation (GO:0006475),101,9,10.27,-,0.88,4.24E-01
protein polyubiquitination (GO:0000209),303,27,30.8,-,0.88,2.80E-01
negative regulation of dephosphorylation (GO:0035305),101,9,10.27,-,0.88,4.24E-01
organophosphate metabolic process (GO:0019637),808,72,82.14,-,0.88,1.37E-01
regulation of anatomical structure morphogenesis (GO:0022603),932,83,94.75,-,0.88,1.16E-01
cellular response to abiotic stimulus (GO:0071214),292,26,29.69,-,0.88,2.84E-01
fatty acid derivative metabolic process (GO:1901568),146,13,14.84,-,0.88,3.78E-01
cellular response to environmental stimulus (GO:0104004),292,26,29.69,-,0.88,2.84E-01
muscle system process (GO:0003012),281,25,28.57,-,0.88,2.88E-01
negative regulation of osteoblast differentiation (GO:0045668),45,4,4.57,-,0.87,5.18E-01
cellular polysaccharide biosynthetic process (GO:0033692),45,4,4.57,-,0.87,5.18E-01
porphyrin-containing compound metabolic process (GO:0006778),45,4,4.57,-,0.87,5.18E-01
protein destabilization (GO:0031648),45,4,4.57,-,0.87,5.18E-01
polysaccharide biosynthetic process (GO:0000271),45,4,4.57,-,0.87,5.18E-01
regulation of cyclase activity (GO:0031279),45,4,4.57,-,0.87,5.18E-01
"regulation of mRNA splicing, via spliceosome (GO:0048024)",90,8,9.15,-,0.87,4.36E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),45,4,4.57,-,0.87,5.18E-01
amino acid activation (GO:0043038),45,4,4.57,-,0.87,5.18E-01
regulation of epithelial to mesenchymal transition (GO:0010717),90,8,9.15,-,0.87,4.36E-01
positive regulation of organ growth (GO:0046622),45,4,4.57,-,0.87,5.18E-01
cardiac conduction (GO:0061337),90,8,9.15,-,0.87,4.36E-01
regulation of dendritic spine morphogenesis (GO:0061001),45,4,4.57,-,0.87,5.18E-01
regulation of angiogenesis (GO:0045765),270,24,27.45,-,0.87,2.92E-01
cellular protein localization (GO:0034613),1475,131,149.95,-,0.87,5.49E-02
establishment of RNA localization (GO:0051236),169,15,17.18,-,0.87,3.54E-01
regulation of proteasomal protein catabolic process (GO:0061136),169,15,17.18,-,0.87,3.54E-01
negative regulation of cell communication (GO:0010648),1296,115,131.75,-,0.87,6.78E-02
sister chromatid segregation (GO:0000819),124,11,12.61,-,0.87,3.94E-01
protein lipidation (GO:0006497),79,7,8.03,-,0.87,4.48E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),79,7,8.03,-,0.87,4.48E-01
cardiac muscle cell differentiation (GO:0055007),79,7,8.03,-,0.87,4.48E-01
regulation of dephosphorylation (GO:0035303),192,17,19.52,-,0.87,3.34E-01
negative regulation of signaling (GO:0023057),1299,115,132.06,-,0.87,6.43E-02
negative regulation of DNA metabolic process (GO:0051053),113,10,11.49,-,0.87,4.03E-01
negative regulation of transmembrane transport (GO:0034763),113,10,11.49,-,0.87,4.03E-01
regulation of cellular component biogenesis (GO:0044087),893,79,90.78,-,0.87,1.10E-01
cellular response to peptide hormone stimulus (GO:0071375),260,23,26.43,-,0.87,2.90E-01
neuron projection development (GO:0031175),656,58,66.69,-,0.87,1.53E-01
cellular macromolecule localization (GO:0070727),1482,131,150.66,-,0.87,4.86E-02
cellular response to organonitrogen compound (GO:0071417),555,49,56.42,-,0.87,1.75E-01
head development (GO:0060322),759,67,77.16,-,0.87,1.29E-01
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),102,9,10.37,-,0.87,4.12E-01
cellular transition metal ion homeostasis (GO:0046916),102,9,10.37,-,0.87,4.12E-01
nucleobase-containing small molecule biosynthetic process (GO:0034404),102,9,10.37,-,0.87,4.12E-01
circulatory system process (GO:0003013),476,42,48.39,-,0.87,1.97E-01
negative regulation of chromosome organization (GO:2001251),68,6,6.91,-,0.87,4.62E-01
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),34,3,3.46,-,0.87,5.46E-01
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",34,3,3.46,-,0.87,5.46E-01
membrane assembly (GO:0071709),34,3,3.46,-,0.87,5.46E-01
phosphatidylcholine biosynthetic process (GO:0006656),34,3,3.46,-,0.87,5.46E-01
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",34,3,3.46,-,0.87,5.46E-01
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",68,6,6.91,-,0.87,4.62E-01
positive regulation of potassium ion transmembrane transport (GO:1901381),34,3,3.46,-,0.87,5.46E-01
negative regulation of B cell activation (GO:0050869),34,3,3.46,-,0.87,5.46E-01
establishment of spindle orientation (GO:0051294),34,3,3.46,-,0.87,5.46E-01
negative regulation of signal transduction in absence of ligand (GO:1901099),34,3,3.46,-,0.87,5.46E-01
negative regulation of secretion (GO:0051048),170,15,17.28,-,0.87,3.45E-01
G2/M transition of mitotic cell cycle (GO:0000086),136,12,13.83,-,0.87,3.75E-01
positive regulation of microtubule polymerization or depolymerization (GO:0031112),34,3,3.46,-,0.87,5.46E-01
animal organ regeneration (GO:0031100),68,6,6.91,-,0.87,4.62E-01
nucleoside biosynthetic process (GO:0009163),34,3,3.46,-,0.87,5.46E-01
response to fluid shear stress (GO:0034405),34,3,3.46,-,0.87,5.46E-01
response to nitrogen compound (GO:1901698),999,88,101.56,-,0.87,8.84E-02
chromatin remodeling (GO:0006338),159,14,16.16,-,0.87,3.51E-01
response to peptide hormone (GO:0043434),375,33,38.12,-,0.87,2.28E-01
negative regulation of signal transduction (GO:0009968),1205,106,122.5,-,0.87,6.42E-02
regulation of vasculature development (GO:1901342),273,24,27.75,-,0.86,2.73E-01
positive regulation of cell cycle process (GO:0090068),273,24,27.75,-,0.86,2.73E-01
mRNA export from nucleus (GO:0006406),91,8,9.25,-,0.86,4.23E-01
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),91,8,9.25,-,0.86,4.23E-01
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),91,8,9.25,-,0.86,4.23E-01
regulation of blood pressure (GO:0008217),182,16,18.5,-,0.86,3.31E-01
ribose phosphate biosynthetic process (GO:0046390),148,13,15.05,-,0.86,3.58E-01
regulation of cytoskeleton organization (GO:0051493),490,43,49.81,-,0.86,1.83E-01
dendrite morphogenesis (GO:0048813),57,5,5.79,-,0.86,4.79E-01
sensory perception of taste (GO:0050909),57,5,5.79,-,0.86,4.79E-01
response to abiotic stimulus (GO:0009628),1083,95,110.1,-,0.86,7.26E-02
detection of light stimulus (GO:0009583),57,5,5.79,-,0.86,4.79E-01
phosphatidylinositol metabolic process (GO:0046488),171,15,17.38,-,0.86,3.36E-01
neuron development (GO:0048666),799,70,81.23,-,0.86,1.09E-01
response to UV (GO:0009411),137,12,13.93,-,0.86,3.65E-01
lipid homeostasis (GO:0055088),137,12,13.93,-,0.86,3.65E-01
regulation of cytokinesis (GO:0032465),80,7,8.13,-,0.86,4.34E-01
T cell receptor signaling pathway (GO:0050852),160,14,16.27,-,0.86,3.42E-01
regulation of phosphatase activity (GO:0010921),160,14,16.27,-,0.86,3.42E-01
insulin receptor signaling pathway (GO:0008286),80,7,8.13,-,0.86,4.34E-01
central nervous system neuron development (GO:0021954),80,7,8.13,-,0.86,4.34E-01
regulation of protein catabolic process (GO:0042176),366,32,37.21,-,0.86,2.20E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),103,9,10.47,-,0.86,4.00E-01
peptidyl-lysine acetylation (GO:0018394),103,9,10.47,-,0.86,4.00E-01
negative regulation of developmental growth (GO:0048640),103,9,10.47,-,0.86,4.00E-01
myelination (GO:0042552),103,9,10.47,-,0.86,4.00E-01
plasma membrane bounded cell projection organization (GO:0120036),1053,92,107.05,-,0.86,7.05E-02
developmental process involved in reproduction (GO:0003006),870,76,88.45,-,0.86,9.37E-02
regulation of protein dephosphorylation (GO:0035304),126,11,12.81,-,0.86,3.72E-01
response to lithium ion (GO:0010226),23,2,2.34,-,0.86,5.86E-01
alditol metabolic process (GO:0019400),23,2,2.34,-,0.86,5.86E-01
substrate-dependent cell migration (GO:0006929),23,2,2.34,-,0.86,5.86E-01
negative regulation of glial cell differentiation (GO:0045686),23,2,2.34,-,0.86,5.86E-01
telencephalon glial cell migration (GO:0022030),23,2,2.34,-,0.86,5.86E-01
endothelial cell proliferation (GO:0001935),23,2,2.34,-,0.86,5.86E-01
myeloid dendritic cell activation (GO:0001773),23,2,2.34,-,0.86,5.86E-01
cell cycle G2/M phase transition (GO:0044839),138,12,14.03,-,0.86,3.55E-01
genetic imprinting (GO:0071514),23,2,2.34,-,0.86,5.86E-01
homologous chromosome segregation (GO:0045143),46,4,4.68,-,0.86,4.99E-01
cellular response to acid chemical (GO:0071229),69,6,7.01,-,0.86,4.47E-01
peptidyl-arginine modification (GO:0018195),23,2,2.34,-,0.86,5.86E-01
regulation of protein autophosphorylation (GO:0031952),46,4,4.68,-,0.86,4.99E-01
positive regulation of oligodendrocyte differentiation (GO:0048714),23,2,2.34,-,0.86,5.86E-01
negative regulation of smooth muscle cell proliferation (GO:0048662),46,4,4.68,-,0.86,4.99E-01
detection of chemical stimulus involved in sensory perception (GO:0050907),138,12,14.03,-,0.86,3.55E-01
positive regulation of lyase activity (GO:0051349),23,2,2.34,-,0.86,5.86E-01
cytoplasmic sequestering of protein (GO:0051220),23,2,2.34,-,0.86,5.86E-01
positive regulation of inflammatory response (GO:0050729),138,12,14.03,-,0.86,3.55E-01
presynapse assembly (GO:0099054),23,2,2.34,-,0.86,5.86E-01
cellular response to sterol (GO:0036315),23,2,2.34,-,0.86,5.86E-01
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),23,2,2.34,-,0.86,5.86E-01
positive regulation of macrophage activation (GO:0043032),23,2,2.34,-,0.86,5.86E-01
nucleoside triphosphate biosynthetic process (GO:0009142),46,4,4.68,-,0.86,4.99E-01
response to auditory stimulus (GO:0010996),23,2,2.34,-,0.86,5.86E-01
benzene-containing compound metabolic process (GO:0042537),23,2,2.34,-,0.86,5.86E-01
positive regulation of hemostasis (GO:1900048),23,2,2.34,-,0.86,5.86E-01
cardiac muscle cell action potential (GO:0086001),46,4,4.68,-,0.86,4.99E-01
negative regulation of ion transmembrane transport (GO:0034766),92,8,9.35,-,0.86,4.10E-01
autophagosome maturation (GO:0097352),23,2,2.34,-,0.86,5.86E-01
apoptotic nuclear changes (GO:0030262),23,2,2.34,-,0.86,5.86E-01
trabecula morphogenesis (GO:0061383),46,4,4.68,-,0.86,4.99E-01
regulation of cytoplasmic transport (GO:1903649),23,2,2.34,-,0.86,5.86E-01
positive regulation of blood coagulation (GO:0030194),23,2,2.34,-,0.86,5.86E-01
labyrinthine layer development (GO:0060711),46,4,4.68,-,0.86,4.99E-01
neuronal stem cell population maintenance (GO:0097150),23,2,2.34,-,0.86,5.86E-01
response to muscle activity (GO:0014850),23,2,2.34,-,0.86,5.86E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),23,2,2.34,-,0.86,5.86E-01
positive regulation of glycolytic process (GO:0045821),23,2,2.34,-,0.86,5.86E-01
negative regulation of regulated secretory pathway (GO:1903306),23,2,2.34,-,0.86,5.86E-01
atrioventricular valve morphogenesis (GO:0003181),23,2,2.34,-,0.86,5.86E-01
cerebral cortex radial glia guided migration (GO:0021801),23,2,2.34,-,0.86,5.86E-01
prostate gland morphogenesis (GO:0060512),23,2,2.34,-,0.86,5.86E-01
cellular component disassembly (GO:0022411),369,32,37.51,-,0.85,2.06E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850),173,15,17.59,-,0.85,3.19E-01
cell projection organization (GO:0030030),1096,95,111.42,-,0.85,5.66E-02
cell part morphogenesis (GO:0032990),508,44,51.64,-,0.85,1.56E-01
meiotic nuclear division (GO:0140013),127,11,12.91,-,0.85,3.61E-01
positive regulation of synaptic transmission (GO:0050806),127,11,12.91,-,0.85,3.61E-01
cellular response to reactive oxygen species (GO:0034614),127,11,12.91,-,0.85,3.61E-01
central nervous system development (GO:0007417),947,82,96.27,-,0.85,7.14E-02
activation of protein kinase activity (GO:0032147),312,27,31.72,-,0.85,2.28E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220),104,9,10.57,-,0.85,3.88E-01
positive regulation of proteasomal protein catabolic process (GO:1901800),104,9,10.57,-,0.85,3.88E-01
cellular response to light stimulus (GO:0071482),104,9,10.57,-,0.85,3.88E-01
organelle fission (GO:0048285),289,25,29.38,-,0.85,2.39E-01
regulation of protein depolymerization (GO:1901879),81,7,8.23,-,0.85,4.20E-01
response to hypoxia (GO:0001666),324,28,32.94,-,0.85,2.21E-01
fatty acid derivative biosynthetic process (GO:1901570),81,7,8.23,-,0.85,4.20E-01
positive regulation of actin filament polymerization (GO:0030838),81,7,8.23,-,0.85,4.20E-01
positive regulation of lipid biosynthetic process (GO:0046889),81,7,8.23,-,0.85,4.20E-01
cellular response to UV (GO:0034644),81,7,8.23,-,0.85,4.20E-01
purine nucleotide biosynthetic process (GO:0006164),139,12,14.13,-,0.85,3.45E-01
chromatin organization (GO:0006325),591,51,60.08,-,0.85,1.28E-01
signal transduction by protein phosphorylation (GO:0023014),394,34,40.05,-,0.85,1.88E-01
glycerolipid metabolic process (GO:0046486),371,32,37.72,-,0.85,1.97E-01
regulation of nitric oxide biosynthetic process (GO:0045428),58,5,5.9,-,0.85,4.62E-01
regulation of interleukin-12 production (GO:0032655),58,5,5.9,-,0.85,4.62E-01
positive regulation of protein polymerization (GO:0032273),116,10,11.79,-,0.85,3.69E-01
ribosome assembly (GO:0042255),58,5,5.9,-,0.85,4.62E-01
symbiotic process (GO:0044403),882,76,89.67,-,0.85,7.38E-02
gastrulation (GO:0007369),151,13,15.35,-,0.85,3.29E-01
bone morphogenesis (GO:0060349),93,8,9.45,-,0.85,3.97E-01
sensory perception of chemical stimulus (GO:0007606),186,16,18.91,-,0.85,2.98E-01
negative regulation of epithelial cell proliferation (GO:0050680),128,11,13.01,-,0.85,3.51E-01
positive regulation of binding (GO:0051099),163,14,16.57,-,0.84,3.15E-01
regulation of actin filament polymerization (GO:0030833),163,14,16.57,-,0.84,3.15E-01
negative regulation of Notch signaling pathway (GO:0045746),35,3,3.56,-,0.84,5.24E-01
positive regulation of heart growth (GO:0060421),35,3,3.56,-,0.84,5.24E-01
muscle tissue morphogenesis (GO:0060415),70,6,7.12,-,0.84,4.32E-01
cardiac septum morphogenesis (GO:0060411),70,6,7.12,-,0.84,4.32E-01
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),140,12,14.23,-,0.84,3.35E-01
meiotic cell cycle process (GO:1903046),140,12,14.23,-,0.84,3.35E-01
ensheathment of neurons (GO:0007272),105,9,10.67,-,0.84,3.76E-01
neural tube patterning (GO:0021532),35,3,3.56,-,0.84,5.24E-01
receptor signaling pathway via JAK-STAT (GO:0007259),35,3,3.56,-,0.84,5.24E-01
positive regulation of double-strand break repair (GO:2000781),35,3,3.56,-,0.84,5.24E-01
prostaglandin metabolic process (GO:0006693),35,3,3.56,-,0.84,5.24E-01
prostanoid metabolic process (GO:0006692),35,3,3.56,-,0.84,5.24E-01
regulation of amino acid transport (GO:0051955),35,3,3.56,-,0.84,5.24E-01
regulation of multicellular organism growth (GO:0040014),70,6,7.12,-,0.84,4.32E-01
adenine nucleotide transport (GO:0051503),35,3,3.56,-,0.84,5.24E-01
regulation of muscle system process (GO:0090257),210,18,21.35,-,0.84,2.75E-01
cellular carbohydrate catabolic process (GO:0044275),35,3,3.56,-,0.84,5.24E-01
vesicle-mediated transport to the plasma membrane (GO:0098876),70,6,7.12,-,0.84,4.32E-01
chromosome organization (GO:0051276),910,78,92.51,-,0.84,6.41E-02
negative regulation of blood vessel endothelial cell migration (GO:0043537),35,3,3.56,-,0.84,5.24E-01
guanosine-containing compound metabolic process (GO:1901068),35,3,3.56,-,0.84,5.24E-01
protein kinase B signaling (GO:0043491),35,3,3.56,-,0.84,5.24E-01
response to alkaloid (GO:0043279),105,9,10.67,-,0.84,3.76E-01
maintenance of blood-brain barrier (GO:0035633),35,3,3.56,-,0.84,5.24E-01
purine ribonucleotide transport (GO:0015868),35,3,3.56,-,0.84,5.24E-01
cardiac muscle cell action potential involved in contraction (GO:0086002),35,3,3.56,-,0.84,5.24E-01
regulation of protein export from nucleus (GO:0046825),35,3,3.56,-,0.84,5.24E-01
axon ensheathment (GO:0008366),105,9,10.67,-,0.84,3.76E-01
positive regulation of epithelial cell apoptotic process (GO:1904037),35,3,3.56,-,0.84,5.24E-01
innate immune response-activating signal transduction (GO:0002758),105,9,10.67,-,0.84,3.76E-01
pyrimidine-containing compound biosynthetic process (GO:0072528),35,3,3.56,-,0.84,5.24E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091),257,22,26.13,-,0.84,2.42E-01
RNA localization (GO:0006403),187,16,19.01,-,0.84,2.90E-01
multicellular organismal homeostasis (GO:0048871),339,29,34.46,-,0.84,1.98E-01
axon guidance (GO:0007411),269,23,27.35,-,0.84,2.33E-01
regulation of JNK cascade (GO:0046328),117,10,11.89,-,0.84,3.58E-01
regulation of organelle organization (GO:0033043),1100,94,111.83,-,0.84,4.22E-02
cellular response to interleukin-1 (GO:0071347),164,14,16.67,-,0.84,3.07E-01
negative regulation of cation transmembrane transport (GO:1904063),82,7,8.34,-,0.84,4.07E-01
endomembrane system organization (GO:0010256),387,33,39.34,-,0.84,1.73E-01
protein-containing complex localization (GO:0031503),223,19,22.67,-,0.84,2.57E-01
neuron projection guidance (GO:0097485),270,23,27.45,-,0.84,2.28E-01
cellular component morphogenesis (GO:0032989),587,50,59.68,-,0.84,1.11E-01
vacuolar transport (GO:0007034),141,12,14.33,-,0.84,3.25E-01
ribonucleotide biosynthetic process (GO:0009260),141,12,14.33,-,0.84,3.25E-01
negative regulation of supramolecular fiber organization (GO:1902904),141,12,14.33,-,0.84,3.25E-01
regulation of lamellipodium organization (GO:1902743),47,4,4.78,-,0.84,4.80E-01
embryonic cranial skeleton morphogenesis (GO:0048701),47,4,4.78,-,0.84,4.80E-01
positive regulation of cold-induced thermogenesis (GO:0120162),94,8,9.56,-,0.84,3.84E-01
response to cold (GO:0009409),47,4,4.78,-,0.84,4.80E-01
response to amyloid-beta (GO:1904645),47,4,4.78,-,0.84,4.80E-01
actomyosin structure organization (GO:0031032),106,9,10.78,-,0.84,3.65E-01
modulation of chemical synaptic transmission (GO:0050804),389,33,39.55,-,0.83,1.65E-01
cellular protein catabolic process (GO:0044257),566,48,57.54,-,0.83,1.10E-01
regulation of cell cycle (GO:0051726),1097,93,111.52,-,0.83,3.59E-02
regulation of DNA-binding transcription factor activity (GO:0051090),413,35,41.99,-,0.83,1.55E-01
pattern recognition receptor signaling pathway (GO:0002221),118,10,12,-,0.83,3.47E-01
glycosyl compound metabolic process (GO:1901657),118,10,12,-,0.83,3.47E-01
cellular carbohydrate biosynthetic process (GO:0034637),59,5,6,-,0.83,4.46E-01
forebrain development (GO:0030900),378,32,38.43,-,0.83,1.67E-01
regulation of trans-synaptic signaling (GO:0099177),390,33,39.65,-,0.83,1.61E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),201,17,20.43,-,0.83,2.64E-01
organophosphate biosynthetic process (GO:0090407),485,41,49.31,-,0.83,1.28E-01
neuron differentiation (GO:0030182),982,83,99.83,-,0.83,4.30E-02
positive regulation of small molecule metabolic process (GO:0062013),142,12,14.44,-,0.83,3.16E-01
regulation of humoral immune response (GO:0002920),71,6,7.22,-,0.83,4.17E-01
outflow tract morphogenesis (GO:0003151),71,6,7.22,-,0.83,4.17E-01
cellular response to nitrogen compound (GO:1901699),604,51,61.4,-,0.83,9.63E-02
regulation of extrinsic apoptotic signaling pathway (GO:2001236),154,13,15.66,-,0.83,3.02E-01
humoral immune response (GO:0006959),237,20,24.09,-,0.83,2.35E-01
organelle localization (GO:0051640),569,48,57.85,-,0.83,1.03E-01
protein tetramerization (GO:0051262),83,7,8.44,-,0.83,3.93E-01
positive regulation of protein binding (GO:0032092),83,7,8.44,-,0.83,3.93E-01
negative regulation of MAPK cascade (GO:0043409),166,14,16.88,-,0.83,2.90E-01
peptidyl-serine phosphorylation (GO:0018105),178,15,18.1,-,0.83,2.78E-01
negative regulation of cellular component organization (GO:0051129),653,55,66.38,-,0.83,8.35E-02
icosanoid metabolic process (GO:0006690),95,8,9.66,-,0.83,3.72E-01
regulation of cell junction assembly (GO:1901888),190,16,19.32,-,0.83,2.67E-01
epithelial cell development (GO:0002064),190,16,19.32,-,0.83,2.67E-01
tissue migration (GO:0090130),95,8,9.66,-,0.83,3.72E-01
response to heat (GO:0009408),95,8,9.66,-,0.83,3.72E-01
negative regulation of phosphatase activity (GO:0010923),95,8,9.66,-,0.83,3.72E-01
regulation of Notch signaling pathway (GO:0008593),95,8,9.66,-,0.83,3.72E-01
positive regulation of production of molecular mediator of immune response (GO:0002702),95,8,9.66,-,0.83,3.72E-01
mitotic cell cycle process (GO:1903047),630,53,64.05,-,0.83,8.66E-02
ribonucleoprotein complex export from nucleus (GO:0071426),107,9,10.88,-,0.83,3.53E-01
covalent chromatin modification (GO:0016569),333,28,33.85,-,0.83,1.77E-01
proteolysis involved in cellular protein catabolic process (GO:0051603),536,45,54.49,-,0.83,1.05E-01
regulation of membrane potential (GO:0042391),418,35,42.49,-,0.82,1.37E-01
nucleobase-containing compound transport (GO:0015931),227,19,23.08,-,0.82,2.31E-01
cilium organization (GO:0044782),323,27,32.84,-,0.82,1.74E-01
response to decreased oxygen levels (GO:0036293),335,28,34.06,-,0.82,1.68E-01
regulation of T cell tolerance induction (GO:0002664),12,1,1.22,-,0.82,6.55E-01
phospholipid efflux (GO:0033700),12,1,1.22,-,0.82,6.55E-01
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),24,2,2.44,-,0.82,5.59E-01
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071),24,2,2.44,-,0.82,5.59E-01
pigment biosynthetic process (GO:0046148),48,4,4.88,-,0.82,4.62E-01
ER overload response (GO:0006983),12,1,1.22,-,0.82,6.55E-01
cerebellar cortex formation (GO:0021697),24,2,2.44,-,0.82,5.59E-01
negative regulation of mitotic sister chromatid separation (GO:2000816),24,2,2.44,-,0.82,5.59E-01
regulation of bicellular tight junction assembly (GO:2000810),24,2,2.44,-,0.82,5.59E-01
mammary gland epithelial cell proliferation (GO:0033598),12,1,1.22,-,0.82,6.55E-01
optic nerve development (GO:0021554),12,1,1.22,-,0.82,6.55E-01
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976),12,1,1.22,-,0.82,6.55E-01
suckling behavior (GO:0001967),12,1,1.22,-,0.82,6.55E-01
startle response (GO:0001964),24,2,2.44,-,0.82,5.59E-01
heart looping (GO:0001947),60,5,6.1,-,0.82,4.29E-01
lymph vessel development (GO:0001945),24,2,2.44,-,0.82,5.59E-01
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),12,1,1.22,-,0.82,6.55E-01
ATP biosynthetic process (GO:0006754),24,2,2.44,-,0.82,5.59E-01
regulation of dendritic cell differentiation (GO:2001198),12,1,1.22,-,0.82,6.55E-01
lymphoid progenitor cell differentiation (GO:0002320),12,1,1.22,-,0.82,6.55E-01
regulation of nephron tubule epithelial cell differentiation (GO:0072182),12,1,1.22,-,0.82,6.55E-01
nephric duct morphogenesis (GO:0072178),12,1,1.22,-,0.82,6.55E-01
regulation of receptor catabolic process (GO:2000644),12,1,1.22,-,0.82,6.55E-01
sphingomyelin metabolic process (GO:0006684),12,1,1.22,-,0.82,6.55E-01
ectodermal placode morphogenesis (GO:0071697),12,1,1.22,-,0.82,6.55E-01
commissural neuron axon guidance (GO:0071679),12,1,1.22,-,0.82,6.55E-01
positive regulation of MHC class II biosynthetic process (GO:0045348),12,1,1.22,-,0.82,6.55E-01
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),12,1,1.22,-,0.82,6.55E-01
mesodermal cell fate commitment (GO:0001710),12,1,1.22,-,0.82,6.55E-01
synapse maturation (GO:0060074),12,1,1.22,-,0.82,6.55E-01
pharyngeal system development (GO:0060037),24,2,2.44,-,0.82,5.59E-01
melanin metabolic process (GO:0006582),12,1,1.22,-,0.82,6.55E-01
tryptophan metabolic process (GO:0006568),12,1,1.22,-,0.82,6.55E-01
acetylcholine receptor signaling pathway (GO:0095500),24,2,2.44,-,0.82,5.59E-01
basic amino acid transmembrane transport (GO:1990822),12,1,1.22,-,0.82,6.55E-01
mitochondrial tRNA processing (GO:0090646),12,1,1.22,-,0.82,6.55E-01
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),12,1,1.22,-,0.82,6.55E-01
positive regulation of tumor necrosis factor production (GO:0032760),84,7,8.54,-,0.82,3.80E-01
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),12,1,1.22,-,0.82,6.55E-01
positive regulation of interferon-alpha production (GO:0032727),24,2,2.44,-,0.82,5.59E-01
protein acetylation (GO:0006473),120,10,12.2,-,0.82,3.26E-01
C-terminal protein amino acid modification (GO:0018410),12,1,1.22,-,0.82,6.55E-01
neuronal ion channel clustering (GO:0045161),12,1,1.22,-,0.82,6.55E-01
angiotensin maturation (GO:0002003),12,1,1.22,-,0.82,6.55E-01
regulation of angiotensin levels in blood (GO:0002002),12,1,1.22,-,0.82,6.55E-01
calcineurin-NFAT signaling cascade (GO:0033173),12,1,1.22,-,0.82,6.55E-01
response to protozoan (GO:0001562),24,2,2.44,-,0.82,5.59E-01
UV-damage excision repair (GO:0070914),12,1,1.22,-,0.82,6.55E-01
global genome nucleotide-excision repair (GO:0070911),24,2,2.44,-,0.82,5.59E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),24,2,2.44,-,0.82,5.59E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048),24,2,2.44,-,0.82,5.59E-01
negative regulation of sister chromatid segregation (GO:0033046),24,2,2.44,-,0.82,5.59E-01
protein mono-ADP-ribosylation (GO:0140289),12,1,1.22,-,0.82,6.55E-01
protein-chromophore linkage (GO:0018298),12,1,1.22,-,0.82,6.55E-01
negative regulation of cell aging (GO:0090344),24,2,2.44,-,0.82,5.59E-01
positive regulation of protein deacetylation (GO:0090312),24,2,2.44,-,0.82,5.59E-01
response to peptidoglycan (GO:0032494),12,1,1.22,-,0.82,6.55E-01
negative regulation of multicellular organism growth (GO:0040015),12,1,1.22,-,0.82,6.55E-01
ribonucleoprotein complex localization (GO:0071166),108,9,10.98,-,0.82,3.42E-01
histone H4 acetylation (GO:0043967),48,4,4.88,-,0.82,4.62E-01
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),12,1,1.22,-,0.82,6.55E-01
regulation of animal organ morphogenesis (GO:2000027),180,15,18.3,-,0.82,2.62E-01
lactate metabolic process (GO:0006089),12,1,1.22,-,0.82,6.55E-01
ethanol oxidation (GO:0006069),12,1,1.22,-,0.82,6.55E-01
maintenance of protein location in nucleus (GO:0051457),24,2,2.44,-,0.82,5.59E-01
fructose 6-phosphate metabolic process (GO:0006002),12,1,1.22,-,0.82,6.55E-01
regulation of ventricular cardiac muscle cell action potential (GO:0098911),12,1,1.22,-,0.82,6.55E-01
intestinal lipid absorption (GO:0098856),12,1,1.22,-,0.82,6.55E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),12,1,1.22,-,0.82,6.55E-01
response to oxygen levels (GO:0070482),360,30,36.6,-,0.82,1.53E-01
negative regulation of T cell receptor signaling pathway (GO:0050860),24,2,2.44,-,0.82,5.59E-01
positive regulation of coagulation (GO:0050820),24,2,2.44,-,0.82,5.59E-01
regulation of dendrite development (GO:0050773),96,8,9.76,-,0.82,3.60E-01
UV protection (GO:0009650),12,1,1.22,-,0.82,6.55E-01
skeletal muscle adaptation (GO:0043501),12,1,1.22,-,0.82,6.55E-01
response to UV-A (GO:0070141),12,1,1.22,-,0.82,6.55E-01
inhibitory synapse assembly (GO:1904862),12,1,1.22,-,0.82,6.55E-01
regulation of aspartic-type peptidase activity (GO:1905245),12,1,1.22,-,0.82,6.55E-01
proteasome assembly (GO:0043248),12,1,1.22,-,0.82,6.55E-01
negative regulation of long-term synaptic potentiation (GO:1900272),12,1,1.22,-,0.82,6.55E-01
inositol phosphate-mediated signaling (GO:0048016),24,2,2.44,-,0.82,5.59E-01
hepatocyte growth factor receptor signaling pathway (GO:0048012),12,1,1.22,-,0.82,6.55E-01
cytoplasmic microtubule organization (GO:0031122),60,5,6.1,-,0.82,4.29E-01
regulation of response to osmotic stress (GO:0047484),12,1,1.22,-,0.82,6.55E-01
vitamin catabolic process (GO:0009111),12,1,1.22,-,0.82,6.55E-01
regulation of cellular response to hypoxia (GO:1900037),12,1,1.22,-,0.82,6.55E-01
nucleotide-sugar transmembrane transport (GO:0015780),12,1,1.22,-,0.82,6.55E-01
cell-cell signaling involved in cardiac conduction (GO:0086019),24,2,2.44,-,0.82,5.59E-01
secondary palate development (GO:0062009),24,2,2.44,-,0.82,5.59E-01
oxygen transport (GO:0015671),12,1,1.22,-,0.82,6.55E-01
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),12,1,1.22,-,0.82,6.55E-01
regulation of deacetylase activity (GO:0150065),12,1,1.22,-,0.82,6.55E-01
iron ion transmembrane transport (GO:0034755),12,1,1.22,-,0.82,6.55E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196),24,2,2.44,-,0.82,5.59E-01
embryonic camera-type eye formation (GO:0060900),12,1,1.22,-,0.82,6.55E-01
zymogen inhibition (GO:0097341),12,1,1.22,-,0.82,6.55E-01
plasma membrane tubulation (GO:0097320),12,1,1.22,-,0.82,6.55E-01
heparin metabolic process (GO:0030202),12,1,1.22,-,0.82,6.55E-01
positive regulation of cardiac muscle hypertrophy (GO:0010613),24,2,2.44,-,0.82,5.59E-01
endochondral bone growth (GO:0003416),24,2,2.44,-,0.82,5.59E-01
lipoprotein biosynthetic process (GO:0042158),84,7,8.54,-,0.82,3.80E-01
endothelial cell activation (GO:0042118),12,1,1.22,-,0.82,6.55E-01
renal filtration (GO:0097205),12,1,1.22,-,0.82,6.55E-01
one-carbon compound transport (GO:0019755),12,1,1.22,-,0.82,6.55E-01
ectodermal placode formation (GO:0060788),12,1,1.22,-,0.82,6.55E-01
regulation of cilium beat frequency (GO:0003356),12,1,1.22,-,0.82,6.55E-01
glycerophospholipid catabolic process (GO:0046475),24,2,2.44,-,0.82,5.59E-01
acylglycerol biosynthetic process (GO:0046463),24,2,2.44,-,0.82,5.59E-01
neutral lipid biosynthetic process (GO:0046460),24,2,2.44,-,0.82,5.59E-01
ruffle assembly (GO:0097178),12,1,1.22,-,0.82,6.55E-01
negative regulation of immunoglobulin mediated immune response (GO:0002890),12,1,1.22,-,0.82,6.55E-01
actin filament depolymerization (GO:0030042),12,1,1.22,-,0.82,6.55E-01
regulation of rhodopsin mediated signaling pathway (GO:0022400),24,2,2.44,-,0.82,5.59E-01
grooming behavior (GO:0007625),12,1,1.22,-,0.82,6.55E-01
branching involved in labyrinthine layer morphogenesis (GO:0060670),12,1,1.22,-,0.82,6.55E-01
positive regulation of amyloid precursor protein catabolic process (GO:1902993),24,2,2.44,-,0.82,5.59E-01
cardiac chamber formation (GO:0003207),12,1,1.22,-,0.82,6.55E-01
very-low-density lipoprotein particle assembly (GO:0034379),12,1,1.22,-,0.82,6.55E-01
positive regulation of muscle hypertrophy (GO:0014742),24,2,2.44,-,0.82,5.59E-01
regulation of membrane lipid distribution (GO:0097035),48,4,4.88,-,0.82,4.62E-01
negative regulation of B cell mediated immunity (GO:0002713),12,1,1.22,-,0.82,6.55E-01
layer formation in cerebral cortex (GO:0021819),12,1,1.22,-,0.82,6.55E-01
carbohydrate transmembrane transport (GO:0034219),36,3,3.66,-,0.82,5.02E-01
response to glucagon (GO:0033762),36,3,3.66,-,0.82,5.02E-01
T cell mediated immunity (GO:0002456),36,3,3.66,-,0.82,5.02E-01
'de novo' protein folding (GO:0006458),36,3,3.66,-,0.82,5.02E-01
cellular response to estradiol stimulus (GO:0071392),36,3,3.66,-,0.82,5.02E-01
glycosyl compound biosynthetic process (GO:1901659),36,3,3.66,-,0.82,5.02E-01
positive regulation of response to endoplasmic reticulum stress (GO:1905898),36,3,3.66,-,0.82,5.02E-01
regulation of hormone metabolic process (GO:0032350),36,3,3.66,-,0.82,5.02E-01
animal organ formation (GO:0048645),36,3,3.66,-,0.82,5.02E-01
eye morphogenesis (GO:0048592),144,12,14.64,-,0.82,2.98E-01
triglyceride homeostasis (GO:0070328),36,3,3.66,-,0.82,5.02E-01
developmental pigmentation (GO:0048066),36,3,3.66,-,0.82,5.02E-01
platelet-derived growth factor receptor signaling pathway (GO:0048008),36,3,3.66,-,0.82,5.02E-01
acylglycerol homeostasis (GO:0055090),36,3,3.66,-,0.82,5.02E-01
purine nucleotide transport (GO:0015865),36,3,3.66,-,0.82,5.02E-01
receptor signaling pathway via STAT (GO:0097696),36,3,3.66,-,0.82,5.02E-01
negative regulation of muscle cell apoptotic process (GO:0010656),36,3,3.66,-,0.82,5.02E-01
B cell proliferation (GO:0042100),36,3,3.66,-,0.82,5.02E-01
regulation of protein targeting (GO:1903533),72,6,7.32,-,0.82,4.03E-01
positive regulation of glucose import (GO:0046326),36,3,3.66,-,0.82,5.02E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),132,11,13.42,-,0.82,3.11E-01
nucleobase-containing small molecule metabolic process (GO:0055086),457,38,46.46,-,0.82,1.16E-01
blood circulation (GO:0008015),385,32,39.14,-,0.82,1.40E-01
protein catabolic process (GO:0030163),614,51,62.42,-,0.82,7.62E-02
mitotic cell cycle (GO:0000278),699,58,71.06,-,0.82,6.05E-02
regulation of protein polymerization (GO:0032271),217,18,22.06,-,0.82,2.27E-01
gamete generation (GO:0007276),605,50,61.51,-,0.81,7.30E-02
viral process (GO:0016032),799,66,81.23,-,0.81,4.36E-02
metencephalon development (GO:0022037),109,9,11.08,-,0.81,3.31E-01
skeletal system morphogenesis (GO:0048705),218,18,22.16,-,0.81,2.21E-01
brain development (GO:0007420),715,59,72.69,-,0.81,5.34E-02
cilium assembly (GO:0060271),303,25,30.8,-,0.81,1.68E-01
peptidyl-tyrosine dephosphorylation (GO:0035335),97,8,9.86,-,0.81,3.48E-01
nuclear chromosome segregation (GO:0098813),182,15,18.5,-,0.81,2.47E-01
embryonic placenta development (GO:0001892),85,7,8.64,-,0.81,3.67E-01
biological phase (GO:0044848),255,21,25.92,-,0.81,1.92E-01
mitotic cell cycle phase (GO:0098763),255,21,25.92,-,0.81,1.92E-01
cell cycle phase (GO:0022403),255,21,25.92,-,0.81,1.92E-01
mitotic cell cycle checkpoint (GO:0007093),146,12,14.84,-,0.81,2.80E-01
nucleoside phosphate catabolic process (GO:1901292),73,6,7.42,-,0.81,3.89E-01
regulation of plasma lipoprotein particle levels (GO:0097006),73,6,7.42,-,0.81,3.89E-01
spermatid development (GO:0007286),134,11,13.62,-,0.81,2.92E-01
regulation of nervous system process (GO:0031644),134,11,13.62,-,0.81,2.92E-01
regulation of cellular carbohydrate metabolic process (GO:0010675),134,11,13.62,-,0.81,2.92E-01
histone modification (GO:0016570),329,27,33.45,-,0.81,1.49E-01
regulation of carbohydrate metabolic process (GO:0006109),195,16,19.82,-,0.81,2.31E-01
cellular iron ion homeostasis (GO:0006879),61,5,6.2,-,0.81,4.14E-01
pattern specification process (GO:0007389),403,33,40.97,-,0.81,1.16E-01
cell cycle phase transition (GO:0044770),281,23,28.57,-,0.81,1.70E-01
response to temperature stimulus (GO:0009266),159,13,16.16,-,0.8,2.60E-01
response to peptide (GO:1901652),453,37,46.05,-,0.8,9.76E-02
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),49,4,4.98,-,0.8,4.43E-01
Golgi to plasma membrane transport (GO:0006893),49,4,4.98,-,0.8,4.43E-01
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),49,4,4.98,-,0.8,4.43E-01
endothelial cell development (GO:0001885),49,4,4.98,-,0.8,4.43E-01
epidermal growth factor receptor signaling pathway (GO:0007173),49,4,4.98,-,0.8,4.43E-01
membrane depolarization (GO:0051899),49,4,4.98,-,0.8,4.43E-01
regulation of cilium assembly (GO:1902017),49,4,4.98,-,0.8,4.43E-01
defense response to virus (GO:0051607),196,16,19.93,-,0.8,2.24E-01
regulation of action potential (GO:0098900),49,4,4.98,-,0.8,4.43E-01
cochlea development (GO:0090102),49,4,4.98,-,0.8,4.43E-01
regulation of microtubule polymerization (GO:0031113),49,4,4.98,-,0.8,4.43E-01
regulation of calcium ion transport into cytosol (GO:0010522),98,8,9.96,-,0.8,3.36E-01
purine-containing compound catabolic process (GO:0072523),49,4,4.98,-,0.8,4.43E-01
heart morphogenesis (GO:0003007),233,19,23.69,-,0.8,1.95E-01
response to radiation (GO:0009314),417,34,42.39,-,0.8,1.07E-01
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),135,11,13.72,-,0.8,2.83E-01
regulation of cell cycle process (GO:0010564),700,57,71.16,-,0.8,4.54E-02
regulation of chromosome organization (GO:0033044),258,21,26.23,-,0.8,1.77E-01
plasma membrane organization (GO:0007009),86,7,8.74,-,0.8,3.54E-01
epithelial cell migration (GO:0010631),86,7,8.74,-,0.8,3.54E-01
negative regulation of peptide secretion (GO:0002792),86,7,8.74,-,0.8,3.54E-01
chordate embryonic development (GO:0043009),578,47,58.76,-,0.8,6.37E-02
nucleoside phosphate metabolic process (GO:0006753),382,31,38.83,-,0.8,1.14E-01
peripheral nervous system development (GO:0007422),74,6,7.52,-,0.8,3.75E-01
vesicle fusion (GO:0006906),74,6,7.52,-,0.8,3.75E-01
myoblast differentiation (GO:0045445),37,3,3.76,-,0.8,4.81E-01
maternal placenta development (GO:0001893),37,3,3.76,-,0.8,4.81E-01
homologous chromosome pairing at meiosis (GO:0007129),37,3,3.76,-,0.8,4.81E-01
cardiac muscle contraction (GO:0060048),74,6,7.52,-,0.8,3.75E-01
sarcomere organization (GO:0045214),37,3,3.76,-,0.8,4.81E-01
lens development in camera-type eye (GO:0002088),74,6,7.52,-,0.8,3.75E-01
negative regulation of interferon-gamma production (GO:0032689),37,3,3.76,-,0.8,4.81E-01
muscle organ morphogenesis (GO:0048644),74,6,7.52,-,0.8,3.75E-01
positive regulation of nervous system process (GO:0031646),37,3,3.76,-,0.8,4.81E-01
autophagy of mitochondrion (GO:0000422),37,3,3.76,-,0.8,4.81E-01
phospholipid catabolic process (GO:0009395),37,3,3.76,-,0.8,4.81E-01
nucleotide-sugar metabolic process (GO:0009225),37,3,3.76,-,0.8,4.81E-01
mitochondrion disassembly (GO:0061726),37,3,3.76,-,0.8,4.81E-01
immunoglobulin mediated immune response (GO:0016064),74,6,7.52,-,0.8,3.75E-01
negative regulation of insulin secretion (GO:0046676),37,3,3.76,-,0.8,4.81E-01
embryonic heart tube development (GO:0035050),74,6,7.52,-,0.8,3.75E-01
positive regulation of fatty acid metabolic process (GO:0045923),37,3,3.76,-,0.8,4.81E-01
somite development (GO:0061053),74,6,7.52,-,0.8,3.75E-01
pyrimidine-containing compound catabolic process (GO:0072529),37,3,3.76,-,0.8,4.81E-01
heart development (GO:0007507),494,40,50.22,-,0.8,7.82E-02
cornification (GO:0070268),99,8,10.06,-,0.79,3.25E-01
nucleotide metabolic process (GO:0009117),372,30,37.82,-,0.79,1.12E-01
artery morphogenesis (GO:0048844),62,5,6.3,-,0.79,3.98E-01
protein transport along microtubule (GO:0098840),62,5,6.3,-,0.79,3.98E-01
microtubule-based protein transport (GO:0099118),62,5,6.3,-,0.79,3.98E-01
regulation of muscle cell apoptotic process (GO:0010660),62,5,6.3,-,0.79,3.98E-01
sensory perception of smell (GO:0007608),124,10,12.61,-,0.79,2.86E-01
mitotic cell cycle phase transition (GO:0044772),273,22,27.75,-,0.79,1.57E-01
reproductive system development (GO:0061458),410,33,41.68,-,0.79,9.64E-02
regulation of neural precursor cell proliferation (GO:2000177),87,7,8.84,-,0.79,3.42E-01
artery development (GO:0060840),87,7,8.84,-,0.79,3.42E-01
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),87,7,8.84,-,0.79,3.42E-01
protein secretion (GO:0009306),112,9,11.39,-,0.79,2.99E-01
polyol metabolic process (GO:0019751),112,9,11.39,-,0.79,2.99E-01
cilium movement (GO:0003341),112,9,11.39,-,0.79,2.99E-01
vesicle organization (GO:0016050),287,23,29.18,-,0.79,1.43E-01
triglyceride catabolic process (GO:0019433),25,2,2.54,-,0.79,5.33E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921),25,2,2.54,-,0.79,5.33E-01
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25,2,2.54,-,0.79,5.33E-01
regulation of water loss via skin (GO:0033561),25,2,2.54,-,0.79,5.33E-01
gamma-aminobutyric acid signaling pathway (GO:0007214),25,2,2.54,-,0.79,5.33E-01
placenta development (GO:0001890),150,12,15.25,-,0.79,2.46E-01
regulation of transcription regulatory region DNA binding (GO:2000677),50,4,5.08,-,0.79,4.26E-01
regulation of syncytium formation by plasma membrane fusion (GO:0060142),25,2,2.54,-,0.79,5.33E-01
positive regulation of mononuclear cell migration (GO:0071677),25,2,2.54,-,0.79,5.33E-01
negative regulation of organic acid transport (GO:0032891),25,2,2.54,-,0.79,5.33E-01
negative regulation of chromosome segregation (GO:0051985),25,2,2.54,-,0.79,5.33E-01
response to dietary excess (GO:0002021),25,2,2.54,-,0.79,5.33E-01
intraspecies interaction between organisms (GO:0051703),50,4,5.08,-,0.79,4.26E-01
regulation of meiotic nuclear division (GO:0040020),25,2,2.54,-,0.79,5.33E-01
positive regulation of protein autophosphorylation (GO:0031954),25,2,2.54,-,0.79,5.33E-01
negative regulation of chromosome separation (GO:1905819),25,2,2.54,-,0.79,5.33E-01
peptidyl-lysine trimethylation (GO:0018023),25,2,2.54,-,0.79,5.33E-01
regulation of monocyte chemotaxis (GO:0090025),25,2,2.54,-,0.79,5.33E-01
regulation of response to nutrient levels (GO:0032107),25,2,2.54,-,0.79,5.33E-01
regulation of response to extracellular stimulus (GO:0032104),25,2,2.54,-,0.79,5.33E-01
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),25,2,2.54,-,0.79,5.33E-01
presynapse organization (GO:0099172),25,2,2.54,-,0.79,5.33E-01
lens fiber cell differentiation (GO:0070306),25,2,2.54,-,0.79,5.33E-01
focal adhesion assembly (GO:0048041),25,2,2.54,-,0.79,5.33E-01
regulation of cellular response to heat (GO:1900034),75,6,7.62,-,0.79,3.61E-01
positive regulation of lipid storage (GO:0010884),25,2,2.54,-,0.79,5.33E-01
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),25,2,2.54,-,0.79,5.33E-01
social behavior (GO:0035176),50,4,5.08,-,0.79,4.26E-01
negative regulation of endothelial cell migration (GO:0010596),50,4,5.08,-,0.79,4.26E-01
positive regulation of carbohydrate metabolic process (GO:0045913),75,6,7.62,-,0.79,3.61E-01
heart valve morphogenesis (GO:0003179),50,4,5.08,-,0.79,4.26E-01
atrioventricular valve development (GO:0003171),25,2,2.54,-,0.79,5.33E-01
regulation of vesicle-mediated transport (GO:0060627),488,39,49.61,-,0.79,6.86E-02
response to interleukin-1 (GO:0070555),188,15,19.11,-,0.78,2.06E-01
RNA export from nucleus (GO:0006405),113,9,11.49,-,0.78,2.89E-01
regulation of protein-containing complex disassembly (GO:0043244),113,9,11.49,-,0.78,2.89E-01
establishment of protein localization to extracellular region (GO:0035592),113,9,11.49,-,0.78,2.89E-01
positive regulation of T cell differentiation (GO:0045582),88,7,8.95,-,0.78,3.30E-01
epithelium migration (GO:0090132),88,7,8.95,-,0.78,3.30E-01
segmentation (GO:0035282),88,7,8.95,-,0.78,3.30E-01
regulation of actin polymerization or depolymerization (GO:0008064),176,14,17.89,-,0.78,2.14E-01
ubiquitin-dependent protein catabolic process (GO:0006511),478,38,48.59,-,0.78,6.68E-02
regulation of generation of precursor metabolites and energy (GO:0043467),151,12,15.35,-,0.78,2.38E-01
negative regulation of secretion by cell (GO:1903531),151,12,15.35,-,0.78,2.38E-01
modification-dependent macromolecule catabolic process (GO:0043632),491,39,49.92,-,0.78,6.31E-02
negative regulation of protein depolymerization (GO:1901880),63,5,6.4,-,0.78,3.83E-01
regulation of B cell proliferation (GO:0030888),63,5,6.4,-,0.78,3.83E-01
negative regulation of BMP signaling pathway (GO:0030514),63,5,6.4,-,0.78,3.83E-01
somatic stem cell population maintenance (GO:0035019),63,5,6.4,-,0.78,3.83E-01
intracellular receptor signaling pathway (GO:0030522),189,15,19.21,-,0.78,2.00E-01
positive regulation of cell cycle (GO:0045787),366,29,37.21,-,0.78,9.72E-02
embryo development ending in birth or egg hatching (GO:0009792),594,47,60.39,-,0.78,4.16E-02
regulation of actin filament length (GO:0030832),177,14,17.99,-,0.78,2.07E-01
regulation of autophagy of mitochondrion (GO:1903146),38,3,3.86,-,0.78,4.60E-01
regulation of actin filament-based movement (GO:1903115),38,3,3.86,-,0.78,4.60E-01
activation of adenylate cyclase activity (GO:0007190),38,3,3.86,-,0.78,4.60E-01
mitotic spindle organization (GO:0007052),152,12,15.45,-,0.78,2.31E-01
glandular epithelial cell differentiation (GO:0002067),38,3,3.86,-,0.78,4.60E-01
negative regulation of organelle assembly (GO:1902116),38,3,3.86,-,0.78,4.60E-01
response to electrical stimulus (GO:0051602),38,3,3.86,-,0.78,4.60E-01
regulation of potassium ion transmembrane transport (GO:1901379),76,6,7.73,-,0.78,3.47E-01
regulation of endocrine process (GO:0044060),38,3,3.86,-,0.78,4.60E-01
regulation of purine nucleotide biosynthetic process (GO:1900371),38,3,3.86,-,0.78,4.60E-01
prostate gland development (GO:0030850),38,3,3.86,-,0.78,4.60E-01
negative regulation of ossification (GO:0030279),38,3,3.86,-,0.78,4.60E-01
phosphatidylcholine metabolic process (GO:0046470),76,6,7.73,-,0.78,3.47E-01
positive regulation of muscle contraction (GO:0045933),38,3,3.86,-,0.78,4.60E-01
plasma lipoprotein particle clearance (GO:0034381),38,3,3.86,-,0.78,4.60E-01
regulation of exocytosis (GO:0017157),190,15,19.32,-,0.78,1.93E-01
modification-dependent protein catabolic process (GO:0019941),482,38,49,-,0.78,5.97E-02
reproductive structure development (GO:0048608),406,32,41.27,-,0.78,7.93E-02
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),178,14,18.1,-,0.77,2.00E-01
regulation of tumor necrosis factor production (GO:0032680),140,11,14.23,-,0.77,2.40E-01
spermatid differentiation (GO:0048515),140,11,14.23,-,0.77,2.40E-01
positive regulation of Notch signaling pathway (GO:0045747),51,4,5.18,-,0.77,4.08E-01
positive regulation of lymphocyte differentiation (GO:0045621),102,8,10.37,-,0.77,2.92E-01
long-chain fatty acid metabolic process (GO:0001676),102,8,10.37,-,0.77,2.92E-01
T cell differentiation in thymus (GO:0033077),51,4,5.18,-,0.77,4.08E-01
mitotic sister chromatid segregation (GO:0000070),102,8,10.37,-,0.77,2.92E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518),51,4,5.18,-,0.77,4.08E-01
positive regulation of cellular carbohydrate metabolic process (GO:0010676),51,4,5.18,-,0.77,4.08E-01
regulation of stress-activated MAPK cascade (GO:0032872),166,13,16.88,-,0.77,2.08E-01
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),230,18,23.38,-,0.77,1.54E-01
non-canonical Wnt signaling pathway (GO:0035567),128,10,13.01,-,0.77,2.50E-01
axo-dendritic transport (GO:0008088),64,5,6.51,-,0.77,3.68E-01
sex differentiation (GO:0007548),256,20,26.03,-,0.77,1.36E-01
proteasomal protein catabolic process (GO:0010498),320,25,32.53,-,0.77,1.03E-01
dorsal/ventral pattern formation (GO:0009953),77,6,7.83,-,0.77,3.34E-01
adult locomotory behavior (GO:0008344),77,6,7.83,-,0.77,3.34E-01
B cell mediated immunity (GO:0019724),77,6,7.83,-,0.77,3.34E-01
receptor-mediated endocytosis (GO:0006898),180,14,18.3,-,0.77,1.88E-01
respiratory electron transport chain (GO:0022904),90,7,9.15,-,0.77,3.06E-01
central nervous system neuron differentiation (GO:0021953),180,14,18.3,-,0.77,1.88E-01
regulation of reactive oxygen species biosynthetic process (GO:1903426),90,7,9.15,-,0.77,3.06E-01
positive regulation of endothelial cell migration (GO:0010595),103,8,10.47,-,0.76,2.82E-01
regulation of protein modification by small protein conjugation or removal (GO:1903320),219,17,22.26,-,0.76,1.54E-01
regulation of cellular protein catabolic process (GO:1903362),232,18,23.59,-,0.76,1.44E-01
regulation of endothelial cell proliferation (GO:0001936),129,10,13.11,-,0.76,2.41E-01
mitochondrial membrane organization (GO:0007006),129,10,13.11,-,0.76,2.41E-01
cell recognition (GO:0008037),142,11,14.44,-,0.76,2.24E-01
negative regulation of organelle organization (GO:0010639),310,24,31.52,-,0.76,9.99E-02
cellular response to peptide (GO:1901653),323,25,32.84,-,0.76,9.41E-02
cell cycle checkpoint (GO:0000075),181,14,18.4,-,0.76,1.82E-01
binding of sperm to zona pellucida (GO:0007339),39,3,3.96,-,0.76,4.40E-01
cilium movement involved in cell motility (GO:0060294),78,6,7.93,-,0.76,3.21E-01
one-carbon metabolic process (GO:0006730),39,3,3.96,-,0.76,4.40E-01
phospholipid translocation (GO:0045332),39,3,3.96,-,0.76,4.40E-01
semaphorin-plexin signaling pathway (GO:0071526),39,3,3.96,-,0.76,4.40E-01
regulation of mitotic sister chromatid segregation (GO:0033047),39,3,3.96,-,0.76,4.40E-01
mitochondrial RNA metabolic process (GO:0000959),39,3,3.96,-,0.76,4.40E-01
peptidyl-threonine modification (GO:0018210),78,6,7.93,-,0.76,3.21E-01
lysosome localization (GO:0032418),39,3,3.96,-,0.76,4.40E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302),169,13,17.18,-,0.76,1.88E-01
regulation of defense response to virus by host (GO:0050691),39,3,3.96,-,0.76,4.40E-01
regulation of nucleotide biosynthetic process (GO:0030808),39,3,3.96,-,0.76,4.40E-01
cholesterol homeostasis (GO:0042632),78,6,7.93,-,0.76,3.21E-01
positive regulation of pattern recognition receptor signaling pathway (GO:0062208),39,3,3.96,-,0.76,4.40E-01
chondroitin sulfate metabolic process (GO:0030204),39,3,3.96,-,0.76,4.40E-01
telencephalon development (GO:0021537),247,19,25.11,-,0.76,1.27E-01
chromosome segregation (GO:0007059),234,18,23.79,-,0.76,1.35E-01
negative regulation of acute inflammatory response (GO:0002674),13,1,1.32,-,0.76,6.19E-01
cerebellar Purkinje cell differentiation (GO:0021702),13,1,1.32,-,0.76,6.19E-01
striated muscle contraction (GO:0006941),104,8,10.57,-,0.76,2.71E-01
negative regulation of epidermis development (GO:0045683),13,1,1.32,-,0.76,6.19E-01
cerebellar Purkinje cell layer formation (GO:0021694),13,1,1.32,-,0.76,6.19E-01
negative regulation of epidermal cell differentiation (GO:0045605),13,1,1.32,-,0.76,6.19E-01
AMP metabolic process (GO:0046033),13,1,1.32,-,0.76,6.19E-01
cellular response to epinephrine stimulus (GO:0071872),13,1,1.32,-,0.76,6.19E-01
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),13,1,1.32,-,0.76,6.19E-01
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),13,1,1.32,-,0.76,6.19E-01
negative regulation of stem cell proliferation (GO:2000647),13,1,1.32,-,0.76,6.19E-01
inositol phosphate biosynthetic process (GO:0032958),13,1,1.32,-,0.76,6.19E-01
ectodermal placode development (GO:0071696),13,1,1.32,-,0.76,6.19E-01
stem cell proliferation (GO:0072089),52,4,5.29,-,0.76,3.91E-01
renal vesicle morphogenesis (GO:0072077),13,1,1.32,-,0.76,6.19E-01
positive regulation of cardiac muscle cell proliferation (GO:0060045),26,2,2.64,-,0.76,5.08E-01
cardiac muscle cell proliferation (GO:0060038),13,1,1.32,-,0.76,6.19E-01
convergent extension (GO:0060026),13,1,1.32,-,0.76,6.19E-01
polyamine biosynthetic process (GO:0006596),13,1,1.32,-,0.76,6.19E-01
glutamate metabolic process (GO:0006536),26,2,2.64,-,0.76,5.08E-01
negative regulation of amino acid transport (GO:0051956),13,1,1.32,-,0.76,6.19E-01
cellular glucose homeostasis (GO:0001678),91,7,9.25,-,0.76,2.95E-01
negative regulation by host of viral process (GO:0044793),13,1,1.32,-,0.76,6.19E-01
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),13,1,1.32,-,0.76,6.19E-01
positive regulation of interleukin-5 production (GO:0032754),13,1,1.32,-,0.76,6.19E-01
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),13,1,1.32,-,0.76,6.19E-01
negative regulation of receptor internalization (GO:0002091),13,1,1.32,-,0.76,6.19E-01
chondrocyte development (GO:0002063),26,2,2.64,-,0.76,5.08E-01
apical protein localization (GO:0045176),13,1,1.32,-,0.76,6.19E-01
cellular response to purine-containing compound (GO:0071415),13,1,1.32,-,0.76,6.19E-01
branching involved in blood vessel morphogenesis (GO:0001569),26,2,2.64,-,0.76,5.08E-01
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),26,2,2.64,-,0.76,5.08E-01
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",13,1,1.32,-,0.76,6.19E-01
cellular response to ethanol (GO:0071361),13,1,1.32,-,0.76,6.19E-01
cellular response to interleukin-15 (GO:0071350),13,1,1.32,-,0.76,6.19E-01
iron coordination entity transport (GO:1901678),13,1,1.32,-,0.76,6.19E-01
negative regulation of nitric oxide biosynthetic process (GO:0045019),13,1,1.32,-,0.76,6.19E-01
DNA deamination (GO:0045006),13,1,1.32,-,0.76,6.19E-01
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),13,1,1.32,-,0.76,6.19E-01
secondary metabolite biosynthetic process (GO:0044550),13,1,1.32,-,0.76,6.19E-01
pyrimidine nucleotide biosynthetic process (GO:0006221),26,2,2.64,-,0.76,5.08E-01
fatty acid derivative catabolic process (GO:1901569),13,1,1.32,-,0.76,6.19E-01
positive regulation of neural precursor cell proliferation (GO:2000179),52,4,5.29,-,0.76,3.91E-01
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509),13,1,1.32,-,0.76,6.19E-01
negative regulation of synapse organization (GO:1905809),13,1,1.32,-,0.76,6.19E-01
embryonic brain development (GO:1990403),13,1,1.32,-,0.76,6.19E-01
negative regulation of oligodendrocyte differentiation (GO:0048715),13,1,1.32,-,0.76,6.19E-01
regulation of cholesterol transport (GO:0032374),52,4,5.29,-,0.76,3.91E-01
negative regulation of double-strand break repair via homologous recombination (GO:2000042),13,1,1.32,-,0.76,6.19E-01
telomere maintenance via recombination (GO:0000722),13,1,1.32,-,0.76,6.19E-01
fructose metabolic process (GO:0006000),13,1,1.32,-,0.76,6.19E-01
nuclear mRNA surveillance (GO:0071028),13,1,1.32,-,0.76,6.19E-01
nuclear RNA surveillance (GO:0071027),13,1,1.32,-,0.76,6.19E-01
regulation of synapse maturation (GO:0090128),13,1,1.32,-,0.76,6.19E-01
COPII-coated vesicle cargo loading (GO:0090110),13,1,1.32,-,0.76,6.19E-01
regulation of B cell receptor signaling pathway (GO:0050855),26,2,2.64,-,0.76,5.08E-01
regulation of pinocytosis (GO:0048548),13,1,1.32,-,0.76,6.19E-01
protein heterotetramerization (GO:0051290),13,1,1.32,-,0.76,6.19E-01
regulation of heat generation (GO:0031650),13,1,1.32,-,0.76,6.19E-01
positive regulation of macrophage migration (GO:1905523),26,2,2.64,-,0.76,5.08E-01
receptor internalization (GO:0031623),65,5,6.61,-,0.76,3.53E-01
PERK-mediated unfolded protein response (GO:0036499),13,1,1.32,-,0.76,6.19E-01
postsynaptic cytoskeleton organization (GO:0099188),13,1,1.32,-,0.76,6.19E-01
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",13,1,1.32,-,0.76,6.19E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478),13,1,1.32,-,0.76,6.19E-01
aggrephagy (GO:0035973),26,2,2.64,-,0.76,5.08E-01
negative regulation of muscle cell differentiation (GO:0051148),52,4,5.29,-,0.76,3.91E-01
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",13,1,1.32,-,0.76,6.19E-01
negative regulation of JUN kinase activity (GO:0043508),13,1,1.32,-,0.76,6.19E-01
photoreceptor cell outer segment organization (GO:0035845),13,1,1.32,-,0.76,6.19E-01
negative regulation of DNA binding (GO:0043392),52,4,5.29,-,0.76,3.91E-01
interleukin-15-mediated signaling pathway (GO:0035723),13,1,1.32,-,0.76,6.19E-01
negative regulation of leukocyte degranulation (GO:0043301),13,1,1.32,-,0.76,6.19E-01
regulation of long-term neuronal synaptic plasticity (GO:0048169),26,2,2.64,-,0.76,5.08E-01
activation of MAPKKK activity (GO:0000185),13,1,1.32,-,0.76,6.19E-01
cellular response to acetylcholine (GO:1905145),26,2,2.64,-,0.76,5.08E-01
response to acetylcholine (GO:1905144),26,2,2.64,-,0.76,5.08E-01
chromatin-mediated maintenance of transcription (GO:0048096),13,1,1.32,-,0.76,6.19E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),91,7,9.25,-,0.76,2.95E-01
sequestering of extracellular ligand from receptor (GO:0035581),13,1,1.32,-,0.76,6.19E-01
positive regulation of chromatin binding (GO:0035563),13,1,1.32,-,0.76,6.19E-01
ribosomal large subunit assembly (GO:0000027),26,2,2.64,-,0.76,5.08E-01
negative regulation of microtubule polymerization (GO:0031115),13,1,1.32,-,0.76,6.19E-01
negative regulation of protein import (GO:1904590),13,1,1.32,-,0.76,6.19E-01
aromatic amino acid transport (GO:0015801),13,1,1.32,-,0.76,6.19E-01
negative regulation of nitric oxide metabolic process (GO:1904406),13,1,1.32,-,0.76,6.19E-01
protein localization to microtubule (GO:0035372),13,1,1.32,-,0.76,6.19E-01
polyol transport (GO:0015791),13,1,1.32,-,0.76,6.19E-01
aromatic amino acid family catabolic process (GO:0009074),26,2,2.64,-,0.76,5.08E-01
dopamine metabolic process (GO:0042417),26,2,2.64,-,0.76,5.08E-01
viral RNA genome replication (GO:0039694),13,1,1.32,-,0.76,6.19E-01
positive regulation of voltage-gated potassium channel activity (GO:1903818),13,1,1.32,-,0.76,6.19E-01
positive regulation of ERAD pathway (GO:1904294),13,1,1.32,-,0.76,6.19E-01
negative regulation of protein import into nucleus (GO:0042308),13,1,1.32,-,0.76,6.19E-01
positive regulation of protein kinase A signaling (GO:0010739),13,1,1.32,-,0.76,6.19E-01
ncRNA catabolic process (GO:0034661),26,2,2.64,-,0.76,5.08E-01
positive regulation of muscle cell apoptotic process (GO:0010661),26,2,2.64,-,0.76,5.08E-01
male sex determination (GO:0030238),13,1,1.32,-,0.76,6.19E-01
determination of heart left/right asymmetry (GO:0061371),65,5,6.61,-,0.76,3.53E-01
axonal transport of mitochondrion (GO:0019896),13,1,1.32,-,0.76,6.19E-01
sphingosine-1-phosphate receptor signaling pathway (GO:0003376),13,1,1.32,-,0.76,6.19E-01
organophosphate catabolic process (GO:0046434),130,10,13.22,-,0.76,2.33E-01
mechanosensory behavior (GO:0007638),13,1,1.32,-,0.76,6.19E-01
high-density lipoprotein particle assembly (GO:0034380),13,1,1.32,-,0.76,6.19E-01
regulation of tau-protein kinase activity (GO:1902947),13,1,1.32,-,0.76,6.19E-01
negative regulation of alcohol biosynthetic process (GO:1902931),13,1,1.32,-,0.76,6.19E-01
membrane invagination (GO:0010324),52,4,5.29,-,0.76,3.91E-01
chaperone-mediated protein folding (GO:0061077),52,4,5.29,-,0.76,3.91E-01
cardiac conduction system development (GO:0003161),13,1,1.32,-,0.76,6.19E-01
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),52,4,5.29,-,0.76,3.91E-01
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),13,1,1.32,-,0.76,6.19E-01
negative regulation of cell cycle G1/S phase transition (GO:1902807),104,8,10.57,-,0.76,2.71E-01
regulation of mitochondrion organization (GO:0010821),157,12,15.96,-,0.75,1.94E-01
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),144,11,14.64,-,0.75,2.09E-01
regulation of RNA splicing (GO:0043484),131,10,13.32,-,0.75,2.24E-01
nuclear division (GO:0000280),262,20,26.64,-,0.75,1.12E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209),118,9,12,-,0.75,2.42E-01
cell-cell signaling by wnt (GO:0198738),328,25,33.34,-,0.75,8.05E-02
Wnt signaling pathway (GO:0016055),328,25,33.34,-,0.75,8.05E-02
cardiac septum development (GO:0003279),105,8,10.67,-,0.75,2.61E-01
cellular component assembly involved in morphogenesis (GO:0010927),92,7,9.35,-,0.75,2.83E-01
regulation of chemokine production (GO:0032642),79,6,8.03,-,0.75,3.09E-01
organelle membrane fusion (GO:0090174),79,6,8.03,-,0.75,3.09E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433),158,12,16.06,-,0.75,1.88E-01
sterol homeostasis (GO:0055092),79,6,8.03,-,0.75,3.09E-01
negative regulation of cytoskeleton organization (GO:0051494),145,11,14.74,-,0.75,2.01E-01
cell cycle arrest (GO:0007050),132,10,13.42,-,0.75,2.16E-01
cellular response to retinoic acid (GO:0071300),66,5,6.71,-,0.75,3.39E-01
cranial skeletal system development (GO:1904888),66,5,6.71,-,0.75,3.39E-01
aerobic respiration (GO:0009060),66,5,6.71,-,0.75,3.39E-01
regulation of cartilage development (GO:0061035),66,5,6.71,-,0.75,3.39E-01
embryonic heart tube morphogenesis (GO:0003143),66,5,6.71,-,0.75,3.39E-01
membrane organization (GO:0061024),766,58,77.87,-,0.74,9.90E-03
protein localization to extracellular region (GO:0071692),119,9,12.1,-,0.74,2.33E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288),106,8,10.78,-,0.74,2.52E-01
regulation of sterol transport (GO:0032371),53,4,5.39,-,0.74,3.75E-01
regulation of phosphoprotein phosphatase activity (GO:0043666),106,8,10.78,-,0.74,2.52E-01
response to ischemia (GO:0002931),53,4,5.39,-,0.74,3.75E-01
protein folding (GO:0006457),199,15,20.23,-,0.74,1.43E-01
action potential (GO:0001508),93,7,9.45,-,0.74,2.73E-01
cytokinesis (GO:0000910),93,7,9.45,-,0.74,2.73E-01
cellular process involved in reproduction in multicellular organism (GO:0022412),319,24,32.43,-,0.74,7.50E-02
nucleotide transport (GO:0006862),40,3,4.07,-,0.74,4.20E-01
cellular response to radiation (GO:0071478),160,12,16.27,-,0.74,1.75E-01
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",40,3,4.07,-,0.74,4.20E-01
regulation of postsynapse organization (GO:0099175),80,6,8.13,-,0.74,2.97E-01
negative regulation of protein secretion (GO:0050709),80,6,8.13,-,0.74,2.97E-01
positive regulation of potassium ion transport (GO:0043268),40,3,4.07,-,0.74,4.20E-01
neutral amino acid transport (GO:0015804),40,3,4.07,-,0.74,4.20E-01
glial cell migration (GO:0008347),40,3,4.07,-,0.74,4.20E-01
heme metabolic process (GO:0042168),40,3,4.07,-,0.74,4.20E-01
icosanoid biosynthetic process (GO:0046456),40,3,4.07,-,0.74,4.20E-01
negative regulation of response to DNA damage stimulus (GO:2001021),67,5,6.81,-,0.73,3.25E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),134,10,13.62,-,0.73,2.01E-01
regulation of blood vessel diameter (GO:0097746),134,10,13.62,-,0.73,2.01E-01
lipid phosphorylation (GO:0046834),67,5,6.81,-,0.73,3.25E-01
regulation of tube diameter (GO:0035296),134,10,13.62,-,0.73,2.01E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029),94,7,9.56,-,0.73,2.62E-01
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),121,9,12.3,-,0.73,2.16E-01
response to alcohol (GO:0097305),242,18,24.6,-,0.73,1.04E-01
hindbrain development (GO:0030902),148,11,15.05,-,0.73,1.81E-01
intrinsic apoptotic signaling pathway (GO:0097193),148,11,15.05,-,0.73,1.81E-01
purine ribonucleoside metabolic process (GO:0046128),54,4,5.49,-,0.73,3.59E-01
leukocyte apoptotic process (GO:0071887),27,2,2.74,-,0.73,4.83E-01
collagen metabolic process (GO:0032963),54,4,5.49,-,0.73,3.59E-01
leukotriene metabolic process (GO:0006691),27,2,2.74,-,0.73,4.83E-01
telomere maintenance via telomerase (GO:0007004),27,2,2.74,-,0.73,4.83E-01
negative regulation of amine transport (GO:0051953),27,2,2.74,-,0.73,4.83E-01
negative regulation of signal transduction by p53 class mediator (GO:1901797),27,2,2.74,-,0.73,4.83E-01
protein K48-linked ubiquitination (GO:0070936),54,4,5.49,-,0.73,3.59E-01
production of small RNA involved in gene silencing by RNA (GO:0070918),27,2,2.74,-,0.73,4.83E-01
negative regulation of reactive oxygen species metabolic process (GO:2000378),54,4,5.49,-,0.73,3.59E-01
cellular response to fatty acid (GO:0071398),54,4,5.49,-,0.73,3.59E-01
negative regulation of stress fiber assembly (GO:0051497),27,2,2.74,-,0.73,4.83E-01
axonal transport (GO:0098930),54,4,5.49,-,0.73,3.59E-01
chromosome separation (GO:0051304),27,2,2.74,-,0.73,4.83E-01
response to fungus (GO:0009620),54,4,5.49,-,0.73,3.59E-01
phosphatidylcholine acyl-chain remodeling (GO:0036151),27,2,2.74,-,0.73,4.83E-01
phospholipid transport (GO:0015914),81,6,8.23,-,0.73,2.85E-01
dsRNA processing (GO:0031050),27,2,2.74,-,0.73,4.83E-01
hippo signaling (GO:0035329),27,2,2.74,-,0.73,4.83E-01
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),27,2,2.74,-,0.73,4.83E-01
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),54,4,5.49,-,0.73,3.59E-01
regulation of tube size (GO:0035150),135,10,13.72,-,0.73,1.94E-01
cellular response to heat (GO:0034605),54,4,5.49,-,0.73,3.59E-01
epithelial structure maintenance (GO:0010669),27,2,2.74,-,0.73,4.83E-01
regulation of endothelial cell migration (GO:0010594),162,12,16.47,-,0.73,1.63E-01
negative regulation of ATP metabolic process (GO:1903579),27,2,2.74,-,0.73,4.83E-01
regulation of T-helper 1 type immune response (GO:0002825),27,2,2.74,-,0.73,4.83E-01
plasma lipoprotein particle assembly (GO:0034377),27,2,2.74,-,0.73,4.83E-01
outflow tract septum morphogenesis (GO:0003148),27,2,2.74,-,0.73,4.83E-01
regulation of response to oxidative stress (GO:1902882),81,6,8.23,-,0.73,2.85E-01
positive regulation of lipid localization (GO:1905954),95,7,9.66,-,0.72,2.52E-01
viral entry into host cell (GO:0046718),95,7,9.66,-,0.72,2.52E-01
interferon-gamma-mediated signaling pathway (GO:0060333),68,5,6.91,-,0.72,3.11E-01
regulation of cellular ketone metabolic process (GO:0010565),177,13,17.99,-,0.72,1.42E-01
negative regulation of cell cycle process (GO:0010948),300,22,30.5,-,0.72,6.66E-02
regulation of signaling receptor activity (GO:0010469),150,11,15.25,-,0.72,1.68E-01
transition metal ion homeostasis (GO:0055076),123,9,12.5,-,0.72,2.00E-01
protein localization to cell junction (GO:1902414),82,6,8.34,-,0.72,2.73E-01
regulation of leukocyte apoptotic process (GO:2000106),82,6,8.34,-,0.72,2.73E-01
histone H3 acetylation (GO:0043966),41,3,4.17,-,0.72,4.01E-01
protein localization to cytoskeleton (GO:0044380),41,3,4.17,-,0.72,4.01E-01
regulation of oligodendrocyte differentiation (GO:0048713),41,3,4.17,-,0.72,4.01E-01
defense response to fungus (GO:0050832),41,3,4.17,-,0.72,4.01E-01
regulation of G0 to G1 transition (GO:0070316),41,3,4.17,-,0.72,4.01E-01
drug metabolic process (GO:0017144),41,3,4.17,-,0.72,4.01E-01
collagen catabolic process (GO:0030574),41,3,4.17,-,0.72,4.01E-01
cytoskeleton-dependent cytokinesis (GO:0061640),82,6,8.34,-,0.72,2.73E-01
positive regulation of ATP metabolic process (GO:1903580),41,3,4.17,-,0.72,4.01E-01
cellular respiration (GO:0045333),137,10,13.93,-,0.72,1.79E-01
vesicle budding from membrane (GO:0006900),96,7,9.76,-,0.72,2.42E-01
mitotic DNA damage checkpoint (GO:0044773),96,7,9.76,-,0.72,2.42E-01
positive regulation of interleukin-8 production (GO:0032757),55,4,5.59,-,0.72,3.43E-01
protein homotetramerization (GO:0051289),55,4,5.59,-,0.72,3.43E-01
inositol phosphate metabolic process (GO:0043647),55,4,5.59,-,0.72,3.43E-01
purine nucleoside metabolic process (GO:0042278),55,4,5.59,-,0.72,3.43E-01
ventricular cardiac muscle tissue development (GO:0003229),55,4,5.59,-,0.72,3.43E-01
cardiac chamber morphogenesis (GO:0003206),124,9,12.61,-,0.71,1.92E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263),138,10,14.03,-,0.71,1.73E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),69,5,7.01,-,0.71,2.98E-01
histone methylation (GO:0016571),83,6,8.44,-,0.71,2.62E-01
cellular response to hypoxia (GO:0071456),180,13,18.3,-,0.71,1.27E-01
positive regulation of angiogenesis (GO:0045766),153,11,15.55,-,0.71,1.49E-01
positive regulation of vasculature development (GO:1904018),153,11,15.55,-,0.71,1.49E-01
regulation of reactive oxygen species metabolic process (GO:2000377),181,13,18.4,-,0.71,1.22E-01
lipid translocation (GO:0034204),42,3,4.27,-,0.7,3.82E-01
cerebral cortex cell migration (GO:0021795),42,3,4.27,-,0.7,3.82E-01
positive regulation of protein acetylation (GO:1901985),42,3,4.27,-,0.7,3.82E-01
acyl-CoA biosynthetic process (GO:0071616),42,3,4.27,-,0.7,3.82E-01
regulation of meiotic cell cycle (GO:0051445),42,3,4.27,-,0.7,3.82E-01
musculoskeletal movement (GO:0050881),42,3,4.27,-,0.7,3.82E-01
multicellular organismal movement (GO:0050879),42,3,4.27,-,0.7,3.82E-01
regulation of calcium ion-dependent exocytosis (GO:0017158),42,3,4.27,-,0.7,3.82E-01
thioester biosynthetic process (GO:0035384),42,3,4.27,-,0.7,3.82E-01
regulation of peptidyl-threonine phosphorylation (GO:0010799),42,3,4.27,-,0.7,3.82E-01
response to UV-C (GO:0010225),14,1,1.42,-,0.7,5.84E-01
negative regulation of gluconeogenesis (GO:0045721),14,1,1.42,-,0.7,5.84E-01
glial cell fate commitment (GO:0021781),14,1,1.42,-,0.7,5.84E-01
synapse assembly (GO:0007416),98,7,9.96,-,0.7,2.23E-01
nuclear pore organization (GO:0006999),14,1,1.42,-,0.7,5.84E-01
skeletal muscle contraction (GO:0003009),28,2,2.85,-,0.7,4.58E-01
regulation of smooth muscle contraction (GO:0006940),56,4,5.69,-,0.7,3.28E-01
negative regulation of catecholamine secretion (GO:0033604),14,1,1.42,-,0.7,5.84E-01
cellular copper ion homeostasis (GO:0006878),14,1,1.42,-,0.7,5.84E-01
negative regulation of activated T cell proliferation (GO:0046007),14,1,1.42,-,0.7,5.84E-01
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),14,1,1.42,-,0.7,5.84E-01
retinal rod cell differentiation (GO:0060221),14,1,1.42,-,0.7,5.84E-01
hematopoietic stem cell differentiation (GO:0060218),14,1,1.42,-,0.7,5.84E-01
prepulse inhibition (GO:0060134),14,1,1.42,-,0.7,5.84E-01
bile acid biosynthetic process (GO:0006699),28,2,2.85,-,0.7,4.58E-01
regulation of cell cycle checkpoint (GO:1901976),28,2,2.85,-,0.7,4.58E-01
renal vesicle development (GO:0072087),14,1,1.42,-,0.7,5.84E-01
formation of cytoplasmic translation initiation complex (GO:0001732),14,1,1.42,-,0.7,5.84E-01
dopaminergic neuron differentiation (GO:0071542),28,2,2.85,-,0.7,4.58E-01
"synaptic transmission, GABAergic (GO:0051932)",14,1,1.42,-,0.7,5.84E-01
regulation of fibrinolysis (GO:0051917),14,1,1.42,-,0.7,5.84E-01
positive regulation of excitatory postsynaptic potential (GO:2000463),28,2,2.85,-,0.7,4.58E-01
N-terminal protein amino acid acetylation (GO:0006474),14,1,1.42,-,0.7,5.84E-01
epithelial cell maturation (GO:0002070),14,1,1.42,-,0.7,5.84E-01
sphingolipid mediated signaling pathway (GO:0090520),14,1,1.42,-,0.7,5.84E-01
interleukin-1 beta production (GO:0032611),14,1,1.42,-,0.7,5.84E-01
cellular response to estrogen stimulus (GO:0071391),14,1,1.42,-,0.7,5.84E-01
cellular response to glucagon stimulus (GO:0071377),28,2,2.85,-,0.7,4.58E-01
apoptotic DNA fragmentation (GO:0006309),14,1,1.42,-,0.7,5.84E-01
DNA catabolic process (GO:0006308),28,2,2.85,-,0.7,4.58E-01
regulation of myoblast proliferation (GO:2000291),14,1,1.42,-,0.7,5.84E-01
mismatch repair (GO:0006298),28,2,2.85,-,0.7,4.58E-01
cellular response to lithium ion (GO:0071285),14,1,1.42,-,0.7,5.84E-01
pyrimidine nucleobase metabolic process (GO:0006206),14,1,1.42,-,0.7,5.84E-01
response to cholesterol (GO:0070723),28,2,2.85,-,0.7,4.58E-01
Rab protein signal transduction (GO:0032482),14,1,1.42,-,0.7,5.84E-01
peptidyl-threonine phosphorylation (GO:0018107),70,5,7.12,-,0.7,2.86E-01
response to interleukin-15 (GO:0070672),14,1,1.42,-,0.7,5.84E-01
mitotic nuclear division (GO:0140014),154,11,15.66,-,0.7,1.44E-01
negative regulation of cytosolic calcium ion concentration (GO:0051481),14,1,1.42,-,0.7,5.84E-01
resolution of meiotic recombination intermediates (GO:0000712),14,1,1.42,-,0.7,5.84E-01
Golgi ribbon formation (GO:0090161),14,1,1.42,-,0.7,5.84E-01
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),14,1,1.42,-,0.7,5.84E-01
lipid digestion (GO:0044241),14,1,1.42,-,0.7,5.84E-01
bone growth (GO:0098868),28,2,2.85,-,0.7,4.58E-01
enteric nervous system development (GO:0048484),14,1,1.42,-,0.7,5.84E-01
regulation of lipoprotein metabolic process (GO:0050746),14,1,1.42,-,0.7,5.84E-01
synaptic vesicle recycling (GO:0036465),56,4,5.69,-,0.7,3.28E-01
regulation of cold-induced thermogenesis (GO:0120161),140,10,14.23,-,0.7,1.60E-01
lens fiber cell development (GO:0070307),14,1,1.42,-,0.7,5.84E-01
regulation of thymocyte apoptotic process (GO:0070243),14,1,1.42,-,0.7,5.84E-01
positive regulation of T cell apoptotic process (GO:0070234),14,1,1.42,-,0.7,5.84E-01
regulation of isotype switching to IgG isotypes (GO:0048302),14,1,1.42,-,0.7,5.84E-01
cellular response to increased oxygen levels (GO:0036295),14,1,1.42,-,0.7,5.84E-01
lipoprotein transport (GO:0042953),14,1,1.42,-,0.7,5.84E-01
protein deubiquitination (GO:0016579),238,17,24.2,-,0.7,7.97E-02
2'-deoxyribonucleotide metabolic process (GO:0009394),28,2,2.85,-,0.7,4.58E-01
positive regulation of ubiquitin protein ligase activity (GO:1904668),14,1,1.42,-,0.7,5.84E-01
embryonic digit morphogenesis (GO:0042733),56,4,5.69,-,0.7,3.28E-01
insulin-like growth factor receptor signaling pathway (GO:0048009),14,1,1.42,-,0.7,5.84E-01
calcineurin-mediated signaling (GO:0097720),14,1,1.42,-,0.7,5.84E-01
fatty acid homeostasis (GO:0055089),14,1,1.42,-,0.7,5.84E-01
phosphate ion transmembrane transport (GO:0035435),14,1,1.42,-,0.7,5.84E-01
superoxide anion generation (GO:0042554),14,1,1.42,-,0.7,5.84E-01
nuclear body organization (GO:0030575),14,1,1.42,-,0.7,5.84E-01
carbohydrate transport (GO:0008643),70,5,7.12,-,0.7,2.86E-01
positive regulation of ruffle assembly (GO:1900029),14,1,1.42,-,0.7,5.84E-01
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),14,1,1.42,-,0.7,5.84E-01
regulation of receptor clustering (GO:1903909),14,1,1.42,-,0.7,5.84E-01
terpenoid biosynthetic process (GO:0016114),14,1,1.42,-,0.7,5.84E-01
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),14,1,1.42,-,0.7,5.84E-01
chondroitin sulfate catabolic process (GO:0030207),14,1,1.42,-,0.7,5.84E-01
isoprenoid biosynthetic process (GO:0008299),28,2,2.85,-,0.7,4.58E-01
neurotransmitter metabolic process (GO:0042133),28,2,2.85,-,0.7,4.58E-01
negative regulation of humoral immune response (GO:0002921),14,1,1.42,-,0.7,5.84E-01
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),14,1,1.42,-,0.7,5.84E-01
epithelial cilium movement involved in extracellular fluid movement (GO:0003351),28,2,2.85,-,0.7,4.58E-01
type B pancreatic cell development (GO:0003323),14,1,1.42,-,0.7,5.84E-01
positive regulation of inositol phosphate biosynthetic process (GO:0060732),14,1,1.42,-,0.7,5.84E-01
striated muscle cell proliferation (GO:0014855),14,1,1.42,-,0.7,5.84E-01
positive regulation of smooth muscle contraction (GO:0045987),28,2,2.85,-,0.7,4.58E-01
cerebral cortex development (GO:0021987),112,8,11.39,-,0.7,1.99E-01
glucose import (GO:0046323),14,1,1.42,-,0.7,5.84E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314),14,1,1.42,-,0.7,5.84E-01
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),14,1,1.42,-,0.7,5.84E-01
positive regulation of meiotic nuclear division (GO:0045836),14,1,1.42,-,0.7,5.84E-01
negative regulation of glycolytic process (GO:0045820),14,1,1.42,-,0.7,5.84E-01
regulation of Wnt signaling pathway (GO:0030111),351,25,35.68,-,0.7,3.70E-02
protein modification by small protein removal (GO:0070646),253,18,25.72,-,0.7,7.00E-02
regulation of viral process (GO:0050792),211,15,21.45,-,0.7,9.29E-02
response to interferon-gamma (GO:0034341),169,12,17.18,-,0.7,1.25E-01
regulation of histone modification (GO:0031056),141,10,14.33,-,0.7,1.53E-01
germ cell development (GO:0007281),226,16,22.98,-,0.7,8.13E-02
regulation of symbiotic process (GO:0043903),226,16,22.98,-,0.7,8.13E-02
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114),396,28,40.26,-,0.7,2.55E-02
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),85,6,8.64,-,0.69,2.41E-01
positive regulation of Wnt signaling pathway (GO:0030177),170,12,17.28,-,0.69,1.20E-01
oogenesis (GO:0048477),71,5,7.22,-,0.69,2.73E-01
organophosphate ester transport (GO:0015748),128,9,13.01,-,0.69,1.64E-01
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",57,4,5.79,-,0.69,3.13E-01
positive regulation of calcium ion transport into cytosol (GO:0010524),57,4,5.79,-,0.69,3.13E-01
viral life cycle (GO:0019058),214,15,21.76,-,0.69,8.29E-02
protein localization to cell periphery (GO:1990778),214,15,21.76,-,0.69,8.29E-02
nucleoside phosphate biosynthetic process (GO:1901293),200,14,20.33,-,0.69,9.13E-02
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),300,21,30.5,-,0.69,4.41E-02
DNA damage checkpoint (GO:0000077),129,9,13.11,-,0.69,1.57E-01
heart contraction (GO:0060047),86,6,8.74,-,0.69,2.30E-01
negative regulation of GTPase activity (GO:0034260),43,3,4.37,-,0.69,3.64E-01
regulation of endocytosis (GO:0030100),201,14,20.43,-,0.69,8.78E-02
regulation of circadian rhythm (GO:0042752),115,8,11.69,-,0.68,1.75E-01
lipoprotein metabolic process (GO:0042157),115,8,11.69,-,0.68,1.75E-01
sensory perception of pain (GO:0019233),72,5,7.32,-,0.68,2.61E-01
positive regulation of lipid transport (GO:0032370),72,5,7.32,-,0.68,2.61E-01
sperm motility (GO:0097722),72,5,7.32,-,0.68,2.61E-01
nucleoside triphosphate metabolic process (GO:0009141),72,5,7.32,-,0.68,2.61E-01
flagellated sperm motility (GO:0030317),72,5,7.32,-,0.68,2.61E-01
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),72,5,7.32,-,0.68,2.61E-01
regulation of small molecule metabolic process (GO:0062012),418,29,42.49,-,0.68,1.75E-02
negative regulation of protein-containing complex assembly (GO:0031333),130,9,13.22,-,0.68,1.51E-01
negative regulation of cell cycle phase transition (GO:1901988),217,15,22.06,-,0.68,7.38E-02
regulation of membrane repolarization (GO:0060306),29,2,2.95,-,0.68,4.35E-01
ventricular system development (GO:0021591),29,2,2.95,-,0.68,4.35E-01
positive regulation of defense response to virus by host (GO:0002230),29,2,2.95,-,0.68,4.35E-01
negative regulation of calcium ion transport (GO:0051926),58,4,5.9,-,0.68,2.99E-01
RNA-dependent DNA biosynthetic process (GO:0006278),29,2,2.95,-,0.68,4.35E-01
acetyl-CoA metabolic process (GO:0006084),29,2,2.95,-,0.68,4.35E-01
postsynaptic signal transduction (GO:0098926),29,2,2.95,-,0.68,4.35E-01
negative regulation of actin filament bundle assembly (GO:0032232),29,2,2.95,-,0.68,4.35E-01
negative regulation of oxidoreductase activity (GO:0051354),29,2,2.95,-,0.68,4.35E-01
aorta morphogenesis (GO:0035909),29,2,2.95,-,0.68,4.35E-01
regulation of defense response to virus by virus (GO:0050690),29,2,2.95,-,0.68,4.35E-01
COPII vesicle coating (GO:0048208),58,4,5.9,-,0.68,2.99E-01
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",58,4,5.9,-,0.68,2.99E-01
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",29,2,2.95,-,0.68,4.35E-01
response to interferon-beta (GO:0035456),29,2,2.95,-,0.68,4.35E-01
membrane depolarization during action potential (GO:0086010),29,2,2.95,-,0.68,4.35E-01
transport of virus (GO:0046794),58,4,5.9,-,0.68,2.99E-01
dendritic spine development (GO:0060996),29,2,2.95,-,0.68,4.35E-01
negative regulation of protein tyrosine kinase activity (GO:0061099),29,2,2.95,-,0.68,4.35E-01
extracellular matrix assembly (GO:0085029),29,2,2.95,-,0.68,4.35E-01
cellular response to decreased oxygen levels (GO:0036294),189,13,19.21,-,0.68,8.93E-02
mitotic DNA integrity checkpoint (GO:0044774),102,7,10.37,-,0.68,1.88E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),102,7,10.37,-,0.68,1.88E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),175,12,17.79,-,0.67,9.84E-02
negative regulation of protein-containing complex disassembly (GO:0043242),73,5,7.42,-,0.67,2.50E-01
regulation of protein ubiquitination (GO:0031396),190,13,19.32,-,0.67,8.58E-02
negative regulation of mitotic cell cycle phase transition (GO:1901991),205,14,20.84,-,0.67,7.49E-02
negative regulation of oxidative stress-induced cell death (GO:1903202),44,3,4.47,-,0.67,3.47E-01
mitotic metaphase plate congression (GO:0007080),44,3,4.47,-,0.67,3.47E-01
regulation of cardiac muscle cell proliferation (GO:0060043),44,3,4.47,-,0.67,3.47E-01
regulation of NIK/NF-kappaB signaling (GO:1901222),88,6,8.95,-,0.67,2.11E-01
synapse organization (GO:0050808),264,18,26.84,-,0.67,4.60E-02
positive regulation of purine nucleotide metabolic process (GO:1900544),44,3,4.47,-,0.67,3.47E-01
positive regulation of nucleotide metabolic process (GO:0045981),44,3,4.47,-,0.67,3.47E-01
cellular response to oxygen levels (GO:0071453),206,14,20.94,-,0.67,7.20E-02
entry into host (GO:0044409),103,7,10.47,-,0.67,1.80E-01
neuron migration (GO:0001764),118,8,12,-,0.67,1.54E-01
protein monoubiquitination (GO:0006513),59,4,6,-,0.67,2.85E-01
regulation of interleukin-2 production (GO:0032663),59,4,6,-,0.67,2.85E-01
positive regulation of organelle assembly (GO:1902117),59,4,6,-,0.67,2.85E-01
myofibril assembly (GO:0030239),59,4,6,-,0.67,2.85E-01
heart valve development (GO:0003170),59,4,6,-,0.67,2.85E-01
NIK/NF-kappaB signaling (GO:0038061),74,5,7.52,-,0.66,2.38E-01
M phase (GO:0000279),163,11,16.57,-,0.66,1.00E-01
mitotic M phase (GO:0000087),163,11,16.57,-,0.66,1.00E-01
acylglycerol metabolic process (GO:0006639),89,6,9.05,-,0.66,2.02E-01
regulation of pattern recognition receptor signaling pathway (GO:0062207),89,6,9.05,-,0.66,2.02E-01
response to ethanol (GO:0045471),134,9,13.62,-,0.66,1.27E-01
development of primary sexual characteristics (GO:0045137),209,14,21.25,-,0.66,6.37E-02
Golgi vesicle transport (GO:0048193),359,24,36.5,-,0.66,1.76E-02
pyrimidine nucleoside biosynthetic process (GO:0046134),15,1,1.52,-,0.66,5.49E-01
toll-like receptor 9 signaling pathway (GO:0034162),15,1,1.52,-,0.66,5.49E-01
negative regulation of osteoclast differentiation (GO:0045671),30,2,3.05,-,0.66,4.12E-01
intra-Golgi vesicle-mediated transport (GO:0006891),30,2,3.05,-,0.66,4.12E-01
response to manganese ion (GO:0010042),15,1,1.52,-,0.66,5.49E-01
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),45,3,4.57,-,0.66,3.29E-01
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991),15,1,1.52,-,0.66,5.49E-01
female gamete generation (GO:0007292),120,8,12.2,-,0.66,1.41E-01
metanephric nephron tubule development (GO:0072234),15,1,1.52,-,0.66,5.49E-01
multi-organism localization (GO:1902579),60,4,6.1,-,0.66,2.71E-01
glycosylceramide metabolic process (GO:0006677),15,1,1.52,-,0.66,5.49E-01
phosphatidylethanolamine biosynthetic process (GO:0006646),15,1,1.52,-,0.66,5.49E-01
T cell activation involved in immune response (GO:0002286),60,4,6.1,-,0.66,2.71E-01
neutral lipid metabolic process (GO:0006638),90,6,9.15,-,0.66,1.93E-01
regulation of monocyte chemotactic protein-1 production (GO:0071637),15,1,1.52,-,0.66,5.49E-01
regulation of integrin-mediated signaling pathway (GO:2001044),15,1,1.52,-,0.66,5.49E-01
positive regulation of endothelial cell chemotaxis (GO:2001028),15,1,1.52,-,0.66,5.49E-01
lipoprotein localization (GO:0044872),15,1,1.52,-,0.66,5.49E-01
sulfate transmembrane transport (GO:1902358),15,1,1.52,-,0.66,5.49E-01
GPI anchor biosynthetic process (GO:0006506),30,2,3.05,-,0.66,4.12E-01
positive regulation by host of viral process (GO:0044794),15,1,1.52,-,0.66,5.49E-01
multi-organism transport (GO:0044766),60,4,6.1,-,0.66,2.71E-01
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",15,1,1.52,-,0.66,5.49E-01
collagen-activated signaling pathway (GO:0038065),15,1,1.52,-,0.66,5.49E-01
protein methylation (GO:0006479),105,7,10.67,-,0.66,1.65E-01
"regulation of circadian sleep/wake cycle, sleep (GO:0045187)",15,1,1.52,-,0.66,5.49E-01
positive regulation of myoblast fusion (GO:1901741),15,1,1.52,-,0.66,5.49E-01
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),15,1,1.52,-,0.66,5.49E-01
regulation of interferon-alpha production (GO:0032647),30,2,3.05,-,0.66,4.12E-01
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),15,1,1.52,-,0.66,5.49E-01
response to redox state (GO:0051775),15,1,1.52,-,0.66,5.49E-01
nucleotide transmembrane transport (GO:1901679),15,1,1.52,-,0.66,5.49E-01
positive regulation of mast cell activation involved in immune response (GO:0033008),15,1,1.52,-,0.66,5.49E-01
positive regulation of brown fat cell differentiation (GO:0090336),15,1,1.52,-,0.66,5.49E-01
exocytic process (GO:0140029),60,4,6.1,-,0.66,2.71E-01
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),15,1,1.52,-,0.66,5.49E-01
peptidyl-lysine dimethylation (GO:0018027),15,1,1.52,-,0.66,5.49E-01
RNA surveillance (GO:0071025),15,1,1.52,-,0.66,5.49E-01
regulation of flagellated sperm motility (GO:1901317),15,1,1.52,-,0.66,5.49E-01
regulation of microtubule cytoskeleton organization (GO:0070507),135,9,13.72,-,0.66,1.22E-01
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),15,1,1.52,-,0.66,5.49E-01
regulation of presynapse assembly (GO:1905606),30,2,3.05,-,0.66,4.12E-01
neuromuscular process controlling posture (GO:0050884),15,1,1.52,-,0.66,5.49E-01
cellular response to vascular endothelial growth factor stimulus (GO:0035924),45,3,4.57,-,0.66,3.29E-01
plasma membrane invagination (GO:0099024),45,3,4.57,-,0.66,3.29E-01
response to potassium ion (GO:0035864),15,1,1.52,-,0.66,5.49E-01
cytoplasmic sequestering of transcription factor (GO:0042994),15,1,1.52,-,0.66,5.49E-01
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),15,1,1.52,-,0.66,5.49E-01
excitatory synapse assembly (GO:1904861),15,1,1.52,-,0.66,5.49E-01
positive regulation of mast cell degranulation (GO:0043306),15,1,1.52,-,0.66,5.49E-01
outer dynein arm assembly (GO:0036158),15,1,1.52,-,0.66,5.49E-01
regulation of carbohydrate biosynthetic process (GO:0043255),90,6,9.15,-,0.66,1.93E-01
regulation of sulfur metabolic process (GO:0042762),15,1,1.52,-,0.66,5.49E-01
DNA replication checkpoint (GO:0000076),15,1,1.52,-,0.66,5.49E-01
nucleoside salvage (GO:0043174),15,1,1.52,-,0.66,5.49E-01
purine-containing compound salvage (GO:0043101),15,1,1.52,-,0.66,5.49E-01
regulation of cell fate specification (GO:0042659),15,1,1.52,-,0.66,5.49E-01
extracellular negative regulation of signal transduction (GO:1900116),15,1,1.52,-,0.66,5.49E-01
extracellular regulation of signal transduction (GO:1900115),15,1,1.52,-,0.66,5.49E-01
neuroblast division (GO:0055057),15,1,1.52,-,0.66,5.49E-01
nucleoside catabolic process (GO:0009164),30,2,3.05,-,0.66,4.12E-01
Golgi to plasma membrane protein transport (GO:0043001),30,2,3.05,-,0.66,4.12E-01
basic amino acid transport (GO:0015802),15,1,1.52,-,0.66,5.49E-01
fatty-acyl-CoA biosynthetic process (GO:0046949),30,2,3.05,-,0.66,4.12E-01
regulation of macrophage cytokine production (GO:0010935),15,1,1.52,-,0.66,5.49E-01
positive regulation of dendrite development (GO:1900006),15,1,1.52,-,0.66,5.49E-01
dosage compensation by inactivation of X chromosome (GO:0009048),15,1,1.52,-,0.66,5.49E-01
negative regulation of myotube differentiation (GO:0010832),15,1,1.52,-,0.66,5.49E-01
protein kinase A signaling (GO:0010737),15,1,1.52,-,0.66,5.49E-01
coronary vasculature morphogenesis (GO:0060977),15,1,1.52,-,0.66,5.49E-01
asymmetric cell division (GO:0008356),15,1,1.52,-,0.66,5.49E-01
positive regulation of histone acetylation (GO:0035066),30,2,3.05,-,0.66,4.12E-01
cardiocyte differentiation (GO:0035051),105,7,10.67,-,0.66,1.65E-01
piRNA metabolic process (GO:0034587),15,1,1.52,-,0.66,5.49E-01
protein alkylation (GO:0008213),105,7,10.67,-,0.66,1.65E-01
positive regulation of exosomal secretion (GO:1903543),15,1,1.52,-,0.66,5.49E-01
regulation of exosomal secretion (GO:1903541),15,1,1.52,-,0.66,5.49E-01
regulation of gastrulation (GO:0010470),15,1,1.52,-,0.66,5.49E-01
regulation of cell fate commitment (GO:0010453),30,2,3.05,-,0.66,4.12E-01
protein localization to plasma membrane (GO:0072659),180,12,18.3,-,0.66,8.00E-02
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),15,1,1.52,-,0.66,5.49E-01
positive regulation of fatty acid oxidation (GO:0046321),15,1,1.52,-,0.66,5.49E-01
dosage compensation (GO:0007549),15,1,1.52,-,0.66,5.49E-01
cellular response to interferon-gamma (GO:0071346),150,10,15.25,-,0.66,1.06E-01
cardiac chamber development (GO:0003205),166,11,16.88,-,0.65,8.81E-02
nucleus organization (GO:0006997),121,8,12.3,-,0.65,1.35E-01
regulation of cell cycle arrest (GO:0071156),106,7,10.78,-,0.65,1.57E-01
positive regulation of viral process (GO:0048524),106,7,10.78,-,0.65,1.57E-01
nucleotide biosynthetic process (GO:0009165),197,13,20.03,-,0.65,6.42E-02
regulation of potassium ion transport (GO:0043266),91,6,9.25,-,0.65,1.84E-01
endothelium development (GO:0003158),91,6,9.25,-,0.65,1.84E-01
regulation of interleukin-8 production (GO:0032677),76,5,7.73,-,0.65,2.17E-01
positive regulation of B cell activation (GO:0050871),76,5,7.73,-,0.65,2.17E-01
cell cycle G1/S phase transition (GO:0044843),122,8,12.4,-,0.65,1.29E-01
negative regulation of synaptic transmission (GO:0050805),61,4,6.2,-,0.65,2.58E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389),183,12,18.6,-,0.65,7.05E-02
regulation of glucose metabolic process (GO:0010906),107,7,10.88,-,0.64,1.50E-01
negative regulation of blood pressure (GO:0045776),46,3,4.68,-,0.64,3.13E-01
negative regulation of protein kinase B signaling (GO:0051898),46,3,4.68,-,0.64,3.13E-01
maintenance of location in cell (GO:0051651),92,6,9.35,-,0.64,1.76E-01
DNA integrity checkpoint (GO:0031570),138,9,14.03,-,0.64,1.07E-01
skeletal muscle cell differentiation (GO:0035914),46,3,4.68,-,0.64,3.13E-01
regulation of organ growth (GO:0046620),92,6,9.35,-,0.64,1.76E-01
nucleobase-containing small molecule catabolic process (GO:0034656),46,3,4.68,-,0.64,3.13E-01
natural killer cell activation (GO:0030101),46,3,4.68,-,0.64,3.13E-01
endothelial cell differentiation (GO:0045446),77,5,7.83,-,0.64,2.07E-01
negative regulation of NF-kappaB transcription factor activity (GO:0032088),77,5,7.83,-,0.64,2.07E-01
iron ion homeostasis (GO:0055072),77,5,7.83,-,0.64,2.07E-01
pyrimidine-containing compound metabolic process (GO:0072527),77,5,7.83,-,0.64,2.07E-01
movement in host environment (GO:0052126),108,7,10.98,-,0.64,1.44E-01
regulation of canonical Wnt signaling pathway (GO:0060828),278,18,28.26,-,0.64,2.60E-02
regulation of heart rate (GO:0002027),93,6,9.45,-,0.63,1.68E-01
regulation of adenylate cyclase activity (GO:0045761),31,2,3.15,-,0.63,3.90E-01
vesicle coating (GO:0006901),62,4,6.3,-,0.63,2.46E-01
extracellular transport (GO:0006858),31,2,3.15,-,0.63,3.90E-01
regulation of B cell differentiation (GO:0045577),31,2,3.15,-,0.63,3.90E-01
GPI anchor metabolic process (GO:0006505),31,2,3.15,-,0.63,3.90E-01
regulation of interleukin-4 production (GO:0032673),31,2,3.15,-,0.63,3.90E-01
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),31,2,3.15,-,0.63,3.90E-01
response to mineralocorticoid (GO:0051385),31,2,3.15,-,0.63,3.90E-01
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),31,2,3.15,-,0.63,3.90E-01
regulation of presynapse organization (GO:0099174),31,2,3.15,-,0.63,3.90E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),31,2,3.15,-,0.63,3.90E-01
glucose transmembrane transport (GO:1904659),31,2,3.15,-,0.63,3.90E-01
deoxyribonucleotide metabolic process (GO:0009262),31,2,3.15,-,0.63,3.90E-01
protein localization to postsynapse (GO:0062237),31,2,3.15,-,0.63,3.90E-01
positive regulation of cardiac muscle tissue growth (GO:0055023),31,2,3.15,-,0.63,3.90E-01
regulation of histone methylation (GO:0031060),62,4,6.3,-,0.63,2.46E-01
ribonucleoside monophosphate biosynthetic process (GO:0009156),31,2,3.15,-,0.63,3.90E-01
nucleobase metabolic process (GO:0009112),31,2,3.15,-,0.63,3.90E-01
negative regulation of exocytosis (GO:0045920),31,2,3.15,-,0.63,3.90E-01
protein localization to vacuole (GO:0072665),62,4,6.3,-,0.63,2.46E-01
placenta blood vessel development (GO:0060674),31,2,3.15,-,0.63,3.90E-01
membrane docking (GO:0022406),171,11,17.38,-,0.63,7.09E-02
gonad development (GO:0008406),203,13,20.64,-,0.63,4.96E-02
positive regulation of cellular protein catabolic process (GO:1903364),141,9,14.33,-,0.63,9.35E-02
sulfur compound transport (GO:0072348),47,3,4.78,-,0.63,2.97E-01
maintenance of protein location (GO:0045185),94,6,9.56,-,0.63,1.60E-01
regulation of viral genome replication (GO:0045069),94,6,9.56,-,0.63,1.60E-01
regulation of neurotransmitter transport (GO:0051588),94,6,9.56,-,0.63,1.60E-01
regulation of leukocyte degranulation (GO:0043300),47,3,4.78,-,0.63,2.97E-01
histone deacetylation (GO:0016575),47,3,4.78,-,0.63,2.97E-01
protein localization to cilium (GO:0061512),47,3,4.78,-,0.63,2.97E-01
response to antibiotic (GO:0046677),47,3,4.78,-,0.63,2.97E-01
response to cocaine (GO:0042220),47,3,4.78,-,0.63,2.97E-01
negative regulation of Ras protein signal transduction (GO:0046580),47,3,4.78,-,0.63,2.97E-01
regulation of microtubule-based movement (GO:0060632),47,3,4.78,-,0.63,2.97E-01
positive regulation of protein catabolic process (GO:0045732),220,14,22.37,-,0.63,3.99E-02
regulation of sister chromatid segregation (GO:0033045),63,4,6.4,-,0.62,2.34E-01
regulation of behavior (GO:0050795),63,4,6.4,-,0.62,2.34E-01
ribosomal small subunit biogenesis (GO:0042274),63,4,6.4,-,0.62,2.34E-01
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),95,6,9.66,-,0.62,1.52E-01
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),95,6,9.66,-,0.62,1.52E-01
morphogenesis of embryonic epithelium (GO:0016331),143,9,14.54,-,0.62,8.53E-02
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504),96,6,9.76,-,0.61,1.45E-01
spliceosomal complex assembly (GO:0000245),48,3,4.88,-,0.61,2.82E-01
receptor clustering (GO:0043113),48,3,4.88,-,0.61,2.82E-01
ventricular cardiac muscle tissue morphogenesis (GO:0055010),48,3,4.88,-,0.61,2.82E-01
neuron recognition (GO:0008038),48,3,4.88,-,0.61,2.82E-01
regulation of oxidative stress-induced cell death (GO:1903201),64,4,6.51,-,0.61,2.22E-01
nucleobase biosynthetic process (GO:0046112),16,1,1.63,-,0.61,5.16E-01
cerebellar Purkinje cell layer morphogenesis (GO:0021692),16,1,1.63,-,0.61,5.16E-01
cGMP metabolic process (GO:0046068),16,1,1.63,-,0.61,5.16E-01
Golgi to vacuole transport (GO:0006896),16,1,1.63,-,0.61,5.16E-01
renal system process involved in regulation of blood volume (GO:0001977),16,1,1.63,-,0.61,5.16E-01
dentate gyrus development (GO:0021542),16,1,1.63,-,0.61,5.16E-01
regulation of epithelial cell differentiation involved in kidney development (GO:2000696),16,1,1.63,-,0.61,5.16E-01
nephric duct development (GO:0072176),16,1,1.63,-,0.61,5.16E-01
sphingosine metabolic process (GO:0006670),16,1,1.63,-,0.61,5.16E-01
mitotic chromosome condensation (GO:0007076),16,1,1.63,-,0.61,5.16E-01
microtubule depolymerization (GO:0007019),16,1,1.63,-,0.61,5.16E-01
mesoderm formation (GO:0001707),64,4,6.51,-,0.61,2.22E-01
negative regulation of cardiac muscle cell proliferation (GO:0060044),16,1,1.63,-,0.61,5.16E-01
mitotic G1/S transition checkpoint (GO:0044819),64,4,6.51,-,0.61,2.22E-01
multi-organism cellular process (GO:0044764),16,1,1.63,-,0.61,5.16E-01
cellular response to ionizing radiation (GO:0071479),64,4,6.51,-,0.61,2.22E-01
regulation of translational elongation (GO:0006448),16,1,1.63,-,0.61,5.16E-01
polysaccharide metabolic process (GO:0005976),80,5,8.13,-,0.61,1.79E-01
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),16,1,1.63,-,0.61,5.16E-01
regulation of hepatocyte proliferation (GO:2000345),16,1,1.63,-,0.61,5.16E-01
negative regulation of viral release from host cell (GO:1902187),16,1,1.63,-,0.61,5.16E-01
interleukin-1 production (GO:0032612),16,1,1.63,-,0.61,5.16E-01
cellular response to exogenous dsRNA (GO:0071360),16,1,1.63,-,0.61,5.16E-01
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),16,1,1.63,-,0.61,5.16E-01
cellular response to ATP (GO:0071318),16,1,1.63,-,0.61,5.16E-01
mitochondrial RNA processing (GO:0000963),16,1,1.63,-,0.61,5.16E-01
regulation of mitophagy (GO:1901524),16,1,1.63,-,0.61,5.16E-01
regulation of neurotransmitter uptake (GO:0051580),16,1,1.63,-,0.61,5.16E-01
histone H2A acetylation (GO:0043968),16,1,1.63,-,0.61,5.16E-01
histone H3-K9 methylation (GO:0051567),16,1,1.63,-,0.61,5.16E-01
2-oxoglutarate metabolic process (GO:0006103),16,1,1.63,-,0.61,5.16E-01
positive regulation of chromosome separation (GO:1905820),16,1,1.63,-,0.61,5.16E-01
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",16,1,1.63,-,0.61,5.16E-01
positive regulation of protein localization to cell surface (GO:2000010),16,1,1.63,-,0.61,5.16E-01
tricarboxylic acid cycle (GO:0006099),32,2,3.25,-,0.61,3.69E-01
negative regulation of voltage-gated calcium channel activity (GO:1901386),16,1,1.63,-,0.61,5.16E-01
dendrite self-avoidance (GO:0070593),16,1,1.63,-,0.61,5.16E-01
activation of protein kinase B activity (GO:0032148),32,2,3.25,-,0.61,3.69E-01
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",32,2,3.25,-,0.61,3.69E-01
mitotic G1 DNA damage checkpoint (GO:0031571),64,4,6.51,-,0.61,2.22E-01
'de novo' posttranslational protein folding (GO:0051084),32,2,3.25,-,0.61,3.69E-01
"protein localization to chromosome, telomeric region (GO:0070198)",16,1,1.63,-,0.61,5.16E-01
positive regulation of mitochondrial translation (GO:0070131),16,1,1.63,-,0.61,5.16E-01
"vesicle targeting, to, from or within Golgi (GO:0048199)",64,4,6.51,-,0.61,2.22E-01
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),32,2,3.25,-,0.61,3.69E-01
positive regulation of vascular associated smooth muscle cell migration (GO:1904754),16,1,1.63,-,0.61,5.16E-01
phosphatidylinositol acyl-chain remodeling (GO:0036149),16,1,1.63,-,0.61,5.16E-01
positive regulation of protein-containing complex disassembly (GO:0043243),32,2,3.25,-,0.61,3.69E-01
ribosomal small subunit assembly (GO:0000028),16,1,1.63,-,0.61,5.16E-01
female genitalia development (GO:0030540),16,1,1.63,-,0.61,5.16E-01
hexose transmembrane transport (GO:0008645),32,2,3.25,-,0.61,3.69E-01
regulation of inositol phosphate biosynthetic process (GO:0010919),16,1,1.63,-,0.61,5.16E-01
rRNA catabolic process (GO:0016075),16,1,1.63,-,0.61,5.16E-01
stabilization of membrane potential (GO:0030322),16,1,1.63,-,0.61,5.16E-01
hyaluronan metabolic process (GO:0030212),32,2,3.25,-,0.61,3.69E-01
negative regulation of Wnt signaling pathway (GO:0030178),208,13,21.15,-,0.61,3.98E-02
sulfate transport (GO:0008272),16,1,1.63,-,0.61,5.16E-01
regulation of cilium movement (GO:0003352),32,2,3.25,-,0.61,3.69E-01
regulation of cytokine biosynthetic process (GO:0042035),16,1,1.63,-,0.61,5.16E-01
chemosensory behavior (GO:0007635),16,1,1.63,-,0.61,5.16E-01
ventricular trabecula myocardium morphogenesis (GO:0003222),16,1,1.63,-,0.61,5.16E-01
regulation of fatty acid oxidation (GO:0046320),32,2,3.25,-,0.61,3.69E-01
cell junction maintenance (GO:0034331),32,2,3.25,-,0.61,3.69E-01
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),32,2,3.25,-,0.61,3.69E-01
positive regulation of protein ubiquitination (GO:0031398),113,7,11.49,-,0.61,1.14E-01
nucleoside metabolic process (GO:0009116),97,6,9.86,-,0.61,1.38E-01
canonical Wnt signaling pathway (GO:0060070),81,5,8.23,-,0.61,1.70E-01
cell fate specification (GO:0001708),81,5,8.23,-,0.61,1.70E-01
regulation of cellular amine metabolic process (GO:0033238),81,5,8.23,-,0.61,1.70E-01
organelle localization by membrane tethering (GO:0140056),162,10,16.47,-,0.61,6.18E-02
regulation of neurotransmitter secretion (GO:0046928),81,5,8.23,-,0.61,1.70E-01
cartilage development (GO:0051216),146,9,14.84,-,0.61,7.42E-02
regulation of heart growth (GO:0060420),65,4,6.61,-,0.61,2.11E-01
regulation of toll-like receptor signaling pathway (GO:0034121),65,4,6.61,-,0.61,2.11E-01
organelle disassembly (GO:1903008),65,4,6.61,-,0.61,2.11E-01
G1 DNA damage checkpoint (GO:0044783),65,4,6.61,-,0.61,2.11E-01
COPII-coated vesicle budding (GO:0090114),65,4,6.61,-,0.61,2.11E-01
alcohol catabolic process (GO:0046164),49,3,4.98,-,0.6,2.67E-01
regulation of cell cycle G2/M phase transition (GO:1902749),196,12,19.93,-,0.6,3.95E-02
negative regulation of fat cell differentiation (GO:0045599),49,3,4.98,-,0.6,2.67E-01
presynaptic endocytosis (GO:0140238),49,3,4.98,-,0.6,2.67E-01
regulation of chondrocyte differentiation (GO:0032330),49,3,4.98,-,0.6,2.67E-01
synaptic vesicle endocytosis (GO:0048488),49,3,4.98,-,0.6,2.67E-01
pallium development (GO:0021543),164,10,16.67,-,0.6,5.63E-02
ephrin receptor signaling pathway (GO:0048013),82,5,8.34,-,0.6,1.62E-01
antigen processing and presentation of peptide antigen (GO:0048002),181,11,18.4,-,0.6,4.49E-02
superoxide metabolic process (GO:0006801),33,2,3.35,-,0.6,3.48E-01
blood vessel remodeling (GO:0001974),33,2,3.35,-,0.6,3.48E-01
positive regulation of peptidyl-lysine acetylation (GO:2000758),33,2,3.35,-,0.6,3.48E-01
positive regulation of interferon-beta production (GO:0032728),33,2,3.35,-,0.6,3.48E-01
interaction with host (GO:0051701),165,10,16.77,-,0.6,5.37E-02
modulation by symbiont of host cellular process (GO:0044068),33,2,3.35,-,0.6,3.48E-01
negative regulation of striated muscle cell differentiation (GO:0051154),33,2,3.35,-,0.6,3.48E-01
entrainment of circadian clock (GO:0009649),33,2,3.35,-,0.6,3.48E-01
mesoderm morphogenesis (GO:0048332),66,4,6.71,-,0.6,2.01E-01
response to sterol (GO:0036314),33,2,3.35,-,0.6,3.48E-01
replication fork processing (GO:0031297),33,2,3.35,-,0.6,3.48E-01
regulation of cardiac muscle cell contraction (GO:0086004),33,2,3.35,-,0.6,3.48E-01
energy homeostasis (GO:0097009),33,2,3.35,-,0.6,3.48E-01
positive regulation of heart contraction (GO:0045823),33,2,3.35,-,0.6,3.48E-01
establishment of endothelial barrier (GO:0061028),33,2,3.35,-,0.6,3.48E-01
anaphase (GO:0051322),149,9,15.15,-,0.59,6.43E-02
mitotic anaphase (GO:0000090),149,9,15.15,-,0.59,6.43E-02
ERAD pathway (GO:0036503),83,5,8.44,-,0.59,1.54E-01
regulation of mononuclear cell migration (GO:0071675),50,3,5.08,-,0.59,2.53E-01
protein deacetylation (GO:0006476),50,3,5.08,-,0.59,2.53E-01
regulation of synaptic vesicle exocytosis (GO:2000300),50,3,5.08,-,0.59,2.53E-01
energy derivation by oxidation of organic compounds (GO:0015980),200,12,20.33,-,0.59,3.27E-02
negative regulation of myeloid leukocyte differentiation (GO:0002762),50,3,5.08,-,0.59,2.53E-01
regulation of organelle assembly (GO:1902115),167,10,16.98,-,0.59,4.88E-02
regulation of cell-matrix adhesion (GO:0001952),117,7,11.89,-,0.59,9.34E-02
ribonucleoside metabolic process (GO:0009119),67,4,6.81,-,0.59,1.90E-01
response to type I interferon (GO:0034340),67,4,6.81,-,0.59,1.90E-01
regulation of regulated secretory pathway (GO:1903305),134,8,13.62,-,0.59,7.37E-02
antigen processing and presentation of exogenous peptide antigen (GO:0002478),168,10,17.08,-,0.59,4.65E-02
localization within membrane (GO:0051668),84,5,8.54,-,0.59,1.46E-01
regulation of receptor-mediated endocytosis (GO:0048259),101,6,10.27,-,0.58,1.13E-01
columnar/cuboidal epithelial cell development (GO:0002066),51,3,5.18,-,0.58,2.40E-01
intracellular transport of virus (GO:0075733),51,3,5.18,-,0.58,2.40E-01
IRE1-mediated unfolded protein response (GO:0036498),51,3,5.18,-,0.58,2.40E-01
regulation of neuronal synaptic plasticity (GO:0048168),51,3,5.18,-,0.58,2.40E-01
cardiac muscle cell development (GO:0055013),51,3,5.18,-,0.58,2.40E-01
antigen processing and presentation of endogenous peptide antigen (GO:0002483),17,1,1.73,-,0.58,4.84E-01
specification of animal organ identity (GO:0010092),17,1,1.73,-,0.58,4.84E-01
nitric oxide biosynthetic process (GO:0006809),17,1,1.73,-,0.58,4.84E-01
inflammatory response to antigenic stimulus (GO:0002437),34,2,3.46,-,0.58,3.29E-01
long-term synaptic depression (GO:0060292),17,1,1.73,-,0.58,4.84E-01
metanephric nephron epithelium development (GO:0072243),17,1,1.73,-,0.58,4.84E-01
regulation of T cell mediated cytotoxicity (GO:0001914),34,2,3.46,-,0.58,3.29E-01
regulation of cardiac muscle cell differentiation (GO:2000725),17,1,1.73,-,0.58,4.84E-01
ureter development (GO:0072189),17,1,1.73,-,0.58,4.84E-01
neuron cell-cell adhesion (GO:0007158),17,1,1.73,-,0.58,4.84E-01
regulation of early endosome to late endosome transport (GO:2000641),17,1,1.73,-,0.58,4.84E-01
acyl-CoA metabolic process (GO:0006637),85,5,8.64,-,0.58,1.39E-01
viral translation (GO:0019081),17,1,1.73,-,0.58,4.84E-01
estrous cycle (GO:0044849),17,1,1.73,-,0.58,4.84E-01
"regulation of synaptic transmission, glutamatergic (GO:0051966)",68,4,6.91,-,0.58,1.81E-01
glycogen catabolic process (GO:0005980),17,1,1.73,-,0.58,4.84E-01
mitochondrial respiratory chain complex assembly (GO:0033108),85,5,8.64,-,0.58,1.39E-01
regulation of ceramide biosynthetic process (GO:2000303),17,1,1.73,-,0.58,4.84E-01
regulation of gene expression by genetic imprinting (GO:0006349),17,1,1.73,-,0.58,4.84E-01
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),17,1,1.73,-,0.58,4.84E-01
muscle cell proliferation (GO:0033002),17,1,1.73,-,0.58,4.84E-01
cardiac muscle cell membrane repolarization (GO:0099622),17,1,1.73,-,0.58,4.84E-01
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),17,1,1.73,-,0.58,4.84E-01
protein localization to chromatin (GO:0071168),17,1,1.73,-,0.58,4.84E-01
positive regulation of skeletal muscle tissue development (GO:0048643),17,1,1.73,-,0.58,4.84E-01
myelin assembly (GO:0032288),17,1,1.73,-,0.58,4.84E-01
regulation of inclusion body assembly (GO:0090083),17,1,1.73,-,0.58,4.84E-01
oocyte development (GO:0048599),34,2,3.46,-,0.58,3.29E-01
reverse cholesterol transport (GO:0043691),17,1,1.73,-,0.58,4.84E-01
lipopolysaccharide-mediated signaling pathway (GO:0031663),34,2,3.46,-,0.58,3.29E-01
response to magnesium ion (GO:0032026),17,1,1.73,-,0.58,4.84E-01
endothelial cell migration (GO:0043542),68,4,6.91,-,0.58,1.81E-01
regulation of T cell apoptotic process (GO:0070232),34,2,3.46,-,0.58,3.29E-01
positive regulation of lymphocyte apoptotic process (GO:0070230),17,1,1.73,-,0.58,4.84E-01
regulation of granulocyte differentiation (GO:0030852),17,1,1.73,-,0.58,4.84E-01
regulation of circadian sleep/wake cycle (GO:0042749),17,1,1.73,-,0.58,4.84E-01
histone H2A monoubiquitination (GO:0035518),17,1,1.73,-,0.58,4.84E-01
copper ion homeostasis (GO:0055070),17,1,1.73,-,0.58,4.84E-01
vitamin transmembrane transport (GO:0035461),17,1,1.73,-,0.58,4.84E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167),34,2,3.46,-,0.58,3.29E-01
preassembly of GPI anchor in ER membrane (GO:0016254),17,1,1.73,-,0.58,4.84E-01
thioester metabolic process (GO:0035383),85,5,8.64,-,0.58,1.39E-01
monosaccharide transmembrane transport (GO:0015749),34,2,3.46,-,0.58,3.29E-01
membrane repolarization during cardiac muscle cell action potential (GO:0086013),17,1,1.73,-,0.58,4.84E-01
membrane repolarization during action potential (GO:0086011),17,1,1.73,-,0.58,4.84E-01
phosphorylated carbohydrate dephosphorylation (GO:0046838),17,1,1.73,-,0.58,4.84E-01
negative regulation of epithelial to mesenchymal transition (GO:0010719),34,2,3.46,-,0.58,3.29E-01
dendritic spine morphogenesis (GO:0060997),17,1,1.73,-,0.58,4.84E-01
negative regulation of organ growth (GO:0046621),34,2,3.46,-,0.58,3.29E-01
cellular response to alcohol (GO:0097306),85,5,8.64,-,0.58,1.39E-01
hyaluronan catabolic process (GO:0030214),17,1,1.73,-,0.58,4.84E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),17,1,1.73,-,0.58,4.84E-01
sphingoid metabolic process (GO:0046519),17,1,1.73,-,0.58,4.84E-01
protein import into mitochondrial matrix (GO:0030150),17,1,1.73,-,0.58,4.84E-01
T-helper 1 type immune response (GO:0042088),17,1,1.73,-,0.58,4.84E-01
protein refolding (GO:0042026),17,1,1.73,-,0.58,4.84E-01
ventricular septum development (GO:0003281),68,4,6.91,-,0.58,1.81E-01
"phototransduction, visible light (GO:0007603)",17,1,1.73,-,0.58,4.84E-01
mammary gland epithelial cell differentiation (GO:0060644),17,1,1.73,-,0.58,4.84E-01
pulmonary valve morphogenesis (GO:0003184),17,1,1.73,-,0.58,4.84E-01
G1/S transition of mitotic cell cycle (GO:0000082),120,7,12.2,-,0.57,8.04E-02
signal transduction involved in DNA damage checkpoint (GO:0072422),69,4,7.01,-,0.57,1.71E-01
signal transduction involved in DNA integrity checkpoint (GO:0072401),69,4,7.01,-,0.57,1.71E-01
retina homeostasis (GO:0001895),69,4,7.01,-,0.57,1.71E-01
endosome organization (GO:0007032),69,4,7.01,-,0.57,1.71E-01
ERBB signaling pathway (GO:0038127),69,4,7.01,-,0.57,1.71E-01
regulation of myoblast differentiation (GO:0045661),52,3,5.29,-,0.57,2.27E-01
metaphase plate congression (GO:0051310),52,3,5.29,-,0.57,2.27E-01
aorta development (GO:0035904),52,3,5.29,-,0.57,2.27E-01
activation of MAPKK activity (GO:0000186),52,3,5.29,-,0.57,2.27E-01
antigen processing and presentation (GO:0019882),208,12,21.15,-,0.57,2.23E-02
regulation of binding (GO:0051098),348,20,35.38,-,0.57,3.34E-03
neural tube development (GO:0021915),157,9,15.96,-,0.56,4.34E-02
regulation of lipid biosynthetic process (GO:0046890),192,11,19.52,-,0.56,2.64E-02
signal transduction involved in cell cycle checkpoint (GO:0072395),70,4,7.12,-,0.56,1.62E-01
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",70,4,7.12,-,0.56,1.62E-01
antigen processing and presentation of exogenous antigen (GO:0019884),175,10,17.79,-,0.56,3.30E-02
positive regulation of blood circulation (GO:1903524),35,2,3.56,-,0.56,3.10E-01
receptor localization to synapse (GO:0097120),35,2,3.56,-,0.56,3.10E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090),176,10,17.89,-,0.56,3.13E-02
regulation of steroid biosynthetic process (GO:0050810),88,5,8.95,-,0.56,1.18E-01
Fc-epsilon receptor signaling pathway (GO:0038095),106,6,10.78,-,0.56,8.76E-02
negative regulation of tumor necrosis factor production (GO:0032720),53,3,5.39,-,0.56,2.14E-01
cellular response to nerve growth factor stimulus (GO:1990090),53,3,5.39,-,0.56,2.14E-01
positive regulation of blood vessel endothelial cell migration (GO:0043536),53,3,5.39,-,0.56,2.14E-01
regulation of lymphocyte apoptotic process (GO:0070228),53,3,5.39,-,0.56,2.14E-01
negative regulation of chromatin organization (GO:1905268),53,3,5.39,-,0.56,2.14E-01
regulation of cardiac conduction (GO:1903779),53,3,5.39,-,0.56,2.14E-01
steroid hormone mediated signaling pathway (GO:0043401),71,4,7.22,-,0.55,1.53E-01
regulation of amine transport (GO:0051952),89,5,9.05,-,0.55,1.12E-01
negative regulation of small molecule metabolic process (GO:0062014),89,5,9.05,-,0.55,1.12E-01
cellular carbohydrate metabolic process (GO:0044262),161,9,16.37,-,0.55,3.54E-02
NADH dehydrogenase complex assembly (GO:0010257),54,3,5.49,-,0.55,2.02E-01
mitochondrial respiratory chain complex I assembly (GO:0032981),54,3,5.49,-,0.55,2.02E-01
sprouting angiogenesis (GO:0002040),54,3,5.49,-,0.55,2.02E-01
modulation by symbiont of host process (GO:0044003),54,3,5.49,-,0.55,2.02E-01
regulation of blood vessel endothelial cell migration (GO:0043535),90,5,9.15,-,0.55,1.06E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058),54,3,5.49,-,0.55,2.02E-01
phosphatidylinositol phosphorylation (GO:0046854),54,3,5.49,-,0.55,2.02E-01
female sex differentiation (GO:0046660),108,6,10.98,-,0.55,7.88E-02
execution phase of apoptosis (GO:0097194),54,3,5.49,-,0.55,2.02E-01
regulation of tolerance induction (GO:0002643),18,1,1.83,-,0.55,4.54E-01
positive regulation of oxidative stress-induced cell death (GO:1903209),18,1,1.83,-,0.55,4.54E-01
epoxygenase P450 pathway (GO:0019373),18,1,1.83,-,0.55,4.54E-01
negative regulation of anoikis (GO:2000811),18,1,1.83,-,0.55,4.54E-01
positive regulation of neurotransmitter secretion (GO:0001956),18,1,1.83,-,0.55,4.54E-01
cell differentiation involved in metanephros development (GO:0072202),18,1,1.83,-,0.55,4.54E-01
definitive hemopoiesis (GO:0060216),18,1,1.83,-,0.55,4.54E-01
natural killer cell activation involved in immune response (GO:0002323),18,1,1.83,-,0.55,4.54E-01
regulation of ATP biosynthetic process (GO:2001169),18,1,1.83,-,0.55,4.54E-01
metanephric tubule development (GO:0072170),18,1,1.83,-,0.55,4.54E-01
synaptonemal complex assembly (GO:0007130),18,1,1.83,-,0.55,4.54E-01
glycerol ether metabolic process (GO:0006662),18,1,1.83,-,0.55,4.54E-01
positive regulation of interleukin-17 production (GO:0032740),18,1,1.83,-,0.55,4.54E-01
glandular epithelial cell development (GO:0002068),18,1,1.83,-,0.55,4.54E-01
negative regulation of gliogenesis (GO:0014014),36,2,3.66,-,0.55,2.92E-01
response to hydroperoxide (GO:0033194),18,1,1.83,-,0.55,4.54E-01
regulation of myoblast fusion (GO:1901739),18,1,1.83,-,0.55,4.54E-01
regulation of clathrin-dependent endocytosis (GO:2000369),18,1,1.83,-,0.55,4.54E-01
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),18,1,1.83,-,0.55,4.54E-01
cellular response to gonadotropin stimulus (GO:0071371),18,1,1.83,-,0.55,4.54E-01
mitotic recombination (GO:0006312),18,1,1.83,-,0.55,4.54E-01
positive regulation of embryonic development (GO:0040019),18,1,1.83,-,0.55,4.54E-01
purine nucleobase metabolic process (GO:0006144),18,1,1.83,-,0.55,4.54E-01
regulation of sphingolipid biosynthetic process (GO:0090153),18,1,1.83,-,0.55,4.54E-01
lymph node development (GO:0048535),18,1,1.83,-,0.55,4.54E-01
protein depolymerization (GO:0051261),36,2,3.66,-,0.55,2.92E-01
"retrograde transport, endosome to plasma membrane (GO:1990126)",18,1,1.83,-,0.55,4.54E-01
regulation of response to food (GO:0032095),18,1,1.83,-,0.55,4.54E-01
response to food (GO:0032094),18,1,1.83,-,0.55,4.54E-01
postsynapse assembly (GO:0099068),18,1,1.83,-,0.55,4.54E-01
response to superoxide (GO:0000303),18,1,1.83,-,0.55,4.54E-01
regulation of telomerase RNA localization to Cajal body (GO:1904872),18,1,1.83,-,0.55,4.54E-01
regulation of vesicle fusion (GO:0031338),18,1,1.83,-,0.55,4.54E-01
retinal ganglion cell axon guidance (GO:0031290),18,1,1.83,-,0.55,4.54E-01
regulation of membrane lipid metabolic process (GO:1905038),18,1,1.83,-,0.55,4.54E-01
glucan catabolic process (GO:0009251),18,1,1.83,-,0.55,4.54E-01
positive regulation of histone methylation (GO:0031062),36,2,3.66,-,0.55,2.92E-01
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),18,1,1.83,-,0.55,4.54E-01
negative regulation of calcium ion transport into cytosol (GO:0010523),18,1,1.83,-,0.55,4.54E-01
regulation of B cell apoptotic process (GO:0002902),18,1,1.83,-,0.55,4.54E-01
regulation of alcohol biosynthetic process (GO:1902930),72,4,7.32,-,0.55,1.45E-01
tube formation (GO:0035148),145,8,14.74,-,0.54,4.21E-02
regulation of fatty acid metabolic process (GO:0019217),91,5,9.25,-,0.54,1.01E-01
ciliary basal body-plasma membrane docking (GO:0097711),91,5,9.25,-,0.54,1.01E-01
Golgi vesicle budding (GO:0048194),73,4,7.42,-,0.54,1.37E-01
neural precursor cell proliferation (GO:0061351),73,4,7.42,-,0.54,1.37E-01
regulation of establishment of planar polarity (GO:0090175),110,6,11.18,-,0.54,7.07E-02
sperm-egg recognition (GO:0035036),55,3,5.59,-,0.54,1.91E-01
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),55,3,5.59,-,0.54,1.91E-01
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",92,5,9.35,-,0.53,9.52E-02
determination of left/right symmetry (GO:0007368),111,6,11.28,-,0.53,6.70E-02
"phagocytosis, engulfment (GO:0006911)",37,2,3.76,-,0.53,2.75E-01
catecholamine metabolic process (GO:0006584),37,2,3.76,-,0.53,2.75E-01
brain morphogenesis (GO:0048854),37,2,3.76,-,0.53,2.75E-01
peptide cross-linking (GO:0018149),37,2,3.76,-,0.53,2.75E-01
regulation of triglyceride metabolic process (GO:0090207),37,2,3.76,-,0.53,2.75E-01
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),37,2,3.76,-,0.53,2.75E-01
catechol-containing compound metabolic process (GO:0009712),37,2,3.76,-,0.53,2.75E-01
positive regulation of TOR signaling (GO:0032008),37,2,3.76,-,0.53,2.75E-01
protein peptidyl-prolyl isomerization (GO:0000413),37,2,3.76,-,0.53,2.75E-01
regulation of cellular response to oxidative stress (GO:1900407),74,4,7.52,-,0.53,1.30E-01
apoptotic cell clearance (GO:0043277),37,2,3.76,-,0.53,2.75E-01
purine nucleoside monophosphate metabolic process (GO:0009126),37,2,3.76,-,0.53,2.75E-01
positive regulation of glucose metabolic process (GO:0010907),37,2,3.76,-,0.53,2.75E-01
protein localization to lysosome (GO:0061462),37,2,3.76,-,0.53,2.75E-01
protein localization to microtubule cytoskeleton (GO:0072698),37,2,3.76,-,0.53,2.75E-01
regulation of amyloid precursor protein catabolic process (GO:1902991),37,2,3.76,-,0.53,2.75E-01
epithelial tube formation (GO:0072175),130,7,13.22,-,0.53,4.76E-02
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),93,5,9.45,-,0.53,9.01E-02
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",56,3,5.69,-,0.53,1.80E-01
telencephalon cell migration (GO:0022029),56,3,5.69,-,0.53,1.80E-01
response to nerve growth factor (GO:1990089),56,3,5.69,-,0.53,1.80E-01
cardiac cell development (GO:0055006),56,3,5.69,-,0.53,1.80E-01
protein localization to synapse (GO:0035418),56,3,5.69,-,0.53,1.80E-01
mitotic interphase (GO:0051329),75,4,7.62,-,0.52,1.23E-01
interphase (GO:0051325),75,4,7.62,-,0.52,1.23E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),75,4,7.62,-,0.52,1.23E-01
microtubule organizing center organization (GO:0031023),94,5,9.56,-,0.52,8.52E-02
triglyceride biosynthetic process (GO:0019432),19,1,1.93,-,0.52,4.25E-01
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),57,3,5.79,-,0.52,1.70E-01
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413),57,3,5.79,-,0.52,1.70E-01
trachea development (GO:0060438),19,1,1.93,-,0.52,4.25E-01
leukocyte migration involved in inflammatory response (GO:0002523),19,1,1.93,-,0.52,4.25E-01
growth hormone receptor signaling pathway (GO:0060396),19,1,1.93,-,0.52,4.25E-01
stress granule assembly (GO:0034063),19,1,1.93,-,0.52,4.25E-01
phosphate ion transport (GO:0006817),19,1,1.93,-,0.52,4.25E-01
regulation of mammary gland epithelial cell proliferation (GO:0033599),19,1,1.93,-,0.52,4.25E-01
negative regulation of cellular senescence (GO:2000773),19,1,1.93,-,0.52,4.25E-01
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403),57,3,5.79,-,0.52,1.70E-01
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402),57,3,5.79,-,0.52,1.70E-01
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400),57,3,5.79,-,0.52,1.70E-01
positive regulation of amino acid transport (GO:0051957),19,1,1.93,-,0.52,4.25E-01
positive regulation of CREB transcription factor activity (GO:0032793),19,1,1.93,-,0.52,4.25E-01
negative regulation of interleukin-8 production (GO:0032717),19,1,1.93,-,0.52,4.25E-01
cellular response to fluid shear stress (GO:0071498),19,1,1.93,-,0.52,4.25E-01
cellular response to low-density lipoprotein particle stimulus (GO:0071404),19,1,1.93,-,0.52,4.25E-01
oxidative demethylation (GO:0070989),19,1,1.93,-,0.52,4.25E-01
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),19,1,1.93,-,0.52,4.25E-01
prostaglandin biosynthetic process (GO:0001516),19,1,1.93,-,0.52,4.25E-01
positive regulation of amyloid-beta formation (GO:1902004),19,1,1.93,-,0.52,4.25E-01
regulation of fatty acid beta-oxidation (GO:0031998),19,1,1.93,-,0.52,4.25E-01
negative regulation of release of cytochrome c from mitochondria (GO:0090201),19,1,1.93,-,0.52,4.25E-01
cellular response to leptin stimulus (GO:0044320),19,1,1.93,-,0.52,4.25E-01
regulation of protein localization to cell surface (GO:2000008),38,2,3.86,-,0.52,2.59E-01
N-acetylglucosamine metabolic process (GO:0006044),19,1,1.93,-,0.52,4.25E-01
oocyte differentiation (GO:0009994),38,2,3.86,-,0.52,2.59E-01
positive regulation of muscle organ development (GO:0048636),19,1,1.93,-,0.52,4.25E-01
regulation of muscle organ development (GO:0048634),38,2,3.86,-,0.52,2.59E-01
cellular polysaccharide metabolic process (GO:0044264),76,4,7.73,-,0.52,1.16E-01
cellular polysaccharide catabolic process (GO:0044247),19,1,1.93,-,0.52,4.25E-01
leukocyte tethering or rolling (GO:0050901),19,1,1.93,-,0.52,4.25E-01
cell aggregation (GO:0098743),19,1,1.93,-,0.52,4.25E-01
negative regulation of G0 to G1 transition (GO:0070317),38,2,3.86,-,0.52,2.59E-01
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),19,1,1.93,-,0.52,4.25E-01
response to oxygen radical (GO:0000305),19,1,1.93,-,0.52,4.25E-01
amyloid-beta metabolic process (GO:0050435),19,1,1.93,-,0.52,4.25E-01
cellular response to amyloid-beta (GO:1904646),38,2,3.86,-,0.52,2.59E-01
embryonic camera-type eye development (GO:0031076),38,2,3.86,-,0.52,2.59E-01
phospholipid dephosphorylation (GO:0046839),38,2,3.86,-,0.52,2.59E-01
protein localization to cell-cell junction (GO:0150105),19,1,1.93,-,0.52,4.25E-01
melanocyte differentiation (GO:0030318),19,1,1.93,-,0.52,4.25E-01
positive regulation of insulin receptor signaling pathway (GO:0046628),19,1,1.93,-,0.52,4.25E-01
development of primary female sexual characteristics (GO:0046545),95,5,9.66,-,0.52,8.06E-02
negative regulation of transposition (GO:0010529),19,1,1.93,-,0.52,4.25E-01
regulation of transposition (GO:0010528),19,1,1.93,-,0.52,4.25E-01
prostanoid biosynthetic process (GO:0046457),19,1,1.93,-,0.52,4.25E-01
type B pancreatic cell differentiation (GO:0003309),19,1,1.93,-,0.52,4.25E-01
ncRNA 5'-end processing (GO:0034471),19,1,1.93,-,0.52,4.25E-01
vesicle transport along actin filament (GO:0030050),19,1,1.93,-,0.52,4.25E-01
positive regulation of calcium ion-dependent exocytosis (GO:0045956),19,1,1.93,-,0.52,4.25E-01
retrograde axonal transport (GO:0008090),19,1,1.93,-,0.52,4.25E-01
positive regulation of striated muscle tissue development (GO:0045844),19,1,1.93,-,0.52,4.25E-01
DNA demethylation (GO:0080111),19,1,1.93,-,0.52,4.25E-01
adult behavior (GO:0030534),134,7,13.62,-,0.51,3.83E-02
regulation of chromosome segregation (GO:0051983),77,4,7.83,-,0.51,1.09E-01
regulation of cardiac muscle tissue growth (GO:0055021),58,3,5.9,-,0.51,1.60E-01
forebrain cell migration (GO:0021885),58,3,5.9,-,0.51,1.60E-01
hippocampus development (GO:0021766),78,4,7.93,-,0.5,1.03E-01
ventricular septum morphogenesis (GO:0060412),39,2,3.96,-,0.5,2.43E-01
ER-nucleus signaling pathway (GO:0006984),39,2,3.96,-,0.5,2.43E-01
multivesicular body sorting pathway (GO:0071985),39,2,3.96,-,0.5,2.43E-01
regulation of steroid metabolic process (GO:0019218),117,6,11.89,-,0.5,4.80E-02
protein targeting to vacuole (GO:0006623),39,2,3.96,-,0.5,2.43E-01
regulation of nuclear division (GO:0051783),117,6,11.89,-,0.5,4.80E-02
determination of bilateral symmetry (GO:0009855),117,6,11.89,-,0.5,4.80E-02
cyclic nucleotide metabolic process (GO:0009187),39,2,3.96,-,0.5,2.43E-01
bile acid metabolic process (GO:0008206),39,2,3.96,-,0.5,2.43E-01
connective tissue development (GO:0061448),195,10,19.82,-,0.5,1.15E-02
response to ionizing radiation (GO:0010212),137,7,13.93,-,0.5,3.24E-02
regulation of postsynaptic membrane potential (GO:0060078),98,5,9.96,-,0.5,6.79E-02
specification of symmetry (GO:0009799),118,6,12,-,0.5,4.54E-02
tissue regeneration (GO:0042246),59,3,6,-,0.5,1.51E-01
anaphase-promoting complex-dependent catabolic process (GO:0031145),79,4,8.03,-,0.5,9.73E-02
demethylation (GO:0070988),60,3,6.1,-,0.49,1.42E-01
vesicle docking (GO:0048278),60,3,6.1,-,0.49,1.42E-01
protein deacylation (GO:0035601),60,3,6.1,-,0.49,1.42E-01
positive regulation of bone resorption (GO:0045780),20,1,2.03,-,0.49,3.97E-01
negative regulation of systemic arterial blood pressure (GO:0003085),20,1,2.03,-,0.49,3.97E-01
vesicle docking involved in exocytosis (GO:0006904),40,2,4.07,-,0.49,2.28E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617),20,1,2.03,-,0.49,3.97E-01
mitotic G2 DNA damage checkpoint (GO:0007095),20,1,2.03,-,0.49,3.97E-01
modulation by virus of host cellular process (GO:0019054),20,1,2.03,-,0.49,3.97E-01
regulation of sister chromatid cohesion (GO:0007063),20,1,2.03,-,0.49,3.97E-01
regulation of microtubule-based process (GO:0032886),220,11,22.37,-,0.49,6.01E-03
reflex (GO:0060004),20,1,2.03,-,0.49,3.97E-01
positive regulation of muscle tissue development (GO:1901863),20,1,2.03,-,0.49,3.97E-01
cell migration involved in sprouting angiogenesis (GO:0002042),20,1,2.03,-,0.49,3.97E-01
regulation of NMDA receptor activity (GO:2000310),40,2,4.07,-,0.49,2.28E-01
cellular response to dsRNA (GO:0071359),20,1,2.03,-,0.49,3.97E-01
regulation of establishment of cell polarity (GO:2000114),20,1,2.03,-,0.49,3.97E-01
mitochondrial calcium ion homeostasis (GO:0051560),20,1,2.03,-,0.49,3.97E-01
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),20,1,2.03,-,0.49,3.97E-01
poly(A)+ mRNA export from nucleus (GO:0016973),20,1,2.03,-,0.49,3.97E-01
chaperone-mediated protein complex assembly (GO:0051131),20,1,2.03,-,0.49,3.97E-01
enteroendocrine cell differentiation (GO:0035883),20,1,2.03,-,0.49,3.97E-01
barbed-end actin filament capping (GO:0051016),20,1,2.03,-,0.49,3.97E-01
beta-catenin destruction complex disassembly (GO:1904886),20,1,2.03,-,0.49,3.97E-01
rRNA transcription (GO:0009303),20,1,2.03,-,0.49,3.97E-01
positive regulation of long-term synaptic potentiation (GO:1900273),20,1,2.03,-,0.49,3.97E-01
nucleoside monophosphate biosynthetic process (GO:0009124),40,2,4.07,-,0.49,2.28E-01
pore complex assembly (GO:0046931),20,1,2.03,-,0.49,3.97E-01
fatty-acyl-CoA metabolic process (GO:0035337),40,2,4.07,-,0.49,2.28E-01
membrane repolarization (GO:0086009),20,1,2.03,-,0.49,3.97E-01
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),20,1,2.03,-,0.49,3.97E-01
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531),20,1,2.03,-,0.49,3.97E-01
positive regulation of dendritic spine development (GO:0060999),40,2,4.07,-,0.49,2.28E-01
negative regulation of cellular carbohydrate metabolic process (GO:0010677),40,2,4.07,-,0.49,2.28E-01
negative regulation of viral entry into host cell (GO:0046597),20,1,2.03,-,0.49,3.97E-01
signal transduction involved in regulation of gene expression (GO:0023019),20,1,2.03,-,0.49,3.97E-01
labyrinthine layer blood vessel development (GO:0060716),20,1,2.03,-,0.49,3.97E-01
endocardial cushion formation (GO:0003272),20,1,2.03,-,0.49,3.97E-01
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),20,1,2.03,-,0.49,3.97E-01
positive regulation of cell cycle arrest (GO:0071158),81,4,8.23,-,0.49,8.64E-02
negative regulation of lipid metabolic process (GO:0045833),81,4,8.23,-,0.49,8.64E-02
embryonic epithelial tube formation (GO:0001838),122,6,12.4,-,0.48,3.60E-02
neuron fate commitment (GO:0048663),61,3,6.2,-,0.48,1.34E-01
S phase (GO:0051320),61,3,6.2,-,0.48,1.34E-01
mitotic S phase (GO:0000084),61,3,6.2,-,0.48,1.34E-01
negative regulation of endothelial cell proliferation (GO:0001937),41,2,4.17,-,0.48,2.14E-01
amino sugar metabolic process (GO:0006040),41,2,4.17,-,0.48,2.14E-01
type I interferon signaling pathway (GO:0060337),62,3,6.3,-,0.48,1.26E-01
regulation of cellular amino acid metabolic process (GO:0006521),62,3,6.3,-,0.48,1.26E-01
regulation of focal adhesion assembly (GO:0051893),62,3,6.3,-,0.48,1.26E-01
cellular response to type I interferon (GO:0071357),62,3,6.3,-,0.48,1.26E-01
regulation of cell-substrate junction assembly (GO:0090109),62,3,6.3,-,0.48,1.26E-01
macromolecule deacylation (GO:0098732),62,3,6.3,-,0.48,1.26E-01
cardiac ventricle development (GO:0003231),124,6,12.61,-,0.48,3.21E-02
vesicle targeting (GO:0006903),83,4,8.44,-,0.47,7.66E-02
centrosome cycle (GO:0007098),83,4,8.44,-,0.47,7.66E-02
limbic system development (GO:0021761),105,5,10.67,-,0.47,4.50E-02
pyrimidine nucleoside catabolic process (GO:0046135),21,1,2.13,-,0.47,3.71E-01
positive regulation of myoblast differentiation (GO:0045663),21,1,2.13,-,0.47,3.71E-01
positive regulation of T-helper cell differentiation (GO:0045624),21,1,2.13,-,0.47,3.71E-01
histone H2A ubiquitination (GO:0033522),21,1,2.13,-,0.47,3.71E-01
regulation of feeding behavior (GO:0060259),21,1,2.13,-,0.47,3.71E-01
regulation of endothelial cell chemotaxis (GO:2001026),21,1,2.13,-,0.47,3.71E-01
cell fate determination (GO:0001709),42,2,4.27,-,0.47,2.01E-01
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",21,1,2.13,-,0.47,3.71E-01
epiboly involved in wound healing (GO:0090505),21,1,2.13,-,0.47,3.71E-01
cellular response to growth hormone stimulus (GO:0071378),21,1,2.13,-,0.47,3.71E-01
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),42,2,4.27,-,0.47,2.01E-01
RNA 5'-end processing (GO:0000966),21,1,2.13,-,0.47,3.71E-01
regulation of brown fat cell differentiation (GO:0090335),21,1,2.13,-,0.47,3.71E-01
actin filament-based transport (GO:0099515),21,1,2.13,-,0.47,3.71E-01
regulation of chromosome separation (GO:1905818),63,3,6.4,-,0.47,1.18E-01
positive regulation of triglyceride metabolic process (GO:0090208),21,1,2.13,-,0.47,3.71E-01
"wound healing, spreading of cells (GO:0044319)",21,1,2.13,-,0.47,3.71E-01
"DNA catabolic process, endonucleolytic (GO:0000737)",21,1,2.13,-,0.47,3.71E-01
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",21,1,2.13,-,0.47,3.71E-01
G1 phase (GO:0051318),21,1,2.13,-,0.47,3.71E-01
synaptonemal complex organization (GO:0070193),21,1,2.13,-,0.47,3.71E-01
polysaccharide catabolic process (GO:0000272),21,1,2.13,-,0.47,3.71E-01
positive regulation of B cell proliferation (GO:0030890),42,2,4.27,-,0.47,2.01E-01
establishment of protein localization to plasma membrane (GO:0061951),42,2,4.27,-,0.47,2.01E-01
exogenous drug catabolic process (GO:0042738),21,1,2.13,-,0.47,3.71E-01
mitotic G1 phase (GO:0000080),21,1,2.13,-,0.47,3.71E-01
negative regulation of histone methylation (GO:0031061),21,1,2.13,-,0.47,3.71E-01
negative regulation of histone modification (GO:0031057),42,2,4.27,-,0.47,2.01E-01
C4-dicarboxylate transport (GO:0015740),21,1,2.13,-,0.47,3.71E-01
positive regulation of protein dephosphorylation (GO:0035307),42,2,4.27,-,0.47,2.01E-01
ribonucleoside catabolic process (GO:0042454),21,1,2.13,-,0.47,3.71E-01
positive regulation of alpha-beta T cell proliferation (GO:0046641),21,1,2.13,-,0.47,3.71E-01
negative regulation of cardiac muscle cell apoptotic process (GO:0010667),21,1,2.13,-,0.47,3.71E-01
nitric oxide metabolic process (GO:0046209),21,1,2.13,-,0.47,3.71E-01
secondary alcohol metabolic process (GO:1902652),127,6,12.91,-,0.46,2.68E-02
I-kappaB kinase/NF-kappaB signaling (GO:0007249),64,3,6.51,-,0.46,1.11E-01
regulation of viral life cycle (GO:1903900),150,7,15.25,-,0.46,1.52E-02
cell redox homeostasis (GO:0045454),43,2,4.37,-,0.46,1.88E-01
cellular extravasation (GO:0045123),43,2,4.37,-,0.46,1.88E-01
regulation of mast cell activation (GO:0033003),43,2,4.37,-,0.46,1.88E-01
modulation of excitatory postsynaptic potential (GO:0098815),43,2,4.37,-,0.46,1.88E-01
non-motile cilium assembly (GO:1905515),43,2,4.37,-,0.46,1.88E-01
coronary vasculature development (GO:0060976),43,2,4.37,-,0.46,1.88E-01
maintenance of protein localization in organelle (GO:0072595),43,2,4.37,-,0.46,1.88E-01
regulation of muscle cell differentiation (GO:0051147),130,6,13.22,-,0.45,2.24E-02
positive regulation of NF-kappaB transcription factor activity (GO:0051092),153,7,15.55,-,0.45,1.27E-02
trabecula formation (GO:0060343),22,1,2.24,-,0.45,3.46E-01
cAMP metabolic process (GO:0046058),22,1,2.24,-,0.45,3.46E-01
neuromuscular synaptic transmission (GO:0007274),22,1,2.24,-,0.45,3.46E-01
protein targeting to lysosome (GO:0006622),22,1,2.24,-,0.45,3.46E-01
epiboly (GO:0090504),22,1,2.24,-,0.45,3.46E-01
regulation of transcription by RNA polymerase III (GO:0006359),22,1,2.24,-,0.45,3.46E-01
maintenance of protein location in cell (GO:0032507),66,3,6.71,-,0.45,9.78E-02
protein hydroxylation (GO:0018126),22,1,2.24,-,0.45,3.46E-01
positive regulation of neurotransmitter transport (GO:0051590),22,1,2.24,-,0.45,3.46E-01
response to leptin (GO:0044321),22,1,2.24,-,0.45,3.46E-01
negative regulation of chondrocyte differentiation (GO:0032331),22,1,2.24,-,0.45,3.46E-01
regulation of spindle assembly (GO:0090169),22,1,2.24,-,0.45,3.46E-01
protein heterooligomerization (GO:0051291),22,1,2.24,-,0.45,3.46E-01
protein insertion into mitochondrial membrane (GO:0051204),22,1,2.24,-,0.45,3.46E-01
necroptotic process (GO:0070266),22,1,2.24,-,0.45,3.46E-01
N-terminal protein amino acid modification (GO:0031365),22,1,2.24,-,0.45,3.46E-01
regulation of vascular associated smooth muscle cell migration (GO:1904752),22,1,2.24,-,0.45,3.46E-01
positive regulation of purine nucleotide biosynthetic process (GO:1900373),22,1,2.24,-,0.45,3.46E-01
positive regulation of nucleotide biosynthetic process (GO:0030810),22,1,2.24,-,0.45,3.46E-01
positive regulation of cyclase activity (GO:0031281),22,1,2.24,-,0.45,3.46E-01
regulation of chromatin binding (GO:0035561),22,1,2.24,-,0.45,3.46E-01
positive regulation of histone modification (GO:0031058),88,4,8.95,-,0.45,5.63E-02
regulation of cell-substrate junction organization (GO:0150116),66,3,6.71,-,0.45,9.78E-02
cellular response to angiotensin (GO:1904385),22,1,2.24,-,0.45,3.46E-01
maturation of SSU-rRNA (GO:0030490),44,2,4.47,-,0.45,1.76E-01
negative regulation of steroid biosynthetic process (GO:0010894),22,1,2.24,-,0.45,3.46E-01
cristae formation (GO:0042407),22,1,2.24,-,0.45,3.46E-01
sterol metabolic process (GO:0016125),132,6,13.42,-,0.45,1.98E-02
negative regulation of smooth muscle cell migration (GO:0014912),22,1,2.24,-,0.45,3.46E-01
endocardial cushion development (GO:0003197),44,2,4.47,-,0.45,1.76E-01
regulation of protein binding (GO:0043393),200,9,20.33,-,0.44,3.95E-03
triglyceride metabolic process (GO:0006641),67,3,6.81,-,0.44,9.17E-02
organic hydroxy compound catabolic process (GO:1901616),67,3,6.81,-,0.44,9.17E-02
morphogenesis of an epithelial sheet (GO:0002011),45,2,4.57,-,0.44,1.65E-01
female gonad development (GO:0008585),90,4,9.15,-,0.44,4.97E-02
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),45,2,4.57,-,0.44,1.65E-01
negative regulation of endocytosis (GO:0045806),45,2,4.57,-,0.44,1.65E-01
ether metabolic process (GO:0018904),23,1,2.34,-,0.43,3.22E-01
regulation of osteoblast proliferation (GO:0033688),23,1,2.34,-,0.43,3.22E-01
"synaptic transmission, cholinergic (GO:0007271)",23,1,2.34,-,0.43,3.22E-01
bone resorption (GO:0045453),23,1,2.34,-,0.43,3.22E-01
reactive nitrogen species metabolic process (GO:2001057),23,1,2.34,-,0.43,3.22E-01
zinc ion transmembrane transport (GO:0071577),23,1,2.34,-,0.43,3.22E-01
protein localization to centrosome (GO:0071539),23,1,2.34,-,0.43,3.22E-01
negative regulation of cAMP-mediated signaling (GO:0043951),23,1,2.34,-,0.43,3.22E-01
positive regulation of meiotic cell cycle (GO:0051446),23,1,2.34,-,0.43,3.22E-01
negative regulation of potassium ion transmembrane transport (GO:1901380),23,1,2.34,-,0.43,3.22E-01
regulation of release of cytochrome c from mitochondria (GO:0090199),46,2,4.68,-,0.43,1.54E-01
regulation of skeletal muscle tissue development (GO:0048641),23,1,2.34,-,0.43,3.22E-01
establishment of chromosome localization (GO:0051303),69,3,7.01,-,0.43,8.06E-02
protein localization to microtubule organizing center (GO:1905508),23,1,2.34,-,0.43,3.22E-01
negative regulation of cold-induced thermogenesis (GO:0120163),46,2,4.68,-,0.43,1.54E-01
drug catabolic process (GO:0042737),23,1,2.34,-,0.43,3.22E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010),69,3,7.01,-,0.43,8.06E-02
peptide catabolic process (GO:0043171),23,1,2.34,-,0.43,3.22E-01
chromosome localization (GO:0050000),69,3,7.01,-,0.43,8.06E-02
respiratory chain complex IV assembly (GO:0008535),23,1,2.34,-,0.43,3.22E-01
positive regulation of heart rate (GO:0010460),23,1,2.34,-,0.43,3.22E-01
negative regulation of steroid metabolic process (GO:0045939),23,1,2.34,-,0.43,3.22E-01
negative regulation of carbohydrate metabolic process (GO:0045912),46,2,4.68,-,0.43,1.54E-01
regulation of protein polyubiquitination (GO:1902914),23,1,2.34,-,0.43,3.22E-01
nuclear envelope organization (GO:0006998),47,2,4.78,-,0.42,1.44E-01
glycogen metabolic process (GO:0005977),47,2,4.78,-,0.42,1.44E-01
ribonucleoside monophosphate metabolic process (GO:0009161),47,2,4.78,-,0.42,1.44E-01
regulation of fatty acid biosynthetic process (GO:0042304),47,2,4.78,-,0.42,1.44E-01
cholesterol metabolic process (GO:0008203),118,5,12,-,0.42,2.01E-02
negative regulation of protein polymerization (GO:0032272),71,3,7.22,-,0.42,7.07E-02
regulation of mitotic nuclear division (GO:0007088),95,4,9.66,-,0.41,3.60E-02
negative regulation of double-strand break repair (GO:2000780),24,1,2.44,-,0.41,3.00E-01
B cell homeostasis (GO:0001782),24,1,2.44,-,0.41,3.00E-01
regulation of establishment or maintenance of cell polarity (GO:0032878),24,1,2.44,-,0.41,3.00E-01
vascular endothelial growth factor signaling pathway (GO:0038084),24,1,2.44,-,0.41,3.00E-01
positive regulation of interleukin-4 production (GO:0032753),24,1,2.44,-,0.41,3.00E-01
mRNA splice site selection (GO:0006376),24,1,2.44,-,0.41,3.00E-01
DNA replication initiation (GO:0006270),24,1,2.44,-,0.41,3.00E-01
motile cilium assembly (GO:0044458),24,1,2.44,-,0.41,3.00E-01
regulation of cAMP-mediated signaling (GO:0043949),48,2,4.88,-,0.41,1.35E-01
cellular glucan metabolic process (GO:0006073),48,2,4.88,-,0.41,1.35E-01
regulation of cardiac muscle cell action potential (GO:0098901),24,1,2.44,-,0.41,3.00E-01
glucan metabolic process (GO:0044042),48,2,4.88,-,0.41,1.35E-01
cleavage involved in rRNA processing (GO:0000469),24,1,2.44,-,0.41,3.00E-01
negative regulation of mRNA processing (GO:0050686),24,1,2.44,-,0.41,3.00E-01
long-chain fatty-acyl-CoA metabolic process (GO:0035336),24,1,2.44,-,0.41,3.00E-01
negative regulation of viral life cycle (GO:1903901),24,1,2.44,-,0.41,3.00E-01
regulation of cardiac muscle hypertrophy (GO:0010611),48,2,4.88,-,0.41,1.35E-01
antigen processing and presentation of endogenous antigen (GO:0019883),24,1,2.44,-,0.41,3.00E-01
ammonium ion metabolic process (GO:0097164),24,1,2.44,-,0.41,3.00E-01
low-density lipoprotein particle clearance (GO:0034383),24,1,2.44,-,0.41,3.00E-01
positive regulation of alcohol biosynthetic process (GO:1902932),24,1,2.44,-,0.41,3.00E-01
cardiac ventricle morphogenesis (GO:0003208),72,3,7.32,-,0.41,6.61E-02
post-Golgi vesicle-mediated transport (GO:0006892),123,5,12.5,-,0.4,1.45E-02
mesenchyme morphogenesis (GO:0072132),50,2,5.08,-,0.39,1.17E-01
actin nucleation (GO:0045010),25,1,2.54,-,0.39,2.79E-01
sensory perception of temperature stimulus (GO:0050951),25,1,2.54,-,0.39,2.79E-01
negative regulation of ERBB signaling pathway (GO:1901185),50,2,5.08,-,0.39,1.17E-01
mesodermal cell differentiation (GO:0048333),25,1,2.54,-,0.39,2.79E-01
positive regulation of leukocyte degranulation (GO:0043302),25,1,2.54,-,0.39,2.79E-01
histone lysine demethylation (GO:0070076),25,1,2.54,-,0.39,2.79E-01
DNA dealkylation (GO:0035510),25,1,2.54,-,0.39,2.79E-01
negative regulation of cardiac muscle tissue growth (GO:0055022),25,1,2.54,-,0.39,2.79E-01
regulation of complement activation (GO:0030449),50,2,5.08,-,0.39,1.17E-01
negative regulation of striated muscle cell apoptotic process (GO:0010664),25,1,2.54,-,0.39,2.79E-01
negative regulation of heart growth (GO:0061117),25,1,2.54,-,0.39,2.79E-01
regulation of muscle hypertrophy (GO:0014743),50,2,5.08,-,0.39,1.17E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),25,1,2.54,-,0.39,2.79E-01
regulation of striated muscle cell differentiation (GO:0051153),76,3,7.73,-,0.39,5.05E-02
spinal cord development (GO:0021510),102,4,10.37,-,0.39,2.27E-02
regulation of interferon-beta production (GO:0032648),51,2,5.18,-,0.39,1.10E-01
peptidyl-proline modification (GO:0018208),51,2,5.18,-,0.39,1.10E-01
cellular component maintenance (GO:0043954),51,2,5.18,-,0.39,1.10E-01
establishment of protein localization to vacuole (GO:0072666),51,2,5.18,-,0.39,1.10E-01
negative regulation of DNA repair (GO:0045738),26,1,2.64,-,0.38,2.59E-01
cardiac epithelial to mesenchymal transition (GO:0060317),26,1,2.64,-,0.38,2.59E-01
myelination in peripheral nervous system (GO:0022011),26,1,2.64,-,0.38,2.59E-01
heme biosynthetic process (GO:0006783),26,1,2.64,-,0.38,2.59E-01
steroid catabolic process (GO:0006706),26,1,2.64,-,0.38,2.59E-01
viral genome replication (GO:0019079),26,1,2.64,-,0.38,2.59E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),26,1,2.64,-,0.38,2.59E-01
positive regulation of receptor internalization (GO:0002092),26,1,2.64,-,0.38,2.59E-01
establishment of protein localization to mitochondrial membrane (GO:0090151),26,1,2.64,-,0.38,2.59E-01
peripheral nervous system axon ensheathment (GO:0032292),26,1,2.64,-,0.38,2.59E-01
embryonic camera-type eye morphogenesis (GO:0048596),26,1,2.64,-,0.38,2.59E-01
glucosamine-containing compound metabolic process (GO:1901071),26,1,2.64,-,0.38,2.59E-01
negative regulation of receptor-mediated endocytosis (GO:0048261),26,1,2.64,-,0.38,2.59E-01
histone demethylation (GO:0016577),26,1,2.64,-,0.38,2.59E-01
eating behavior (GO:0042755),26,1,2.64,-,0.38,2.59E-01
adrenal gland development (GO:0030325),26,1,2.64,-,0.38,2.59E-01
decidualization (GO:0046697),26,1,2.64,-,0.38,2.59E-01
programmed necrotic cell death (GO:0097300),26,1,2.64,-,0.38,2.59E-01
chondroitin sulfate biosynthetic process (GO:0030206),26,1,2.64,-,0.38,2.59E-01
protein localization to postsynaptic membrane (GO:1903539),26,1,2.64,-,0.38,2.59E-01
cell differentiation involved in embryonic placenta development (GO:0060706),26,1,2.64,-,0.38,2.59E-01
striated muscle adaptation (GO:0014888),26,1,2.64,-,0.38,2.59E-01
negative regulation of fatty acid metabolic process (GO:0045922),26,1,2.64,-,0.38,2.59E-01
positive regulation of regulated secretory pathway (GO:1903307),52,2,5.29,-,0.38,1.02E-01
negative regulation of binding (GO:0051100),158,6,16.06,-,0.37,3.72E-03
endochondral bone morphogenesis (GO:0060350),53,2,5.39,-,0.37,9.52E-02
regulation of receptor internalization (GO:0002090),53,2,5.39,-,0.37,9.52E-02
regulation of catecholamine secretion (GO:0050433),53,2,5.39,-,0.37,9.52E-02
arachidonic acid metabolic process (GO:0019369),54,2,5.49,-,0.36,8.87E-02
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",81,3,8.23,-,0.36,3.58E-02
zinc ion transport (GO:0006829),27,1,2.74,-,0.36,2.40E-01
endochondral ossification (GO:0001958),27,1,2.74,-,0.36,2.40E-01
positive regulation of T cell mediated cytotoxicity (GO:0001916),27,1,2.74,-,0.36,2.40E-01
female meiotic nuclear division (GO:0007143),27,1,2.74,-,0.36,2.40E-01
gastrulation with mouth forming second (GO:0001702),27,1,2.74,-,0.36,2.40E-01
mitotic G2/M transition checkpoint (GO:0044818),27,1,2.74,-,0.36,2.40E-01
response to angiotensin (GO:1990776),27,1,2.74,-,0.36,2.40E-01
regulation of the force of heart contraction (GO:0002026),27,1,2.74,-,0.36,2.40E-01
ovarian follicle development (GO:0001541),54,2,5.49,-,0.36,8.87E-02
positive regulation of release of cytochrome c from mitochondria (GO:0090200),27,1,2.74,-,0.36,2.40E-01
protein K63-linked deubiquitination (GO:0070536),27,1,2.74,-,0.36,2.40E-01
brown fat cell differentiation (GO:0050873),27,1,2.74,-,0.36,2.40E-01
necrotic cell death (GO:0070265),27,1,2.74,-,0.36,2.40E-01
chaperone cofactor-dependent protein refolding (GO:0051085),27,1,2.74,-,0.36,2.40E-01
replacement ossification (GO:0036075),27,1,2.74,-,0.36,2.40E-01
response to gonadotropin (GO:0034698),27,1,2.74,-,0.36,2.40E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071),54,2,5.49,-,0.36,8.87E-02
response to gamma radiation (GO:0010332),54,2,5.49,-,0.36,8.87E-02
regulation of necroptotic process (GO:0060544),27,1,2.74,-,0.36,2.40E-01
postsynapse organization (GO:0099173),82,3,8.34,-,0.36,3.34E-02
positive regulation of blood vessel diameter (GO:0097755),55,2,5.59,-,0.36,8.25E-02
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),83,3,8.44,-,0.36,3.11E-02
post-embryonic development (GO:0009791),84,3,8.54,-,0.35,2.90E-02
neuronal action potential (GO:0019228),28,1,2.85,-,0.35,2.23E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),56,2,5.69,-,0.35,7.68E-02
positive regulation of leukocyte apoptotic process (GO:2000108),28,1,2.85,-,0.35,2.23E-01
regulation of histone H3-K4 methylation (GO:0051569),28,1,2.85,-,0.35,2.23E-01
pigment cell differentiation (GO:0050931),28,1,2.85,-,0.35,2.23E-01
regulation of cardiocyte differentiation (GO:1905207),28,1,2.85,-,0.35,2.23E-01
cortical cytoskeleton organization (GO:0030865),56,2,5.69,-,0.35,7.68E-02
granulocyte differentiation (GO:0030851),28,1,2.85,-,0.35,2.23E-01
entrainment of circadian clock by photoperiod (GO:0043153),28,1,2.85,-,0.35,2.23E-01
response to lipoprotein particle (GO:0055094),28,1,2.85,-,0.35,2.23E-01
regulation of cholesterol efflux (GO:0010874),28,1,2.85,-,0.35,2.23E-01
protein localization to chromosome (GO:0034502),56,2,5.69,-,0.35,7.68E-02
negative regulation of cartilage development (GO:0061037),28,1,2.85,-,0.35,2.23E-01
aortic valve morphogenesis (GO:0003180),28,1,2.85,-,0.35,2.23E-01
negative regulation of actin filament polymerization (GO:0030837),57,2,5.79,-,0.35,7.14E-02
regulation of mitotic sister chromatid separation (GO:0010965),57,2,5.79,-,0.35,7.14E-02
response to X-ray (GO:0010165),29,1,2.95,-,0.34,2.07E-01
postsynaptic membrane organization (GO:0001941),29,1,2.95,-,0.34,2.07E-01
porphyrin-containing compound biosynthetic process (GO:0006779),29,1,2.95,-,0.34,2.07E-01
protein demethylation (GO:0006482),29,1,2.95,-,0.34,2.07E-01
Schwann cell development (GO:0014044),29,1,2.95,-,0.34,2.07E-01
tetrapyrrole biosynthetic process (GO:0033014),29,1,2.95,-,0.34,2.07E-01
neuron fate specification (GO:0048665),29,1,2.95,-,0.34,2.07E-01
G2 DNA damage checkpoint (GO:0031572),29,1,2.95,-,0.34,2.07E-01
skeletal muscle tissue regeneration (GO:0043403),29,1,2.95,-,0.34,2.07E-01
beta-catenin-TCF complex assembly (GO:1904837),29,1,2.95,-,0.34,2.07E-01
histone phosphorylation (GO:0016572),29,1,2.95,-,0.34,2.07E-01
regulation of histone deacetylation (GO:0031063),29,1,2.95,-,0.34,2.07E-01
phosphatidylinositol dephosphorylation (GO:0046856),29,1,2.95,-,0.34,2.07E-01
regulation of dendritic spine development (GO:0060998),58,2,5.9,-,0.34,6.64E-02
protein dealkylation (GO:0008214),29,1,2.95,-,0.34,2.07E-01
dendritic spine organization (GO:0097061),29,1,2.95,-,0.34,2.07E-01
tube closure (GO:0060606),88,3,8.95,-,0.34,2.18E-02
somitogenesis (GO:0001756),60,2,6.1,-,0.33,5.73E-02
cellular response to lipoprotein particle stimulus (GO:0071402),30,1,3.05,-,0.33,1.92E-01
regulation of amyloid-beta formation (GO:1902003),30,1,3.05,-,0.33,1.92E-01
TOR signaling (GO:0031929),30,1,3.05,-,0.33,1.92E-01
positive regulation of cholesterol transport (GO:0032376),30,1,3.05,-,0.33,1.92E-01
positive regulation of sterol transport (GO:0032373),30,1,3.05,-,0.33,1.92E-01
blood vessel endothelial cell migration (GO:0043534),30,1,3.05,-,0.33,1.92E-01
negative regulation of potassium ion transport (GO:0043267),30,1,3.05,-,0.33,1.92E-01
regulation of programmed necrotic cell death (GO:0062098),30,1,3.05,-,0.33,1.92E-01
negative regulation of cell-substrate adhesion (GO:0010812),60,2,6.1,-,0.33,5.73E-02
adult walking behavior (GO:0007628),30,1,3.05,-,0.33,1.92E-01
energy reserve metabolic process (GO:0006112),61,2,6.2,-,0.32,5.33E-02
negative regulation of cell cycle G2/M phase transition (GO:1902750),92,3,9.35,-,0.32,1.63E-02
interleukin-1-mediated signaling pathway (GO:0070498),92,3,9.35,-,0.32,1.63E-02
response to growth hormone (GO:0060416),31,1,3.15,-,0.32,1.77E-01
positive regulation of interleukin-2 production (GO:0032743),31,1,3.15,-,0.32,1.77E-01
regulation of viral release from host cell (GO:1902186),31,1,3.15,-,0.32,1.77E-01
regulation of protein targeting to membrane (GO:0090313),31,1,3.15,-,0.32,1.77E-01
positive regulation of NIK/NF-kappaB signaling (GO:1901224),62,2,6.3,-,0.32,4.94E-02
spleen development (GO:0048536),31,1,3.15,-,0.32,1.77E-01
muscle adaptation (GO:0043500),31,1,3.15,-,0.32,1.77E-01
photoperiodism (GO:0009648),31,1,3.15,-,0.32,1.77E-01
regulation of mast cell degranulation (GO:0043304),31,1,3.15,-,0.32,1.77E-01
regulation of alpha-beta T cell proliferation (GO:0046640),31,1,3.15,-,0.32,1.77E-01
primary neural tube formation (GO:0014020),94,3,9.56,-,0.31,1.41E-02
nucleoside monophosphate metabolic process (GO:0009123),63,2,6.4,-,0.31,4.59E-02
modulation by virus of host process (GO:0019048),32,1,3.25,-,0.31,1.64E-01
walking behavior (GO:0090659),32,1,3.25,-,0.31,1.64E-01
regulation of mast cell activation involved in immune response (GO:0033006),32,1,3.25,-,0.31,1.64E-01
positive regulation of ubiquitin-protein transferase activity (GO:0051443),32,1,3.25,-,0.31,1.64E-01
vasodilation (GO:0042311),32,1,3.25,-,0.31,1.64E-01
adipose tissue development (GO:0060612),32,1,3.25,-,0.31,1.64E-01
MyD88-independent toll-like receptor signaling pathway (GO:0002756),32,1,3.25,-,0.31,1.64E-01
negative regulation of toll-like receptor signaling pathway (GO:0034122),33,1,3.35,-,0.3,1.52E-01
regulation of mitotic spindle organization (GO:0060236),33,1,3.35,-,0.3,1.52E-01
signal transduction in absence of ligand (GO:0038034),33,1,3.35,-,0.3,1.52E-01
cellular response to alkaloid (GO:0071312),33,1,3.35,-,0.3,1.52E-01
endosome transport via multivesicular body sorting pathway (GO:0032509),33,1,3.35,-,0.3,1.52E-01
pyrimidine nucleoside metabolic process (GO:0006213),33,1,3.35,-,0.3,1.52E-01
histone H3-K4 methylation (GO:0051568),33,1,3.35,-,0.3,1.52E-01
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),33,1,3.35,-,0.3,1.52E-01
heart trabecula morphogenesis (GO:0061384),33,1,3.35,-,0.3,1.52E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),33,1,3.35,-,0.3,1.52E-01
positive regulation of muscle cell differentiation (GO:0051149),67,2,6.81,-,0.29,3.39E-02
neural tube formation (GO:0001841),102,3,10.37,-,0.29,7.74E-03
spinal cord motor neuron differentiation (GO:0021522),34,1,3.46,-,0.29,1.40E-01
regulation of sensory perception of pain (GO:0051930),34,1,3.46,-,0.29,1.40E-01
regulation of dopamine secretion (GO:0014059),34,1,3.46,-,0.29,1.40E-01
cytokinetic process (GO:0032506),34,1,3.46,-,0.29,1.40E-01
sensory perception of bitter taste (GO:0050913),34,1,3.46,-,0.29,1.40E-01
regulation of cardiac muscle cell apoptotic process (GO:0010665),34,1,3.46,-,0.29,1.40E-01
endocardial cushion morphogenesis (GO:0003203),34,1,3.46,-,0.29,1.40E-01
negative regulation of JNK cascade (GO:0046329),34,1,3.46,-,0.29,1.40E-01
negative regulation of cell-matrix adhesion (GO:0001953),35,1,3.56,-,0.28,1.30E-01
regulation of sensory perception (GO:0051931),35,1,3.56,-,0.28,1.30E-01
Schwann cell differentiation (GO:0014037),35,1,3.56,-,0.28,1.30E-01
actin filament capping (GO:0051693),35,1,3.56,-,0.28,1.30E-01
stem cell division (GO:0017145),35,1,3.56,-,0.28,1.30E-01
cortical actin cytoskeleton organization (GO:0030866),35,1,3.56,-,0.28,1.30E-01
embryonic eye morphogenesis (GO:0048048),35,1,3.56,-,0.28,1.30E-01
ubiquitin-dependent ERAD pathway (GO:0030433),70,2,7.12,-,0.28,2.69E-02
regulation of spindle organization (GO:0090224),36,1,3.66,-,0.27,1.20E-01
regulation of striated muscle tissue development (GO:0016202),36,1,3.66,-,0.27,1.20E-01
chromosome condensation (GO:0030261),36,1,3.66,-,0.27,1.20E-01
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),36,1,3.66,-,0.27,1.20E-01
pyridine-containing compound metabolic process (GO:0072524),36,1,3.66,-,0.27,1.20E-01
regulation of muscle adaptation (GO:0043502),73,2,7.42,-,0.27,2.13E-02
negative regulation of calcium ion transmembrane transport (GO:1903170),37,1,3.76,-,0.27,1.10E-01
positive regulation of amine transport (GO:0051954),37,1,3.76,-,0.27,1.10E-01
neuron projection organization (GO:0106027),37,1,3.76,-,0.27,1.10E-01
regulation of striated muscle cell apoptotic process (GO:0010662),37,1,3.76,-,0.27,1.10E-01
regulation of muscle tissue development (GO:1901861),38,1,3.86,-,0.26,1.02E-01
positive regulation of viral genome replication (GO:0045070),38,1,3.86,-,0.26,1.02E-01
positive regulation of striated muscle cell differentiation (GO:0051155),38,1,3.86,-,0.26,1.02E-01
negative regulation of actin filament depolymerization (GO:0030835),38,1,3.86,-,0.26,1.02E-01
neuron maturation (GO:0042551),38,1,3.86,-,0.26,1.02E-01
regulation of necrotic cell death (GO:0010939),38,1,3.86,-,0.26,1.02E-01
virion assembly (GO:0019068),39,1,3.96,-,0.25,9.39E-02
regulation of myotube differentiation (GO:0010830),39,1,3.96,-,0.25,9.39E-02
secondary alcohol biosynthetic process (GO:1902653),40,1,4.07,-,0.25,8.66E-02
cholesterol biosynthetic process (GO:0006695),40,1,4.07,-,0.25,8.66E-02
response to exogenous dsRNA (GO:0043330),40,1,4.07,-,0.25,8.66E-02
phototransduction (GO:0007602),40,1,4.07,-,0.25,8.66E-02
inner mitochondrial membrane organization (GO:0007007),41,1,4.17,-,0.24,7.98E-02
negative regulation of type I interferon production (GO:0032480),41,1,4.17,-,0.24,7.98E-02
cellular modified amino acid biosynthetic process (GO:0042398),41,1,4.17,-,0.24,7.98E-02
regulation of viral entry into host cell (GO:0046596),41,1,4.17,-,0.24,7.98E-02
negative regulation of autophagy (GO:0010507),82,2,8.34,-,0.24,1.04E-02
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),82,2,8.34,-,0.24,1.04E-02
neural tube closure (GO:0001843),87,2,8.84,-,0.23,6.96E-03
negative regulation of stress-activated MAPK cascade (GO:0032873),44,1,4.47,-,0.22,6.22E-02
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),44,1,4.47,-,0.22,6.22E-02
regulation of ERBB signaling pathway (GO:1901184),89,2,9.05,-,0.22,5.90E-03
sterol biosynthetic process (GO:0016126),45,1,4.57,-,0.22,5.72E-02
ventral spinal cord development (GO:0021517),46,1,4.68,-,0.21,5.26E-02
response to dsRNA (GO:0043331),46,1,4.68,-,0.21,5.26E-02
modulation by symbiont of entry into host (GO:0052372),48,1,4.88,-,0.2,4.45E-02
negative regulation of protein binding (GO:0032091),97,2,9.86,-,0.2,3.04E-03
positive regulation of nuclear division (GO:0051785),49,1,4.98,-,0.2,4.09E-02
regulation of actin filament depolymerization (GO:0030834),49,1,4.98,-,0.2,4.09E-02
negative regulation of lipid biosynthetic process (GO:0051055),50,1,5.08,-,0.2,3.75E-02
negative regulation of mitochondrion organization (GO:0010823),51,1,5.18,-,0.19,3.45E-02
cell differentiation in spinal cord (GO:0021515),55,1,5.59,-,0.18,2.44E-02
regulation of cholesterol metabolic process (GO:0090181),59,1,6,-,0.17,1.72E-02
excitatory postsynaptic potential (GO:0060079),61,1,6.2,-,0.16,1.45E-02
protein autoubiquitination (GO:0051865),61,1,6.2,-,0.16,1.45E-02
"chemical synaptic transmission, postsynaptic (GO:0099565)",66,1,6.71,-,0.15,9.30E-03
regulation of calcium-mediated signaling (GO:0050848),66,1,6.71,-,0.15,9.30E-03
negative regulation of chronic inflammatory response (GO:0002677),5,0,0.51,-, < 0.01,6.01E-01
protein hexamerization (GO:0034214),8,0,0.81,-, < 0.01,4.43E-01
quinolinate catabolic process (GO:0034213),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of T cell anergy (GO:0002669),4,0,0.41,-, < 0.01,6.66E-01
regulation of T cell anergy (GO:0002667),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of B cell tolerance induction (GO:0002663),2,0,0.2,-, < 0.01,8.16E-01
regulation of B cell tolerance induction (GO:0002661),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of peripheral tolerance induction (GO:0002660),2,0,0.2,-, < 0.01,8.16E-01
amyloid-beta formation (GO:0034205),8,0,0.81,-, < 0.01,4.43E-01
glycolipid translocation (GO:0034203),1,0,0.1,-, < 0.01,9.03E-01
response to oleic acid (GO:0034201),6,0,0.61,-, < 0.01,5.43E-01
regulation of peripheral tolerance induction (GO:0002658),2,0,0.2,-, < 0.01,8.16E-01
response to vitamin B1 (GO:0010266),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of tolerance induction dependent upon immune response (GO:0002654),2,0,0.2,-, < 0.01,8.16E-01
regulation of tolerance induction dependent upon immune response (GO:0002652),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of tolerance induction to self antigen (GO:0002651),1,0,0.1,-, < 0.01,9.03E-01
animal organ senescence (GO:0010260),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of chromatin assembly or disassembly (GO:0045798),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of intestinal cholesterol absorption (GO:0045797),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cell volume (GO:0045795),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell volume (GO:0045794),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of cell size (GO:0045793),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of cell size (GO:0045792),8,0,0.81,-, < 0.01,4.43E-01
regulation of tolerance induction to self antigen (GO:0002649),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of central tolerance induction (GO:0002648),1,0,0.1,-, < 0.01,9.03E-01
regulation of central tolerance induction (GO:0002646),1,0,0.1,-, < 0.01,9.03E-01
glucose mediated signaling pathway (GO:0010255),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of tolerance induction (GO:0002644),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of immunoglobulin production (GO:0002638),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of germinal center formation (GO:0002636),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of germinal center formation (GO:0002635),2,0,0.2,-, < 0.01,8.16E-01
regulation of germinal center formation (GO:0002634),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of T cell antigen processing and presentation (GO:0002626),1,0,0.1,-, < 0.01,9.03E-01
regulation of T cell antigen processing and presentation (GO:0002625),2,0,0.2,-, < 0.01,8.16E-01
regulation of B cell antigen processing and presentation (GO:0002622),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of asymmetric cell division (GO:0045769),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular amino acid metabolic process (GO:0045763),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of adenylate cyclase activity (GO:0045762),10,0,1.02,-, < 0.01,3.62E-01
response to UV-B (GO:0010224),16,0,1.63,-, < 0.01,1.96E-01
negative regulation of action potential (GO:0045759),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of Toll signaling pathway (GO:0045751),1,0,0.1,-, < 0.01,9.03E-01
regulation of hexokinase activity (GO:1903299),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298),5,0,0.51,-, < 0.01,6.01E-01
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297),5,0,0.51,-, < 0.01,6.01E-01
"positive regulation of glutamate secretion, neurotransmission (GO:1903296)",3,0,0.3,-, < 0.01,7.37E-01
"regulation of glutamate secretion, neurotransmission (GO:1903294)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),8,0,0.81,-, < 0.01,4.43E-01
protein localization to Golgi membrane (GO:1903292),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),35,0,3.56,-, < 0.01,2.84E-02
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),11,0,1.12,-, < 0.01,3.27E-01
arginine catabolic process to proline (GO:0019493),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hydrogen peroxide catabolic process (GO:1903285),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of glutathione peroxidase activity (GO:1903284),1,0,0.1,-, < 0.01,9.03E-01
regulation of glutathione peroxidase activity (GO:1903282),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of calcium:sodium antiporter activity (GO:1903280),1,0,0.1,-, < 0.01,9.03E-01
forebrain dorsal/ventral pattern formation (GO:0021798),7,0,0.71,-, < 0.01,4.91E-01
forebrain anterior/posterior pattern specification (GO:0021797),3,0,0.3,-, < 0.01,7.37E-01
chemorepulsion of branchiomotor axon (GO:0021793),1,0,0.1,-, < 0.01,9.03E-01
respiratory burst after phagocytosis (GO:0045728),2,0,0.2,-, < 0.01,8.16E-01
beta-alanine biosynthetic process (GO:0019483),2,0,0.2,-, < 0.01,8.16E-01
beta-alanine metabolic process (GO:0019482),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of integrin biosynthetic process (GO:0045726),3,0,0.3,-, < 0.01,7.37E-01
"L-alanine catabolic process, by transamination (GO:0019481)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glycogen biosynthetic process (GO:0045725),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of cilium assembly (GO:0045724),18,0,1.83,-, < 0.01,1.60E-01
negative regulation of integrin biosynthetic process (GO:0045720),2,0,0.2,-, < 0.01,8.16E-01
ribosome localization (GO:0033750),14,0,1.42,-, < 0.01,2.41E-01
postganglionic parasympathetic fiber development (GO:0021784),2,0,0.2,-, < 0.01,8.16E-01
L-lysine catabolic process (GO:0019477),4,0,0.41,-, < 0.01,6.66E-01
glial cell fate specification (GO:0021780),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of glycogen biosynthetic process (GO:0045719),7,0,0.71,-, < 0.01,4.91E-01
L-lysine catabolic process to acetyl-CoA (GO:0019474),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of fatty acid biosynthetic process (GO:0045717),15,0,1.52,-, < 0.01,2.17E-01
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),8,0,0.81,-, < 0.01,4.43E-01
4-hydroxyproline metabolic process (GO:0019471),3,0,0.3,-, < 0.01,7.37E-01
4-hydroxyproline catabolic process (GO:0019470),3,0,0.3,-, < 0.01,7.37E-01
oligodendrocyte cell fate commitment (GO:0021779),5,0,0.51,-, < 0.01,6.01E-01
oligodendrocyte cell fate specification (GO:0021778),5,0,0.51,-, < 0.01,6.01E-01
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776),2,0,0.2,-, < 0.01,8.16E-01
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775),2,0,0.2,-, < 0.01,8.16E-01
striatal medium spiny neuron differentiation (GO:0021773),4,0,0.41,-, < 0.01,6.66E-01
lateral geniculate nucleus development (GO:0021771),1,0,0.1,-, < 0.01,9.03E-01
exon-exon junction complex disassembly (GO:1903259),1,0,0.1,-, < 0.01,9.03E-01
ectoderm and mesoderm interaction (GO:0007499),1,0,0.1,-, < 0.01,9.03E-01
multi-ciliated epithelial cell differentiation (GO:1903251),8,0,0.81,-, < 0.01,4.43E-01
visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495),1,0,0.1,-, < 0.01,9.03E-01
endodermal cell fate determination (GO:0007493),2,0,0.2,-, < 0.01,8.16E-01
orbitofrontal cortex development (GO:0021769),4,0,0.41,-, < 0.01,6.66E-01
nucleus accumbens development (GO:0021768),1,0,0.1,-, < 0.01,9.03E-01
mammillary body development (GO:0021767),2,0,0.2,-, < 0.01,8.16E-01
amygdala development (GO:0021764),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of citrulline biosynthetic process (GO:1903249),1,0,0.1,-, < 0.01,9.03E-01
regulation of citrulline biosynthetic process (GO:1903248),1,0,0.1,-, < 0.01,9.03E-01
L-cysteine catabolic process to taurine (GO:0019452),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243),5,0,0.51,-, < 0.01,6.01E-01
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),8,0,0.81,-, < 0.01,4.43E-01
U2-type prespliceosome assembly (GO:1903241),3,0,0.3,-, < 0.01,7.37E-01
globus pallidus development (GO:0021759),4,0,0.41,-, < 0.01,6.66E-01
putamen development (GO:0021758),1,0,0.1,-, < 0.01,9.03E-01
caudate nucleus development (GO:0021757),1,0,0.1,-, < 0.01,9.03E-01
pronephric duct morphogenesis (GO:0039023),1,0,0.1,-, < 0.01,9.03E-01
striatum development (GO:0021756),19,0,1.93,-, < 0.01,1.45E-01
pronephric duct development (GO:0039022),1,0,0.1,-, < 0.01,9.03E-01
facial nucleus development (GO:0021754),1,0,0.1,-, < 0.01,9.03E-01
L-cysteine catabolic process to hypotaurine (GO:0019449),1,0,0.1,-, < 0.01,9.03E-01
L-cysteine catabolic process (GO:0019448),4,0,0.41,-, < 0.01,6.66E-01
vestibular nucleus development (GO:0021750),2,0,0.2,-, < 0.01,8.16E-01
tryptophan catabolic process to acetyl-CoA (GO:0019442),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235),1,0,0.1,-, < 0.01,9.03E-01
tryptophan catabolic process to kynurenine (GO:0019441),5,0,0.51,-, < 0.01,6.01E-01
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233),3,0,0.3,-, < 0.01,7.37E-01
melanosome assembly (GO:1903232),4,0,0.41,-, < 0.01,6.66E-01
pattern specification involved in pronephros development (GO:0039017),2,0,0.2,-, < 0.01,8.16E-01
cochlear nucleus development (GO:0021747),3,0,0.3,-, < 0.01,7.37E-01
principal sensory nucleus of trigeminal nerve development (GO:0021740),2,0,0.2,-, < 0.01,8.16E-01
mesenchymal stem cell differentiation (GO:0072497),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of endodermal cell differentiation (GO:1903225),3,0,0.3,-, < 0.01,7.37E-01
regulation of endodermal cell differentiation (GO:1903224),4,0,0.41,-, < 0.01,6.66E-01
removal of superoxide radicals (GO:0019430),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of oxidative stress-induced neuron death (GO:1903223),7,0,0.71,-, < 0.01,4.91E-01
regulation of rhodopsin gene expression (GO:0007468),4,0,0.41,-, < 0.01,6.66E-01
DNA integration (GO:0015074),8,0,0.81,-, < 0.01,4.43E-01
pronephric nephron tubule morphogenesis (GO:0039008),1,0,0.1,-, < 0.01,9.03E-01
pronephric nephron morphogenesis (GO:0039007),1,0,0.1,-, < 0.01,9.03E-01
pronephric field specification (GO:0039003),2,0,0.2,-, < 0.01,8.16E-01
midbrain-hindbrain boundary maturation (GO:0021732),1,0,0.1,-, < 0.01,9.03E-01
acetyl-CoA biosynthetic process from acetate (GO:0019427),2,0,0.2,-, < 0.01,8.16E-01
trigeminal sensory nucleus development (GO:0021730),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of the force of heart contraction by chemical signal (GO:0003099),3,0,0.3,-, < 0.01,7.37E-01
pressure natriuresis (GO:0003095),3,0,0.3,-, < 0.01,7.37E-01
regulation of glomerular filtration (GO:0003093),11,0,1.12,-, < 0.01,3.27E-01
superior olivary nucleus maturation (GO:0021722),2,0,0.2,-, < 0.01,8.16E-01
sulfur oxidation (GO:0019417),2,0,0.2,-, < 0.01,8.16E-01
acetate biosynthetic process (GO:0019413),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of renal output by angiotensin (GO:0003083),1,0,0.1,-, < 0.01,9.03E-01
superior olivary nucleus development (GO:0021718),2,0,0.2,-, < 0.01,8.16E-01
dolichol biosynthetic process (GO:0019408),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of behavioral fear response (GO:2000986),1,0,0.1,-, < 0.01,9.03E-01
hexitol catabolic process (GO:0019407),1,0,0.1,-, < 0.01,9.03E-01
hexitol biosynthetic process (GO:0019406),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ATP citrate synthase activity (GO:2000984),1,0,0.1,-, < 0.01,9.03E-01
alditol catabolic process (GO:0019405),6,0,0.61,-, < 0.01,5.43E-01
regulation of ATP citrate synthase activity (GO:2000983),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of inner ear receptor cell differentiation (GO:2000982),1,0,0.1,-, < 0.01,9.03E-01
galactitol metabolic process (GO:0019402),1,0,0.1,-, < 0.01,9.03E-01
ectodermal digestive tract development (GO:0007439),2,0,0.2,-, < 0.01,8.16E-01
lung induction (GO:0060492),3,0,0.3,-, < 0.01,7.37E-01
lateral sprouting involved in lung morphogenesis (GO:0060490),1,0,0.1,-, < 0.01,9.03E-01
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072),5,0,0.51,-, < 0.01,6.01E-01
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of forebrain neuron differentiation (GO:2000979),1,0,0.1,-, < 0.01,9.03E-01
locus ceruleus development (GO:0021703),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of detection of glucose (GO:2000971),1,0,0.1,-, < 0.01,9.03E-01
regulation of detection of glucose (GO:2000970),1,0,0.1,-, < 0.01,9.03E-01
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489),1,0,0.1,-, < 0.01,9.03E-01
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488),1,0,0.1,-, < 0.01,9.03E-01
club cell differentiation (GO:0060486),4,0,0.41,-, < 0.01,6.66E-01
lobar bronchus development (GO:0060482),5,0,0.51,-, < 0.01,6.01E-01
lobar bronchus epithelium development (GO:0060481),4,0,0.41,-, < 0.01,6.66E-01
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069),1,0,0.1,-, < 0.01,9.03E-01
lung goblet cell differentiation (GO:0060480),3,0,0.3,-, < 0.01,7.37E-01
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of heart rate by epinephrine (GO:0003065),1,0,0.1,-, < 0.01,9.03E-01
regulation of heart rate by hormone (GO:0003064),2,0,0.2,-, < 0.01,8.16E-01
protein deglutathionylation (GO:0080058),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of flagellated sperm motility involved in capacitation (GO:0060474),3,0,0.3,-, < 0.01,7.37E-01
axon target recognition (GO:0007412),4,0,0.41,-, < 0.01,6.66E-01
hormonal regulation of the force of heart contraction (GO:0003058),1,0,0.1,-, < 0.01,9.03E-01
regulation of the force of heart contraction by chemical signal (GO:0003057),6,0,0.61,-, < 0.01,5.43E-01
regulation of vascular associated smooth muscle contraction (GO:0003056),8,0,0.81,-, < 0.01,4.43E-01
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050),2,0,0.2,-, < 0.01,8.16E-01
signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434),1,0,0.1,-, < 0.01,9.03E-01
response to G1 DNA damage checkpoint signaling (GO:0072432),1,0,0.1,-, < 0.01,9.03E-01
activation of meiosis involved in egg activation (GO:0060466),1,0,0.1,-, < 0.01,9.03E-01
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",8,0,0.81,-, < 0.01,4.43E-01
pharynx development (GO:0060465),3,0,0.3,-, < 0.01,7.37E-01
glial cell fate determination (GO:0007403),1,0,0.1,-, < 0.01,9.03E-01
right lung morphogenesis (GO:0060461),1,0,0.1,-, < 0.01,9.03E-01
neuroblast fate determination (GO:0007400),1,0,0.1,-, < 0.01,9.03E-01
response to intra-S DNA damage checkpoint signaling (GO:0072429),2,0,0.2,-, < 0.01,8.16E-01
signal transduction involved in G2 DNA damage checkpoint (GO:0072425),10,0,1.02,-, < 0.01,3.62E-01
response to nitrite (GO:0080033),1,0,0.1,-, < 0.01,9.03E-01
response to DNA damage checkpoint signaling (GO:0072423),5,0,0.51,-, < 0.01,6.01E-01
detection of DNA damage stimulus involved in DNA damage checkpoint (GO:0072421),1,0,0.1,-, < 0.01,9.03E-01
somatic sex determination (GO:0018993),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of gastric acid secretion (GO:0060455),5,0,0.51,-, < 0.01,6.01E-01
germ-line sex determination (GO:0018992),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of gastric acid secretion (GO:0060454),2,0,0.2,-, < 0.01,8.16E-01
regulation of gastric acid secretion (GO:0060453),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of hindgut contraction (GO:0060450),1,0,0.1,-, < 0.01,9.03E-01
D-gluconate catabolic process (GO:0046177),2,0,0.2,-, < 0.01,8.16E-01
aldonic acid catabolic process (GO:0046176),2,0,0.2,-, < 0.01,8.16E-01
polyol catabolic process (GO:0046174),24,0,2.44,-, < 0.01,8.70E-02
response to mitotic cell cycle checkpoint signaling (GO:0072414),1,0,0.1,-, < 0.01,9.03E-01
dichotomous subdivision of terminal units involved in lung branching (GO:0060448),2,0,0.2,-, < 0.01,8.16E-01
mitochondrial large ribosomal subunit assembly (GO:1902775),3,0,0.3,-, < 0.01,7.37E-01
late endosome to lysosome transport (GO:1902774),3,0,0.3,-, < 0.01,7.37E-01
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029),1,0,0.1,-, < 0.01,9.03E-01
trachea formation (GO:0060440),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of choline O-acetyltransferase activity (GO:1902771),1,0,0.1,-, < 0.01,9.03E-01
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027),1,0,0.1,-, < 0.01,9.03E-01
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026),1,0,0.1,-, < 0.01,9.03E-01
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025),3,0,0.3,-, < 0.01,7.37E-01
glycerol-3-phosphate catabolic process (GO:0046168),2,0,0.2,-, < 0.01,8.16E-01
glycerol-3-phosphate biosynthetic process (GO:0046167),3,0,0.3,-, < 0.01,7.37E-01
heme a metabolic process (GO:0046160),2,0,0.2,-, < 0.01,8.16E-01
activation of protein kinase A activity (GO:0034199),18,0,1.83,-, < 0.01,1.60E-01
response to DNA integrity checkpoint signaling (GO:0072402),5,0,0.51,-, < 0.01,6.01E-01
trichloroethylene metabolic process (GO:0018979),1,0,0.1,-, < 0.01,9.03E-01
triglyceride transport (GO:0034197),4,0,0.41,-, < 0.01,6.66E-01
acylglycerol transport (GO:0034196),4,0,0.41,-, < 0.01,6.66E-01
regulation of choline O-acetyltransferase activity (GO:1902769),1,0,0.1,-, < 0.01,9.03E-01
isoprenoid biosynthetic process via mevalonate (GO:1902767),2,0,0.2,-, < 0.01,8.16E-01
skeletal muscle satellite cell migration (GO:1902766),2,0,0.2,-, < 0.01,8.16E-01
bronchus morphogenesis (GO:0060434),2,0,0.2,-, < 0.01,8.16E-01
bronchus development (GO:0060433),10,0,1.02,-, < 0.01,3.62E-01
primary lung bud formation (GO:0060431),1,0,0.1,-, < 0.01,9.03E-01
lymph circulation (GO:0003017),2,0,0.2,-, < 0.01,8.16E-01
involuntary skeletal muscle contraction (GO:0003011),3,0,0.3,-, < 0.01,7.37E-01
voluntary skeletal muscle contraction (GO:0003010),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of sterol import (GO:2000911),1,0,0.1,-, < 0.01,9.03E-01
thiocyanate metabolic process (GO:0018969),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183),2,0,0.2,-, < 0.01,8.16E-01
lung connective tissue development (GO:0060427),1,0,0.1,-, < 0.01,9.03E-01
propylene metabolic process (GO:0018964),1,0,0.1,-, < 0.01,9.03E-01
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),6,0,0.61,-, < 0.01,5.43E-01
lung vasculature development (GO:0060426),6,0,0.61,-, < 0.01,5.43E-01
phthalate metabolic process (GO:0018963),2,0,0.2,-, < 0.01,8.16E-01
4-nitrophenol metabolic process (GO:0018960),1,0,0.1,-, < 0.01,9.03E-01
cellular response to nitrogen starvation (GO:0006995),11,0,1.12,-, < 0.01,3.27E-01
response to sterol depletion (GO:0006991),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of lens fiber cell differentiation (GO:1902747),5,0,0.51,-, < 0.01,6.01E-01
imidazole-containing compound catabolic process (GO:0052805),6,0,0.61,-, < 0.01,5.43E-01
aorta smooth muscle tissue morphogenesis (GO:0060414),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of lamellipodium organization (GO:1902744),5,0,0.51,-, < 0.01,6.01E-01
imidazole-containing compound metabolic process (GO:0052803),12,0,1.22,-, < 0.01,2.95E-01
apoptotic process involved in development (GO:1902742),24,0,2.44,-, < 0.01,8.70E-02
response to lipid hydroperoxide (GO:0006982),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of vitamin metabolic process (GO:0046137),6,0,0.61,-, < 0.01,5.43E-01
pyrimidine ribonucleoside catabolic process (GO:0046133),13,0,1.32,-, < 0.01,2.67E-01
pyrimidine ribonucleoside metabolic process (GO:0046131),13,0,1.32,-, < 0.01,2.67E-01
toll-like receptor 10 signaling pathway (GO:0034166),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164),4,0,0.41,-, < 0.01,6.66E-01
regulation of acetylcholine metabolic process (GO:0060408),1,0,0.1,-, < 0.01,9.03E-01
regulation of toll-like receptor 9 signaling pathway (GO:0034163),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of penile erection (GO:0060407),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161),3,0,0.3,-, < 0.01,7.37E-01
axonemal microtubule depolymerization (GO:0060404),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of growth hormone receptor signaling pathway (GO:0060400),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of proteoglycan biosynthetic process (GO:1902730),4,0,0.41,-, < 0.01,6.66E-01
pyrimidine deoxyribonucleoside catabolic process (GO:0046127),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine deoxyribonucleoside metabolic process (GO:0046125),5,0,0.51,-, < 0.01,6.01E-01
purine deoxyribonucleoside catabolic process (GO:0046124),1,0,0.1,-, < 0.01,9.03E-01
purine deoxyribonucleoside metabolic process (GO:0046122),2,0,0.2,-, < 0.01,8.16E-01
deoxyribonucleoside catabolic process (GO:0046121),3,0,0.3,-, < 0.01,7.37E-01
deoxyribonucleoside biosynthetic process (GO:0046120),2,0,0.2,-, < 0.01,8.16E-01
regulation of toll-like receptor 8 signaling pathway (GO:0034159),3,0,0.3,-, < 0.01,7.37E-01
toll-like receptor 8 signaling pathway (GO:0034158),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of toll-like receptor 7 signaling pathway (GO:0034156),1,0,0.1,-, < 0.01,9.03E-01
regulation of toll-like receptor 7 signaling pathway (GO:0034155),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of proteoglycan biosynthetic process (GO:1902729),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728),2,0,0.2,-, < 0.01,8.16E-01
toll-like receptor 6 signaling pathway (GO:0034150),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of satellite cell differentiation (GO:1902725),4,0,0.41,-, < 0.01,6.66E-01
naphthalene metabolic process (GO:0018931),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of prolactin secretion (GO:1902722),2,0,0.2,-, < 0.01,8.16E-01
nucleobase catabolic process (GO:0046113),6,0,0.61,-, < 0.01,5.43E-01
xanthine biosynthetic process (GO:0046111),1,0,0.1,-, < 0.01,9.03E-01
xanthine metabolic process (GO:0046110),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148),1,0,0.1,-, < 0.01,9.03E-01
regulation of toll-like receptor 5 signaling pathway (GO:0034147),1,0,0.1,-, < 0.01,9.03E-01
toll-like receptor 5 signaling pathway (GO:0034146),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140),3,0,0.3,-, < 0.01,7.37E-01
"complement activation, classical pathway (GO:0006958)",33,0,3.35,-, < 0.01,3.48E-02
"complement activation, alternative pathway (GO:0006957)",13,0,1.32,-, < 0.01,2.67E-01
complement activation (GO:0006956),47,0,4.78,-, < 0.01,8.35E-03
uridine metabolic process (GO:0046108),2,0,0.2,-, < 0.01,8.16E-01
thymidine biosynthetic process (GO:0046105),2,0,0.2,-, < 0.01,8.16E-01
thymidine metabolic process (GO:0046104),5,0,0.51,-, < 0.01,6.01E-01
inosine biosynthetic process (GO:0046103),3,0,0.3,-, < 0.01,7.37E-01
hypoxanthine biosynthetic process (GO:0046101),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590),2,0,0.2,-, < 0.01,8.16E-01
hypoxanthine metabolic process (GO:0046100),3,0,0.3,-, < 0.01,7.37E-01
regulation of toll-like receptor 3 signaling pathway (GO:0034139),9,0,0.91,-, < 0.01,4.00E-01
fluorene metabolic process (GO:0018917),1,0,0.1,-, < 0.01,9.03E-01
extracellular exosome assembly (GO:0071971),1,0,0.1,-, < 0.01,9.03E-01
benzene metabolic process (GO:0018910),1,0,0.1,-, < 0.01,9.03E-01
induction by virus of host cell-cell fusion (GO:0006948),1,0,0.1,-, < 0.01,9.03E-01
regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587),2,0,0.2,-, < 0.01,8.16E-01
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of antigen processing and presentation of peptide antigen (GO:0002584),4,0,0.41,-, < 0.01,6.66E-01
regulation of antigen processing and presentation of peptide antigen (GO:0002583),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581),3,0,0.3,-, < 0.01,7.37E-01
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),6,0,0.61,-, < 0.01,5.43E-01
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125),2,0,0.2,-, < 0.01,8.16E-01
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124),4,0,0.41,-, < 0.01,6.66E-01
fungal-type cell wall polysaccharide metabolic process (GO:0071966),1,0,0.1,-, < 0.01,9.03E-01
establishment or maintenance of cell polarity regulating cell shape (GO:0071963),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of erythrocyte aggregation (GO:0034120),1,0,0.1,-, < 0.01,9.03E-01
"mitotic sister chromatid cohesion, centromeric (GO:0071962)",2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933),3,0,0.3,-, < 0.01,7.37E-01
"substrate-dependent cell migration, cell attachment to substrate (GO:0006931)",2,0,0.2,-, < 0.01,8.16E-01
vitamin E biosynthetic process (GO:0010189),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cellular defense response (GO:0010186),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular defense response (GO:0010185),1,0,0.1,-, < 0.01,9.03E-01
basophil chemotaxis (GO:0002575),1,0,0.1,-, < 0.01,9.03E-01
sugar mediated signaling pathway (GO:0010182),3,0,0.3,-, < 0.01,7.37E-01
pro-T cell differentiation (GO:0002572),1,0,0.1,-, < 0.01,9.03E-01
regulation of erythrocyte aggregation (GO:0034118),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of heterotypic cell-cell adhesion (GO:0034115),10,0,1.02,-, < 0.01,3.62E-01
chemokine (C-C motif) ligand 11 production (GO:0071954),2,0,0.2,-, < 0.01,8.16E-01
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951),1,0,0.1,-, < 0.01,9.03E-01
activation-induced cell death of T cells (GO:0006924),6,0,0.61,-, < 0.01,5.43E-01
somatic diversification of T cell receptor genes (GO:0002568),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of tissue remodeling (GO:0034105),11,0,1.12,-, < 0.01,3.27E-01
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),5,0,0.51,-, < 0.01,6.01E-01
"phagocytosis, recognition (GO:0006910)",15,0,1.52,-, < 0.01,2.17E-01
wax metabolic process (GO:0010166),3,0,0.3,-, < 0.01,7.37E-01
response to cesium ion (GO:0010164),1,0,0.1,-, < 0.01,9.03E-01
serotonin secretion by platelet (GO:0002554),3,0,0.3,-, < 0.01,7.37E-01
histamine secretion by mast cell (GO:0002553),2,0,0.2,-, < 0.01,8.16E-01
vitamin A import (GO:0071939),1,0,0.1,-, < 0.01,9.03E-01
vitamin A transport (GO:0071938),1,0,0.1,-, < 0.01,9.03E-01
thiamine transmembrane transport (GO:0071934),3,0,0.3,-, < 0.01,7.37E-01
replication fork reversal (GO:0071932),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),3,0,0.3,-, < 0.01,7.37E-01
specification of animal organ position (GO:0010159),3,0,0.3,-, < 0.01,7.37E-01
response to chlorate (GO:0010157),2,0,0.2,-, < 0.01,8.16E-01
chronic inflammatory response (GO:0002544),14,0,1.42,-, < 0.01,2.41E-01
activation of blood coagulation via clotting cascade (GO:0002543),2,0,0.2,-, < 0.01,8.16E-01
Factor XII activation (GO:0002542),2,0,0.2,-, < 0.01,8.16E-01
activation of plasma proteins involved in acute inflammatory response (GO:0002541),1,0,0.1,-, < 0.01,9.03E-01
alpha-tubulin acetylation (GO:0071929),1,0,0.1,-, < 0.01,9.03E-01
endocannabinoid signaling pathway (GO:0071926),3,0,0.3,-, < 0.01,7.37E-01
regulation of cohesin loading (GO:0071922),5,0,0.51,-, < 0.01,6.01E-01
cohesin loading (GO:0071921),1,0,0.1,-, < 0.01,9.03E-01
nitric oxide production involved in inflammatory response (GO:0002537),2,0,0.2,-, < 0.01,8.16E-01
respiratory burst involved in inflammatory response (GO:0002536),1,0,0.1,-, < 0.01,9.03E-01
cytokine production involved in inflammatory response (GO:0002534),4,0,0.41,-, < 0.01,6.66E-01
"farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)",2,0,0.2,-, < 0.01,8.16E-01
G-quadruplex DNA formation (GO:0071919),1,0,0.1,-, < 0.01,9.03E-01
urea transmembrane transport (GO:0071918),6,0,0.61,-, < 0.01,5.43E-01
synchronous neurotransmitter secretion (GO:0071911),1,0,0.1,-, < 0.01,9.03E-01
determination of liver left/right asymmetry (GO:0071910),6,0,0.61,-, < 0.01,5.43E-01
pyrimidine ribonucleotide salvage (GO:0010138),5,0,0.51,-, < 0.01,6.01E-01
regulation of vascular permeability involved in acute inflammatory response (GO:0002528),4,0,0.41,-, < 0.01,6.66E-01
hypersensitivity (GO:0002524),2,0,0.2,-, < 0.01,8.16E-01
proline catabolic process to glutamate (GO:0010133),3,0,0.3,-, < 0.01,7.37E-01
leukocyte migration involved in immune response (GO:0002522),2,0,0.2,-, < 0.01,8.16E-01
determination of stomach left/right asymmetry (GO:0071909),1,0,0.1,-, < 0.01,9.03E-01
determination of intestine left/right asymmetry (GO:0071908),1,0,0.1,-, < 0.01,9.03E-01
determination of digestive tract left/right asymmetry (GO:0071907),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of myoblast differentiation (GO:0045662),27,0,2.74,-, < 0.01,6.41E-02
positive regulation of neutrophil differentiation (GO:0045660),1,0,0.1,-, < 0.01,9.03E-01
neurofilament bundle assembly (GO:0033693),3,0,0.3,-, < 0.01,7.37E-01
natural killer cell tolerance induction (GO:0002519),3,0,0.3,-, < 0.01,7.37E-01
lymphocyte chemotaxis across high endothelial venule (GO:0002518),1,0,0.1,-, < 0.01,9.03E-01
T cell tolerance induction (GO:0002517),2,0,0.2,-, < 0.01,8.16E-01
phenylacetate catabolic process (GO:0010124),2,0,0.2,-, < 0.01,8.16E-01
B cell tolerance induction (GO:0002514),1,0,0.1,-, < 0.01,9.03E-01
tolerance induction to self antigen (GO:0002513),5,0,0.51,-, < 0.01,6.01E-01
arginine catabolic process to proline via ornithine (GO:0010121),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neutrophil differentiation (GO:0045659),2,0,0.2,-, < 0.01,8.16E-01
regulation of neutrophil differentiation (GO:0045658),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of monocyte differentiation (GO:0045656),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of osteoblast proliferation (GO:0033689),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of luteinizing hormone secretion (GO:0033686),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of luteinizing hormone secretion (GO:0033685),3,0,0.3,-, < 0.01,7.37E-01
regulation of luteinizing hormone secretion (GO:0033684),6,0,0.61,-, < 0.01,5.43E-01
central tolerance induction to self antigen (GO:0002509),1,0,0.1,-, < 0.01,9.03E-01
central tolerance induction (GO:0002508),2,0,0.2,-, < 0.01,8.16E-01
tolerance induction (GO:0002507),15,0,1.52,-, < 0.01,2.17E-01
peptide antigen assembly with MHC class II protein complex (GO:0002503),4,0,0.41,-, < 0.01,6.66E-01
peptide antigen assembly with MHC class I protein complex (GO:0002502),2,0,0.2,-, < 0.01,8.16E-01
peptide antigen assembly with MHC protein complex (GO:0002501),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of eosinophil differentiation (GO:0045645),2,0,0.2,-, < 0.01,8.16E-01
regulation of eosinophil differentiation (GO:0045643),2,0,0.2,-, < 0.01,8.16E-01
cellular response to iron ion starvation (GO:0010106),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of melanocyte differentiation (GO:0045636),5,0,0.51,-, < 0.01,6.01E-01
regulation of melanocyte differentiation (GO:0045634),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of mechanoreceptor differentiation (GO:0045633),1,0,0.1,-, < 0.01,9.03E-01
regulation of SUMO transferase activity (GO:1903182),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of T-helper 2 cell differentiation (GO:0045630),7,0,0.71,-, < 0.01,4.91E-01
negative regulation by symbiont of host apoptotic process (GO:0033668),10,0,1.02,-, < 0.01,3.62E-01
cerebellar cortex maturation (GO:0021699),3,0,0.3,-, < 0.01,7.37E-01
cerebellar cortex structural organization (GO:0021698),2,0,0.2,-, < 0.01,8.16E-01
cerebellar Purkinje cell layer structural organization (GO:0021693),2,0,0.2,-, < 0.01,8.16E-01
cerebellar Purkinje cell layer maturation (GO:0021691),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of T-helper 2 cell differentiation (GO:0045629),4,0,0.41,-, < 0.01,6.66E-01
regulation of T-helper 2 cell differentiation (GO:0045628),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of T-helper 1 cell differentiation (GO:0045627),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of T-helper 1 cell differentiation (GO:0045626),3,0,0.3,-, < 0.01,7.37E-01
regulation of T-helper 1 cell differentiation (GO:0045625),10,0,1.02,-, < 0.01,3.62E-01
cerebellar molecular layer formation (GO:0021688),1,0,0.1,-, < 0.01,9.03E-01
cerebellar molecular layer morphogenesis (GO:0021687),2,0,0.2,-, < 0.01,8.16E-01
cerebellar granular layer maturation (GO:0021686),1,0,0.1,-, < 0.01,9.03E-01
cerebellar granular layer structural organization (GO:0021685),1,0,0.1,-, < 0.01,9.03E-01
nerve maturation (GO:0021682),1,0,0.1,-, < 0.01,9.03E-01
galactolipid catabolic process (GO:0019376),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of keratinocyte differentiation (GO:0045617),7,0,0.71,-, < 0.01,4.91E-01
response to polycyclic arene (GO:1903165),1,0,0.1,-, < 0.01,9.03E-01
cyclooxygenase pathway (GO:0019371),11,0,1.12,-, < 0.01,3.27E-01
cerebellar molecular layer development (GO:0021679),3,0,0.3,-, < 0.01,7.37E-01
third ventricle development (GO:0021678),5,0,0.51,-, < 0.01,6.01E-01
lysobisphosphatidic acid metabolic process (GO:2001311),2,0,0.2,-, < 0.01,8.16E-01
pyridine nucleotide salvage (GO:0019365),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of inner ear auditory receptor cell differentiation (GO:0045609),1,0,0.1,-, < 0.01,9.03E-01
pyridine nucleotide catabolic process (GO:0019364),2,0,0.2,-, < 0.01,8.16E-01
pyridine nucleotide biosynthetic process (GO:0019363),28,0,2.85,-, < 0.01,5.79E-02
pyridine nucleotide metabolic process (GO:0019362),30,0,3.05,-, < 0.01,4.72E-02
positive regulation of endothelial cell differentiation (GO:0045603),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of endothelial cell differentiation (GO:0045602),9,0,0.91,-, < 0.01,4.00E-01
regulation of endothelial cell differentiation (GO:0045601),34,0,3.46,-, < 0.01,3.14E-02
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633),1,0,0.1,-, < 0.01,9.03E-01
lipoxin B4 biosynthetic process (GO:2001306),1,0,0.1,-, < 0.01,9.03E-01
lipoxin B4 metabolic process (GO:2001304),1,0,0.1,-, < 0.01,9.03E-01
rhombomere 5 formation (GO:0021666),1,0,0.1,-, < 0.01,9.03E-01
lipoxin A4 biosynthetic process (GO:2001303),3,0,0.3,-, < 0.01,7.37E-01
rhombomere 5 structural organization (GO:0021665),1,0,0.1,-, < 0.01,9.03E-01
lipoxin A4 metabolic process (GO:2001302),4,0,0.41,-, < 0.01,6.66E-01
rhombomere 5 morphogenesis (GO:0021664),1,0,0.1,-, < 0.01,9.03E-01
nicotinamide nucleotide biosynthetic process (GO:0019359),28,0,2.85,-, < 0.01,5.79E-02
rhombomere 3 formation (GO:0021660),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of autophagy of mitochondrion (GO:1903147),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of establishment of endothelial barrier (GO:1903142),6,0,0.61,-, < 0.01,5.43E-01
posterior compartment specification (GO:0007388),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of establishment of endothelial barrier (GO:1903141),2,0,0.2,-, < 0.01,8.16E-01
anterior compartment pattern formation (GO:0007387),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment of endothelial barrier (GO:1903140),16,0,1.63,-, < 0.01,1.96E-01
compartment pattern specification (GO:0007386),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626),2,0,0.2,-, < 0.01,8.16E-01
rhombomere 3 structural organization (GO:0021659),1,0,0.1,-, < 0.01,9.03E-01
rhombomere 3 morphogenesis (GO:0021658),2,0,0.2,-, < 0.01,8.16E-01
membrane protein proteolysis (GO:0033619),38,0,3.86,-, < 0.01,2.09E-02
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),5,0,0.51,-, < 0.01,6.01E-01
vestibulocochlear nerve structural organization (GO:0021649),2,0,0.2,-, < 0.01,8.16E-01
vagus nerve morphogenesis (GO:0021644),2,0,0.2,-, < 0.01,8.16E-01
trochlear nerve formation (GO:0021642),1,0,0.1,-, < 0.01,9.03E-01
phenol-containing compound catabolic process (GO:0019336),9,0,0.91,-, < 0.01,4.00E-01
response to cell cycle checkpoint signaling (GO:0072396),5,0,0.51,-, < 0.01,6.01E-01
detection of stimulus involved in cell cycle checkpoint (GO:0072394),1,0,0.1,-, < 0.01,9.03E-01
microtubule anchoring at microtubule organizing center (GO:0072393),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of centriole-centriole cohesion (GO:1903126),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of thioredoxin peroxidase activity (GO:1903124),1,0,0.1,-, < 0.01,9.03E-01
regulation of thioredoxin peroxidase activity (GO:1903123),1,0,0.1,-, < 0.01,9.03E-01
chemokine receptor transport within lipid bilayer (GO:0033606),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of catecholamine secretion (GO:0033605),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of dopamine secretion (GO:0033603),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of dopamine secretion (GO:0033602),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of mammary gland epithelial cell proliferation (GO:0033600),4,0,0.41,-, < 0.01,6.66E-01
trochlear nerve morphogenesis (GO:0021639),1,0,0.1,-, < 0.01,9.03E-01
optic nerve structural organization (GO:0021633),1,0,0.1,-, < 0.01,9.03E-01
flavin adenine dinucleotide catabolic process (GO:0072389),1,0,0.1,-, < 0.01,9.03E-01
optic nerve morphogenesis (GO:0021631),5,0,0.51,-, < 0.01,6.01E-01
flavin adenine dinucleotide biosynthetic process (GO:0072388),1,0,0.1,-, < 0.01,9.03E-01
flavin adenine dinucleotide metabolic process (GO:0072387),2,0,0.2,-, < 0.01,8.16E-01
minus-end-directed organelle transport along microtubule (GO:0072385),5,0,0.51,-, < 0.01,6.01E-01
urate homeostasis (GO:1903118),1,0,0.1,-, < 0.01,9.03E-01
pentose catabolic process (GO:0019323),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of actin filament-based movement (GO:1903116),1,0,0.1,-, < 0.01,9.03E-01
minus-end-directed vesicle transport along microtubule (GO:0072382),1,0,0.1,-, < 0.01,9.03E-01
zygotic specification of dorsal/ventral axis (GO:0007352),3,0,0.3,-, < 0.01,7.37E-01
olfactory nerve structural organization (GO:0021629),1,0,0.1,-, < 0.01,9.03E-01
olfactory nerve morphogenesis (GO:0021627),1,0,0.1,-, < 0.01,9.03E-01
central nervous system maturation (GO:0021626),9,0,0.91,-, < 0.01,4.00E-01
amylopectin metabolic process (GO:2000896),1,0,0.1,-, < 0.01,9.03E-01
"blood coagulation, common pathway (GO:0072377)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitochondrial transcription (GO:1903109),2,0,0.2,-, < 0.01,8.16E-01
regulation of mitochondrial transcription (GO:1903108),4,0,0.41,-, < 0.01,6.66E-01
inositol catabolic process (GO:0019310),1,0,0.1,-, < 0.01,9.03E-01
cellularization (GO:0007349),1,0,0.1,-, < 0.01,9.03E-01
"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)",1,0,0.1,-, < 0.01,9.03E-01
pronuclear fusion (GO:0007344),1,0,0.1,-, < 0.01,9.03E-01
hypoglossal nerve morphogenesis (GO:0021618),1,0,0.1,-, < 0.01,9.03E-01
glossopharyngeal nerve morphogenesis (GO:0021615),4,0,0.41,-, < 0.01,6.66E-01
D-ribose catabolic process (GO:0019303),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of dipeptide transport (GO:2000880),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of growth hormone receptor signaling pathway (GO:0060399),3,0,0.3,-, < 0.01,7.37E-01
regulation of growth hormone receptor signaling pathway (GO:0060398),6,0,0.61,-, < 0.01,5.43E-01
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of SMAD protein signal transduction (GO:0060392),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of oligopeptide transport (GO:2000878),2,0,0.2,-, < 0.01,8.16E-01
chromosome passenger complex localization to kinetochore (GO:0072356),1,0,0.1,-, < 0.01,9.03E-01
histone H3-T3 phosphorylation (GO:0072355),1,0,0.1,-, < 0.01,9.03E-01
synapse assembly involved in innervation (GO:0060386),1,0,0.1,-, < 0.01,9.03E-01
sperm displacement (GO:0007321),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of single-stranded telomeric DNA binding (GO:0060381),1,0,0.1,-, < 0.01,9.03E-01
regulation of single-stranded telomeric DNA binding (GO:0060380),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of estradiol secretion (GO:2000866),2,0,0.2,-, < 0.01,8.16E-01
regulation of estradiol secretion (GO:2000864),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of aldosterone secretion (GO:2000860),2,0,0.2,-, < 0.01,8.16E-01
cellular lactam catabolic process (GO:0072340),1,0,0.1,-, < 0.01,9.03E-01
cardiac muscle cell myoblast differentiation (GO:0060379),10,0,1.02,-, < 0.01,3.62E-01
regulation of brood size (GO:0060378),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mast cell differentiation (GO:0060377),1,0,0.1,-, < 0.01,9.03E-01
mast cell differentiation (GO:0060374),3,0,0.3,-, < 0.01,7.37E-01
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),5,0,0.51,-, < 0.01,6.01E-01
susceptibility to T cell mediated cytotoxicity (GO:0060370),2,0,0.2,-, < 0.01,8.16E-01
guanine biosynthetic process (GO:0046099),1,0,0.1,-, < 0.01,9.03E-01
guanine metabolic process (GO:0046098),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of mineralocorticoid secretion (GO:2000857),2,0,0.2,-, < 0.01,8.16E-01
deoxycytidine metabolic process (GO:0046092),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of corticosterone secretion (GO:2000854),3,0,0.3,-, < 0.01,7.37E-01
deoxyadenosine metabolic process (GO:0046090),1,0,0.1,-, < 0.01,9.03E-01
regulation of corticosterone secretion (GO:2000852),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of glucocorticoid secretion (GO:2000851),6,0,0.61,-, < 0.01,5.43E-01
sagittal suture morphogenesis (GO:0060367),1,0,0.1,-, < 0.01,9.03E-01
lambdoid suture morphogenesis (GO:0060366),1,0,0.1,-, < 0.01,9.03E-01
respiratory basal cell differentiation (GO:1902691),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of NAD metabolic process (GO:1902690),1,0,0.1,-, < 0.01,9.03E-01
cytidine metabolic process (GO:0046087),11,0,1.12,-, < 0.01,3.27E-01
adenosine biosynthetic process (GO:0046086),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of corticosteroid hormone secretion (GO:2000848),8,0,0.81,-, < 0.01,4.43E-01
adenosine metabolic process (GO:0046085),9,0,0.91,-, < 0.01,4.00E-01
adenine biosynthetic process (GO:0046084),3,0,0.3,-, < 0.01,7.37E-01
adenine metabolic process (GO:0046083),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of testosterone secretion (GO:2000845),1,0,0.1,-, < 0.01,9.03E-01
dUTP catabolic process (GO:0046081),1,0,0.1,-, < 0.01,9.03E-01
regulation of testosterone secretion (GO:2000843),1,0,0.1,-, < 0.01,9.03E-01
dUTP metabolic process (GO:0046080),1,0,0.1,-, < 0.01,9.03E-01
response to ammonium ion (GO:0060359),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of leucine import (GO:0060358),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of NAD metabolic process (GO:1902689),3,0,0.3,-, < 0.01,7.37E-01
regulation of leucine import (GO:0060357),2,0,0.2,-, < 0.01,8.16E-01
regulation of NAD metabolic process (GO:1902688),4,0,0.41,-, < 0.01,6.66E-01
inositol phosphorylation (GO:0052746),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cell adhesion molecule production (GO:0060355),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of cell adhesion molecule production (GO:0060354),5,0,0.51,-, < 0.01,6.01E-01
regulation of cell adhesion molecule production (GO:0060353),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of receptor localization to synapse (GO:1902684),1,0,0.1,-, < 0.01,9.03E-01
cell adhesion molecule production (GO:0060352),3,0,0.3,-, < 0.01,7.37E-01
cartilage development involved in endochondral bone morphogenesis (GO:0060351),26,0,2.64,-, < 0.01,7.10E-02
dUMP catabolic process (GO:0046079),1,0,0.1,-, < 0.01,9.03E-01
dUMP metabolic process (GO:0046078),3,0,0.3,-, < 0.01,7.37E-01
dUDP metabolic process (GO:0046077),1,0,0.1,-, < 0.01,9.03E-01
dTTP metabolic process (GO:0046075),3,0,0.3,-, < 0.01,7.37E-01
vesicle uncoating (GO:0072319),7,0,0.71,-, < 0.01,4.91E-01
clathrin coat disassembly (GO:0072318),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of androgen secretion (GO:2000836),1,0,0.1,-, < 0.01,9.03E-01
dTMP metabolic process (GO:0046073),3,0,0.3,-, < 0.01,7.37E-01
dTDP metabolic process (GO:0046072),1,0,0.1,-, < 0.01,9.03E-01
regulation of androgen secretion (GO:2000834),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of steroid hormone secretion (GO:2000833),9,0,0.91,-, < 0.01,4.00E-01
dGTP metabolic process (GO:0046070),4,0,0.41,-, < 0.01,6.66E-01
metanephric glomerular epithelial cell development (GO:0072313),2,0,0.2,-, < 0.01,8.16E-01
metanephric glomerular epithelial cell differentiation (GO:0072312),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of parathyroid hormone secretion (GO:2000830),1,0,0.1,-, < 0.01,9.03E-01
heart trabecula formation (GO:0060347),13,0,1.32,-, < 0.01,2.67E-01
carbon tetrachloride metabolic process (GO:0018885),1,0,0.1,-, < 0.01,9.03E-01
spleen trabecula formation (GO:0060345),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),13,0,1.32,-, < 0.01,2.67E-01
dGDP catabolic process (GO:0046067),1,0,0.1,-, < 0.01,9.03E-01
dGDP metabolic process (GO:0046066),2,0,0.2,-, < 0.01,8.16E-01
regulation of parathyroid hormone secretion (GO:2000828),2,0,0.2,-, < 0.01,8.16E-01
dCTP metabolic process (GO:0046065),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial RNA surveillance (GO:2000827),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307),6,0,0.61,-, < 0.01,5.43E-01
dATP catabolic process (GO:0046061),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305),2,0,0.2,-, < 0.01,8.16E-01
dATP metabolic process (GO:0046060),5,0,0.51,-, < 0.01,6.01E-01
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303),1,0,0.1,-, < 0.01,9.03E-01
regulation of grooming behavior (GO:2000821),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),2,0,0.2,-, < 0.01,8.16E-01
biphenyl metabolic process (GO:0018879),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of metanephric glomerulus development (GO:0072300),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of axon guidance (GO:1902669),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of axon guidance (GO:1902668),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of maintenance of sister chromatid cohesion (GO:0034093),4,0,0.41,-, < 0.01,6.66E-01
regulation of axon guidance (GO:1902667),13,0,1.32,-, < 0.01,2.67E-01
benzoate metabolic process (GO:0018874),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of maintenance of sister chromatid cohesion (GO:0034092),2,0,0.2,-, < 0.01,8.16E-01
regulation of maintenance of sister chromatid cohesion (GO:0034091),6,0,0.61,-, < 0.01,5.43E-01
dADP catabolic process (GO:0046057),1,0,0.1,-, < 0.01,9.03E-01
regulation of nucleotide-excision repair (GO:2000819),3,0,0.3,-, < 0.01,7.37E-01
dADP metabolic process (GO:0046056),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of myoblast proliferation (GO:2000818),2,0,0.2,-, < 0.01,8.16E-01
dGMP metabolic process (GO:0046054),1,0,0.1,-, < 0.01,9.03E-01
dAMP metabolic process (GO:0046053),2,0,0.2,-, < 0.01,8.16E-01
regulation of mRNA stability involved in response to oxidative stress (GO:2000815),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of barbed-end actin filament capping (GO:2000813),2,0,0.2,-, < 0.01,8.16E-01
regulation of barbed-end actin filament capping (GO:2000812),2,0,0.2,-, < 0.01,8.16E-01
establishment of mitotic sister chromatid cohesion (GO:0034087),2,0,0.2,-, < 0.01,8.16E-01
establishment of sister chromatid cohesion (GO:0034085),3,0,0.3,-, < 0.01,7.37E-01
cytoplasmic actin-based contraction involved in cell motility (GO:0060327),2,0,0.2,-, < 0.01,8.16E-01
Golgi to endosome transport (GO:0006895),15,0,1.52,-, < 0.01,2.17E-01
UMP metabolic process (GO:0046049),10,0,1.02,-, < 0.01,3.62E-01
UDP metabolic process (GO:0046048),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of synaptic vesicle clustering (GO:2000809),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of synaptic vesicle clustering (GO:2000808),1,0,0.1,-, < 0.01,9.03E-01
"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)",1,0,0.1,-, < 0.01,9.03E-01
ITP metabolic process (GO:0046041),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802),1,0,0.1,-, < 0.01,9.03E-01
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800),1,0,0.1,-, < 0.01,9.03E-01
primitive erythrocyte differentiation (GO:0060319),2,0,0.2,-, < 0.01,8.16E-01
definitive erythrocyte differentiation (GO:0060318),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of elastin catabolic process (GO:0060311),1,0,0.1,-, < 0.01,9.03E-01
regulation of elastin catabolic process (GO:0060310),1,0,0.1,-, < 0.01,9.03E-01
intracellular sequestering of iron ion (GO:0006880),5,0,0.51,-, < 0.01,6.01E-01
GMP catabolic process (GO:0046038),1,0,0.1,-, < 0.01,9.03E-01
GMP metabolic process (GO:0046037),13,0,1.32,-, < 0.01,2.67E-01
ADP catabolic process (GO:0046032),1,0,0.1,-, < 0.01,9.03E-01
NAD-cap decapping (GO:0110155),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell diameter (GO:0060305),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphatidylinositol dephosphorylation (GO:0060304),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of biomineralization (GO:0110150),28,0,2.85,-, < 0.01,5.79E-02
"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)",3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cytokine activity (GO:0060302),2,0,0.2,-, < 0.01,8.16E-01
"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cytokine activity (GO:0060301),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of membrane hyperpolarization (GO:1902632),1,0,0.1,-, < 0.01,9.03E-01
regulation of cytokine activity (GO:0060300),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of membrane hyperpolarization (GO:1902631),1,0,0.1,-, < 0.01,9.03E-01
regulation of membrane hyperpolarization (GO:1902630),3,0,0.3,-, < 0.01,7.37E-01
response to anoxia (GO:0034059),2,0,0.2,-, < 0.01,8.16E-01
endosomal vesicle fusion (GO:0034058),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of estrogen receptor binding (GO:0071899),3,0,0.3,-, < 0.01,7.37E-01
regulation of estrogen receptor binding (GO:0071898),3,0,0.3,-, < 0.01,7.37E-01
regulation of mRNA stability involved in cellular response to UV (GO:1902629),1,0,0.1,-, < 0.01,9.03E-01
suppression by symbiont of host defense-related programmed cell death (GO:0034054),1,0,0.1,-, < 0.01,9.03E-01
modulation by symbiont of host defense-related programmed cell death (GO:0034053),1,0,0.1,-, < 0.01,9.03E-01
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894),1,0,0.1,-, < 0.01,9.03E-01
BMP signaling pathway involved in nephric duct formation (GO:0071893),1,0,0.1,-, < 0.01,9.03E-01
assembly of large subunit precursor of preribosome (GO:1902626),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of neutrophil migration (GO:1902623),4,0,0.41,-, < 0.01,6.66E-01
glutamine transport (GO:0006868),8,0,0.81,-, < 0.01,4.43E-01
asparagine transport (GO:0006867),3,0,0.3,-, < 0.01,7.37E-01
pyrimidine nucleotide transport (GO:0006864),2,0,0.2,-, < 0.01,8.16E-01
purine nucleobase transport (GO:0006863),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of transcription by glucose (GO:0046016),4,0,0.41,-, < 0.01,6.66E-01
regulation of transcription by glucose (GO:0046015),5,0,0.51,-, < 0.01,6.01E-01
regulation of T cell homeostatic proliferation (GO:0046013),3,0,0.3,-, < 0.01,7.37E-01
cellular response to fluoride (GO:1902618),1,0,0.1,-, < 0.01,9.03E-01
response to fluoride (GO:1902617),5,0,0.51,-, < 0.01,6.01E-01
phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882),1,0,0.1,-, < 0.01,9.03E-01
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613),1,0,0.1,-, < 0.01,9.03E-01
regulation of anti-Mullerian hormone signaling pathway (GO:1902612),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial pyruvate transmembrane transport (GO:0006850),2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878),2,0,0.2,-, < 0.01,8.16E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608),2,0,0.2,-, < 0.01,8.16E-01
cellular response to norepinephrine stimulus (GO:0071874),2,0,0.2,-, < 0.01,8.16E-01
regulation of large conductance calcium-activated potassium channel activity (GO:1902606),2,0,0.2,-, < 0.01,8.16E-01
response to norepinephrine (GO:0071873),3,0,0.3,-, < 0.01,7.37E-01
heterotrimeric G-protein complex assembly (GO:1902605),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial citrate transmembrane transport (GO:0006843),1,0,0.1,-, < 0.01,9.03E-01
"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)",1,0,0.1,-, < 0.01,9.03E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488),1,0,0.1,-, < 0.01,9.03E-01
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)",1,0,0.1,-, < 0.01,9.03E-01
"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)",1,0,0.1,-, < 0.01,9.03E-01
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477),3,0,0.3,-, < 0.01,7.37E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476),6,0,0.61,-, < 0.01,5.43E-01
antigen processing and presentation via MHC class Ib (GO:0002475),13,0,1.32,-, < 0.01,2.67E-01
plasmacytoid dendritic cell antigen processing and presentation (GO:0002470),1,0,0.1,-, < 0.01,9.03E-01
response to triglyceride (GO:0034014),1,0,0.1,-, < 0.01,9.03E-01
fungal-type cell wall organization or biogenesis (GO:0071852),1,0,0.1,-, < 0.01,9.03E-01
mitotic cell cycle arrest (GO:0071850),16,0,1.63,-, < 0.01,1.96E-01
copper ion transport (GO:0006825),16,0,1.63,-, < 0.01,1.96E-01
dendritic cell antigen processing and presentation (GO:0002468),1,0,0.1,-, < 0.01,9.03E-01
germinal center formation (GO:0002467),7,0,0.71,-, < 0.01,4.91E-01
peripheral tolerance induction (GO:0002465),2,0,0.2,-, < 0.01,8.16E-01
tolerance induction dependent upon immune response (GO:0002461),2,0,0.2,-, < 0.01,8.16E-01
zygote asymmetric cell division (GO:0010070),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848),2,0,0.2,-, < 0.01,8.16E-01
actin filament debranching (GO:0071846),2,0,0.2,-, < 0.01,8.16E-01
peripheral T cell tolerance induction (GO:0002458),1,0,0.1,-, < 0.01,9.03E-01
T cell antigen processing and presentation (GO:0002457),3,0,0.3,-, < 0.01,7.37E-01
humoral immune response mediated by circulating immunoglobulin (GO:0002455),38,0,3.86,-, < 0.01,2.09E-02
peripheral B cell tolerance induction (GO:0002451),1,0,0.1,-, < 0.01,9.03E-01
apoptotic process in bone marrow cell (GO:0071839),1,0,0.1,-, < 0.01,9.03E-01
cell proliferation in bone marrow (GO:0071838),1,0,0.1,-, < 0.01,9.03E-01
intermediate-density lipoprotein particle clearance (GO:0071831),1,0,0.1,-, < 0.01,9.03E-01
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028),6,0,0.61,-, < 0.01,5.43E-01
triglyceride-rich lipoprotein particle clearance (GO:0071830),7,0,0.71,-, < 0.01,4.91E-01
interkinetic nuclear migration (GO:0022027),5,0,0.51,-, < 0.01,6.01E-01
regulation of nitrogen utilization (GO:0006808),3,0,0.3,-, < 0.01,7.37E-01
malonyl-CoA biosynthetic process (GO:2001295),2,0,0.2,-, < 0.01,8.16E-01
eosinophil mediated immunity (GO:0002447),3,0,0.3,-, < 0.01,7.37E-01
serotonin secretion involved in inflammatory response (GO:0002442),3,0,0.3,-, < 0.01,7.37E-01
histamine secretion involved in inflammatory response (GO:0002441),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of gamma-delta T cell differentiation (GO:0045588),7,0,0.71,-, < 0.01,4.91E-01
regulation of gamma-delta T cell differentiation (GO:0045586),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of cytotoxic T cell differentiation (GO:0045585),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cytotoxic T cell differentiation (GO:0045584),1,0,0.1,-, < 0.01,9.03E-01
regulation of cytotoxic T cell differentiation (GO:0045583),3,0,0.3,-, < 0.01,7.37E-01
lateral ganglionic eminence cell proliferation (GO:0022018),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of caveolin-mediated endocytosis (GO:2001288),4,0,0.41,-, < 0.01,6.66E-01
pallium cell proliferation in forebrain (GO:0022013),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of caveolin-mediated endocytosis (GO:2001287),2,0,0.2,-, < 0.01,8.16E-01
subpallium cell proliferation in forebrain (GO:0022012),1,0,0.1,-, < 0.01,9.03E-01
regulation of caveolin-mediated endocytosis (GO:2001286),7,0,0.71,-, < 0.01,4.91E-01
chronic inflammatory response to antigenic stimulus (GO:0002439),2,0,0.2,-, < 0.01,8.16E-01
acute inflammatory response to antigenic stimulus (GO:0002438),10,0,1.02,-, < 0.01,3.62E-01
response to mycotoxin (GO:0010046),3,0,0.3,-, < 0.01,7.37E-01
immune complex clearance by monocytes and macrophages (GO:0002436),1,0,0.1,-, < 0.01,9.03E-01
response to nickel cation (GO:0010045),1,0,0.1,-, < 0.01,9.03E-01
immune complex clearance by erythrocytes (GO:0002435),1,0,0.1,-, < 0.01,9.03E-01
response to aluminum ion (GO:0010044),4,0,0.41,-, < 0.01,6.66E-01
immune complex clearance (GO:0002434),3,0,0.3,-, < 0.01,7.37E-01
granuloma formation (GO:0002432),2,0,0.2,-, < 0.01,8.16E-01
response to iron(II) ion (GO:0010040),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of B cell differentiation (GO:0045579),15,0,1.52,-, < 0.01,2.17E-01
negative regulation of B cell differentiation (GO:0045578),6,0,0.61,-, < 0.01,5.43E-01
basophil activation (GO:0045575),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812),2,0,0.2,-, < 0.01,8.16E-01
central nervous system vasculogenesis (GO:0022009),5,0,0.51,-, < 0.01,6.01E-01
convergent extension involved in neural plate elongation (GO:0022007),2,0,0.2,-, < 0.01,8.16E-01
midbrain-hindbrain boundary maturation during brain development (GO:0022004),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272),2,0,0.2,-, < 0.01,8.16E-01
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428),7,0,0.71,-, < 0.01,4.91E-01
response to carbon dioxide (GO:0010037),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271),3,0,0.3,-, < 0.01,7.37E-01
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),5,0,0.51,-, < 0.01,6.01E-01
immunoglobulin production in mucosal tissue (GO:0002426),1,0,0.1,-, < 0.01,9.03E-01
response to acetate (GO:0010034),1,0,0.1,-, < 0.01,9.03E-01
T cell mediated immune response to tumor cell (GO:0002424),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of podosome assembly (GO:0071803),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of podosome assembly (GO:0071802),1,0,0.1,-, < 0.01,9.03E-01
regulation of podosome assembly (GO:0071801),15,0,1.52,-, < 0.01,2.17E-01
podosome assembly (GO:0071800),4,0,0.41,-, < 0.01,6.66E-01
response to genistein (GO:0033595),2,0,0.2,-, < 0.01,8.16E-01
response to cobalamin (GO:0033590),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of C-C chemokine binding (GO:2001264),1,0,0.1,-, < 0.01,9.03E-01
regulation of C-C chemokine binding (GO:2001263),1,0,0.1,-, < 0.01,9.03E-01
T cell mediated cytotoxicity directed against tumor cell target (GO:0002419),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of semaphorin-plexin signaling pathway (GO:2001262),1,0,0.1,-, < 0.01,9.03E-01
regulation of semaphorin-plexin signaling pathway (GO:2001260),3,0,0.3,-, < 0.01,7.37E-01
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor (GO:0002416),1,0,0.1,-, < 0.01,9.03E-01
wax biosynthetic process (GO:0010025),3,0,0.3,-, < 0.01,7.37E-01
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415),2,0,0.2,-, < 0.01,8.16E-01
immunoglobulin transcytosis in epithelial cells (GO:0002414),3,0,0.3,-, < 0.01,7.37E-01
amylopectin biosynthetic process (GO:0010021),1,0,0.1,-, < 0.01,9.03E-01
regulation of store-operated calcium entry (GO:2001256),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of histone H3-K36 trimethylation (GO:2001255),2,0,0.2,-, < 0.01,8.16E-01
regulation of histone H3-K36 trimethylation (GO:2001253),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of ammonia assimilation cycle (GO:2001250),1,0,0.1,-, < 0.01,9.03E-01
protein localization to meiotic spindle midzone (GO:1903096),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cholesterol biosynthetic process (GO:0045542),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of cholesterol biosynthetic process (GO:0045541),5,0,0.51,-, < 0.01,6.01E-01
regulation of cholesterol biosynthetic process (GO:0045540),44,0,4.47,-, < 0.01,1.13E-02
protein glycosylation in Golgi (GO:0033578),2,0,0.2,-, < 0.01,8.16E-01
protein glycosylation in endoplasmic reticulum (GO:0033577),2,0,0.2,-, < 0.01,8.16E-01
regulation of ammonia assimilation cycle (GO:2001248),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphatidylcholine biosynthetic process (GO:2001245),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241),11,0,1.12,-, < 0.01,3.27E-01
cardioblast differentiation (GO:0010002),12,0,1.22,-, < 0.01,2.95E-01
siderophore biosynthetic process (GO:0019290),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082),1,0,0.1,-, < 0.01,9.03E-01
regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080),1,0,0.1,-, < 0.01,9.03E-01
"DNA replication, Okazaki fragment processing (GO:0033567)",2,0,0.2,-, < 0.01,8.16E-01
gamma-tubulin complex localization (GO:0033566),2,0,0.2,-, < 0.01,8.16E-01
dorsal/ventral axon guidance (GO:0033563),3,0,0.3,-, < 0.01,7.37E-01
abducens nerve formation (GO:0021599),2,0,0.2,-, < 0.01,8.16E-01
abducens nerve morphogenesis (GO:0021598),2,0,0.2,-, < 0.01,8.16E-01
rhombomere structural organization (GO:0021595),1,0,0.1,-, < 0.01,9.03E-01
rhombomere formation (GO:0021594),1,0,0.1,-, < 0.01,9.03E-01
rhombomere morphogenesis (GO:0021593),2,0,0.2,-, < 0.01,8.16E-01
fourth ventricle development (GO:0021592),2,0,0.2,-, < 0.01,8.16E-01
"isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)",3,0,0.3,-, < 0.01,7.37E-01
cerebellum maturation (GO:0021590),4,0,0.41,-, < 0.01,6.66E-01
glycine betaine biosynthetic process from choline (GO:0019285),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of response to gamma radiation (GO:2001229),1,0,0.1,-, < 0.01,9.03E-01
regulation of response to gamma radiation (GO:2001228),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of chloride transport (GO:2001226),3,0,0.3,-, < 0.01,7.37E-01
cerebellum structural organization (GO:0021589),2,0,0.2,-, < 0.01,8.16E-01
regulation of chloride transport (GO:2001225),11,0,1.12,-, < 0.01,3.27E-01
cerebellum formation (GO:0021588),1,0,0.1,-, < 0.01,9.03E-01
pons maturation (GO:0021586),3,0,0.3,-, < 0.01,7.37E-01
UDP-N-acetylgalactosamine metabolic process (GO:0019276),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of protein lipidation (GO:1903060),2,0,0.2,-, < 0.01,8.16E-01
hindbrain maturation (GO:0021578),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of vasculogenesis (GO:2001214),11,0,1.12,-, < 0.01,3.27E-01
hindbrain structural organization (GO:0021577),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of vasculogenesis (GO:2001213),2,0,0.2,-, < 0.01,8.16E-01
hindbrain formation (GO:0021576),1,0,0.1,-, < 0.01,9.03E-01
regulation of vasculogenesis (GO:2001212),16,0,1.63,-, < 0.01,1.96E-01
rhombomere 6 development (GO:0021572),1,0,0.1,-, < 0.01,9.03E-01
rhombomere 5 development (GO:0021571),3,0,0.3,-, < 0.01,7.37E-01
rhombomere 4 development (GO:0021570),2,0,0.2,-, < 0.01,8.16E-01
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999),2,0,0.2,-, < 0.01,8.16E-01
"glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)",2,0,0.2,-, < 0.01,8.16E-01
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997),2,0,0.2,-, < 0.01,8.16E-01
N-acetylneuraminate catabolic process (GO:0019262),6,0,0.61,-, < 0.01,5.43E-01
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994),2,0,0.2,-, < 0.01,8.16E-01
vitellogenesis (GO:0007296),4,0,0.41,-, < 0.01,6.66E-01
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),8,0,0.81,-, < 0.01,4.43E-01
sperm individualization (GO:0007291),1,0,0.1,-, < 0.01,9.03E-01
spermatid nucleus elongation (GO:0007290),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of transcription elongation by RNA polymerase I (GO:2001208),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription elongation from RNA polymerase I promoter (GO:2001207),1,0,0.1,-, < 0.01,9.03E-01
rhombomere 3 development (GO:0021569),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of osteoclast development (GO:2001205),5,0,0.51,-, < 0.01,6.01E-01
rhombomere 2 development (GO:0021568),2,0,0.2,-, < 0.01,8.16E-01
hypoglossal nerve development (GO:0021566),1,0,0.1,-, < 0.01,9.03E-01
vagus nerve development (GO:0021564),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of dendritic cell differentiation (GO:2001200),4,0,0.41,-, < 0.01,6.66E-01
glossopharyngeal nerve development (GO:0021563),4,0,0.41,-, < 0.01,6.66E-01
abducens nerve development (GO:0021560),2,0,0.2,-, < 0.01,8.16E-01
regulation of acetylcholine-gated cation channel activity (GO:1903048),1,0,0.1,-, < 0.01,9.03E-01
glucose 1-phosphate metabolic process (GO:0019255),2,0,0.2,-, < 0.01,8.16E-01
"carnitine metabolic process, CoA-linked (GO:0019254)",3,0,0.3,-, < 0.01,7.37E-01
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985),1,0,0.1,-, < 0.01,9.03E-01
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984),1,0,0.1,-, < 0.01,9.03E-01
baroreceptor response to increased systemic arterial blood pressure (GO:0001983),2,0,0.2,-, < 0.01,8.16E-01
spermatid nucleus differentiation (GO:0007289),20,0,2.03,-, < 0.01,1.31E-01
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980),1,0,0.1,-, < 0.01,9.03E-01
trochlear nerve development (GO:0021558),2,0,0.2,-, < 0.01,8.16E-01
midbrain-hindbrain boundary morphogenesis (GO:0021555),3,0,0.3,-, < 0.01,7.37E-01
olfactory nerve development (GO:0021553),4,0,0.41,-, < 0.01,6.66E-01
central nervous system morphogenesis (GO:0021551),2,0,0.2,-, < 0.01,8.16E-01
medulla oblongata development (GO:0021550),2,0,0.2,-, < 0.01,8.16E-01
regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979),1,0,0.1,-, < 0.01,9.03E-01
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978),2,0,0.2,-, < 0.01,8.16E-01
lactate biosynthetic process from pyruvate (GO:0019244),1,0,0.1,-, < 0.01,9.03E-01
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243),3,0,0.3,-, < 0.01,7.37E-01
methylglyoxal biosynthetic process (GO:0019242),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of microtubule plus-end binding (GO:1903033),2,0,0.2,-, < 0.01,8.16E-01
regulation of microtubule plus-end binding (GO:1903031),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of activation of membrane attack complex (GO:0001971),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of activation of membrane attack complex (GO:0001970),2,0,0.2,-, < 0.01,8.16E-01
neuron-neuron synaptic transmission (GO:0007270),8,0,0.81,-, < 0.01,4.43E-01
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514),1,0,0.1,-, < 0.01,9.03E-01
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512),3,0,0.3,-, < 0.01,7.37E-01
midbrain-hindbrain boundary initiation (GO:0021547),1,0,0.1,-, < 0.01,9.03E-01
rhombomere development (GO:0021546),7,0,0.71,-, < 0.01,4.91E-01
subpallium development (GO:0021544),25,0,2.54,-, < 0.01,7.86E-02
ammon gyrus development (GO:0021541),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric glomerulus development (GO:0072298),3,0,0.3,-, < 0.01,7.37E-01
response to pheromone (GO:0019236),8,0,0.81,-, < 0.01,4.43E-01
regulation of activation of membrane attack complex (GO:0001969),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),6,0,0.61,-, < 0.01,5.43E-01
proprioception (GO:0019230),4,0,0.41,-, < 0.01,6.66E-01
tyrosine phosphorylation of STAT protein (GO:0007260),8,0,0.81,-, < 0.01,4.43E-01
epithalamus development (GO:0021538),3,0,0.3,-, < 0.01,7.37E-01
cell migration in hindbrain (GO:0021535),14,0,1.42,-, < 0.01,2.41E-01
metanephric nephron tubule formation (GO:0072289),4,0,0.41,-, < 0.01,6.66E-01
spinal cord oligodendrocyte cell fate specification (GO:0021530),3,0,0.3,-, < 0.01,7.37E-01
metanephric distal tubule morphogenesis (GO:0072287),1,0,0.1,-, < 0.01,9.03E-01
metanephric connecting tubule development (GO:0072286),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of exo-alpha-sialidase activity (GO:1903017),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of exo-alpha-sialidase activity (GO:1903016),2,0,0.2,-, < 0.01,8.16E-01
regulation of exo-alpha-sialidase activity (GO:1903015),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of bone development (GO:1903012),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of bone development (GO:1903011),1,0,0.1,-, < 0.01,9.03E-01
JUN phosphorylation (GO:0007258),4,0,0.41,-, < 0.01,6.66E-01
regulation of bone development (GO:1903010),7,0,0.71,-, < 0.01,4.91E-01
intestinal D-glucose absorption (GO:0001951),2,0,0.2,-, < 0.01,8.16E-01
cytoplasmic sequestering of NF-kappaB (GO:0007253),7,0,0.71,-, < 0.01,4.91E-01
I-kappaB phosphorylation (GO:0007252),12,0,1.22,-, < 0.01,2.95E-01
spinal cord oligodendrocyte cell differentiation (GO:0021529),5,0,0.51,-, < 0.01,6.01E-01
commissural neuron differentiation in spinal cord (GO:0021528),1,0,0.1,-, < 0.01,9.03E-01
spinal cord association neuron differentiation (GO:0021527),14,0,1.42,-, < 0.01,2.41E-01
medial motor column neuron differentiation (GO:0021526),2,0,0.2,-, < 0.01,8.16E-01
visceral motor neuron differentiation (GO:0021524),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of amniotic stem cell differentiation (GO:2000798),1,0,0.1,-, < 0.01,9.03E-01
somatic motor neuron differentiation (GO:0021523),6,0,0.61,-, < 0.01,5.43E-01
regulation of amniotic stem cell differentiation (GO:2000797),1,0,0.1,-, < 0.01,9.03E-01
ventral spinal cord interneuron specification (GO:0021521),8,0,0.81,-, < 0.01,4.43E-01
metanephric comma-shaped body morphogenesis (GO:0072278),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795),1,0,0.1,-, < 0.01,9.03E-01
spinal cord motor neuron cell fate specification (GO:0021520),11,0,1.12,-, < 0.01,3.27E-01
metanephric glomerular capillary formation (GO:0072277),3,0,0.3,-, < 0.01,7.37E-01
metanephric glomerulus vasculature morphogenesis (GO:0072276),3,0,0.3,-, < 0.01,7.37E-01
cell proliferation involved in heart valve development (GO:2000793),1,0,0.1,-, < 0.01,9.03E-01
sebaceous gland cell differentiation (GO:0001949),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerulus morphogenesis (GO:0072275),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerular basement membrane development (GO:0072274),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein K63-linked deubiquitination (GO:1903006),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791),2,0,0.2,-, < 0.01,8.16E-01
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790),2,0,0.2,-, < 0.01,8.16E-01
proximal/distal pattern formation involved in metanephric nephron development (GO:0072272),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein K63-linked deubiquitination (GO:1903004),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of lipid transport across blood-brain barrier (GO:1903002),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of lipid transport across blood-brain barrier (GO:1903001),1,0,0.1,-, < 0.01,9.03E-01
regulation of lipid transport across blood-brain barrier (GO:1903000),1,0,0.1,-, < 0.01,9.03E-01
spinal cord association neuron specification (GO:0021519),1,0,0.1,-, < 0.01,9.03E-01
dorsal spinal cord development (GO:0021516),20,0,2.03,-, < 0.01,1.31E-01
ventral spinal cord interneuron differentiation (GO:0021514),14,0,1.42,-, < 0.01,2.41E-01
pattern specification involved in metanephros development (GO:0072268),4,0,0.41,-, < 0.01,6.66E-01
metanephric capsule specification (GO:0072267),1,0,0.1,-, < 0.01,9.03E-01
metanephric capsule formation (GO:0072266),1,0,0.1,-, < 0.01,9.03E-01
metanephric capsule morphogenesis (GO:0072265),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of sarcomere organization (GO:0060299),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of sarcomere organization (GO:0060298),3,0,0.3,-, < 0.01,7.37E-01
osmosensory signaling pathway (GO:0007231),4,0,0.41,-, < 0.01,6.66E-01
roof plate formation (GO:0021509),1,0,0.1,-, < 0.01,9.03E-01
floor plate formation (GO:0021508),2,0,0.2,-, < 0.01,8.16E-01
neural fold bending (GO:0021503),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777),2,0,0.2,-, < 0.01,8.16E-01
neural fold elevation formation (GO:0021502),3,0,0.3,-, < 0.01,7.37E-01
metanephric interstitial fibroblast development (GO:0072259),1,0,0.1,-, < 0.01,9.03E-01
prechordal plate formation (GO:0021501),1,0,0.1,-, < 0.01,9.03E-01
metanephric interstitial fibroblast differentiation (GO:0072258),1,0,0.1,-, < 0.01,9.03E-01
histone H3-S10 phosphorylation involved in chromosome condensation (GO:2000775),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerular mesangial cell development (GO:0072255),1,0,0.1,-, < 0.01,9.03E-01
regulation of exocyst assembly (GO:0001928),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerular mesangial cell differentiation (GO:0072254),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771),1,0,0.1,-, < 0.01,9.03E-01
B-1 B cell differentiation (GO:0001923),5,0,0.51,-, < 0.01,6.01E-01
B-1 B cell homeostasis (GO:0001922),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of receptor recycling (GO:0001921),13,0,1.32,-, < 0.01,2.67E-01
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of receptor recycling (GO:0001920),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of oocyte development (GO:0060283),1,0,0.1,-, < 0.01,9.03E-01
Notch receptor processing (GO:0007220),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of ovulation (GO:0060280),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerular visceral epithelial cell development (GO:0072249),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cytoplasmic translation (GO:2000766),8,0,0.81,-, < 0.01,4.43E-01
metanephric glomerular visceral epithelial cell differentiation (GO:0072248),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1,0,0.1,-, < 0.01,9.03E-01
regulation of receptor recycling (GO:0001919),21,0,2.13,-, < 0.01,1.18E-01
metanephric glomerular epithelium development (GO:0072244),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761),1,0,0.1,-, < 0.01,9.03E-01
metanephric DCT cell differentiation (GO:0072240),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ovulation (GO:0060279),2,0,0.2,-, < 0.01,8.16E-01
regulation of ovulation (GO:0060278),3,0,0.3,-, < 0.01,7.37E-01
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759),1,0,0.1,-, < 0.01,9.03E-01
metanephric glomerulus vasculature development (GO:0072239),6,0,0.61,-, < 0.01,5.43E-01
metanephric proximal tubule development (GO:0072237),2,0,0.2,-, < 0.01,8.16E-01
metanephric loop of Henle development (GO:0072236),5,0,0.51,-, < 0.01,6.01E-01
metanephric distal tubule development (GO:0072235),7,0,0.71,-, < 0.01,4.91E-01
killing by symbiont of host cells (GO:0001907),3,0,0.3,-, < 0.01,7.37E-01
metanephric thick ascending limb development (GO:0072233),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of respiratory burst (GO:0060268),5,0,0.51,-, < 0.01,6.01E-01
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway (GO:0007207),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of respiratory burst (GO:0060267),7,0,0.71,-, < 0.01,4.91E-01
phospholipase C-activating G protein-coupled glutamate receptor signaling pathway (GO:0007206),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of respiratory burst involved in inflammatory response (GO:0060266),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of respiratory burst involved in inflammatory response (GO:0060265),2,0,0.2,-, < 0.01,8.16E-01
regulation of DNA replication origin binding (GO:1902595),2,0,0.2,-, < 0.01,8.16E-01
regulation of respiratory burst involved in inflammatory response (GO:0060264),5,0,0.51,-, < 0.01,6.01E-01
regulation of respiratory burst (GO:0060263),15,0,1.52,-, < 0.01,2.17E-01
negative regulation of N-terminal protein palmitoylation (GO:0060262),1,0,0.1,-, < 0.01,9.03E-01
cyclic purine nucleotide metabolic process (GO:0052652),22,0,2.24,-, < 0.01,1.07E-01
monoacylglycerol catabolic process (GO:0052651),5,0,0.51,-, < 0.01,6.01E-01
metanephric proximal convoluted tubule development (GO:0072229),1,0,0.1,-, < 0.01,9.03E-01
metanephric macula densa development (GO:0072227),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of anterior head development (GO:2000744),2,0,0.2,-, < 0.01,8.16E-01
regulation of anterior head development (GO:2000742),2,0,0.2,-, < 0.01,8.16E-01
metanephric glomerulus development (GO:0072224),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of mesenchymal stem cell differentiation (GO:2000741),4,0,0.41,-, < 0.01,6.66E-01
metanephric glomerular mesangium development (GO:0072223),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of mesenchymal stem cell differentiation (GO:2000740),1,0,0.1,-, < 0.01,9.03E-01
metanephric distal convoluted tubule development (GO:0072221),5,0,0.51,-, < 0.01,6.01E-01
multi-organism intercellular transport (GO:1902586),1,0,0.1,-, < 0.01,9.03E-01
alditol phosphate metabolic process (GO:0052646),10,0,1.02,-, < 0.01,3.62E-01
regulation of N-terminal protein palmitoylation (GO:0060254),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glial cell proliferation (GO:0060253),13,0,1.32,-, < 0.01,2.67E-01
regulation of mesenchymal stem cell differentiation (GO:2000739),6,0,0.61,-, < 0.01,5.43E-01
metanephric cortical collecting duct development (GO:0072219),1,0,0.1,-, < 0.01,9.03E-01
metanephric ascending thin limb development (GO:0072218),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of metanephros development (GO:0072217),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of metanephros development (GO:0072216),3,0,0.3,-, < 0.01,7.37E-01
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733),1,0,0.1,-, < 0.01,9.03E-01
metanephric cortex development (GO:0072214),1,0,0.1,-, < 0.01,9.03E-01
metanephric capsule development (GO:0072213),1,0,0.1,-, < 0.01,9.03E-01
regulation of termination of RNA polymerase I transcription (GO:2000730),1,0,0.1,-, < 0.01,9.03E-01
regulation of calcium import into the mitochondrion (GO:0110097),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hippocampal neuron apoptotic process (GO:0110091),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cell proliferation involved in contact inhibition (GO:0060244),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of serine-type peptidase activity (GO:1902573),2,0,0.2,-, < 0.01,8.16E-01
protein localization to nucleolus (GO:1902570),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of cardiac muscle cell differentiation (GO:2000727),10,0,1.02,-, < 0.01,3.62E-01
metanephric mesangial cell differentiation (GO:0072209),2,0,0.2,-, < 0.01,8.16E-01
metanephric smooth muscle tissue development (GO:0072208),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724),2,0,0.2,-, < 0.01,8.16E-01
metanephric juxtaglomerular apparatus development (GO:0072206),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722),3,0,0.3,-, < 0.01,7.37E-01
cell-cell signaling involved in metanephros development (GO:0072204),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mesenchymal cell proliferation (GO:0072201),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of activation of Janus kinase activity (GO:1902569),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of eosinophil activation (GO:1902568),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of eosinophil activation (GO:1902567),2,0,0.2,-, < 0.01,8.16E-01
regulation of eosinophil activation (GO:1902566),4,0,0.41,-, < 0.01,6.66E-01
lens induction in camera-type eye (GO:0060235),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of neutrophil activation (GO:1902565),5,0,0.51,-, < 0.01,6.01E-01
neuroblast delamination (GO:0060234),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ferroptosis (GO:0110076),2,0,0.2,-, < 0.01,8.16E-01
regulation of ferroptosis (GO:0110075),2,0,0.2,-, < 0.01,8.16E-01
3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of catalase activity (GO:1902553),1,0,0.1,-, < 0.01,9.03E-01
regulation of catalase activity (GO:1902551),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of dense core granule biogenesis (GO:2000706),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703),1,0,0.1,-, < 0.01,9.03E-01
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702),1,0,0.1,-, < 0.01,9.03E-01
hemangioblast cell differentiation (GO:0060217),1,0,0.1,-, < 0.01,9.03E-01
regulation of angiotensin-activated signaling pathway (GO:0110061),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of DNA N-glycosylase activity (GO:1902546),1,0,0.1,-, < 0.01,9.03E-01
primitive hemopoiesis (GO:0060215),6,0,0.61,-, < 0.01,5.43E-01
endocardium formation (GO:0060214),4,0,0.41,-, < 0.01,6.66E-01
regulation of DNA N-glycosylase activity (GO:1902544),2,0,0.2,-, < 0.01,8.16E-01
heme oxidation (GO:0006788),2,0,0.2,-, < 0.01,8.16E-01
heme A biosynthetic process (GO:0006784),2,0,0.2,-, < 0.01,8.16E-01
succinyl-CoA pathway (GO:0006781),1,0,0.1,-, < 0.01,9.03E-01
uroporphyrinogen III biosynthetic process (GO:0006780),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of blood vessel endothelial cell differentiation (GO:0110059),1,0,0.1,-, < 0.01,9.03E-01
regulation of blood vessel endothelial cell differentiation (GO:0110057),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein linear polyubiquitination (GO:1902530),1,0,0.1,-, < 0.01,9.03E-01
vitamin A metabolic process (GO:0006776),8,0,0.81,-, < 0.01,4.43E-01
thiamine metabolic process (GO:0006772),4,0,0.41,-, < 0.01,6.66E-01
riboflavin metabolic process (GO:0006771),7,0,0.71,-, < 0.01,4.91E-01
cellular response to prostaglandin D stimulus (GO:0071799),3,0,0.3,-, < 0.01,7.37E-01
response to prostaglandin D (GO:0071798),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein linear polyubiquitination (GO:1902528),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein monoubiquitination (GO:1902527),5,0,0.51,-, < 0.01,6.01E-01
regulation of protein monoubiquitination (GO:1902525),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of protein K48-linked ubiquitination (GO:1902524),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of protein K63-linked ubiquitination (GO:1902523),4,0,0.41,-, < 0.01,6.66E-01
biotin metabolic process (GO:0006768),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032),3,0,0.3,-, < 0.01,7.37E-01
regulation of G2/MI transition of meiotic cell cycle (GO:0110030),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of apoptotic DNA fragmentation (GO:1902511),2,0,0.2,-, < 0.01,8.16E-01
glutathione catabolic process (GO:0006751),5,0,0.51,-, < 0.01,6.01E-01
MHC class II protein complex assembly (GO:0002399),4,0,0.41,-, < 0.01,6.66E-01
glutathione biosynthetic process (GO:0006750),13,0,1.32,-, < 0.01,2.67E-01
MHC class Ib protein complex assembly (GO:0002398),1,0,0.1,-, < 0.01,9.03E-01
MHC class I protein complex assembly (GO:0002397),3,0,0.3,-, < 0.01,7.37E-01
MHC protein complex assembly (GO:0002396),7,0,0.71,-, < 0.01,4.91E-01
regulation of DNA strand resection involved in replication fork processing (GO:0110026),1,0,0.1,-, < 0.01,9.03E-01
DNA strand resection involved in replication fork processing (GO:0110025),2,0,0.2,-, < 0.01,8.16E-01
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504),1,0,0.1,-, < 0.01,9.03E-01
FAD biosynthetic process (GO:0006747),1,0,0.1,-, < 0.01,9.03E-01
ubiquinone biosynthetic process (GO:0006744),14,0,1.42,-, < 0.01,2.41E-01
ubiquinone metabolic process (GO:0006743),16,0,1.63,-, < 0.01,1.96E-01
NADP catabolic process (GO:0006742),1,0,0.1,-, < 0.01,9.03E-01
NADP biosynthetic process (GO:0006741),3,0,0.3,-, < 0.01,7.37E-01
immune response in brain or nervous system (GO:0002383),1,0,0.1,-, < 0.01,9.03E-01
immunoglobulin secretion involved in immune response (GO:0002380),1,0,0.1,-, < 0.01,9.03E-01
cap-independent translational initiation of linear mRNA (GO:0110017),2,0,0.2,-, < 0.01,8.16E-01
regulation of basement membrane organization (GO:0110011),5,0,0.51,-, < 0.01,6.01E-01
immunoglobulin biosynthetic process involved in immune response (GO:0002379),1,0,0.1,-, < 0.01,9.03E-01
immunoglobulin biosynthetic process (GO:0002378),3,0,0.3,-, < 0.01,7.37E-01
cytokine secretion involved in immune response (GO:0002374),4,0,0.41,-, < 0.01,6.66E-01
dendritic cell cytokine production (GO:0002371),1,0,0.1,-, < 0.01,9.03E-01
formin-nucleated actin cable organization (GO:0110009),3,0,0.3,-, < 0.01,7.37E-01
ncRNA deadenylation (GO:0110008),1,0,0.1,-, < 0.01,9.03E-01
triterpenoid metabolic process (GO:0006722),2,0,0.2,-, < 0.01,8.16E-01
T cell cytokine production (GO:0002369),11,0,1.12,-, < 0.01,3.27E-01
NK T cell lineage commitment (GO:0002364),1,0,0.1,-, < 0.01,9.03E-01
"CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)",2,0,0.2,-, < 0.01,8.16E-01
"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)",4,0,0.41,-, < 0.01,6.66E-01
sesquiterpenoid metabolic process (GO:0006714),3,0,0.3,-, < 0.01,7.37E-01
glucocorticoid catabolic process (GO:0006713),1,0,0.1,-, < 0.01,9.03E-01
androgen catabolic process (GO:0006710),4,0,0.41,-, < 0.01,6.66E-01
B cell homeostatic proliferation (GO:0002358),2,0,0.2,-, < 0.01,8.16E-01
detection of tumor cell (GO:0002355),1,0,0.1,-, < 0.01,9.03E-01
plasma kallikrein-kinin cascade (GO:0002353),3,0,0.3,-, < 0.01,7.37E-01
B cell negative selection (GO:0002352),2,0,0.2,-, < 0.01,8.16E-01
serotonin production involved in inflammatory response (GO:0002351),3,0,0.3,-, < 0.01,7.37E-01
transcriptional activation by promoter-enhancer looping (GO:0071733),4,0,0.41,-, < 0.01,6.66E-01
cholesterol catabolic process (GO:0006707),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of dendritic cell differentiation (GO:2001199),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of gamma-delta T cell activation involved in immune response (GO:2001193),1,0,0.1,-, < 0.01,9.03E-01
histamine production involved in inflammatory response (GO:0002349),2,0,0.2,-, < 0.01,8.16E-01
regulation of gamma-delta T cell activation involved in immune response (GO:2001191),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190),3,0,0.3,-, < 0.01,7.37E-01
B cell affinity maturation (GO:0002344),1,0,0.1,-, < 0.01,9.03E-01
peripheral B cell selection (GO:0002343),1,0,0.1,-, < 0.01,9.03E-01
cellular response to diacyl bacterial lipopeptide (GO:0071726),4,0,0.41,-, < 0.01,6.66E-01
response to diacyl bacterial lipopeptide (GO:0071724),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189),3,0,0.3,-, < 0.01,7.37E-01
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),6,0,0.61,-, < 0.01,5.43E-01
"negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",6,0,0.61,-, < 0.01,5.43E-01
B cell selection (GO:0002339),3,0,0.3,-, < 0.01,7.37E-01
B-1a B cell differentiation (GO:0002337),2,0,0.2,-, < 0.01,8.16E-01
B-1 B cell lineage commitment (GO:0002336),1,0,0.1,-, < 0.01,9.03E-01
transitional one stage B cell differentiation (GO:0002333),1,0,0.1,-, < 0.01,9.03E-01
transitional stage B cell differentiation (GO:0002332),1,0,0.1,-, < 0.01,9.03E-01
pre-B cell allelic exclusion (GO:0002331),3,0,0.3,-, < 0.01,7.37E-01
sodium-independent icosanoid transport (GO:0071718),1,0,0.1,-, < 0.01,9.03E-01
ER-associated misfolded protein catabolic process (GO:0071712),10,0,1.02,-, < 0.01,3.62E-01
pre-B cell differentiation (GO:0002329),5,0,0.51,-, < 0.01,6.01E-01
pro-B cell differentiation (GO:0002328),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of ATP biosynthetic process (GO:2001171),13,0,1.32,-, < 0.01,2.67E-01
B cell lineage commitment (GO:0002326),6,0,0.61,-, < 0.01,5.43E-01
B cell proliferation involved in immune response (GO:0002322),6,0,0.61,-, < 0.01,5.43E-01
immunoglobulin heavy chain V-D-J recombination (GO:0071707),1,0,0.1,-, < 0.01,9.03E-01
tumor necrosis factor superfamily cytokine production (GO:0071706),9,0,0.91,-, < 0.01,4.00E-01
galactose catabolic process via UDP-galactose (GO:0033499),3,0,0.3,-, < 0.01,7.37E-01
cholesterol biosynthetic process via lathosterol (GO:0033490),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of histone H3-K79 methylation (GO:2001162),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of histone H3-K79 methylation (GO:2001161),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H3-K79 methylation (GO:2001160),3,0,0.3,-, < 0.01,7.37E-01
follicular B cell differentiation (GO:0002316),1,0,0.1,-, < 0.01,9.03E-01
cholesterol biosynthetic process via desmosterol (GO:0033489),4,0,0.41,-, < 0.01,6.66E-01
"cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of renal water transport (GO:2001153),1,0,0.1,-, < 0.01,9.03E-01
T cell proliferation involved in immune response (GO:0002309),4,0,0.41,-, < 0.01,6.66E-01
regulation of renal water transport (GO:2001151),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of dipeptide transmembrane transport (GO:2001150),2,0,0.2,-, < 0.01,8.16E-01
"CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)",2,0,0.2,-, < 0.01,8.16E-01
gamma-delta intraepithelial T cell differentiation (GO:0002304),2,0,0.2,-, < 0.01,8.16E-01
"CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)",1,0,0.1,-, < 0.01,9.03E-01
"CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)",1,0,0.1,-, < 0.01,9.03E-01
S-methylmethionine metabolic process (GO:0033477),1,0,0.1,-, < 0.01,9.03E-01
regulation of dipeptide transmembrane transport (GO:2001148),2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)",1,0,0.1,-, < 0.01,9.03E-01
nicotinate transport (GO:2001142),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phospholipid transport (GO:2001139),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of endocytic recycling (GO:2001137),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of endocytic recycling (GO:2001136),1,0,0.1,-, < 0.01,9.03E-01
nonribosomal peptide biosynthetic process (GO:0019184),15,0,1.52,-, < 0.01,2.17E-01
positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045425),2,0,0.2,-, < 0.01,8.16E-01
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045423),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of translational frameshifting (GO:2001125),1,0,0.1,-, < 0.01,9.03E-01
regulation of translational frameshifting (GO:2001124),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of lens epithelial cell proliferation (GO:2001111),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cytolysis by symbiont of host cells (GO:0001899),1,0,0.1,-, < 0.01,9.03E-01
regulation of cytolysis by symbiont of host cells (GO:0001898),1,0,0.1,-, < 0.01,9.03E-01
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199),2,0,0.2,-, < 0.01,8.16E-01
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),7,0,0.71,-, < 0.01,4.91E-01
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195),5,0,0.51,-, < 0.01,6.01E-01
regulation of lens epithelial cell proliferation (GO:2001109),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107),1,0,0.1,-, < 0.01,9.03E-01
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106),4,0,0.41,-, < 0.01,6.66E-01
selenium compound metabolic process (GO:0001887),5,0,0.51,-, < 0.01,6.01E-01
endothelial cell morphogenesis (GO:0001886),11,0,1.12,-, < 0.01,3.27E-01
SMAD protein complex assembly (GO:0007183),7,0,0.71,-, < 0.01,4.91E-01
common-partner SMAD protein phosphorylation (GO:0007182),6,0,0.61,-, < 0.01,5.43E-01
regulation of epidermal growth factor-activated receptor activity (GO:0007176),27,0,2.74,-, < 0.01,6.41E-02
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),13,0,1.32,-, < 0.01,2.67E-01
epidermal growth factor catabolic process (GO:0007174),2,0,0.2,-, < 0.01,8.16E-01
signal complex assembly (GO:0007172),8,0,0.81,-, < 0.01,4.43E-01
mesenchymal cell proliferation involved in ureter development (GO:0072198),1,0,0.1,-, < 0.01,9.03E-01
ureter morphogenesis (GO:0072197),7,0,0.71,-, < 0.01,4.91E-01
"negative regulation of complement activation, lectin pathway (GO:0001869)",2,0,0.2,-, < 0.01,8.16E-01
"regulation of complement activation, lectin pathway (GO:0001868)",2,0,0.2,-, < 0.01,8.16E-01
kidney smooth muscle tissue development (GO:0072194),2,0,0.2,-, < 0.01,8.16E-01
"complement activation, lectin pathway (GO:0001867)",9,0,0.91,-, < 0.01,4.00E-01
NK T cell proliferation (GO:0001866),2,0,0.2,-, < 0.01,8.16E-01
ureter epithelial cell differentiation (GO:0072192),1,0,0.1,-, < 0.01,9.03E-01
ureter urothelium development (GO:0072190),3,0,0.3,-, < 0.01,7.37E-01
receptor guanylyl cyclase signaling pathway (GO:0007168),9,0,0.91,-, < 0.01,4.00E-01
calcium-independent cell-matrix adhesion (GO:0007161),3,0,0.3,-, < 0.01,7.37E-01
metanephric cap morphogenesis (GO:0072186),1,0,0.1,-, < 0.01,9.03E-01
metanephric cap development (GO:0072185),1,0,0.1,-, < 0.01,9.03E-01
renal vesicle progenitor cell differentiation (GO:0072184),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697),4,0,0.41,-, < 0.01,6.66E-01
metanephric tubule formation (GO:0072174),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac muscle cell myoblast differentiation (GO:2000690),1,0,0.1,-, < 0.01,9.03E-01
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),7,0,0.71,-, < 0.01,4.91E-01
female meiosis II (GO:0007147),1,0,0.1,-, < 0.01,9.03E-01
neural plate development (GO:0001840),9,0,0.91,-, < 0.01,4.00E-01
meiotic recombination nodule assembly (GO:0007146),1,0,0.1,-, < 0.01,9.03E-01
female meiosis I (GO:0007144),7,0,0.71,-, < 0.01,4.91E-01
specification of posterior mesonephric tubule identity (GO:0072169),1,0,0.1,-, < 0.01,9.03E-01
specification of anterior mesonephric tubule identity (GO:0072168),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cellular response to X-ray (GO:2000685),1,0,0.1,-, < 0.01,9.03E-01
specification of mesonephric tubule identity (GO:0072167),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular response to X-ray (GO:2000683),2,0,0.2,-, < 0.01,8.16E-01
neural plate morphogenesis (GO:0001839),6,0,0.61,-, < 0.01,5.43E-01
anterior mesonephric tubule development (GO:0072165),1,0,0.1,-, < 0.01,9.03E-01
male somatic sex determination (GO:0019102),1,0,0.1,-, < 0.01,9.03E-01
metanephric mesenchymal cell differentiation (GO:0072162),5,0,0.51,-, < 0.01,6.01E-01
blastocyst hatching (GO:0001835),23,0,2.34,-, < 0.01,9.63E-02
female somatic sex determination (GO:0019101),1,0,0.1,-, < 0.01,9.03E-01
mesenchymal cell differentiation involved in kidney development (GO:0072161),7,0,0.71,-, < 0.01,4.91E-01
trophectodermal cell proliferation (GO:0001834),2,0,0.2,-, < 0.01,8.16E-01
male germ-line sex determination (GO:0019100),2,0,0.2,-, < 0.01,8.16E-01
cloacal septation (GO:0060197),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of transcription regulatory region DNA binding (GO:2000678),21,0,2.13,-, < 0.01,1.18E-01
negative regulation of type B pancreatic cell apoptotic process (GO:2000675),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of motor neuron apoptotic process (GO:2000672),4,0,0.41,-, < 0.01,6.66E-01
inner cell mass cellular morphogenesis (GO:0001828),2,0,0.2,-, < 0.01,8.16E-01
regulation of motor neuron apoptotic process (GO:2000671),5,0,0.51,-, < 0.01,6.01E-01
inner cell mass cell fate commitment (GO:0001827),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of dendritic cell apoptotic process (GO:2000670),4,0,0.41,-, < 0.01,6.66E-01
histamine secretion (GO:0001821),5,0,0.51,-, < 0.01,6.01E-01
serotonin secretion (GO:0001820),3,0,0.3,-, < 0.01,7.37E-01
cell cycle switching (GO:0060184),3,0,0.3,-, < 0.01,7.37E-01
apelin receptor signaling pathway (GO:0060183),2,0,0.2,-, < 0.01,8.16E-01
epithelial cell fate commitment (GO:0072148),14,0,1.42,-, < 0.01,2.41E-01
glomerular mesangial cell development (GO:0072144),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of interleukin-1-mediated signaling pathway (GO:2000661),1,0,0.1,-, < 0.01,9.03E-01
mesangial cell development (GO:0072143),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815),1,0,0.1,-, < 0.01,9.03E-01
renal interstitial fibroblast development (GO:0072141),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of antibody-dependent cellular cytotoxicity (GO:0001814),1,0,0.1,-, < 0.01,9.03E-01
regulation of antibody-dependent cellular cytotoxicity (GO:0001813),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of type I hypersensitivity (GO:0001812),1,0,0.1,-, < 0.01,9.03E-01
regulation of exocyst localization (GO:0060178),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of type I hypersensitivity (GO:0001811),1,0,0.1,-, < 0.01,9.03E-01
regulation of angiotensin metabolic process (GO:0060177),2,0,0.2,-, < 0.01,8.16E-01
regulation of type I hypersensitivity (GO:0001810),2,0,0.2,-, < 0.01,8.16E-01
endomitotic cell cycle (GO:0007113),3,0,0.3,-, < 0.01,7.37E-01
ribonucleoprotein complex disassembly (GO:0032988),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of apolipoprotein binding (GO:2000657),1,0,0.1,-, < 0.01,9.03E-01
keratinocyte activation (GO:0032980),1,0,0.1,-, < 0.01,9.03E-01
regulation of apolipoprotein binding (GO:2000656),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular response to testosterone stimulus (GO:2000655),1,0,0.1,-, < 0.01,9.03E-01
condensed mesenchymal cell proliferation (GO:0072137),2,0,0.2,-, < 0.01,8.16E-01
regulation of cellular response to testosterone stimulus (GO:2000654),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of type IV hypersensitivity (GO:0001809),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of type IV hypersensitivity (GO:0001808),2,0,0.2,-, < 0.01,8.16E-01
nephrogenic mesenchyme morphogenesis (GO:0072134),2,0,0.2,-, < 0.01,8.16E-01
regulation of type IV hypersensitivity (GO:0001807),4,0,0.41,-, < 0.01,6.66E-01
metanephric mesenchyme morphogenesis (GO:0072133),3,0,0.3,-, < 0.01,7.37E-01
type IV hypersensitivity (GO:0001806),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of type III hypersensitivity (GO:0001805),1,0,0.1,-, < 0.01,9.03E-01
kidney mesenchyme morphogenesis (GO:0072131),3,0,0.3,-, < 0.01,7.37E-01
renal capsule specification (GO:0072130),1,0,0.1,-, < 0.01,9.03E-01
regulation of type III hypersensitivity (GO:0001803),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of adenosine receptor signaling pathway (GO:0060169),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein autoubiquitination (GO:1902499),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of adenosine receptor signaling pathway (GO:0060168),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein autoubiquitination (GO:1902498),5,0,0.51,-, < 0.01,6.01E-01
regulation of adenosine receptor signaling pathway (GO:0060167),4,0,0.41,-, < 0.01,6.66E-01
regulation of timing of subpallium neuron differentiation (GO:0060165),1,0,0.1,-, < 0.01,9.03E-01
regulation of timing of neuron differentiation (GO:0060164),3,0,0.3,-, < 0.01,7.37E-01
subpallium neuron fate commitment (GO:0060163),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of dopamine receptor signaling pathway (GO:0060161),5,0,0.51,-, < 0.01,6.01E-01
mitotic centrosome separation (GO:0007100),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of dopamine receptor signaling pathway (GO:0060160),4,0,0.41,-, < 0.01,6.66E-01
protein insertion into mitochondrial inner membrane from matrix (GO:0032979),4,0,0.41,-, < 0.01,6.66E-01
protein insertion into membrane from inner side (GO:0032978),4,0,0.41,-, < 0.01,6.66E-01
release of matrix enzymes from mitochondria (GO:0032976),1,0,0.1,-, < 0.01,9.03E-01
amino acid transmembrane export from vacuole (GO:0032974),1,0,0.1,-, < 0.01,9.03E-01
regulation of muscle filament sliding speed (GO:0032972),2,0,0.2,-, < 0.01,8.16E-01
renal capsule formation (GO:0072129),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of receptor catabolic process (GO:2000646),8,0,0.81,-, < 0.01,4.43E-01
renal capsule morphogenesis (GO:0072128),1,0,0.1,-, < 0.01,9.03E-01
renal capsule development (GO:0072127),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of early endosome to late endosome transport (GO:2000643),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of SREBP signaling pathway (GO:2000640),1,0,0.1,-, < 0.01,9.03E-01
regulation of dopamine receptor signaling pathway (GO:0060159),10,0,1.02,-, < 0.01,3.62E-01
urinary bladder development (GO:0060157),4,0,0.41,-, < 0.01,6.66E-01
platelet dense granule organization (GO:0060155),7,0,0.71,-, < 0.01,4.91E-01
cytotoxic T cell pyroptotic process (GO:1902483),2,0,0.2,-, < 0.01,8.16E-01
microtubule-based peroxisome localization (GO:0060152),2,0,0.2,-, < 0.01,8.16E-01
peroxisome localization (GO:0060151),2,0,0.2,-, < 0.01,8.16E-01
protein localization to mitotic spindle (GO:1902480),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of SREBP signaling pathway (GO:2000639),3,0,0.3,-, < 0.01,7.37E-01
regulation of SREBP signaling pathway (GO:2000638),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of pre-miRNA processing (GO:2000632),2,0,0.2,-, < 0.01,8.16E-01
regulation of pre-miRNA processing (GO:2000631),2,0,0.2,-, < 0.01,8.16E-01
glomerular mesangial cell proliferation (GO:0072110),2,0,0.2,-, < 0.01,8.16E-01
inositol trisphosphate biosynthetic process (GO:0032959),2,0,0.2,-, < 0.01,8.16E-01
inositol trisphosphate metabolic process (GO:0032957),5,0,0.51,-, < 0.01,6.01E-01
regulation of cytokinetic process (GO:0032954),3,0,0.3,-, < 0.01,7.37E-01
glomerular mesangium development (GO:0072109),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108),4,0,0.41,-, < 0.01,6.66E-01
"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)",4,0,0.41,-, < 0.01,6.66E-01
ureteric peristalsis (GO:0072105),2,0,0.2,-, < 0.01,8.16E-01
"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)",4,0,0.41,-, < 0.01,6.66E-01
positive regulation of histone H4-K16 acetylation (GO:2000620),2,0,0.2,-, < 0.01,8.16E-01
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101),1,0,0.1,-, < 0.01,9.03E-01
specification of ureteric bud anterior/posterior symmetry (GO:0072100),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of apoptotic process by virus (GO:0060139),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of histone H3-K27 trimethylation (GO:1902466),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H3-K27 trimethylation (GO:1902464),1,0,0.1,-, < 0.01,9.03E-01
regulation of thyroid-stimulating hormone secretion (GO:2000612),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of thyroid hormone generation (GO:2000611),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of stem cell population maintenance (GO:1902459),9,0,0.91,-, < 0.01,4.00E-01
inner ear receptor cell fate commitment (GO:0060120),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of translation in response to oxidative stress (GO:0032938),1,0,0.1,-, < 0.01,9.03E-01
SREBP signaling pathway (GO:0032933),9,0,0.91,-, < 0.01,4.00E-01
regulation of thyroid hormone generation (GO:2000609),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of cell proliferation involved in mesonephros development (GO:2000607),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell proliferation involved in mesonephros development (GO:2000606),1,0,0.1,-, < 0.01,9.03E-01
vestibular receptor cell development (GO:0060118),2,0,0.2,-, < 0.01,8.16E-01
vestibular receptor cell morphogenesis (GO:0060116),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445),3,0,0.3,-, < 0.01,7.37E-01
vestibular receptor cell differentiation (GO:0060114),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443),1,0,0.1,-, < 0.01,9.03E-01
generation of ovulation cycle rhythm (GO:0060112),1,0,0.1,-, < 0.01,9.03E-01
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442),1,0,0.1,-, < 0.01,9.03E-01
positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052501),1,0,0.1,-, < 0.01,9.03E-01
sphingomyelin catabolic process (GO:0006685),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of superoxide anion generation (GO:0032929),3,0,0.3,-, < 0.01,7.37E-01
galactosylceramide catabolic process (GO:0006683),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of activin receptor signaling pathway (GO:0032926),10,0,1.02,-, < 0.01,3.62E-01
glucosylceramide catabolic process (GO:0006680),3,0,0.3,-, < 0.01,7.37E-01
putrescine acetylation (GO:0032920),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of male mating behavior (GO:1902437),2,0,0.2,-, < 0.01,8.16E-01
regulation of male mating behavior (GO:1902435),2,0,0.2,-, < 0.01,8.16E-01
glucosylceramide biosynthetic process (GO:0006679),2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of phagocytosis, engulfment (GO:0060101)",1,0,0.1,-, < 0.01,9.03E-01
glucosylceramide metabolic process (GO:0006678),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of amyloid-beta formation (GO:1902430),12,0,1.22,-, < 0.01,2.95E-01
spermine acetylation (GO:0032919),1,0,0.1,-, < 0.01,9.03E-01
spermidine acetylation (GO:0032918),2,0,0.2,-, < 0.01,8.16E-01
polyamine acetylation (GO:0032917),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of transforming growth factor beta3 production (GO:0032916),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of transforming growth factor beta3 production (GO:0032913),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of transforming growth factor beta2 production (GO:0032912),2,0,0.2,-, < 0.01,8.16E-01
regulation of transforming growth factor beta3 production (GO:0032910),4,0,0.41,-, < 0.01,6.66E-01
maintenance of protein location in extracellular region (GO:0071694),6,0,0.61,-, < 0.01,5.43E-01
deactivation of mitotic spindle assembly checkpoint (GO:1902426),1,0,0.1,-, < 0.01,9.03E-01
protein transport within extracellular region (GO:0071693),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425),2,0,0.2,-, < 0.01,8.16E-01
cardiac muscle thin filament assembly (GO:0071691),3,0,0.3,-, < 0.01,7.37E-01
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423),2,0,0.2,-, < 0.01,8.16E-01
sphinganine-1-phosphate biosynthetic process (GO:0006669),1,0,0.1,-, < 0.01,9.03E-01
sphinganine-1-phosphate metabolic process (GO:0006668),2,0,0.2,-, < 0.01,8.16E-01
sphinganine metabolic process (GO:0006667),2,0,0.2,-, < 0.01,8.16E-01
3-keto-sphinganine metabolic process (GO:0006666),1,0,0.1,-, < 0.01,9.03E-01
platelet activating factor biosynthetic process (GO:0006663),4,0,0.41,-, < 0.01,6.66E-01
phosphatidylserine catabolic process (GO:0006660),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of neurotrophin production (GO:0032901),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neurotrophin production (GO:0032900),1,0,0.1,-, < 0.01,9.03E-01
TORC1 signaling (GO:0038202),9,0,0.91,-, < 0.01,4.00E-01
striated muscle myosin thick filament assembly (GO:0071688),3,0,0.3,-, < 0.01,7.37E-01
organism emergence from protective structure (GO:0071684),23,0,2.34,-, < 0.01,9.63E-02
positive regulation of mRNA binding (GO:1902416),6,0,0.61,-, < 0.01,5.43E-01
regulation of mRNA binding (GO:1902415),7,0,0.71,-, < 0.01,4.91E-01
cellular response to indole-3-methanol (GO:0071681),5,0,0.51,-, < 0.01,6.01E-01
response to indole-3-methanol (GO:0071680),5,0,0.51,-, < 0.01,6.01E-01
regulation of mitotic cytokinesis (GO:1902412),6,0,0.61,-, < 0.01,5.43E-01
phosphatidylserine biosynthetic process (GO:0006659),4,0,0.41,-, < 0.01,6.66E-01
mitotic cytokinetic process (GO:1902410),21,0,2.13,-, < 0.01,1.18E-01
CDP-choline pathway (GO:0006657),7,0,0.71,-, < 0.01,4.91E-01
phosphatidylglycerol biosynthetic process (GO:0006655),11,0,1.12,-, < 0.01,3.27E-01
alpha-beta intraepithelial T cell differentiation (GO:0002299),1,0,0.1,-, < 0.01,9.03E-01
T-helper 1 cell lineage commitment (GO:0002296),2,0,0.2,-, < 0.01,8.16E-01
olfactory bulb axon guidance (GO:0071678),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mononuclear cell migration (GO:0071676),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of smooth muscle cell chemotaxis (GO:0071673),4,0,0.41,-, < 0.01,6.66E-01
phospholipid transfer to membrane (GO:0006649),1,0,0.1,-, < 0.01,9.03E-01
triglyceride mobilization (GO:0006642),3,0,0.3,-, < 0.01,7.37E-01
monoacylglycerol biosynthetic process (GO:0006640),5,0,0.51,-, < 0.01,6.01E-01
monocyte activation involved in immune response (GO:0002280),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of IP-10 production (GO:0071660),1,0,0.1,-, < 0.01,9.03E-01
tRNA demethylation (GO:1990983),1,0,0.1,-, < 0.01,9.03E-01
eosinophil activation involved in immune response (GO:0002278),3,0,0.3,-, < 0.01,7.37E-01
myeloid dendritic cell activation involved in immune response (GO:0002277),3,0,0.3,-, < 0.01,7.37E-01
basophil activation involved in immune response (GO:0002276),2,0,0.2,-, < 0.01,8.16E-01
plasmacytoid dendritic cell differentiation (GO:0002273),1,0,0.1,-, < 0.01,9.03E-01
plasmacytoid dendritic cell activation (GO:0002270),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of IP-10 production (GO:0071659),1,0,0.1,-, < 0.01,9.03E-01
regulation of IP-10 production (GO:0071658),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of granulocyte colony-stimulating factor production (GO:0071657),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of granulocyte colony-stimulating factor production (GO:0071656),1,0,0.1,-, < 0.01,9.03E-01
regulation of granulocyte colony-stimulating factor production (GO:0071655),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654),1,0,0.1,-, < 0.01,9.03E-01
regulation of chemokine (C-C motif) ligand 1 production (GO:0071652),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650),4,0,0.41,-, < 0.01,6.66E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627),5,0,0.51,-, < 0.01,6.01E-01
vacuolar protein processing (GO:0006624),2,0,0.2,-, < 0.01,8.16E-01
protein retention in ER lumen (GO:0006621),9,0,0.91,-, < 0.01,4.00E-01
follicular dendritic cell differentiation (GO:0002268),1,0,0.1,-, < 0.01,9.03E-01
follicular dendritic cell activation (GO:0002266),2,0,0.2,-, < 0.01,8.16E-01
astrocyte activation involved in immune response (GO:0002265),4,0,0.41,-, < 0.01,6.66E-01
endothelial cell activation involved in immune response (GO:0002264),1,0,0.1,-, < 0.01,9.03E-01
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644),1,0,0.1,-, < 0.01,9.03E-01
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641),3,0,0.3,-, < 0.01,7.37E-01
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640),5,0,0.51,-, < 0.01,6.01E-01
modulation by host of viral RNA-binding transcription factor activity (GO:1990969),1,0,0.1,-, < 0.01,9.03E-01
"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)",2,0,0.2,-, < 0.01,8.16E-01
modulation by host of RNA binding by virus (GO:1990968),1,0,0.1,-, < 0.01,9.03E-01
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",8,0,0.81,-, < 0.01,4.43E-01
establishment of blood-retinal barrier (GO:1990963),1,0,0.1,-, < 0.01,9.03E-01
ribosomal protein import into nucleus (GO:0006610),4,0,0.41,-, < 0.01,6.66E-01
kinin cascade (GO:0002254),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of monocyte chemotactic protein-1 production (GO:0071639),10,0,1.02,-, < 0.01,3.62E-01
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630),2,0,0.2,-, < 0.01,8.16E-01
homogentisate metabolic process (GO:1901999),1,0,0.1,-, < 0.01,9.03E-01
NLS-bearing protein import into nucleus (GO:0006607),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of meiotic cell cycle phase transition (GO:1901995),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of meiotic cell cycle phase transition (GO:1901994),3,0,0.3,-, < 0.01,7.37E-01
phosphocreatine metabolic process (GO:0006603),3,0,0.3,-, < 0.01,7.37E-01
regulation of meiotic cell cycle phase transition (GO:1901993),7,0,0.71,-, < 0.01,4.91E-01
creatine biosynthetic process (GO:0006601),2,0,0.2,-, < 0.01,8.16E-01
creatine metabolic process (GO:0006600),6,0,0.61,-, < 0.01,5.43E-01
connective tissue replacement involved in inflammatory response wound healing (GO:0002248),5,0,0.51,-, < 0.01,6.01E-01
wound healing involved in inflammatory response (GO:0002246),6,0,0.61,-, < 0.01,5.43E-01
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of granulocyte chemotaxis (GO:0071623),3,0,0.3,-, < 0.01,7.37E-01
response to ketamine (GO:1901986),1,0,0.1,-, < 0.01,9.03E-01
leukocyte chemotaxis involved in inflammatory response (GO:0002232),6,0,0.61,-, < 0.01,5.43E-01
oxidative deethylation (GO:0071615),1,0,0.1,-, < 0.01,9.03E-01
granulocyte colony-stimulating factor production (GO:0071611),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell cycle checkpoint (GO:1901978),8,0,0.81,-, < 0.01,4.43E-01
peptidyl-aspartic acid autophosphorylation (GO:1990938),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitotic sister chromatid separation (GO:1901970),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of antimicrobial peptide production (GO:0002225),5,0,0.51,-, < 0.01,6.01E-01
chemokine (C-C motif) ligand 5 production (GO:0071609),1,0,0.1,-, < 0.01,9.03E-01
transforming growth factor beta production (GO:0071604),1,0,0.1,-, < 0.01,9.03E-01
endothelial cell-cell adhesion (GO:0071603),4,0,0.41,-, < 0.01,6.66E-01
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963),2,0,0.2,-, < 0.01,8.16E-01
S-adenosyl-L-methionine transmembrane transport (GO:1901962),1,0,0.1,-, < 0.01,9.03E-01
"putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)",1,0,0.1,-, < 0.01,9.03E-01
putrescine biosynthetic process from arginine (GO:0033388),1,0,0.1,-, < 0.01,9.03E-01
putrescine biosynthetic process from ornithine (GO:0033387),2,0,0.2,-, < 0.01,8.16E-01
geranylgeranyl diphosphate biosynthetic process (GO:0033386),1,0,0.1,-, < 0.01,9.03E-01
geranylgeranyl diphosphate metabolic process (GO:0033385),1,0,0.1,-, < 0.01,9.03E-01
geranyl diphosphate biosynthetic process (GO:0033384),2,0,0.2,-, < 0.01,8.16E-01
geranyl diphosphate metabolic process (GO:0033383),2,0,0.2,-, < 0.01,8.16E-01
maintenance of granzyme B location in T cell secretory granule (GO:0033382),1,0,0.1,-, < 0.01,9.03E-01
granzyme B localization to T cell secretory granule (GO:0033380),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mesenchymal cell apoptotic process (GO:2001055),2,0,0.2,-, < 0.01,8.16E-01
response to psychosocial stress (GO:1990911),4,0,0.41,-, < 0.01,6.66E-01
response to hypobaric hypoxia (GO:1990910),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of tendon cell differentiation (GO:2001051),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of MHC class I biosynthetic process (GO:0045344),1,0,0.1,-, < 0.01,9.03E-01
MHC class II biosynthetic process (GO:0045342),1,0,0.1,-, < 0.01,9.03E-01
maintenance of protease location in T cell secretory granule (GO:0033379),1,0,0.1,-, < 0.01,9.03E-01
maintenance of protein location in T cell secretory granule (GO:0033377),1,0,0.1,-, < 0.01,9.03E-01
protease localization to T cell secretory granule (GO:0033375),1,0,0.1,-, < 0.01,9.03E-01
protein localization to T cell secretory granule (GO:0033374),1,0,0.1,-, < 0.01,9.03E-01
maintenance of protease location in mast cell secretory granule (GO:0033373),1,0,0.1,-, < 0.01,9.03E-01
regulation of tendon cell differentiation (GO:2001049),1,0,0.1,-, < 0.01,9.03E-01
T cell secretory granule organization (GO:0033371),1,0,0.1,-, < 0.01,9.03E-01
maintenance of protein location in mast cell secretory granule (GO:0033370),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of integrin-mediated signaling pathway (GO:2001045),3,0,0.3,-, < 0.01,7.37E-01
farnesyl diphosphate metabolic process (GO:0045338),5,0,0.51,-, < 0.01,6.01E-01
farnesyl diphosphate biosynthetic process (GO:0045337),4,0,0.41,-, < 0.01,6.66E-01
protease localization to mast cell secretory granule (GO:0033368),1,0,0.1,-, < 0.01,9.03E-01
protein localization to mast cell secretory granule (GO:0033367),1,0,0.1,-, < 0.01,9.03E-01
mast cell secretory granule organization (GO:0033364),2,0,0.2,-, < 0.01,8.16E-01
regulation of cellular response to drug (GO:2001038),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of tongue muscle cell differentiation (GO:2001037),2,0,0.2,-, < 0.01,8.16E-01
regulation of tongue muscle cell differentiation (GO:2001035),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),4,0,0.41,-, < 0.01,6.66E-01
transformation of host cell by virus (GO:0019087),3,0,0.3,-, < 0.01,7.37E-01
late endosome to vacuole transport (GO:0045324),23,0,2.34,-, < 0.01,9.63E-02
negative regulation of endothelial cell chemotaxis (GO:2001027),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of response to drug (GO:2001024),1,0,0.1,-, < 0.01,9.03E-01
regulation of response to drug (GO:2001023),4,0,0.41,-, < 0.01,6.66E-01
viral release from host cell (GO:0019076),6,0,0.61,-, < 0.01,5.43E-01
virus maturation (GO:0019075),2,0,0.2,-, < 0.01,8.16E-01
viral RNA genome packaging (GO:0019074),2,0,0.2,-, < 0.01,8.16E-01
viral genome packaging (GO:0019072),2,0,0.2,-, < 0.01,8.16E-01
asparagine catabolic process via L-aspartate (GO:0033345),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of exoribonuclease activity (GO:1901919),1,0,0.1,-, < 0.01,9.03E-01
regulation of exoribonuclease activity (GO:1901917),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of retrograde axon cargo transport (GO:2001019),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of collagen binding (GO:0033342),1,0,0.1,-, < 0.01,9.03E-01
regulation of collagen binding (GO:0033341),1,0,0.1,-, < 0.01,9.03E-01
regulation of retrograde axon cargo transport (GO:2001017),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of skeletal muscle cell differentiation (GO:2001015),6,0,0.61,-, < 0.01,5.43E-01
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),4,0,0.41,-, < 0.01,6.66E-01
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),4,0,0.41,-, < 0.01,6.66E-01
mesenchymal cell differentiation involved in renal system development (GO:2001012),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of type IIa hypersensitivity (GO:0001798),3,0,0.3,-, < 0.01,7.37E-01
fusion of virus membrane with host plasma membrane (GO:0019064),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of type IIa hypersensitivity (GO:0001797),1,0,0.1,-, < 0.01,9.03E-01
regulation of type IIa hypersensitivity (GO:0001796),4,0,0.41,-, < 0.01,6.66E-01
virion attachment to host cell (GO:0019062),10,0,1.02,-, < 0.01,3.62E-01
uncoating of virus (GO:0019061),1,0,0.1,-, < 0.01,9.03E-01
intracellular transport of viral protein in host cell (GO:0019060),2,0,0.2,-, < 0.01,8.16E-01
centriole replication (GO:0007099),19,0,1.93,-, < 0.01,1.45E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),6,0,0.61,-, < 0.01,5.43E-01
diadenosine hexaphosphate catabolic process (GO:1901909),4,0,0.41,-, < 0.01,6.66E-01
diadenosine hexaphosphate metabolic process (GO:1901908),4,0,0.41,-, < 0.01,6.66E-01
diadenosine pentaphosphate catabolic process (GO:1901907),4,0,0.41,-, < 0.01,6.66E-01
diadenosine pentaphosphate metabolic process (GO:1901906),4,0,0.41,-, < 0.01,6.66E-01
modulation by virus of host transcription (GO:0019056),1,0,0.1,-, < 0.01,9.03E-01
natural killer cell proliferation (GO:0001787),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host apoptotic process (GO:0019050),3,0,0.3,-, < 0.01,7.37E-01
B cell apoptotic process (GO:0001783),8,0,0.81,-, < 0.01,4.43E-01
traversing start control point of mitotic cell cycle (GO:0007089),4,0,0.41,-, < 0.01,6.66E-01
mitotic nuclear envelope reassembly (GO:0007084),3,0,0.3,-, < 0.01,7.37E-01
UDP-D-xylose biosynthetic process (GO:0033320),1,0,0.1,-, < 0.01,9.03E-01
mitigation of host defenses by virus (GO:0019049),2,0,0.2,-, < 0.01,8.16E-01
natural killer cell differentiation (GO:0001779),10,0,1.02,-, < 0.01,3.62E-01
T cell homeostatic proliferation (GO:0001777),1,0,0.1,-, < 0.01,9.03E-01
mitotic chromosome movement towards spindle pole (GO:0007079),4,0,0.41,-, < 0.01,6.66E-01
mitotic nuclear envelope disassembly (GO:0007077),11,0,1.12,-, < 0.01,3.27E-01
establishment of natural killer cell polarity (GO:0001770),1,0,0.1,-, < 0.01,9.03E-01
UDP-D-xylose metabolic process (GO:0033319),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription involved in exit from mitosis (GO:0007072),1,0,0.1,-, < 0.01,9.03E-01
meiotic spindle assembly checkpoint (GO:0033316),1,0,0.1,-, < 0.01,9.03E-01
mitotic DNA replication checkpoint (GO:0033314),9,0,0.91,-, < 0.01,4.00E-01
meiotic cell cycle checkpoint (GO:0033313),6,0,0.61,-, < 0.01,5.43E-01
anterior/posterior pattern specification involved in ureteric bud development (GO:0072099),1,0,0.1,-, < 0.01,9.03E-01
anterior/posterior pattern specification involved in kidney development (GO:0072098),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of branch elongation involved in ureteric bud branching (GO:0072096),1,0,0.1,-, < 0.01,9.03E-01
membrane raft polarization (GO:0001766),3,0,0.3,-, < 0.01,7.37E-01
ureteric bud invasion (GO:0072092),3,0,0.3,-, < 0.01,7.37E-01
membrane raft assembly (GO:0001765),10,0,1.02,-, < 0.01,3.62E-01
primary adaptive immune response involving T cells and B cells (GO:0090721),1,0,0.1,-, < 0.01,9.03E-01
primary adaptive immune response (GO:0090720),1,0,0.1,-, < 0.01,9.03E-01
cell cycle comprising mitosis without cytokinesis (GO:0033301),1,0,0.1,-, < 0.01,9.03E-01
immunological memory formation process (GO:0090715),1,0,0.1,-, < 0.01,9.03E-01
immunological memory process (GO:0090713),1,0,0.1,-, < 0.01,9.03E-01
spindle assembly involved in female meiosis I (GO:0007057),2,0,0.2,-, < 0.01,8.16E-01
spindle assembly involved in female meiosis (GO:0007056),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of optic nerve formation (GO:2000597),1,0,0.1,-, < 0.01,9.03E-01
regulation of optic nerve formation (GO:2000595),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of metanephric DCT cell differentiation (GO:2000594),2,0,0.2,-, < 0.01,8.16E-01
nephrogenic mesenchyme development (GO:0072076),3,0,0.3,-, < 0.01,7.37E-01
regulation of metanephric DCT cell differentiation (GO:2000592),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of metanephric mesenchymal cell migration (GO:2000591),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of metanephric mesenchymal cell migration (GO:2000590),1,0,0.1,-, < 0.01,9.03E-01
kidney interstitial fibroblast differentiation (GO:0072071),2,0,0.2,-, < 0.01,8.16E-01
optic placode formation (GO:0001743),2,0,0.2,-, < 0.01,8.16E-01
lysosomal lumen acidification (GO:0007042),9,0,0.91,-, < 0.01,4.00E-01
regulation of metanephric mesenchymal cell migration (GO:2000589),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588),2,0,0.2,-, < 0.01,8.16E-01
DCT cell differentiation (GO:0072069),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584),2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)",3,0,0.3,-, < 0.01,7.37E-01
"regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)",3,0,0.3,-, < 0.01,7.37E-01
inner medullary collecting duct development (GO:0072061),3,0,0.3,-, < 0.01,7.37E-01
outer medullary collecting duct development (GO:0072060),1,0,0.1,-, < 0.01,9.03E-01
mitotic cytokinesis checkpoint (GO:0044878),3,0,0.3,-, < 0.01,7.37E-01
lipoprotein localization to membrane (GO:0044873),1,0,0.1,-, < 0.01,9.03E-01
negative regulation by host of viral glycoprotein metabolic process (GO:0044871),2,0,0.2,-, < 0.01,8.16E-01
modulation by host of viral glycoprotein metabolic process (GO:0044870),2,0,0.2,-, < 0.01,8.16E-01
cortical collecting duct development (GO:0072059),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of microtubule motor activity (GO:2000576),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of microtubule motor activity (GO:2000575),1,0,0.1,-, < 0.01,9.03E-01
regulation of microtubule motor activity (GO:2000574),9,0,0.91,-, < 0.01,4.00E-01
renal cortex development (GO:0072055),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572),1,0,0.1,-, < 0.01,9.03E-01
renal outer medulla development (GO:0072054),2,0,0.2,-, < 0.01,8.16E-01
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571),1,0,0.1,-, < 0.01,9.03E-01
renal inner medulla development (GO:0072053),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of T-helper 2 cell activation (GO:2000570),1,0,0.1,-, < 0.01,9.03E-01
juxtaglomerular apparatus development (GO:0072051),2,0,0.2,-, < 0.01,8.16E-01
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869),2,0,0.2,-, < 0.01,8.16E-01
relaxation of vascular associated smooth muscle (GO:0060087),7,0,0.71,-, < 0.01,4.91E-01
modulation by host of viral molecular function (GO:0044868),3,0,0.3,-, < 0.01,7.37E-01
circadian temperature homeostasis (GO:0060086),2,0,0.2,-, < 0.01,8.16E-01
modulation by host of viral catalytic activity (GO:0044867),2,0,0.2,-, < 0.01,8.16E-01
modulation by host of viral exo-alpha-sialidase activity (GO:0044866),2,0,0.2,-, < 0.01,8.16E-01
synaptic transmission involved in micturition (GO:0060084),3,0,0.3,-, < 0.01,7.37E-01
post-chaperonin tubulin folding pathway (GO:0007023),5,0,0.51,-, < 0.01,6.01E-01
eye blink reflex (GO:0060082),1,0,0.1,-, < 0.01,9.03E-01
tubulin complex assembly (GO:0007021),9,0,0.91,-, < 0.01,4.00E-01
inhibitory postsynaptic potential (GO:0060080),10,0,1.02,-, < 0.01,3.62E-01
regulation of neurotrophin production (GO:0032899),2,0,0.2,-, < 0.01,8.16E-01
regulation of T-helper 2 cell activation (GO:2000569),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of memory T cell activation (GO:2000568),2,0,0.2,-, < 0.01,8.16E-01
regulation of memory T cell activation (GO:2000567),2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000565)",1,0,0.1,-, < 0.01,9.03E-01
thyroid-stimulating hormone signaling pathway (GO:0038194),2,0,0.2,-, < 0.01,8.16E-01
thromboxane A2 signaling pathway (GO:0038193),1,0,0.1,-, < 0.01,9.03E-01
establishment of planar polarity involved in nephron morphogenesis (GO:0072046),1,0,0.1,-, < 0.01,9.03E-01
gastric inhibitory peptide signaling pathway (GO:0038192),1,0,0.1,-, < 0.01,9.03E-01
VEGF-activated neuropilin signaling pathway (GO:0038190),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of CD24 production (GO:2000560),1,0,0.1,-, < 0.01,9.03E-01
ectodermal cell fate commitment (GO:0001712),2,0,0.2,-, < 0.01,8.16E-01
plasma membrane raft organization (GO:0044857),8,0,0.81,-, < 0.01,4.43E-01
actin ubiquitination (GO:0007014),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane raft localization (GO:0044856),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane raft distribution (GO:0044855),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane raft assembly (GO:0044854),5,0,0.51,-, < 0.01,6.01E-01
regulation of polysaccharide biosynthetic process (GO:0032885),35,0,3.56,-, < 0.01,2.84E-02
neuropilin signaling pathway (GO:0038189),4,0,0.41,-, < 0.01,6.66E-01
regulation of CD24 production (GO:2000559),1,0,0.1,-, < 0.01,9.03E-01
cholecystokinin signaling pathway (GO:0038188),2,0,0.2,-, < 0.01,8.16E-01
regulation of polysaccharide metabolic process (GO:0032881),40,0,4.07,-, < 0.01,1.71E-02
intracellular bile acid receptor signaling pathway (GO:0038185),1,0,0.1,-, < 0.01,9.03E-01
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038),2,0,0.2,-, < 0.01,8.16E-01
cell surface bile acid receptor signaling pathway (GO:0038184),1,0,0.1,-, < 0.01,9.03E-01
renal vesicle induction (GO:0072034),3,0,0.3,-, < 0.01,7.37E-01
ectoderm formation (GO:0001705),3,0,0.3,-, < 0.01,7.37E-01
vagina development (GO:0060068),9,0,0.91,-, < 0.01,4.00E-01
cervix development (GO:0060067),2,0,0.2,-, < 0.01,8.16E-01
oviduct development (GO:0060066),3,0,0.3,-, < 0.01,7.37E-01
protein localization to bicellular tight junction (GO:1902396),6,0,0.61,-, < 0.01,5.43E-01
uterus development (GO:0060065),23,0,2.34,-, < 0.01,9.63E-02
Spemann organizer formation at the anterior end of the primitive streak (GO:0060064),1,0,0.1,-, < 0.01,9.03E-01
Spemann organizer formation (GO:0060061),4,0,0.41,-, < 0.01,6.66E-01
post-embryonic retina morphogenesis in camera-type eye (GO:0060060),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of DNA endoreduplication (GO:0032877),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of DNA endoreduplication (GO:0032876),1,0,0.1,-, < 0.01,9.03E-01
regulation of DNA endoreduplication (GO:0032875),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of dendritic cell dendrite assembly (GO:2000549),1,0,0.1,-, < 0.01,9.03E-01
complement component C5a signaling pathway (GO:0038178),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545),1,0,0.1,-, < 0.01,9.03E-01
connecting tubule development (GO:0072027),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of gastrulation (GO:2000543),6,0,0.61,-, < 0.01,5.43E-01
interleukin-33-mediated signaling pathway (GO:0038172),3,0,0.3,-, < 0.01,7.37E-01
distal convoluted tubule development (GO:0072025),5,0,0.51,-, < 0.01,6.01E-01
cannabinoid signaling pathway (GO:0038171),6,0,0.61,-, < 0.01,5.43E-01
macula densa development (GO:0072024),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein geranylgeranylation (GO:2000541),1,0,0.1,-, < 0.01,9.03E-01
thick ascending limb development (GO:0072023),2,0,0.2,-, < 0.01,8.16E-01
ascending thin limb development (GO:0072021),4,0,0.41,-, < 0.01,6.66E-01
embryonic retina morphogenesis in camera-type eye (GO:0060059),7,0,0.71,-, < 0.01,4.91E-01
ceramide 1-phosphate transport (GO:1902389),4,0,0.41,-, < 0.01,6.66E-01
actomyosin contractile ring organization (GO:0044837),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of protein glycosylation (GO:0060051),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of endoribonuclease activity (GO:1902380),1,0,0.1,-, < 0.01,9.03E-01
modulation by host of viral RNA genome replication (GO:0044830),4,0,0.41,-, < 0.01,6.66E-01
regulation of protein geranylgeranylation (GO:2000539),1,0,0.1,-, < 0.01,9.03E-01
angiotensin-activated signaling pathway (GO:0038166),12,0,1.22,-, < 0.01,2.95E-01
proximal convoluted tubule development (GO:0072019),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of entry of bacterium into host cell (GO:2000536),2,0,0.2,-, < 0.01,8.16E-01
oncostatin-M-mediated signaling pathway (GO:0038165),7,0,0.71,-, < 0.01,4.91E-01
regulation of entry of bacterium into host cell (GO:2000535),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of renal albumin absorption (GO:2000534),1,0,0.1,-, < 0.01,9.03E-01
thrombopoietin-mediated signaling pathway (GO:0038163),5,0,0.51,-, < 0.01,6.01E-01
glomerular parietal epithelial cell development (GO:0072016),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of renal albumin absorption (GO:2000533),1,0,0.1,-, < 0.01,9.03E-01
regulation of renal albumin absorption (GO:2000532),2,0,0.2,-, < 0.01,8.16E-01
prolactin signaling pathway (GO:0038161),1,0,0.1,-, < 0.01,9.03E-01
CXCL12-activated CXCR4 signaling pathway (GO:0038160),1,0,0.1,-, < 0.01,9.03E-01
glomerular endothelium development (GO:0072011),3,0,0.3,-, < 0.01,7.37E-01
VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378),1,0,0.1,-, < 0.01,9.03E-01
positive regulation by host of viral genome replication (GO:0044829),8,0,0.81,-, < 0.01,4.43E-01
regulation of rRNA catabolic process (GO:1902374),1,0,0.1,-, < 0.01,9.03E-01
modulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052433),12,0,1.22,-, < 0.01,2.95E-01
retinal bipolar neuron differentiation (GO:0060040),5,0,0.51,-, < 0.01,6.01E-01
meiotic telomere tethering at nuclear periphery (GO:0044821),3,0,0.3,-, < 0.01,7.37E-01
C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159),1,0,0.1,-, < 0.01,9.03E-01
granulocyte colony-stimulating factor signaling pathway (GO:0038158),2,0,0.2,-, < 0.01,8.16E-01
interleukin-3-mediated signaling pathway (GO:0038156),4,0,0.41,-, < 0.01,6.66E-01
interleukin-23-mediated signaling pathway (GO:0038155),9,0,0.91,-, < 0.01,4.00E-01
glomerular mesangial cell differentiation (GO:0072008),6,0,0.61,-, < 0.01,5.43E-01
mesangial cell differentiation (GO:0072007),7,0,0.71,-, < 0.01,4.91E-01
kidney field specification (GO:0072004),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of immunological synapse formation (GO:2000521),2,0,0.2,-, < 0.01,8.16E-01
kidney rudiment formation (GO:0072003),3,0,0.3,-, < 0.01,7.37E-01
modulation by host of symbiont molecular function (GO:0052428),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367),1,0,0.1,-, < 0.01,9.03E-01
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366),1,0,0.1,-, < 0.01,9.03E-01
notochord cell development (GO:0060035),1,0,0.1,-, < 0.01,9.03E-01
notochord cell differentiation (GO:0060034),1,0,0.1,-, < 0.01,9.03E-01
notochord regression (GO:0060032),2,0,0.2,-, < 0.01,8.16E-01
melanocyte apoptotic process (GO:1902362),1,0,0.1,-, < 0.01,9.03E-01
modulation by host of symbiont catalytic activity (GO:0052422),3,0,0.3,-, < 0.01,7.37E-01
mediolateral intercalation (GO:0060031),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cellular pH reduction (GO:0032848),1,0,0.1,-, < 0.01,9.03E-01
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),4,0,0.41,-, < 0.01,6.66E-01
convergent extension involved in organogenesis (GO:0060029),5,0,0.51,-, < 0.01,6.01E-01
metabolism by host of substance in symbiont (GO:0052419),1,0,0.1,-, < 0.01,9.03E-01
metabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052418),1,0,0.1,-, < 0.01,9.03E-01
convergent extension involved in gastrulation (GO:0060027),7,0,0.71,-, < 0.01,4.91E-01
metabolism by host of symbiont protein (GO:0052417),1,0,0.1,-, < 0.01,9.03E-01
oxaloacetate(2-) transmembrane transport (GO:1902356),3,0,0.3,-, < 0.01,7.37E-01
metabolism by host of symbiont macromolecule (GO:0052416),1,0,0.1,-, < 0.01,9.03E-01
rhythmic synaptic transmission (GO:0060024),4,0,0.41,-, < 0.01,6.66E-01
late nucleophagy (GO:0044805),4,0,0.41,-, < 0.01,6.66E-01
soft palate development (GO:0060023),5,0,0.51,-, < 0.01,6.01E-01
autophagy of nucleus (GO:0044804),12,0,1.22,-, < 0.01,2.95E-01
hard palate development (GO:0060022),6,0,0.61,-, < 0.01,5.43E-01
phosphagen metabolic process (GO:0006599),3,0,0.3,-, < 0.01,7.37E-01
spermine biosynthetic process (GO:0006597),3,0,0.3,-, < 0.01,7.37E-01
ornithine biosynthetic process (GO:0006592),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of dendritic cell chemotaxis (GO:2000509),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of blood vessel remodeling (GO:2000504),2,0,0.2,-, < 0.01,8.16E-01
ERBB2-ERBB3 signaling pathway (GO:0038133),1,0,0.1,-, < 0.01,9.03E-01
ERBB4 signaling pathway (GO:0038130),1,0,0.1,-, < 0.01,9.03E-01
response to chloroquine (GO:1902349),1,0,0.1,-, < 0.01,9.03E-01
astrocyte fate commitment (GO:0060018),4,0,0.41,-, < 0.01,6.66E-01
parathyroid gland development (GO:0060017),7,0,0.71,-, < 0.01,4.91E-01
granulosa cell development (GO:0060016),1,0,0.1,-, < 0.01,9.03E-01
negative regulation by host of symbiont molecular function (GO:0052405),5,0,0.51,-, < 0.01,6.01E-01
granulosa cell differentiation (GO:0060014),2,0,0.2,-, < 0.01,8.16E-01
righting reflex (GO:0060013),8,0,0.81,-, < 0.01,4.43E-01
negative regulation by host of symbiont catalytic activity (GO:0052403),2,0,0.2,-, < 0.01,8.16E-01
octopamine biosynthetic process (GO:0006589),2,0,0.2,-, < 0.01,8.16E-01
Sertoli cell fate commitment (GO:0060010),1,0,0.1,-, < 0.01,9.03E-01
dopamine biosynthetic process from tyrosine (GO:0006585),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827),3,0,0.3,-, < 0.01,7.37E-01
regulation of natural killer cell differentiation involved in immune response (GO:0032826),4,0,0.41,-, < 0.01,6.66E-01
acetylcholine catabolic process (GO:0006581),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of natural killer cell differentiation (GO:0032824),3,0,0.3,-, < 0.01,7.37E-01
ERBB3 signaling pathway (GO:0038129),2,0,0.2,-, < 0.01,8.16E-01
ERBB2 signaling pathway (GO:0038128),31,0,3.15,-, < 0.01,4.27E-02
toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124),4,0,0.41,-, < 0.01,6.66E-01
Sertoli cell development (GO:0060009),14,0,1.42,-, < 0.01,2.41E-01
Sertoli cell differentiation (GO:0060008),19,0,1.93,-, < 0.01,1.45E-01
linear vestibuloocular reflex (GO:0060007),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of retinal ganglion cell axon guidance (GO:1902336),2,0,0.2,-, < 0.01,8.16E-01
vestibular reflex (GO:0060005),4,0,0.41,-, < 0.01,6.66E-01
copper ion export (GO:0060003),3,0,0.3,-, < 0.01,7.37E-01
amino-acid betaine catabolic process (GO:0006579),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of natural killer cell proliferation (GO:0032819),7,0,0.71,-, < 0.01,4.91E-01
regulation of natural killer cell proliferation (GO:0032817),9,0,0.91,-, < 0.01,4.00E-01
tyrosine biosynthetic process (GO:0006571),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of epinephrine secretion (GO:0032812),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of epinephrine secretion (GO:0032811),4,0,0.41,-, < 0.01,6.66E-01
interleukin-21-mediated signaling pathway (GO:0038114),8,0,0.81,-, < 0.01,4.43E-01
interleukin-9-mediated signaling pathway (GO:0038113),9,0,0.91,-, < 0.01,4.00E-01
interleukin-8-mediated signaling pathway (GO:0038112),2,0,0.2,-, < 0.01,8.16E-01
interleukin-2-mediated signaling pathway (GO:0038110),11,0,1.12,-, < 0.01,3.27E-01
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),3,0,0.3,-, < 0.01,7.37E-01
proline biosynthetic process (GO:0006561),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805),3,0,0.3,-, < 0.01,7.37E-01
Kit signaling pathway (GO:0038109),2,0,0.2,-, < 0.01,8.16E-01
low-density lipoprotein particle receptor catabolic process (GO:0032802),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108),4,0,0.41,-, < 0.01,6.66E-01
sequestering of nodal from receptor via nodal binding (GO:0038101),1,0,0.1,-, < 0.01,9.03E-01
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319),1,0,0.1,-, < 0.01,9.03E-01
CAAX-box protein processing (GO:0071586),2,0,0.2,-, < 0.01,8.16E-01
detoxification of cadmium ion (GO:0071585),1,0,0.1,-, < 0.01,9.03E-01
nuclear DNA replication termination (GO:1902317),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of zinc ion transmembrane import (GO:0071584),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of zinc ion transmembrane transport (GO:0071583),1,0,0.1,-, < 0.01,9.03E-01
nuclear cell cycle DNA replication initiation (GO:1902315),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of zinc ion transport (GO:0071582),1,0,0.1,-, < 0.01,9.03E-01
regulation of zinc ion transmembrane import (GO:0071581),1,0,0.1,-, < 0.01,9.03E-01
regulation of zinc ion transmembrane transport (GO:0071580),1,0,0.1,-, < 0.01,9.03E-01
regulation of copper ion transmembrane transport (GO:1902311),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of peptidyl-serine dephosphorylation (GO:1902310),2,0,0.2,-, < 0.01,8.16E-01
S-adenosylmethioninamine biosynthetic process (GO:0006557),1,0,0.1,-, < 0.01,9.03E-01
S-adenosylmethionine biosynthetic process (GO:0006556),3,0,0.3,-, < 0.01,7.37E-01
lysine catabolic process (GO:0006554),11,0,1.12,-, < 0.01,3.27E-01
lysine metabolic process (GO:0006553),12,0,1.22,-, < 0.01,2.95E-01
isoleucine catabolic process (GO:0006550),4,0,0.41,-, < 0.01,6.66E-01
hepatocyte cell migration (GO:0002194),1,0,0.1,-, < 0.01,9.03E-01
IRES-dependent translational initiation of linear mRNA (GO:0002192),2,0,0.2,-, < 0.01,8.16E-01
cap-dependent translational initiation (GO:0002191),2,0,0.2,-, < 0.01,8.16E-01
cap-independent translational initiation (GO:0002190),2,0,0.2,-, < 0.01,8.16E-01
regulation of zinc ion transport (GO:0071579),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of peptidyl-serine dephosphorylation (GO:1902309),2,0,0.2,-, < 0.01,8.16E-01
regulation of peptidyl-serine dephosphorylation (GO:1902308),4,0,0.41,-, < 0.01,6.66E-01
histidine catabolic process (GO:0006548),6,0,0.61,-, < 0.01,5.43E-01
histidine metabolic process (GO:0006547),8,0,0.81,-, < 0.01,4.43E-01
glutamine catabolic process (GO:0006543),3,0,0.3,-, < 0.01,7.37E-01
glutamine biosynthetic process (GO:0006542),2,0,0.2,-, < 0.01,8.16E-01
glutamine metabolic process (GO:0006541),19,0,1.93,-, < 0.01,1.45E-01
glutamate decarboxylation to succinate (GO:0006540),1,0,0.1,-, < 0.01,9.03E-01
translation reinitiation (GO:0002188),3,0,0.3,-, < 0.01,7.37E-01
cytoplasmic translational termination (GO:0002184),3,0,0.3,-, < 0.01,7.37E-01
glutamate catabolic process via 2-oxoglutarate (GO:0006539),1,0,0.1,-, < 0.01,9.03E-01
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),5,0,0.51,-, < 0.01,6.01E-01
cysteine biosynthetic process from serine (GO:0006535),1,0,0.1,-, < 0.01,9.03E-01
RNA acetylation (GO:1990884),1,0,0.1,-, < 0.01,9.03E-01
rRNA acetylation (GO:1990882),1,0,0.1,-, < 0.01,9.03E-01
asparagine catabolic process (GO:0006530),1,0,0.1,-, < 0.01,9.03E-01
male germ cell proliferation (GO:0002176),1,0,0.1,-, < 0.01,9.03E-01
protein localization to paranode region of axon (GO:0002175),5,0,0.51,-, < 0.01,6.01E-01
histone H3-K27 demethylation (GO:0071557),5,0,0.51,-, < 0.01,6.01E-01
cell wall organization or biogenesis (GO:0071554),4,0,0.41,-, < 0.01,6.66E-01
death-inducing signaling complex assembly (GO:0071550),7,0,0.71,-, < 0.01,4.91E-01
asparagine biosynthetic process (GO:0006529),2,0,0.2,-, < 0.01,8.16E-01
asparagine metabolic process (GO:0006528),5,0,0.51,-, < 0.01,6.01E-01
cellular response to gastrin (GO:1990878),1,0,0.1,-, < 0.01,9.03E-01
lysophospholipid transport (GO:0051977),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of transmission of nerve impulse (GO:0051971),6,0,0.61,-, < 0.01,5.43E-01
inositol phosphate catabolic process (GO:0071545),17,0,1.73,-, < 0.01,1.77E-01
diphosphoinositol polyphosphate catabolic process (GO:0071544),1,0,0.1,-, < 0.01,9.03E-01
diphosphoinositol polyphosphate metabolic process (GO:0071543),4,0,0.41,-, < 0.01,6.66E-01
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",30,0,3.05,-, < 0.01,4.72E-02
response to gastrin (GO:1990867),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of synapse assembly (GO:0051964),8,0,0.81,-, < 0.01,4.43E-01
response to growth hormone-releasing hormone (GO:1990864),1,0,0.1,-, < 0.01,9.03E-01
desmosome assembly (GO:0002159),4,0,0.41,-, < 0.01,6.66E-01
regulation of thyroid hormone mediated signaling pathway (GO:0002155),4,0,0.41,-, < 0.01,6.66E-01
bile acid conjugation (GO:0002152),1,0,0.1,-, < 0.01,9.03E-01
otolith mineralization (GO:0045299),1,0,0.1,-, < 0.01,9.03E-01
membrane protein ectodomain proteolysis (GO:0006509),20,0,2.03,-, < 0.01,1.31E-01
cellular response to endothelin (GO:1990859),2,0,0.2,-, < 0.01,8.16E-01
GPI anchor release (GO:0006507),1,0,0.1,-, < 0.01,9.03E-01
methotrexate transport (GO:0051958),2,0,0.2,-, < 0.01,8.16E-01
cellular response to lectin (GO:1990858),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895),3,0,0.3,-, < 0.01,7.37E-01
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894),9,0,0.91,-, < 0.01,4.00E-01
C-terminal protein lipidation (GO:0006501),6,0,0.61,-, < 0.01,5.43E-01
hypochlorous acid biosynthetic process (GO:0002149),1,0,0.1,-, < 0.01,9.03E-01
N-terminal protein palmitoylation (GO:0006500),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951),1,0,0.1,-, < 0.01,9.03E-01
hypochlorous acid metabolic process (GO:0002148),1,0,0.1,-, < 0.01,9.03E-01
cementum mineralization (GO:0071529),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cell junction assembly (GO:1901889),32,0,3.25,-, < 0.01,3.85E-02
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein depolymerization (GO:1901881),17,0,1.73,-, < 0.01,1.77E-01
regulation of amino acid uptake involved in synaptic transmission (GO:0051941),3,0,0.3,-, < 0.01,7.37E-01
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),8,0,0.81,-, < 0.01,4.43E-01
response to lectin (GO:1990840),1,0,0.1,-, < 0.01,9.03E-01
maintenance of imprinting at mating-type locus (GO:0071517),1,0,0.1,-, < 0.01,9.03E-01
establishment of imprinting at mating-type locus (GO:0071516),1,0,0.1,-, < 0.01,9.03E-01
genetic imprinting at mating-type locus (GO:0071515),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of calcium ion binding (GO:1901877),2,0,0.2,-, < 0.01,8.16E-01
regulation of calcium ion binding (GO:1901876),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of post-translational protein modification (GO:1901874),1,0,0.1,-, < 0.01,9.03E-01
regulation of post-translational protein modification (GO:1901873),2,0,0.2,-, < 0.01,8.16E-01
response to odorant (GO:1990834),3,0,0.3,-, < 0.01,7.37E-01
slow axonal transport (GO:1990832),1,0,0.1,-, < 0.01,9.03E-01
tRNA nucleoside ribose methylation (GO:0002128),1,0,0.1,-, < 0.01,9.03E-01
tRNA wobble base cytosine methylation (GO:0002127),1,0,0.1,-, < 0.01,9.03E-01
inter-male aggressive behavior (GO:0002121),2,0,0.2,-, < 0.01,8.16E-01
cellular response to mycophenolic acid (GO:0071506),2,0,0.2,-, < 0.01,8.16E-01
response to mycophenolic acid (GO:0071505),2,0,0.2,-, < 0.01,8.16E-01
secretion of lysosomal enzymes (GO:0033299),4,0,0.41,-, < 0.01,6.66E-01
cellular response to sterol depletion (GO:0071501),10,0,1.02,-, < 0.01,3.62E-01
cellular response to nitrosative stress (GO:0071500),4,0,0.41,-, < 0.01,6.66E-01
hepatocyte dedifferentiation (GO:1990828),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of muscle tissue development (GO:1901862),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of mitochondrial DNA metabolic process (GO:1901860),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of fibrinolysis (GO:0051919),4,0,0.41,-, < 0.01,6.66E-01
regulation of mitochondrial DNA metabolic process (GO:1901858),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cellular respiration (GO:1901856),1,0,0.1,-, < 0.01,9.03E-01
induction of synaptic plasticity by chemical substance (GO:0051915),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of synaptic plasticity by chemical substance (GO:0051914),1,0,0.1,-, < 0.01,9.03E-01
regulation of synaptic plasticity by chemical substance (GO:0051913),1,0,0.1,-, < 0.01,9.03E-01
tRNA wobble cytosine modification (GO:0002101),2,0,0.2,-, < 0.01,8.16E-01
tRNA wobble adenosine to inosine editing (GO:0002100),1,0,0.1,-, < 0.01,9.03E-01
cell proliferation in midbrain (GO:0033278),6,0,0.61,-, < 0.01,5.43E-01
response to vitamin B2 (GO:0033274),1,0,0.1,-, < 0.01,9.03E-01
endoplasmic reticulum tubular network membrane organization (GO:1990809),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846),1,0,0.1,-, < 0.01,9.03E-01
protein palmitoleylation (GO:0045234),1,0,0.1,-, < 0.01,9.03E-01
RNA localization to nucleus (GO:0090685),4,0,0.41,-, < 0.01,6.66E-01
external encapsulating structure organization (GO:0045229),2,0,0.2,-, < 0.01,8.16E-01
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676),1,0,0.1,-, < 0.01,9.03E-01
endothelial cell-matrix adhesion (GO:0090673),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of FasL production (GO:0045221),1,0,0.1,-, < 0.01,9.03E-01
RNA localization to Cajal body (GO:0090670),4,0,0.41,-, < 0.01,6.66E-01
zeaxanthin biosynthetic process (GO:1901827),1,0,0.1,-, < 0.01,9.03E-01
zeaxanthin metabolic process (GO:1901825),1,0,0.1,-, < 0.01,9.03E-01
regulation of FasL production (GO:0045219),1,0,0.1,-, < 0.01,9.03E-01
zonula adherens maintenance (GO:0045218),2,0,0.2,-, < 0.01,8.16E-01
endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668),1,0,0.1,-, < 0.01,9.03E-01
cell chemotaxis to vascular endothelial growth factor (GO:0090667),1,0,0.1,-, < 0.01,9.03E-01
scaRNA localization to Cajal body (GO:0090666),4,0,0.41,-, < 0.01,6.66E-01
neurotransmitter receptor metabolic process (GO:0045213),3,0,0.3,-, < 0.01,7.37E-01
galanin-activated signaling pathway (GO:0090663),2,0,0.2,-, < 0.01,8.16E-01
FasL biosynthetic process (GO:0045210),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular amine catabolic process (GO:0033242),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular amine catabolic process (GO:0033241),1,0,0.1,-, < 0.01,9.03E-01
"MAPK phosphatase export from nucleus, leptomycin B sensitive (GO:0045209)",1,0,0.1,-, < 0.01,9.03E-01
MAPK phosphatase export from nucleus (GO:0045208),1,0,0.1,-, < 0.01,9.03E-01
gastric acid secretion (GO:0001696),5,0,0.51,-, < 0.01,6.01E-01
histamine catabolic process (GO:0001695),1,0,0.1,-, < 0.01,9.03E-01
histamine biosynthetic process (GO:0001694),2,0,0.2,-, < 0.01,8.16E-01
MAPK export from nucleus (GO:0045204),2,0,0.2,-, < 0.01,8.16E-01
histamine metabolic process (GO:0001692),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of cellular amine metabolic process (GO:0033239),7,0,0.71,-, < 0.01,4.91E-01
cellular response to oxygen-glucose deprivation (GO:0090650),7,0,0.71,-, < 0.01,4.91E-01
beta-glucoside catabolic process (GO:1901805),2,0,0.2,-, < 0.01,8.16E-01
beta-glucoside metabolic process (GO:1901804),2,0,0.2,-, < 0.01,8.16E-01
response to oxygen-glucose deprivation (GO:0090649),9,0,0.91,-, < 0.01,4.00E-01
modulation of age-related behavioral decline (GO:0090647),9,0,0.91,-, < 0.01,4.00E-01
tRNA 5'-leader removal (GO:0001682),11,0,1.12,-, < 0.01,3.27E-01
tRNA 3'-terminal CCA addition (GO:0001680),1,0,0.1,-, < 0.01,9.03E-01
dsRNA transport (GO:0033227),3,0,0.3,-, < 0.01,7.37E-01
reductive iron assimilation (GO:0033215),1,0,0.1,-, < 0.01,9.03E-01
siderophore-dependent iron import into cell (GO:0033214),1,0,0.1,-, < 0.01,9.03E-01
leptin-mediated signaling pathway (GO:0033210),11,0,1.12,-, < 0.01,3.27E-01
conditioned taste aversion (GO:0001661),5,0,0.51,-, < 0.01,6.01E-01
fever generation (GO:0001660),3,0,0.3,-, < 0.01,7.37E-01
meiotic cytokinesis (GO:0033206),7,0,0.71,-, < 0.01,4.91E-01
temperature homeostasis (GO:0001659),28,0,2.85,-, < 0.01,5.79E-02
mitochondrial mRNA 3'-end processing (GO:0090616),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial mRNA processing (GO:0090615),2,0,0.2,-, < 0.01,8.16E-01
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),5,0,0.51,-, < 0.01,6.01E-01
trans-Golgi network to recycling endosome transport (GO:0044795),1,0,0.1,-, < 0.01,9.03E-01
positive regulation by host of viral release from host cell (GO:0044791),5,0,0.51,-, < 0.01,6.01E-01
negative regulation by host of viral release from host cell (GO:0044790),1,0,0.1,-, < 0.01,9.03E-01
cytoplasm protein quality control (GO:0140455),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hepatic stellate cell activation (GO:2000491),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of hepatic stellate cell activation (GO:2000490),2,0,0.2,-, < 0.01,8.16E-01
protein targeting to Golgi apparatus (GO:0140450),1,0,0.1,-, < 0.01,9.03E-01
modulation by host of viral release from host cell (GO:0044789),5,0,0.51,-, < 0.01,6.01E-01
metaphase/anaphase transition of cell cycle (GO:0044784),6,0,0.61,-, < 0.01,5.43E-01
regulation of hepatic stellate cell activation (GO:2000489),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of glutamine transport (GO:2000487),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glutamine transport (GO:2000486),1,0,0.1,-, < 0.01,9.03E-01
regulation of glutamine transport (GO:2000485),2,0,0.2,-, < 0.01,8.16E-01
cytokine precursor processing (GO:0140447),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cAMP-dependent protein kinase activity (GO:2000481),6,0,0.61,-, < 0.01,5.43E-01
meiotic spindle checkpoint (GO:0044779),1,0,0.1,-, < 0.01,9.03E-01
meiotic DNA integrity checkpoint (GO:0044778),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric glomerular visceral epithelial cell development (GO:2000477),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hematopoietic stem cell migration (GO:2000473),2,0,0.2,-, < 0.01,8.16E-01
regulation of hematopoietic stem cell migration (GO:2000471),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of peroxidase activity (GO:2000470),2,0,0.2,-, < 0.01,8.16E-01
suppression of symbiont entry into host by host (GO:0052373),1,0,0.1,-, < 0.01,9.03E-01
low-density lipoprotein receptor particle metabolic process (GO:0032799),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of peroxidase activity (GO:2000469),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of CREB transcription factor activity (GO:0032792),6,0,0.61,-, < 0.01,5.43E-01
regulation of peroxidase activity (GO:2000468),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glycogen (starch) synthase activity (GO:2000467),3,0,0.3,-, < 0.01,7.37E-01
ribosome disassembly (GO:0032790),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of glycogen (starch) synthase activity (GO:2000466),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of astrocyte chemotaxis (GO:2000464),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),3,0,0.3,-, < 0.01,7.37E-01
catabolism by host of substance in symbiont (GO:0052364),1,0,0.1,-, < 0.01,9.03E-01
catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363),1,0,0.1,-, < 0.01,9.03E-01
catabolism by host of symbiont protein (GO:0052362),1,0,0.1,-, < 0.01,9.03E-01
response to human chorionic gonadotropin (GO:0044752),4,0,0.41,-, < 0.01,6.66E-01
catabolism by organism of macromolecule in other organism involved in symbiotic interaction (GO:0052361),1,0,0.1,-, < 0.01,9.03E-01
catabolism by host of symbiont macromolecule (GO:0052360),1,0,0.1,-, < 0.01,9.03E-01
unsaturated monocarboxylic acid metabolic process (GO:0032789),1,0,0.1,-, < 0.01,9.03E-01
saturated monocarboxylic acid metabolic process (GO:0032788),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),8,0,0.81,-, < 0.01,4.43E-01
regulation of astrocyte chemotaxis (GO:2000458),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of ATPase activity (GO:0032780),16,0,1.63,-, < 0.01,1.96E-01
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086),3,0,0.3,-, < 0.01,7.37E-01
"positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)",2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)",2,0,0.2,-, < 0.01,8.16E-01
cell cycle DNA replication maintenance of fidelity (GO:1902298),2,0,0.2,-, < 0.01,8.16E-01
DNA strand elongation involved in cell cycle DNA replication (GO:1902296),1,0,0.1,-, < 0.01,9.03E-01
cell cycle DNA replication termination (GO:1902294),1,0,0.1,-, < 0.01,9.03E-01
cell cycle DNA replication initiation (GO:1902292),5,0,0.51,-, < 0.01,6.01E-01
DNA methylation on cytosine (GO:0032776),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of monophenol monooxygenase activity (GO:0032773),1,0,0.1,-, < 0.01,9.03E-01
"regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448),2,0,0.2,-, < 0.01,8.16E-01
regulation of monophenol monooxygenase activity (GO:0032771),1,0,0.1,-, < 0.01,9.03E-01
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of primary amine oxidase activity (GO:1902283),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mast cell cytokine production (GO:0032765),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of mast cell cytokine production (GO:0032764),2,0,0.2,-, < 0.01,8.16E-01
regulation of mast cell cytokine production (GO:0032763),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of monocyte extravasation (GO:2000439),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of monocyte extravasation (GO:2000438),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of lymphotoxin A production (GO:0032761),2,0,0.2,-, < 0.01,8.16E-01
regulation of monocyte extravasation (GO:2000437),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of protein neddylation (GO:2000436),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of protein neddylation (GO:2000435),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein neddylation (GO:2000434),9,0,0.91,-, < 0.01,4.00E-01
"regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)",1,0,0.1,-, < 0.01,9.03E-01
nitric oxide-cGMP-mediated signaling pathway (GO:0038060),2,0,0.2,-, < 0.01,8.16E-01
DNA demethylation of male pronucleus (GO:0044727),1,0,0.1,-, < 0.01,9.03E-01
chromatin reprogramming in the zygote (GO:0044725),1,0,0.1,-, < 0.01,9.03E-01
(R)-carnitine transmembrane transport (GO:1902270),1,0,0.1,-, < 0.01,9.03E-01
"protein import into peroxisome matrix, substrate release (GO:0044721)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052330),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of TRAIL production (GO:0032759),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of interleukin-3 production (GO:0032752),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of apoptotic cell clearance (GO:2000427),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of apoptotic cell clearance (GO:2000426),2,0,0.2,-, < 0.01,8.16E-01
regulation of apoptotic cell clearance (GO:2000425),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of eosinophil chemotaxis (GO:2000424),2,0,0.2,-, < 0.01,8.16E-01
regulation of eosinophil chemotaxis (GO:2000422),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of eosinophil extravasation (GO:2000420),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of polyamine transmembrane transport (GO:1902269),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of polyamine transmembrane transport (GO:1902268),3,0,0.3,-, < 0.01,7.37E-01
regulation of polyamine transmembrane transport (GO:1902267),4,0,0.41,-, < 0.01,6.66E-01
apoptotic process involved in embryonic digit morphogenesis (GO:1902263),3,0,0.3,-, < 0.01,7.37E-01
apoptotic process involved in blood vessel morphogenesis (GO:1902262),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of delayed rectifier potassium channel activity (GO:1902261),4,0,0.41,-, < 0.01,6.66E-01
regulation of eosinophil extravasation (GO:2000419),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of eosinophil migration (GO:2000418),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of eosinophil migration (GO:2000417),2,0,0.2,-, < 0.01,8.16E-01
regulation of eosinophil migration (GO:2000416),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of fibronectin-dependent thymocyte migration (GO:2000415),1,0,0.1,-, < 0.01,9.03E-01
interleukin-5-mediated signaling pathway (GO:0038043),2,0,0.2,-, < 0.01,8.16E-01
regulation of fibronectin-dependent thymocyte migration (GO:2000413),1,0,0.1,-, < 0.01,9.03E-01
cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257),2,0,0.2,-, < 0.01,8.16E-01
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256),3,0,0.3,-, < 0.01,7.37E-01
phytoalexin metabolic process (GO:0052314),2,0,0.2,-, < 0.01,8.16E-01
N-terminal protein myristoylation (GO:0006499),4,0,0.41,-, < 0.01,6.66E-01
modulation of transcription in other organism involved in symbiotic interaction (GO:0052312),1,0,0.1,-, < 0.01,9.03E-01
N-terminal protein lipidation (GO:0006498),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of interleukin-16 production (GO:0032739),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-15 production (GO:0032738),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-13 production (GO:0032736),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of T cell extravasation (GO:2000409),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of interleukin-1 alpha production (GO:0032730),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),5,0,0.51,-, < 0.01,6.01E-01
C-terminal protein methylation (GO:0006481),2,0,0.2,-, < 0.01,8.16E-01
N-terminal protein amino acid methylation (GO:0006480),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of connective tissue growth factor production (GO:0032723),2,0,0.2,-, < 0.01,8.16E-01
epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029),1,0,0.1,-, < 0.01,9.03E-01
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028),2,0,0.2,-, < 0.01,8.16E-01
apolipoprotein A-I-mediated signaling pathway (GO:0038027),5,0,0.51,-, < 0.01,6.01E-01
reelin-mediated signaling pathway (GO:0038026),8,0,0.81,-, < 0.01,4.43E-01
insulin receptor recycling (GO:0038020),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239),1,0,0.1,-, < 0.01,9.03E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of interleukin-3 production (GO:0032712),1,0,0.1,-, < 0.01,9.03E-01
Wnt receptor catabolic process (GO:0038018),2,0,0.2,-, < 0.01,8.16E-01
insulin receptor internalization (GO:0038016),2,0,0.2,-, < 0.01,8.16E-01
cellular response to laminar fluid shear stress (GO:0071499),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228),1,0,0.1,-, < 0.01,9.03E-01
cellular response to UV-C (GO:0071494),5,0,0.51,-, < 0.01,6.01E-01
cellular response to UV-B (GO:0071493),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220),1,0,0.1,-, < 0.01,9.03E-01
steroid hormone receptor complex assembly (GO:0006463),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of interleukin-23 production (GO:0032707),2,0,0.2,-, < 0.01,8.16E-01
regulation of signal transduction by receptor internalization (GO:0038009),1,0,0.1,-, < 0.01,9.03E-01
TRAF-mediated signal transduction (GO:0038008),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of interleukin-18 production (GO:0032701),2,0,0.2,-, < 0.01,8.16E-01
opioid receptor signaling pathway (GO:0038003),10,0,1.02,-, < 0.01,3.62E-01
cellular response to high light intensity (GO:0071486),1,0,0.1,-, < 0.01,9.03E-01
cellular response to light intensity (GO:0071484),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216),2,0,0.2,-, < 0.01,8.16E-01
cellular response to gamma radiation (GO:0071480),27,0,2.74,-, < 0.01,6.41E-02
positive regulation of serotonin secretion (GO:0014064),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of serotonin secretion (GO:0014063),5,0,0.51,-, < 0.01,6.01E-01
regulation of serotonin secretion (GO:0014062),8,0,0.81,-, < 0.01,4.43E-01
regulation of norepinephrine secretion (GO:0014061),15,0,1.52,-, < 0.01,2.17E-01
regulation of epinephrine secretion (GO:0014060),6,0,0.61,-, < 0.01,5.43E-01
cellular hyperosmotic salinity response (GO:0071475),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204),1,0,0.1,-, < 0.01,9.03E-01
cellular response to non-ionic osmotic stress (GO:0071471),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203),1,0,0.1,-, < 0.01,9.03E-01
regulation of translational termination (GO:0006449),10,0,1.02,-, < 0.01,3.62E-01
"positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of acetylcholine secretion, neurotransmission (GO:0014056)",3,0,0.3,-, < 0.01,7.37E-01
pancreas regeneration (GO:1990798),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of gamma-aminobutyric acid secretion (GO:0014054),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of gamma-aminobutyric acid secretion (GO:0014053),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of focal adhesion assembly (GO:0051895),18,0,1.83,-, < 0.01,1.60E-01
regulation of gamma-aminobutyric acid secretion (GO:0014052),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of cardioblast differentiation (GO:0051892),2,0,0.2,-, < 0.01,8.16E-01
cellular response to glial cell derived neurotrophic factor (GO:1990792),2,0,0.2,-, < 0.01,8.16E-01
lens morphogenesis in camera-type eye (GO:0002089),22,0,2.24,-, < 0.01,1.07E-01
positive regulation of cardioblast differentiation (GO:0051891),6,0,0.61,-, < 0.01,5.43E-01
dorsal root ganglion development (GO:1990791),7,0,0.71,-, < 0.01,4.91E-01
regulation of cardioblast differentiation (GO:0051890),8,0,0.81,-, < 0.01,4.43E-01
response to glial cell derived neurotrophic factor (GO:1990790),2,0,0.2,-, < 0.01,8.16E-01
regulation of respiratory gaseous exchange by nervous system process (GO:0002087),11,0,1.12,-, < 0.01,3.27E-01
diaphragm contraction (GO:0002086),2,0,0.2,-, < 0.01,8.16E-01
protein depalmitoylation (GO:0002084),9,0,0.91,-, < 0.01,4.00E-01
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),5,0,0.51,-, < 0.01,6.01E-01
cellular response to hydrostatic pressure (GO:0071464),3,0,0.3,-, < 0.01,7.37E-01
cellular response to water stimulus (GO:0071462),6,0,0.61,-, < 0.01,5.43E-01
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),11,0,1.12,-, < 0.01,3.27E-01
cellular response to redox state (GO:0071461),4,0,0.41,-, < 0.01,6.66E-01
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400),1,0,0.1,-, < 0.01,9.03E-01
valyl-tRNA aminoacylation (GO:0006438),2,0,0.2,-, < 0.01,8.16E-01
tyrosyl-tRNA aminoacylation (GO:0006437),2,0,0.2,-, < 0.01,8.16E-01
tryptophanyl-tRNA aminoacylation (GO:0006436),2,0,0.2,-, < 0.01,8.16E-01
establishment of endothelial blood-brain barrier (GO:0014045),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of hh target transcription factor activity (GO:1990787),1,0,0.1,-, < 0.01,9.03E-01
threonyl-tRNA aminoacylation (GO:0006435),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of timing of anagen (GO:0051886),1,0,0.1,-, < 0.01,9.03E-01
cellular response to dsDNA (GO:1990786),1,0,0.1,-, < 0.01,9.03E-01
seryl-tRNA aminoacylation (GO:0006434),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of timing of anagen (GO:0051885),2,0,0.2,-, < 0.01,8.16E-01
response to water-immersion restraint stress (GO:1990785),3,0,0.3,-, < 0.01,7.37E-01
prolyl-tRNA aminoacylation (GO:0006433),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of neuron maturation (GO:0014042),5,0,0.51,-, < 0.01,6.01E-01
regulation of timing of anagen (GO:0051884),5,0,0.51,-, < 0.01,6.01E-01
response to dsDNA (GO:1990784),1,0,0.1,-, < 0.01,9.03E-01
phenylalanyl-tRNA aminoacylation (GO:0006432),2,0,0.2,-, < 0.01,8.16E-01
methionyl-tRNA aminoacylation (GO:0006431),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of Schwann cell differentiation (GO:0014040),3,0,0.3,-, < 0.01,7.37E-01
mitochondrial depolarization (GO:0051882),3,0,0.3,-, < 0.01,7.37E-01
lysyl-tRNA aminoacylation (GO:0006430),1,0,0.1,-, < 0.01,9.03E-01
glandular epithelial cell maturation (GO:0002071),2,0,0.2,-, < 0.01,8.16E-01
"protein localization to chromosome, centromeric region (GO:0071459)",16,0,1.63,-, < 0.01,1.96E-01
cellular response to hyperoxia (GO:0071455),7,0,0.71,-, < 0.01,4.91E-01
cellular response to anoxia (GO:0071454),1,0,0.1,-, < 0.01,9.03E-01
cellular response to superoxide (GO:0071451),15,0,1.52,-, < 0.01,2.17E-01
cellular response to oxygen radical (GO:0071450),15,0,1.52,-, < 0.01,2.17E-01
leucyl-tRNA aminoacylation (GO:0006429),2,0,0.2,-, < 0.01,8.16E-01
regulation of Schwann cell differentiation (GO:0014038),4,0,0.41,-, < 0.01,6.66E-01
isoleucyl-tRNA aminoacylation (GO:0006428),1,0,0.1,-, < 0.01,9.03E-01
neural crest cell fate specification (GO:0014036),2,0,0.2,-, < 0.01,8.16E-01
lateral element assembly (GO:0051878),1,0,0.1,-, < 0.01,9.03E-01
glycyl-tRNA aminoacylation (GO:0006426),1,0,0.1,-, < 0.01,9.03E-01
glutaminyl-tRNA aminoacylation (GO:0006425),2,0,0.2,-, < 0.01,8.16E-01
glutamyl-tRNA aminoacylation (GO:0006424),2,0,0.2,-, < 0.01,8.16E-01
cysteinyl-tRNA aminoacylation (GO:0006423),2,0,0.2,-, < 0.01,8.16E-01
tumor necrosis factor secretion (GO:1990774),3,0,0.3,-, < 0.01,7.37E-01
aspartyl-tRNA aminoacylation (GO:0006422),1,0,0.1,-, < 0.01,9.03E-01
columnar/cuboidal epithelial cell maturation (GO:0002069),6,0,0.61,-, < 0.01,5.43E-01
arginyl-tRNA aminoacylation (GO:0006420),3,0,0.3,-, < 0.01,7.37E-01
clathrin-dependent extracellular exosome endocytosis (GO:1990771),1,0,0.1,-, < 0.01,9.03E-01
cellular response to lipid hydroperoxide (GO:0071449),1,0,0.1,-, < 0.01,9.03E-01
cellular response to pheromone (GO:0071444),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of histone H3-K14 acetylation (GO:0071442),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of histone H3-K14 acetylation (GO:0071441),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H3-K14 acetylation (GO:0071440),4,0,0.41,-, < 0.01,6.66E-01
alanyl-tRNA aminoacylation (GO:0006419),2,0,0.2,-, < 0.01,8.16E-01
notochord formation (GO:0014028),4,0,0.41,-, < 0.01,6.66E-01
neural plate elongation (GO:0014022),2,0,0.2,-, < 0.01,8.16E-01
myofibroblast contraction (GO:1990764),1,0,0.1,-, < 0.01,9.03E-01
osteoblast fate commitment (GO:0002051),4,0,0.41,-, < 0.01,6.66E-01
neuroblast fate commitment (GO:0014017),1,0,0.1,-, < 0.01,9.03E-01
rRNA export from nucleus (GO:0006407),2,0,0.2,-, < 0.01,8.16E-01
neuroblast differentiation (GO:0014016),3,0,0.3,-, < 0.01,7.37E-01
mitotic sister chromatid biorientation (GO:1990758),1,0,0.1,-, < 0.01,9.03E-01
RNA import into nucleus (GO:0006404),3,0,0.3,-, < 0.01,7.37E-01
mitotic spindle microtubule depolymerization (GO:1990755),1,0,0.1,-, < 0.01,9.03E-01
peripheral nervous system axon regeneration (GO:0014012),6,0,0.61,-, < 0.01,5.43E-01
Schwann cell proliferation (GO:0014010),2,0,0.2,-, < 0.01,8.16E-01
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),6,0,0.61,-, < 0.01,5.43E-01
zonula adherens assembly (GO:0045186),2,0,0.2,-, < 0.01,8.16E-01
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),15,0,1.52,-, < 0.01,2.17E-01
hematopoietic stem cell proliferation (GO:0071425),13,0,1.32,-, < 0.01,2.67E-01
malate transmembrane transport (GO:0071423),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of microglia differentiation (GO:0014008),1,0,0.1,-, < 0.01,9.03E-01
regulation of microglia differentiation (GO:0014006),1,0,0.1,-, < 0.01,9.03E-01
benzoyl-CoA metabolic process (GO:1901787),1,0,0.1,-, < 0.01,9.03E-01
microglia development (GO:0014005),3,0,0.3,-, < 0.01,7.37E-01
microglia differentiation (GO:0014004),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of L-glutamate import across plasma membrane (GO:0002038),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of L-glutamate import across plasma membrane (GO:0002037),1,0,0.1,-, < 0.01,9.03E-01
regulation of L-glutamate import across plasma membrane (GO:0002036),6,0,0.61,-, < 0.01,5.43E-01
regulation of blood vessel diameter by renin-angiotensin (GO:0002034),5,0,0.51,-, < 0.01,6.01E-01
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033),1,0,0.1,-, < 0.01,9.03E-01
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032),2,0,0.2,-, < 0.01,8.16E-01
cellular response to amine stimulus (GO:0071418),2,0,0.2,-, < 0.01,8.16E-01
cellular response to hydroxyisoflavone (GO:0071413),1,0,0.1,-, < 0.01,9.03E-01
cellular response to genistein (GO:0071412),1,0,0.1,-, < 0.01,9.03E-01
response to manganese-induced endoplasmic reticulum stress (GO:1990737),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of synapse structural plasticity (GO:0051835),4,0,0.41,-, < 0.01,6.66E-01
"UV-damage excision repair, DNA incision (GO:1990731)",1,0,0.1,-, < 0.01,9.03E-01
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025),3,0,0.3,-, < 0.01,7.37E-01
reduction of food intake in response to dietary excess (GO:0002023),4,0,0.41,-, < 0.01,6.66E-01
cell-cell signaling involved in cell fate commitment (GO:0045168),3,0,0.3,-, < 0.01,7.37E-01
asymmetric protein localization involved in cell fate determination (GO:0045167),1,0,0.1,-, < 0.01,9.03E-01
cellular response to cycloheximide (GO:0071409),4,0,0.41,-, < 0.01,6.66E-01
clustering of voltage-gated potassium channels (GO:0045163),3,0,0.3,-, < 0.01,7.37E-01
cellular response to high density lipoprotein particle stimulus (GO:0071403),2,0,0.2,-, < 0.01,8.16E-01
cellular response to triglyceride (GO:0071401),1,0,0.1,-, < 0.01,9.03E-01
cellular response to oleic acid (GO:0071400),3,0,0.3,-, < 0.01,7.37E-01
regulation of synapse structural plasticity (GO:0051823),9,0,0.91,-, < 0.01,4.00E-01
regulation of renal output by angiotensin (GO:0002019),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of histone ubiquitination (GO:0033183),4,0,0.41,-, < 0.01,6.66E-01
leukotriene A4 biosynthetic process (GO:1901753),1,0,0.1,-, < 0.01,9.03E-01
leukotriene A4 metabolic process (GO:1901751),2,0,0.2,-, < 0.01,8.16E-01
xylulose catabolic process (GO:0005998),1,0,0.1,-, < 0.01,9.03E-01
leukotriene D4 biosynthetic process (GO:1901750),3,0,0.3,-, < 0.01,7.37E-01
detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007),1,0,0.1,-, < 0.01,9.03E-01
trehalose catabolic process (GO:0005993),1,0,0.1,-, < 0.01,9.03E-01
trehalose metabolic process (GO:0005991),2,0,0.2,-, < 0.01,8.16E-01
renin secretion into blood stream (GO:0002001),2,0,0.2,-, < 0.01,8.16E-01
inflammatory response to wounding (GO:0090594),7,0,0.71,-, < 0.01,4.91E-01
meiotic telomere clustering (GO:0045141),9,0,0.91,-, < 0.01,4.00E-01
leukotriene D4 metabolic process (GO:1901748),3,0,0.3,-, < 0.01,7.37E-01
presynaptic active zone organization (GO:1990709),5,0,0.51,-, < 0.01,6.01E-01
conditioned place preference (GO:1990708),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051803),1,0,0.1,-, < 0.01,9.03E-01
lactose biosynthetic process (GO:0005989),3,0,0.3,-, < 0.01,7.37E-01
regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051802),1,0,0.1,-, < 0.01,9.03E-01
lactose metabolic process (GO:0005988),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of myoblast fusion (GO:1901740),2,0,0.2,-, < 0.01,8.16E-01
nucleolar chromatin organization (GO:1990700),1,0,0.1,-, < 0.01,9.03E-01
sucrose biosynthetic process (GO:0005986),2,0,0.2,-, < 0.01,8.16E-01
sucrose metabolic process (GO:0005985),3,0,0.3,-, < 0.01,7.37E-01
disaccharide metabolic process (GO:0005984),10,0,1.02,-, < 0.01,3.62E-01
starch catabolic process (GO:0005983),1,0,0.1,-, < 0.01,9.03E-01
starch metabolic process (GO:0005982),1,0,0.1,-, < 0.01,9.03E-01
regulation of glycogen catabolic process (GO:0005981),6,0,0.61,-, < 0.01,5.43E-01
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168),1,0,0.1,-, < 0.01,9.03E-01
regulation of glycogen biosynthetic process (GO:0005979),27,0,2.74,-, < 0.01,6.41E-02
positive regulation of platelet aggregation (GO:1901731),3,0,0.3,-, < 0.01,7.37E-01
dsDNA loop formation (GO:0090579),5,0,0.51,-, < 0.01,6.01E-01
T cell receptor V(D)J recombination (GO:0033153),5,0,0.51,-, < 0.01,6.01E-01
NADPH oxidation (GO:0070995),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of histone deacetylase activity (GO:1901727),6,0,0.61,-, < 0.01,5.43E-01
immunoglobulin V(D)J recombination (GO:0033152),5,0,0.51,-, < 0.01,6.01E-01
detection of oxidative stress (GO:0070994),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of histone deacetylase activity (GO:1901726),2,0,0.2,-, < 0.01,8.16E-01
V(D)J recombination (GO:0033151),15,0,1.52,-, < 0.01,2.17E-01
regulation of histone deacetylase activity (GO:1901725),9,0,0.91,-, < 0.01,4.00E-01
azole transmembrane transport (GO:0045117),12,0,1.22,-, < 0.01,2.95E-01
protein neddylation (GO:0045116),12,0,1.22,-, < 0.01,2.95E-01
regulation of integrin biosynthetic process (GO:0045113),5,0,0.51,-, < 0.01,6.01E-01
integrin biosynthetic process (GO:0045112),1,0,0.1,-, < 0.01,9.03E-01
intermediate filament bundle assembly (GO:0045110),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140),3,0,0.3,-, < 0.01,7.37E-01
L-asparagine metabolic process (GO:0070982),2,0,0.2,-, < 0.01,8.16E-01
L-asparagine biosynthetic process (GO:0070981),1,0,0.1,-, < 0.01,9.03E-01
regulation of intermediate filament polymerization or depolymerization (GO:0045108),1,0,0.1,-, < 0.01,9.03E-01
establishment of endothelial intestinal barrier (GO:0090557),11,0,1.12,-, < 0.01,3.27E-01
intermediate filament polymerization or depolymerization (GO:0045105),1,0,0.1,-, < 0.01,9.03E-01
protein K11-linked ubiquitination (GO:0070979),25,0,2.54,-, < 0.01,7.86E-02
positive regulation of glucokinase activity (GO:0033133),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of glucokinase activity (GO:0033132),4,0,0.41,-, < 0.01,6.66E-01
mesenchymal cell differentiation involved in bone development (GO:1901706),1,0,0.1,-, < 0.01,9.03E-01
regulation of glucokinase activity (GO:0033131),8,0,0.81,-, < 0.01,4.43E-01
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582),1,0,0.1,-, < 0.01,9.03E-01
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),29,0,2.95,-, < 0.01,5.23E-02
positive regulation of histone phosphorylation (GO:0033129),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of histone phosphorylation (GO:0033128),2,0,0.2,-, < 0.01,8.16E-01
regulation of histone phosphorylation (GO:0033127),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of neutrophil mediated killing of bacterium (GO:0070962),1,0,0.1,-, < 0.01,9.03E-01
medium-chain fatty acid transport (GO:0001579),2,0,0.2,-, < 0.01,8.16E-01
globoside biosynthetic process (GO:0001576),2,0,0.2,-, < 0.01,8.16E-01
globoside metabolic process (GO:0001575),2,0,0.2,-, < 0.01,8.16E-01
lactosylceramide biosynthetic process (GO:0001572),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of RNA splicing (GO:0033119),19,0,1.93,-, < 0.01,1.45E-01
regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951),2,0,0.2,-, < 0.01,8.16E-01
regulation of neutrophil mediated killing of bacterium (GO:0070950),2,0,0.2,-, < 0.01,8.16E-01
cell septum assembly (GO:0090529),1,0,0.1,-, < 0.01,9.03E-01
vesicle tethering involved in exocytosis (GO:0090522),1,0,0.1,-, < 0.01,9.03E-01
neutrophil-mediated killing of fungus (GO:0070947),1,0,0.1,-, < 0.01,9.03E-01
neutrophil-mediated killing of gram-positive bacterium (GO:0070946),1,0,0.1,-, < 0.01,9.03E-01
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),5,0,0.51,-, < 0.01,6.01E-01
oocyte maturation (GO:0001556),18,0,1.83,-, < 0.01,1.60E-01
luteolysis (GO:0001554),7,0,0.71,-, < 0.01,4.91E-01
cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361),1,0,0.1,-, < 0.01,9.03E-01
ovarian follicle atresia (GO:0001552),2,0,0.2,-, < 0.01,8.16E-01
ovarian cumulus expansion (GO:0001550),3,0,0.3,-, < 0.01,7.37E-01
histone H4 deacetylation (GO:0070933),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of ubiquitin-dependent endocytosis (GO:2000397),2,0,0.2,-, < 0.01,8.16E-01
regulation of ubiquitin-dependent endocytosis (GO:2000395),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of lamellipodium morphogenesis (GO:2000394),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of lamellipodium morphogenesis (GO:2000393),2,0,0.2,-, < 0.01,8.16E-01
regulation of lamellipodium morphogenesis (GO:2000392),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of neutrophil extravasation (GO:2000391),7,0,0.71,-, < 0.01,4.91E-01
antral ovarian follicle growth (GO:0001547),7,0,0.71,-, < 0.01,4.91E-01
lipid import into cell (GO:0140354),9,0,0.91,-, < 0.01,4.00E-01
lipid export from cell (GO:0140353),8,0,0.81,-, < 0.01,4.43E-01
primary ovarian follicle growth (GO:0001545),2,0,0.2,-, < 0.01,8.16E-01
initiation of primordial ovarian follicle growth (GO:0001544),2,0,0.2,-, < 0.01,8.16E-01
ovarian follicle rupture (GO:0001543),1,0,0.1,-, < 0.01,9.03E-01
ovulation from ovarian follicle (GO:0001542),9,0,0.91,-, < 0.01,4.00E-01
endocardial cushion to mesenchymal transition (GO:0090500),3,0,0.3,-, < 0.01,7.37E-01
regulation of ATP:ADP antiporter activity (GO:0070926),1,0,0.1,-, < 0.01,9.03E-01
regulation of neutrophil extravasation (GO:2000389),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of antral ovarian follicle growth (GO:2000388),1,0,0.1,-, < 0.01,9.03E-01
regulation of antral ovarian follicle growth (GO:2000387),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ovarian follicle development (GO:2000386),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of ectoderm development (GO:2000384),1,0,0.1,-, < 0.01,9.03E-01
regulation of ectoderm development (GO:2000383),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mesoderm development (GO:2000381),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of oxygen metabolic process (GO:2000376),2,0,0.2,-, < 0.01,8.16E-01
regulation of oxygen metabolic process (GO:2000374),3,0,0.3,-, < 0.01,7.37E-01
aminophospholipid translocation (GO:0140331),5,0,0.51,-, < 0.01,6.01E-01
transepithelial L-ascorbic acid transport (GO:0070904),2,0,0.2,-, < 0.01,8.16E-01
mitochondrial tRNA pseudouridine synthesis (GO:0070902),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial tRNA methylation (GO:0070901),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of acrosomal vesicle exocytosis (GO:2000368),2,0,0.2,-, < 0.01,8.16E-01
regulation of acrosomal vesicle exocytosis (GO:2000367),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of interleukin-1 alpha production (GO:0032690),2,0,0.2,-, < 0.01,8.16E-01
lysophospholipid translocation (GO:0140329),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of prostaglandin-E synthase activity (GO:2000363),3,0,0.3,-, < 0.01,7.37E-01
regulation of prostaglandin-E synthase activity (GO:2000361),3,0,0.3,-, < 0.01,7.37E-01
negative regulation by symbiont of host autophagy (GO:0140321),1,0,0.1,-, < 0.01,9.03E-01
adhesion of symbiont to host cell (GO:0044650),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of interferon-beta production (GO:0032688),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of interferon-alpha production (GO:0032687),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of hepatocyte growth factor production (GO:0032686),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of connective tissue growth factor production (GO:0032683),1,0,0.1,-, < 0.01,9.03E-01
regulation of lymphotoxin A production (GO:0032681),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of endothelial cell apoptotic process (GO:2000353),20,0,2.03,-, < 0.01,1.31E-01
acetylcholine catabolic process in synaptic cleft (GO:0001507),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of CD40 signaling pathway (GO:2000350),1,0,0.1,-, < 0.01,9.03E-01
cartilage condensation (GO:0001502),18,0,1.83,-, < 0.01,1.60E-01
histone H3-K4 dimethylation (GO:0044648),5,0,0.51,-, < 0.01,6.01E-01
regulation of TRAIL production (GO:0032679),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of CD40 signaling pathway (GO:2000349),2,0,0.2,-, < 0.01,8.16E-01
regulation of interleukin-3 production (GO:0032672),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of hepatocyte proliferation (GO:2000346),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340),4,0,0.41,-, < 0.01,6.66E-01
serine import into mitochondrion (GO:0140300),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of viral release from host cell (GO:1902188),15,0,1.52,-, < 0.01,2.17E-01
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395),1,0,0.1,-, < 0.01,9.03E-01
modulation of programmed cell death in other organism involved in symbiotic interaction (GO:0052248),12,0,1.22,-, < 0.01,2.95E-01
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of blood microparticle formation (GO:2000334),2,0,0.2,-, < 0.01,8.16E-01
regulation of blood microparticle formation (GO:2000332),2,0,0.2,-, < 0.01,8.16E-01
regulation of terminal button organization (GO:2000331),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of T-helper 17 cell lineage commitment (GO:2000330),4,0,0.41,-, < 0.01,6.66E-01
fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of keratinocyte apoptotic process (GO:1902173),1,0,0.1,-, < 0.01,9.03E-01
regulation of interleukin-16 production (GO:0032659),1,0,0.1,-, < 0.01,9.03E-01
regulation of interleukin-15 production (GO:0032658),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of nuclear receptor transcription coactivator activity (GO:2000327),3,0,0.3,-, < 0.01,7.37E-01
regulation of interleukin-1 alpha production (GO:0032650),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324),2,0,0.2,-, < 0.01,8.16E-01
protein myristoylation (GO:0018377),4,0,0.41,-, < 0.01,6.66E-01
metabolism of macromolecule in other organism involved in symbiotic interaction (GO:0052229),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167),1,0,0.1,-, < 0.01,9.03E-01
catabolism of substance in other organism involved in symbiotic interaction (GO:0052227),1,0,0.1,-, < 0.01,9.03E-01
"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)",3,0,0.3,-, < 0.01,7.37E-01
"regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161),1,0,0.1,-, < 0.01,9.03E-01
regulation of hepatocyte growth factor production (GO:0032646),1,0,0.1,-, < 0.01,9.03E-01
regulation of connective tissue growth factor production (GO:0032643),3,0,0.3,-, < 0.01,7.37E-01
lymphotoxin A production (GO:0032641),1,0,0.1,-, < 0.01,9.03E-01
tumor necrosis factor production (GO:0032640),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314),1,0,0.1,-, < 0.01,9.03E-01
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313),2,0,0.2,-, < 0.01,8.16E-01
regulation of cyclic nucleotide-gated ion channel activity (GO:1902159),2,0,0.2,-, < 0.01,8.16E-01
metabolism of substance in other organism involved in symbiotic interaction (GO:0052214),1,0,0.1,-, < 0.01,9.03E-01
regulation of response to DNA damage checkpoint signaling (GO:1902153),1,0,0.1,-, < 0.01,9.03E-01
regulation of response to DNA integrity checkpoint signaling (GO:1902151),1,0,0.1,-, < 0.01,9.03E-01
protein deadenylylation (GO:0044602),1,0,0.1,-, < 0.01,9.03E-01
protein denucleotidylation (GO:0044601),1,0,0.1,-, < 0.01,9.03E-01
transcription elongation from mitochondrial promoter (GO:0006392),1,0,0.1,-, < 0.01,9.03E-01
interleukin-6 production (GO:0032635),11,0,1.12,-, < 0.01,3.27E-01
interleukin-5 production (GO:0032634),1,0,0.1,-, < 0.01,9.03E-01
interleukin-3 production (GO:0032632),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of synaptic vesicle exocytosis (GO:2000302),7,0,0.71,-, < 0.01,4.91E-01
regulation of response to cell cycle checkpoint signaling (GO:1902145),1,0,0.1,-, < 0.01,9.03E-01
modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204),7,0,0.71,-, < 0.01,4.91E-01
induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703),3,0,0.3,-, < 0.01,7.37E-01
protein esterification (GO:0018350),1,0,0.1,-, < 0.01,9.03E-01
modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203),4,0,0.41,-, < 0.01,6.66E-01
response to host defenses (GO:0052200),10,0,1.02,-, < 0.01,3.62E-01
interleukin-18 production (GO:0032621),2,0,0.2,-, < 0.01,8.16E-01
interleukin-17 production (GO:0032620),5,0,0.51,-, < 0.01,6.01E-01
protein geranylgeranylation (GO:0018344),6,0,0.61,-, < 0.01,5.43E-01
protein farnesylation (GO:0018343),3,0,0.3,-, < 0.01,7.37E-01
protein prenylation (GO:0018342),10,0,1.02,-, < 0.01,3.62E-01
interleukin-15 production (GO:0032618),1,0,0.1,-, < 0.01,9.03E-01
interleukin-13 production (GO:0032616),3,0,0.3,-, < 0.01,7.37E-01
interleukin-1 alpha production (GO:0032610),1,0,0.1,-, < 0.01,9.03E-01
protein succinylation (GO:0018335),3,0,0.3,-, < 0.01,7.37E-01
cellular response to testosterone stimulus (GO:0071394),10,0,1.02,-, < 0.01,3.62E-01
cellular response to progesterone stimulus (GO:0071393),4,0,0.41,-, < 0.01,6.66E-01
interferon-beta production (GO:0032608),2,0,0.2,-, < 0.01,8.16E-01
interferon-alpha production (GO:0032607),3,0,0.3,-, < 0.01,7.37E-01
granulocyte macrophage colony-stimulating factor production (GO:0032604),1,0,0.1,-, < 0.01,9.03E-01
fractalkine production (GO:0032603),2,0,0.2,-, < 0.01,8.16E-01
chemokine production (GO:0032602),10,0,1.02,-, < 0.01,3.62E-01
chemokine receptor transport out of membrane raft (GO:0032600),1,0,0.1,-, < 0.01,9.03E-01
cellular response to mineralocorticoid stimulus (GO:0071389),5,0,0.51,-, < 0.01,6.01E-01
cellular response to cortisol stimulus (GO:0071387),1,0,0.1,-, < 0.01,9.03E-01
cellular response to corticosterone stimulus (GO:0071386),3,0,0.3,-, < 0.01,7.37E-01
protein tyrosinylation (GO:0018322),1,0,0.1,-, < 0.01,9.03E-01
viral penetration into host nucleus (GO:0075732),3,0,0.3,-, < 0.01,7.37E-01
protein C-linked glycosylation via tryptophan (GO:0018317),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109),3,0,0.3,-, < 0.01,7.37E-01
cellular response to corticotropin-releasing hormone stimulus (GO:0071376),4,0,0.41,-, < 0.01,6.66E-01
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315),1,0,0.1,-, < 0.01,9.03E-01
cellular response to parathyroid hormone stimulus (GO:0071374),8,0,0.81,-, < 0.01,4.43E-01
cellular response to luteinizing hormone stimulus (GO:0071373),3,0,0.3,-, < 0.01,7.37E-01
cellular response to follicle-stimulating hormone stimulus (GO:0071372),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103),2,0,0.2,-, < 0.01,8.16E-01
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),14,0,1.42,-, < 0.01,2.41E-01
protein depalmitoleylation (GO:1990697),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of timing of catagen (GO:0051796),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of timing of catagen (GO:0051795),3,0,0.3,-, < 0.01,7.37E-01
regulation of timing of catagen (GO:0051794),4,0,0.41,-, < 0.01,6.66E-01
medium-chain fatty acid catabolic process (GO:0051793),5,0,0.51,-, < 0.01,6.01E-01
medium-chain fatty acid biosynthetic process (GO:0051792),6,0,0.61,-, < 0.01,5.43E-01
medium-chain fatty acid metabolic process (GO:0051791),13,0,1.32,-, < 0.01,2.67E-01
short-chain fatty acid biosynthetic process (GO:0051790),4,0,0.41,-, < 0.01,6.66E-01
response to misfolded protein (GO:0051788),22,0,2.24,-, < 0.01,1.07E-01
behavioral response to nutrient (GO:0051780),1,0,0.1,-, < 0.01,9.03E-01
cellular response to interleukin-9 (GO:0071355),9,0,0.91,-, < 0.01,4.00E-01
cellular response to interleukin-2 (GO:0071352),12,0,1.22,-, < 0.01,2.95E-01
cellular response to interleukin-18 (GO:0071351),7,0,0.71,-, < 0.01,4.91E-01
histone H4-K16 deacetylation (GO:1990678),1,0,0.1,-, < 0.01,9.03E-01
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),6,0,0.61,-, < 0.01,5.43E-01
"transposition, DNA-mediated (GO:0006313)",2,0,0.2,-, < 0.01,8.16E-01
homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758),1,0,0.1,-, < 0.01,9.03E-01
cannabinoid biosynthetic process (GO:1901696),1,0,0.1,-, < 0.01,9.03E-01
sebum secreting cell proliferation (GO:1990654),1,0,0.1,-, < 0.01,9.03E-01
cellular response to sucrose stimulus (GO:0071329),1,0,0.1,-, < 0.01,9.03E-01
cellular response to disaccharide stimulus (GO:0071324),1,0,0.1,-, < 0.01,9.03E-01
cellular response to cGMP (GO:0071321),6,0,0.61,-, < 0.01,5.43E-01
cellular response to prolactin (GO:1990646),2,0,0.2,-, < 0.01,8.16E-01
arsenate ion transmembrane transport (GO:1901684),1,0,0.1,-, < 0.01,9.03E-01
cellular response to nicotine (GO:0071316),9,0,0.91,-, < 0.01,4.00E-01
cellular response to cocaine (GO:0071314),3,0,0.3,-, < 0.01,7.37E-01
cellular response to caffeine (GO:0071313),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of histone H3-K27 acetylation (GO:1901676),1,0,0.1,-, < 0.01,9.03E-01
response to prolactin (GO:1990637),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of histone H3-K27 acetylation (GO:1901675),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H3-K27 acetylation (GO:1901674),2,0,0.2,-, < 0.01,8.16E-01
regulation of mitotic spindle assembly (GO:1901673),16,0,1.63,-, < 0.01,1.96E-01
regulatory T cell differentiation (GO:0045066),6,0,0.61,-, < 0.01,5.43E-01
cytotoxic T cell differentiation (GO:0045065),1,0,0.1,-, < 0.01,9.03E-01
T-helper 2 cell differentiation (GO:0045064),3,0,0.3,-, < 0.01,7.37E-01
cellular response to vitamin K (GO:0071307),2,0,0.2,-, < 0.01,8.16E-01
extrathymic T cell selection (GO:0045062),1,0,0.1,-, < 0.01,9.03E-01
cellular response to vitamin E (GO:0071306),2,0,0.2,-, < 0.01,8.16E-01
"germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)",3,0,0.3,-, < 0.01,7.37E-01
"cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666),3,0,0.3,-, < 0.01,7.37E-01
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664),3,0,0.3,-, < 0.01,7.37E-01
quinone biosynthetic process (GO:1901663),14,0,1.42,-, < 0.01,2.41E-01
quinone catabolic process (GO:1901662),5,0,0.51,-, < 0.01,6.01E-01
calcium ion export (GO:1901660),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of immature T cell proliferation in thymus (GO:0033088),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of immature T cell proliferation (GO:0033087),4,0,0.41,-, < 0.01,6.66E-01
regulation of extrathymic T cell differentiation (GO:0033082),2,0,0.2,-, < 0.01,8.16E-01
glycoside transport (GO:1901656),3,0,0.3,-, < 0.01,7.37E-01
immature T cell proliferation in thymus (GO:0033080),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytolysis in other organism (GO:0051713),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial membrane fusion (GO:1990613),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of killing of cells of other organism (GO:0051711),1,0,0.1,-, < 0.01,9.03E-01
regulation of cytolysis in other organism (GO:0051710),1,0,0.1,-, < 0.01,9.03E-01
immature T cell proliferation (GO:0033079),1,0,0.1,-, < 0.01,9.03E-01
extrathymic T cell differentiation (GO:0033078),1,0,0.1,-, < 0.01,9.03E-01
isoquinoline alkaloid metabolic process (GO:0033076),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of synoviocyte proliferation (GO:1901647),2,0,0.2,-, < 0.01,8.16E-01
regulation of synoviocyte proliferation (GO:1901645),2,0,0.2,-, < 0.01,8.16E-01
nucleoside transmembrane transport (GO:1901642),7,0,0.71,-, < 0.01,4.91E-01
protein insertion into mitochondrial inner membrane (GO:0045039),9,0,0.91,-, < 0.01,4.00E-01
purine nucleotide-sugar transmembrane transport (GO:0090480),1,0,0.1,-, < 0.01,9.03E-01
XDP catabolic process (GO:1901639),1,0,0.1,-, < 0.01,9.03E-01
G0 to G1 transition (GO:0045023),2,0,0.2,-, < 0.01,8.16E-01
directional locomotion (GO:0033058),3,0,0.3,-, < 0.01,7.37E-01
mitochondrial tRNA wobble uridine modification (GO:0070899),1,0,0.1,-, < 0.01,9.03E-01
RNA polymerase III preinitiation complex assembly (GO:0070898),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of postsynaptic membrane organization (GO:1901628),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of transposon integration (GO:0070895),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of postsynaptic membrane organization (GO:1901627),1,0,0.1,-, < 0.01,9.03E-01
regulation of transposon integration (GO:0070894),2,0,0.2,-, < 0.01,8.16E-01
regulation of postsynaptic membrane organization (GO:1901626),3,0,0.3,-, < 0.01,7.37E-01
cellular response to ergosterol (GO:1901625),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621),6,0,0.61,-, < 0.01,5.43E-01
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620),10,0,1.02,-, < 0.01,3.62E-01
mitochondrial magnesium ion transmembrane transport (GO:0045016),1,0,0.1,-, < 0.01,9.03E-01
glutamate homeostasis (GO:0090461),4,0,0.41,-, < 0.01,6.66E-01
platelet alpha granule organization (GO:0070889),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),14,0,1.42,-, < 0.01,2.41E-01
regulation of calcineurin-NFAT signaling cascade (GO:0070884),32,0,3.25,-, < 0.01,3.85E-02
regulation of proline transport (GO:0070881),1,0,0.1,-, < 0.01,9.03E-01
DNA replication proofreading (GO:0045004),2,0,0.2,-, < 0.01,8.16E-01
double-strand break repair via single-strand annealing (GO:0045002),3,0,0.3,-, < 0.01,7.37E-01
polysaccharide localization (GO:0033037),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of vesicle transport along microtubule (GO:1901609),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of myeloid cell apoptotic process (GO:0033034),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of glycogen metabolic process (GO:0070875),16,0,1.63,-, < 0.01,1.96E-01
negative regulation of glycogen metabolic process (GO:0070874),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of neutrophil apoptotic process (GO:0033031),4,0,0.41,-, < 0.01,6.66E-01
regulation of glycogen metabolic process (GO:0070873),32,0,3.25,-, < 0.01,3.85E-02
negative regulation of neutrophil apoptotic process (GO:0033030),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-glutamate ADP-deribosylation (GO:0140291),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-serine ADP-deribosylation (GO:0140290),1,0,0.1,-, < 0.01,9.03E-01
regulation of neutrophil apoptotic process (GO:0033029),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of mast cell apoptotic process (GO:0033026),2,0,0.2,-, < 0.01,8.16E-01
heterochromatin organization involved in chromatin silencing (GO:0070868),6,0,0.61,-, < 0.01,5.43E-01
regulation of mast cell apoptotic process (GO:0033025),3,0,0.3,-, < 0.01,7.37E-01
mast cell homeostasis (GO:0033023),1,0,0.1,-, < 0.01,9.03E-01
endosome fission (GO:0140285),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of bile acid biosynthetic process (GO:0070859),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of bile acid biosynthetic process (GO:0070858),2,0,0.2,-, < 0.01,8.16E-01
regulation of bile acid biosynthetic process (GO:0070857),9,0,0.91,-, < 0.01,4.00E-01
detection of endogenous biotic stimulus (GO:0090429),1,0,0.1,-, < 0.01,9.03E-01
activation of meiosis (GO:0090427),4,0,0.41,-, < 0.01,6.66E-01
acinar cell differentiation (GO:0090425),1,0,0.1,-, < 0.01,9.03E-01
naphthalene-containing compound metabolic process (GO:0090420),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mast cell activation involved in immune response (GO:0033007),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of mast cell activation (GO:0033004),13,0,1.32,-, < 0.01,2.67E-01
polyubiquitinated misfolded protein transport (GO:0070845),1,0,0.1,-, < 0.01,9.03E-01
polyubiquitinated protein transport (GO:0070844),1,0,0.1,-, < 0.01,9.03E-01
misfolded protein transport (GO:0070843),1,0,0.1,-, < 0.01,9.03E-01
aggresome assembly (GO:0070842),4,0,0.41,-, < 0.01,6.66E-01
inclusion body assembly (GO:0070841),6,0,0.61,-, < 0.01,5.43E-01
malonate catabolic process (GO:0090410),1,0,0.1,-, < 0.01,9.03E-01
divalent metal ion export (GO:0070839),9,0,0.91,-, < 0.01,4.00E-01
dehydroascorbic acid transport (GO:0070837),6,0,0.61,-, < 0.01,5.43E-01
caveola assembly (GO:0070836),4,0,0.41,-, < 0.01,6.66E-01
basement membrane assembly (GO:0070831),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299),3,0,0.3,-, < 0.01,7.37E-01
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of hydrogen peroxide catabolic process (GO:2000296),2,0,0.2,-, < 0.01,8.16E-01
regulation of hydrogen peroxide catabolic process (GO:2000295),4,0,0.41,-, < 0.01,6.66E-01
regulation of myotome development (GO:2000290),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199),3,0,0.3,-, < 0.01,7.37E-01
heterochromatin maintenance (GO:0070829),5,0,0.51,-, < 0.01,6.01E-01
chromatin maintenance (GO:0070827),7,0,0.71,-, < 0.01,4.91E-01
butyryl-CoA catabolic process (GO:0044580),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of myotome development (GO:2000287),1,0,0.1,-, < 0.01,9.03E-01
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cellular amino acid biosynthetic process (GO:2000283),1,0,0.1,-, < 0.01,9.03E-01
protein catabolic process at synapse (GO:0140246),1,0,0.1,-, < 0.01,9.03E-01
peripheral nervous system neuron axonogenesis (GO:0048936),3,0,0.3,-, < 0.01,7.37E-01
peripheral nervous system neuron development (GO:0048935),13,0,1.32,-, < 0.01,2.67E-01
peripheral nervous system neuron differentiation (GO:0048934),13,0,1.32,-, < 0.01,2.67E-01
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of signaling receptor activity (GO:2000272),41,0,4.17,-, < 0.01,1.54E-02
lateral line system development (GO:0048925),1,0,0.1,-, < 0.01,9.03E-01
dendritic cell proliferation (GO:0044565),2,0,0.2,-, < 0.01,8.16E-01
response to defenses of other organism (GO:0052173),10,0,1.02,-, < 0.01,3.62E-01
protein transport out of membrane raft (GO:0032599),1,0,0.1,-, < 0.01,9.03E-01
B cell receptor transport into membrane raft (GO:0032597),1,0,0.1,-, < 0.01,9.03E-01
B cell receptor transport within lipid bilayer (GO:0032595),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of blood coagulation, extrinsic pathway (GO:2000264)",4,0,0.41,-, < 0.01,6.66E-01
"regulation of blood coagulation, extrinsic pathway (GO:2000263)",4,0,0.41,-, < 0.01,6.66E-01
"negative regulation of blood coagulation, common pathway (GO:2000261)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of blood coagulation, common pathway (GO:2000260)",1,0,0.1,-, < 0.01,9.03E-01
relaxation of smooth muscle (GO:0044557),8,0,0.81,-, < 0.01,4.43E-01
ER-dependent peroxisome organization (GO:0032581),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of male germ cell proliferation (GO:2000256),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of male germ cell proliferation (GO:2000255),2,0,0.2,-, < 0.01,8.16E-01
regulation of male germ cell proliferation (GO:2000254),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of feeding behavior (GO:2000252),5,0,0.51,-, < 0.01,6.01E-01
guanine nucleotide transport (GO:0001408),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of long-chain fatty acid import into cell (GO:0140214),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of actin cytoskeleton reorganization (GO:2000250),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of long-chain fatty acid import into cell (GO:0140213),4,0,0.41,-, < 0.01,6.66E-01
regulation of long-chain fatty acid import into cell (GO:0140212),8,0,0.81,-, < 0.01,4.43E-01
NLRP3 inflammasome complex assembly (GO:0044546),2,0,0.2,-, < 0.01,8.16E-01
positive regulation by symbiont of host apoptotic process (GO:0052151),3,0,0.3,-, < 0.01,7.37E-01
modulation by symbiont of host apoptotic process (GO:0052150),12,0,1.22,-, < 0.01,2.95E-01
long-chain fatty acid import into cell (GO:0044539),9,0,0.91,-, < 0.01,4.00E-01
modulation by symbiont of host catalytic activity (GO:0052148),1,0,0.1,-, < 0.01,9.03E-01
protein-FAD linkage (GO:0018293),1,0,0.1,-, < 0.01,9.03E-01
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083),5,0,0.51,-, < 0.01,6.01E-01
retrograde axonal protein transport (GO:0099642),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of apoptotic process in other organism (GO:0044533),1,0,0.1,-, < 0.01,9.03E-01
anterograde axonal protein transport (GO:0099641),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081),2,0,0.2,-, < 0.01,8.16E-01
modulation of apoptotic process in other organism (GO:0044532),12,0,1.22,-, < 0.01,2.95E-01
regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080),3,0,0.3,-, < 0.01,7.37E-01
modulation of programmed cell death in other organism (GO:0044531),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of rRNA processing (GO:2000234),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of rRNA processing (GO:2000233),3,0,0.3,-, < 0.01,7.37E-01
regulation of rRNA processing (GO:2000232),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of pancreatic stellate cell proliferation (GO:2000231),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of pancreatic stellate cell proliferation (GO:2000230),1,0,0.1,-, < 0.01,9.03E-01
"neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",6,0,0.61,-, < 0.01,5.43E-01
endosome to plasma membrane protein transport (GO:0099638),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of lateral motor column neuron migration (GO:1902078),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitochondrial mRNA stability (GO:0044528),7,0,0.71,-, < 0.01,4.91E-01
regulation of lateral motor column neuron migration (GO:1902076),1,0,0.1,-, < 0.01,9.03E-01
iron incorporation into metallo-sulfur cluster (GO:0018283),2,0,0.2,-, < 0.01,8.16E-01
metal incorporation into metallo-sulfur cluster (GO:0018282),2,0,0.2,-, < 0.01,8.16E-01
protein localization to postsynaptic specialization membrane (GO:0099633),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073),1,0,0.1,-, < 0.01,9.03E-01
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of sphingolipid mediated signaling pathway (GO:1902070),1,0,0.1,-, < 0.01,9.03E-01
regulation of pancreatic stellate cell proliferation (GO:2000229),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of pancreatic A cell differentiation (GO:2000227),1,0,0.1,-, < 0.01,9.03E-01
regulation of pancreatic A cell differentiation (GO:2000226),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of testosterone biosynthetic process (GO:2000225),2,0,0.2,-, < 0.01,8.16E-01
regulation of testosterone biosynthetic process (GO:2000224),3,0,0.3,-, < 0.01,7.37E-01
protein deamination (GO:0018277),1,0,0.1,-, < 0.01,9.03E-01
isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1,0,0.1,-, < 0.01,9.03E-01
neurotransmitter receptor diffusion trapping (GO:0099628),8,0,0.81,-, < 0.01,4.43E-01
regulation of sphingolipid mediated signaling pathway (GO:1902068),2,0,0.2,-, < 0.01,8.16E-01
ventricular cardiac muscle cell membrane repolarization (GO:0099625),10,0,1.02,-, < 0.01,3.62E-01
response to L-glutamate (GO:1902065),10,0,1.02,-, < 0.01,3.62E-01
atrial cardiac muscle cell membrane repolarization (GO:0099624),5,0,0.51,-, < 0.01,6.01E-01
regulation of transcription from RNA polymerase II promoter involved in spermatogenesis (GO:1902064),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glutamate metabolic process (GO:2000213),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glutamate metabolic process (GO:2000212),1,0,0.1,-, < 0.01,9.03E-01
regulation of glutamate metabolic process (GO:2000211),3,0,0.3,-, < 0.01,7.37E-01
isopeptide cross-linking (GO:0018262),3,0,0.3,-, < 0.01,7.37E-01
modulation of signal transduction in other organism (GO:0044501),2,0,0.2,-, < 0.01,8.16E-01
regulation of microvillus assembly (GO:0032534),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of ribosomal small subunit export from nucleus (GO:2000208),1,0,0.1,-, < 0.01,9.03E-01
regulation of ribosomal small subunit export from nucleus (GO:2000206),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ribosomal subunit export from nucleus (GO:2000202),1,0,0.1,-, < 0.01,9.03E-01
regulation of ribosomal subunit export from nucleus (GO:2000200),1,0,0.1,-, < 0.01,9.03E-01
regulation of action potential firing pattern (GO:0099608),1,0,0.1,-, < 0.01,9.03E-01
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607),1,0,0.1,-, < 0.01,9.03E-01
polyamine transmembrane transport (GO:1902047),1,0,0.1,-, < 0.01,9.03E-01
microtubule plus-end directed mitotic chromosome migration (GO:0099606),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of Fas signaling pathway (GO:1902045),1,0,0.1,-, < 0.01,9.03E-01
regulation of Fas signaling pathway (GO:1902044),3,0,0.3,-, < 0.01,7.37E-01
"base-excision repair, base-free sugar-phosphate removal (GO:0006286)",2,0,0.2,-, < 0.01,8.16E-01
protein exit from endoplasmic reticulum (GO:0032527),24,0,2.44,-, < 0.01,8.70E-02
somite rostral/caudal axis specification (GO:0032525),10,0,1.02,-, < 0.01,3.62E-01
protein-DNA covalent cross-linking repair (GO:0106300),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of hematopoietic stem cell differentiation (GO:1902038),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hematopoietic stem cell proliferation (GO:1902035),5,0,0.51,-, < 0.01,6.01E-01
regulation of hematopoietic stem cell proliferation (GO:1902033),8,0,0.81,-, < 0.01,4.43E-01
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973),2,0,0.2,-, < 0.01,8.16E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),5,0,0.51,-, < 0.01,6.01E-01
"tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)",1,0,0.1,-, < 0.01,9.03E-01
DNA replication termination (GO:0006274),1,0,0.1,-, < 0.01,9.03E-01
leading strand elongation (GO:0006272),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of phosphoprotein phosphatase activity (GO:0032516),20,0,2.03,-, < 0.01,1.31E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),16,0,1.63,-, < 0.01,1.96E-01
cellular response to L-ascorbic acid (GO:0071298),1,0,0.1,-, < 0.01,9.03E-01
tRNA exon ligation (GO:0000968),1,0,0.1,-, < 0.01,9.03E-01
L-histidine transport (GO:1902024),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial RNA 3'-end processing (GO:0000965),5,0,0.51,-, < 0.01,6.01E-01
mitochondrial RNA 5'-end processing (GO:0000964),3,0,0.3,-, < 0.01,7.37E-01
L-lysine transport (GO:1902022),4,0,0.41,-, < 0.01,6.66E-01
"DNA replication, synthesis of RNA primer (GO:0006269)",4,0,0.41,-, < 0.01,6.66E-01
positive regulation of mitochondrial RNA catabolic process (GO:0000962),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cilium-dependent cell motility (GO:1902020),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of mitochondrial RNA catabolic process (GO:0000961),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitochondrial RNA catabolic process (GO:0000960),4,0,0.41,-, < 0.01,6.66E-01
DNA topological change (GO:0006265),9,0,0.91,-, < 0.01,4.00E-01
cellular response to manganese ion (GO:0071287),7,0,0.71,-, < 0.01,4.91E-01
cellular response to magnesium ion (GO:0071286),6,0,0.61,-, < 0.01,5.43E-01
mitochondrial mRNA catabolic process (GO:0000958),3,0,0.3,-, < 0.01,7.37E-01
cellular response to lead ion (GO:0071284),4,0,0.41,-, < 0.01,6.66E-01
mitochondrial RNA catabolic process (GO:0000957),3,0,0.3,-, < 0.01,7.37E-01
cellular response to iron(III) ion (GO:0071283),2,0,0.2,-, < 0.01,8.16E-01
UDP-glucose catabolic process (GO:0006258),1,0,0.1,-, < 0.01,9.03E-01
UDP catabolic process (GO:0006256),2,0,0.2,-, < 0.01,8.16E-01
dCTP catabolic process (GO:0006253),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-aspartic acid phosphorylation (GO:0018217),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-arginine methylation (GO:0018216),13,0,1.32,-, < 0.01,2.67E-01
protein carboxylation (GO:0018214),3,0,0.3,-, < 0.01,7.37E-01
peptidyl-tryptophan modification (GO:0018211),5,0,0.51,-, < 0.01,6.01E-01
homogentisate catabolic process (GO:1902000),1,0,0.1,-, < 0.01,9.03E-01
protein delipidation (GO:0051697),1,0,0.1,-, < 0.01,9.03E-01
actin filament uncapping (GO:0051695),2,0,0.2,-, < 0.01,8.16E-01
pointed-end actin filament capping (GO:0051694),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of translational initiation in response to starvation (GO:0071264),2,0,0.2,-, < 0.01,8.16E-01
regulation of translational initiation in response to starvation (GO:0071262),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-glycine modification (GO:0018201),4,0,0.41,-, < 0.01,6.66E-01
dTTP biosynthetic process (GO:0006235),3,0,0.3,-, < 0.01,7.37E-01
establishment of ER localization (GO:0051686),1,0,0.1,-, < 0.01,9.03E-01
dTDP biosynthetic process (GO:0006233),1,0,0.1,-, < 0.01,9.03E-01
dTMP biosynthetic process (GO:0006231),3,0,0.3,-, < 0.01,7.37E-01
cellular response to magnetism (GO:0071259),2,0,0.2,-, < 0.01,8.16E-01
cellular response to gravity (GO:0071258),1,0,0.1,-, < 0.01,9.03E-01
cellular response to electrical stimulus (GO:0071257),9,0,0.91,-, < 0.01,4.00E-01
cellular response to nitrite (GO:0071250),1,0,0.1,-, < 0.01,9.03E-01
septin ring assembly (GO:0000921),1,0,0.1,-, < 0.01,9.03E-01
dUDP biosynthetic process (GO:0006227),1,0,0.1,-, < 0.01,9.03E-01
dUMP biosynthetic process (GO:0006226),2,0,0.2,-, < 0.01,8.16E-01
UMP biosynthetic process (GO:0006222),10,0,1.02,-, < 0.01,3.62E-01
transport of viral material towards nucleus (GO:0075606),1,0,0.1,-, < 0.01,9.03E-01
cellular response to chromate (GO:0071247),2,0,0.2,-, < 0.01,8.16E-01
division septum assembly (GO:0000917),1,0,0.1,-, < 0.01,9.03E-01
actomyosin contractile ring contraction (GO:0000916),1,0,0.1,-, < 0.01,9.03E-01
cellular response to ammonium ion (GO:0071242),3,0,0.3,-, < 0.01,7.37E-01
actomyosin contractile ring assembly (GO:0000915),4,0,0.41,-, < 0.01,6.66E-01
glutamatergic neuron differentiation (GO:1905962),5,0,0.51,-, < 0.01,6.01E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),4,0,0.41,-, < 0.01,6.66E-01
uridine catabolic process (GO:0006218),2,0,0.2,-, < 0.01,8.16E-01
UDP-N-acetylglucosamine transmembrane transport (GO:1990569),5,0,0.51,-, < 0.01,6.01E-01
cytidine catabolic process (GO:0006216),11,0,1.12,-, < 0.01,3.27E-01
actin cortical patch localization (GO:0051666),1,0,0.1,-, < 0.01,9.03E-01
thymidine catabolic process (GO:0006214),1,0,0.1,-, < 0.01,9.03E-01
membrane raft localization (GO:0051665),6,0,0.61,-, < 0.01,5.43E-01
nuclear pore localization (GO:0051664),1,0,0.1,-, < 0.01,9.03E-01
uracil catabolic process (GO:0006212),2,0,0.2,-, < 0.01,8.16E-01
5-methylcytosine catabolic process (GO:0006211),3,0,0.3,-, < 0.01,7.37E-01
thymine catabolic process (GO:0006210),3,0,0.3,-, < 0.01,7.37E-01
cellular response to antibiotic (GO:0071236),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of endothelial tube morphogenesis (GO:1905956),2,0,0.2,-, < 0.01,8.16E-01
cellular response to folic acid (GO:0071231),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine nucleobase catabolic process (GO:0006208),3,0,0.3,-, < 0.01,7.37E-01
maintenance of mitochondrion location (GO:0051659),2,0,0.2,-, < 0.01,8.16E-01
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207),6,0,0.61,-, < 0.01,5.43E-01
response to capsazepine (GO:1901594),1,0,0.1,-, < 0.01,9.03E-01
dGTP catabolic process (GO:0006203),3,0,0.3,-, < 0.01,7.37E-01
cellular response to tumor cell (GO:0071228),2,0,0.2,-, < 0.01,8.16E-01
cellular response to muramyl dipeptide (GO:0071225),9,0,0.91,-, < 0.01,4.00E-01
cellular response to peptidoglycan (GO:0071224),4,0,0.41,-, < 0.01,6.66E-01
regulation of response to calcium ion (GO:1905945),1,0,0.1,-, < 0.01,9.03E-01
cellular response to lipoteichoic acid (GO:0071223),9,0,0.91,-, < 0.01,4.00E-01
mitochondrial NAD transmembrane transport (GO:1990549),2,0,0.2,-, < 0.01,8.16E-01
mitochondrial FAD transmembrane transport (GO:1990548),1,0,0.1,-, < 0.01,9.03E-01
regulation of acid-sensing ion channel activity (GO:1901585),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1,0,0.1,-, < 0.01,9.03E-01
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580),1,0,0.1,-, < 0.01,9.03E-01
cellular response to misfolded protein (GO:0071218),19,0,1.93,-, < 0.01,1.45E-01
positive regulation of germ cell proliferation (GO:1905938),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of germ cell proliferation (GO:1905937),2,0,0.2,-, < 0.01,8.16E-01
regulation of germ cell proliferation (GO:1905936),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cell fate determination (GO:1905934),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell fate determination (GO:1905933),1,0,0.1,-, < 0.01,9.03E-01
protein targeting to vacuole involved in autophagy (GO:0071211),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932),1,0,0.1,-, < 0.01,9.03E-01
barbed-end actin filament uncapping (GO:0051638),1,0,0.1,-, < 0.01,9.03E-01
neuron projection maintenance (GO:1990535),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of invadopodium disassembly (GO:1905929),1,0,0.1,-, < 0.01,9.03E-01
establishment of protein localization to juxtaparanode region of axon (GO:0071206),1,0,0.1,-, < 0.01,9.03E-01
regulation of invadopodium disassembly (GO:1905927),1,0,0.1,-, < 0.01,9.03E-01
protein localization to juxtaparanode region of axon (GO:0071205),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of CoA-transferase activity (GO:1905920),1,0,0.1,-, < 0.01,9.03E-01
epinephrine uptake (GO:0051625),2,0,0.2,-, < 0.01,8.16E-01
response to camptothecin (GO:1901563),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of norepinephrine uptake (GO:0051623),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of norepinephrine uptake (GO:0051622),1,0,0.1,-, < 0.01,9.03E-01
response to benomyl (GO:1901561),1,0,0.1,-, < 0.01,9.03E-01
regulation of norepinephrine uptake (GO:0051621),2,0,0.2,-, < 0.01,8.16E-01
regulation of CoA-transferase activity (GO:1905918),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of calcium ion export across plasma membrane (GO:1905913),1,0,0.1,-, < 0.01,9.03E-01
response to metformin (GO:1901558),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine nucleotide import into mitochondrion (GO:1990519),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of endothelial cell development (GO:1901552),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of serotonin uptake (GO:0051612),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of endothelial cell development (GO:1901551),2,0,0.2,-, < 0.01,8.16E-01
regulation of serotonin uptake (GO:0051611),4,0,0.41,-, < 0.01,6.66E-01
regulation of endothelial cell development (GO:1901550),16,0,1.63,-, < 0.01,1.96E-01
negative regulation of excitatory postsynaptic potential (GO:0090394),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of amyloid fibril formation (GO:1905908),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of amyloid fibril formation (GO:1905907),6,0,0.61,-, < 0.01,5.43E-01
regulation of amyloid fibril formation (GO:1905906),8,0,0.81,-, < 0.01,4.43E-01
mitotic DNA replication maintenance of fidelity (GO:1990505),2,0,0.2,-, < 0.01,8.16E-01
dense core granule exocytosis (GO:1990504),6,0,0.61,-, < 0.01,5.43E-01
exocyst localization (GO:0051601),5,0,0.51,-, < 0.01,6.01E-01
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389),1,0,0.1,-, < 0.01,9.03E-01
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387),2,0,0.2,-, < 0.01,8.16E-01
phagosome maturation involved in apoptotic cell clearance (GO:0090386),2,0,0.2,-, < 0.01,8.16E-01
phagosome-lysosome docking (GO:0090384),1,0,0.1,-, < 0.01,9.03E-01
regulation of heart induction (GO:0090381),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of DNA demethylation (GO:1901537),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of anion channel activity (GO:1901529),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of mitophagy (GO:1901525),7,0,0.71,-, < 0.01,4.91E-01
icosanoid catabolic process (GO:1901523),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of mRNA modification (GO:0090366),1,0,0.1,-, < 0.01,9.03E-01
regulation of mRNA modification (GO:0090365),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of platelet-derived growth factor production (GO:0090362),2,0,0.2,-, < 0.01,8.16E-01
regulation of platelet-derived growth factor production (GO:0090361),3,0,0.3,-, < 0.01,7.37E-01
phosphatidylserine exposure on apoptotic cell surface (GO:0070782),5,0,0.51,-, < 0.01,6.01E-01
regulation of tryptophan metabolic process (GO:0090357),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular organofluorine metabolic process (GO:0090350),1,0,0.1,-, < 0.01,9.03E-01
D-aspartate import across plasma membrane (GO:0070779),4,0,0.41,-, < 0.01,6.66E-01
L-aspartate transmembrane transport (GO:0070778),11,0,1.12,-, < 0.01,3.27E-01
D-aspartate transport (GO:0070777),4,0,0.41,-, < 0.01,6.66E-01
regulation of endothelial tube morphogenesis (GO:1901509),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of acylglycerol transport (GO:1901508),2,0,0.2,-, < 0.01,8.16E-01
regulation of acylglycerol transport (GO:1901506),2,0,0.2,-, < 0.01,8.16E-01
ether biosynthetic process (GO:1901503),10,0,1.02,-, < 0.01,3.62E-01
ether catabolic process (GO:1901502),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140196),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular organohalogen metabolic process (GO:0090349),1,0,0.1,-, < 0.01,9.03E-01
neuromast hair cell differentiation (GO:0048886),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular organofluorine metabolic process (GO:0090348),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular organohalogen metabolic process (GO:0090347),1,0,0.1,-, < 0.01,9.03E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193),1,0,0.1,-, < 0.01,9.03E-01
neuromast development (GO:0048884),1,0,0.1,-, < 0.01,9.03E-01
cellular organofluorine metabolic process (GO:0090346),1,0,0.1,-, < 0.01,9.03E-01
regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192),2,0,0.2,-, < 0.01,8.16E-01
cellular organohalogen metabolic process (GO:0090345),1,0,0.1,-, < 0.01,9.03E-01
lateral line development (GO:0048882),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of secretion of lysosomal enzymes (GO:0090341),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of secretion of lysosomal enzymes (GO:0090340),1,0,0.1,-, < 0.01,9.03E-01
chemical homeostasis within a tissue (GO:0048875),10,0,1.02,-, < 0.01,3.62E-01
host-mediated regulation of intestinal microbiota composition (GO:0048874),2,0,0.2,-, < 0.01,8.16E-01
stem cell fate specification (GO:0048866),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of locomotion involved in locomotory behavior (GO:0090327),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of locomotion involved in locomotory behavior (GO:0090326),1,0,0.1,-, < 0.01,9.03E-01
regulation of locomotion involved in locomotory behavior (GO:0090325),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of oxidative phosphorylation (GO:0090324),7,0,0.71,-, < 0.01,4.91E-01
leukemia inhibitory factor signaling pathway (GO:0048861),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein targeting to membrane (GO:0090314),26,0,2.64,-, < 0.01,7.10E-02
negative regulation of DNA methylation-dependent heterochromatin assembly (GO:0090310),3,0,0.3,-, < 0.01,7.37E-01
histone H3-K27 methylation (GO:0070734),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of ribonucleoprotein complex localization (GO:2000199),1,0,0.1,-, < 0.01,9.03E-01
regulation of ribonucleoprotein complex localization (GO:2000197),6,0,0.61,-, < 0.01,5.43E-01
spindle assembly involved in meiosis (GO:0090306),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of neural crest formation (GO:0090301),1,0,0.1,-, < 0.01,9.03E-01
cyclic nucleotide transport (GO:0070729),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of phosphate transmembrane transport (GO:2000187),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphate transmembrane transport (GO:2000185),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of progesterone biosynthetic process (GO:2000184),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of androgen biosynthetic process (GO:2000180),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of postsynaptic cytosolic calcium concentration (GO:0099588),1,0,0.1,-, < 0.01,9.03E-01
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716),1,0,0.1,-, < 0.01,9.03E-01
sodium-dependent organic cation transport (GO:0070715),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of branching morphogenesis of a nerve (GO:2000173),1,0,0.1,-, < 0.01,9.03E-01
regulation of branching morphogenesis of a nerve (GO:2000172),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of dendrite development (GO:2000171),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170),3,0,0.3,-, < 0.01,7.37E-01
hair follicle maturation (GO:0048820),7,0,0.71,-, < 0.01,4.91E-01
"regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)",2,0,0.2,-, < 0.01,8.16E-01
detection of peptidoglycan (GO:0032499),1,0,0.1,-, < 0.01,9.03E-01
detection of muramyl dipeptide (GO:0032498),1,0,0.1,-, < 0.01,9.03E-01
detection of lipopolysaccharide (GO:0032497),3,0,0.3,-, < 0.01,7.37E-01
response to muramyl dipeptide (GO:0032495),18,0,1.83,-, < 0.01,1.60E-01
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),8,0,0.81,-, < 0.01,4.43E-01
detection of molecule of fungal origin (GO:0032491),1,0,0.1,-, < 0.01,9.03E-01
regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167),1,0,0.1,-, < 0.01,9.03E-01
regulation of hair follicle maturation (GO:0048819),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of hair follicle maturation (GO:0048818),5,0,0.51,-, < 0.01,6.01E-01
cytosol to ERGIC protein transport (GO:0106273),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hair follicle maturation (GO:0048817),2,0,0.2,-, < 0.01,8.16E-01
protein localization to ERGIC (GO:0106272),1,0,0.1,-, < 0.01,9.03E-01
age-dependent response to reactive oxygen species (GO:0001315),1,0,0.1,-, < 0.01,9.03E-01
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566),10,0,1.02,-, < 0.01,3.62E-01
maintenance of postsynaptic density structure (GO:0099562),7,0,0.71,-, < 0.01,4.91E-01
regulation of Cdc42 protein signal transduction (GO:0032489),7,0,0.71,-, < 0.01,4.91E-01
regulation of Rap protein signal transduction (GO:0032487),4,0,0.41,-, < 0.01,6.66E-01
regulation of Ral protein signal transduction (GO:0032485),3,0,0.3,-, < 0.01,7.37E-01
regulation of Rab protein signal transduction (GO:0032483),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of ubiquitin-specific protease activity (GO:2000158),2,0,0.2,-, < 0.01,8.16E-01
"regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)",2,0,0.2,-, < 0.01,8.16E-01
extracellular vesicle biogenesis (GO:0140112),7,0,0.71,-, < 0.01,4.91E-01
maintenance of synapse structure (GO:0099558),16,0,1.63,-, < 0.01,1.96E-01
"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)",3,0,0.3,-, < 0.01,7.37E-01
negative regulation by symbiont of host molecular function (GO:0052056),2,0,0.2,-, < 0.01,8.16E-01
"trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)",1,0,0.1,-, < 0.01,9.03E-01
modulation by symbiont of host molecular function (GO:0052055),2,0,0.2,-, < 0.01,8.16E-01
"trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)",1,0,0.1,-, < 0.01,9.03E-01
"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)",3,0,0.3,-, < 0.01,7.37E-01
negative regulation by symbiont of host catalytic activity (GO:0052053),1,0,0.1,-, < 0.01,9.03E-01
"trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)",3,0,0.3,-, < 0.01,7.37E-01
"trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)",2,0,0.2,-, < 0.01,8.16E-01
"trans-synaptic signaling, modulating synaptic transmission (GO:0099550)",11,0,1.12,-, < 0.01,3.27E-01
otolith formation (GO:0032475),1,0,0.1,-, < 0.01,9.03E-01
Golgi calcium ion transport (GO:0032472),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-glutamine modification (GO:0018199),4,0,0.41,-, < 0.01,6.66E-01
trans-synaptic signaling by nitric oxide (GO:0099548),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-alanine modification (GO:0018194),1,0,0.1,-, < 0.01,9.03E-01
"protein catabolic process, modulating synaptic transmission (GO:0099546)",1,0,0.1,-, < 0.01,9.03E-01
enzyme active site formation via cysteine modification to L-cysteine persulfide (GO:0018192),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-serine octanoylation (GO:0018191),1,0,0.1,-, < 0.01,9.03E-01
trans-synaptic signaling by soluble gas (GO:0099543),2,0,0.2,-, < 0.01,8.16E-01
protein octanoylation (GO:0018190),1,0,0.1,-, < 0.01,9.03E-01
trans-synaptic signaling by endocannabinoid (GO:0099542),5,0,0.51,-, < 0.01,6.01E-01
positive regulation by symbiont of host programmed cell death (GO:0052042),3,0,0.3,-, < 0.01,7.37E-01
trans-synaptic signaling by lipid (GO:0099541),5,0,0.51,-, < 0.01,6.01E-01
negative regulation by symbiont of host programmed cell death (GO:0052041),11,0,1.12,-, < 0.01,3.27E-01
trans-synaptic signaling by neuropeptide (GO:0099540),2,0,0.2,-, < 0.01,8.16E-01
modulation by symbiont of host programmed cell death (GO:0052040),16,0,1.63,-, < 0.01,1.96E-01
Golgi calcium ion homeostasis (GO:0032468),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cytokinesis (GO:0032466),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of protein homooligomerization (GO:0032464),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein homooligomerization (GO:0032463),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein homooligomerization (GO:0032462),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of protein oligomerization (GO:0032461),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein oligomerization (GO:0032460),2,0,0.2,-, < 0.01,8.16E-01
synaptic signaling via neuropeptide (GO:0099538),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533),3,0,0.3,-, < 0.01,7.37E-01
modulation by symbiont of host defense response (GO:0052031),7,0,0.71,-, < 0.01,4.91E-01
regulation of protein oligomerization (GO:0032459),4,0,0.41,-, < 0.01,6.66E-01
slow endocytic recycling (GO:0032458),1,0,0.1,-, < 0.01,9.03E-01
regulation of endocannabinoid signaling pathway (GO:2000124),3,0,0.3,-, < 0.01,7.37E-01
regulation of removal of superoxide radicals (GO:2000121),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of sodium-dependent phosphate transport (GO:2000120),2,0,0.2,-, < 0.01,8.16E-01
protein depropionylation (GO:0106230),2,0,0.2,-, < 0.01,8.16E-01
suppression by symbiont of host signal transduction pathway (GO:0052029),1,0,0.1,-, < 0.01,9.03E-01
protein nucleotidylation (GO:0018175),2,0,0.2,-, < 0.01,8.16E-01
postsynapse to nucleus signaling pathway (GO:0099527),5,0,0.51,-, < 0.01,6.01E-01
modulation by symbiont of host signal transduction pathway (GO:0052027),2,0,0.2,-, < 0.01,8.16E-01
presynapse to nucleus signaling pathway (GO:0099526),2,0,0.2,-, < 0.01,8.16E-01
translocation of molecules into host (GO:0044417),8,0,0.81,-, < 0.01,4.43E-01
modulation by symbiont of host transcription (GO:0052026),1,0,0.1,-, < 0.01,9.03E-01
presynaptic dense core vesicle exocytosis (GO:0099525),4,0,0.41,-, < 0.01,6.66E-01
suppression of host defenses by symbiont (GO:0044414),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-lysine glutarylation (GO:0106227),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of macrophage apoptotic process (GO:2000111),3,0,0.3,-, < 0.01,7.37E-01
C-terminal protein-tyrosinylation (GO:0018166),1,0,0.1,-, < 0.01,9.03E-01
adhesion of symbiont to host (GO:0044406),12,0,1.22,-, < 0.01,2.95E-01
peptidyl-pyrromethane cofactor linkage (GO:0018160),1,0,0.1,-, < 0.01,9.03E-01
AMP catabolic process (GO:0006196),2,0,0.2,-, < 0.01,8.16E-01
ITP catabolic process (GO:0006193),1,0,0.1,-, < 0.01,9.03E-01
activation of phospholipase A2 activity (GO:0032431),3,0,0.3,-, < 0.01,7.37E-01
thermosensory behavior (GO:0040040),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of phospholipase A2 activity (GO:0032430),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of mammary stem cell proliferation (GO:2000103),1,0,0.1,-, < 0.01,9.03E-01
regulation of mammary stem cell proliferation (GO:2000101),1,0,0.1,-, < 0.01,9.03E-01
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153),2,0,0.2,-, < 0.01,8.16E-01
regulation of presynaptic membrane potential (GO:0099505),5,0,0.51,-, < 0.01,6.01E-01
dGDP biosynthetic process (GO:0006185),1,0,0.1,-, < 0.01,9.03E-01
polar body extrusion after meiotic divisions (GO:0040038),5,0,0.51,-, < 0.01,6.01E-01
cGMP biosynthetic process (GO:0006182),11,0,1.12,-, < 0.01,3.27E-01
post-embryonic body morphogenesis (GO:0040032),1,0,0.1,-, < 0.01,9.03E-01
snRNA modification (GO:0040031),6,0,0.61,-, < 0.01,5.43E-01
"regulation of molecular function, epigenetic (GO:0040030)",2,0,0.2,-, < 0.01,8.16E-01
guanine salvage (GO:0006178),1,0,0.1,-, < 0.01,9.03E-01
GMP biosynthetic process (GO:0006177),3,0,0.3,-, < 0.01,7.37E-01
dATP biosynthetic process (GO:0006175),1,0,0.1,-, < 0.01,9.03E-01
dADP biosynthetic process (GO:0006173),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of sodium:proton antiporter activity (GO:0032417),4,0,0.41,-, < 0.01,6.66E-01
ADP biosynthetic process (GO:0006172),5,0,0.51,-, < 0.01,6.01E-01
cAMP biosynthetic process (GO:0006171),10,0,1.02,-, < 0.01,3.62E-01
dAMP biosynthetic process (GO:0006170),2,0,0.2,-, < 0.01,8.16E-01
adenine salvage (GO:0006168),2,0,0.2,-, < 0.01,8.16E-01
purine ribonucleoside salvage (GO:0006166),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of growth rate (GO:0040010),3,0,0.3,-, < 0.01,7.37E-01
peptidyl-cysteine methylation (GO:0018125),3,0,0.3,-, < 0.01,7.37E-01
peptidyl-arginine ADP-ribosylation (GO:0018120),4,0,0.41,-, < 0.01,6.66E-01
deoxyadenosine catabolic process (GO:0006157),1,0,0.1,-, < 0.01,9.03E-01
adenosine catabolic process (GO:0006154),3,0,0.3,-, < 0.01,7.37E-01
histone H2A-S1 phosphorylation (GO:0043990),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-cysteine S-nitrosylation (GO:0018119),6,0,0.61,-, < 0.01,5.43E-01
protein adenylylation (GO:0018117),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cellular response to tunicamycin (GO:1905896),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular response to tunicamycin (GO:1905895),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular response to tunicamycin (GO:1905894),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cellular response to thapsigargin (GO:1905893),1,0,0.1,-, < 0.01,9.03E-01
site-specific DNA replication termination at RTS1 barrier (GO:0071171),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular response to thapsigargin (GO:1905892),1,0,0.1,-, < 0.01,9.03E-01
site-specific DNA replication termination (GO:0071170),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular response to thapsigargin (GO:1905891),2,0,0.2,-, < 0.01,8.16E-01
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890),1,0,0.1,-, < 0.01,9.03E-01
response to hydrostatic pressure (GO:0051599),7,0,0.71,-, < 0.01,4.91E-01
guanine catabolic process (GO:0006147),1,0,0.1,-, < 0.01,9.03E-01
meiotic recombination checkpoint (GO:0051598),2,0,0.2,-, < 0.01,8.16E-01
histone H3-S28 phosphorylation (GO:0043988),2,0,0.2,-, < 0.01,8.16E-01
purine nucleobase catabolic process (GO:0006145),4,0,0.41,-, < 0.01,6.66E-01
histone H3-S10 phosphorylation (GO:0043987),5,0,0.51,-, < 0.01,6.01E-01
histone H4-R3 methylation (GO:0043985),6,0,0.61,-, < 0.01,5.43E-01
detection of glucose (GO:0051594),3,0,0.3,-, < 0.01,7.37E-01
histone H4-K16 acetylation (GO:0043984),10,0,1.02,-, < 0.01,3.62E-01
histone H4-K12 acetylation (GO:0043983),6,0,0.61,-, < 0.01,5.43E-01
histone H4-K8 acetylation (GO:0043982),12,0,1.22,-, < 0.01,2.95E-01
histone H4-K5 acetylation (GO:0043981),12,0,1.22,-, < 0.01,2.95E-01
histone H2B-K12 acetylation (GO:0043980),1,0,0.1,-, < 0.01,9.03E-01
viral translational frameshifting (GO:0075523),1,0,0.1,-, < 0.01,9.03E-01
IRES-dependent viral translational initiation (GO:0075522),9,0,0.91,-, < 0.01,4.00E-01
microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of triglyceride transport (GO:1905885),2,0,0.2,-, < 0.01,8.16E-01
protein C-linked glycosylation (GO:0018103),5,0,0.51,-, < 0.01,6.01E-01
DNA replication preinitiation complex assembly (GO:0071163),3,0,0.3,-, < 0.01,7.37E-01
regulation of triglyceride transport (GO:1905883),2,0,0.2,-, < 0.01,8.16E-01
histone H2B-K5 acetylation (GO:0043979),1,0,0.1,-, < 0.01,9.03E-01
histone H2A-K5 acetylation (GO:0043977),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585),1,0,0.1,-, < 0.01,9.03E-01
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),8,0,0.81,-, < 0.01,4.43E-01
histone H3-K4 acetylation (GO:0043973),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of neurotransmitter uptake (GO:0051582),4,0,0.41,-, < 0.01,6.66E-01
histone H3-K23 acetylation (GO:0043972),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of neurotransmitter uptake (GO:0051581),3,0,0.3,-, < 0.01,7.37E-01
histone H3-K9 acetylation (GO:0043970),2,0,0.2,-, < 0.01,8.16E-01
microtubule-dependent intracellular transport of viral material (GO:0075519),1,0,0.1,-, < 0.01,9.03E-01
clathrin-dependent endocytosis of virus by host cell (GO:0075512),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein localization to cell leading edge (GO:1905872),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein localization to cell leading edge (GO:1905871),1,0,0.1,-, < 0.01,9.03E-01
regulation of arginine metabolic process (GO:0000821),4,0,0.41,-, < 0.01,6.66E-01
glycerophosphate shuttle (GO:0006127),2,0,0.2,-, < 0.01,8.16E-01
response to ultrasound (GO:1990478),2,0,0.2,-, < 0.01,8.16E-01
regulation of glutamine family amino acid metabolic process (GO:0000820),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of histone H3-K9 methylation (GO:0051574),9,0,0.91,-, < 0.01,4.00E-01
"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",4,0,0.41,-, < 0.01,6.66E-01
negative regulation of histone H3-K4 methylation (GO:0051572),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of histone H3-K4 methylation (GO:0051571),17,0,1.73,-, < 0.01,1.77E-01
negative regulation of fatty acid beta-oxidation (GO:0031999),5,0,0.51,-, < 0.01,6.01E-01
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506),1,0,0.1,-, < 0.01,9.03E-01
mRNA export from nucleus in response to heat stress (GO:0031990),2,0,0.2,-, < 0.01,8.16E-01
invadopodium organization (GO:1905863),1,0,0.1,-, < 0.01,9.03E-01
resolution of mitotic recombination intermediates (GO:0071140),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of heparan sulfate proteoglycan binding (GO:1905860),1,0,0.1,-, < 0.01,9.03E-01
acetaldehyde metabolic process (GO:0006117),1,0,0.1,-, < 0.01,9.03E-01
protein autosumoylation (GO:1990466),1,0,0.1,-, < 0.01,9.03E-01
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mitochondrial calcium ion concentration (GO:0051562),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of cAMP-mediated signaling (GO:0043950),19,0,1.93,-, < 0.01,1.45E-01
bombesin receptor signaling pathway (GO:0031989),2,0,0.2,-, < 0.01,8.16E-01
resolution of recombination intermediates (GO:0071139),2,0,0.2,-, < 0.01,8.16E-01
regulation of heparan sulfate proteoglycan binding (GO:1905858),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of pentose-phosphate shunt (GO:1905856),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of heparan sulfate binding (GO:1905855),1,0,0.1,-, < 0.01,9.03E-01
regulation of heparan sulfate binding (GO:1905853),1,0,0.1,-, < 0.01,9.03E-01
malate metabolic process (GO:0006108),8,0,0.81,-, < 0.01,4.43E-01
positive regulation by host of symbiont catalytic activity (GO:0043947),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0043946),1,0,0.1,-, < 0.01,9.03E-01
regulation of cysteine metabolic process (GO:1901494),1,0,0.1,-, < 0.01,9.03E-01
flavone metabolic process (GO:0051552),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of lymphangiogenesis (GO:1901491),3,0,0.3,-, < 0.01,7.37E-01
cellular stress response to acidic pH (GO:1990451),1,0,0.1,-, < 0.01,9.03E-01
regulation of cellular response to gamma radiation (GO:1905843),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of keratinocyte migration (GO:0051548),2,0,0.2,-, < 0.01,8.16E-01
keratinocyte migration (GO:0051546),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of elastin biosynthetic process (GO:0051545),1,0,0.1,-, < 0.01,9.03E-01
regulation of elastin biosynthetic process (GO:0051543),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-threonine autophosphorylation (GO:1990443),2,0,0.2,-, < 0.01,8.16E-01
elastin biosynthetic process (GO:0051542),1,0,0.1,-, < 0.01,9.03E-01
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of telomeric D-loop disassembly (GO:1905839),2,0,0.2,-, < 0.01,8.16E-01
regulation of telomeric D-loop disassembly (GO:1905838),2,0,0.2,-, < 0.01,8.16E-01
histone biotinylation (GO:0071110),1,0,0.1,-, < 0.01,9.03E-01
U6 2'-O-snRNA methylation (GO:1990438),1,0,0.1,-, < 0.01,9.03E-01
snRNA 2'-O-methylation (GO:1990437),1,0,0.1,-, < 0.01,9.03E-01
modulation by host of viral transcription (GO:0043921),2,0,0.2,-, < 0.01,8.16E-01
mineralocorticoid receptor signaling pathway (GO:0031959),1,0,0.1,-, < 0.01,9.03E-01
corticosteroid receptor signaling pathway (GO:0031958),7,0,0.71,-, < 0.01,4.91E-01
superior temporal gyrus development (GO:0071109),2,0,0.2,-, < 0.01,8.16E-01
protein K48-linked deubiquitination (GO:0071108),29,0,2.95,-, < 0.01,5.23E-02
response to parathyroid hormone (GO:0071107),10,0,1.02,-, < 0.01,3.62E-01
regulation of prostaglandin catabolic process (GO:1905828),1,0,0.1,-, < 0.01,9.03E-01
response to interleukin-9 (GO:0071104),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of tetrapyrrole biosynthetic process (GO:1901465),1,0,0.1,-, < 0.01,9.03E-01
mitotic recombination-dependent replication fork processing (GO:1990426),2,0,0.2,-, < 0.01,8.16E-01
regulation of tetrapyrrole biosynthetic process (GO:1901463),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of glucocorticoid biosynthetic process (GO:0031948),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glucocorticoid metabolic process (GO:0031945),1,0,0.1,-, < 0.01,9.03E-01
response to insulin-like growth factor stimulus (GO:1990418),2,0,0.2,-, < 0.01,8.16E-01
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),10,0,1.02,-, < 0.01,3.62E-01
replication-born double-strand break repair via sister chromatid exchange (GO:1990414),8,0,0.81,-, < 0.01,4.43E-01
adrenomedullin receptor signaling pathway (GO:1990410),4,0,0.41,-, < 0.01,6.66E-01
regulation of neural crest formation (GO:0090299),1,0,0.1,-, < 0.01,9.03E-01
mitochondria-nucleus signaling pathway (GO:0031930),2,0,0.2,-, < 0.01,8.16E-01
nitrogen catabolite activation of transcription (GO:0090294),1,0,0.1,-, < 0.01,9.03E-01
nitrogen catabolite regulation of transcription (GO:0090293),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of osteoclast proliferation (GO:0090291),2,0,0.2,-, < 0.01,8.16E-01
regulation of cellular response to manganese ion (GO:1905802),1,0,0.1,-, < 0.01,9.03E-01
calcitonin gene-related peptide receptor signaling pathway (GO:1990408),3,0,0.3,-, < 0.01,7.37E-01
embryonic liver development (GO:1990402),2,0,0.2,-, < 0.01,8.16E-01
embryonic lung development (GO:1990401),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein glycosylation in Golgi (GO:0090285),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein glycosylation in Golgi (GO:0090284),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein glycosylation in Golgi (GO:0090283),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of calcium ion import (GO:0090281),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of calcium ion import (GO:0090280),19,0,1.93,-, < 0.01,1.45E-01
positive regulation of synaptic plasticity (GO:0031915),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of synaptic plasticity (GO:0031914),4,0,0.41,-, < 0.01,6.66E-01
regulation of calcium ion import (GO:0090279),36,0,3.66,-, < 0.01,2.56E-02
positive regulation of somatostatin secretion (GO:0090274),2,0,0.2,-, < 0.01,8.16E-01
regulation of somatostatin secretion (GO:0090273),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of fibroblast growth factor production (GO:0090272),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of fibroblast growth factor production (GO:0090271),5,0,0.51,-, < 0.01,6.01E-01
regulation of fibroblast growth factor production (GO:0090270),8,0,0.81,-, < 0.01,4.43E-01
response to benzene (GO:1901423),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),7,0,0.71,-, < 0.01,4.91E-01
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of inclusion body assembly (GO:0090261),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of retinal ganglion cell axon guidance (GO:0090260),2,0,0.2,-, < 0.01,8.16E-01
seminal clot liquefaction (GO:0070684),1,0,0.1,-, < 0.01,9.03E-01
proteasome regulatory particle assembly (GO:0070682),3,0,0.3,-, < 0.01,7.37E-01
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681),2,0,0.2,-, < 0.01,8.16E-01
regulation of retinal ganglion cell axon guidance (GO:0090259),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of mitochondrial fission (GO:0090258),4,0,0.41,-, < 0.01,6.66E-01
spontaneous exocytosis of neurotransmitter (GO:0048792),1,0,0.1,-, < 0.01,9.03E-01
maintenance of presynaptic active zone structure (GO:0048790),3,0,0.3,-, < 0.01,7.37E-01
protein localization involved in establishment of planar polarity (GO:0090251),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),3,0,0.3,-, < 0.01,7.37E-01
cytoskeletal matrix organization at active zone (GO:0048789),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell motility involved in somitogenic axis elongation (GO:0090249),2,0,0.2,-, < 0.01,8.16E-01
convergent extension involved in somitogenesis (GO:0090246),1,0,0.1,-, < 0.01,9.03E-01
axis elongation involved in somitogenesis (GO:0090245),4,0,0.41,-, < 0.01,6.66E-01
Wnt signaling pathway involved in somitogenesis (GO:0090244),5,0,0.51,-, < 0.01,6.01E-01
retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242),1,0,0.1,-, < 0.01,9.03E-01
response to interleukin-2 (GO:0070669),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of mast cell proliferation (GO:0070668),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mast cell proliferation (GO:0070667),3,0,0.3,-, < 0.01,7.37E-01
regulation of mast cell proliferation (GO:0070666),4,0,0.41,-, < 0.01,6.66E-01
mast cell proliferation (GO:0070662),1,0,0.1,-, < 0.01,9.03E-01
erythrophore differentiation (GO:0048773),1,0,0.1,-, < 0.01,9.03E-01
regulation of kinetochore assembly (GO:0090234),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of spindle checkpoint (GO:0090233),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of spindle checkpoint (GO:0090232),7,0,0.71,-, < 0.01,4.91E-01
regulation of spindle checkpoint (GO:0090231),14,0,1.42,-, < 0.01,2.41E-01
nonfunctional rRNA decay (GO:0070651),1,0,0.1,-, < 0.01,9.03E-01
sarcomerogenesis (GO:0048769),3,0,0.3,-, < 0.01,7.37E-01
cardiac endothelial to mesenchymal transition (GO:0140074),1,0,0.1,-, < 0.01,9.03E-01
regulation of microtubule nucleation by Ran protein signal transduction (GO:0090226),1,0,0.1,-, < 0.01,9.03E-01
centrosome-templated microtubule nucleation (GO:0090222),2,0,0.2,-, < 0.01,8.16E-01
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220),10,0,1.02,-, < 0.01,3.62E-01
formin-nucleated actin cable assembly (GO:0070649),3,0,0.3,-, < 0.01,7.37E-01
vitamin D3 metabolic process (GO:0070640),5,0,0.51,-, < 0.01,6.01E-01
pigment granule maturation (GO:0048757),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of lipid kinase activity (GO:0090219),4,0,0.41,-, < 0.01,6.66E-01
branching morphogenesis of a nerve (GO:0048755),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216),1,0,0.1,-, < 0.01,9.03E-01
regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of establishment of blood-brain barrier (GO:0090212),2,0,0.2,-, < 0.01,8.16E-01
regulation of establishment of blood-brain barrier (GO:0090210),3,0,0.3,-, < 0.01,7.37E-01
transepithelial ammonium transport (GO:0070634),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098),2,0,0.2,-, < 0.01,8.16E-01
regulation of smooth muscle cell-matrix adhesion (GO:2000097),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cholesterol metabolic process (GO:0090206),5,0,0.51,-, < 0.01,6.01E-01
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of skeletal muscle fiber development (GO:0048743),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of cholesterol metabolic process (GO:0090205),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of endocardial cushion to mesenchymal transition (GO:0140051),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle fiber development (GO:0048742),11,0,1.12,-, < 0.01,3.27E-01
gene looping (GO:0090202),4,0,0.41,-, < 0.01,6.66E-01
glucose import in response to insulin stimulus (GO:0044381),4,0,0.41,-, < 0.01,6.66E-01
zymogen granule exocytosis (GO:0070625),1,0,0.1,-, < 0.01,9.03E-01
regulation of endocardial cushion to mesenchymal transition (GO:0140049),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1,0,0.1,-, < 0.01,9.03E-01
sebaceous gland development (GO:0048733),7,0,0.71,-, < 0.01,4.91E-01
regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of type B pancreatic cell development (GO:2000078),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of type B pancreatic cell development (GO:2000077),2,0,0.2,-, < 0.01,8.16E-01
cell-cell adhesion in response to extracellular stimulus (GO:0140039),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of molecular function in other organism (GO:0044362),7,0,0.71,-, < 0.01,4.91E-01
regulation of centromeric sister chromatid cohesion (GO:0070602),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cortisol biosynthetic process (GO:2000066),1,0,0.1,-, < 0.01,9.03E-01
modulation of molecular function in other organism (GO:0044359),9,0,0.91,-, < 0.01,4.00E-01
regulation of rRNA stability (GO:0044357),1,0,0.1,-, < 0.01,9.03E-01
clearance of foreign intracellular DNA (GO:0044355),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of intracellular cholesterol transport (GO:0032385),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of intracellular cholesterol transport (GO:0032384),2,0,0.2,-, < 0.01,8.16E-01
regulation of intracellular cholesterol transport (GO:0032383),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of intracellular sterol transport (GO:0032382),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of intracellular sterol transport (GO:0032381),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057),1,0,0.1,-, < 0.01,9.03E-01
regulation of intracellular sterol transport (GO:0032380),8,0,0.81,-, < 0.01,4.43E-01
regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054),1,0,0.1,-, < 0.01,9.03E-01
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053),1,0,0.1,-, < 0.01,9.03E-01
histone displacement (GO:0001207),1,0,0.1,-, < 0.01,9.03E-01
embryonic viscerocranium morphogenesis (GO:0048703),11,0,1.12,-, < 0.01,3.27E-01
DNA excision (GO:0044349),1,0,0.1,-, < 0.01,9.03E-01
fibroblast apoptotic process (GO:0044346),3,0,0.3,-, < 0.01,7.37E-01
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345),1,0,0.1,-, < 0.01,9.03E-01
type B pancreatic cell proliferation (GO:0044342),9,0,0.91,-, < 0.01,4.00E-01
sodium-dependent phosphate transport (GO:0044341),3,0,0.3,-, < 0.01,7.37E-01
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of intracellular lipid transport (GO:0032379),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of intracellular lipid transport (GO:0032378),2,0,0.2,-, < 0.01,8.16E-01
regulation of intracellular lipid transport (GO:0032377),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),11,0,1.12,-, < 0.01,3.27E-01
L-aspartate import across plasma membrane (GO:0140009),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of cardiac cell fate specification (GO:2000044),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac cell fate specification (GO:2000043),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041),2,0,0.2,-, < 0.01,8.16E-01
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040),2,0,0.2,-, < 0.01,8.16E-01
canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339),2,0,0.2,-, < 0.01,8.16E-01
protein polyglycylation (GO:0018094),1,0,0.1,-, < 0.01,9.03E-01
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338),3,0,0.3,-, < 0.01,7.37E-01
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336),3,0,0.3,-, < 0.01,7.37E-01
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334),2,0,0.2,-, < 0.01,8.16E-01
canonical Wnt signaling pathway involved in positive regulation of wound healing (GO:0044330),1,0,0.1,-, < 0.01,9.03E-01
oxygen homeostasis (GO:0032364),7,0,0.71,-, < 0.01,4.91E-01
regulation of stem cell division (GO:2000035),9,0,0.91,-, < 0.01,4.00E-01
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329),1,0,0.1,-, < 0.01,9.03E-01
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328),1,0,0.1,-, < 0.01,9.03E-01
response to follicle-stimulating hormone (GO:0032354),16,0,1.63,-, < 0.01,1.96E-01
positive regulation of hormone metabolic process (GO:0032352),13,0,1.32,-, < 0.01,2.67E-01
negative regulation of glycine import across plasma membrane (GO:1900924),2,0,0.2,-, < 0.01,8.16E-01
regulation of glycine import across plasma membrane (GO:1900923),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cardiac muscle cell contraction (GO:0106135),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cardiac muscle cell contraction (GO:0106134),1,0,0.1,-, < 0.01,9.03E-01
protein K27-linked ubiquitination (GO:0044314),4,0,0.41,-, < 0.01,6.66E-01
protein K6-linked deubiquitination (GO:0044313),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of aldosterone biosynthetic process (GO:0032349),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of aldosterone metabolic process (GO:0032346),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of male gonad development (GO:2000019),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of determination of dorsal identity (GO:2000017),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of determination of dorsal identity (GO:2000016),2,0,0.2,-, < 0.01,8.16E-01
regulation of determination of dorsal identity (GO:2000015),4,0,0.41,-, < 0.01,6.66E-01
regulation of adaxial/abaxial pattern formation (GO:2000011),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of sterol biosynthetic process (GO:0106120),8,0,0.81,-, < 0.01,4.43E-01
glyoxylate cycle (GO:0006097),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein localization to cell surface (GO:2000009),13,0,1.32,-, < 0.01,2.67E-01
negative regulation of sterol biosynthetic process (GO:0106119),5,0,0.51,-, < 0.01,6.01E-01
regulation of sterol biosynthetic process (GO:0106118),44,0,4.47,-, < 0.01,1.13E-02
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric comma-shaped body morphogenesis (GO:2000006),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric S-shaped body morphogenesis (GO:2000004),1,0,0.1,-, < 0.01,9.03E-01
acetyl-CoA biosynthetic process from pyruvate (GO:0006086),7,0,0.71,-, < 0.01,4.91E-01
serine transport (GO:0032329),10,0,1.02,-, < 0.01,3.62E-01
alanine transport (GO:0032328),15,0,1.52,-, < 0.01,2.17E-01
acetate metabolic process (GO:0006083),2,0,0.2,-, < 0.01,8.16E-01
regulation of glutamate receptor clustering (GO:0106104),6,0,0.61,-, < 0.01,5.43E-01
ER-dependent peroxisome localization (GO:0106101),1,0,0.1,-, < 0.01,9.03E-01
glycerol-3-phosphate metabolic process (GO:0006072),8,0,0.81,-, < 0.01,4.43E-01
prostaglandin secretion (GO:0032310),3,0,0.3,-, < 0.01,7.37E-01
UDP-glucuronate biosynthetic process (GO:0006065),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of prostaglandin secretion (GO:0032307),2,0,0.2,-, < 0.01,8.16E-01
sorbitol catabolic process (GO:0006062),1,0,0.1,-, < 0.01,9.03E-01
sorbitol biosynthetic process (GO:0006061),1,0,0.1,-, < 0.01,9.03E-01
sorbitol metabolic process (GO:0006060),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-histidine methylation (GO:0018021),2,0,0.2,-, < 0.01,8.16E-01
hexitol metabolic process (GO:0006059),3,0,0.3,-, < 0.01,7.37E-01
mannoprotein biosynthetic process (GO:0006057),1,0,0.1,-, < 0.01,9.03E-01
mannoprotein metabolic process (GO:0006056),1,0,0.1,-, < 0.01,9.03E-01
N-acetylneuraminate metabolic process (GO:0006054),11,0,1.12,-, < 0.01,3.27E-01
N-acetylmannosamine metabolic process (GO:0006051),2,0,0.2,-, < 0.01,8.16E-01
mannosamine metabolic process (GO:0006050),2,0,0.2,-, < 0.01,8.16E-01
regulation of intraciliary retrograde transport (GO:1905799),2,0,0.2,-, < 0.01,8.16E-01
N-terminal peptidyl-proline dimethylation (GO:0018016),1,0,0.1,-, < 0.01,9.03E-01
cellular response to puromycin (GO:1905795),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-glycine methylation (GO:0018013),1,0,0.1,-, < 0.01,9.03E-01
response to puromycin (GO:1905794),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-alanine trimethylation (GO:0018012),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phospholipid biosynthetic process (GO:0071072),5,0,0.51,-, < 0.01,6.01E-01
protein localization to pericentriolar material (GO:1905793),2,0,0.2,-, < 0.01,8.16E-01
N-terminal peptidyl-alanine methylation (GO:0018011),1,0,0.1,-, < 0.01,9.03E-01
UDP-N-acetylglucosamine catabolic process (GO:0006049),1,0,0.1,-, < 0.01,9.03E-01
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),11,0,1.12,-, < 0.01,3.27E-01
karyogamy (GO:0000741),1,0,0.1,-, < 0.01,9.03E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047),16,0,1.63,-, < 0.01,1.96E-01
N-acetylglucosamine catabolic process (GO:0006046),3,0,0.3,-, < 0.01,7.37E-01
N-acetylglucosamine biosynthetic process (GO:0006045),2,0,0.2,-, < 0.01,8.16E-01
glucosamine catabolic process (GO:0006043),2,0,0.2,-, < 0.01,8.16E-01
glucosamine metabolic process (GO:0006041),4,0,0.41,-, < 0.01,6.66E-01
protein K33-linked ubiquitination (GO:1990390),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-glycine N-myristoylation (GO:0018008),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788),1,0,0.1,-, < 0.01,9.03E-01
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),3,0,0.3,-, < 0.01,7.37E-01
peptidyl-lysine N6-acetylation (GO:0018003),2,0,0.2,-, < 0.01,8.16E-01
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784),3,0,0.3,-, < 0.01,7.37E-01
N-terminal peptidyl-glutamic acid acetylation (GO:0018002),1,0,0.1,-, < 0.01,9.03E-01
removal of nonhomologous ends (GO:0000735),1,0,0.1,-, < 0.01,9.03E-01
strand displacement (GO:0000732),1,0,0.1,-, < 0.01,9.03E-01
mitotic cleavage furrow ingression (GO:1990386),1,0,0.1,-, < 0.01,9.03E-01
chitin catabolic process (GO:0006032),6,0,0.61,-, < 0.01,5.43E-01
chitin metabolic process (GO:0006030),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of exonuclease activity (GO:1905779),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of exonuclease activity (GO:1905778),2,0,0.2,-, < 0.01,8.16E-01
regulation of exonuclease activity (GO:1905777),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of DNA helicase activity (GO:1905775),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of mesodermal cell differentiation (GO:1905772),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mesodermal cell differentiation (GO:1905771),3,0,0.3,-, < 0.01,7.37E-01
regulation of mesodermal cell differentiation (GO:1905770),7,0,0.71,-, < 0.01,4.91E-01
lipid transport across blood-brain barrier (GO:1990379),5,0,0.51,-, < 0.01,6.01E-01
inhibitory chemical synaptic transmission (GO:0098977),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720),4,0,0.41,-, < 0.01,6.66E-01
excitatory chemical synaptic transmission (GO:0098976),9,0,0.91,-, < 0.01,4.00E-01
anterograde dendritic transport of mitochondrion (GO:0098972),1,0,0.1,-, < 0.01,9.03E-01
inositol biosynthetic process (GO:0006021),3,0,0.3,-, < 0.01,7.37E-01
inositol metabolic process (GO:0006020),10,0,1.02,-, < 0.01,3.62E-01
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),8,0,0.81,-, < 0.01,4.43E-01
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049),2,0,0.2,-, < 0.01,8.16E-01
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048),2,0,0.2,-, < 0.01,8.16E-01
polyadenylation-dependent mRNA catabolic process (GO:0071047),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of double-stranded telomeric DNA binding (GO:1905768),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),6,0,0.61,-, < 0.01,5.43E-01
regulation of double-stranded telomeric DNA binding (GO:1905767),1,0,0.1,-, < 0.01,9.03E-01
nuclear histone mRNA catabolic process (GO:0071045),1,0,0.1,-, < 0.01,9.03E-01
"nucleotide-excision repair, DNA damage removal (GO:0000718)",1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protection from non-homologous end joining at telomere (GO:1905765),3,0,0.3,-, < 0.01,7.37E-01
CUT metabolic process (GO:0071043),4,0,0.41,-, < 0.01,6.66E-01
regulation of protection from non-homologous end joining at telomere (GO:1905764),3,0,0.3,-, < 0.01,7.37E-01
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042),4,0,0.41,-, < 0.01,6.66E-01
antisense RNA transcript catabolic process (GO:0071041),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040),1,0,0.1,-, < 0.01,9.03E-01
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968),1,0,0.1,-, < 0.01,9.03E-01
meiotic DNA repair synthesis (GO:0000711),2,0,0.2,-, < 0.01,8.16E-01
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of corticotropin-releasing hormone secretion (GO:0051466),3,0,0.3,-, < 0.01,7.37E-01
D-ribose metabolic process (GO:0006014),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cortisol secretion (GO:0051464),4,0,0.41,-, < 0.01,6.66E-01
dendritic transport of messenger ribonucleoprotein complex (GO:0098963),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cortisol secretion (GO:0051463),1,0,0.1,-, < 0.01,9.03E-01
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),14,0,1.42,-, < 0.01,2.41E-01
UDP-glucose metabolic process (GO:0006011),4,0,0.41,-, < 0.01,6.66E-01
regulation of cortisol secretion (GO:0051462),5,0,0.51,-, < 0.01,6.01E-01
dendritic transport of ribonucleoprotein complex (GO:0098961),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of corticotropin secretion (GO:0051461),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of corticotropin secretion (GO:0051460),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),6,0,0.61,-, < 0.01,5.43E-01
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036),1,0,0.1,-, < 0.01,9.03E-01
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),6,0,0.61,-, < 0.01,5.43E-01
CUT catabolic process (GO:0071034),4,0,0.41,-, < 0.01,6.66E-01
nuclear retention of pre-mRNA at the site of transcription (GO:0071033),5,0,0.51,-, < 0.01,6.01E-01
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031),2,0,0.2,-, < 0.01,8.16E-01
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of endosome to plasma membrane protein transport (GO:1905751),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cardioblast cell fate specification (GO:0009997),1,0,0.1,-, < 0.01,9.03E-01
regulation of corticotropin secretion (GO:0051459),6,0,0.61,-, < 0.01,5.43E-01
retrograde axonal transport of mitochondrion (GO:0098958),2,0,0.2,-, < 0.01,8.16E-01
regulation of transforming growth factor beta3 activation (GO:1901398),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell fate specification (GO:0009996),5,0,0.51,-, < 0.01,6.01E-01
corticotropin secretion (GO:0051458),1,0,0.1,-, < 0.01,9.03E-01
anterograde axonal transport of mitochondrion (GO:0098957),4,0,0.41,-, < 0.01,6.66E-01
"fructose 2,6-bisphosphate metabolic process (GO:0006003)",4,0,0.41,-, < 0.01,6.66E-01
intracellular pH elevation (GO:0051454),6,0,0.61,-, < 0.01,5.43E-01
receptor diffusion trapping (GO:0098953),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of transforming growth factor beta1 activation (GO:1901393),1,0,0.1,-, < 0.01,9.03E-01
myoblast proliferation (GO:0051450),4,0,0.41,-, < 0.01,6.66E-01
nuclear ncRNA surveillance (GO:0071029),6,0,0.61,-, < 0.01,5.43E-01
regulation of endosome to plasma membrane protein transport (GO:1905749),4,0,0.41,-, < 0.01,6.66E-01
cytoplasmic RNA surveillance (GO:0071026),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of transforming growth factor beta activation (GO:1901389),2,0,0.2,-, < 0.01,8.16E-01
gap junction-mediated intercellular transport (GO:1990349),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of meiotic cell cycle (GO:0051447),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of chorionic trophoblast cell proliferation (GO:1901384),1,0,0.1,-, < 0.01,9.03E-01
"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",7,0,0.71,-, < 0.01,4.91E-01
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of L-proline import across plasma membrane (GO:1905737),1,0,0.1,-, < 0.01,9.03E-01
regulation of L-proline import across plasma membrane (GO:1905735),1,0,0.1,-, < 0.01,9.03E-01
dendritic transport of mitochondrion (GO:0098939),2,0,0.2,-, < 0.01,8.16E-01
acetate ester transport (GO:1901374),3,0,0.3,-, < 0.01,7.37E-01
cytidine deamination (GO:0009972),11,0,1.12,-, < 0.01,3.27E-01
lipid hydroperoxide transport (GO:1901373),1,0,0.1,-, < 0.01,9.03E-01
response to magnetism (GO:0071000),3,0,0.3,-, < 0.01,7.37E-01
presynaptic signal transduction (GO:0098928),2,0,0.2,-, < 0.01,8.16E-01
retrograde trans-synaptic signaling by nitric oxide (GO:0098924),1,0,0.1,-, < 0.01,9.03E-01
retrograde trans-synaptic signaling by soluble gas (GO:0098923),1,0,0.1,-, < 0.01,9.03E-01
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921),2,0,0.2,-, < 0.01,8.16E-01
retrograde trans-synaptic signaling by lipid (GO:0098920),2,0,0.2,-, < 0.01,8.16E-01
protein localization to perinuclear region of cytoplasm (GO:1905719),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cornification (GO:1905716),1,0,0.1,-, < 0.01,9.03E-01
regulation of cornification (GO:1905715),1,0,0.1,-, < 0.01,9.03E-01
response to phosphatidylethanolamine (GO:1905711),1,0,0.1,-, < 0.01,9.03E-01
epidermal cell fate specification (GO:0009957),3,0,0.3,-, < 0.01,7.37E-01
radial pattern formation (GO:0009956),1,0,0.1,-, < 0.01,9.03E-01
retrograde trans-synaptic signaling (GO:0098917),7,0,0.71,-, < 0.01,4.91E-01
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),10,0,1.02,-, < 0.01,3.62E-01
response to rapamycin (GO:1901355),3,0,0.3,-, < 0.01,7.37E-01
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),5,0,0.51,-, < 0.01,6.01E-01
response to cortisol (GO:0051414),5,0,0.51,-, < 0.01,6.01E-01
cellular response to insulin-like growth factor stimulus (GO:1990314),9,0,0.91,-, < 0.01,4.00E-01
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912),3,0,0.3,-, < 0.01,7.37E-01
dorsal/ventral axis specification (GO:0009950),11,0,1.12,-, < 0.01,3.27E-01
response to corticosterone (GO:0051412),21,0,2.13,-, < 0.01,1.18E-01
regulation of atrial cardiac muscle cell action potential (GO:0098910),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of membrane permeability (GO:1905709),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of glomerulus development (GO:0090194),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glomerulus development (GO:0090193),4,0,0.41,-, < 0.01,6.66E-01
regulation of glomerulus development (GO:0090192),5,0,0.51,-, < 0.01,6.01E-01
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of inhibitory synapse assembly (GO:1905703),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),8,0,0.81,-, < 0.01,4.43E-01
response to nitrosative stress (GO:0051409),8,0,0.81,-, < 0.01,4.43E-01
regulation of SA node cell action potential (GO:0098907),1,0,0.1,-, < 0.01,9.03E-01
regulation of Purkinje myocyte action potential (GO:0098906),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346),1,0,0.1,-, < 0.01,9.03E-01
regulation of bundle of His cell action potential (GO:0098905),2,0,0.2,-, < 0.01,8.16E-01
regulation of AV node cell action potential (GO:0098904),3,0,0.3,-, < 0.01,7.37E-01
response to leptomycin B (GO:1901344),2,0,0.2,-, < 0.01,8.16E-01
regulation of membrane depolarization during action potential (GO:0098902),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of store-operated calcium channel activity (GO:1901340),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of pancreatic juice secretion (GO:0090188),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of pancreatic juice secretion (GO:0090187),2,0,0.2,-, < 0.01,8.16E-01
regulation of pancreatic juice secretion (GO:0090186),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of kidney development (GO:0090184),10,0,1.02,-, < 0.01,3.62E-01
regulation of secretion of lysosomal enzymes (GO:0090182),2,0,0.2,-, < 0.01,8.16E-01
thioester transport (GO:1901337),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of odontoblast differentiation (GO:1901331),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in neural tube closure (GO:0090179),12,0,1.22,-, < 0.01,2.95E-01
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178),14,0,1.42,-, < 0.01,2.41E-01
establishment of planar polarity involved in neural tube closure (GO:0090177),1,0,0.1,-, < 0.01,9.03E-01
microtubule cytoskeleton organization involved in homologous chromosome segregation (GO:0090172),1,0,0.1,-, < 0.01,9.03E-01
chondrocyte morphogenesis (GO:0090171),1,0,0.1,-, < 0.01,9.03E-01
regulation of Golgi inheritance (GO:0090170),4,0,0.41,-, < 0.01,6.66E-01
regulation of odontoblast differentiation (GO:1901329),4,0,0.41,-, < 0.01,6.66E-01
response to cytochalasin B (GO:1901328),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of heart induction (GO:1901321),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of heart induction (GO:1901320),1,0,0.1,-, < 0.01,9.03E-01
Golgi reassembly (GO:0090168),4,0,0.41,-, < 0.01,6.66E-01
Golgi disassembly (GO:0090166),6,0,0.61,-, < 0.01,5.43E-01
asymmetric Golgi ribbon formation (GO:0090164),2,0,0.2,-, < 0.01,8.16E-01
Golgi to lysosome transport (GO:0090160),8,0,0.81,-, < 0.01,4.43E-01
cellular component macromolecule biosynthetic process (GO:0070589),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of flagellated sperm motility (GO:1901318),3,0,0.3,-, < 0.01,7.37E-01
mitochondrion morphogenesis (GO:0070584),21,0,2.13,-, < 0.01,1.18E-01
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315),4,0,0.41,-, < 0.01,6.66E-01
auditory receptor cell fate commitment (GO:0009912),4,0,0.41,-, < 0.01,6.66E-01
regulation of histone H2A K63-linked ubiquitination (GO:1901314),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of sterol regulatory element binding protein cleavage (GO:1901310),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of collateral sprouting in absence of injury (GO:0048697),2,0,0.2,-, < 0.01,8.16E-01
regulation of collateral sprouting in absence of injury (GO:0048696),2,0,0.2,-, < 0.01,8.16E-01
endoplasmic reticulum membrane organization (GO:0090158),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of collateral sprouting of injured axon (GO:0048694),1,0,0.1,-, < 0.01,9.03E-01
cellular sphingolipid homeostasis (GO:0090156),5,0,0.51,-, < 0.01,6.01E-01
regulation of collateral sprouting of injured axon (GO:0048693),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of sphingolipid biosynthetic process (GO:0090155),6,0,0.61,-, < 0.01,5.43E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of axon extension involved in regeneration (GO:0048692),2,0,0.2,-, < 0.01,8.16E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of axon extension involved in regeneration (GO:0048691),2,0,0.2,-, < 0.01,8.16E-01
regulation of axon extension involved in regeneration (GO:0048690),4,0,0.41,-, < 0.01,6.66E-01
regulation of sterol regulatory element binding protein cleavage (GO:1901308),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of spermidine biosynthetic process (GO:1901307),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of neuron projection regeneration (GO:0070572),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of neuron projection regeneration (GO:0070571),13,0,1.32,-, < 0.01,2.67E-01
regulation of spermidine biosynthetic process (GO:1901304),1,0,0.1,-, < 0.01,9.03E-01
regulation of neuron projection regeneration (GO:0070570),27,0,2.74,-, < 0.01,6.41E-02
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303),1,0,0.1,-, < 0.01,9.03E-01
regulation of cargo loading into COPII-coated vesicle (GO:1901301),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300),4,0,0.41,-, < 0.01,6.66E-01
dimethylallyl diphosphate metabolic process (GO:0050993),2,0,0.2,-, < 0.01,8.16E-01
dimethylallyl diphosphate biosynthetic process (GO:0050992),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of sprouting of injured axon (GO:0048688),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of sprouting of injured axon (GO:0048687),2,0,0.2,-, < 0.01,8.16E-01
mitochondrial membrane fission (GO:0090149),2,0,0.2,-, < 0.01,8.16E-01
regulation of sprouting of injured axon (GO:0048686),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685),1,0,0.1,-, < 0.01,9.03E-01
regulation of collateral sprouting of intact axon in response to injury (GO:0048683),1,0,0.1,-, < 0.01,9.03E-01
sprouting of injured axon (GO:0048682),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial nucleoid organization (GO:0090144),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of axon regeneration (GO:0048681),12,0,1.22,-, < 0.01,2.95E-01
nucleoid organization (GO:0090143),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of axon regeneration (GO:0048680),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of mitochondrial fission (GO:0090141),14,0,1.42,-, < 0.01,2.41E-01
regulation of mitochondrial fission (GO:0090140),24,0,2.44,-, < 0.01,8.70E-02
positive regulation of vitamin D receptor signaling pathway (GO:0070564),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of vitamin D receptor signaling pathway (GO:0070563),2,0,0.2,-, < 0.01,8.16E-01
protein secretion by platelet (GO:0070560),2,0,0.2,-, < 0.01,8.16E-01
regulation of axon regeneration (GO:0048679),24,0,2.44,-, < 0.01,8.70E-02
axon extension involved in regeneration (GO:0048677),1,0,0.1,-, < 0.01,9.03E-01
transcriptional start site selection at RNA polymerase II promoter (GO:0001174),1,0,0.1,-, < 0.01,9.03E-01
actin filament branching (GO:0090135),3,0,0.3,-, < 0.01,7.37E-01
DNA-templated transcriptional start site selection (GO:0001173),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in mesendoderm migration (GO:0090134),1,0,0.1,-, < 0.01,9.03E-01
"transcription, RNA-templated (GO:0001172)",2,0,0.2,-, < 0.01,8.16E-01
negative regulation of collateral sprouting (GO:0048671),9,0,0.91,-, < 0.01,4.00E-01
mesendoderm migration (GO:0090133),1,0,0.1,-, < 0.01,9.03E-01
rDNA condensation (GO:0070550),1,0,0.1,-, < 0.01,9.03E-01
detection of mechanical stimulus involved in equilibrioception (GO:0050973),1,0,0.1,-, < 0.01,9.03E-01
collateral sprouting in absence of injury (GO:0048669),2,0,0.2,-, < 0.01,8.16E-01
collateral sprouting (GO:0048668),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of synapse maturation (GO:0090129),8,0,0.81,-, < 0.01,4.43E-01
neuron fate determination (GO:0048664),8,0,0.81,-, < 0.01,4.43E-01
protein-containing complex assembly involved in synapse maturation (GO:0090126),1,0,0.1,-, < 0.01,9.03E-01
cholesterol ester hydrolysis involved in cholesterol transport (GO:0090122),1,0,0.1,-, < 0.01,9.03E-01
histone H3-K36 demethylation (GO:0070544),8,0,0.81,-, < 0.01,4.43E-01
response to linoleic acid (GO:0070543),2,0,0.2,-, < 0.01,8.16E-01
response to platinum ion (GO:0070541),3,0,0.3,-, < 0.01,7.37E-01
detection of chemical stimulus involved in sensory perception of pain (GO:0050968),3,0,0.3,-, < 0.01,7.37E-01
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966),12,0,1.22,-, < 0.01,2.95E-01
detection of temperature stimulus involved in sensory perception of pain (GO:0050965),18,0,1.83,-, < 0.01,1.60E-01
smooth muscle cell proliferation (GO:0048659),3,0,0.3,-, < 0.01,7.37E-01
detection of temperature stimulus involved in sensory perception (GO:0050961),19,0,1.93,-, < 0.01,1.45E-01
detection of temperature stimulus involved in thermoception (GO:0050960),2,0,0.2,-, < 0.01,8.16E-01
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118),3,0,0.3,-, < 0.01,7.37E-01
C-5 methylation of cytosine (GO:0090116),3,0,0.3,-, < 0.01,7.37E-01
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113),4,0,0.41,-, < 0.01,6.66E-01
histone H2A K63-linked deubiquitination (GO:0070537),3,0,0.3,-, < 0.01,7.37E-01
histone H2A K63-linked ubiquitination (GO:0070535),2,0,0.2,-, < 0.01,8.16E-01
thermoception (GO:0050955),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of high-density lipoprotein particle assembly (GO:0090108),2,0,0.2,-, < 0.01,8.16E-01
regulation of high-density lipoprotein particle assembly (GO:0090107),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of skeletal muscle tissue development (GO:0048642),4,0,0.41,-, < 0.01,6.66E-01
pancreatic epsilon cell differentiation (GO:0090104),1,0,0.1,-, < 0.01,9.03E-01
response to ceramide (GO:0106096),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of pigment cell differentiation (GO:0050942),7,0,0.71,-, < 0.01,4.91E-01
glial cell projection elongation (GO:0106091),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of muscle organ development (GO:0048635),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of skeletal muscle tissue growth (GO:0048633),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of skeletal muscle tissue growth (GO:0048632),2,0,0.2,-, < 0.01,8.16E-01
regulation of skeletal muscle tissue growth (GO:0048631),5,0,0.51,-, < 0.01,6.01E-01
skeletal muscle tissue growth (GO:0048630),3,0,0.3,-, < 0.01,7.37E-01
cell wall disruption in other organism (GO:0044278),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of histone H4-K20 methylation (GO:0070512),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H4-K20 methylation (GO:0070510),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088),1,0,0.1,-, < 0.01,9.03E-01
regulation of pigment cell differentiation (GO:0050932),8,0,0.81,-, < 0.01,4.43E-01
myoblast development (GO:0048627),3,0,0.3,-, < 0.01,7.37E-01
post-embryonic digestive tract morphogenesis (GO:0048621),1,0,0.1,-, < 0.01,9.03E-01
glycerol ether catabolic process (GO:0044269),2,0,0.2,-, < 0.01,8.16E-01
protein-DNA complex remodeling (GO:0001120),2,0,0.2,-, < 0.01,8.16E-01
cholesterol import (GO:0070508),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of DNA-dependent DNA replication initiation (GO:0032298),2,0,0.2,-, < 0.01,8.16E-01
induction of negative chemotaxis (GO:0050929),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of positive chemotaxis (GO:0050928),1,0,0.1,-, < 0.01,9.03E-01
peripheral nervous system myelin formation (GO:0032290),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of negative chemotaxis (GO:0050925),2,0,0.2,-, < 0.01,8.16E-01
histone succinylation (GO:0106077),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of negative chemotaxis (GO:0050924),1,0,0.1,-, < 0.01,9.03E-01
regulation of negative chemotaxis (GO:0050923),4,0,0.41,-, < 0.01,6.66E-01
embryonic hindgut morphogenesis (GO:0048619),3,0,0.3,-, < 0.01,7.37E-01
aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071),5,0,0.51,-, < 0.01,6.01E-01
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),11,0,1.12,-, < 0.01,3.27E-01
embryonic ectodermal digestive tract morphogenesis (GO:0048613),1,0,0.1,-, < 0.01,9.03E-01
transcription open complex formation at RNA polymerase II promoter (GO:0001113),1,0,0.1,-, < 0.01,9.03E-01
DNA-templated transcription open complex formation (GO:0001112),2,0,0.2,-, < 0.01,8.16E-01
embryonic ectodermal digestive tract development (GO:0048611),2,0,0.2,-, < 0.01,8.16E-01
intestinal lipid catabolic process (GO:0044258),2,0,0.2,-, < 0.01,8.16E-01
central nervous system myelin formation (GO:0032289),4,0,0.41,-, < 0.01,6.66E-01
peripheral nervous system myelin maintenance (GO:0032287),8,0,0.81,-, < 0.01,4.43E-01
central nervous system myelin maintenance (GO:0032286),4,0,0.41,-, < 0.01,6.66E-01
sensory perception of sweet taste (GO:0050916),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of exit from mitosis (GO:0001100),1,0,0.1,-, < 0.01,9.03E-01
polysaccharide digestion (GO:0044245),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of gonadotropin secretion (GO:0032278),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of gonadotropin secretion (GO:0032277),8,0,0.81,-, < 0.01,4.43E-01
regulation of gonadotropin secretion (GO:0032276),11,0,1.12,-, < 0.01,3.27E-01
luteinizing hormone secretion (GO:0032275),4,0,0.41,-, < 0.01,6.66E-01
gonadotropin secretion (GO:0032274),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of calcineurin-mediated signaling (GO:0106058),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of calcineurin-mediated signaling (GO:0106057),14,0,1.42,-, < 0.01,2.41E-01
diapedesis (GO:0050904),7,0,0.71,-, < 0.01,4.91E-01
regulation of calcineurin-mediated signaling (GO:0106056),33,0,3.35,-, < 0.01,3.48E-02
leukocyte adhesive activation (GO:0050902),2,0,0.2,-, < 0.01,8.16E-01
IMP salvage (GO:0032264),4,0,0.41,-, < 0.01,6.66E-01
GMP salvage (GO:0032263),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine nucleotide salvage (GO:0032262),5,0,0.51,-, < 0.01,6.01E-01
purine nucleotide salvage (GO:0032261),7,0,0.71,-, < 0.01,4.91E-01
regulation of GABA-A receptor activity (GO:0106040),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826),1,0,0.1,-, < 0.01,9.03E-01
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825),5,0,0.51,-, < 0.01,6.01E-01
protein maturation by [2Fe-2S] cluster transfer (GO:0106034),2,0,0.2,-, < 0.01,8.16E-01
CTP salvage (GO:0044211),3,0,0.3,-, < 0.01,7.37E-01
'de novo' CTP biosynthetic process (GO:0044210),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of nucleoside transport (GO:0032244),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nucleoside transport (GO:0032243),1,0,0.1,-, < 0.01,9.03E-01
regulation of nucleoside transport (GO:0032242),2,0,0.2,-, < 0.01,8.16E-01
neuron projection retraction (GO:0106028),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nucleobase-containing compound transport (GO:0032240),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of vesicle docking (GO:0106022),1,0,0.1,-, < 0.01,9.03E-01
regulation of vesicle docking (GO:0106020),3,0,0.3,-, < 0.01,7.37E-01
AMP salvage (GO:0044209),2,0,0.2,-, < 0.01,8.16E-01
UMP salvage (GO:0044206),5,0,0.51,-, < 0.01,6.01E-01
'de novo' UMP biosynthetic process (GO:0044205),4,0,0.41,-, < 0.01,6.66E-01
adenosine transport (GO:0032238),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of inflammatory response to wounding (GO:0106016),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of inflammatory response to wounding (GO:0106015),1,0,0.1,-, < 0.01,9.03E-01
regulation of inflammatory response to wounding (GO:0106014),3,0,0.3,-, < 0.01,7.37E-01
"negative regulation of synaptic transmission, GABAergic (GO:0032229)",7,0,0.71,-, < 0.01,4.91E-01
"negative regulation of synaptic transmission, dopaminergic (GO:0032227)",2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of synaptic transmission, dopaminergic (GO:0032226)",4,0,0.41,-, < 0.01,6.66E-01
"regulation of synaptic transmission, dopaminergic (GO:0032225)",8,0,0.81,-, < 0.01,4.43E-01
"negative regulation of synaptic transmission, cholinergic (GO:0032223)",1,0,0.1,-, < 0.01,9.03E-01
RNA 5'-cap (guanine-N7)-methylation (GO:0106005),2,0,0.2,-, < 0.01,8.16E-01
tRNA (guanine-N7)-methylation (GO:0106004),2,0,0.2,-, < 0.01,8.16E-01
riboflavin transport (GO:0032218),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of telomere maintenance via semi-conservative replication (GO:0032214),2,0,0.2,-, < 0.01,8.16E-01
regulation of telomere maintenance via semi-conservative replication (GO:0032213),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of telomere maintenance via recombination (GO:0032208),1,0,0.1,-, < 0.01,9.03E-01
regulation of telomere maintenance via recombination (GO:0032207),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of phosphatidic acid biosynthetic process (GO:1905695),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphatidic acid biosynthetic process (GO:1905693),1,0,0.1,-, < 0.01,9.03E-01
regulation of nerve growth factor receptor activity (GO:0051394),1,0,0.1,-, < 0.01,9.03E-01
tRNA acetylation (GO:0051391),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of diacylglycerol kinase activity (GO:1905689),1,0,0.1,-, < 0.01,9.03E-01
regulation of diacylglycerol kinase activity (GO:1905687),1,0,0.1,-, < 0.01,9.03E-01
regulation of plasma membrane repair (GO:1905684),2,0,0.2,-, < 0.01,8.16E-01
inactivation of MAPKK activity (GO:0051389),2,0,0.2,-, < 0.01,8.16E-01
"neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",6,0,0.61,-, < 0.01,5.43E-01
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387),4,0,0.41,-, < 0.01,6.66E-01
modification of dendritic spine (GO:0098886),1,0,0.1,-, < 0.01,9.03E-01
modification of postsynaptic actin cytoskeleton (GO:0098885),3,0,0.3,-, < 0.01,7.37E-01
synapse pruning (GO:0098883),8,0,0.81,-, < 0.01,4.43E-01
maintenance of postsynaptic specialization structure (GO:0098880),7,0,0.71,-, < 0.01,4.91E-01
RNA localization to chromatin (GO:1990280),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adaptive immune memory response (GO:1905676),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of adaptive immune memory response (GO:1905675),2,0,0.2,-, < 0.01,8.16E-01
regulation of adaptive immune memory response (GO:1905674),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of lysosome organization (GO:1905673),1,0,0.1,-, < 0.01,9.03E-01
regulation of lysosome organization (GO:1905671),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of protein localization to endosome (GO:1905668),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of protein localization to endosome (GO:1905667),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein localization to endosome (GO:1905666),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of calcium ion import across plasma membrane (GO:1905665),3,0,0.3,-, < 0.01,7.37E-01
regulation of calcium ion import across plasma membrane (GO:1905664),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662),1,0,0.1,-, < 0.01,9.03E-01
regulation of telomerase RNA reverse transcriptase activity (GO:1905661),3,0,0.3,-, < 0.01,7.37E-01
intramembranous bone growth (GO:0098867),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),7,0,0.71,-, < 0.01,4.91E-01
anti-Mullerian hormone signaling pathway (GO:1990262),1,0,0.1,-, < 0.01,9.03E-01
pre-mRNA catabolic process (GO:1990261),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of artery morphogenesis (GO:1905653),5,0,0.51,-, < 0.01,6.01E-01
regulation of artery morphogenesis (GO:1905651),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297),1,0,0.1,-, < 0.01,9.03E-01
histone glutamine methylation (GO:1990258),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296),1,0,0.1,-, < 0.01,9.03E-01
proprioception involved in equilibrioception (GO:0051355),1,0,0.1,-, < 0.01,9.03E-01
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295),2,0,0.2,-, < 0.01,8.16E-01
signal clustering (GO:1990256),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ligase activity (GO:0051352),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ligase activity (GO:0051351),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of double-strand break repair via single-strand annealing (GO:1901291),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of DNA methylation (GO:1905642),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic animal morphogenesis (GO:0009886),14,0,1.42,-, < 0.01,2.41E-01
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344),6,0,0.61,-, < 0.01,5.43E-01
histone H2A-T120 phosphorylation (GO:1990245),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343),5,0,0.51,-, < 0.01,6.01E-01
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),10,0,1.02,-, < 0.01,3.62E-01
regulation of ligase activity (GO:0051340),9,0,0.91,-, < 0.01,4.00E-01
regulation of protein localization to chromatin (GO:1905634),8,0,0.81,-, < 0.01,4.43E-01
folate transmembrane transport (GO:0098838),6,0,0.61,-, < 0.01,5.43E-01
intestinal folate absorption (GO:0098829),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-cysteine modification to L-cysteine persulfide (GO:0098822),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mRNA cap binding (GO:1905612),1,0,0.1,-, < 0.01,9.03E-01
regulation of mRNA cap binding (GO:1905610),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of macrophage colony-stimulating factor production (GO:1901258),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of macrophage colony-stimulating factor production (GO:1901257),1,0,0.1,-, < 0.01,9.03E-01
regulation of macrophage colony-stimulating factor production (GO:1901256),5,0,0.51,-, < 0.01,6.01E-01
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of intracellular transport of viral material (GO:1901254),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of intracellular transport of viral material (GO:1901253),2,0,0.2,-, < 0.01,8.16E-01
regulation of intracellular transport of viral material (GO:1901252),3,0,0.3,-, < 0.01,7.37E-01
meiotic metaphase plate congression (GO:0051311),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of lung goblet cell differentiation (GO:1901251),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095),1,0,0.1,-, < 0.01,9.03E-01
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of presynapse assembly (GO:1905608),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of presynapse assembly (GO:1905607),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of blood-brain barrier permeability (GO:1905604),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601),2,0,0.2,-, < 0.01,8.16E-01
female meiosis chromosome separation (GO:0051309),2,0,0.2,-, < 0.01,8.16E-01
regulation of lung goblet cell differentiation (GO:1901249),1,0,0.1,-, < 0.01,9.03E-01
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of lung ciliated cell differentiation (GO:1901248),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of lung ciliated cell differentiation (GO:1901247),1,0,0.1,-, < 0.01,9.03E-01
mitotic sister chromatid separation (GO:0051306),4,0,0.41,-, < 0.01,6.66E-01
regulation of lung ciliated cell differentiation (GO:1901246),2,0,0.2,-, < 0.01,8.16E-01
chromosome movement towards spindle pole (GO:0051305),7,0,0.71,-, < 0.01,4.91E-01
regulation of dipeptide transport (GO:0090089),2,0,0.2,-, < 0.01,8.16E-01
regulation of oligopeptide transport (GO:0090088),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),4,0,0.41,-, < 0.01,6.66E-01
regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081),5,0,0.51,-, < 0.01,6.01E-01
abscission (GO:0009838),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of convergent extension involved in axis elongation (GO:1901233),1,0,0.1,-, < 0.01,9.03E-01
regulation of convergent extension involved in axis elongation (GO:1901232),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231),1,0,0.1,-, < 0.01,9.03E-01
relaxation of skeletal muscle (GO:0090076),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein homodimerization activity (GO:0090074),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein homodimerization activity (GO:0090073),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ribosome biogenesis (GO:0090071),5,0,0.51,-, < 0.01,6.01E-01
regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229),1,0,0.1,-, < 0.01,9.03E-01
unidimensional cell growth (GO:0009826),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),6,0,0.61,-, < 0.01,5.43E-01
regulation of thrombin-activated receptor signaling pathway (GO:0070494),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1,0,0.1,-, < 0.01,9.03E-01
alkaloid catabolic process (GO:0009822),3,0,0.3,-, < 0.01,7.37E-01
alkaloid metabolic process (GO:0009820),7,0,0.71,-, < 0.01,4.91E-01
regulation of ribosome biogenesis (GO:0090069),5,0,0.51,-, < 0.01,6.01E-01
regulation of thalamus size (GO:0090067),1,0,0.1,-, < 0.01,9.03E-01
regulation of production of siRNA involved in RNA interference (GO:0090065),2,0,0.2,-, < 0.01,8.16E-01
T cell aggregation (GO:0070489),2,0,0.2,-, < 0.01,8.16E-01
neutrophil aggregation (GO:0070488),2,0,0.2,-, < 0.01,8.16E-01
monocyte aggregation (GO:0070487),3,0,0.3,-, < 0.01,7.37E-01
"defense response to fungus, incompatible interaction (GO:0009817)",1,0,0.1,-, < 0.01,9.03E-01
"defense response, incompatible interaction (GO:0009814)",1,0,0.1,-, < 0.01,9.03E-01
"nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)",1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),9,0,0.91,-, < 0.01,4.00E-01
stilbene metabolic process (GO:0009810),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cardiac chamber formation (GO:1901211),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac chamber formation (GO:1901210),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic camera-type eye morphogenesis (GO:0048597),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),15,0,1.52,-, < 0.01,2.17E-01
"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)",1,0,0.1,-, < 0.01,9.03E-01
rRNA (guanine-N7)-methylation (GO:0070476),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of heart looping (GO:1901208),1,0,0.1,-, < 0.01,9.03E-01
regulation of heart looping (GO:1901207),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of uterine smooth muscle contraction (GO:0070473),1,0,0.1,-, < 0.01,9.03E-01
uterine smooth muscle contraction (GO:0070471),1,0,0.1,-, < 0.01,9.03E-01
determination of affect (GO:0050894),1,0,0.1,-, < 0.01,9.03E-01
sensory processing (GO:0050893),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of tubulin deacetylation (GO:0090044),1,0,0.1,-, < 0.01,9.03E-01
tubulin deacetylation (GO:0090042),3,0,0.3,-, < 0.01,7.37E-01
nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080),1,0,0.1,-, < 0.01,9.03E-01
plus-end specific microtubule depolymerization (GO:0070462),1,0,0.1,-, < 0.01,9.03E-01
"musculoskeletal movement, spinal reflex action (GO:0050883)",3,0,0.3,-, < 0.01,7.37E-01
voluntary musculoskeletal movement (GO:0050882),7,0,0.71,-, < 0.01,4.91E-01
nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein kinase C signaling (GO:0090038),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of protein kinase C signaling (GO:0090037),10,0,1.02,-, < 0.01,3.62E-01
regulation of protein kinase C signaling (GO:0090036),19,0,1.93,-, < 0.01,1.45E-01
positive regulation of chaperone-mediated protein complex assembly (GO:0090035),1,0,0.1,-, < 0.01,9.03E-01
regulation of chaperone-mediated protein complex assembly (GO:0090034),1,0,0.1,-, < 0.01,9.03E-01
long-day photoperiodism (GO:0048571),1,0,0.1,-, < 0.01,9.03E-01
notochord morphogenesis (GO:0048570),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of steroid hormone biosynthetic process (GO:0090031),3,0,0.3,-, < 0.01,7.37E-01
prolactin secretion (GO:0070459),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of heme biosynthetic process (GO:0070455),1,0,0.1,-, < 0.01,9.03E-01
regulation of heme biosynthetic process (GO:0070453),3,0,0.3,-, < 0.01,7.37E-01
post-embryonic animal organ development (GO:0048569),17,0,1.73,-, < 0.01,1.77E-01
ectodermal digestive tract morphogenesis (GO:0048567),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of monocyte chemotaxis (GO:0090027),6,0,0.61,-, < 0.01,5.43E-01
post-embryonic animal organ morphogenesis (GO:0048563),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of neutrophil chemotaxis (GO:0090024),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446),1,0,0.1,-, < 0.01,9.03E-01
regulation of oligodendrocyte progenitor proliferation (GO:0070445),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of pinocytosis (GO:0048550),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433),2,0,0.2,-, < 0.01,8.16E-01
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),6,0,0.61,-, < 0.01,5.43E-01
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of B cell receptor signaling pathway (GO:0050859),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of calcium-mediated signaling (GO:0050850),29,0,2.95,-, < 0.01,5.23E-02
Peyer's patch development (GO:0048541),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429),1,0,0.1,-, < 0.01,9.03E-01
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428),4,0,0.41,-, < 0.01,6.66E-01
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425),2,0,0.2,-, < 0.01,8.16E-01
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),25,0,2.54,-, < 0.01,7.86E-02
cell wall macromolecule catabolic process (GO:0016998),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of calcium-mediated signaling (GO:0050849),18,0,1.83,-, < 0.01,1.60E-01
progesterone receptor signaling pathway (GO:0050847),9,0,0.91,-, < 0.01,4.00E-01
bone marrow development (GO:0048539),7,0,0.71,-, < 0.01,4.91E-01
mucosa-associated lymphoid tissue development (GO:0048537),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of heterochromatin organization (GO:0120262),5,0,0.51,-, < 0.01,6.01E-01
trehalose metabolism in response to stress (GO:0070413),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of behavior (GO:0048521),12,0,1.22,-, < 0.01,2.95E-01
olefinic compound catabolic process (GO:0120256),1,0,0.1,-, < 0.01,9.03E-01
carbamoyl phosphate biosynthetic process (GO:0070409),1,0,0.1,-, < 0.01,9.03E-01
carbamoyl phosphate metabolic process (GO:0070408),1,0,0.1,-, < 0.01,9.03E-01
oxidation-dependent protein catabolic process (GO:0070407),1,0,0.1,-, < 0.01,9.03E-01
"transposition, RNA-mediated (GO:0032197)",2,0,0.2,-, < 0.01,8.16E-01
transposition (GO:0032196),4,0,0.41,-, < 0.01,6.66E-01
"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)",1,0,0.1,-, < 0.01,9.03E-01
regulation of liquid surface tension (GO:0050828),2,0,0.2,-, < 0.01,8.16E-01
peptide antigen stabilization (GO:0050823),1,0,0.1,-, < 0.01,9.03E-01
peptide stabilization (GO:0050822),1,0,0.1,-, < 0.01,9.03E-01
histone H3-K14 acetylation (GO:0044154),7,0,0.71,-, < 0.01,4.91E-01
septin cytoskeleton organization (GO:0032185),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of D-amino-acid oxidase activity (GO:1900758),1,0,0.1,-, < 0.01,9.03E-01
regulation of D-amino-acid oxidase activity (GO:1900757),1,0,0.1,-, < 0.01,9.03E-01
doxorubicin transport (GO:1900753),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of development of symbiont involved in interaction with host (GO:0044147),1,0,0.1,-, < 0.01,9.03E-01
modulation of development of symbiont involved in interaction with host (GO:0044145),1,0,0.1,-, < 0.01,9.03E-01
(R)-carnitine transport (GO:1900749),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),5,0,0.51,-, < 0.01,6.01E-01
"circadian sleep/wake cycle, sleep (GO:0050802)",3,0,0.3,-, < 0.01,7.37E-01
protein localization to motile cilium (GO:0120229),1,0,0.1,-, < 0.01,9.03E-01
larynx development (GO:0120224),2,0,0.2,-, < 0.01,8.16E-01
larynx morphogenesis (GO:0120223),2,0,0.2,-, < 0.01,8.16E-01
maintenance of ciliary planar beating movement pattern (GO:0120221),1,0,0.1,-, < 0.01,9.03E-01
astrocyte-dopaminergic neuron signaling (GO:0036520),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737),1,0,0.1,-, < 0.01,9.03E-01
chemorepulsion of dopaminergic neuron axon (GO:0036518),2,0,0.2,-, < 0.01,8.16E-01
chemoattraction of serotonergic neuron axon (GO:0036517),1,0,0.1,-, < 0.01,9.03E-01
serotonergic neuron axon guidance (GO:0036515),3,0,0.3,-, < 0.01,7.37E-01
dopaminergic neuron axon guidance (GO:0036514),4,0,0.41,-, < 0.01,6.66E-01
trimming of second mannose on A branch (GO:0036512),2,0,0.2,-, < 0.01,8.16E-01
proacrosomal vesicle fusion (GO:0120211),1,0,0.1,-, < 0.01,9.03E-01
trimming of first mannose on A branch (GO:0036511),2,0,0.2,-, < 0.01,8.16E-01
trimming of terminal mannose on C branch (GO:0036510),3,0,0.3,-, < 0.01,7.37E-01
positive regulation by symbiont of entry into host (GO:0075294),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of uterine smooth muscle relaxation (GO:1900721),1,0,0.1,-, < 0.01,9.03E-01
trimming of terminal mannose on B branch (GO:0036509),2,0,0.2,-, < 0.01,8.16E-01
"protein alpha-1,2-demannosylation (GO:0036508)",23,0,2.34,-, < 0.01,9.63E-02
growth of symbiont in host (GO:0044117),3,0,0.3,-, < 0.01,7.37E-01
protein demannosylation (GO:0036507),23,0,2.34,-, < 0.01,9.63E-02
development involved in symbiotic interaction (GO:0044111),1,0,0.1,-, < 0.01,9.03E-01
growth involved in symbiotic interaction (GO:0044110),3,0,0.3,-, < 0.01,7.37E-01
regulation of uterine smooth muscle relaxation (GO:1900719),1,0,0.1,-, < 0.01,9.03E-01
cellular alcohol biosynthetic process (GO:0044108),4,0,0.41,-, < 0.01,6.66E-01
cellular alcohol metabolic process (GO:0044107),4,0,0.41,-, < 0.01,6.66E-01
sequestering of zinc ion (GO:0032119),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of response to nutrient levels (GO:0032108),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of response to extracellular stimulus (GO:0032105),12,0,1.22,-, < 0.01,2.95E-01
cell dedifferentiation (GO:0043697),5,0,0.51,-, < 0.01,6.01E-01
dedifferentiation (GO:0043696),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of low-density lipoprotein receptor activity (GO:1905599),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of low-density lipoprotein receptor activity (GO:1905598),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of low-density lipoprotein particle receptor binding (GO:1905596),1,0,0.1,-, < 0.01,9.03E-01
regulation of low-density lipoprotein particle receptor binding (GO:1905595),2,0,0.2,-, < 0.01,8.16E-01
centrosome separation (GO:0051299),8,0,0.81,-, < 0.01,4.43E-01
centrosome duplication (GO:0051298),32,0,3.25,-, < 0.01,3.85E-02
establishment of meiotic spindle orientation (GO:0051296),1,0,0.1,-, < 0.01,9.03E-01
mRNA cleavage involved in gene silencing (GO:0098795),1,0,0.1,-, < 0.01,9.03E-01
co-translational protein modification (GO:0043686),2,0,0.2,-, < 0.01,8.16E-01
establishment of meiotic spindle localization (GO:0051295),5,0,0.51,-, < 0.01,6.01E-01
induction of programmed cell death (GO:0012502),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of L-arginine import across plasma membrane (GO:1905589),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of low-density lipoprotein particle clearance (GO:1905581),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of ERBB3 signaling pathway (GO:1905580),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of sequestering of calcium ion (GO:0051284),14,0,1.42,-, < 0.01,2.41E-01
response to mitochondrial depolarisation (GO:0098780),16,0,1.63,-, < 0.01,1.96E-01
exosomal secretion (GO:1990182),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),13,0,1.32,-, < 0.01,2.67E-01
mitochondrial tRNA 3'-end processing (GO:1990180),3,0,0.3,-, < 0.01,7.37E-01
regulation of ERBB3 signaling pathway (GO:1905578),1,0,0.1,-, < 0.01,9.03E-01
ganglioside GM1 transport to membrane (GO:1905572),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),7,0,0.71,-, < 0.01,4.91E-01
protein localization to nucleoplasm (GO:1990173),1,0,0.1,-, < 0.01,9.03E-01
G protein-coupled receptor catabolic process (GO:1990172),1,0,0.1,-, < 0.01,9.03E-01
stress response to cadmium ion (GO:1990170),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of vascular endothelial cell proliferation (GO:1905563),5,0,0.51,-, < 0.01,6.01E-01
protein K33-linked deubiquitination (GO:1990168),4,0,0.41,-, < 0.01,6.66E-01
protein K27-linked deubiquitination (GO:1990167),3,0,0.3,-, < 0.01,7.37E-01
protein localization to site of double-strand break (GO:1990166),3,0,0.3,-, < 0.01,7.37E-01
recognition of apoptotic cell (GO:0043654),6,0,0.61,-, < 0.01,5.43E-01
histone H2A phosphorylation (GO:1990164),5,0,0.51,-, < 0.01,6.01E-01
mitochondrial fragmentation involved in apoptotic process (GO:0043653),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein localization to endoplasmic reticulum (GO:1905552),2,0,0.2,-, < 0.01,8.16E-01
cellular response to interleukin-8 (GO:0098759),3,0,0.3,-, < 0.01,7.37E-01
response to interleukin-8 (GO:0098758),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein localization to endoplasmic reticulum (GO:1905550),2,0,0.2,-, < 0.01,8.16E-01
cellular response to interleukin-21 (GO:0098757),8,0,0.81,-, < 0.01,4.43E-01
meiotic spindle midzone assembly (GO:0051257),2,0,0.2,-, < 0.01,8.16E-01
response to interleukin-21 (GO:0098756),8,0,0.81,-, < 0.01,4.43E-01
"regulation of mitotic cell cycle, embryonic (GO:0009794)",4,0,0.41,-, < 0.01,6.66E-01
mitotic spindle midzone assembly (GO:0051256),6,0,0.61,-, < 0.01,5.43E-01
spindle midzone assembly (GO:0051255),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of formation of translation preinitiation complex (GO:1901194),1,0,0.1,-, < 0.01,9.03E-01
regulation of formation of translation preinitiation complex (GO:1901193),1,0,0.1,-, < 0.01,9.03E-01
cellular response to phenylpropanoid (GO:1905546),1,0,0.1,-, < 0.01,9.03E-01
cerebellar neuron development (GO:0098749),3,0,0.3,-, < 0.01,7.37E-01
regulation of L-arginine import across plasma membrane (GO:1905541),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of ephrin receptor signaling pathway (GO:1901189),1,0,0.1,-, < 0.01,9.03E-01
regulation of asymmetric cell division (GO:0009786),4,0,0.41,-, < 0.01,6.66E-01
"fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)",1,0,0.1,-, < 0.01,9.03E-01
regulation of ephrin receptor signaling pathway (GO:1901187),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of ERBB signaling pathway (GO:1901186),37,0,3.76,-, < 0.01,2.31E-02
maintenance of translational fidelity (GO:1990145),2,0,0.2,-, < 0.01,8.16E-01
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537),1,0,0.1,-, < 0.01,9.03E-01
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of leucine import across plasma membrane (GO:1905533),2,0,0.2,-, < 0.01,8.16E-01
regulation of leucine import across plasma membrane (GO:1905532),2,0,0.2,-, < 0.01,8.16E-01
sequestering of metal ion (GO:0051238),10,0,1.02,-, < 0.01,3.62E-01
protein insertion into plasma membrane (GO:0098737),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of the force of heart contraction (GO:0098736),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of the force of heart contraction (GO:0098735),5,0,0.51,-, < 0.01,6.01E-01
macromolecule depalmitoylation (GO:0098734),11,0,1.12,-, < 0.01,3.27E-01
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134),1,0,0.1,-, < 0.01,9.03E-01
meiotic spindle elongation (GO:0051232),1,0,0.1,-, < 0.01,9.03E-01
cortical microtubule organization (GO:0043622),4,0,0.41,-, < 0.01,6.66E-01
spindle elongation (GO:0051231),7,0,0.71,-, < 0.01,4.91E-01
spindle disassembly (GO:0051230),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of heat generation (GO:0031652),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of heat generation (GO:0031651),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of Golgi lumen acidification (GO:1905528),1,0,0.1,-, < 0.01,9.03E-01
regulation of Golgi lumen acidification (GO:1905526),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein autoubiquitination (GO:1905524),1,0,0.1,-, < 0.01,9.03E-01
germline stem cell asymmetric division (GO:0098728),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of presynaptic active zone assembly (GO:1905520),2,0,0.2,-, < 0.01,8.16E-01
mitotic spindle disassembly (GO:0051228),2,0,0.2,-, < 0.01,8.16E-01
symmetric cell division (GO:0098725),1,0,0.1,-, < 0.01,9.03E-01
keratinocyte proliferation (GO:0043616),10,0,1.02,-, < 0.01,3.62E-01
astrocyte cell migration (GO:0043615),6,0,0.61,-, < 0.01,5.43E-01
regulation of carbohydrate utilization (GO:0043610),1,0,0.1,-, < 0.01,9.03E-01
heat generation (GO:0031649),5,0,0.51,-, < 0.01,6.01E-01
regulation of presynaptic active zone assembly (GO:1905518),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of short-term synaptic potentiation (GO:1905513),1,0,0.1,-, < 0.01,9.03E-01
regulation of short-term synaptic potentiation (GO:1905512),1,0,0.1,-, < 0.01,9.03E-01
sodium ion import across plasma membrane (GO:0098719),18,0,1.83,-, < 0.01,1.60E-01
hexose mediated signaling (GO:0009757),3,0,0.3,-, < 0.01,7.37E-01
serine import across plasma membrane (GO:0098718),1,0,0.1,-, < 0.01,9.03E-01
carbohydrate mediated signaling (GO:0009756),5,0,0.51,-, < 0.01,6.01E-01
B cell receptor apoptotic signaling pathway (GO:1990117),1,0,0.1,-, < 0.01,9.03E-01
formamide metabolic process (GO:0043606),3,0,0.3,-, < 0.01,7.37E-01
leucine import across plasma membrane (GO:0098713),3,0,0.3,-, < 0.01,7.37E-01
RNA polymerase II core complex assembly (GO:1990114),1,0,0.1,-, < 0.01,9.03E-01
nitrate catabolic process (GO:0043602),1,0,0.1,-, < 0.01,9.03E-01
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of motile cilium assembly (GO:1905505),1,0,0.1,-, < 0.01,9.03E-01
regulation of motile cilium assembly (GO:1905503),1,0,0.1,-, < 0.01,9.03E-01
glucose import across plasma membrane (GO:0098708),4,0,0.41,-, < 0.01,6.66E-01
sequestering of calcium ion (GO:0051208),4,0,0.41,-, < 0.01,6.66E-01
protein linear deubiquitination (GO:1990108),2,0,0.2,-, < 0.01,8.16E-01
copper ion import across plasma membrane (GO:0098705),1,0,0.1,-, < 0.01,9.03E-01
insulin catabolic process (GO:1901143),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of fever generation (GO:0031622),7,0,0.71,-, < 0.01,4.91E-01
detection of hexose stimulus (GO:0009732),3,0,0.3,-, < 0.01,7.37E-01
detection of carbohydrate stimulus (GO:0009730),3,0,0.3,-, < 0.01,7.37E-01
detection of endogenous stimulus (GO:0009726),3,0,0.3,-, < 0.01,7.37E-01
gentamycin metabolic process (GO:1901128),1,0,0.1,-, < 0.01,9.03E-01
response to lipoteichoic acid (GO:0070391),9,0,0.91,-, < 0.01,4.00E-01
tRNA-guanine transglycosylation (GO:0101030),3,0,0.3,-, < 0.01,7.37E-01
mitotic nuclear membrane organization (GO:0101024),3,0,0.3,-, < 0.01,7.37E-01
DNA cytosine deamination (GO:0070383),9,0,0.91,-, < 0.01,4.00E-01
synaptic vesicle membrane organization (GO:0048499),4,0,0.41,-, < 0.01,6.66E-01
ERK5 cascade (GO:0070375),2,0,0.2,-, < 0.01,8.16E-01
activated T cell proliferation (GO:0050798),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of hepatocyte differentiation (GO:0070368),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hepatocyte differentiation (GO:0070367),1,0,0.1,-, < 0.01,9.03E-01
regulation of hepatocyte differentiation (GO:0070366),2,0,0.2,-, < 0.01,8.16E-01
cocaine metabolic process (GO:0050783),1,0,0.1,-, < 0.01,9.03E-01
actin polymerization-dependent cell motility (GO:0070358),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of dendrite morphogenesis (GO:0050774),8,0,0.81,-, < 0.01,4.43E-01
regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of brown fat cell proliferation (GO:0070349),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494),1,0,0.1,-, < 0.01,9.03E-01
regulation of brown fat cell proliferation (GO:0070347),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of bile acid secretion (GO:0120189),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein localization to chromatin (GO:0120187),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of focal adhesion disassembly (GO:0120183),6,0,0.61,-, < 0.01,5.43E-01
regulation of focal adhesion disassembly (GO:0120182),6,0,0.61,-, < 0.01,5.43E-01
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481),2,0,0.2,-, < 0.01,8.16E-01
regulation of thymidylate synthase biosynthetic process (GO:0050758),1,0,0.1,-, < 0.01,9.03E-01
chemokine metabolic process (GO:0050755),2,0,0.2,-, < 0.01,8.16E-01
neuron death in response to oxidative stress (GO:0036475),3,0,0.3,-, < 0.01,7.37E-01
cell death in response to hydrogen peroxide (GO:0036474),4,0,0.41,-, < 0.01,6.66E-01
trans-synaptic signaling by BDNF (GO:0099191),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of lipoprotein metabolic process (GO:0050748),5,0,0.51,-, < 0.01,6.01E-01
detection of cold stimulus involved in thermoception (GO:0120169),1,0,0.1,-, < 0.01,9.03E-01
"trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)",1,0,0.1,-, < 0.01,9.03E-01
zinc ion import into synaptic vesicle (GO:0099180),1,0,0.1,-, < 0.01,9.03E-01
G1 to G0 transition involved in cell differentiation (GO:0070315),3,0,0.3,-, < 0.01,7.37E-01
G1 to G0 transition (GO:0070314),8,0,0.81,-, < 0.01,4.43E-01
regulation of synaptic membrane adhesion (GO:0099179),2,0,0.2,-, < 0.01,8.16E-01
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of collagen catabolic process (GO:0120158),1,0,0.1,-, < 0.01,9.03E-01
regulation of respiratory system process (GO:0044065),14,0,1.42,-, < 0.01,2.41E-01
lens fiber cell morphogenesis (GO:0070309),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of ERBB4 signaling pathway (GO:0120154),1,0,0.1,-, < 0.01,9.03E-01
postsynaptic modulation of chemical synaptic transmission (GO:0099170),6,0,0.61,-, < 0.01,5.43E-01
cap mRNA methylation (GO:0036451),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of appetite (GO:0032099),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of response to food (GO:0032096),12,0,1.22,-, < 0.01,2.95E-01
synaptic signaling by nitric oxide (GO:0099163),2,0,0.2,-, < 0.01,8.16E-01
calcium import into the mitochondrion (GO:0036444),6,0,0.61,-, < 0.01,5.43E-01
translocation of peptides or proteins into host cell cytoplasm (GO:0044053),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytokine secretion (GO:0050710),14,0,1.42,-, < 0.01,2.41E-01
regulation of recycling endosome localization within postsynapse (GO:0099158),1,0,0.1,-, < 0.01,9.03E-01
cell-cell signaling via exosome (GO:0099156),1,0,0.1,-, < 0.01,9.03E-01
maintenance of lens transparency (GO:0036438),4,0,0.41,-, < 0.01,6.66E-01
"regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)",2,0,0.2,-, < 0.01,8.16E-01
negative regulation of endodeoxyribonuclease activity (GO:0032078),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of deoxyribonuclease activity (GO:0032076),2,0,0.2,-, < 0.01,8.16E-01
regulation of restriction endodeoxyribonuclease activity (GO:0032072),1,0,0.1,-, < 0.01,9.03E-01
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149),9,0,0.91,-, < 0.01,4.00E-01
regulation of synaptic vesicle docking (GO:0099148),1,0,0.1,-, < 0.01,9.03E-01
cell wall macromolecule biosynthetic process (GO:0044038),1,0,0.1,-, < 0.01,9.03E-01
response to zinc ion starvation (GO:0120127),2,0,0.2,-, < 0.01,8.16E-01
cell wall macromolecule metabolic process (GO:0044036),4,0,0.41,-, < 0.01,6.66E-01
multi-organism catabolic process (GO:0044035),1,0,0.1,-, < 0.01,9.03E-01
multi-organism metabolic process (GO:0044033),1,0,0.1,-, < 0.01,9.03E-01
bleb assembly (GO:0032060),10,0,1.02,-, < 0.01,3.62E-01
hypomethylation of CpG island (GO:0044029),2,0,0.2,-, < 0.01,8.16E-01
DNA hypomethylation (GO:0044028),2,0,0.2,-, < 0.01,8.16E-01
hypermethylation of CpG island (GO:0044027),2,0,0.2,-, < 0.01,8.16E-01
DNA hypermethylation (GO:0044026),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of translational initiation in response to stress (GO:0032058),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of translation in response to stress (GO:0032056),9,0,0.91,-, < 0.01,4.00E-01
ciliary basal body organization (GO:0032053),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of monocyte aggregation (GO:1900625),3,0,0.3,-, < 0.01,7.37E-01
regulation of monocyte aggregation (GO:1900623),3,0,0.3,-, < 0.01,7.37E-01
conversion of ds siRNA to ss siRNA (GO:0036404),1,0,0.1,-, < 0.01,9.03E-01
cardiolipin biosynthetic process (GO:0032049),9,0,0.91,-, < 0.01,4.00E-01
tRNA 5'-end processing (GO:0099116),14,0,1.42,-, < 0.01,2.41E-01
box H/ACA snoRNA 3'-end processing (GO:0000495),2,0,0.2,-, < 0.01,8.16E-01
box C/D snoRNA 3'-end processing (GO:0000494),2,0,0.2,-, < 0.01,8.16E-01
maturation of 5S rRNA (GO:0000481),1,0,0.1,-, < 0.01,9.03E-01
trypsinogen activation (GO:0032023),1,0,0.1,-, < 0.01,9.03E-01
ISG15-protein conjugation (GO:0032020),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of ARF protein signal transduction (GO:0032014),2,0,0.2,-, < 0.01,8.16E-01
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",9,0,0.91,-, < 0.01,4.00E-01
"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1,0,0.1,-, < 0.01,9.03E-01
detection of muscle stretch (GO:0035995),7,0,0.71,-, < 0.01,4.91E-01
deltoid tuberosity development (GO:0035993),1,0,0.1,-, < 0.01,9.03E-01
tendon formation (GO:0035992),2,0,0.2,-, < 0.01,8.16E-01
tendon cell differentiation (GO:0035990),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of fatty acid beta-oxidation (GO:0032000),10,0,1.02,-, < 0.01,3.62E-01
exonucleolytic trimming involved in rRNA processing (GO:0000459),9,0,0.91,-, < 0.01,4.00E-01
enzyme-directed rRNA pseudouridine synthesis (GO:0000455),5,0,0.51,-, < 0.01,6.01E-01
enzyme-directed rRNA 2'-O-methylation (GO:0000453),1,0,0.1,-, < 0.01,9.03E-01
rRNA 2'-O-methylation (GO:0000451),2,0,0.2,-, < 0.01,8.16E-01
tendon development (GO:0035989),5,0,0.51,-, < 0.01,6.01E-01
cellular response to trichostatin A (GO:0035984),3,0,0.3,-, < 0.01,7.37E-01
response to trichostatin A (GO:0035983),3,0,0.3,-, < 0.01,7.37E-01
response to host (GO:0075136),10,0,1.02,-, < 0.01,3.62E-01
"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of branching morphogenesis of a nerve (GO:1905492),1,0,0.1,-, < 0.01,9.03E-01
postsynaptic specialization assembly (GO:0098698),8,0,0.81,-, < 0.01,4.43E-01
skin morphogenesis (GO:0043589),10,0,1.02,-, < 0.01,3.62E-01
histone H2A-S139 phosphorylation (GO:0035978),2,0,0.2,-, < 0.01,8.16E-01
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),5,0,0.51,-, < 0.01,6.01E-01
regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694),1,0,0.1,-, < 0.01,9.03E-01
nose morphogenesis (GO:0043585),3,0,0.3,-, < 0.01,7.37E-01
calcium-dependent self proteolysis (GO:1990092),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-histidine dephosphorylation (GO:0035971),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of motor neuron migration (GO:1905485),1,0,0.1,-, < 0.01,9.03E-01
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435),1,0,0.1,-, < 0.01,9.03E-01
regulation of motor neuron migration (GO:1905483),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432),3,0,0.3,-, < 0.01,7.37E-01
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430),3,0,0.3,-, < 0.01,7.37E-01
regulation of respiratory gaseous exchange (GO:0043576),21,0,2.13,-, < 0.01,1.18E-01
lens fiber cell apoptotic process (GO:1990086),4,0,0.41,-, < 0.01,6.66E-01
COPI-coated vesicle budding (GO:0035964),6,0,0.61,-, < 0.01,5.43E-01
cellular response to interleukin-13 (GO:0035963),3,0,0.3,-, < 0.01,7.37E-01
response to interleukin-13 (GO:0035962),4,0,0.41,-, < 0.01,6.66E-01
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429),4,0,0.41,-, < 0.01,6.66E-01
canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474),1,0,0.1,-, < 0.01,9.03E-01
pexophagy (GO:0000425),7,0,0.71,-, < 0.01,4.91E-01
mitophagy (GO:0000423),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of sulfur metabolic process (GO:0051176),3,0,0.3,-, < 0.01,7.37E-01
polyuridylation-dependent mRNA catabolic process (GO:1990074),1,0,0.1,-, < 0.01,9.03E-01
cellular response to nitrogen levels (GO:0043562),11,0,1.12,-, < 0.01,3.27E-01
wybutosine biosynthetic process (GO:0031591),2,0,0.2,-, < 0.01,8.16E-01
wybutosine metabolic process (GO:0031590),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of clathrin-coated pit assembly (GO:1905469),1,0,0.1,-, < 0.01,9.03E-01
regulation of clathrin-coated pit assembly (GO:1905468),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of histone H3-K36 methylation (GO:0000416),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of histone H3-K36 methylation (GO:0000415),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of DNA duplex unwinding (GO:1905463),3,0,0.3,-, < 0.01,7.37E-01
regulation of histone H3-K36 methylation (GO:0000414),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of transcription by galactose (GO:0000411),1,0,0.1,-, < 0.01,9.03E-01
regulation of translation in response to oxidative stress (GO:0043556),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial mRNA surveillance (GO:0035946),1,0,0.1,-, < 0.01,9.03E-01
L-xylitol metabolic process (GO:0051164),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial ncRNA surveillance (GO:0035945),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553),3,0,0.3,-, < 0.01,7.37E-01
L-xylitol catabolic process (GO:0051160),1,0,0.1,-, < 0.01,9.03E-01
membrane raft distribution (GO:0031580),5,0,0.51,-, < 0.01,6.01E-01
regulation of transcription by galactose (GO:0000409),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of myeloid progenitor cell differentiation (GO:1905454),1,0,0.1,-, < 0.01,9.03E-01
regulation of myeloid progenitor cell differentiation (GO:1905453),1,0,0.1,-, < 0.01,9.03E-01
inorganic anion import across plasma membrane (GO:0098658),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of autophagosome maturation (GO:1901097),6,0,0.61,-, < 0.01,5.43E-01
corticosterone secretion (GO:0035934),1,0,0.1,-, < 0.01,9.03E-01
glucocorticoid secretion (GO:0035933),2,0,0.2,-, < 0.01,8.16E-01
aldosterone secretion (GO:0035932),1,0,0.1,-, < 0.01,9.03E-01
activation of protein kinase C activity (GO:1990051),5,0,0.51,-, < 0.01,6.01E-01
mineralocorticoid secretion (GO:0035931),1,0,0.1,-, < 0.01,9.03E-01
membrane raft organization (GO:0031579),22,0,2.24,-, < 0.01,1.07E-01
corticosteroid hormone secretion (GO:0035930),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447),2,0,0.2,-, < 0.01,8.16E-01
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of clathrin coat assembly (GO:1905445),1,0,0.1,-, < 0.01,9.03E-01
regulation of clathrin coat assembly (GO:1905443),1,0,0.1,-, < 0.01,9.03E-01
steroid hormone secretion (GO:0035929),5,0,0.51,-, < 0.01,6.01E-01
regulation of actin phosphorylation (GO:0043538),1,0,0.1,-, < 0.01,9.03E-01
rRNA import into mitochondrion (GO:0035928),3,0,0.3,-, < 0.01,7.37E-01
RNA import into mitochondrion (GO:0035927),5,0,0.51,-, < 0.01,6.01E-01
induced systemic resistance (GO:0009682),1,0,0.1,-, < 0.01,9.03E-01
protein localization to lipid droplet (GO:1990044),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of NK T cell proliferation (GO:0051142),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of relaxation of smooth muscle (GO:1901082),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of NK T cell proliferation (GO:0051141),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of relaxation of smooth muscle (GO:1901081),1,0,0.1,-, < 0.01,9.03E-01
foramen ovale closure (GO:0035922),2,0,0.2,-, < 0.01,8.16E-01
regulation of NK T cell proliferation (GO:0051140),5,0,0.51,-, < 0.01,6.01E-01
regulation of relaxation of smooth muscle (GO:1901080),2,0,0.2,-, < 0.01,8.16E-01
desmosome disassembly (GO:0035921),1,0,0.1,-, < 0.01,9.03E-01
non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of histone H3-K4 trimethylation (GO:1905437),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone H3-K4 trimethylation (GO:1905435),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433),1,0,0.1,-, < 0.01,9.03E-01
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432),1,0,0.1,-, < 0.01,9.03E-01
cellular response to glycine (GO:1905430),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of NK T cell differentiation (GO:0051138),3,0,0.3,-, < 0.01,7.37E-01
regulation of NK T cell differentiation (GO:0051136),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of engulfment of apoptotic cell (GO:1901076),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of NK T cell activation (GO:0051135),7,0,0.71,-, < 0.01,4.91E-01
calcium ion import into sarcoplasmic reticulum (GO:1990036),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of NK T cell activation (GO:0051134),2,0,0.2,-, < 0.01,8.16E-01
regulation of engulfment of apoptotic cell (GO:1901074),3,0,0.3,-, < 0.01,7.37E-01
pore formation in membrane of other organism (GO:0035915),2,0,0.2,-, < 0.01,8.16E-01
regulation of NK T cell activation (GO:0051133),9,0,0.91,-, < 0.01,4.00E-01
glucosamine-containing compound biosynthetic process (GO:1901073),2,0,0.2,-, < 0.01,8.16E-01
calcium ion export across plasma membrane (GO:1990034),5,0,0.51,-, < 0.01,6.01E-01
NK T cell activation (GO:0051132),2,0,0.2,-, < 0.01,8.16E-01
glucosamine-containing compound catabolic process (GO:1901072),9,0,0.91,-, < 0.01,4.00E-01
dorsal aorta morphogenesis (GO:0035912),8,0,0.81,-, < 0.01,4.43E-01
ascending aorta morphogenesis (GO:0035910),4,0,0.41,-, < 0.01,6.66E-01
"regulation of DNA-templated transcription, termination (GO:0031554)",2,0,0.2,-, < 0.01,8.16E-01
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550),2,0,0.2,-, < 0.01,8.16E-01
response to glycine (GO:1905429),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426),2,0,0.2,-, < 0.01,8.16E-01
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424),2,0,0.2,-, < 0.01,8.16E-01
guanosine-containing compound catabolic process (GO:1901069),2,0,0.2,-, < 0.01,8.16E-01
regulation of myosin II filament organization (GO:0043519),1,0,0.1,-, < 0.01,9.03E-01
vasomotion (GO:1990029),1,0,0.1,-, < 0.01,9.03E-01
dorsal aorta development (GO:0035907),9,0,0.91,-, < 0.01,4.00E-01
descending aorta development (GO:0035906),1,0,0.1,-, < 0.01,9.03E-01
ascending aorta development (GO:0035905),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549),1,0,0.1,-, < 0.01,9.03E-01
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548),3,0,0.3,-, < 0.01,7.37E-01
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of dense core granule exocytosis (GO:1905415),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of dense core granule exocytosis (GO:1905414),1,0,0.1,-, < 0.01,9.03E-01
sarcosine catabolic process (GO:1901053),1,0,0.1,-, < 0.01,9.03E-01
sarcosine metabolic process (GO:1901052),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of creatine transmembrane transporter activity (GO:1905408),2,0,0.2,-, < 0.01,8.16E-01
regulation of creatine transmembrane transporter activity (GO:1905407),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of mitotic cohesin loading (GO:1905406),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitotic cohesin loading (GO:1905405),1,0,0.1,-, < 0.01,9.03E-01
"positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)",1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)",2,0,0.2,-, < 0.01,8.16E-01
response to low light intensity stimulus (GO:0009645),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of DNA ligation (GO:0051106),5,0,0.51,-, < 0.01,6.01E-01
regulation of DNA ligation (GO:0051105),5,0,0.51,-, < 0.01,6.01E-01
DNA ligation involved in DNA recombination (GO:0051102),1,0,0.1,-, < 0.01,9.03E-01
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),6,0,0.61,-, < 0.01,5.43E-01
amyloid fibril formation (GO:1990000),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of response to reactive oxygen species (GO:1901033),5,0,0.51,-, < 0.01,6.01E-01
sarcoplasmic reticulum calcium ion transport (GO:0070296),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),9,0,0.91,-, < 0.01,4.00E-01
renal water absorption (GO:0070295),3,0,0.3,-, < 0.01,7.37E-01
ripoptosome assembly involved in necroptotic process (GO:1901026),2,0,0.2,-, < 0.01,8.16E-01
cell wall glycoprotein biosynthetic process (GO:0031506),1,0,0.1,-, < 0.01,9.03E-01
intermediate mesodermal cell differentiation (GO:0048392),1,0,0.1,-, < 0.01,9.03E-01
intermediate mesoderm formation (GO:0048391),1,0,0.1,-, < 0.01,9.03E-01
intermediate mesoderm morphogenesis (GO:0048390),1,0,0.1,-, < 0.01,9.03E-01
response to symbiotic bacterium (GO:0009609),5,0,0.51,-, < 0.01,6.01E-01
extracellular matrix constituent secretion (GO:0070278),3,0,0.3,-, < 0.01,7.37E-01
response to symbiont (GO:0009608),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998),1,0,0.1,-, < 0.01,9.03E-01
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997),4,0,0.41,-, < 0.01,6.66E-01
ubiquinone-6 biosynthetic process (GO:1901006),1,0,0.1,-, < 0.01,9.03E-01
ubiquinone-6 metabolic process (GO:1901004),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of fermentation (GO:1901003),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992),1,0,0.1,-, < 0.01,9.03E-01
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990),1,0,0.1,-, < 0.01,9.03E-01
regulation of response to salt stress (GO:1901000),3,0,0.3,-, < 0.01,7.37E-01
intermediate mesoderm development (GO:0048389),2,0,0.2,-, < 0.01,8.16E-01
endosomal lumen acidification (GO:0048388),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of retinoic acid receptor signaling pathway (GO:0048386),4,0,0.41,-, < 0.01,6.66E-01
retinoic acid receptor signaling pathway (GO:0048384),19,0,1.93,-, < 0.01,1.45E-01
oncosis (GO:0070267),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of quinolinate biosynthetic process (GO:1904985),1,0,0.1,-, < 0.01,9.03E-01
regulation of quinolinate biosynthetic process (GO:1904984),1,0,0.1,-, < 0.01,9.03E-01
glycine import into mitochondrion (GO:1904983),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of defense response to virus by host (GO:0050689),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of endosome organization (GO:1904980),1,0,0.1,-, < 0.01,9.03E-01
regulation of lateral mesodermal cell fate specification (GO:0048378),2,0,0.2,-, < 0.01,8.16E-01
lateral mesodermal cell differentiation (GO:0048371),1,0,0.1,-, < 0.01,9.03E-01
lateral mesoderm formation (GO:0048370),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of endosome organization (GO:1904979),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mucus secretion (GO:0070256),2,0,0.2,-, < 0.01,8.16E-01
regulation of endosome organization (GO:1904978),3,0,0.3,-, < 0.01,7.37E-01
lymphatic endothelial cell migration (GO:1904977),2,0,0.2,-, < 0.01,8.16E-01
mucus secretion (GO:0070254),2,0,0.2,-, < 0.01,8.16E-01
cellular response to bleomycin (GO:1904976),2,0,0.2,-, < 0.01,8.16E-01
somatostatin secretion (GO:0070253),2,0,0.2,-, < 0.01,8.16E-01
response to bleomycin (GO:1904975),2,0,0.2,-, < 0.01,8.16E-01
lateral mesoderm morphogenesis (GO:0048369),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of peptidyl-lysine crotonylation (GO:0120094),1,0,0.1,-, < 0.01,9.03E-01
regulation of natural killer cell apoptotic process (GO:0070247),1,0,0.1,-, < 0.01,9.03E-01
regulation of peptidyl-lysine crotonylation (GO:0120093),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of thymocyte apoptotic process (GO:0070245),6,0,0.61,-, < 0.01,5.43E-01
thymocyte apoptotic process (GO:0070242),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of activated T cell autonomous cell death (GO:0070241),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cytochrome-c oxidase activity (GO:1904960),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of homocysteine metabolic process (GO:0050668),1,0,0.1,-, < 0.01,9.03E-01
regulation of homocysteine metabolic process (GO:0050666),2,0,0.2,-, < 0.01,8.16E-01
cytokine secretion (GO:0050663),15,0,1.52,-, < 0.01,2.17E-01
paraxial mesoderm structural organization (GO:0048352),1,0,0.1,-, < 0.01,9.03E-01
regulation of activated T cell autonomous cell death (GO:0070239),1,0,0.1,-, < 0.01,9.03E-01
regulation of cytochrome-c oxidase activity (GO:1904959),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of activation-induced cell death of T cells (GO:0070236),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958),3,0,0.3,-, < 0.01,7.37E-01
regulation of activation-induced cell death of T cells (GO:0070235),3,0,0.3,-, < 0.01,7.37E-01
regulation of midbrain dopaminergic neuron differentiation (GO:1904956),5,0,0.51,-, < 0.01,6.01E-01
planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation (GO:1904955),1,0,0.1,-, < 0.01,9.03E-01
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954),4,0,0.41,-, < 0.01,6.66E-01
T cell apoptotic process (GO:0070231),17,0,1.73,-, < 0.01,1.77E-01
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),10,0,1.02,-, < 0.01,3.62E-01
dermatan sulfate proteoglycan metabolic process (GO:0050655),16,0,1.63,-, < 0.01,1.96E-01
"chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)",2,0,0.2,-, < 0.01,8.16E-01
"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652)",1,0,0.1,-, < 0.01,9.03E-01
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),15,0,1.52,-, < 0.01,2.17E-01
paraxial mesodermal cell fate commitment (GO:0048343),2,0,0.2,-, < 0.01,8.16E-01
paraxial mesodermal cell differentiation (GO:0048342),2,0,0.2,-, < 0.01,8.16E-01
paraxial mesoderm formation (GO:0048341),8,0,0.81,-, < 0.01,4.43E-01
paraxial mesoderm morphogenesis (GO:0048340),11,0,1.12,-, < 0.01,3.27E-01
cell adhesion involved in sprouting angiogenesis (GO:0120078),1,0,0.1,-, < 0.01,9.03E-01
calcitriol biosynthetic process from calciol (GO:0036378),4,0,0.41,-, < 0.01,6.66E-01
angiogenic sprout fusion (GO:0120077),1,0,0.1,-, < 0.01,9.03E-01
calcium export from the mitochondrion (GO:0099093),1,0,0.1,-, < 0.01,9.03E-01
lymphocyte apoptotic process (GO:0070227),21,0,2.13,-, < 0.01,1.18E-01
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072),1,0,0.1,-, < 0.01,9.03E-01
midbrain dopaminergic neuron differentiation (GO:1904948),12,0,1.22,-, < 0.01,2.95E-01
regulation of pyloric antrum smooth muscle contraction (GO:0120071),1,0,0.1,-, < 0.01,9.03E-01
folate import into mitochondrion (GO:1904947),1,0,0.1,-, < 0.01,9.03E-01
paraxial mesoderm development (GO:0048339),18,0,1.83,-, < 0.01,1.60E-01
mesoderm structural organization (GO:0048338),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mesodermal cell fate specification (GO:0048337),1,0,0.1,-, < 0.01,9.03E-01
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089),1,0,0.1,-, < 0.01,9.03E-01
transcription factor catabolic process (GO:0036369),2,0,0.2,-, < 0.01,8.16E-01
postsynaptic specialization organization (GO:0099084),17,0,1.73,-, < 0.01,1.77E-01
"retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099083)",1,0,0.1,-, < 0.01,9.03E-01
retrograde trans-synaptic signaling by neuropeptide (GO:0099082),1,0,0.1,-, < 0.01,9.03E-01
transforming growth factor beta activation (GO:0036363),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in axon guidance (GO:1904938),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of gastric emptying (GO:0120061),1,0,0.1,-, < 0.01,9.03E-01
regulation of gastric emptying (GO:0120060),1,0,0.1,-, < 0.01,9.03E-01
interneuron migration (GO:1904936),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of cell proliferation in midbrain (GO:1904935),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell proliferation in midbrain (GO:1904934),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell proliferation in midbrain (GO:1904933),2,0,0.2,-, < 0.01,8.16E-01
renal potassium excretion (GO:0036359),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of small intestinal transit (GO:0120058),2,0,0.2,-, < 0.01,8.16E-01
mitochondrion-derived vesicle mediated transport (GO:0099075),2,0,0.2,-, < 0.01,8.16E-01
regulation of small intestinal transit (GO:0120057),2,0,0.2,-, < 0.01,8.16E-01
mitochondrion to lysosome transport (GO:0099074),2,0,0.2,-, < 0.01,8.16E-01
protein heterotrimerization (GO:0070208),1,0,0.1,-, < 0.01,9.03E-01
histone H2A-K15 ubiquitination (GO:0036352),1,0,0.1,-, < 0.01,9.03E-01
histone H2A-K13 ubiquitination (GO:0036351),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment of protein localization to telomere (GO:0070203),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),11,0,1.12,-, < 0.01,3.27E-01
regulation of establishment of protein localization to chromosome (GO:0070202),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924),1,0,0.1,-, < 0.01,9.03E-01
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923),12,0,1.22,-, < 0.01,2.95E-01
Golgi inheritance (GO:0048313),10,0,1.02,-, < 0.01,3.62E-01
snRNA (adenine-N6)-methylation (GO:0120049),1,0,0.1,-, < 0.01,9.03E-01
stereocilium maintenance (GO:0120045),1,0,0.1,-, < 0.01,9.03E-01
psychomotor behavior (GO:0036343),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of macrophage proliferation (GO:0120042),1,0,0.1,-, < 0.01,9.03E-01
post-anal tail morphogenesis (GO:0036342),17,0,1.73,-, < 0.01,1.77E-01
negative regulation of establishment of protein-containing complex localization to telomere (GO:1904914),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment of protein-containing complex localization to telomere (GO:1904913),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of establishment of RNA localization to telomere (GO:1904911),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment of RNA localization to telomere (GO:1904910),1,0,0.1,-, < 0.01,9.03E-01
organelle inheritance (GO:0048308),10,0,1.02,-, < 0.01,3.62E-01
immunoglobulin secretion (GO:0048305),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of isotype switching to IgG isotypes (GO:0048304),10,0,1.02,-, < 0.01,3.62E-01
Fas signaling pathway (GO:0036337),2,0,0.2,-, < 0.01,8.16E-01
intestinal stem cell homeostasis (GO:0036335),4,0,0.41,-, < 0.01,6.66E-01
epidermal stem cell homeostasis (GO:0036334),1,0,0.1,-, < 0.01,9.03E-01
hepatocyte homeostasis (GO:0036333),1,0,0.1,-, < 0.01,9.03E-01
vesicle scission (GO:0099050),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)",2,0,0.2,-, < 0.01,8.16E-01
"regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)",2,0,0.2,-, < 0.01,8.16E-01
avascular cornea development in camera-type eye (GO:0036331),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905),1,0,0.1,-, < 0.01,9.03E-01
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),6,0,0.61,-, < 0.01,5.43E-01
ESCRT III complex disassembly (GO:1904903),10,0,1.02,-, < 0.01,3.62E-01
ESCRT III complex assembly (GO:1904902),1,0,0.1,-, < 0.01,9.03E-01
clearance of foreign intracellular nucleic acids (GO:0099046),1,0,0.1,-, < 0.01,9.03E-01
vesicle tethering to endoplasmic reticulum (GO:0099044),2,0,0.2,-, < 0.01,8.16E-01
vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325),1,0,0.1,-, < 0.01,9.03E-01
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),5,0,0.51,-, < 0.01,6.01E-01
vesicle tethering to Golgi (GO:0099041),5,0,0.51,-, < 0.01,6.01E-01
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323),1,0,0.1,-, < 0.01,9.03E-01
ceramide translocation (GO:0099040),2,0,0.2,-, < 0.01,8.16E-01
ghrelin secretion (GO:0036321),1,0,0.1,-, < 0.01,9.03E-01
palmitic acid biosynthetic process (GO:1900535),1,0,0.1,-, < 0.01,9.03E-01
palmitic acid metabolic process (GO:1900533),1,0,0.1,-, < 0.01,9.03E-01
sphingolipid translocation (GO:0099039),4,0,0.41,-, < 0.01,6.66E-01
SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316),2,0,0.2,-, < 0.01,8.16E-01
protein localization to M-band (GO:0036309),1,0,0.1,-, < 0.01,9.03E-01
embryonic heart tube elongation (GO:0036306),1,0,0.1,-, < 0.01,9.03E-01
ameloblast differentiation (GO:0036305),1,0,0.1,-, < 0.01,9.03E-01
vesicle tethering (GO:0099022),8,0,0.81,-, < 0.01,4.43E-01
umbilical cord morphogenesis (GO:0036304),2,0,0.2,-, < 0.01,8.16E-01
atrioventricular canal development (GO:0036302),7,0,0.71,-, < 0.01,4.91E-01
mRNA 5'-splice site recognition (GO:0000395),3,0,0.3,-, < 0.01,7.37E-01
neuronal dense core vesicle exocytosis (GO:0099011),4,0,0.41,-, < 0.01,6.66E-01
modification of postsynaptic structure (GO:0099010),5,0,0.51,-, < 0.01,6.01E-01
mRNA 3'-splice site recognition (GO:0000389),6,0,0.61,-, < 0.01,5.43E-01
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388),1,0,0.1,-, < 0.01,9.03E-01
calmodulin dependent kinase signaling pathway (GO:0099004),4,0,0.41,-, < 0.01,6.66E-01
RNA exon ligation (GO:0000378),1,0,0.1,-, < 0.01,9.03E-01
parathyroid hormone secretion (GO:0035898),1,0,0.1,-, < 0.01,9.03E-01
exit from host cell (GO:0035891),6,0,0.61,-, < 0.01,5.43E-01
exit from host (GO:0035890),6,0,0.61,-, < 0.01,5.43E-01
cis assembly of pre-catalytic spliceosome (GO:0000354),2,0,0.2,-, < 0.01,8.16E-01
generation of catalytic spliceosome for second transesterification step (GO:0000350),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein heterodimerization activity (GO:0043497),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein homodimerization activity (GO:0043496),2,0,0.2,-, < 0.01,8.16E-01
vascular associated smooth muscle cell differentiation (GO:0035886),14,0,1.42,-, < 0.01,2.41E-01
amacrine cell differentiation (GO:0035881),5,0,0.51,-, < 0.01,6.01E-01
malate-aspartate shuttle (GO:0043490),4,0,0.41,-, < 0.01,6.66E-01
embryonic nail plate morphogenesis (GO:0035880),3,0,0.3,-, < 0.01,7.37E-01
cellular response to flavonoid (GO:1905396),1,0,0.1,-, < 0.01,9.03E-01
response to flavonoid (GO:1905395),3,0,0.3,-, < 0.01,7.37E-01
observational learning (GO:0098597),8,0,0.81,-, < 0.01,4.43E-01
plasma membrane lactate transport (GO:0035879),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of helicase activity (GO:0051097),5,0,0.51,-, < 0.01,6.01E-01
imitative learning (GO:0098596),7,0,0.71,-, < 0.01,4.91E-01
endosome to pigment granule transport (GO:0043485),9,0,0.91,-, < 0.01,4.00E-01
cellular pigment accumulation (GO:0043482),11,0,1.12,-, < 0.01,3.27E-01
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",26,0,2.64,-, < 0.01,7.10E-02
protein K11-linked deubiquitination (GO:0035871),10,0,1.02,-, < 0.01,3.62E-01
protein deneddylation (GO:0000338),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein localization to presynapse (GO:1905386),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to presynapse (GO:1905384),2,0,0.2,-, < 0.01,8.16E-01
protein localization to presynapse (GO:1905383),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381),1,0,0.1,-, < 0.01,9.03E-01
constitutive protein ectodomain proteolysis (GO:0051089),1,0,0.1,-, < 0.01,9.03E-01
regulation of snRNA transcription by RNA polymerase II (GO:1905380),5,0,0.51,-, < 0.01,6.01E-01
chaperone mediated protein folding independent of cofactor (GO:0051086),1,0,0.1,-, < 0.01,9.03E-01
pigment accumulation (GO:0043476),11,0,1.12,-, < 0.01,3.27E-01
'de novo' cotranslational protein folding (GO:0051083),2,0,0.2,-, < 0.01,8.16E-01
innate vocalization behavior (GO:0098582),1,0,0.1,-, < 0.01,9.03E-01
nuclear envelope disassembly (GO:0051081),15,0,1.52,-, < 0.01,2.17E-01
dITP catabolic process (GO:0035863),1,0,0.1,-, < 0.01,9.03E-01
dITP metabolic process (GO:0035862),1,0,0.1,-, < 0.01,9.03E-01
response to D-galactose (GO:1905377),1,0,0.1,-, < 0.01,9.03E-01
re-entry into mitotic cell cycle (GO:0000320),3,0,0.3,-, < 0.01,7.37E-01
regulation of fermentation (GO:0043465),5,0,0.51,-, < 0.01,6.01E-01
eosinophil fate commitment (GO:0035854),2,0,0.2,-, < 0.01,8.16E-01
chromosome passenger complex localization to spindle midzone (GO:0035853),1,0,0.1,-, < 0.01,9.03E-01
horizontal cell localization (GO:0035852),1,0,0.1,-, < 0.01,9.03E-01
regulation of mating type switching (GO:0031494),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of intralumenal vesicle formation (GO:1905366),1,0,0.1,-, < 0.01,9.03E-01
regulation of intralumenal vesicle formation (GO:1905365),1,0,0.1,-, < 0.01,9.03E-01
regulation of endosomal vesicle fusion (GO:1905364),1,0,0.1,-, < 0.01,9.03E-01
nephric duct elongation (GO:0035849),1,0,0.1,-, < 0.01,9.03E-01
dihydrobiopterin metabolic process (GO:0051066),2,0,0.2,-, < 0.01,8.16E-01
uterine epithelium development (GO:0035847),1,0,0.1,-, < 0.01,9.03E-01
oviduct epithelium development (GO:0035846),1,0,0.1,-, < 0.01,9.03E-01
cloaca development (GO:0035844),4,0,0.41,-, < 0.01,6.66E-01
protein localization to meiotic spindle (GO:1905359),1,0,0.1,-, < 0.01,9.03E-01
spine apparatus assembly (GO:1905355),1,0,0.1,-, < 0.01,9.03E-01
response to singlet oxygen (GO:0000304),1,0,0.1,-, < 0.01,9.03E-01
detection of virus (GO:0009597),6,0,0.61,-, < 0.01,5.43E-01
detection of gravity (GO:0009590),1,0,0.1,-, < 0.01,9.03E-01
ciliary transition zone assembly (GO:1905349),1,0,0.1,-, < 0.01,9.03E-01
prostaglandin catabolic process (GO:1905344),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein localization to kinetochore (GO:1905342),3,0,0.3,-, < 0.01,7.37E-01
N-terminal peptidyl-serine acetylation (GO:0017198),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein localization to kinetochore (GO:1905341),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein localization to kinetochore (GO:1905340),3,0,0.3,-, < 0.01,7.37E-01
N-terminal peptidyl-methionine acetylation (GO:0017196),7,0,0.71,-, < 0.01,4.91E-01
acetoacetic acid metabolic process (GO:0043438),1,0,0.1,-, < 0.01,9.03E-01
response to corticotropin-releasing hormone (GO:0043435),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of calcium-independent cell-cell adhesion (GO:0051041),1,0,0.1,-, < 0.01,9.03E-01
glycine betaine transport (GO:0031460),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-glutamic acid carboxylation (GO:0017187),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of transcription involved in meiotic cell cycle (GO:0051039),1,0,0.1,-, < 0.01,9.03E-01
"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)",2,0,0.2,-, < 0.01,8.16E-01
peptidyl-lysine hydroxylation (GO:0017185),7,0,0.71,-, < 0.01,4.91E-01
regulation of transcription involved in meiotic cell cycle (GO:0051037),1,0,0.1,-, < 0.01,9.03E-01
regulation of endosome size (GO:0051036),5,0,0.51,-, < 0.01,6.01E-01
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535),5,0,0.51,-, < 0.01,6.01E-01
centriole assembly (GO:0098534),23,0,2.34,-, < 0.01,9.63E-02
histone H3-K27 trimethylation (GO:0098532),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of strand invasion (GO:0098530),1,0,0.1,-, < 0.01,9.03E-01
renal sodium excretion (GO:0035812),2,0,0.2,-, < 0.01,8.16E-01
anthranilate metabolic process (GO:0043420),3,0,0.3,-, < 0.01,7.37E-01
glycine betaine biosynthetic process (GO:0031456),2,0,0.2,-, < 0.01,8.16E-01
glycine betaine metabolic process (GO:0031455),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of heterochromatin assembly (GO:0031452),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of mesenchymal stem cell migration (GO:1905322),3,0,0.3,-, < 0.01,7.37E-01
rRNA transport (GO:0051029),5,0,0.51,-, < 0.01,6.01E-01
regulation of mesenchymal stem cell migration (GO:1905320),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of skeletal muscle tissue regeneration (GO:0043417),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of immunoglobulin secretion (GO:0051025),3,0,0.3,-, < 0.01,7.37E-01
regulation of skeletal muscle tissue regeneration (GO:0043416),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of skeletal muscle tissue regeneration (GO:0043415),5,0,0.51,-, < 0.01,6.01E-01
egg coat formation (GO:0035803),2,0,0.2,-, < 0.01,8.16E-01
regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448),2,0,0.2,-, < 0.01,8.16E-01
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446),2,0,0.2,-, < 0.01,8.16E-01
slow-twitch skeletal muscle fiber contraction (GO:0031444),1,0,0.1,-, < 0.01,9.03E-01
fast-twitch skeletal muscle fiber contraction (GO:0031443),1,0,0.1,-, < 0.01,9.03E-01
inferior endocardial cushion morphogenesis (GO:1905317),1,0,0.1,-, < 0.01,9.03E-01
transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312),3,0,0.3,-, < 0.01,7.37E-01
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310),3,0,0.3,-, < 0.01,7.37E-01
microtubule sliding (GO:0051012),2,0,0.2,-, < 0.01,8.16E-01
glucocorticoid mediated signaling pathway (GO:0043402),1,0,0.1,-, < 0.01,9.03E-01
cortisol secretion (GO:0043400),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cohesin loading (GO:1905309),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cardiac myofibril assembly (GO:1905305),1,0,0.1,-, < 0.01,9.03E-01
regulation of cardiac myofibril assembly (GO:1905304),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of macropinocytosis (GO:1905302),1,0,0.1,-, < 0.01,9.03E-01
polynucleotide 5' dephosphorylation (GO:0098507),2,0,0.2,-, < 0.01,8.16E-01
polynucleotide 3' dephosphorylation (GO:0098506),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lipoprotein lipase activity (GO:0051005),6,0,0.61,-, < 0.01,5.43E-01
DNA dephosphorylation (GO:0098502),2,0,0.2,-, < 0.01,8.16E-01
meiotic attachment of telomere to nuclear envelope (GO:0070197),3,0,0.3,-, < 0.01,7.37E-01
synaptonemal complex disassembly (GO:0070194),2,0,0.2,-, < 0.01,8.16E-01
oxylipin biosynthetic process (GO:0031408),3,0,0.3,-, < 0.01,7.37E-01
oxylipin metabolic process (GO:0031407),4,0,0.41,-, < 0.01,6.66E-01
nucleologenesis (GO:0017126),2,0,0.2,-, < 0.01,8.16E-01
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane phospholipid scrambling (GO:0017121),15,0,1.52,-, < 0.01,2.17E-01
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of Golgi to plasma membrane protein transport (GO:0042998),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of isotype switching to IgA isotypes (GO:0048298),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of isotype switching to IgA isotypes (GO:0048297),1,0,0.1,-, < 0.01,9.03E-01
regulation of isotype switching to IgA isotypes (GO:0048296),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of isotype switching to IgE isotypes (GO:0048295),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of isotype switching to IgE isotypes (GO:0048294),3,0,0.3,-, < 0.01,7.37E-01
regulation of isotype switching to IgE isotypes (GO:0048293),7,0,0.71,-, < 0.01,4.91E-01
isotype switching to IgA isotypes (GO:0048290),1,0,0.1,-, < 0.01,9.03E-01
D-serine biosynthetic process (GO:0070179),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of enamel mineralization (GO:0070175),2,0,0.2,-, < 0.01,8.16E-01
ESCRT complex disassembly (GO:1904896),10,0,1.02,-, < 0.01,3.62E-01
regulation of enamel mineralization (GO:0070173),4,0,0.41,-, < 0.01,6.66E-01
ESCRT complex assembly (GO:1904895),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of tooth mineralization (GO:0070171),2,0,0.2,-, < 0.01,8.16E-01
sequestering of actin monomers (GO:0042989),11,0,1.12,-, < 0.01,3.27E-01
amyloid precursor protein catabolic process (GO:0042987),12,0,1.22,-, < 0.01,2.95E-01
amyloid precursor protein biosynthetic process (GO:0042983),1,0,0.1,-, < 0.01,9.03E-01
amyloid precursor protein metabolic process (GO:0042982),18,0,1.83,-, < 0.01,1.60E-01
vesicle fusion with Golgi apparatus (GO:0048280),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of biomineral tissue development (GO:0070168),27,0,2.74,-, < 0.01,6.41E-02
Wnt signalosome assembly (GO:1904887),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adiponectin secretion (GO:0070165),1,0,0.1,-, < 0.01,9.03E-01
beta-catenin destruction complex assembly (GO:1904885),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of telomerase catalytic core complex assembly (GO:1904884),2,0,0.2,-, < 0.01,8.16E-01
regulation of telomerase catalytic core complex assembly (GO:1904882),2,0,0.2,-, < 0.01,8.16E-01
cellular response to hydrogen sulfide (GO:1904881),2,0,0.2,-, < 0.01,8.16E-01
response to hydrogen sulfide (GO:1904880),3,0,0.3,-, < 0.01,7.37E-01
activation of Janus kinase activity (GO:0042976),6,0,0.61,-, < 0.01,5.43E-01
mitochondrial threonyl-tRNA aminoacylation (GO:0070159),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial seryl-tRNA aminoacylation (GO:0070158),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of DNA ligase activity (GO:1904877),1,0,0.1,-, < 0.01,9.03E-01
regulation of DNA ligase activity (GO:1904875),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial glycyl-tRNA aminoacylation (GO:0070150),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein localization to Cajal body (GO:1904871),11,0,1.12,-, < 0.01,3.27E-01
lactone transport (GO:0042969),1,0,0.1,-, < 0.01,9.03E-01
determination of ventral identity (GO:0048264),1,0,0.1,-, < 0.01,9.03E-01
determination of dorsal identity (GO:0048263),5,0,0.51,-, < 0.01,6.01E-01
regulation of centriole-centriole cohesion (GO:0030997),3,0,0.3,-, < 0.01,7.37E-01
determination of dorsal/ventral asymmetry (GO:0048262),6,0,0.61,-, < 0.01,5.43E-01
recombinational interstrand cross-link repair (GO:0036298),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to Cajal body (GO:1904869),11,0,1.12,-, < 0.01,3.27E-01
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial alanyl-tRNA aminoacylation (GO:0070143),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of beta-catenin-TCF complex assembly (GO:1904864),2,0,0.2,-, < 0.01,8.16E-01
regulation of beta-catenin-TCF complex assembly (GO:1904863),2,0,0.2,-, < 0.01,8.16E-01
lauric acid metabolic process (GO:0048252),1,0,0.1,-, < 0.01,9.03E-01
iron import into the mitochondrion (GO:0048250),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mitochondrial translation (GO:0070130),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of establishment of protein localization to telomere (GO:1904851),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of establishment of protein localization to telomere (GO:1904850),1,0,0.1,-, < 0.01,9.03E-01
glucoside transport (GO:0042946),2,0,0.2,-, < 0.01,8.16E-01
D-serine transport (GO:0042942),3,0,0.3,-, < 0.01,7.37E-01
D-alanine transport (GO:0042941),1,0,0.1,-, < 0.01,9.03E-01
D-amino acid transport (GO:0042940),7,0,0.71,-, < 0.01,4.91E-01
norepinephrine secretion (GO:0048243),1,0,0.1,-, < 0.01,9.03E-01
epinephrine secretion (GO:0048242),1,0,0.1,-, < 0.01,9.03E-01
epinephrine transport (GO:0048241),4,0,0.41,-, < 0.01,6.66E-01
sperm capacitation (GO:0048240),21,0,2.13,-, < 0.01,1.18E-01
thiamine pyrophosphate transmembrane transport (GO:0030974),2,0,0.2,-, < 0.01,8.16E-01
"retrograde protein transport, ER to cytosol (GO:0030970)",17,0,1.73,-, < 0.01,1.77E-01
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial translational initiation (GO:0070124),2,0,0.2,-, < 0.01,8.16E-01
cellular response to L-glutamine (GO:1904845),3,0,0.3,-, < 0.01,7.37E-01
response to L-glutamine (GO:1904844),3,0,0.3,-, < 0.01,7.37E-01
cellular response to nitroglycerin (GO:1904843),1,0,0.1,-, < 0.01,9.03E-01
Kupffer's vesicle development (GO:0070121),1,0,0.1,-, < 0.01,9.03E-01
response to nitroglycerin (GO:1904842),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein targeting to vacuolar membrane (GO:1900483),1,0,0.1,-, < 0.01,9.03E-01
enterobactin transport (GO:0042930),1,0,0.1,-, < 0.01,9.03E-01
swimming behavior (GO:0036269),1,0,0.1,-, < 0.01,9.03E-01
RNA (guanine-N7)-methylation (GO:0036265),6,0,0.61,-, < 0.01,5.43E-01
7-methylguanosine cap hypermethylation (GO:0036261),1,0,0.1,-, < 0.01,9.03E-01
dorsal root ganglion morphogenesis (GO:1904835),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane to endosome transport (GO:0048227),8,0,0.81,-, < 0.01,4.43E-01
glucocorticoid receptor signaling pathway (GO:0042921),6,0,0.61,-, < 0.01,5.43E-01
astral microtubule nucleation (GO:0030954),1,0,0.1,-, < 0.01,9.03E-01
multivesicular body assembly (GO:0036258),30,0,3.05,-, < 0.01,4.72E-02
multivesicular body organization (GO:0036257),31,0,3.15,-, < 0.01,4.27E-02
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105),2,0,0.2,-, < 0.01,8.16E-01
regulation of hydrogen sulfide biosynthetic process (GO:1904826),1,0,0.1,-, < 0.01,9.03E-01
peroxisome transport along microtubule (GO:0036250),1,0,0.1,-, < 0.01,9.03E-01
purine nucleobase transmembrane transport (GO:1904823),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of chemokine-mediated signaling pathway (GO:0070101),2,0,0.2,-, < 0.01,8.16E-01
alkanesulfonate transport (GO:0042918),6,0,0.61,-, < 0.01,5.43E-01
inter-Golgi cisterna vesicle-mediated transport (GO:0048219),1,0,0.1,-, < 0.01,9.03E-01
Golgi vesicle prefusion complex stabilization (GO:0048213),2,0,0.2,-, < 0.01,8.16E-01
Golgi vesicle docking (GO:0048211),2,0,0.2,-, < 0.01,8.16E-01
Golgi vesicle fusion to target membrane (GO:0048210),4,0,0.41,-, < 0.01,6.66E-01
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",12,0,1.22,-, < 0.01,2.95E-01
"negative regulation of protein localization to chromosome, telomeric region (GO:1904815)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of protein localization to chromosome, telomeric region (GO:1904814)",13,0,1.32,-, < 0.01,2.67E-01
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of long-term synaptic depression (GO:1900453),3,0,0.3,-, < 0.01,7.37E-01
"regulation of vesicle targeting, to, from or within Golgi (GO:0048209)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glutamate receptor signaling pathway (GO:1900451),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of glutamate receptor signaling pathway (GO:1900450),1,0,0.1,-, < 0.01,9.03E-01
COPI coating of Golgi vesicle (GO:0048205),6,0,0.61,-, < 0.01,5.43E-01
"vesicle targeting, trans-Golgi to endosome (GO:0048203)",2,0,0.2,-, < 0.01,8.16E-01
Golgi transport vesicle coating (GO:0048200),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of protein oxidation (GO:1904808),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein oxidation (GO:1904806),1,0,0.1,-, < 0.01,9.03E-01
regulation of translation involved in cellular response to UV (GO:1904803),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neuron remodeling (GO:1904800),1,0,0.1,-, < 0.01,9.03E-01
protein localization to nuclear inner membrane (GO:0036228),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-serine acetylation (GO:0030920),1,0,0.1,-, < 0.01,9.03E-01
paranodal junction assembly (GO:0030913),6,0,0.61,-, < 0.01,5.43E-01
cellular response to stem cell factor stimulus (GO:0036216),2,0,0.2,-, < 0.01,8.16E-01
response to stem cell factor (GO:0036215),2,0,0.2,-, < 0.01,8.16E-01
contractile ring contraction (GO:0036213),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of defense response to bacterium (GO:1900426),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of defense response to bacterium (GO:1900425),5,0,0.51,-, < 0.01,6.01E-01
regulation of defense response to bacterium (GO:1900424),14,0,1.42,-, < 0.01,2.41E-01
notochord development (GO:0030903),19,0,1.93,-, < 0.01,1.45E-01
spermine transport (GO:0000296),2,0,0.2,-, < 0.01,8.16E-01
peptidoglycan metabolic process (GO:0000270),6,0,0.61,-, < 0.01,5.43E-01
ureter maturation (GO:0035799),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of mitochondrial membrane permeability (GO:0035795),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793),3,0,0.3,-, < 0.01,7.37E-01
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791),8,0,0.81,-, < 0.01,4.43E-01
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790),1,0,0.1,-, < 0.01,9.03E-01
allantoin catabolic process (GO:0000256),1,0,0.1,-, < 0.01,9.03E-01
allantoin metabolic process (GO:0000255),2,0,0.2,-, < 0.01,8.16E-01
metanephric mesenchymal cell migration (GO:0035789),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in metanephros development (GO:0035788),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in kidney development (GO:0035787),1,0,0.1,-, < 0.01,9.03E-01
"CD4-positive, alpha-beta T cell costimulation (GO:0035783)",1,0,0.1,-, < 0.01,9.03E-01
CD86 biosynthetic process (GO:0035781),2,0,0.2,-, < 0.01,8.16E-01
CD80 biosynthetic process (GO:0035780),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of CAMKK-AMPK signaling cascade (GO:1905291),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of memory T cell differentiation (GO:0043382),7,0,0.71,-, < 0.01,4.91E-01
interleukin-13-mediated signaling pathway (GO:0035772),1,0,0.1,-, < 0.01,9.03E-01
interleukin-4-mediated signaling pathway (GO:0035771),4,0,0.41,-, < 0.01,6.66E-01
regulation of CAMKK-AMPK signaling cascade (GO:1905289),3,0,0.3,-, < 0.01,7.37E-01
fibrous ring of heart morphogenesis (GO:1905285),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of retrograde transport, endosome to Golgi (GO:1905280)",1,0,0.1,-, < 0.01,9.03E-01
memory T cell differentiation (GO:0043379),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)",2,0,0.2,-, < 0.01,8.16E-01
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768),1,0,0.1,-, < 0.01,9.03E-01
cell chemotaxis to fibroblast growth factor (GO:0035766),1,0,0.1,-, < 0.01,9.03E-01
"CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)",2,0,0.2,-, < 0.01,8.16E-01
"CD8-positive, alpha-beta T cell differentiation (GO:0043374)",8,0,0.81,-, < 0.01,4.43E-01
"regulation of retrograde transport, endosome to Golgi (GO:1905279)",3,0,0.3,-, < 0.01,7.37E-01
"positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)",1,0,0.1,-, < 0.01,9.03E-01
beta selection (GO:0043366),3,0,0.3,-, < 0.01,7.37E-01
B cell chemotaxis (GO:0035754),6,0,0.61,-, < 0.01,5.43E-01
lysosomal lumen pH elevation (GO:0035752),1,0,0.1,-, < 0.01,9.03E-01
regulation of lysosomal lumen pH (GO:0035751),14,0,1.42,-, < 0.01,2.41E-01
protein localization to myelin sheath abaxonal region (GO:0035750),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of prostaglandin biosynthetic process (GO:0031393),2,0,0.2,-, < 0.01,8.16E-01
endonucleolytic cleavage involved in tRNA processing (GO:1905267),2,0,0.2,-, < 0.01,8.16E-01
meiotic spindle organization (GO:0000212),14,0,1.42,-, < 0.01,2.41E-01
T-helper 2 cell cytokine production (GO:0035745),4,0,0.41,-, < 0.01,6.66E-01
T-helper 1 cell cytokine production (GO:0035744),3,0,0.3,-, < 0.01,7.37E-01
"CD4-positive, alpha-beta T cell cytokine production (GO:0035743)",8,0,0.81,-, < 0.01,4.43E-01
regulation of RNA binding transcription factor activity (GO:1905255),1,0,0.1,-, < 0.01,9.03E-01
hepatic stellate cell activation (GO:0035733),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of aspartic-type peptidase activity (GO:1905247),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),1,0,0.1,-, < 0.01,9.03E-01
protein unfolding (GO:0043335),3,0,0.3,-, < 0.01,7.37E-01
intraciliary retrograde transport (GO:0035721),12,0,1.22,-, < 0.01,2.95E-01
intraciliary anterograde transport (GO:0035720),4,0,0.41,-, < 0.01,6.66E-01
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),1,0,0.1,-, < 0.01,9.03E-01
cellular response to L-glutamate (GO:1905232),5,0,0.51,-, < 0.01,6.01E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of natural killer cell degranulation (GO:0043323),4,0,0.41,-, < 0.01,6.66E-01
response to nitrogen dioxide (GO:0035713),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of natural killer cell degranulation (GO:0043322),1,0,0.1,-, < 0.01,9.03E-01
regulation of natural killer cell degranulation (GO:0043321),4,0,0.41,-, < 0.01,6.66E-01
T-helper 2 cell activation (GO:0035712),1,0,0.1,-, < 0.01,9.03E-01
cellular response to thyrotropin-releasing hormone (GO:1905229),1,0,0.1,-, < 0.01,9.03E-01
regulation of adhesion of symbiont to host epithelial cell (GO:1905226),1,0,0.1,-, < 0.01,9.03E-01
response to thyrotropin-releasing hormone (GO:1905225),2,0,0.2,-, < 0.01,8.16E-01
clathrin-coated pit assembly (GO:1905224),2,0,0.2,-, < 0.01,8.16E-01
epicardium morphogenesis (GO:1905223),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of platelet formation (GO:1905221),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytotoxic T cell degranulation (GO:0043318),2,0,0.2,-, < 0.01,8.16E-01
regulation of cytotoxic T cell degranulation (GO:0043317),2,0,0.2,-, < 0.01,8.16E-01
cytotoxic T cell degranulation (GO:0043316),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of neutrophil degranulation (GO:0043315),4,0,0.41,-, < 0.01,6.66E-01
T-helper 17 cell chemotaxis (GO:0035705),1,0,0.1,-, < 0.01,9.03E-01
helper T cell chemotaxis (GO:0035704),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of eosinophil degranulation (GO:0043311),2,0,0.2,-, < 0.01,8.16E-01
monocyte homeostasis (GO:0035702),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of eosinophil degranulation (GO:0043310),1,0,0.1,-, < 0.01,9.03E-01
regulation of platelet formation (GO:1905219),1,0,0.1,-, < 0.01,9.03E-01
response to astaxanthin (GO:1905217),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of RNA binding (GO:1905216),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of RNA binding (GO:1905215),1,0,0.1,-, < 0.01,9.03E-01
regulation of RNA binding (GO:1905214),9,0,0.91,-, < 0.01,4.00E-01
regulation of eosinophil degranulation (GO:0043309),3,0,0.3,-, < 0.01,7.37E-01
eosinophil degranulation (GO:0043308),3,0,0.3,-, < 0.01,7.37E-01
eosinophil activation (GO:0043307),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of mast cell degranulation (GO:0043305),7,0,0.71,-, < 0.01,4.91E-01
gamma-aminobutyric acid catabolic process (GO:0009450),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of vesicle fusion (GO:0031339),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of sulfur amino acid metabolic process (GO:0031337),1,0,0.1,-, < 0.01,9.03E-01
regulation of sulfur amino acid metabolic process (GO:0031335),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of cardiocyte differentiation (GO:1905209),17,0,1.73,-, < 0.01,1.77E-01
positive regulation of hydrogen peroxide-induced cell death (GO:1905206),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of connective tissue replacement (GO:1905205),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of connective tissue replacement (GO:1905204),1,0,0.1,-, < 0.01,9.03E-01
regulation of connective tissue replacement (GO:1905203),4,0,0.41,-, < 0.01,6.66E-01
gamma-aminobutyric acid biosynthetic process (GO:0009449),3,0,0.3,-, < 0.01,7.37E-01
gamma-aminobutyric acid metabolic process (GO:0009448),5,0,0.51,-, < 0.01,6.01E-01
putrescine biosynthetic process (GO:0009446),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055),2,0,0.2,-, < 0.01,8.16E-01
pyruvate oxidation (GO:0009444),1,0,0.1,-, < 0.01,9.03E-01
pyridoxal 5'-phosphate salvage (GO:0009443),1,0,0.1,-, < 0.01,9.03E-01
cyanate catabolic process (GO:0009440),1,0,0.1,-, < 0.01,9.03E-01
cyanate metabolic process (GO:0009439),1,0,0.1,-, < 0.01,9.03E-01
glyoxylate catabolic process (GO:0009436),2,0,0.2,-, < 0.01,8.16E-01
NAD biosynthetic process (GO:0009435),25,0,2.54,-, < 0.01,7.86E-02
mitochondrial outer membrane translocase complex assembly (GO:0070096),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of glucagon secretion (GO:0070094),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of glucagon secretion (GO:0070093),4,0,0.41,-, < 0.01,6.66E-01
ubiquitin-dependent endocytosis (GO:0070086),3,0,0.3,-, < 0.01,7.37E-01
protein initiator methionine removal (GO:0070084),2,0,0.2,-, < 0.01,8.16E-01
histone H4-R3 demethylation (GO:0070079),1,0,0.1,-, < 0.01,9.03E-01
histone H3-R2 demethylation (GO:0070078),1,0,0.1,-, < 0.01,9.03E-01
histone arginine demethylation (GO:0070077),1,0,0.1,-, < 0.01,9.03E-01
regulation of neuron remodeling (GO:1904799),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of core promoter binding (GO:1904797),2,0,0.2,-, < 0.01,8.16E-01
protein nitrosylation (GO:0017014),6,0,0.61,-, < 0.01,5.43E-01
pathogenesis (GO:0009405),1,0,0.1,-, < 0.01,9.03E-01
toxin biosynthetic process (GO:0009403),1,0,0.1,-, < 0.01,9.03E-01
regulation of euchromatin binding (GO:1904793),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of shelterin complex assembly (GO:1904792),1,0,0.1,-, < 0.01,9.03E-01
regulation of shelterin complex assembly (GO:1904790),1,0,0.1,-, < 0.01,9.03E-01
cysteine transport (GO:0042883),2,0,0.2,-, < 0.01,8.16E-01
NLRP1 inflammasome complex assembly (GO:1904784),1,0,0.1,-, < 0.01,9.03E-01
'de novo' actin filament nucleation (GO:0070060),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of NMDA glutamate receptor activity (GO:1904782),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of protein localization to centrosome (GO:1904781),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of hepatocyte growth factor biosynthetic process (GO:0048178),1,0,0.1,-, < 0.01,9.03E-01
regulation of hepatocyte growth factor biosynthetic process (GO:0048176),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of short-term neuronal synaptic plasticity (GO:0048174),1,0,0.1,-, < 0.01,9.03E-01
regulation of short-term neuronal synaptic plasticity (GO:0048172),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of long-term neuronal synaptic plasticity (GO:0048170),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of protein localization to cell cortex (GO:1904777),1,0,0.1,-, < 0.01,9.03E-01
response to tetrachloromethane (GO:1904772),2,0,0.2,-, < 0.01,8.16E-01
antisense RNA metabolic process (GO:0042868),1,0,0.1,-, < 0.01,9.03E-01
fused antrum stage (GO:0048165),3,0,0.3,-, < 0.01,7.37E-01
primary follicle stage (GO:0048160),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of macroautophagy by TORC1 signaling (GO:1904766),1,0,0.1,-, < 0.01,9.03E-01
chaperone-mediated autophagy translocation complex disassembly (GO:1904764),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of myofibroblast differentiation (GO:1904761),3,0,0.3,-, < 0.01,7.37E-01
L-alanine catabolic process (GO:0042853),4,0,0.41,-, < 0.01,6.66E-01
L-alanine metabolic process (GO:0042851),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of myeloid dendritic cell activation (GO:0030887),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of myeloid dendritic cell activation (GO:0030886),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of vascular associated smooth muscle cell migration (GO:1904753),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of protein localization to nucleolus (GO:1904751),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of protein localization to nucleolus (GO:1904750),1,0,0.1,-, < 0.01,9.03E-01
behavioral response to ethanol (GO:0048149),9,0,0.91,-, < 0.01,4.00E-01
behavioral response to cocaine (GO:0048148),13,0,1.32,-, < 0.01,2.67E-01
D-glucuronate catabolic process (GO:0042840),1,0,0.1,-, < 0.01,9.03E-01
fibroblast proliferation (GO:0048144),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of telomeric DNA binding (GO:1904744),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of telomeric DNA binding (GO:1904743),2,0,0.2,-, < 0.01,8.16E-01
regulation of telomeric DNA binding (GO:1904742),4,0,0.41,-, < 0.01,6.66E-01
protein arginylation (GO:0016598),1,0,0.1,-, < 0.01,9.03E-01
D-glucuronate metabolic process (GO:0042839),1,0,0.1,-, < 0.01,9.03E-01
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383),1,0,0.1,-, < 0.01,9.03E-01
male germ-line stem cell asymmetric division (GO:0048133),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of polarized epithelial cell differentiation (GO:0030862),1,0,0.1,-, < 0.01,9.03E-01
regulation of polarized epithelial cell differentiation (GO:0030860),2,0,0.2,-, < 0.01,8.16E-01
cell-abiotic substrate adhesion (GO:0036164),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of electron transfer activity (GO:1904734),2,0,0.2,-, < 0.01,8.16E-01
regulation of electron transfer activity (GO:1904732),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of intestinal lipid absorption (GO:1904731),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of secondary metabolite biosynthetic process (GO:1900377),4,0,0.41,-, < 0.01,6.66E-01
catecholamine secretion (GO:0050432),2,0,0.2,-, < 0.01,8.16E-01
pyridoxal phosphate biosynthetic process (GO:0042823),2,0,0.2,-, < 0.01,8.16E-01
pyridoxal phosphate metabolic process (GO:0042822),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of RNA interference (GO:1900370),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of granulocyte differentiation (GO:0030853),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723),1,0,0.1,-, < 0.01,9.03E-01
histone deubiquitination (GO:0016578),21,0,2.13,-, < 0.01,1.18E-01
negative regulation of RNA interference (GO:1900369),2,0,0.2,-, < 0.01,8.16E-01
regulation of RNA interference (GO:1900368),3,0,0.3,-, < 0.01,7.37E-01
vitamin B6 biosynthetic process (GO:0042819),3,0,0.3,-, < 0.01,7.37E-01
vitamin B6 metabolic process (GO:0042816),4,0,0.41,-, < 0.01,6.66E-01
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of intermediate filament depolymerization (GO:0030844),1,0,0.1,-, < 0.01,9.03E-01
regulation of intermediate filament depolymerization (GO:0030842),1,0,0.1,-, < 0.01,9.03E-01
dendritic cell homeostasis (GO:0036145),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of AMPA glutamate receptor clustering (GO:1904719),2,0,0.2,-, < 0.01,8.16E-01
regulation of AMPA glutamate receptor clustering (GO:1904717),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of chaperone-mediated autophagy (GO:1904716),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of chaperone-mediated autophagy (GO:1904715),3,0,0.3,-, < 0.01,7.37E-01
regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of granulosa cell apoptotic process (GO:1904710),1,0,0.1,-, < 0.01,9.03E-01
"protein import into peroxisome matrix, docking (GO:0016560)",4,0,0.41,-, < 0.01,6.66E-01
establishment of body hair planar orientation (GO:0048105),3,0,0.3,-, < 0.01,7.37E-01
establishment of body hair or bristle planar orientation (GO:0048104),3,0,0.3,-, < 0.01,7.37E-01
somatic stem cell division (GO:0048103),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of actin filament depolymerization (GO:0030836),11,0,1.12,-, < 0.01,3.27E-01
regulation of granulosa cell apoptotic process (GO:1904708),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to adherens junction (GO:1904702),1,0,0.1,-, < 0.01,9.03E-01
peroxisome membrane biogenesis (GO:0016557),4,0,0.41,-, < 0.01,6.66E-01
cytidine to uridine editing (GO:0016554),11,0,1.12,-, < 0.01,3.27E-01
histone H3-K9 trimethylation (GO:0036124),5,0,0.51,-, < 0.01,6.01E-01
histone H3-K9 dimethylation (GO:0036123),3,0,0.3,-, < 0.01,7.37E-01
cellular response to platelet-derived growth factor stimulus (GO:0036120),20,0,2.03,-, < 0.01,1.31E-01
regulation of cardiac endothelial to mesenchymal transition (GO:0061999),1,0,0.1,-, < 0.01,9.03E-01
response to platelet-derived growth factor (GO:0036119),21,0,2.13,-, < 0.01,1.18E-01
long-chain fatty-acyl-CoA catabolic process (GO:0036116),1,0,0.1,-, < 0.01,9.03E-01
fatty-acyl-CoA catabolic process (GO:0036115),3,0,0.3,-, < 0.01,7.37E-01
medium-chain fatty-acyl-CoA catabolic process (GO:0036114),2,0,0.2,-, < 0.01,8.16E-01
very long-chain fatty-acyl-CoA catabolic process (GO:0036113),1,0,0.1,-, < 0.01,9.03E-01
medium-chain fatty-acyl-CoA metabolic process (GO:0036112),4,0,0.41,-, < 0.01,6.66E-01
very long-chain fatty-acyl-CoA metabolic process (GO:0036111),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of transcription by glucose (GO:0061986),1,0,0.1,-, < 0.01,9.03E-01
leukotriene B4 metabolic process (GO:0036102),6,0,0.61,-, < 0.01,5.43E-01
leukotriene B4 catabolic process (GO:0036101),5,0,0.51,-, < 0.01,6.01E-01
leukotriene catabolic process (GO:0036100),5,0,0.51,-, < 0.01,6.01E-01
perichondral bone morphogenesis (GO:0061974),1,0,0.1,-, < 0.01,9.03E-01
membrane bone morphogenesis (GO:0061973),1,0,0.1,-, < 0.01,9.03E-01
establishment of left/right asymmetry (GO:0061966),1,0,0.1,-, < 0.01,9.03E-01
midbody abscission (GO:0061952),17,0,1.73,-, < 0.01,1.77E-01
inactivation of MAPK activity involved in osmosensory signaling pathway (GO:0000173),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein K48-linked ubiquitination (GO:0061945),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of protein K48-linked ubiquitination (GO:0061944),2,0,0.2,-, < 0.01,8.16E-01
phosphorelay signal transduction system (GO:0000160),1,0,0.1,-, < 0.01,9.03E-01
monocyte extravasation (GO:0035696),5,0,0.51,-, < 0.01,6.01E-01
macrophage migration inhibitory factor signaling pathway (GO:0035691),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of erythrocyte enucleation (GO:0061931),1,0,0.1,-, < 0.01,9.03E-01
regulation of erythrocyte enucleation (GO:0061930),1,0,0.1,-, < 0.01,9.03E-01
helper T cell diapedesis (GO:0035685),2,0,0.2,-, < 0.01,8.16E-01
helper T cell extravasation (GO:0035684),3,0,0.3,-, < 0.01,7.37E-01
memory T cell extravasation (GO:0035683),2,0,0.2,-, < 0.01,8.16E-01
manchette disassembly (GO:1905199),1,0,0.1,-, < 0.01,9.03E-01
manchette assembly (GO:1905198),2,0,0.2,-, < 0.01,8.16E-01
neuromast hair cell development (GO:0035675),1,0,0.1,-, < 0.01,9.03E-01
tricarboxylic acid transmembrane transport (GO:0035674),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188),1,0,0.1,-, < 0.01,9.03E-01
regulation of metaphase/anaphase transition of meiosis I (GO:1905186),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein serine/threonine phosphatase activity (GO:1905184),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein serine/threonine phosphatase activity (GO:1905183),1,0,0.1,-, < 0.01,9.03E-01
anoikis (GO:0043276),11,0,1.12,-, < 0.01,3.27E-01
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),29,0,2.95,-, < 0.01,5.23E-02
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665),1,0,0.1,-, < 0.01,9.03E-01
autophagosome-lysosome fusion (GO:0061909),2,0,0.2,-, < 0.01,8.16E-01
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cardiac muscle tissue regeneration (GO:1905179),2,0,0.2,-, < 0.01,8.16E-01
regulation of cardiac muscle tissue regeneration (GO:1905178),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176),1,0,0.1,-, < 0.01,9.03E-01
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of protein localization to phagocytic vesicle (GO:1905171),2,0,0.2,-, < 0.01,8.16E-01
interleukin-18-mediated signaling pathway (GO:0035655),7,0,0.71,-, < 0.01,4.91E-01
membrane protein intracellular domain proteolysis (GO:0031293),20,0,2.03,-, < 0.01,1.31E-01
Ran protein signal transduction (GO:0031291),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein localization to phagocytic vesicle (GO:1905169),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of lysosomal protein catabolic process (GO:1905167),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of lysosomal protein catabolic process (GO:1905166),4,0,0.41,-, < 0.01,6.66E-01
regulation of lysosomal protein catabolic process (GO:1905165),9,0,0.91,-, < 0.01,4.00E-01
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117),2,0,0.2,-, < 0.01,8.16E-01
endosome to melanosome transport (GO:0035646),9,0,0.91,-, < 0.01,4.00E-01
phosphoanandamide dephosphorylation (GO:0035644),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of guanylate cyclase activity (GO:0031283),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of membrane invagination (GO:1905154),2,0,0.2,-, < 0.01,8.16E-01
histidine biosynthetic process (GO:0000105),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of voltage-gated sodium channel activity (GO:1905152),1,0,0.1,-, < 0.01,9.03E-01
FMN biosynthetic process (GO:0009398),1,0,0.1,-, < 0.01,9.03E-01
folic acid-containing compound biosynthetic process (GO:0009396),9,0,0.91,-, < 0.01,4.00E-01
sulfur amino acid transport (GO:0000101),7,0,0.71,-, < 0.01,4.91E-01
entry of bacterium into host cell (GO:0035635),8,0,0.81,-, < 0.01,4.43E-01
response to stilbenoid (GO:0035634),6,0,0.61,-, < 0.01,5.43E-01
regulation of lateral pseudopodium assembly (GO:0031275),1,0,0.1,-, < 0.01,9.03E-01
lysosomal protein catabolic process (GO:1905146),6,0,0.61,-, < 0.01,5.43E-01
eukaryotic translation initiation factor 2 complex assembly (GO:1905143),1,0,0.1,-, < 0.01,9.03E-01
translational attenuation (GO:0009386),2,0,0.2,-, < 0.01,8.16E-01
ceramide transport (GO:0035627),10,0,1.02,-, < 0.01,3.62E-01
receptor transactivation (GO:0035624),5,0,0.51,-, < 0.01,6.01E-01
renal glucose absorption (GO:0035623),1,0,0.1,-, < 0.01,9.03E-01
ER to Golgi ceramide transport (GO:0035621),2,0,0.2,-, < 0.01,8.16E-01
biotin import across plasma membrane (GO:1905135),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of meiotic chromosome separation (GO:1905134),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of meiotic chromosome separation (GO:1905133),2,0,0.2,-, < 0.01,8.16E-01
regulation of meiotic chromosome separation (GO:1905132),3,0,0.3,-, < 0.01,7.37E-01
stress granule disassembly (GO:0035617),5,0,0.51,-, < 0.01,6.01E-01
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616),3,0,0.3,-, < 0.01,7.37E-01
protein branching point deglutamylation (GO:0035611),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of axo-dendritic protein transport (GO:1905128),1,0,0.1,-, < 0.01,9.03E-01
regulation of axo-dendritic protein transport (GO:1905126),1,0,0.1,-, < 0.01,9.03E-01
regulation of glucosylceramidase activity (GO:1905123),2,0,0.2,-, < 0.01,8.16E-01
myelin maintenance (GO:0043217),16,0,1.63,-, < 0.01,1.96E-01
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-cysteine S-trans-nitrosylation (GO:0035606),2,0,0.2,-, < 0.01,8.16E-01
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604),1,0,0.1,-, < 0.01,9.03E-01
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603),1,0,0.1,-, < 0.01,9.03E-01
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602),1,0,0.1,-, < 0.01,9.03E-01
tRNA methylthiolation (GO:0035600),2,0,0.2,-, < 0.01,8.16E-01
actin rod assembly (GO:0031247),1,0,0.1,-, < 0.01,9.03E-01
"posttranslational protein targeting to membrane, translocation (GO:0031204)",7,0,0.71,-, < 0.01,4.91E-01
snRNA transcription by RNA polymerase III (GO:0042796),7,0,0.71,-, < 0.01,4.91E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of acinar cell proliferation (GO:1904699),1,0,0.1,-, < 0.01,9.03E-01
regulation of acinar cell proliferation (GO:1904697),1,0,0.1,-, < 0.01,9.03E-01
protein biotinylation (GO:0009305),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of vascular associated smooth muscle contraction (GO:1904695),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of vascular associated smooth muscle contraction (GO:1904694),2,0,0.2,-, < 0.01,8.16E-01
midbrain morphogenesis (GO:1904693),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of type B pancreatic cell proliferation (GO:1904692),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of type B pancreatic cell proliferation (GO:1904691),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of developmental pigmentation (GO:0048087),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of cytoplasmic translational initiation (GO:1904689),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of metalloendopeptidase activity (GO:1904685),2,0,0.2,-, < 0.01,8.16E-01
response to 3-methylcholanthrene (GO:1904681),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane ATP synthesis coupled electron transport (GO:0042774),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of eye pigmentation (GO:0048075),1,0,0.1,-, < 0.01,9.03E-01
regulation of eye pigmentation (GO:0048073),2,0,0.2,-, < 0.01,8.16E-01
regulation of developmental pigmentation (GO:0048070),13,0,1.32,-, < 0.01,2.67E-01
myo-inositol import across plasma membrane (GO:1904679),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of somatic stem cell division (GO:1904677),1,0,0.1,-, < 0.01,9.03E-01
regulation of somatic stem cell division (GO:1904675),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of somatic stem cell population maintenance (GO:1904674),2,0,0.2,-, < 0.01,8.16E-01
ATP export (GO:1904669),2,0,0.2,-, < 0.01,8.16E-01
germ cell proliferation (GO:0036093),1,0,0.1,-, < 0.01,9.03E-01
cleavage furrow ingression (GO:0036090),2,0,0.2,-, < 0.01,8.16E-01
long-chain fatty acid catabolic process (GO:0042758),10,0,1.02,-, < 0.01,3.62E-01
post-embryonic eye morphogenesis (GO:0048050),7,0,0.71,-, < 0.01,4.91E-01
GDP-fucose import into Golgi lumen (GO:0036085),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of fat cell apoptotic process (GO:1904651),1,0,0.1,-, < 0.01,9.03E-01
"circadian sleep/wake cycle, non-REM sleep (GO:0042748)",1,0,0.1,-, < 0.01,9.03E-01
"circadian sleep/wake cycle, REM sleep (GO:0042747)",2,0,0.2,-, < 0.01,8.16E-01
circadian sleep/wake cycle (GO:0042745),6,0,0.61,-, < 0.01,5.43E-01
regulation of fat cell apoptotic process (GO:1904649),2,0,0.2,-, < 0.01,8.16E-01
response to rotenone (GO:1904647),1,0,0.1,-, < 0.01,9.03E-01
N-glycan fucosylation (GO:0036071),2,0,0.2,-, < 0.01,8.16E-01
response to curcumin (GO:1904643),1,0,0.1,-, < 0.01,9.03E-01
D-xylose metabolic process (GO:0042732),2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)",1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)",1,0,0.1,-, < 0.01,9.03E-01
heme O biosynthetic process (GO:0048034),1,0,0.1,-, < 0.01,9.03E-01
heme o metabolic process (GO:0048033),1,0,0.1,-, < 0.01,9.03E-01
cellular response to resveratrol (GO:1904639),1,0,0.1,-, < 0.01,9.03E-01
response to resveratrol (GO:1904638),2,0,0.2,-, < 0.01,8.16E-01
slit diaphragm assembly (GO:0036060),1,0,0.1,-, < 0.01,9.03E-01
farnesol catabolic process (GO:0016488),2,0,0.2,-, < 0.01,8.16E-01
farnesol metabolic process (GO:0016487),2,0,0.2,-, < 0.01,8.16E-01
response to glucoside (GO:1904631),1,0,0.1,-, < 0.01,9.03E-01
"regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)",2,0,0.2,-, < 0.01,8.16E-01
flavin-containing compound catabolic process (GO:0042728),1,0,0.1,-, < 0.01,9.03E-01
flavin-containing compound biosynthetic process (GO:0042727),2,0,0.2,-, < 0.01,8.16E-01
regulation of proteinase activated receptor activity (GO:1900276),1,0,0.1,-, < 0.01,9.03E-01
flavin-containing compound metabolic process (GO:0042726),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of phospholipase C activity (GO:1900275),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of transcription by RNA polymerase III (GO:0016480),3,0,0.3,-, < 0.01,7.37E-01
thiamine-containing compound metabolic process (GO:0042723),7,0,0.71,-, < 0.01,4.91E-01
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",15,0,1.52,-, < 0.01,2.17E-01
negative regulation of melanin biosynthetic process (GO:0048022),4,0,0.41,-, < 0.01,6.66E-01
filtration diaphragm assembly (GO:0036058),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of transcription by RNA polymerase I (GO:0016479),3,0,0.3,-, < 0.01,7.37E-01
cellular response to dimethyl sulfoxide (GO:1904620),1,0,0.1,-, < 0.01,9.03E-01
regulation of embryonic cell shape (GO:0016476),1,0,0.1,-, < 0.01,9.03E-01
Tie signaling pathway (GO:0048014),4,0,0.41,-, < 0.01,6.66E-01
peptidyl-lysine desuccinylation (GO:0036049),2,0,0.2,-, < 0.01,8.16E-01
protein desuccinylation (GO:0036048),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-lysine demalonylation (GO:0036047),1,0,0.1,-, < 0.01,9.03E-01
protein demalonylation (GO:0036046),1,0,0.1,-, < 0.01,9.03E-01
response to dimethyl sulfoxide (GO:1904619),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of actin binding (GO:1904618),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of actin binding (GO:1904617),1,0,0.1,-, < 0.01,9.03E-01
regulation of actin binding (GO:1904616),3,0,0.3,-, < 0.01,7.37E-01
"cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)",2,0,0.2,-, < 0.01,8.16E-01
"response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)",4,0,0.41,-, < 0.01,6.66E-01
"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",6,0,0.61,-, < 0.01,5.43E-01
progesterone secretion (GO:0042701),2,0,0.2,-, < 0.01,8.16E-01
"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",5,0,0.51,-, < 0.01,6.01E-01
luteinizing hormone signaling pathway (GO:0042700),2,0,0.2,-, < 0.01,8.16E-01
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),6,0,0.61,-, < 0.01,5.43E-01
"CD8-positive, alpha-beta T cell activation (GO:0036037)",11,0,1.12,-, < 0.01,3.27E-01
sequestering of triglyceride (GO:0030730),4,0,0.41,-, < 0.01,6.66E-01
recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytoplasmic translational elongation (GO:1900248),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of RIG-I signaling pathway (GO:1900246),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of MDA-5 signaling pathway (GO:1900245),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of synaptic vesicle endocytosis (GO:1900243),1,0,0.1,-, < 0.01,9.03E-01
ovulation (GO:0030728),19,0,1.93,-, < 0.01,1.45E-01
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of Kit signaling pathway (GO:1900235),2,0,0.2,-, < 0.01,8.16E-01
regulation of Kit signaling pathway (GO:1900234),2,0,0.2,-, < 0.01,8.16E-01
P granule organization (GO:0030719),2,0,0.2,-, < 0.01,8.16E-01
germ-line stem cell population maintenance (GO:0030718),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of astrocyte activation (GO:0061889),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of single-species biofilm formation in or on host organism (GO:1900229),2,0,0.2,-, < 0.01,8.16E-01
regulation of single-species biofilm formation in or on host organism (GO:1900228),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of amyloid-beta clearance (GO:1900223),8,0,0.81,-, < 0.01,4.43E-01
regulation of anterograde axonal transport of mitochondrion (GO:0061880),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218),2,0,0.2,-, < 0.01,8.16E-01
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215),2,0,0.2,-, < 0.01,8.16E-01
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of hepatic stellate cell migration (GO:0061871),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hepatic stellate cell migration (GO:0061870),1,0,0.1,-, < 0.01,9.03E-01
regulation of hepatic stellate cell migration (GO:0061869),2,0,0.2,-, < 0.01,8.16E-01
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),32,0,3.25,-, < 0.01,3.85E-02
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neuroblast migration (GO:0061855),1,0,0.1,-, < 0.01,9.03E-01
regulation of neuroblast migration (GO:0061853),1,0,0.1,-, < 0.01,9.03E-01
response to cholecystokinin (GO:0061847),2,0,0.2,-, < 0.01,8.16E-01
neuropeptide processing (GO:0061837),1,0,0.1,-, < 0.01,9.03E-01
protein localization to tricellular tight junction (GO:0061833),2,0,0.2,-, < 0.01,8.16E-01
ribosomal small subunit export from nucleus (GO:0000056),8,0,0.81,-, < 0.01,4.43E-01
ribosomal large subunit export from nucleus (GO:0000055),8,0,0.81,-, < 0.01,4.43E-01
ribosomal subunit export from nucleus (GO:0000054),14,0,1.42,-, < 0.01,2.41E-01
argininosuccinate metabolic process (GO:0000053),1,0,0.1,-, < 0.01,9.03E-01
calcium-mediated signaling using extracellular calcium source (GO:0035585),4,0,0.41,-, < 0.01,6.66E-01
sequestering of TGFbeta in extracellular matrix (GO:0035583),3,0,0.3,-, < 0.01,7.37E-01
sequestering of BMP in extracellular matrix (GO:0035582),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098),5,0,0.51,-, < 0.01,6.01E-01
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090),1,0,0.1,-, < 0.01,9.03E-01
telomeric DNA-containing double minutes formation (GO:0061819),3,0,0.3,-, < 0.01,7.37E-01
histone H4-K20 demethylation (GO:0035574),2,0,0.2,-, < 0.01,8.16E-01
N-terminal peptidyl-serine trimethylation (GO:0035573),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-serine dimethylation (GO:0035572),1,0,0.1,-, < 0.01,9.03E-01
vacuolar sequestering (GO:0043181),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-serine methylation (GO:0035570),1,0,0.1,-, < 0.01,9.03E-01
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089),1,0,0.1,-, < 0.01,9.03E-01
electron transport coupled proton transport (GO:0015990),1,0,0.1,-, < 0.01,9.03E-01
cell wall mannoprotein biosynthetic process (GO:0000032),1,0,0.1,-, < 0.01,9.03E-01
N-terminal peptidyl-proline methylation (GO:0035568),1,0,0.1,-, < 0.01,9.03E-01
regulation of metanephros size (GO:0035566),2,0,0.2,-, < 0.01,8.16E-01
nucleotide salvage (GO:0043173),13,0,1.32,-, < 0.01,2.67E-01
negative regulation of chromatin binding (GO:0035562),8,0,0.81,-, < 0.01,4.43E-01
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1,0,0.1,-, < 0.01,9.03E-01
maltose metabolic process (GO:0000023),2,0,0.2,-, < 0.01,8.16E-01
mitotic spindle elongation (GO:0000022),6,0,0.61,-, < 0.01,5.43E-01
cell envelope organization (GO:0043163),2,0,0.2,-, < 0.01,8.16E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),21,0,2.13,-, < 0.01,1.18E-01
L-proline biosynthetic process (GO:0055129),5,0,0.51,-, < 0.01,6.01E-01
allantois development (GO:1905069),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitotic recombination (GO:0000019),6,0,0.61,-, < 0.01,5.43E-01
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066),2,0,0.2,-, < 0.01,8.16E-01
alpha-glucoside transport (GO:0000017),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cardioblast proliferation (GO:1905062),1,0,0.1,-, < 0.01,9.03E-01
single strand break repair (GO:0000012),9,0,0.91,-, < 0.01,4.00E-01
determination of left/right asymmetry in nervous system (GO:0035545),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of SNARE complex assembly (GO:0035544),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of SNARE complex assembly (GO:0035543),1,0,0.1,-, < 0.01,9.03E-01
diadenosine tetraphosphate biosynthetic process (GO:0015966),3,0,0.3,-, < 0.01,7.37E-01
diadenosine tetraphosphate metabolic process (GO:0015965),3,0,0.3,-, < 0.01,7.37E-01
diadenosine triphosphate catabolic process (GO:0015964),1,0,0.1,-, < 0.01,9.03E-01
diadenosine triphosphate metabolic process (GO:0015962),1,0,0.1,-, < 0.01,9.03E-01
diadenosine polyphosphate catabolic process (GO:0015961),5,0,0.51,-, < 0.01,6.01E-01
diadenosine polyphosphate biosynthetic process (GO:0015960),3,0,0.3,-, < 0.01,7.37E-01
epiboly involved in gastrulation with mouth forming second (GO:0055113),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of base-excision repair (GO:1905053),1,0,0.1,-, < 0.01,9.03E-01
regulation of base-excision repair (GO:1905051),1,0,0.1,-, < 0.01,9.03E-01
ingression involved in gastrulation with mouth forming second (GO:0055111),1,0,0.1,-, < 0.01,9.03E-01
diadenosine polyphosphate metabolic process (GO:0015959),8,0,0.81,-, < 0.01,4.43E-01
Golgi to transport vesicle transport (GO:0055108),1,0,0.1,-, < 0.01,9.03E-01
Golgi to secretory granule transport (GO:0055107),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of epithelium regeneration (GO:1905042),1,0,0.1,-, < 0.01,9.03E-01
regulation of epithelium regeneration (GO:1905041),2,0,0.2,-, < 0.01,8.16E-01
otic placode development (GO:1905040),1,0,0.1,-, < 0.01,9.03E-01
"DNA replication, removal of RNA primer (GO:0043137)",4,0,0.41,-, < 0.01,6.66E-01
"retrograde transport, plasma membrane to Golgi (GO:0035526)",2,0,0.2,-, < 0.01,8.16E-01
regulation of hindgut contraction (GO:0043134),2,0,0.2,-, < 0.01,8.16E-01
protein K29-linked deubiquitination (GO:0035523),5,0,0.51,-, < 0.01,6.01E-01
monoubiquitinated histone H2A deubiquitination (GO:0035522),4,0,0.41,-, < 0.01,6.66E-01
monoubiquitinated histone deubiquitination (GO:0035521),4,0,0.41,-, < 0.01,6.66E-01
monoubiquitinated protein deubiquitination (GO:0035520),9,0,0.91,-, < 0.01,4.00E-01
nucleobase-containing small molecule interconversion (GO:0015949),19,0,1.93,-, < 0.01,1.45E-01
phosphatidylinositol catabolic process (GO:0031161),1,0,0.1,-, < 0.01,9.03E-01
formate metabolic process (GO:0015942),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of antifungal innate immune response (GO:1905035),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032),1,0,0.1,-, < 0.01,9.03E-01
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031),4,0,0.41,-, < 0.01,6.66E-01
surfactant homeostasis (GO:0043129),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128),1,0,0.1,-, < 0.01,9.03E-01
protein K29-linked ubiquitination (GO:0035519),5,0,0.51,-, < 0.01,6.01E-01
regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126),1,0,0.1,-, < 0.01,9.03E-01
coenzyme A catabolic process (GO:0015938),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025),1,0,0.1,-, < 0.01,9.03E-01
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),5,0,0.51,-, < 0.01,6.01E-01
2'-deoxyribonucleotide biosynthetic process (GO:0009265),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508),1,0,0.1,-, < 0.01,9.03E-01
deoxyribonucleotide biosynthetic process (GO:0009263),13,0,1.32,-, < 0.01,2.67E-01
replication fork arrest (GO:0043111),4,0,0.41,-, < 0.01,6.66E-01
metanephric part of ureteric bud development (GO:0035502),4,0,0.41,-, < 0.01,6.66E-01
lipopolysaccharide transport (GO:0015920),2,0,0.2,-, < 0.01,8.16E-01
regulation of 'de novo' NAD biosynthetic process from tryptophan (GO:1905012),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of L-lysine import across plasma membrane (GO:1905010),1,0,0.1,-, < 0.01,9.03E-01
10-formyltetrahydrofolate biosynthetic process (GO:0009257),2,0,0.2,-, < 0.01,8.16E-01
peptidoglycan catabolic process (GO:0009253),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of GTP cyclohydrolase I activity (GO:0043105),1,0,0.1,-, < 0.01,9.03E-01
hypoxanthine salvage (GO:0043103),2,0,0.2,-, < 0.01,8.16E-01
aminophospholipid transport (GO:0015917),7,0,0.71,-, < 0.01,4.91E-01
sister chromatid biorientation (GO:0031134),3,0,0.3,-, < 0.01,7.37E-01
fatty-acyl-CoA transport (GO:0015916),2,0,0.2,-, < 0.01,8.16E-01
regulation of axon diameter (GO:0031133),5,0,0.51,-, < 0.01,6.01E-01
long-chain fatty acid import across plasma membrane (GO:0015911),3,0,0.3,-, < 0.01,7.37E-01
regulation of L-lysine import across plasma membrane (GO:1905008),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006),2,0,0.2,-, < 0.01,8.16E-01
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),6,0,0.61,-, < 0.01,5.43E-01
picolinic acid biosynthetic process (GO:1905004),1,0,0.1,-, < 0.01,9.03E-01
picolinic acid metabolic process (GO:1905003),1,0,0.1,-, < 0.01,9.03E-01
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000),1,0,0.1,-, < 0.01,9.03E-01
isopentenyl diphosphate biosynthetic process (GO:0009240),5,0,0.51,-, < 0.01,6.01E-01
inductive cell-cell signaling (GO:0031129),1,0,0.1,-, < 0.01,9.03E-01
rRNA 3'-end processing (GO:0031125),9,0,0.91,-, < 0.01,4.00E-01
tetracycline transmembrane transport (GO:0015904),1,0,0.1,-, < 0.01,9.03E-01
snRNA pseudouridine synthesis (GO:0031120),3,0,0.3,-, < 0.01,7.37E-01
siderophore metabolic process (GO:0009237),1,0,0.1,-, < 0.01,9.03E-01
menaquinone biosynthetic process (GO:0009234),1,0,0.1,-, < 0.01,9.03E-01
menaquinone metabolic process (GO:0009233),5,0,0.51,-, < 0.01,6.01E-01
riboflavin biosynthetic process (GO:0009231),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of microtubule depolymerization (GO:0031117),4,0,0.41,-, < 0.01,6.66E-01
thiamine diphosphate biosynthetic process (GO:0009229),1,0,0.1,-, < 0.01,9.03E-01
nucleotide-sugar catabolic process (GO:0009227),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine ribonucleotide catabolic process (GO:0009222),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),6,0,0.61,-, < 0.01,5.43E-01
septin ring organization (GO:0031106),1,0,0.1,-, < 0.01,9.03E-01
dendrite regeneration (GO:0031104),2,0,0.2,-, < 0.01,8.16E-01
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217),5,0,0.51,-, < 0.01,6.01E-01
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216),1,0,0.1,-, < 0.01,9.03E-01
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215),8,0,0.81,-, < 0.01,4.43E-01
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212),3,0,0.3,-, < 0.01,7.37E-01
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211),5,0,0.51,-, < 0.01,6.01E-01
muscle cell fate specification (GO:0042694),1,0,0.1,-, < 0.01,9.03E-01
purine ribonucleoside triphosphate catabolic process (GO:0009207),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597),1,0,0.1,-, < 0.01,9.03E-01
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596),1,0,0.1,-, < 0.01,9.03E-01
deoxyribonucleoside triphosphate catabolic process (GO:0009204),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of termination of RNA polymerase II transcription (GO:1904595),1,0,0.1,-, < 0.01,9.03E-01
ribonucleoside triphosphate catabolic process (GO:0009203),1,0,0.1,-, < 0.01,9.03E-01
regulation of termination of RNA polymerase II transcription (GO:1904594),1,0,0.1,-, < 0.01,9.03E-01
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202),4,0,0.41,-, < 0.01,6.66E-01
deoxyribonucleoside triphosphate metabolic process (GO:0009200),15,0,1.52,-, < 0.01,2.17E-01
regulation of cardioblast cell fate specification (GO:0042686),1,0,0.1,-, < 0.01,9.03E-01
cellular response to glycoprotein (GO:1904588),1,0,0.1,-, < 0.01,9.03E-01
response to glycoprotein (GO:1904587),7,0,0.71,-, < 0.01,4.91E-01
cellular response to putrescine (GO:1904586),2,0,0.2,-, < 0.01,8.16E-01
response to putrescine (GO:1904585),2,0,0.2,-, < 0.01,8.16E-01
cellular response to thapsigargin (GO:1904579),2,0,0.2,-, < 0.01,8.16E-01
response to thapsigargin (GO:1904578),2,0,0.2,-, < 0.01,8.16E-01
cellular response to tunicamycin (GO:1904577),1,0,0.1,-, < 0.01,9.03E-01
response to tunicamycin (GO:1904576),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of selenocysteine insertion sequence binding (GO:1904574),1,0,0.1,-, < 0.01,9.03E-01
regulation of selenocysteine insertion sequence binding (GO:1904573),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mRNA binding (GO:1904572),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of selenocysteine incorporation (GO:1904570),1,0,0.1,-, < 0.01,9.03E-01
regulation of inner ear auditory receptor cell fate specification (GO:0042669),1,0,0.1,-, < 0.01,9.03E-01
auditory receptor cell fate determination (GO:0042668),1,0,0.1,-, < 0.01,9.03E-01
auditory receptor cell fate specification (GO:0042667),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ectodermal cell fate specification (GO:0042666),1,0,0.1,-, < 0.01,9.03E-01
regulation of ectodermal cell fate specification (GO:0042665),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of endodermal cell fate specification (GO:0042664),1,0,0.1,-, < 0.01,9.03E-01
regulation of endodermal cell fate specification (GO:0042663),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of mesodermal cell fate specification (GO:0042662),3,0,0.3,-, < 0.01,7.37E-01
regulation of mesodermal cell fate specification (GO:0042661),6,0,0.61,-, < 0.01,5.43E-01
regulation of selenocysteine incorporation (GO:1904569),1,0,0.1,-, < 0.01,9.03E-01
cellular response to wortmannin (GO:1904568),1,0,0.1,-, < 0.01,9.03E-01
response to wortmannin (GO:1904567),1,0,0.1,-, < 0.01,9.03E-01
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566),1,0,0.1,-, < 0.01,9.03E-01
platelet activating factor catabolic process (GO:0062234),2,0,0.2,-, < 0.01,8.16E-01
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565),1,0,0.1,-, < 0.01,9.03E-01
prostanoid catabolic process (GO:0062232),1,0,0.1,-, < 0.01,9.03E-01
phosphatidylinositol 5-phosphate metabolic process (GO:1904562),2,0,0.2,-, < 0.01,8.16E-01
mitigation of host immune response by virus (GO:0030683),2,0,0.2,-, < 0.01,8.16E-01
mitigation of host defenses by symbiont (GO:0030682),4,0,0.41,-, < 0.01,6.66E-01
L-alanine transmembrane transport (GO:1904557),4,0,0.41,-, < 0.01,6.66E-01
L-tryptophan transmembrane transport (GO:1904556),2,0,0.2,-, < 0.01,8.16E-01
response to arachidonic acid (GO:1904550),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of oocyte maturation (GO:1900195),3,0,0.3,-, < 0.01,7.37E-01
membrane bending (GO:0097753),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of oocyte maturation (GO:1900194),2,0,0.2,-, < 0.01,8.16E-01
regulation of DNA stability (GO:0097752),4,0,0.41,-, < 0.01,6.66E-01
regulation of oocyte maturation (GO:1900193),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of single-species biofilm formation (GO:1900191),2,0,0.2,-, < 0.01,8.16E-01
endosome membrane tubulation (GO:0097750),2,0,0.2,-, < 0.01,8.16E-01
regulation of single-species biofilm formation (GO:1900190),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of free ubiquitin chain polymerization (GO:1904544),1,0,0.1,-, < 0.01,9.03E-01
regulation of free ubiquitin chain polymerization (GO:1904542),1,0,0.1,-, < 0.01,9.03E-01
membrane tubulation (GO:0097749),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of clathrin-dependent endocytosis (GO:1900186),5,0,0.51,-, < 0.01,6.01E-01
mitochondrial tRNA 5'-end processing (GO:0097745),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of hair cycle (GO:0042636),1,0,0.1,-, < 0.01,9.03E-01
urate salt excretion (GO:0097744),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hair cycle (GO:0042635),1,0,0.1,-, < 0.01,9.03E-01
de novo centriole assembly (GO:0097742),5,0,0.51,-, < 0.01,6.01E-01
cellular response to water deprivation (GO:0042631),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539),1,0,0.1,-, < 0.01,9.03E-01
regulation of glycolytic process through fructose-6-phosphate (GO:1904538),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of telomeric loop disassembly (GO:1904535),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of telomeric loop disassembly (GO:1904534),2,0,0.2,-, < 0.01,8.16E-01
regulation of telomeric loop disassembly (GO:1904533),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of actin filament binding (GO:1904531),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of actin filament binding (GO:1904530),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176),2,0,0.2,-, < 0.01,8.16E-01
extracellular exosome biogenesis (GO:0097734),5,0,0.51,-, < 0.01,6.01E-01
regulation of actin filament binding (GO:1904529),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of microtubule binding (GO:1904527),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of glial cell-derived neurotrophic factor production (GO:1900168),3,0,0.3,-, < 0.01,7.37E-01
regulation of glial cell-derived neurotrophic factor production (GO:1900166),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of TORC2 signaling (GO:1904515),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of bone mineralization involved in bone maturation (GO:1900159),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of protein localization to basolateral plasma membrane (GO:1904510),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of bone mineralization involved in bone maturation (GO:1900158),3,0,0.3,-, < 0.01,7.37E-01
regulation of bone mineralization involved in bone maturation (GO:1900157),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of bone trabecula formation (GO:1900155),2,0,0.2,-, < 0.01,8.16E-01
regulation of bone trabecula formation (GO:1900154),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to basolateral plasma membrane (GO:1904508),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of telomere maintenance in response to DNA damage (GO:1904506),4,0,0.41,-, < 0.01,6.66E-01
regulation of telomere maintenance in response to DNA damage (GO:1904505),4,0,0.41,-, < 0.01,6.66E-01
connective tissue replacement (GO:0097709),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of chromatin-mediated maintenance of transcription (GO:1904501),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of oligodendrocyte apoptotic process (GO:1900143),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of oligodendrocyte apoptotic process (GO:1900142),1,0,0.1,-, < 0.01,9.03E-01
regulation of oligodendrocyte apoptotic process (GO:1900141),2,0,0.2,-, < 0.01,8.16E-01
meiotic chromosome movement towards spindle pole (GO:0016344),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of renin secretion into blood stream (GO:1900135),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of renin secretion into blood stream (GO:1900134),1,0,0.1,-, < 0.01,9.03E-01
regulation of renin secretion into blood stream (GO:1900133),4,0,0.41,-, < 0.01,6.66E-01
calcium-dependent cell-matrix adhesion (GO:0016340),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lipid binding (GO:1900131),1,0,0.1,-, < 0.01,9.03E-01
regulation of lipid binding (GO:1900130),1,0,0.1,-, < 0.01,9.03E-01
dense core granule priming (GO:0061789),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of hyaluronan biosynthetic process (GO:1900127),4,0,0.41,-, < 0.01,6.66E-01
establishment or maintenance of polarity of follicular epithelium (GO:0016334),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hyaluronan biosynthetic process (GO:1900126),4,0,0.41,-, < 0.01,6.66E-01
morphogenesis of follicular epithelium (GO:0016333),1,0,0.1,-, < 0.01,9.03E-01
regulation of hyaluronan biosynthetic process (GO:1900125),8,0,0.81,-, < 0.01,4.43E-01
establishment or maintenance of polarity of embryonic epithelium (GO:0016332),1,0,0.1,-, < 0.01,9.03E-01
vesicle fusion with vesicle (GO:0061782),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of receptor binding (GO:1900122),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of receptor binding (GO:1900121),15,0,1.52,-, < 0.01,2.17E-01
regulation of receptor binding (GO:1900120),26,0,2.64,-, < 0.01,7.10E-02
positive regulation of DNA repair by transcription from RNA polymerase II promoter (GO:0100026),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of execution phase of apoptosis (GO:1900118),9,0,0.91,-, < 0.01,4.00E-01
neuron remodeling (GO:0016322),12,0,1.22,-, < 0.01,2.95E-01
xenobiotic transport across blood-nerve barrier (GO:0061772),1,0,0.1,-, < 0.01,9.03E-01
female meiosis chromosome segregation (GO:0016321),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of histone H3-K9 trimethylation (GO:1900114),3,0,0.3,-, < 0.01,7.37E-01
response to caloric restriction (GO:0061771),4,0,0.41,-, < 0.01,6.66E-01
endoplasmic reticulum membrane fusion (GO:0016320),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of histone H3-K9 dimethylation (GO:1900111),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lung blood pressure (GO:0061767),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nodal signaling pathway (GO:1900108),3,0,0.3,-, < 0.01,7.37E-01
regulation of heart induction by canonical Wnt signaling pathway (GO:0100012),1,0,0.1,-, < 0.01,9.03E-01
multivesicular body-lysosome fusion (GO:0061763),2,0,0.2,-, < 0.01,8.16E-01
CAMKK-AMPK signaling cascade (GO:0061762),3,0,0.3,-, < 0.01,7.37E-01
antifungal innate immune response (GO:0061760),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of plasma cell differentiation (GO:1900100),3,0,0.3,-, < 0.01,7.37E-01
low-density lipoprotein particle mediated signaling (GO:0055096),3,0,0.3,-, < 0.01,7.37E-01
lipoprotein particle mediated signaling (GO:0055095),3,0,0.3,-, < 0.01,7.37E-01
phospholipid homeostasis (GO:0055091),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of protein kinase activity by protein phosphorylation (GO:0100002),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle contraction by action potential (GO:0100001),1,0,0.1,-, < 0.01,9.03E-01
substrate localization to autophagosome (GO:0061753),1,0,0.1,-, < 0.01,9.03E-01
motor behavior (GO:0061744),10,0,1.02,-, < 0.01,3.62E-01
chaperone-mediated protein transport involved in chaperone-mediated autophagy (GO:0061741),2,0,0.2,-, < 0.01,8.16E-01
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740),3,0,0.3,-, < 0.01,7.37E-01
carnosine biosynthetic process (GO:0035499),1,0,0.1,-, < 0.01,9.03E-01
carnosine metabolic process (GO:0035498),1,0,0.1,-, < 0.01,9.03E-01
protein lipidation involved in autophagosome assembly (GO:0061739),3,0,0.3,-, < 0.01,7.37E-01
SNARE complex disassembly (GO:0035494),3,0,0.3,-, < 0.01,7.37E-01
late endosomal microautophagy (GO:0061738),3,0,0.3,-, < 0.01,7.37E-01
leukotriene signaling pathway (GO:0061737),5,0,0.51,-, < 0.01,6.01E-01
engulfment of target by autophagosome (GO:0061736),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of leukotriene production involved in inflammatory response (GO:0035491),1,0,0.1,-, < 0.01,9.03E-01
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734),4,0,0.41,-, < 0.01,6.66E-01
regulation of leukotriene production involved in inflammatory response (GO:0035490),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732),5,0,0.51,-, < 0.01,6.01E-01
purine nucleobase salvage (GO:0043096),3,0,0.3,-, < 0.01,7.37E-01
regulation of GTP cyclohydrolase I activity (GO:0043095),1,0,0.1,-, < 0.01,9.03E-01
gastric emptying (GO:0035483),2,0,0.2,-, < 0.01,8.16E-01
gastric motility (GO:0035482),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481),4,0,0.41,-, < 0.01,6.66E-01
lipophagy (GO:0061724),2,0,0.2,-, < 0.01,8.16E-01
regulation of Notch signaling pathway involved in heart induction (GO:0035480),4,0,0.41,-, < 0.01,6.66E-01
glycophagy (GO:0061723),2,0,0.2,-, < 0.01,8.16E-01
miRNA 2'-O-methylation (GO:0061715),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of vascular wound healing (GO:0035470),5,0,0.51,-, < 0.01,6.01E-01
anterior neural tube closure (GO:0061713),1,0,0.1,-, < 0.01,9.03E-01
siderophore transport (GO:0015891),3,0,0.3,-, < 0.01,7.37E-01
determination of pancreatic left/right asymmetry (GO:0035469),5,0,0.51,-, < 0.01,6.01E-01
thiamine transport (GO:0015888),4,0,0.41,-, < 0.01,6.66E-01
pantothenate transmembrane transport (GO:0015887),1,0,0.1,-, < 0.01,9.03E-01
folic acid transport (GO:0015884),8,0,0.81,-, < 0.01,4.43E-01
L-ascorbic acid transmembrane transport (GO:0015882),2,0,0.2,-, < 0.01,8.16E-01
cellular response to interferon-alpha (GO:0035457),12,0,1.22,-, < 0.01,2.95E-01
response to interferon-alpha (GO:0035455),22,0,2.24,-, < 0.01,1.07E-01
intercellular bridge organization (GO:0043063),1,0,0.1,-, < 0.01,9.03E-01
meiotic metaphase I plate congression (GO:0043060),1,0,0.1,-, < 0.01,9.03E-01
biotin transport (GO:0015878),3,0,0.3,-, < 0.01,7.37E-01
acetyl-CoA transport (GO:0015876),1,0,0.1,-, < 0.01,9.03E-01
acetylcholine transport (GO:0015870),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cardiac muscle tissue development (GO:0055026),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cardiac muscle tissue development (GO:0055025),2,0,0.2,-, < 0.01,8.16E-01
regulation of cardiac muscle tissue development (GO:0055024),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of cardiac muscle fiber development (GO:0055020),1,0,0.1,-, < 0.01,9.03E-01
borate transmembrane transport (GO:0035445),1,0,0.1,-, < 0.01,9.03E-01
nickel cation transmembrane transport (GO:0035444),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in vasculogenesis (GO:0035441),4,0,0.41,-, < 0.01,6.66E-01
pyrimidine nucleoside transport (GO:0015864),5,0,0.51,-, < 0.01,6.01E-01
uridine transport (GO:0015862),5,0,0.51,-, < 0.01,6.01E-01
cytidine transport (GO:0015861),1,0,0.1,-, < 0.01,9.03E-01
purine nucleoside transmembrane transport (GO:0015860),4,0,0.41,-, < 0.01,6.66E-01
regulation of cardiac muscle fiber development (GO:0055018),1,0,0.1,-, < 0.01,9.03E-01
ventricular cardiac muscle cell development (GO:0055015),11,0,1.12,-, < 0.01,3.27E-01
atrial cardiac muscle cell development (GO:0055014),2,0,0.2,-, < 0.01,8.16E-01
ventricular cardiac muscle cell differentiation (GO:0055012),17,0,1.73,-, < 0.01,1.77E-01
atrial cardiac muscle cell differentiation (GO:0055011),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197),1,0,0.1,-, < 0.01,9.03E-01
otic placode formation (GO:0043049),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196),1,0,0.1,-, < 0.01,9.03E-01
dolichyl monophosphate biosynthetic process (GO:0043048),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195),2,0,0.2,-, < 0.01,8.16E-01
DNA methylation involved in gamete generation (GO:0043046),20,0,2.03,-, < 0.01,1.31E-01
maintenance of protein localization in endoplasmic reticulum (GO:0035437),14,0,1.42,-, < 0.01,2.41E-01
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193),2,0,0.2,-, < 0.01,8.16E-01
deoxyribonucleoside diphosphate catabolic process (GO:0009192),1,0,0.1,-, < 0.01,9.03E-01
ribonucleoside diphosphate catabolic process (GO:0009191),7,0,0.71,-, < 0.01,4.91E-01
cyclic nucleotide biosynthetic process (GO:0009190),22,0,2.24,-, < 0.01,1.07E-01
copper ion transmembrane transport (GO:0035434),6,0,0.61,-, < 0.01,5.43E-01
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic camera-type eye development (GO:0031077),7,0,0.71,-, < 0.01,4.91E-01
nucleoside transport (GO:0015858),7,0,0.71,-, < 0.01,4.91E-01
pyrimidine nucleobase transport (GO:0015855),5,0,0.51,-, < 0.01,6.01E-01
guanine transport (GO:0015854),1,0,0.1,-, < 0.01,9.03E-01
adenine transport (GO:0015853),4,0,0.41,-, < 0.01,6.66E-01
nucleobase transport (GO:0015851),9,0,0.91,-, < 0.01,4.00E-01
atrial cardiac muscle tissue morphogenesis (GO:0055009),6,0,0.61,-, < 0.01,5.43E-01
ventricular cardiac myofibril assembly (GO:0055005),3,0,0.3,-, < 0.01,7.37E-01
cardiac myofibril assembly (GO:0055003),18,0,1.83,-, < 0.01,1.60E-01
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189),3,0,0.3,-, < 0.01,7.37E-01
ribonucleoside diphosphate biosynthetic process (GO:0009188),6,0,0.61,-, < 0.01,5.43E-01
deoxyribonucleoside diphosphate metabolic process (GO:0009186),4,0,0.41,-, < 0.01,6.66E-01
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184),1,0,0.1,-, < 0.01,9.03E-01
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183),2,0,0.2,-, < 0.01,8.16E-01
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182),3,0,0.3,-, < 0.01,7.37E-01
autocrine signaling (GO:0035425),8,0,0.81,-, < 0.01,4.43E-01
purine ribonucleoside diphosphate catabolic process (GO:0009181),4,0,0.41,-, < 0.01,6.66E-01
purine ribonucleoside diphosphate biosynthetic process (GO:0009180),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of histone deacetylation (GO:0031065),19,0,1.93,-, < 0.01,1.45E-01
negative regulation of histone deacetylation (GO:0031064),5,0,0.51,-, < 0.01,6.01E-01
polyamine transport (GO:0015846),2,0,0.2,-, < 0.01,8.16E-01
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842),4,0,0.41,-, < 0.01,6.66E-01
urea transport (GO:0015840),7,0,0.71,-, < 0.01,4.91E-01
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177),4,0,0.41,-, < 0.01,6.66E-01
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176),5,0,0.51,-, < 0.01,6.01E-01
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174),10,0,1.02,-, < 0.01,3.62E-01
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173),10,0,1.02,-, < 0.01,3.62E-01
purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171),2,0,0.2,-, < 0.01,8.16E-01
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170),3,0,0.3,-, < 0.01,7.37E-01
pre-miRNA processing (GO:0031054),10,0,1.02,-, < 0.01,3.62E-01
chromosome breakage (GO:0031052),2,0,0.2,-, < 0.01,8.16E-01
purine ribonucleoside monophosphate catabolic process (GO:0009169),3,0,0.3,-, < 0.01,7.37E-01
histone H3-Y41 phosphorylation (GO:0035409),1,0,0.1,-, < 0.01,9.03E-01
histone H3-T6 phosphorylation (GO:0035408),2,0,0.2,-, < 0.01,8.16E-01
histone H3-T11 phosphorylation (GO:0035407),2,0,0.2,-, < 0.01,8.16E-01
deoxyribonucleoside monophosphate metabolic process (GO:0009162),11,0,1.12,-, < 0.01,3.27E-01
histone-tyrosine phosphorylation (GO:0035406),1,0,0.1,-, < 0.01,9.03E-01
histone-threonine phosphorylation (GO:0035405),6,0,0.61,-, < 0.01,5.43E-01
histone-serine phosphorylation (GO:0035404),11,0,1.12,-, < 0.01,3.27E-01
regulation of fusion of sperm to egg plasma membrane (GO:0043012),1,0,0.1,-, < 0.01,9.03E-01
programmed DNA elimination (GO:0031049),2,0,0.2,-, < 0.01,8.16E-01
heterochromatin assembly by small RNA (GO:0031048),2,0,0.2,-, < 0.01,8.16E-01
valine transport (GO:0015829),1,0,0.1,-, < 0.01,9.03E-01
tyrosine transport (GO:0015828),1,0,0.1,-, < 0.01,9.03E-01
tryptophan transport (GO:0015827),5,0,0.51,-, < 0.01,6.01E-01
threonine transport (GO:0015826),1,0,0.1,-, < 0.01,9.03E-01
L-serine transport (GO:0015825),7,0,0.71,-, < 0.01,4.91E-01
phenylalanine transport (GO:0015823),2,0,0.2,-, < 0.01,8.16E-01
methionine transport (GO:0015821),1,0,0.1,-, < 0.01,9.03E-01
leucine transport (GO:0015820),6,0,0.61,-, < 0.01,5.43E-01
deoxyribonucleoside monophosphate catabolic process (GO:0009159),2,0,0.2,-, < 0.01,8.16E-01
ribonucleoside monophosphate catabolic process (GO:0009158),3,0,0.3,-, < 0.01,7.37E-01
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157),8,0,0.81,-, < 0.01,4.43E-01
purine deoxyribonucleotide catabolic process (GO:0009155),6,0,0.61,-, < 0.01,5.43E-01
purine deoxyribonucleotide biosynthetic process (GO:0009153),5,0,0.51,-, < 0.01,6.01E-01
activation of phospholipase A2 activity by calcium-mediated signaling (GO:0043006),1,0,0.1,-, < 0.01,9.03E-01
purine deoxyribonucleotide metabolic process (GO:0009151),11,0,1.12,-, < 0.01,3.27E-01
cytoplasmic sequestering of CFTR protein (GO:0043004),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002),1,0,0.1,-, < 0.01,9.03E-01
Golgi to plasma membrane CFTR protein transport (GO:0043000),2,0,0.2,-, < 0.01,8.16E-01
lysine transport (GO:0015819),1,0,0.1,-, < 0.01,9.03E-01
histidine transport (GO:0015817),2,0,0.2,-, < 0.01,8.16E-01
myosin filament assembly (GO:0031034),3,0,0.3,-, < 0.01,7.37E-01
myosin filament organization (GO:0031033),3,0,0.3,-, < 0.01,7.37E-01
L-cystine transport (GO:0015811),4,0,0.41,-, < 0.01,6.66E-01
aspartate transmembrane transport (GO:0015810),9,0,0.91,-, < 0.01,4.00E-01
pyrimidine nucleoside triphosphate catabolic process (GO:0009149),2,0,0.2,-, < 0.01,8.16E-01
purine nucleoside triphosphate catabolic process (GO:0009146),6,0,0.61,-, < 0.01,5.43E-01
nucleoside triphosphate catabolic process (GO:0009143),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of hemoglobin biosynthetic process (GO:0046985),4,0,0.41,-, < 0.01,6.66E-01
pyrimidine nucleoside diphosphate catabolic process (GO:0009140),2,0,0.2,-, < 0.01,8.16E-01
L-alanine transport (GO:0015808),10,0,1.02,-, < 0.01,3.62E-01
S-adenosyl-L-methionine transport (GO:0015805),1,0,0.1,-, < 0.01,9.03E-01
nuclear migration along microfilament (GO:0031022),2,0,0.2,-, < 0.01,8.16E-01
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine nucleoside diphosphate metabolic process (GO:0009138),3,0,0.3,-, < 0.01,7.37E-01
purine nucleoside diphosphate catabolic process (GO:0009137),4,0,0.41,-, < 0.01,6.66E-01
purine nucleoside diphosphate biosynthetic process (GO:0009136),6,0,0.61,-, < 0.01,5.43E-01
nucleoside diphosphate catabolic process (GO:0009134),12,0,1.22,-, < 0.01,2.95E-01
nucleoside diphosphate biosynthetic process (GO:0009133),8,0,0.81,-, < 0.01,4.43E-01
pyrimidine nucleoside monophosphate catabolic process (GO:0009131),1,0,0.1,-, < 0.01,9.03E-01
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130),14,0,1.42,-, < 0.01,2.41E-01
exocrine pancreas development (GO:0031017),7,0,0.71,-, < 0.01,4.91E-01
pyrimidine nucleoside monophosphate metabolic process (GO:0009129),15,0,1.52,-, < 0.01,2.17E-01
purine nucleoside monophosphate catabolic process (GO:0009128),4,0,0.41,-, < 0.01,6.66E-01
peptide antigen transport (GO:0046968),3,0,0.3,-, < 0.01,7.37E-01
cytosol to endoplasmic reticulum transport (GO:0046967),4,0,0.41,-, < 0.01,6.66E-01
nucleoside monophosphate catabolic process (GO:0009125),6,0,0.61,-, < 0.01,5.43E-01
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963),2,0,0.2,-, < 0.01,8.16E-01
deoxyribonucleoside metabolic process (GO:0009120),8,0,0.81,-, < 0.01,4.43E-01
sensitization (GO:0046960),2,0,0.2,-, < 0.01,8.16E-01
response to caffeine (GO:0031000),17,0,1.73,-, < 0.01,1.77E-01
radial spoke assembly (GO:0062177),2,0,0.2,-, < 0.01,8.16E-01
R-loop disassembly (GO:0062176),4,0,0.41,-, < 0.01,6.66E-01
xanthine catabolic process (GO:0009115),2,0,0.2,-, < 0.01,8.16E-01
brexanolone metabolic process (GO:0062173),1,0,0.1,-, < 0.01,9.03E-01
vitamin biosynthetic process (GO:0009110),12,0,1.22,-, < 0.01,2.95E-01
behavioral response to starvation (GO:0042595),2,0,0.2,-, < 0.01,8.16E-01
regulation of chromatin-mediated maintenance of transcription (GO:1904499),1,0,0.1,-, < 0.01,9.03E-01
lipoate biosynthetic process (GO:0009107),1,0,0.1,-, < 0.01,9.03E-01
lipoate metabolic process (GO:0009106),1,0,0.1,-, < 0.01,9.03E-01
hydroxylysine biosynthetic process (GO:0046947),2,0,0.2,-, < 0.01,8.16E-01
hydroxylysine metabolic process (GO:0046946),2,0,0.2,-, < 0.01,8.16E-01
lipopolysaccharide catabolic process (GO:0009104),1,0,0.1,-, < 0.01,9.03E-01
protein localization to ciliary transition zone (GO:1904491),8,0,0.81,-, < 0.01,4.43E-01
vascular endothelial cell response to fluid shear stress (GO:0097699),1,0,0.1,-, < 0.01,9.03E-01
telomere maintenance via base-excision repair (GO:0097698),1,0,0.1,-, < 0.01,9.03E-01
nucleoside monophosphate phosphorylation (GO:0046940),8,0,0.81,-, < 0.01,4.43E-01
establishment of protein-containing complex localization to telomere (GO:0097695),2,0,0.2,-, < 0.01,8.16E-01
establishment of RNA localization to telomere (GO:0097694),2,0,0.2,-, < 0.01,8.16E-01
histone H3-K4 monomethylation (GO:0097692),7,0,0.71,-, < 0.01,4.91E-01
protein folding in endoplasmic reticulum (GO:0034975),10,0,1.02,-, < 0.01,3.62E-01
histone H3-R26 methylation (GO:0034972),1,0,0.1,-, < 0.01,9.03E-01
histone H3-R17 methylation (GO:0034971),1,0,0.1,-, < 0.01,9.03E-01
histone H3-R2 methylation (GO:0034970),1,0,0.1,-, < 0.01,9.03E-01
cellular response to tetrahydrofolate (GO:1904482),1,0,0.1,-, < 0.01,9.03E-01
response to tetrahydrofolate (GO:1904481),1,0,0.1,-, < 0.01,9.03E-01
glutamate receptor clustering (GO:0097688),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of intestinal absorption (GO:1904480),3,0,0.3,-, < 0.01,7.37E-01
histone arginine methylation (GO:0034969),10,0,1.02,-, < 0.01,3.62E-01
box H/ACA snoRNA processing (GO:0034964),2,0,0.2,-, < 0.01,8.16E-01
box C/D snoRNA processing (GO:0034963),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of transport across blood-brain barrier (GO:0150202),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transport across blood-brain barrier (GO:0150201),1,0,0.1,-, < 0.01,9.03E-01
regulation of transport across blood-brain barrier (GO:0150200),1,0,0.1,-, < 0.01,9.03E-01
detection of stimulus involved in sensory perception of pain (GO:0062149),25,0,2.54,-, < 0.01,7.86E-02
positive regulation of Ras GTPase binding (GO:1904477),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of Ras GTPase binding (GO:1904476),1,0,0.1,-, < 0.01,9.03E-01
regulation of Ras GTPase binding (GO:1904475),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of endothelin production (GO:1904472),2,0,0.2,-, < 0.01,8.16E-01
regulation of endothelin production (GO:1904470),2,0,0.2,-, < 0.01,8.16E-01
histone H3-K36 dimethylation (GO:0097676),4,0,0.41,-, < 0.01,6.66E-01
endothelin maturation (GO:0034959),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of matrix metallopeptidase secretion (GO:1904466),3,0,0.3,-, < 0.01,7.37E-01
symbiont intracellular protein transport in host (GO:0030581),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of neuronal action potential (GO:1904457),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neuronal action potential (GO:1904456),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of aspartate secretion (GO:1904450),2,0,0.2,-, < 0.01,8.16E-01
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of plasma cell differentiation (GO:1900099),1,0,0.1,-, < 0.01,9.03E-01
regulation of plasma cell differentiation (GO:1900098),4,0,0.41,-, < 0.01,6.66E-01
tetrahydrofolylpolyglutamate metabolic process (GO:0046900),2,0,0.2,-, < 0.01,8.16E-01
regulation of dosage compensation by inactivation of X chromosome (GO:1900095),1,0,0.1,-, < 0.01,9.03E-01
cell wall biogenesis (GO:0042546),1,0,0.1,-, < 0.01,9.03E-01
protein N-linked glycosylation via arginine (GO:0042543),1,0,0.1,-, < 0.01,9.03E-01
ubiquitin-dependent SMAD protein catabolic process (GO:0030579),6,0,0.61,-, < 0.01,5.43E-01
PML body organization (GO:0030578),6,0,0.61,-, < 0.01,5.43E-01
bile acid catabolic process (GO:0030573),2,0,0.2,-, < 0.01,8.16E-01
regulation of eIF2 alpha phosphorylation by heme (GO:0010999),3,0,0.3,-, < 0.01,7.37E-01
regulation of aspartate secretion (GO:1904448),2,0,0.2,-, < 0.01,8.16E-01
folate import across plasma membrane (GO:1904447),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442),1,0,0.1,-, < 0.01,9.03E-01
zinc ion import into organelle (GO:0062111),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of SMAD protein complex assembly (GO:0010991),5,0,0.51,-, < 0.01,6.01E-01
regulation of thyroid gland epithelial cell proliferation (GO:1904441),1,0,0.1,-, < 0.01,9.03E-01
amylin receptor signaling pathway (GO:0097647),7,0,0.71,-, < 0.01,4.91E-01
calcitonin family receptor signaling pathway (GO:0097646),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085),1,0,0.1,-, < 0.01,9.03E-01
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of arginine catabolic process (GO:1900082),1,0,0.1,-, < 0.01,9.03E-01
L-ornithine import across plasma membrane (GO:0097640),1,0,0.1,-, < 0.01,9.03E-01
regulation of arginine catabolic process (GO:1900081),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of iron ion import across plasma membrane (GO:1904439),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transferrin receptor binding (GO:1904437),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of high-density lipoprotein particle clearance (GO:0010987),1,0,0.1,-, < 0.01,9.03E-01
regulation of transferrin receptor binding (GO:1904435),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of ferrous iron binding (GO:1904434),2,0,0.2,-, < 0.01,8.16E-01
double-stranded RNA biosynthetic process (GO:0062103),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of high-density lipoprotein particle clearance (GO:0010983),2,0,0.2,-, < 0.01,8.16E-01
regulation of high-density lipoprotein particle clearance (GO:0010982),3,0,0.3,-, < 0.01,7.37E-01
regulation of ferrous iron binding (GO:1904432),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of t-circle formation (GO:1904431),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of programmed necrotic cell death (GO:0062100),4,0,0.41,-, < 0.01,6.66E-01
L-lysine import across plasma membrane (GO:0097639),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of t-circle formation (GO:1904430),3,0,0.3,-, < 0.01,7.37E-01
regulation of arginine biosynthetic process (GO:1900079),1,0,0.1,-, < 0.01,9.03E-01
regulation of t-circle formation (GO:1904429),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of tubulin deacetylation (GO:1904428),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of GTP binding (GO:1904426),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of GTP binding (GO:1904425),3,0,0.3,-, < 0.01,7.37E-01
regulation of GTP binding (GO:1904424),14,0,1.42,-, < 0.01,2.41E-01
regulation of cellular hyperosmotic salinity response (GO:1900069),3,0,0.3,-, < 0.01,7.37E-01
potassium ion export across plasma membrane (GO:0097623),11,0,1.12,-, < 0.01,3.27E-01
regulation of peroxisome organization (GO:1900063),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of ceramide biosynthetic process (GO:1900060),5,0,0.51,-, < 0.01,6.01E-01
regulation of polyamine biosynthetic process (GO:0010967),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of xenophagy (GO:1904417),6,0,0.61,-, < 0.01,5.43E-01
regulation of xenophagy (GO:1904415),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of cardiac ventricle development (GO:1904414),1,0,0.1,-, < 0.01,9.03E-01
"O-glycan processing, core 3 (GO:0016269)",1,0,0.1,-, < 0.01,9.03E-01
regulation of glucan biosynthetic process (GO:0010962),27,0,2.74,-, < 0.01,6.41E-02
regulation of cardiac ventricle development (GO:1904412),1,0,0.1,-, < 0.01,9.03E-01
cellular magnesium ion homeostasis (GO:0010961),5,0,0.51,-, < 0.01,6.01E-01
lipopolysaccharide metabolic process (GO:0008653),1,0,0.1,-, < 0.01,9.03E-01
selenocysteine catabolic process (GO:0016261),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of retinoic acid biosynthetic process (GO:1900054),1,0,0.1,-, < 0.01,9.03E-01
selenocysteine biosynthetic process (GO:0016260),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of retinoic acid biosynthetic process (GO:1900053),1,0,0.1,-, < 0.01,9.03E-01
regulation of retinoic acid biosynthetic process (GO:1900052),2,0,0.2,-, < 0.01,8.16E-01
serine phosphorylation of STAT protein (GO:0042501),4,0,0.41,-, < 0.01,6.66E-01
regulation of amino acid import across plasma membrane (GO:0010958),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of vitamin D biosynthetic process (GO:0010957),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956),3,0,0.3,-, < 0.01,7.37E-01
selenocysteine metabolic process (GO:0016259),5,0,0.51,-, < 0.01,6.01E-01
response to Thyroid stimulating hormone (GO:1904400),1,0,0.1,-, < 0.01,9.03E-01
N-glycan processing to lysosome (GO:0016256),1,0,0.1,-, < 0.01,9.03E-01
attachment of GPI anchor to protein (GO:0016255),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of protein K63-linked ubiquitination (GO:1900045),7,0,0.71,-, < 0.01,4.91E-01
regulation of protein K63-linked ubiquitination (GO:1900044),12,0,1.22,-, < 0.01,2.95E-01
peptidyl-lysine deglutarylation (GO:0061699),2,0,0.2,-, < 0.01,8.16E-01
protein deglutarylation (GO:0061698),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of necrotic cell death (GO:0010940),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of cellular response to hypoxia (GO:1900039),1,0,0.1,-, < 0.01,9.03E-01
regulation of autophagosome size (GO:0016243),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cellular response to heat (GO:1900036),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of macroautophagy (GO:0016242),35,0,3.56,-, < 0.01,2.84E-02
negative regulation of cellular response to heat (GO:1900035),1,0,0.1,-, < 0.01,9.03E-01
autophagosome membrane docking (GO:0016240),3,0,0.3,-, < 0.01,7.37E-01
cytoplasmic microtubule depolymerization (GO:0010938),1,0,0.1,-, < 0.01,9.03E-01
macrophage cytokine production (GO:0010934),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of macrophage tolerance induction (GO:0010933),1,0,0.1,-, < 0.01,9.03E-01
regulation of macrophage tolerance induction (GO:0010932),1,0,0.1,-, < 0.01,9.03E-01
lysosomal microautophagy (GO:0016237),3,0,0.3,-, < 0.01,7.37E-01
hormone-mediated apoptotic signaling pathway (GO:0008628),4,0,0.41,-, < 0.01,6.66E-01
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627),2,0,0.2,-, < 0.01,8.16E-01
granzyme-mediated apoptotic signaling pathway (GO:0008626),1,0,0.1,-, < 0.01,9.03E-01
chaperone-mediated autophagy (GO:0061684),8,0,0.81,-, < 0.01,4.43E-01
seminal vesicle morphogenesis (GO:0061682),1,0,0.1,-, < 0.01,9.03E-01
inorganic diphosphate transport (GO:0030505),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of bone mineralization (GO:0030502),17,0,1.73,-, < 0.01,1.77E-01
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925),1,0,0.1,-, < 0.01,9.03E-01
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of inositol phosphate biosynthetic process (GO:0010920),1,0,0.1,-, < 0.01,9.03E-01
guanosine metabolic process (GO:0008617),1,0,0.1,-, < 0.01,9.03E-01
pyridoxine biosynthetic process (GO:0008615),2,0,0.2,-, < 0.01,8.16E-01
pyridoxine metabolic process (GO:0008614),2,0,0.2,-, < 0.01,8.16E-01
ether lipid biosynthetic process (GO:0008611),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011),1,0,0.1,-, < 0.01,9.03E-01
regulation of corticotropin-releasing hormone receptor activity (GO:1900010),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mitochondrial membrane potential (GO:0010917),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916),4,0,0.41,-, < 0.01,6.66E-01
regulation of very-low-density lipoprotein particle clearance (GO:0010915),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of eating behavior (GO:1903999),3,0,0.3,-, < 0.01,7.37E-01
regulation of eating behavior (GO:1903998),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of serine-type endopeptidase activity (GO:1900005),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909),3,0,0.3,-, < 0.01,7.37E-01
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of UDP-glucose catabolic process (GO:0010905),1,0,0.1,-, < 0.01,9.03E-01
regulation of UDP-glucose catabolic process (GO:0010904),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902),2,0,0.2,-, < 0.01,8.16E-01
iron ion export across plasma membrane (GO:1903988),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phosphatidylcholine catabolic process (GO:0010900),1,0,0.1,-, < 0.01,9.03E-01
muscle attachment (GO:0016203),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of microglial cell activation (GO:1903979),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974),2,0,0.2,-, < 0.01,8.16E-01
chemoattraction of axon (GO:0061642),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of response to macrophage colony-stimulating factor (GO:1903971),2,0,0.2,-, < 0.01,8.16E-01
helper T cell enhancement of adaptive immune response (GO:0035397),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein complex stability (GO:0061635),8,0,0.81,-, < 0.01,4.43E-01
monounsaturated fatty acid biosynthetic process (GO:1903966),2,0,0.2,-, < 0.01,8.16E-01
monounsaturated fatty acid catabolic process (GO:1903965),1,0,0.1,-, < 0.01,9.03E-01
monounsaturated fatty acid metabolic process (GO:1903964),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of anion transmembrane transport (GO:1903961),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of anion transmembrane transport (GO:1903960),14,0,1.42,-, < 0.01,2.41E-01
Roundabout signaling pathway (GO:0035385),5,0,0.51,-, < 0.01,6.01E-01
regulation of anion transmembrane transport (GO:1903959),31,0,3.15,-, < 0.01,4.27E-02
sterol transmembrane transport (GO:0035382),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954),1,0,0.1,-, < 0.01,9.03E-01
glycolytic process from galactose (GO:0061623),1,0,0.1,-, < 0.01,9.03E-01
glycolytic process through glucose-1-phosphate (GO:0061622),2,0,0.2,-, < 0.01,8.16E-01
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952),1,0,0.1,-, < 0.01,9.03E-01
sterol import (GO:0035376),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of atrial cardiac muscle cell action potential (GO:1903949),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946),1,0,0.1,-, < 0.01,9.03E-01
pri-miRNA transcription by RNA polymerase II (GO:0061614),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hepatocyte apoptotic process (GO:1903944),2,0,0.2,-, < 0.01,8.16E-01
regulation of hepatocyte apoptotic process (GO:1903943),2,0,0.2,-, < 0.01,8.16E-01
myo-inositol transport (GO:0015798),5,0,0.51,-, < 0.01,6.01E-01
mannose to fructose-6-phosphate metabolic process (GO:0061611),1,0,0.1,-, < 0.01,9.03E-01
mannitol transport (GO:0015797),1,0,0.1,-, < 0.01,9.03E-01
UDP-xylose transmembrane transport (GO:0015790),1,0,0.1,-, < 0.01,9.03E-01
thymine transport (GO:0035364),1,0,0.1,-, < 0.01,9.03E-01
regulation of TORC2 signaling (GO:1903939),2,0,0.2,-, < 0.01,8.16E-01
response to acrylamide (GO:1903937),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),9,0,0.91,-, < 0.01,4.00E-01
UDP-N-acetylgalactosamine transmembrane transport (GO:0015789),3,0,0.3,-, < 0.01,7.37E-01
UDP-glucuronic acid transmembrane transport (GO:0015787),3,0,0.3,-, < 0.01,7.37E-01
GDP-fucose transmembrane transport (GO:0015783),1,0,0.1,-, < 0.01,9.03E-01
CMP-N-acetylneuraminate transmembrane transport (GO:0015782),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359),3,0,0.3,-, < 0.01,7.37E-01
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),14,0,1.42,-, < 0.01,2.41E-01
cellular triglyceride homeostasis (GO:0035356),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of protein processing in phagocytic vesicle (GO:1903923),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein processing in phagocytic vesicle (GO:1903921),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of actin filament severing (GO:1903920),1,0,0.1,-, < 0.01,9.03E-01
polysaccharide transport (GO:0015774),1,0,0.1,-, < 0.01,9.03E-01
oligosaccharide transport (GO:0015772),3,0,0.3,-, < 0.01,7.37E-01
sucrose transport (GO:0015770),3,0,0.3,-, < 0.01,7.37E-01
viral budding via host ESCRT complex (GO:0039702),20,0,2.03,-, < 0.01,1.31E-01
hypoxanthine transport (GO:0035344),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of actin filament severing (GO:1903919),2,0,0.2,-, < 0.01,8.16E-01
regulation of actin filament severing (GO:1903918),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917),1,0,0.1,-, < 0.01,9.03E-01
angiotensin-activated signaling pathway involved in heart process (GO:0086098),2,0,0.2,-, < 0.01,8.16E-01
regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916),1,0,0.1,-, < 0.01,9.03E-01
inosine transport (GO:0035340),1,0,0.1,-, < 0.01,9.03E-01
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912),5,0,0.51,-, < 0.01,6.01E-01
disaccharide transport (GO:0015766),3,0,0.3,-, < 0.01,7.37E-01
regulation of the force of heart contraction by cardiac conduction (GO:0086092),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of receptor clustering (GO:1903910),1,0,0.1,-, < 0.01,9.03E-01
glucose-6-phosphate transport (GO:0015760),6,0,0.61,-, < 0.01,5.43E-01
"aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)",1,0,0.1,-, < 0.01,9.03E-01
cysteine catabolic process (GO:0009093),4,0,0.41,-, < 0.01,6.66E-01
"Notch receptor processing, ligand-dependent (GO:0035333)",7,0,0.71,-, < 0.01,4.91E-01
regulation of plasma membrane raft polarization (GO:1903906),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of establishment of T cell polarity (GO:1903905),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of establishment of T cell polarity (GO:1903904),1,0,0.1,-, < 0.01,9.03E-01
regulation of establishment of T cell polarity (GO:1903903),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of viral life cycle (GO:1903902),29,0,2.95,-, < 0.01,5.23E-02
galactose transmembrane transport (GO:0015757),2,0,0.2,-, < 0.01,8.16E-01
fucose transmembrane transport (GO:0015756),2,0,0.2,-, < 0.01,8.16E-01
pentose transmembrane transport (GO:0015750),2,0,0.2,-, < 0.01,8.16E-01
methionine catabolic process (GO:0009087),1,0,0.1,-, < 0.01,9.03E-01
lysine biosynthetic process (GO:0009085),2,0,0.2,-, < 0.01,8.16E-01
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072),1,0,0.1,-, < 0.01,9.03E-01
SA node cell to atrial cardiac muscle cell communication (GO:0086070),8,0,0.81,-, < 0.01,4.43E-01
malate transport (GO:0015743),3,0,0.3,-, < 0.01,7.37E-01
"non-replicative transposition, DNA-mediated (GO:0098038)",1,0,0.1,-, < 0.01,9.03E-01
aromatic amino acid family biosynthetic process (GO:0009073),3,0,0.3,-, < 0.01,7.37E-01
AV node cell to bundle of His cell communication (GO:0086067),10,0,1.02,-, < 0.01,3.62E-01
atrial cardiac muscle cell to AV node cell communication (GO:0086066),12,0,1.22,-, < 0.01,2.95E-01
taurine transport (GO:0015734),6,0,0.61,-, < 0.01,5.43E-01
Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling (GO:0086055),1,0,0.1,-, < 0.01,9.03E-01
oxaloacetate transport (GO:0015729),3,0,0.3,-, < 0.01,7.37E-01
bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054),1,0,0.1,-, < 0.01,9.03E-01
mevalonate transport (GO:0015728),1,0,0.1,-, < 0.01,9.03E-01
AV node cell to bundle of His cell communication by electrical coupling (GO:0086053),2,0,0.2,-, < 0.01,8.16E-01
membrane repolarization during SA node cell action potential (GO:0086052),1,0,0.1,-, < 0.01,9.03E-01
membrane repolarization during bundle of His cell action potential (GO:0086050),1,0,0.1,-, < 0.01,9.03E-01
formate transport (GO:0015724),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphatidylserine metabolic process (GO:0150178),1,0,0.1,-, < 0.01,9.03E-01
regulation of phosphatidylethanolamine metabolic process (GO:0150175),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of phosphatidylcholine metabolic process (GO:0150173),3,0,0.3,-, < 0.01,7.37E-01
regulation of phosphatidylcholine metabolic process (GO:0150172),9,0,0.91,-, < 0.01,4.00E-01
response to cycloheximide (GO:0046898),6,0,0.61,-, < 0.01,5.43E-01
membrane depolarization during SA node cell action potential (GO:0086046),4,0,0.41,-, < 0.01,6.66E-01
membrane depolarization during AV node cell action potential (GO:0086045),5,0,0.51,-, < 0.01,6.01E-01
atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044),1,0,0.1,-, < 0.01,9.03E-01
hexose phosphate transport (GO:0015712),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of hormone biosynthetic process (GO:0046886),8,0,0.81,-, < 0.01,4.43E-01
follicle-stimulating hormone secretion (GO:0046884),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of follicle-stimulating hormone secretion (GO:0046882),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of follicle-stimulating hormone secretion (GO:0046881),6,0,0.61,-, < 0.01,5.43E-01
regulation of follicle-stimulating hormone secretion (GO:0046880),6,0,0.61,-, < 0.01,5.43E-01
regulation of cardiac muscle cell membrane potential (GO:0086036),6,0,0.61,-, < 0.01,5.43E-01
thiosulfate transport (GO:0015709),3,0,0.3,-, < 0.01,7.37E-01
nitrite transport (GO:0015707),1,0,0.1,-, < 0.01,9.03E-01
nitrate transport (GO:0015706),1,0,0.1,-, < 0.01,9.03E-01
iodide transport (GO:0015705),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of programmed necrotic cell death (GO:0062099),16,0,1.63,-, < 0.01,1.96E-01
stomach development (GO:0062094),2,0,0.2,-, < 0.01,8.16E-01
quinolinate metabolic process (GO:0046874),4,0,0.41,-, < 0.01,6.66E-01
AV node cell to bundle of His cell signaling (GO:0086027),7,0,0.71,-, < 0.01,4.91E-01
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),11,0,1.12,-, < 0.01,3.27E-01
SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021),2,0,0.2,-, < 0.01,8.16E-01
cell-cell junction disassembly (GO:0150147),1,0,0.1,-, < 0.01,9.03E-01
cell junction disassembly (GO:0150146),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of CD80 production (GO:0150145),1,0,0.1,-, < 0.01,9.03E-01
regulation of CD80 production (GO:0150143),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of CD86 production (GO:0150142),1,0,0.1,-, < 0.01,9.03E-01
regulation of CD86 production (GO:0150140),1,0,0.1,-, < 0.01,9.03E-01
terpenoid transport (GO:0046865),2,0,0.2,-, < 0.01,8.16E-01
isoprenoid transport (GO:0046864),2,0,0.2,-, < 0.01,8.16E-01
SA node cell to atrial cardiac muscle cell signaling (GO:0086018),7,0,0.71,-, < 0.01,4.91E-01
AV node cell action potential (GO:0086016),7,0,0.71,-, < 0.01,4.91E-01
SA node cell action potential (GO:0086015),7,0,0.71,-, < 0.01,4.91E-01
atrial cardiac muscle cell action potential (GO:0086014),11,0,1.12,-, < 0.01,3.27E-01
inositol phosphate dephosphorylation (GO:0046855),15,0,1.52,-, < 0.01,2.17E-01
detection of diacyl bacterial lipopeptide (GO:0042496),2,0,0.2,-, < 0.01,8.16E-01
ventricular cardiac muscle cell action potential (GO:0086005),19,0,1.93,-, < 0.01,1.45E-01
gamma-delta T cell differentiation (GO:0042492),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of interleukin-33 production (GO:0150129),1,0,0.1,-, < 0.01,9.03E-01
regulation of interleukin-33 production (GO:0150127),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of neuromuscular junction development (GO:1904397),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394),1,0,0.1,-, < 0.01,9.03E-01
response to ciliary neurotrophic factor (GO:1904391),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of odontogenesis of dentin-containing tooth (GO:0042488),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell-substrate junction organization (GO:0150118),18,0,1.83,-, < 0.01,1.60E-01
negative regulation of cholesterol esterification (GO:0150110),1,0,0.1,-, < 0.01,9.03E-01
rod bipolar cell differentiation (GO:1904389),1,0,0.1,-, < 0.01,9.03E-01
cellular response to L-phenylalanine derivative (GO:1904387),2,0,0.2,-, < 0.01,8.16E-01
glycolipid transport (GO:0046836),7,0,0.71,-, < 0.01,4.91E-01
carbohydrate phosphorylation (GO:0046835),23,0,2.34,-, < 0.01,9.63E-02
response to sodium phosphate (GO:1904383),2,0,0.2,-, < 0.01,8.16E-01
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of RNA export from nucleus (GO:0046832),2,0,0.2,-, < 0.01,8.16E-01
Golgi apparatus mannose trimming (GO:1904381),3,0,0.3,-, < 0.01,7.37E-01
endoplasmic reticulum mannose trimming (GO:1904380),19,0,1.93,-, < 0.01,1.45E-01
outer ear morphogenesis (GO:0042473),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein localization to cell-cell junction (GO:0150107),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein localization to cell-cell junction (GO:0150106),3,0,0.3,-, < 0.01,7.37E-01
reactive gliosis (GO:0150103),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of monocyte activation (GO:0150102),2,0,0.2,-, < 0.01,8.16E-01
regulation of microtubule anchoring at centrosome (GO:0150101),1,0,0.1,-, < 0.01,9.03E-01
protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein export from nucleus (GO:0046827),20,0,2.03,-, < 0.01,1.31E-01
negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),8,0,0.81,-, < 0.01,4.43E-01
regulation of cardiac epithelial to mesenchymal transition (GO:0062042),9,0,0.91,-, < 0.01,4.00E-01
sequestering of iron ion (GO:0097577),6,0,0.61,-, < 0.01,5.43E-01
sensory perception of cold stimulus (GO:0062035),1,0,0.1,-, < 0.01,9.03E-01
coreceptor-mediated virion attachment to host cell (GO:0046814),1,0,0.1,-, < 0.01,9.03E-01
receptor-mediated virion attachment to host cell (GO:0046813),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of stress granule assembly (GO:0062030),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026),1,0,0.1,-, < 0.01,9.03E-01
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of telomere capping (GO:1904354),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein catabolic process in the vacuole (GO:1904352),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of protein catabolic process in the vacuole (GO:1904351),4,0,0.41,-, < 0.01,6.66E-01
regulation of protein catabolic process in the vacuole (GO:1904350),11,0,1.12,-, < 0.01,3.27E-01
photoreceptor cell morphogenesis (GO:0008594),4,0,0.41,-, < 0.01,6.66E-01
regulation of Toll signaling pathway (GO:0008592),4,0,0.41,-, < 0.01,6.66E-01
"regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)",1,0,0.1,-, < 0.01,9.03E-01
mitochondrial double-strand break repair via homologous recombination (GO:0097552),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial double-strand break repair (GO:0097551),1,0,0.1,-, < 0.01,9.03E-01
nuclear migration along microtubule (GO:0030473),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of small intestine smooth muscle contraction (GO:1904349),3,0,0.3,-, < 0.01,7.37E-01
regulation of phosphatidylcholine catabolic process (GO:0010899),3,0,0.3,-, < 0.01,7.37E-01
regulation of small intestine smooth muscle contraction (GO:1904347),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of gastric mucosal blood circulation (GO:1904346),2,0,0.2,-, < 0.01,8.16E-01
regulation of gastric mucosal blood circulation (GO:1904344),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of colon smooth muscle contraction (GO:1904343),1,0,0.1,-, < 0.01,9.03E-01
axon midline choice point recognition (GO:0016199),5,0,0.51,-, < 0.01,6.01E-01
axon choice point recognition (GO:0016198),7,0,0.71,-, < 0.01,4.91E-01
regulation of colon smooth muscle contraction (GO:1904341),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of dopaminergic neuron differentiation (GO:1904340),4,0,0.41,-, < 0.01,6.66E-01
synaptic vesicle uncoating (GO:0016191),5,0,0.51,-, < 0.01,6.01E-01
indole metabolic process (GO:0042431),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cholesterol storage (GO:0010887),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of cholesterol storage (GO:0010886),7,0,0.71,-, < 0.01,4.91E-01
regulation of cholesterol storage (GO:0010885),16,0,1.63,-, < 0.01,1.96E-01
"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)",1,0,0.1,-, < 0.01,9.03E-01
synaptic vesicle maturation (GO:0016188),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000),1,0,0.1,-, < 0.01,9.03E-01
choline catabolic process (GO:0042426),6,0,0.61,-, < 0.01,5.43E-01
synaptic vesicle budding from endosome (GO:0016182),1,0,0.1,-, < 0.01,9.03E-01
cellular stress response to acid chemical (GO:0097533),2,0,0.2,-, < 0.01,8.16E-01
catecholamine catabolic process (GO:0042424),7,0,0.71,-, < 0.01,4.91E-01
stress response to acid chemical (GO:0097532),2,0,0.2,-, < 0.01,8.16E-01
norepinephrine biosynthetic process (GO:0042421),6,0,0.61,-, < 0.01,5.43E-01
dopamine catabolic process (GO:0042420),6,0,0.61,-, < 0.01,5.43E-01
"regulation of complement activation, alternative pathway (GO:0030451)",3,0,0.3,-, < 0.01,7.37E-01
"regulation of complement activation, classical pathway (GO:0030450)",4,0,0.41,-, < 0.01,6.66E-01
cholesterol transport involved in cholesterol storage (GO:0010879),1,0,0.1,-, < 0.01,9.03E-01
regulation of myofibroblast contraction (GO:1904328),1,0,0.1,-, < 0.01,9.03E-01
protein localization to cytosolic proteasome complex (GO:1904327),1,0,0.1,-, < 0.01,9.03E-01
lipid transport involved in lipid storage (GO:0010877),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cholesterol efflux (GO:0010875),20,0,2.03,-, < 0.01,1.31E-01
positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325),1,0,0.1,-, < 0.01,9.03E-01
regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323),1,0,0.1,-, < 0.01,9.03E-01
cellular response to forskolin (GO:1904322),12,0,1.22,-, < 0.01,2.95E-01
response to forskolin (GO:1904321),12,0,1.22,-, < 0.01,2.95E-01
epinephrine biosynthetic process (GO:0042418),2,0,0.2,-, < 0.01,8.16E-01
norepinephrine metabolic process (GO:0042415),10,0,1.02,-, < 0.01,3.62E-01
epinephrine metabolic process (GO:0042414),3,0,0.3,-, < 0.01,7.37E-01
carnitine catabolic process (GO:0042413),1,0,0.1,-, < 0.01,9.03E-01
taurine biosynthetic process (GO:0042412),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of triglyceride biosynthetic process (GO:0010868),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of triglyceride biosynthetic process (GO:0010867),12,0,1.22,-, < 0.01,2.95E-01
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317),1,0,0.1,-, < 0.01,9.03E-01
regulation of triglyceride biosynthetic process (GO:0010866),17,0,1.73,-, < 0.01,1.77E-01
response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316),1,0,0.1,-, < 0.01,9.03E-01
response to methamphetamine hydrochloride (GO:1904313),2,0,0.2,-, < 0.01,8.16E-01
thyroid hormone catabolic process (GO:0042404),1,0,0.1,-, < 0.01,9.03E-01
"base-excision repair, AP site formation via deaminated base removal (GO:0097510)",1,0,0.1,-, < 0.01,9.03E-01
sleep (GO:0030431),15,0,1.52,-, < 0.01,2.17E-01
response to desipramine (GO:1904307),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306),5,0,0.51,-, < 0.01,6.01E-01
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of maternal process involved in parturition (GO:1904303),1,0,0.1,-, < 0.01,9.03E-01
regulation of maternal process involved in parturition (GO:1904301),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcytosis (GO:1904300),2,0,0.2,-, < 0.01,8.16E-01
receptor localization to non-motile cilium (GO:0097500),2,0,0.2,-, < 0.01,8.16E-01
production of siRNA involved in RNA interference (GO:0030422),7,0,0.71,-, < 0.01,4.91E-01
defecation (GO:0030421),1,0,0.1,-, < 0.01,9.03E-01
"regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of reciprocal meiotic recombination (GO:0010845),4,0,0.41,-, < 0.01,6.66E-01
"positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)",2,0,0.2,-, < 0.01,8.16E-01
"regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)",3,0,0.3,-, < 0.01,7.37E-01
calcium activated galactosylceramide scrambling (GO:0061591),5,0,0.51,-, < 0.01,6.01E-01
calcium activated phosphatidylcholine scrambling (GO:0061590),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of protein ADP-ribosylation (GO:0010836),3,0,0.3,-, < 0.01,7.37E-01
calcium activated phosphatidylserine scrambling (GO:0061589),4,0,0.41,-, < 0.01,6.66E-01
calcium activated phospholipid scrambling (GO:0061588),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of myotube differentiation (GO:0010831),11,0,1.12,-, < 0.01,3.27E-01
brassinosteroid biosynthetic process (GO:0016132),1,0,0.1,-, < 0.01,9.03E-01
brassinosteroid metabolic process (GO:0016131),1,0,0.1,-, < 0.01,9.03E-01
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of centrosome duplication (GO:0010826),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of centrosome duplication (GO:0010825),3,0,0.3,-, < 0.01,7.37E-01
regulation of centrosome duplication (GO:0010824),42,0,4.27,-, < 0.01,1.39E-02
phytosteroid biosynthetic process (GO:0016129),1,0,0.1,-, < 0.01,9.03E-01
phytosteroid metabolic process (GO:0016128),1,0,0.1,-, < 0.01,9.03E-01
sterol catabolic process (GO:0016127),11,0,1.12,-, < 0.01,3.27E-01
xanthophyll biosynthetic process (GO:0016123),1,0,0.1,-, < 0.01,9.03E-01
negative stranded viral RNA replication (GO:0039689),3,0,0.3,-, < 0.01,7.37E-01
calcitonin catabolic process (GO:0010816),1,0,0.1,-, < 0.01,9.03E-01
bradykinin catabolic process (GO:0010815),5,0,0.51,-, < 0.01,6.01E-01
substance P catabolic process (GO:0010814),1,0,0.1,-, < 0.01,9.03E-01
neuropeptide catabolic process (GO:0010813),2,0,0.2,-, < 0.01,8.16E-01
carotenoid biosynthetic process (GO:0016117),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of PERK-mediated unfolded protein response (GO:1903898),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),4,0,0.41,-, < 0.01,6.66E-01
regulation of IRE1-mediated unfolded protein response (GO:1903894),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of ATF6-mediated unfolded protein response (GO:1903893),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of synaptic vesicle priming (GO:0010808),1,0,0.1,-, < 0.01,9.03E-01
regulation of synaptic vesicle priming (GO:0010807),6,0,0.61,-, < 0.01,5.43E-01
tetraterpenoid biosynthetic process (GO:0016109),1,0,0.1,-, < 0.01,9.03E-01
sesquiterpenoid catabolic process (GO:0016107),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),28,0,2.85,-, < 0.01,5.79E-02
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886),1,0,0.1,-, < 0.01,9.03E-01
triterpenoid biosynthetic process (GO:0016104),1,0,0.1,-, < 0.01,9.03E-01
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883),1,0,0.1,-, < 0.01,9.03E-01
ganglion morphogenesis (GO:0061552),2,0,0.2,-, < 0.01,8.16E-01
regulation of interleukin-17-mediated signaling pathway (GO:1903881),1,0,0.1,-, < 0.01,9.03E-01
modulation by virus of host gene expression (GO:0039656),3,0,0.3,-, < 0.01,7.37E-01
suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process (GO:0039650),1,0,0.1,-, < 0.01,9.03E-01
"glycine secretion, neurotransmission (GO:0061537)",1,0,0.1,-, < 0.01,9.03E-01
glycine secretion (GO:0061536),1,0,0.1,-, < 0.01,9.03E-01
"glutamate secretion, neurotransmission (GO:0061535)",1,0,0.1,-, < 0.01,9.03E-01
"gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)",1,0,0.1,-, < 0.01,9.03E-01
negative regulation of dendrite extension (GO:1903860),1,0,0.1,-, < 0.01,9.03E-01
brain segmentation (GO:0035284),3,0,0.3,-, < 0.01,7.37E-01
central nervous system segmentation (GO:0035283),3,0,0.3,-, < 0.01,7.37E-01
acetylcholine secretion (GO:0061526),1,0,0.1,-, < 0.01,9.03E-01
pre-miRNA export from nucleus (GO:0035281),2,0,0.2,-, < 0.01,8.16E-01
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),6,0,0.61,-, < 0.01,5.43E-01
cilium disassembly (GO:0061523),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cristae formation (GO:1903852),3,0,0.3,-, < 0.01,7.37E-01
regulation of cristae formation (GO:1903850),4,0,0.41,-, < 0.01,6.66E-01
mRNA cleavage involved in gene silencing by miRNA (GO:0035279),1,0,0.1,-, < 0.01,9.03E-01
macrophage homeostasis (GO:0061519),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of aorta morphogenesis (GO:1903849),2,0,0.2,-, < 0.01,8.16E-01
regulation of aorta morphogenesis (GO:1903847),2,0,0.2,-, < 0.01,8.16E-01
interleukin-34-mediated signaling pathway (GO:0061514),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),3,0,0.3,-, < 0.01,7.37E-01
cellular response to arsenite ion (GO:1903843),5,0,0.51,-, < 0.01,6.01E-01
response to arsenite ion (GO:1903842),5,0,0.51,-, < 0.01,6.01E-01
centriole elongation (GO:0061511),2,0,0.2,-, < 0.01,8.16E-01
cellular response to arsenite(3-) (GO:1903841),2,0,0.2,-, < 0.01,8.16E-01
response to arsenite(3-) (GO:1903840),2,0,0.2,-, < 0.01,8.16E-01
magnesium ion transport (GO:0015693),15,0,1.52,-, < 0.01,2.17E-01
lead ion transport (GO:0015692),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mRNA 3'-UTR binding (GO:1903839),1,0,0.1,-, < 0.01,9.03E-01
regulation of mRNA 3'-UTR binding (GO:1903837),1,0,0.1,-, < 0.01,9.03E-01
gonad morphogenesis (GO:0035262),2,0,0.2,-, < 0.01,8.16E-01
external genitalia morphogenesis (GO:0035261),2,0,0.2,-, < 0.01,8.16E-01
molybdate ion transport (GO:0015689),1,0,0.1,-, < 0.01,9.03E-01
magnesium ion transmembrane transport (GO:1903830),14,0,1.42,-, < 0.01,2.41E-01
protein maturation by copper ion transfer (GO:0015680),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of telomere single strand break repair (GO:1903824),1,0,0.1,-, < 0.01,9.03E-01
plasma membrane copper ion transport (GO:0015679),1,0,0.1,-, < 0.01,9.03E-01
copper ion import (GO:0015677),5,0,0.51,-, < 0.01,6.01E-01
vanadium ion transport (GO:0015676),1,0,0.1,-, < 0.01,9.03E-01
nickel cation transport (GO:0015675),1,0,0.1,-, < 0.01,9.03E-01
peptidyl-arginine omega-N-methylation (GO:0035247),7,0,0.71,-, < 0.01,4.91E-01
peptidyl-arginine N-methylation (GO:0035246),9,0,0.91,-, < 0.01,4.00E-01
L-serine import across plasma membrane (GO:1903812),1,0,0.1,-, < 0.01,9.03E-01
L-histidine import across plasma membrane (GO:1903810),1,0,0.1,-, < 0.01,9.03E-01
ectopic germ cell programmed cell death (GO:0035234),7,0,0.71,-, < 0.01,4.91E-01
L-glutamine import across plasma membrane (GO:1903803),1,0,0.1,-, < 0.01,9.03E-01
L-leucine import across plasma membrane (GO:1903801),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of glutamate-cysteine ligase activity (GO:0035229),1,0,0.1,-, < 0.01,9.03E-01
regulation of glutamate-cysteine ligase activity (GO:0035227),1,0,0.1,-, < 0.01,9.03E-01
neuron-glial cell signaling (GO:0150099),5,0,0.51,-, < 0.01,6.01E-01
glial cell-neuron signaling (GO:0150098),4,0,0.41,-, < 0.01,6.66E-01
"multiple spine synapse organization, single dendrite (GO:0150090)",1,0,0.1,-, < 0.01,9.03E-01
cell competition in a multicellular organism (GO:0035212),1,0,0.1,-, < 0.01,9.03E-01
multiple spine synapse organization (GO:0150089),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of deacetylase activity (GO:0150066),2,0,0.2,-, < 0.01,8.16E-01
vertebrate eye-specific patterning (GO:0150064),3,0,0.3,-, < 0.01,7.37E-01
complement-mediated synapse pruning (GO:0150062),3,0,0.3,-, < 0.01,7.37E-01
viral replication complex formation and maintenance (GO:0046786),1,0,0.1,-, < 0.01,9.03E-01
viral mRNA export from host cell nucleus (GO:0046784),7,0,0.71,-, < 0.01,4.91E-01
modification by virus of host mRNA processing (GO:0046778),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein localization to lysosome (GO:0150033),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein localization to lysosome (GO:0150032),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to lysosome (GO:0150031),3,0,0.3,-, < 0.01,7.37E-01
viral budding (GO:0046755),25,0,2.54,-, < 0.01,7.86E-02
phosphagen biosynthetic process (GO:0042396),3,0,0.3,-, < 0.01,7.37E-01
oxidised low-density lipoprotein particle clearance (GO:0150024),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcytosis (GO:1904298),2,0,0.2,-, < 0.01,8.16E-01
viral capsid secondary envelopment (GO:0046745),1,0,0.1,-, < 0.01,9.03E-01
protein localization to non-motile cilium (GO:0097499),7,0,0.71,-, < 0.01,4.91E-01
endothelial tube lumen extension (GO:0097498),2,0,0.2,-, < 0.01,8.16E-01
blood vessel endothelial cell delamination (GO:0097497),1,0,0.1,-, < 0.01,9.03E-01
regulation of vesicle size (GO:0097494),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of neuron projection arborization (GO:0150012),8,0,0.81,-, < 0.01,4.43E-01
regulation of neuron projection arborization (GO:0150011),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283),1,0,0.1,-, < 0.01,9.03E-01
regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282),1,0,0.1,-, < 0.01,9.03E-01
basement membrane disassembly (GO:0034769),3,0,0.3,-, < 0.01,7.37E-01
vitamin K catabolic process (GO:0042377),4,0,0.41,-, < 0.01,6.66E-01
phylloquinone catabolic process (GO:0042376),5,0,0.51,-, < 0.01,6.01E-01
phylloquinone metabolic process (GO:0042374),5,0,0.51,-, < 0.01,6.01E-01
vitamin K metabolic process (GO:0042373),8,0,0.81,-, < 0.01,4.43E-01
vitamin K biosynthetic process (GO:0042371),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of iron ion transmembrane transport (GO:0034760),3,0,0.3,-, < 0.01,7.37E-01
regulation of spontaneous synaptic transmission (GO:0150003),6,0,0.61,-, < 0.01,5.43E-01
positive regulation by virus of viral protein levels in host cell (GO:0046726),3,0,0.3,-, < 0.01,7.37E-01
tricellular tight junction assembly (GO:1904274),1,0,0.1,-, < 0.01,9.03E-01
negative regulation by virus of viral protein levels in host cell (GO:0046725),2,0,0.2,-, < 0.01,8.16E-01
L-alanine import across plasma membrane (GO:1904273),3,0,0.3,-, < 0.01,7.37E-01
oxalic acid secretion (GO:0046724),2,0,0.2,-, < 0.01,8.16E-01
lactic acid secretion (GO:0046722),1,0,0.1,-, < 0.01,9.03E-01
pyroptosome complex assembly (GO:1904270),1,0,0.1,-, < 0.01,9.03E-01
vitamin D catabolic process (GO:0042369),3,0,0.3,-, < 0.01,7.37E-01
lateral motor column neuron migration (GO:0097477),3,0,0.3,-, < 0.01,7.37E-01
vitamin D biosynthetic process (GO:0042368),4,0,0.41,-, < 0.01,6.66E-01
spinal cord motor neuron migration (GO:0097476),4,0,0.41,-, < 0.01,6.66E-01
motor neuron migration (GO:0097475),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of iron ion transport (GO:0034757),3,0,0.3,-, < 0.01,7.37E-01
water-soluble vitamin catabolic process (GO:0042365),1,0,0.1,-, < 0.01,9.03E-01
retinal rod cell apoptotic process (GO:0097473),1,0,0.1,-, < 0.01,9.03E-01
water-soluble vitamin biosynthetic process (GO:0042364),6,0,0.61,-, < 0.01,5.43E-01
fat-soluble vitamin biosynthetic process (GO:0042362),6,0,0.61,-, < 0.01,5.43E-01
menaquinone catabolic process (GO:0042361),4,0,0.41,-, < 0.01,6.66E-01
vitamin E metabolic process (GO:0042360),4,0,0.41,-, < 0.01,6.66E-01
membrane disassembly (GO:0030397),15,0,1.52,-, < 0.01,2.17E-01
fructoselysine metabolic process (GO:0030393),1,0,0.1,-, < 0.01,9.03E-01
regulation by virus of viral protein levels in host cell (GO:0046719),7,0,0.71,-, < 0.01,4.91E-01
muscle cell cellular homeostasis (GO:0046716),22,0,2.24,-, < 0.01,1.07E-01
borate transport (GO:0046713),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),5,0,0.51,-, < 0.01,6.01E-01
GDP catabolic process (GO:0046712),1,0,0.1,-, < 0.01,9.03E-01
programmed cell death in response to reactive oxygen species (GO:0097468),3,0,0.3,-, < 0.01,7.37E-01
GDP biosynthetic process (GO:0046711),1,0,0.1,-, < 0.01,9.03E-01
GDP metabolic process (GO:0046710),10,0,1.02,-, < 0.01,3.62E-01
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),5,0,0.51,-, < 0.01,6.01E-01
thiamine diphosphate metabolic process (GO:0042357),2,0,0.2,-, < 0.01,8.16E-01
'de novo' GDP-L-fucose biosynthetic process (GO:0042351),2,0,0.2,-, < 0.01,8.16E-01
GDP-L-fucose biosynthetic process (GO:0042350),2,0,0.2,-, < 0.01,8.16E-01
sperm mitochondrion organization (GO:0030382),2,0,0.2,-, < 0.01,8.16E-01
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),5,0,0.51,-, < 0.01,6.01E-01
IDP catabolic process (GO:0046709),2,0,0.2,-, < 0.01,8.16E-01
IDP metabolic process (GO:0046707),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of iron ion transmembrane transporter activity (GO:1904256),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of iron ion transmembrane transporter activity (GO:1904255),1,0,0.1,-, < 0.01,9.03E-01
regulation of iron ion transmembrane transporter activity (GO:1904254),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of bile acid metabolic process (GO:1904253),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of bile acid metabolic process (GO:1904252),2,0,0.2,-, < 0.01,8.16E-01
regulation of bile acid metabolic process (GO:1904251),12,0,1.22,-, < 0.01,2.95E-01
regulation of multivesicular body size involved in endosome transport (GO:0010797),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247),1,0,0.1,-, < 0.01,9.03E-01
regulation of multivesicular body size (GO:0010796),3,0,0.3,-, < 0.01,7.37E-01
regulation of ubiquinone biosynthetic process (GO:0010795),2,0,0.2,-, < 0.01,8.16E-01
regulation of mRNA export from nucleus (GO:0010793),5,0,0.51,-, < 0.01,6.01E-01
monoterpenoid metabolic process (GO:0016098),6,0,0.61,-, < 0.01,5.43E-01
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792),3,0,0.3,-, < 0.01,7.37E-01
polyprenol catabolic process (GO:0016095),3,0,0.3,-, < 0.01,7.37E-01
histone H3-K79 methylation (GO:0034729),1,0,0.1,-, < 0.01,9.03E-01
piecemeal microautophagy of the nucleus (GO:0034727),3,0,0.3,-, < 0.01,7.37E-01
"histone H3-K4 demethylation, trimethyl-H3-K4-specific (GO:0034721)",5,0,0.51,-, < 0.01,6.01E-01
histone H3-K4 demethylation (GO:0034720),9,0,0.91,-, < 0.01,4.00E-01
pericyte cell differentiation (GO:1904238),8,0,0.81,-, < 0.01,4.43E-01
"positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)",3,0,0.3,-, < 0.01,7.37E-01
"regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)",3,0,0.3,-, < 0.01,7.37E-01
positive regulation of aconitate hydratase activity (GO:1904234),3,0,0.3,-, < 0.01,7.37E-01
regulation of aconitate hydratase activity (GO:1904232),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of succinate dehydrogenase activity (GO:1904231),2,0,0.2,-, < 0.01,8.16E-01
synaptic vesicle targeting (GO:0016080),3,0,0.3,-, < 0.01,7.37E-01
"negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)",2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)",2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)",5,0,0.51,-, < 0.01,6.01E-01
"regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)",4,0,0.41,-, < 0.01,6.66E-01
regulation of succinate dehydrogenase activity (GO:1904229),3,0,0.3,-, < 0.01,7.37E-01
"negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)",1,0,0.1,-, < 0.01,9.03E-01
tRNA catabolic process (GO:0016078),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of serine C-palmitoyltransferase activity (GO:1904222),3,0,0.3,-, < 0.01,7.37E-01
snoRNA catabolic process (GO:0016077),2,0,0.2,-, < 0.01,8.16E-01
snRNA catabolic process (GO:0016076),3,0,0.3,-, < 0.01,7.37E-01
regulation of serine C-palmitoyltransferase activity (GO:1904220),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767),2,0,0.2,-, < 0.01,8.16E-01
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of iodide transmembrane transport (GO:1904213),1,0,0.1,-, < 0.01,9.03E-01
regulation of iodide transmembrane transport (GO:1904212),1,0,0.1,-, < 0.01,9.03E-01
"membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)",2,0,0.2,-, < 0.01,8.16E-01
homoiothermy (GO:0042309),2,0,0.2,-, < 0.01,8.16E-01
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of skeletal muscle hypertrophy (GO:1904206),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of skeletal muscle hypertrophy (GO:1904205),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cGMP-mediated signaling (GO:0010754),6,0,0.61,-, < 0.01,5.43E-01
regulation of skeletal muscle hypertrophy (GO:1904204),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cGMP-mediated signaling (GO:0010753),6,0,0.61,-, < 0.01,5.43E-01
regulation of cGMP-mediated signaling (GO:0010752),13,0,1.32,-, < 0.01,2.67E-01
negative regulation of iodide transport (GO:1904202),1,0,0.1,-, < 0.01,9.03E-01
regulation of iodide transport (GO:1904201),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of nitric oxide mediated signal transduction (GO:0010751),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of nitric oxide mediated signal transduction (GO:0010750),4,0,0.41,-, < 0.01,6.66E-01
iodide transmembrane transport (GO:1904200),1,0,0.1,-, < 0.01,9.03E-01
neuroblast migration (GO:0097402),1,0,0.1,-, < 0.01,9.03E-01
synaptic vesicle lumen acidification (GO:0097401),1,0,0.1,-, < 0.01,9.03E-01
interleukin-17-mediated signaling pathway (GO:0097400),9,0,0.91,-, < 0.01,4.00E-01
prenylcysteine metabolic process (GO:0030329),2,0,0.2,-, < 0.01,8.16E-01
prenylcysteine catabolic process (GO:0030328),2,0,0.2,-, < 0.01,8.16E-01
prenylated protein catabolic process (GO:0030327),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747),2,0,0.2,-, < 0.01,8.16E-01
regulation of long-chain fatty acid import across plasma membrane (GO:0010746),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of macrophage derived foam cell differentiation (GO:0010745),13,0,1.32,-, < 0.01,2.67E-01
detection of temperature stimulus (GO:0016048),22,0,2.24,-, < 0.01,1.07E-01
detection of fungus (GO:0016046),2,0,0.2,-, < 0.01,8.16E-01
poly-N-acetyllactosamine biosynthetic process (GO:0030311),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of transcription via serum response element binding (GO:0010735),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of protein glutathionylation (GO:0010734),2,0,0.2,-, < 0.01,8.16E-01
absorption of visible light (GO:0016038),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein glutathionylation (GO:0010732),2,0,0.2,-, < 0.01,8.16E-01
light absorption (GO:0016037),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730),4,0,0.41,-, < 0.01,6.66E-01
cellular response to phosphate starvation (GO:0016036),2,0,0.2,-, < 0.01,8.16E-01
memory T cell proliferation (GO:0061485),1,0,0.1,-, < 0.01,9.03E-01
tRNA import into mitochondrion (GO:0016031),2,0,0.2,-, < 0.01,8.16E-01
response to TNF agonist (GO:0061481),1,0,0.1,-, < 0.01,9.03E-01
poly-N-acetyllactosamine metabolic process (GO:0030309),13,0,1.32,-, < 0.01,2.67E-01
deoxynucleotide transport (GO:0030302),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729),3,0,0.3,-, < 0.01,7.37E-01
regulation of hydrogen peroxide biosynthetic process (GO:0010728),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of hydrogen peroxide metabolic process (GO:0010727),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of hydrogen peroxide metabolic process (GO:0010726),5,0,0.51,-, < 0.01,6.01E-01
regulation of primitive erythrocyte differentiation (GO:0010725),2,0,0.2,-, < 0.01,8.16E-01
regulation of definitive erythrocyte differentiation (GO:0010724),3,0,0.3,-, < 0.01,7.37E-01
regulation of ferrochelatase activity (GO:0010722),1,0,0.1,-, < 0.01,9.03E-01
response to anticoagulant (GO:0061476),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of extracellular matrix disassembly (GO:0010716),4,0,0.41,-, < 0.01,6.66E-01
regulation of type B pancreatic cell proliferation (GO:0061469),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of collagen catabolic process (GO:0010711),1,0,0.1,-, < 0.01,9.03E-01
regulation of collagen catabolic process (GO:0010710),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of inorganic anion transmembrane transport (GO:1903797),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of inorganic anion transmembrane transport (GO:1903796),2,0,0.2,-, < 0.01,8.16E-01
regulation of inorganic anion transmembrane transport (GO:1903795),7,0,0.71,-, < 0.01,4.91E-01
guanine nucleotide transmembrane transport (GO:1903790),2,0,0.2,-, < 0.01,8.16E-01
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001),1,0,0.1,-, < 0.01,9.03E-01
globoside biosynthetic process via lactosylceramide (GO:0010707),1,0,0.1,-, < 0.01,9.03E-01
ganglioside biosynthetic process via lactosylceramide (GO:0010706),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of norepinephrine secretion (GO:0010701),4,0,0.41,-, < 0.01,6.66E-01
regulation of amino acid transmembrane transport (GO:1903789),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of norepinephrine secretion (GO:0010700),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of glutathione biosynthetic process (GO:1903788),1,0,0.1,-, < 0.01,9.03E-01
regulation of glutathione biosynthetic process (GO:1903786),2,0,0.2,-, < 0.01,8.16E-01
suppression by virus of host STAT2 activity (GO:0039564),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host STAT1 activity (GO:0039563),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host STAT activity (GO:0039562),1,0,0.1,-, < 0.01,9.03E-01
charged-tRNA amino acid modification (GO:0019988),1,0,0.1,-, < 0.01,9.03E-01
endocardial cushion cell fate commitment (GO:0061445),1,0,0.1,-, < 0.01,9.03E-01
endocardial cushion cell development (GO:0061444),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of viral budding via host ESCRT complex (GO:1903774),3,0,0.3,-, < 0.01,7.37E-01
endocardial cushion cell differentiation (GO:0061443),2,0,0.2,-, < 0.01,8.16E-01
regulation of viral budding via host ESCRT complex (GO:1903772),4,0,0.41,-, < 0.01,6.66E-01
renal artery morphogenesis (GO:0061441),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of beta-galactosidase activity (GO:1903770),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of potassium ion export across plasma membrane (GO:1903766),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of potassium ion export across plasma membrane (GO:1903765),2,0,0.2,-, < 0.01,8.16E-01
regulation of potassium ion export across plasma membrane (GO:1903764),5,0,0.51,-, < 0.01,6.01E-01
cellular response to caloric restriction (GO:0061433),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762),2,0,0.2,-, < 0.01,8.16E-01
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760),3,0,0.3,-, < 0.01,7.37E-01
hatching (GO:0035188),23,0,2.34,-, < 0.01,9.63E-02
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of SUMO transferase activity (GO:1903755),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of p38MAPK cascade (GO:1903753),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of RIG-I signaling pathway (GO:0039536),8,0,0.81,-, < 0.01,4.43E-01
regulation of RIG-I signaling pathway (GO:0039535),18,0,1.83,-, < 0.01,1.60E-01
negative regulation of MDA-5 signaling pathway (GO:0039534),3,0,0.3,-, < 0.01,7.37E-01
regulation of MDA-5 signaling pathway (GO:0039533),5,0,0.51,-, < 0.01,6.01E-01
MDA-5 signaling pathway (GO:0039530),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of anterograde synaptic vesicle transport (GO:1903744),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of anterograde synaptic vesicle transport (GO:1903743),1,0,0.1,-, < 0.01,9.03E-01
regulation of anterograde synaptic vesicle transport (GO:1903742),2,0,0.2,-, < 0.01,8.16E-01
modulation by virus of host apoptotic process (GO:0039526),4,0,0.41,-, < 0.01,6.66E-01
suppression by virus of host autophagy (GO:0039521),1,0,0.1,-, < 0.01,9.03E-01
induction by virus of host autophagy (GO:0039520),2,0,0.2,-, < 0.01,8.16E-01
post-embryonic hemopoiesis (GO:0035166),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400),2,0,0.2,-, < 0.01,8.16E-01
modulation by virus of host autophagy (GO:0039519),3,0,0.3,-, < 0.01,7.37E-01
modulation by virus of host catalytic activity (GO:0039516),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host JAK-STAT cascade (GO:0039514),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host catalytic activity (GO:0039513),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phospholipid metabolic process (GO:1903726),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of centriole elongation (GO:1903724),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of centriole elongation (GO:1903723),1,0,0.1,-, < 0.01,9.03E-01
regulation of centriole elongation (GO:1903722),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of I-kappaB phosphorylation (GO:1903721),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of I-kappaB phosphorylation (GO:1903720),1,0,0.1,-, < 0.01,9.03E-01
suppression by virus of host molecular function (GO:0039507),2,0,0.2,-, < 0.01,8.16E-01
modulation by virus of host molecular function (GO:0039506),2,0,0.2,-, < 0.01,8.16E-01
regulation of I-kappaB phosphorylation (GO:1903719),6,0,0.61,-, < 0.01,5.43E-01
asparagine transmembrane transport (GO:1903713),1,0,0.1,-, < 0.01,9.03E-01
cysteine transmembrane transport (GO:1903712),1,0,0.1,-, < 0.01,9.03E-01
spermine transmembrane transport (GO:1903710),1,0,0.1,-, < 0.01,9.03E-01
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",4,0,0.41,-, < 0.01,6.66E-01
"peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)",3,0,0.3,-, < 0.01,7.37E-01
uterine gland development (GO:1903709),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of production of siRNA involved in RNA interference (GO:1903704),1,0,0.1,-, < 0.01,9.03E-01
substantia propria of cornea development (GO:1903701),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic forelimb morphogenesis (GO:0035128),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic limb morphogenesis (GO:0035127),1,0,0.1,-, < 0.01,9.03E-01
post-embryonic appendage morphogenesis (GO:0035120),1,0,0.1,-, < 0.01,9.03E-01
cell-cell signaling involved in kidney development (GO:0060995),2,0,0.2,-, < 0.01,8.16E-01
response to fungicide (GO:0060992),5,0,0.51,-, < 0.01,6.01E-01
endocrine hormone secretion (GO:0060986),11,0,1.12,-, < 0.01,3.27E-01
coronary artery morphogenesis (GO:0060982),8,0,0.81,-, < 0.01,4.43E-01
cell migration involved in coronary angiogenesis (GO:0060981),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in coronary vasculogenesis (GO:0060980),1,0,0.1,-, < 0.01,9.03E-01
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979),4,0,0.41,-, < 0.01,6.66E-01
angiogenesis involved in coronary vascular morphogenesis (GO:0060978),3,0,0.3,-, < 0.01,7.37E-01
cardioblast migration to the midline involved in heart field formation (GO:0060975),1,0,0.1,-, < 0.01,9.03E-01
cell migration involved in heart formation (GO:0060974),2,0,0.2,-, < 0.01,8.16E-01
cell migration involved in heart development (GO:0060973),13,0,1.32,-, < 0.01,2.67E-01
embryonic heart tube left/right pattern formation (GO:0060971),5,0,0.51,-, < 0.01,6.01E-01
sperm competition (GO:0046692),1,0,0.1,-, < 0.01,9.03E-01
response to tellurium ion (GO:0046690),1,0,0.1,-, < 0.01,9.03E-01
response to chromate (GO:0046687),2,0,0.2,-, < 0.01,8.16E-01
response to DDT (GO:0046680),1,0,0.1,-, < 0.01,9.03E-01
endocardial cell fate commitment (GO:0060957),1,0,0.1,-, < 0.01,9.03E-01
endocardial cell differentiation (GO:0060956),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of retinal cell programmed cell death (GO:0046671),2,0,0.2,-, < 0.01,8.16E-01
cardiac vascular smooth muscle cell development (GO:0060948),3,0,0.3,-, < 0.01,7.37E-01
cardiac vascular smooth muscle cell differentiation (GO:0060947),6,0,0.61,-, < 0.01,5.43E-01
cardiac neuron differentiation (GO:0060945),1,0,0.1,-, < 0.01,9.03E-01
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940),2,0,0.2,-, < 0.01,8.16E-01
regulation of retinal cell programmed cell death (GO:0046668),3,0,0.3,-, < 0.01,7.37E-01
retinal cell programmed cell death (GO:0046666),2,0,0.2,-, < 0.01,8.16E-01
response to luteinizing hormone (GO:0034699),4,0,0.41,-, < 0.01,6.66E-01
response to prostaglandin F (GO:0034696),1,0,0.1,-, < 0.01,9.03E-01
epicardium-derived cardiac fibroblast cell development (GO:0060939),3,0,0.3,-, < 0.01,7.37E-01
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938),3,0,0.3,-, < 0.01,7.37E-01
cardiac fibroblast cell development (GO:0060936),3,0,0.3,-, < 0.01,7.37E-01
cardiac fibroblast cell differentiation (GO:0060935),3,0,0.3,-, < 0.01,7.37E-01
His-Purkinje system cell differentiation (GO:0060932),2,0,0.2,-, < 0.01,8.16E-01
sinoatrial node cell development (GO:0060931),2,0,0.2,-, < 0.01,8.16E-01
folic acid catabolic process (GO:0046657),1,0,0.1,-, < 0.01,9.03E-01
tetrahydrofolate biosynthetic process (GO:0046654),7,0,0.71,-, < 0.01,4.91E-01
vocal learning (GO:0042297),7,0,0.71,-, < 0.01,4.91E-01
atrioventricular node cell fate commitment (GO:0060929),1,0,0.1,-, < 0.01,9.03E-01
atrioventricular node cell development (GO:0060928),2,0,0.2,-, < 0.01,8.16E-01
cardiac pacemaker cell fate commitment (GO:0060927),1,0,0.1,-, < 0.01,9.03E-01
cardiac pacemaker cell development (GO:0060926),4,0,0.41,-, < 0.01,6.66E-01
atrioventricular node cell differentiation (GO:0060922),2,0,0.2,-, < 0.01,8.16E-01
sinoatrial node cell differentiation (GO:0060921),3,0,0.3,-, < 0.01,7.37E-01
cardiac pacemaker cell differentiation (GO:0060920),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of granulosa cell proliferation (GO:1904197),1,0,0.1,-, < 0.01,9.03E-01
regulation of granulosa cell proliferation (GO:1904195),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of gamma-delta T cell activation (GO:0046645),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of cholangiocyte apoptotic process (GO:1904193),1,0,0.1,-, < 0.01,9.03E-01
regulation of gamma-delta T cell activation (GO:0046643),11,0,1.12,-, < 0.01,3.27E-01
regulation of cholangiocyte apoptotic process (GO:1904192),1,0,0.1,-, < 0.01,9.03E-01
cellular response to interleukin-17 (GO:0097398),9,0,0.91,-, < 0.01,4.00E-01
response to interleukin-17 (GO:0097396),9,0,0.91,-, < 0.01,4.00E-01
heart formation (GO:0060914),15,0,1.52,-, < 0.01,2.17E-01
chemotaxis to arachidonic acid (GO:0034670),1,0,0.1,-, < 0.01,9.03E-01
cardiac cell fate determination (GO:0060913),4,0,0.41,-, < 0.01,6.66E-01
cardiac cell fate specification (GO:0060912),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of transformation of host cell by virus (GO:1904188),1,0,0.1,-, < 0.01,9.03E-01
regulation of transformation of host cell by virus (GO:1904187),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of pyruvate dehydrogenase activity (GO:1904184),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of pyruvate dehydrogenase activity (GO:1904183),5,0,0.51,-, < 0.01,6.01E-01
regulation of pyruvate dehydrogenase activity (GO:1904182),8,0,0.81,-, < 0.01,4.43E-01
alpha-beta T cell proliferation (GO:0046633),3,0,0.3,-, < 0.01,7.37E-01
cellular lipid biosynthetic process (GO:0097384),9,0,0.91,-, < 0.01,4.00E-01
error-free postreplication DNA repair (GO:0042275),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of macrophage cytokine production (GO:0060907),10,0,1.02,-, < 0.01,3.62E-01
dorsal spinal cord interneuron anterior axon guidance (GO:0097380),1,0,0.1,-, < 0.01,9.03E-01
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271),3,0,0.3,-, < 0.01,7.37E-01
protection from natural killer cell mediated cytotoxicity (GO:0042270),6,0,0.61,-, < 0.01,5.43E-01
regulation of protein folding in endoplasmic reticulum (GO:0060904),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of meiosis I (GO:0060903),1,0,0.1,-, < 0.01,9.03E-01
regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adipose tissue development (GO:1904179),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of adipose tissue development (GO:1904178),2,0,0.2,-, < 0.01,8.16E-01
regulation of adipose tissue development (GO:1904177),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of bleb assembly (GO:1904172),2,0,0.2,-, < 0.01,8.16E-01
dorsal spinal cord interneuron posterior axon guidance (GO:0097379),1,0,0.1,-, < 0.01,9.03E-01
regulation of bleb assembly (GO:1904170),2,0,0.2,-, < 0.01,8.16E-01
dorsal spinal cord interneuron axon guidance (GO:0097378),2,0,0.2,-, < 0.01,8.16E-01
spinal cord interneuron axon guidance (GO:0097377),2,0,0.2,-, < 0.01,8.16E-01
regulation of cytolysis (GO:0042268),4,0,0.41,-, < 0.01,6.66E-01
sensory neuron axon guidance (GO:0097374),3,0,0.3,-, < 0.01,7.37E-01
DNA protection (GO:0042262),5,0,0.51,-, < 0.01,6.01E-01
protein O-GlcNAcylation via threonine (GO:0097370),1,0,0.1,-, < 0.01,9.03E-01
optic placode formation involved in camera-type eye formation (GO:0046619),2,0,0.2,-, < 0.01,8.16E-01
DNA synthesis involved in UV-damage excision repair (GO:1904161),2,0,0.2,-, < 0.01,8.16E-01
establishment of Sertoli cell barrier (GO:0097368),5,0,0.51,-, < 0.01,6.01E-01
mitochondrion migration along actin filament (GO:0034642),1,0,0.1,-, < 0.01,9.03E-01
axonemal central apparatus assembly (GO:1904158),4,0,0.41,-, < 0.01,6.66E-01
DN3 thymocyte differentiation (GO:1904156),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of centrosome cycle (GO:0046606),12,0,1.22,-, < 0.01,2.95E-01
DN2 thymocyte differentiation (GO:1904155),2,0,0.2,-, < 0.01,8.16E-01
regulation of centrosome cycle (GO:0046605),46,0,4.68,-, < 0.01,9.25E-03
negative regulation of mitotic centrosome separation (GO:0046603),1,0,0.1,-, < 0.01,9.03E-01
UDP-glucosylation (GO:0097359),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of centriole replication (GO:0046601),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of centriole replication (GO:0046600),7,0,0.71,-, < 0.01,4.91E-01
establishment of planar polarity of embryonic epithelium (GO:0042249),4,0,0.41,-, < 0.01,6.66E-01
establishment of planar polarity of follicular epithelium (GO:0042247),1,0,0.1,-, < 0.01,9.03E-01
protein localization to heterochromatin (GO:0097355),1,0,0.1,-, < 0.01,9.03E-01
prenylation (GO:0097354),10,0,1.02,-, < 0.01,3.62E-01
RNA repair (GO:0042245),2,0,0.2,-, < 0.01,8.16E-01
neutrophil clearance (GO:0097350),5,0,0.51,-, < 0.01,6.01E-01
retinol transport (GO:0034633),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of microglial cell migration (GO:1904141),7,0,0.71,-, < 0.01,4.91E-01
'de novo' NAD biosynthetic process (GO:0034627),6,0,0.61,-, < 0.01,5.43E-01
ripoptosome assembly (GO:0097343),2,0,0.2,-, < 0.01,8.16E-01
inhibition of cysteine-type endopeptidase activity (GO:0097340),11,0,1.12,-, < 0.01,3.27E-01
nuclear fragmentation involved in apoptotic nuclear change (GO:0030264),1,0,0.1,-, < 0.01,9.03E-01
apoptotic chromosome condensation (GO:0030263),5,0,0.51,-, < 0.01,6.01E-01
response to antipsychotic drug (GO:0097332),2,0,0.2,-, < 0.01,8.16E-01
microglial cell migration (GO:1904124),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of otic vesicle morphogenesis (GO:1904120),1,0,0.1,-, < 0.01,9.03E-01
melanocyte adhesion (GO:0097326),1,0,0.1,-, < 0.01,9.03E-01
melanocyte proliferation (GO:0097325),3,0,0.3,-, < 0.01,7.37E-01
melanocyte migration (GO:0097324),2,0,0.2,-, < 0.01,8.16E-01
B cell adhesion (GO:0097323),2,0,0.2,-, < 0.01,8.16E-01
autophagy of peroxisome (GO:0030242),11,0,1.12,-, < 0.01,3.27E-01
skeletal muscle myosin thick filament assembly (GO:0030241),3,0,0.3,-, < 0.01,7.37E-01
ectodermal cell differentiation (GO:0010668),6,0,0.61,-, < 0.01,5.43E-01
regulation of otic vesicle morphogenesis (GO:1904118),1,0,0.1,-, < 0.01,9.03E-01
cellular response to vasopressin (GO:1904117),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cardiac muscle cell apoptotic process (GO:0010666),13,0,1.32,-, < 0.01,2.67E-01
response to vasopressin (GO:1904116),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of striated muscle cell apoptotic process (GO:0010663),13,0,1.32,-, < 0.01,2.67E-01
L-histidine transmembrane transport (GO:0089709),6,0,0.61,-, < 0.01,5.43E-01
L-histidine transmembrane export from vacuole (GO:0089708),1,0,0.1,-, < 0.01,9.03E-01
olfactory learning (GO:0008355),2,0,0.2,-, < 0.01,8.16E-01
germ cell migration (GO:0008354),6,0,0.61,-, < 0.01,5.43E-01
cap2 mRNA methylation (GO:0097310),1,0,0.1,-, < 0.01,9.03E-01
protein kinase D signaling (GO:0089700),3,0,0.3,-, < 0.01,7.37E-01
female sex determination (GO:0030237),2,0,0.2,-, < 0.01,8.16E-01
cardiac muscle cell apoptotic process (GO:0010659),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of cholesterol import (GO:1904109),1,0,0.1,-, < 0.01,9.03E-01
striated muscle cell apoptotic process (GO:0010658),6,0,0.61,-, < 0.01,5.43E-01
protein localization to ciliary inversin compartment (GO:1904108),1,0,0.1,-, < 0.01,9.03E-01
muscle cell apoptotic process (GO:0010657),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of convergent extension involved in gastrulation (GO:1904105),2,0,0.2,-, < 0.01,8.16E-01
regulation of convergent extension involved in gastrulation (GO:1904103),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cell communication by chemical coupling (GO:0010652),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of antimicrobial humoral response (GO:0008348),1,0,0.1,-, < 0.01,9.03E-01
cap1 mRNA methylation (GO:0097309),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of cell communication by electrical coupling (GO:0010650),2,0,0.2,-, < 0.01,8.16E-01
membrane to membrane docking (GO:0022614),5,0,0.51,-, < 0.01,6.01E-01
neutrophil differentiation (GO:0030223),4,0,0.41,-, < 0.01,6.66E-01
eosinophil differentiation (GO:0030222),3,0,0.3,-, < 0.01,7.37E-01
basophil differentiation (GO:0030221),2,0,0.2,-, < 0.01,8.16E-01
regulation of cell communication by chemical coupling (GO:0010645),2,0,0.2,-, < 0.01,8.16E-01
cell communication by chemical coupling (GO:0010643),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061394),2,0,0.2,-, < 0.01,8.16E-01
heparin catabolic process (GO:0030211),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mitochondrial fusion (GO:0010637),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of mitochondrial fusion (GO:0010636),3,0,0.3,-, < 0.01,7.37E-01
regulation of mitochondrial fusion (GO:0010635),12,0,1.22,-, < 0.01,2.95E-01
closure of optic fissure (GO:0061386),2,0,0.2,-, < 0.01,8.16E-01
cell migration in diencephalon (GO:0061381),1,0,0.1,-, < 0.01,9.03E-01
dermatan sulfate catabolic process (GO:0030209),1,0,0.1,-, < 0.01,9.03E-01
dermatan sulfate biosynthetic process (GO:0030208),12,0,1.22,-, < 0.01,2.95E-01
dermatan sulfate metabolic process (GO:0030205),13,0,1.32,-, < 0.01,2.67E-01
heparan sulfate proteoglycan catabolic process (GO:0030200),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of Schwann cell proliferation (GO:0010626),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of transcription by transcription factor localization (GO:0010621),3,0,0.3,-, < 0.01,7.37E-01
mammillothalamic axonal tract development (GO:0061374),1,0,0.1,-, < 0.01,9.03E-01
mammillary axonal complex development (GO:0061373),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cardiac muscle adaptation (GO:0010616),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of cardiac muscle adaptation (GO:0010615),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of cardiac muscle hypertrophy (GO:0010614),24,0,2.44,-, < 0.01,8.70E-02
regulation of cardiac muscle adaptation (GO:0010612),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of testicular blood vessel morphogenesis (GO:0061369),1,0,0.1,-, < 0.01,9.03E-01
behavioral response to formalin induced pain (GO:0061368),2,0,0.2,-, < 0.01,8.16E-01
tarsal gland development (GO:1903699),1,0,0.1,-, < 0.01,9.03E-01
regulation of mRNA stability involved in response to stress (GO:0010610),3,0,0.3,-, < 0.01,7.37E-01
behavioral response to chemical pain (GO:0061366),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of microvillus assembly (GO:1903697),1,0,0.1,-, < 0.01,9.03E-01
apoptotic process involved in luteolysis (GO:0061364),3,0,0.3,-, < 0.01,7.37E-01
optic chiasma development (GO:0061360),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of wound healing, spreading of epidermal cells (GO:1903690)",4,0,0.41,-, < 0.01,6.66E-01
mRNA localization resulting in posttranscriptional regulation of gene expression (GO:0010609),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606),6,0,0.61,-, < 0.01,5.43E-01
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of Wnt protein secretion (GO:0061358),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of Wnt protein secretion (GO:0061357),3,0,0.3,-, < 0.01,7.37E-01
regulation of Wnt protein secretion (GO:0061356),4,0,0.41,-, < 0.01,6.66E-01
Wnt protein secretion (GO:0061355),2,0,0.2,-, < 0.01,8.16E-01
planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in heart morphogenesis (GO:0061346),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cap-dependent translational initiation (GO:1903676),1,0,0.1,-, < 0.01,9.03E-01
regulation of cap-dependent translational initiation (GO:1903674),1,0,0.1,-, < 0.01,9.03E-01
mitotic cleavage furrow formation (GO:1903673),1,0,0.1,-, < 0.01,9.03E-01
non-canonical Wnt signaling pathway involved in heart development (GO:0061341),1,0,0.1,-, < 0.01,9.03E-01
lysine biosynthetic process via aminoadipic acid (GO:0019878),2,0,0.2,-, < 0.01,8.16E-01
behavioral response to nicotine (GO:0035095),7,0,0.71,-, < 0.01,4.91E-01
"spermatogenesis, exchange of chromosomal proteins (GO:0035093)",7,0,0.71,-, < 0.01,4.91E-01
sperm chromatin condensation (GO:0035092),11,0,1.12,-, < 0.01,3.27E-01
positive regulation of complement-dependent cytotoxicity (GO:1903661),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of complement-dependent cytotoxicity (GO:1903660),3,0,0.3,-, < 0.01,7.37E-01
siRNA loading onto RISC involved in RNA interference (GO:0035087),3,0,0.3,-, < 0.01,7.37E-01
regulation of complement-dependent cytotoxicity (GO:1903659),7,0,0.71,-, < 0.01,4.91E-01
cell proliferation involved in outflow tract morphogenesis (GO:0061325),1,0,0.1,-, < 0.01,9.03E-01
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324),1,0,0.1,-, < 0.01,9.03E-01
cell proliferation involved in heart morphogenesis (GO:0061323),1,0,0.1,-, < 0.01,9.03E-01
uracil metabolic process (GO:0019860),3,0,0.3,-, < 0.01,7.37E-01
thymine metabolic process (GO:0019859),3,0,0.3,-, < 0.01,7.37E-01
cytosine metabolic process (GO:0019858),2,0,0.2,-, < 0.01,8.16E-01
5-methylcytosine metabolic process (GO:0019857),3,0,0.3,-, < 0.01,7.37E-01
pyrimidine nucleobase biosynthetic process (GO:0019856),7,0,0.71,-, < 0.01,4.91E-01
L-ascorbic acid biosynthetic process (GO:0019853),2,0,0.2,-, < 0.01,8.16E-01
L-ascorbic acid metabolic process (GO:0019852),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of chaperone-mediated protein folding (GO:1903645),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of gastrin-induced gastric acid secretion (GO:1903640),1,0,0.1,-, < 0.01,9.03E-01
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309),5,0,0.51,-, < 0.01,6.01E-01
regulation of gastrin-induced gastric acid secretion (GO:1903639),1,0,0.1,-, < 0.01,9.03E-01
cardiac neural crest cell development involved in heart development (GO:0061308),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638),1,0,0.1,-, < 0.01,9.03E-01
cardiac neural crest cell differentiation involved in heart development (GO:0061307),8,0,0.81,-, < 0.01,4.43E-01
nuclear speck organization (GO:0035063),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein insertion into mitochondrial outer membrane (GO:1903636),1,0,0.1,-, < 0.01,9.03E-01
retinal blood vessel morphogenesis (GO:0061304),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of leucine-tRNA ligase activity (GO:1903634),1,0,0.1,-, < 0.01,9.03E-01
regulation of leucine-tRNA ligase activity (GO:1903633),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632),1,0,0.1,-, < 0.01,9.03E-01
cerebellum vasculature morphogenesis (GO:0061301),1,0,0.1,-, < 0.01,9.03E-01
cerebellum vasculature development (GO:0061300),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of aminoacyl-tRNA ligase activity (GO:1903631),1,0,0.1,-, < 0.01,9.03E-01
regulation of aminoacyl-tRNA ligase activity (GO:1903630),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of dUTP diphosphatase activity (GO:1903629),1,0,0.1,-, < 0.01,9.03E-01
regulation of dUTP diphosphatase activity (GO:1903627),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of DNA catabolic process (GO:1903625),3,0,0.3,-, < 0.01,7.37E-01
protein localization to photoreceptor connecting cilium (GO:1903621),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transdifferentiation (GO:1903620),1,0,0.1,-, < 0.01,9.03E-01
regulation of transdifferentiation (GO:1903618),1,0,0.1,-, < 0.01,9.03E-01
"fertilization, exchange of chromosomal proteins (GO:0035042)",1,0,0.1,-, < 0.01,9.03E-01
sperm chromatin decondensation (GO:0035041),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein tyrosine phosphatase activity (GO:1903615),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of calcium-dependent ATPase activity (GO:1903612),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of calcium-dependent ATPase activity (GO:1903611),1,0,0.1,-, < 0.01,9.03E-01
regulation of calcium-dependent ATPase activity (GO:1903610),2,0,0.2,-, < 0.01,8.16E-01
male pronucleus assembly (GO:0035039),2,0,0.2,-, < 0.01,8.16E-01
female pronucleus assembly (GO:0035038),1,0,0.1,-, < 0.01,9.03E-01
sperm entry (GO:0035037),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of inward rectifier potassium channel activity (GO:1903609),1,0,0.1,-, < 0.01,9.03E-01
quinolinate biosynthetic process (GO:0019805),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of Rac protein signal transduction (GO:0035021),3,0,0.3,-, < 0.01,7.37E-01
neural plate regionalization (GO:0060897),4,0,0.41,-, < 0.01,6.66E-01
neural plate pattern specification (GO:0060896),6,0,0.61,-, < 0.01,5.43E-01
limb epidermis development (GO:0060887),1,0,0.1,-, < 0.01,9.03E-01
neuronal signal transduction (GO:0023041),5,0,0.51,-, < 0.01,6.01E-01
lateral semicircular canal development (GO:0060875),1,0,0.1,-, < 0.01,9.03E-01
anterior semicircular canal development (GO:0060873),1,0,0.1,-, < 0.01,9.03E-01
regulation of centriole replication (GO:0046599),18,0,1.83,-, < 0.01,1.60E-01
positive regulation of viral entry into host cell (GO:0046598),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of calcium-dependent cell-cell adhesion (GO:0046588),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587),1,0,0.1,-, < 0.01,9.03E-01
regulation of calcium-dependent cell-cell adhesion (GO:0046586),2,0,0.2,-, < 0.01,8.16E-01
signal transduction by trans-phosphorylation (GO:0023016),3,0,0.3,-, < 0.01,7.37E-01
establishment of glial blood-brain barrier (GO:0060857),2,0,0.2,-, < 0.01,8.16E-01
establishment of blood-brain barrier (GO:0060856),10,0,1.02,-, < 0.01,3.62E-01
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription involved in cell fate commitment (GO:0060850),13,0,1.32,-, < 0.01,2.67E-01
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433),8,0,0.81,-, < 0.01,4.43E-01
growth plate cartilage chondrocyte development (GO:0003431),5,0,0.51,-, < 0.01,6.01E-01
growth plate cartilage chondrocyte growth (GO:0003430),3,0,0.3,-, < 0.01,7.37E-01
regulation of transcription involved in lymphatic endothelial cell fate commitment (GO:0060849),2,0,0.2,-, < 0.01,8.16E-01
endothelial cell fate specification (GO:0060847),3,0,0.3,-, < 0.01,7.37E-01
blood vessel endothelial cell fate commitment (GO:0060846),3,0,0.3,-, < 0.01,7.37E-01
arterial endothelial cell fate commitment (GO:0060844),2,0,0.2,-, < 0.01,8.16E-01
venous endothelial cell differentiation (GO:0060843),1,0,0.1,-, < 0.01,9.03E-01
arterial endothelial cell differentiation (GO:0060842),6,0,0.61,-, < 0.01,5.43E-01
growth plate cartilage chondrocyte morphogenesis (GO:0003429),1,0,0.1,-, < 0.01,9.03E-01
growth plate cartilage morphogenesis (GO:0003422),2,0,0.2,-, < 0.01,8.16E-01
growth plate cartilage axis specification (GO:0003421),1,0,0.1,-, < 0.01,9.03E-01
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420),1,0,0.1,-, < 0.01,9.03E-01
endothelial cell fate commitment (GO:0060839),7,0,0.71,-, < 0.01,4.91E-01
lymphatic endothelial cell fate commitment (GO:0060838),3,0,0.3,-, < 0.01,7.37E-01
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831),7,0,0.71,-, < 0.01,4.91E-01
growth plate cartilage chondrocyte proliferation (GO:0003419),2,0,0.2,-, < 0.01,8.16E-01
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830),3,0,0.3,-, < 0.01,7.37E-01
growth plate cartilage chondrocyte differentiation (GO:0003418),8,0,0.81,-, < 0.01,4.43E-01
growth plate cartilage development (GO:0003417),16,0,1.63,-, < 0.01,1.96E-01
chondrocyte hypertrophy (GO:0003415),4,0,0.41,-, < 0.01,6.66E-01
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414),1,0,0.1,-, < 0.01,9.03E-01
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413),12,0,1.22,-, < 0.01,2.95E-01
hydroxyproline transport (GO:0034589),1,0,0.1,-, < 0.01,9.03E-01
halogenated hydrocarbon metabolic process (GO:0042197),2,0,0.2,-, < 0.01,8.16E-01
chlorinated hydrocarbon metabolic process (GO:0042196),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1,0,0.1,-, < 0.01,9.03E-01
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827),1,0,0.1,-, < 0.01,9.03E-01
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825),1,0,0.1,-, < 0.01,9.03E-01
inactivation of X chromosome by DNA methylation (GO:0060821),1,0,0.1,-, < 0.01,9.03E-01
inactivation of X chromosome by heterochromatin assembly (GO:0060820),1,0,0.1,-, < 0.01,9.03E-01
optic cup formation involved in camera-type eye development (GO:0003408),3,0,0.3,-, < 0.01,7.37E-01
planar cell polarity pathway involved in axis elongation (GO:0003402),3,0,0.3,-, < 0.01,7.37E-01
regulation of COPII vesicle coating (GO:0003400),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of autophagic cell death (GO:1904093),2,0,0.2,-, < 0.01,8.16E-01
development of secondary male sexual characteristics (GO:0046544),1,0,0.1,-, < 0.01,9.03E-01
regulation of autophagic cell death (GO:1904092),5,0,0.51,-, < 0.01,6.01E-01
saliva secretion (GO:0046541),5,0,0.51,-, < 0.01,6.01E-01
regulation of nucleus size (GO:0097298),1,0,0.1,-, < 0.01,9.03E-01
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),4,0,0.41,-, < 0.01,6.66E-01
inactivation of X chromosome by genetic imprinting (GO:0060819),2,0,0.2,-, < 0.01,8.16E-01
inactivation of paternal X chromosome (GO:0060817),1,0,0.1,-, < 0.01,9.03E-01
random inactivation of X chromosome (GO:0060816),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of photoreceptor cell differentiation (GO:0046533),5,0,0.51,-, < 0.01,6.01E-01
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809),2,0,0.2,-, < 0.01,8.16E-01
immune complex formation (GO:0097281),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification (GO:0060807),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell differentiation involved in embryonic placenta development (GO:0060800),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of trophectodermal cell proliferation (GO:1904075),1,0,0.1,-, < 0.01,9.03E-01
regulation of trophectodermal cell proliferation (GO:1904073),1,0,0.1,-, < 0.01,9.03E-01
presynaptic active zone assembly (GO:1904071),3,0,0.3,-, < 0.01,7.37E-01
complement-dependent cytotoxicity (GO:0097278),2,0,0.2,-, < 0.01,8.16E-01
sphingoid catabolic process (GO:0046521),1,0,0.1,-, < 0.01,9.03E-01
mitochondrial respiratory chain complex II assembly (GO:0034553),3,0,0.3,-, < 0.01,7.37E-01
respiratory chain complex II assembly (GO:0034552),3,0,0.3,-, < 0.01,7.37E-01
sphinganine biosynthetic process (GO:0046511),2,0,0.2,-, < 0.01,8.16E-01
lipoprotein catabolic process (GO:0042159),15,0,1.52,-, < 0.01,2.17E-01
self proteolysis (GO:0097264),7,0,0.71,-, < 0.01,4.91E-01
melatonin biosynthetic process (GO:0030187),1,0,0.1,-, < 0.01,9.03E-01
melatonin metabolic process (GO:0030186),1,0,0.1,-, < 0.01,9.03E-01
regulation of locomotor rhythm (GO:1904059),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of sensory perception of pain (GO:1904058),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of sensory perception of pain (GO:1904057),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cholangiocyte proliferation (GO:1904056),2,0,0.2,-, < 0.01,8.16E-01
regulation of cholangiocyte proliferation (GO:1904054),3,0,0.3,-, < 0.01,7.37E-01
glycerol ether biosynthetic process (GO:0046504),9,0,0.91,-, < 0.01,4.00E-01
uroporphyrinogen III metabolic process (GO:0046502),2,0,0.2,-, < 0.01,8.16E-01
intracellular mRNA localization (GO:0008298),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of spontaneous neurotransmitter secretion (GO:1904050),1,0,0.1,-, < 0.01,9.03E-01
strand invasion (GO:0042148),3,0,0.3,-, < 0.01,7.37E-01
renal tubular secretion (GO:0097254),1,0,0.1,-, < 0.01,9.03E-01
oligodendrocyte apoptotic process (GO:0097252),2,0,0.2,-, < 0.01,8.16E-01
late meiotic recombination nodule assembly (GO:0042140),1,0,0.1,-, < 0.01,9.03E-01
regulation of DNA-dependent DNA replication initiation (GO:0030174),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of spontaneous neurotransmitter secretion (GO:1904049),1,0,0.1,-, < 0.01,9.03E-01
regulation of spontaneous neurotransmitter secretion (GO:1904048),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of vascular endothelial growth factor production (GO:1904046),2,0,0.2,-, < 0.01,8.16E-01
cellular response to aldosterone (GO:1904045),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of lamellipodium assembly (GO:0010593),3,0,0.3,-, < 0.01,7.37E-01
meiotic DNA double-strand break formation (GO:0042138),2,0,0.2,-, < 0.01,8.16E-01
sequestering of neurotransmitter (GO:0042137),2,0,0.2,-, < 0.01,8.16E-01
neurotransmitter catabolic process (GO:0042135),10,0,1.02,-, < 0.01,3.62E-01
chromosome attachment to the nuclear envelope (GO:0097240),3,0,0.3,-, < 0.01,7.37E-01
proteoglycan catabolic process (GO:0030167),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of iron export across plasma membrane (GO:1904039),1,0,0.1,-, < 0.01,9.03E-01
regulation of iron export across plasma membrane (GO:1904038),1,0,0.1,-, < 0.01,9.03E-01
glutamine secretion (GO:0010585),1,0,0.1,-, < 0.01,9.03E-01
nitrate metabolic process (GO:0042126),4,0,0.41,-, < 0.01,6.66E-01
response to vitamin B6 (GO:0034516),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of collagen fibril organization (GO:1904028),2,0,0.2,-, < 0.01,8.16E-01
regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024),3,0,0.3,-, < 0.01,7.37E-01
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of platelet activation (GO:0010572),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of G protein-coupled receptor internalization (GO:1904022),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of G protein-coupled receptor internalization (GO:1904021),2,0,0.2,-, < 0.01,8.16E-01
regulation of G protein-coupled receptor internalization (GO:1904020),4,0,0.41,-, < 0.01,6.66E-01
monocyte activation (GO:0042117),10,0,1.02,-, < 0.01,3.62E-01
mitochondrial mRNA polyadenylation (GO:0097222),1,0,0.1,-, < 0.01,9.03E-01
protein localization to kinetochore (GO:0034501),11,0,1.12,-, < 0.01,3.27E-01
response to Aroclor 1254 (GO:1904010),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cytokine biosynthetic process (GO:0042108),3,0,0.3,-, < 0.01,7.37E-01
cytokine metabolic process (GO:0042107),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of lysosomal membrane permeability (GO:0097214),2,0,0.2,-, < 0.01,8.16E-01
regulation of lysosomal membrane permeability (GO:0097213),3,0,0.3,-, < 0.01,7.37E-01
lysosomal membrane organization (GO:0097212),4,0,0.41,-, < 0.01,6.66E-01
cellular response to monosodium glutamate (GO:1904009),1,0,0.1,-, < 0.01,9.03E-01
tRNA threonylcarbamoyladenosine modification (GO:0002949),3,0,0.3,-, < 0.01,7.37E-01
response to monosodium glutamate (GO:1904008),2,0,0.2,-, < 0.01,8.16E-01
tRNA C5-cytosine methylation (GO:0002946),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of eating behavior (GO:1904000),4,0,0.41,-, < 0.01,6.66E-01
myotube differentiation involved in skeletal muscle regeneration (GO:0014908),5,0,0.51,-, < 0.01,6.01E-01
myoblast fusion involved in skeletal muscle regeneration (GO:0014905),3,0,0.3,-, < 0.01,7.37E-01
muscle hyperplasia (GO:0014900),2,0,0.2,-, < 0.01,8.16E-01
tRNA N1-guanine methylation (GO:0002939),2,0,0.2,-, < 0.01,8.16E-01
trabecular meshwork development (GO:0002930),2,0,0.2,-, < 0.01,8.16E-01
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290),2,0,0.2,-, < 0.01,8.16E-01
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926),2,0,0.2,-, < 0.01,8.16E-01
Wnt signaling pathway involved in kidney development (GO:0061289),2,0,0.2,-, < 0.01,8.16E-01
opsonization (GO:0008228),9,0,0.91,-, < 0.01,4.00E-01
vasopressin secretion (GO:0030103),2,0,0.2,-, < 0.01,8.16E-01
"negative regulation of transposition, RNA-mediated (GO:0010526)",1,0,0.1,-, < 0.01,9.03E-01
"regulation of transposition, RNA-mediated (GO:0010525)",1,0,0.1,-, < 0.01,9.03E-01
positive regulation of lymphocyte anergy (GO:0002913),4,0,0.41,-, < 0.01,6.66E-01
regulation of lymphocyte anergy (GO:0002911),7,0,0.71,-, < 0.01,4.91E-01
regulation of reciprocal meiotic recombination (GO:0010520),4,0,0.41,-, < 0.01,6.66E-01
spermine metabolic process (GO:0008215),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of B cell apoptotic process (GO:0002904),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of gap junction assembly (GO:1903598),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of gap junction assembly (GO:1903597),2,0,0.2,-, < 0.01,8.16E-01
regulation of gap junction assembly (GO:1903596),5,0,0.51,-, < 0.01,6.01E-01
polyamine homeostasis (GO:0010509),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of histone deubiquitination (GO:1903586),1,0,0.1,-, < 0.01,9.03E-01
regulation of histone deubiquitination (GO:1903584),1,0,0.1,-, < 0.01,9.03E-01
response to L-arginine (GO:1903576),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein kinase D signaling (GO:1903572),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein kinase D signaling (GO:1903570),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of protein localization to ciliary membrane (GO:1903569),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein localization to ciliary membrane (GO:1903568),1,0,0.1,-, < 0.01,9.03E-01
regulation of protein localization to ciliary membrane (GO:1903567),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of protein localization to cilium (GO:1903566),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of protein localization to cilium (GO:1903565),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein localization to cilium (GO:1903564),7,0,0.71,-, < 0.01,4.91E-01
pattern specification involved in mesonephros development (GO:0061227),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of extracellular exosome assembly (GO:1903553),4,0,0.41,-, < 0.01,6.66E-01
regulation of extracellular exosome assembly (GO:1903551),6,0,0.61,-, < 0.01,5.43E-01
regulation of growth hormone activity (GO:1903547),1,0,0.1,-, < 0.01,9.03E-01
protein localization to photoreceptor outer segment (GO:1903546),5,0,0.51,-, < 0.01,6.01E-01
cellular response to butyrate (GO:1903545),1,0,0.1,-, < 0.01,9.03E-01
response to butyrate (GO:1903544),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of exosomal secretion (GO:1903542),2,0,0.2,-, < 0.01,8.16E-01
regulation of isoprenoid metabolic process (GO:0019747),3,0,0.3,-, < 0.01,7.37E-01
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538),2,0,0.2,-, < 0.01,8.16E-01
paramesonephric duct development (GO:0061205),4,0,0.41,-, < 0.01,6.66E-01
pentacyclic triterpenoid metabolic process (GO:0019742),1,0,0.1,-, < 0.01,9.03E-01
nitrogen utilization (GO:0019740),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of single strand break repair (GO:1903517),1,0,0.1,-, < 0.01,9.03E-01
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515),2,0,0.2,-, < 0.01,8.16E-01
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),8,0,0.81,-, < 0.01,4.43E-01
endoplasmic reticulum to cytosol transport (GO:1903513),17,0,1.73,-, < 0.01,1.77E-01
phytanic acid metabolic process (GO:1903512),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitotic spindle checkpoint (GO:1903504),14,0,1.42,-, < 0.01,2.41E-01
apical constriction (GO:0003383),4,0,0.41,-, < 0.01,6.66E-01
regulation of transcription involved in primary germ layer cell fate commitment (GO:0060796),1,0,0.1,-, < 0.01,9.03E-01
cellular response to camptothecin (GO:0072757),4,0,0.41,-, < 0.01,6.66E-01
cellular response to benomyl (GO:0072755),1,0,0.1,-, < 0.01,9.03E-01
cellular response to rapamycin (GO:0072752),2,0,0.2,-, < 0.01,8.16E-01
cellular response to leptomycin B (GO:0072750),2,0,0.2,-, < 0.01,8.16E-01
hair follicle placode formation (GO:0060789),5,0,0.51,-, < 0.01,6.01E-01
regulation of apoptosis involved in tissue homeostasis (GO:0060785),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell proliferation involved in tissue homeostasis (GO:0060784),1,0,0.1,-, < 0.01,9.03E-01
cellular response to cytochalasin B (GO:0072749),1,0,0.1,-, < 0.01,9.03E-01
cellular response to anisomycin (GO:0072740),1,0,0.1,-, < 0.01,9.03E-01
planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775),2,0,0.2,-, < 0.01,8.16E-01
noradrenergic neuron fate commitment (GO:0003359),1,0,0.1,-, < 0.01,9.03E-01
noradrenergic neuron development (GO:0003358),2,0,0.2,-, < 0.01,8.16E-01
noradrenergic neuron differentiation (GO:0003357),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of cilium movement (GO:0003354),3,0,0.3,-, < 0.01,7.37E-01
S-adenosylmethioninamine metabolic process (GO:0046499),1,0,0.1,-, < 0.01,9.03E-01
S-adenosylhomocysteine metabolic process (GO:0046498),3,0,0.3,-, < 0.01,7.37E-01
pulmonary myocardium development (GO:0003350),2,0,0.2,-, < 0.01,8.16E-01
nicotinamide nucleotide metabolic process (GO:0046496),30,0,3.05,-, < 0.01,4.72E-02
response to anisomycin (GO:0072739),1,0,0.1,-, < 0.01,9.03E-01
cellular response to diamide (GO:0072738),2,0,0.2,-, < 0.01,8.16E-01
response to diamide (GO:0072737),2,0,0.2,-, < 0.01,8.16E-01
L-methylmalonyl-CoA metabolic process (GO:0046491),1,0,0.1,-, < 0.01,9.03E-01
cellular response to staurosporine (GO:0072734),4,0,0.41,-, < 0.01,6.66E-01
isopentenyl diphosphate metabolic process (GO:0046490),5,0,0.51,-, < 0.01,6.01E-01
response to staurosporine (GO:0072733),4,0,0.41,-, < 0.01,6.66E-01
epithelial cell proliferation involved in prostate gland development (GO:0060767),1,0,0.1,-, < 0.01,9.03E-01
cell-cell signaling involved in mammary gland development (GO:0060764),1,0,0.1,-, < 0.01,9.03E-01
mammary duct terminal end bud growth (GO:0060763),4,0,0.41,-, < 0.01,6.66E-01
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762),5,0,0.51,-, < 0.01,6.01E-01
cardiac endothelial cell differentiation (GO:0003348),6,0,0.61,-, < 0.01,5.43E-01
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345),1,0,0.1,-, < 0.01,9.03E-01
pericardium morphogenesis (GO:0003344),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340),2,0,0.2,-, < 0.01,8.16E-01
ether lipid metabolic process (GO:0046485),16,0,1.63,-, < 0.01,1.96E-01
negative regulation of mast cell chemotaxis (GO:0060755),1,0,0.1,-, < 0.01,9.03E-01
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339),7,0,0.71,-, < 0.01,4.91E-01
corneocyte desquamation (GO:0003336),1,0,0.1,-, < 0.01,9.03E-01
corneocyte development (GO:0003335),3,0,0.3,-, < 0.01,7.37E-01
keratinocyte development (GO:0003334),12,0,1.22,-, < 0.01,2.95E-01
negative regulation of extracellular matrix constituent secretion (GO:0003332),4,0,0.41,-, < 0.01,6.66E-01
lactosylceramide metabolic process (GO:0046478),1,0,0.1,-, < 0.01,9.03E-01
glycosylceramide catabolic process (GO:0046477),6,0,0.61,-, < 0.01,5.43E-01
cellular response to cisplatin (GO:0072719),6,0,0.61,-, < 0.01,5.43E-01
response to cisplatin (GO:0072718),8,0,0.81,-, < 0.01,4.43E-01
cellular response to actinomycin D (GO:0072717),3,0,0.3,-, < 0.01,7.37E-01
response to actinomycin D (GO:0072716),3,0,0.3,-, < 0.01,7.37E-01
cellular response to selenite ion (GO:0072715),1,0,0.1,-, < 0.01,9.03E-01
response to selenite ion (GO:0072714),1,0,0.1,-, < 0.01,9.03E-01
cellular response to hydroxyurea (GO:0072711),12,0,1.22,-, < 0.01,2.95E-01
response to hydroxyurea (GO:0072710),12,0,1.22,-, < 0.01,2.95E-01
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748),3,0,0.3,-, < 0.01,7.37E-01
epithelial cell maturation involved in prostate gland development (GO:0060743),2,0,0.2,-, < 0.01,8.16E-01
prostate gland stromal morphogenesis (GO:0060741),3,0,0.3,-, < 0.01,7.37E-01
pancreatic PP cell fate commitment (GO:0003329),2,0,0.2,-, < 0.01,8.16E-01
type B pancreatic cell fate commitment (GO:0003327),1,0,0.1,-, < 0.01,9.03E-01
pancreatic A cell fate commitment (GO:0003326),2,0,0.2,-, < 0.01,8.16E-01
pancreatic A cell development (GO:0003322),1,0,0.1,-, < 0.01,9.03E-01
platelet activating factor metabolic process (GO:0046469),8,0,0.81,-, < 0.01,4.43E-01
cellular response to sorbitol (GO:0072709),3,0,0.3,-, < 0.01,7.37E-01
response to sorbitol (GO:0072708),4,0,0.41,-, < 0.01,6.66E-01
monoacylglycerol metabolic process (GO:0046462),10,0,1.02,-, < 0.01,3.62E-01
cellular response to methyl methanesulfonate (GO:0072703),1,0,0.1,-, < 0.01,9.03E-01
early endosome to Golgi transport (GO:0034498),7,0,0.71,-, < 0.01,4.91E-01
response to methyl methanesulfonate (GO:0072702),1,0,0.1,-, < 0.01,9.03E-01
mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739),1,0,0.1,-, < 0.01,9.03E-01
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735),1,0,0.1,-, < 0.01,9.03E-01
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of intestinal epithelial structure maintenance (GO:0060731),1,0,0.1,-, < 0.01,9.03E-01
regulation of intestinal epithelial structure maintenance (GO:0060730),2,0,0.2,-, < 0.01,8.16E-01
cell migration to the midline involved in heart development (GO:0003318),1,0,0.1,-, < 0.01,9.03E-01
pancreatic PP cell differentiation (GO:0003312),2,0,0.2,-, < 0.01,8.16E-01
short-chain fatty acid metabolic process (GO:0046459),16,0,1.63,-, < 0.01,1.96E-01
pancreatic D cell differentiation (GO:0003311),1,0,0.1,-, < 0.01,9.03E-01
pancreatic A cell differentiation (GO:0003310),6,0,0.61,-, < 0.01,5.43E-01
hexadecanal metabolic process (GO:0046458),1,0,0.1,-, < 0.01,9.03E-01
dihydrofolate metabolic process (GO:0046452),3,0,0.3,-, < 0.01,7.37E-01
vacuolar transmembrane transport (GO:0034486),2,0,0.2,-, < 0.01,8.16E-01
intestinal epithelial structure maintenance (GO:0060729),5,0,0.51,-, < 0.01,6.01E-01
type 2 immune response (GO:0042092),10,0,1.02,-, < 0.01,3.62E-01
creatinine metabolic process (GO:0046449),1,0,0.1,-, < 0.01,9.03E-01
tropane alkaloid metabolic process (GO:0046448),1,0,0.1,-, < 0.01,9.03E-01
FMN metabolic process (GO:0046444),1,0,0.1,-, < 0.01,9.03E-01
FAD metabolic process (GO:0046443),1,0,0.1,-, < 0.01,9.03E-01
L-lysine metabolic process (GO:0046440),4,0,0.41,-, < 0.01,6.66E-01
cytokine biosynthetic process (GO:0042089),4,0,0.41,-, < 0.01,6.66E-01
phosphatidylglycerol catabolic process (GO:0034478),1,0,0.1,-, < 0.01,9.03E-01
U6 snRNA 3'-end processing (GO:0034477),2,0,0.2,-, < 0.01,8.16E-01
U5 snRNA 3'-end processing (GO:0034476),3,0,0.3,-, < 0.01,7.37E-01
U2 snRNA 3'-end processing (GO:0034474),1,0,0.1,-, < 0.01,9.03E-01
U1 snRNA 3'-end processing (GO:0034473),3,0,0.3,-, < 0.01,7.37E-01
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715),3,0,0.3,-, < 0.01,7.37E-01
spongiotrophoblast layer development (GO:0060712),1,0,0.1,-, < 0.01,9.03E-01
cardiac muscle hypertrophy in response to stress (GO:0014898),13,0,1.32,-, < 0.01,2.67E-01
smooth muscle hypertrophy (GO:0014895),1,0,0.1,-, < 0.01,9.03E-01
response to denervation involved in regulation of muscle adaptation (GO:0014894),10,0,1.02,-, < 0.01,3.62E-01
striated muscle atrophy (GO:0014891),8,0,0.81,-, < 0.01,4.43E-01
L-cysteine metabolic process (GO:0046439),4,0,0.41,-, < 0.01,6.66E-01
D-amino acid biosynthetic process (GO:0046437),1,0,0.1,-, < 0.01,9.03E-01
germ-line stem cell division (GO:0042078),4,0,0.41,-, < 0.01,6.66E-01
trophoblast giant cell differentiation (GO:0060707),14,0,1.42,-, < 0.01,2.41E-01
90S preribosome assembly (GO:0034463),1,0,0.1,-, < 0.01,9.03E-01
small-subunit processome assembly (GO:0034462),3,0,0.3,-, < 0.01,7.37E-01
muscle atrophy (GO:0014889),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of endoribonuclease activity (GO:0060702),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of ribonuclease activity (GO:0060701),2,0,0.2,-, < 0.01,8.16E-01
regulation of ribonuclease activity (GO:0060700),9,0,0.91,-, < 0.01,4.00E-01
cardiac muscle adaptation (GO:0014887),13,0,1.32,-, < 0.01,2.67E-01
transition between slow and fast fiber (GO:0014886),1,0,0.1,-, < 0.01,9.03E-01
transition between fast and slow fiber (GO:0014883),6,0,0.61,-, < 0.01,5.43E-01
epoxide metabolic process (GO:0097176),5,0,0.51,-, < 0.01,6.01E-01
microtubule anchoring at centrosome (GO:0034454),9,0,0.91,-, < 0.01,4.00E-01
microtubule anchoring (GO:0034453),22,0,2.24,-, < 0.01,1.07E-01
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878),3,0,0.3,-, < 0.01,7.37E-01
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877),10,0,1.02,-, < 0.01,3.62E-01
response to injury involved in regulation of muscle adaptation (GO:0014876),1,0,0.1,-, < 0.01,9.03E-01
response to stimulus involved in regulation of muscle adaptation (GO:0014874),15,0,1.52,-, < 0.01,2.17E-01
response to muscle activity involved in regulation of muscle adaptation (GO:0014873),3,0,0.3,-, < 0.01,7.37E-01
response to muscle inactivity (GO:0014870),10,0,1.02,-, < 0.01,3.62E-01
mesenchymal stem cell proliferation (GO:0097168),1,0,0.1,-, < 0.01,9.03E-01
circadian regulation of translation (GO:0097167),4,0,0.41,-, < 0.01,6.66E-01
very-low-density lipoprotein particle clearance (GO:0034447),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of plasma lipoprotein oxidation (GO:0034445),2,0,0.2,-, < 0.01,8.16E-01
regulation of plasma lipoprotein oxidation (GO:0034444),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lipoprotein oxidation (GO:0034443),1,0,0.1,-, < 0.01,9.03E-01
regulation of lipoprotein oxidation (GO:0034442),2,0,0.2,-, < 0.01,8.16E-01
plasma lipoprotein particle oxidation (GO:0034441),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862),2,0,0.2,-, < 0.01,8.16E-01
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of central B cell tolerance induction (GO:0002897),1,0,0.1,-, < 0.01,9.03E-01
regulation of central B cell tolerance induction (GO:0002895),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of type II hypersensitivity (GO:0002894),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of type II hypersensitivity (GO:0002893),1,0,0.1,-, < 0.01,9.03E-01
regulation of type II hypersensitivity (GO:0002892),4,0,0.41,-, < 0.01,6.66E-01
fasciculation of motor neuron axon (GO:0097156),2,0,0.2,-, < 0.01,8.16E-01
olfactory behavior (GO:0042048),9,0,0.91,-, < 0.01,4.00E-01
fasciculation of sensory neuron axon (GO:0097155),3,0,0.3,-, < 0.01,7.37E-01
GABAergic neuron differentiation (GO:0097154),13,0,1.32,-, < 0.01,2.67E-01
mesenchymal cell apoptotic process (GO:0097152),2,0,0.2,-, < 0.01,8.16E-01
metal incorporation into metallo-molybdopterin complex (GO:0042040),1,0,0.1,-, < 0.01,9.03E-01
skeletal muscle cell proliferation (GO:0014856),1,0,0.1,-, < 0.01,9.03E-01
response to inactivity (GO:0014854),13,0,1.32,-, < 0.01,2.67E-01
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853),1,0,0.1,-, < 0.01,9.03E-01
insulin processing (GO:0030070),3,0,0.3,-, < 0.01,7.37E-01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852),1,0,0.1,-, < 0.01,9.03E-01
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),19,0,1.93,-, < 0.01,1.45E-01
negative regulation of hypersensitivity (GO:0002884),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882),1,0,0.1,-, < 0.01,9.03E-01
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880),1,0,0.1,-, < 0.01,9.03E-01
"peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)",1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytokine biosynthetic process (GO:0042036),5,0,0.51,-, < 0.01,6.01E-01
chemokine biosynthetic process (GO:0042033),1,0,0.1,-, < 0.01,9.03E-01
ureter smooth muscle contraction (GO:0014849),2,0,0.2,-, < 0.01,8.16E-01
esophagus smooth muscle contraction (GO:0014846),2,0,0.2,-, < 0.01,8.16E-01
skeletal muscle satellite cell proliferation (GO:0014841),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878),1,0,0.1,-, < 0.01,9.03E-01
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875),1,0,0.1,-, < 0.01,9.03E-01
regulation of epidermal cell division (GO:0010482),3,0,0.3,-, < 0.01,7.37E-01
epidermal cell division (GO:0010481),1,0,0.1,-, < 0.01,9.03E-01
"tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)",1,0,0.1,-, < 0.01,9.03E-01
DNA endoreduplication (GO:0042023),1,0,0.1,-, < 0.01,9.03E-01
myoblast migration involved in skeletal muscle regeneration (GO:0014839),4,0,0.41,-, < 0.01,6.66E-01
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835),1,0,0.1,-, < 0.01,9.03E-01
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834),4,0,0.41,-, < 0.01,6.66E-01
response to sulfur dioxide (GO:0010477),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),6,0,0.61,-, < 0.01,5.43E-01
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402),2,0,0.2,-, < 0.01,8.16E-01
actin modification (GO:0030047),3,0,0.3,-, < 0.01,7.37E-01
actin filament fragmentation (GO:0030043),4,0,0.41,-, < 0.01,6.66E-01
artery smooth muscle contraction (GO:0014824),9,0,0.91,-, < 0.01,4.00E-01
detection of wounding (GO:0014822),1,0,0.1,-, < 0.01,9.03E-01
tonic smooth muscle contraction (GO:0014820),10,0,1.02,-, < 0.01,3.62E-01
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859),2,0,0.2,-, < 0.01,8.16E-01
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),8,0,0.81,-, < 0.01,4.43E-01
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856),2,0,0.2,-, < 0.01,8.16E-01
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854),2,0,0.2,-, < 0.01,8.16E-01
postsynaptic density protein 95 clustering (GO:0097119),6,0,0.61,-, < 0.01,5.43E-01
regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852),2,0,0.2,-, < 0.01,8.16E-01
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of peripheral T cell tolerance induction (GO:0002851),1,0,0.1,-, < 0.01,9.03E-01
guanylate kinase-associated protein clustering (GO:0097117),2,0,0.2,-, < 0.01,8.16E-01
gephyrin clustering involved in postsynaptic density assembly (GO:0097116),4,0,0.41,-, < 0.01,6.66E-01
neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1,0,0.1,-, < 0.01,9.03E-01
NMDA glutamate receptor clustering (GO:0097114),5,0,0.51,-, < 0.01,6.01E-01
AMPA glutamate receptor clustering (GO:0097113),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of translational initiation by iron (GO:0045994),2,0,0.2,-, < 0.01,8.16E-01
gamma-aminobutyric acid receptor clustering (GO:0097112),5,0,0.51,-, < 0.01,6.01E-01
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of embryonic development (GO:0045992),2,0,0.2,-, < 0.01,8.16E-01
carbon catabolite activation of transcription (GO:0045991),5,0,0.51,-, < 0.01,6.01E-01
carbon catabolite regulation of transcription (GO:0045990),5,0,0.51,-, < 0.01,6.01E-01
translocation of peptides or proteins into host (GO:0042000),1,0,0.1,-, < 0.01,9.03E-01
actin filament reorganization involved in cell cycle (GO:0030037),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle contraction (GO:0014819),13,0,1.32,-, < 0.01,2.67E-01
skeletal muscle satellite cell differentiation (GO:0014816),4,0,0.41,-, < 0.01,6.66E-01
microvillar actin bundle assembly (GO:0030034),1,0,0.1,-, < 0.01,9.03E-01
skeletal muscle satellite cell commitment (GO:0014813),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of heart rate (GO:0010459),11,0,1.12,-, < 0.01,3.27E-01
exit from mitosis (GO:0010458),13,0,1.32,-, < 0.01,2.67E-01
regulation of peripheral T cell tolerance induction (GO:0002849),1,0,0.1,-, < 0.01,9.03E-01
centriole-centriole cohesion (GO:0010457),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of tolerance induction to tumor cell (GO:0002845),1,0,0.1,-, < 0.01,9.03E-01
regulation of tolerance induction to tumor cell (GO:0002843),1,0,0.1,-, < 0.01,9.03E-01
postsynaptic density assembly (GO:0097107),8,0,0.81,-, < 0.01,4.43E-01
postsynaptic density organization (GO:0097106),17,0,1.73,-, < 0.01,1.77E-01
negative regulation of smooth muscle contraction (GO:0045986),14,0,1.42,-, < 0.01,2.41E-01
endothelial tip cell fate specification (GO:0097102),2,0,0.2,-, < 0.01,8.16E-01
blood vessel endothelial cell fate specification (GO:0097101),3,0,0.3,-, < 0.01,7.37E-01
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809),4,0,0.41,-, < 0.01,6.66E-01
protein maturation by protein folding (GO:0022417),9,0,0.91,-, < 0.01,4.00E-01
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),7,0,0.71,-, < 0.01,4.91E-01
smooth muscle hyperplasia (GO:0014806),2,0,0.2,-, < 0.01,8.16E-01
smooth muscle adaptation (GO:0014805),4,0,0.41,-, < 0.01,6.66E-01
circadian sleep/wake cycle process (GO:0022410),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of immune response to tumor cell (GO:0002838),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of response to tumor cell (GO:0002835),2,0,0.2,-, < 0.01,8.16E-01
fungiform papilla formation (GO:0061198),3,0,0.3,-, < 0.01,7.37E-01
"positive regulation of mitotic cell cycle, embryonic (GO:0045977)",1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of mitotic cell cycle, embryonic (GO:0045976)",2,0,0.2,-, < 0.01,8.16E-01
negative regulation of ribosomal DNA heterochromatin assembly (GO:0061188),2,0,0.2,-, < 0.01,8.16E-01
regulation of ribosomal DNA heterochromatin assembly (GO:0061187),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of dermatome development (GO:0061185),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of dermatome development (GO:0061184),3,0,0.3,-, < 0.01,7.37E-01
regulation of dermatome development (GO:0061183),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of chondrocyte development (GO:0061182),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of dopamine metabolic process (GO:0045963),4,0,0.41,-, < 0.01,6.66E-01
hydrogen peroxide-mediated programmed cell death (GO:0010421),2,0,0.2,-, < 0.01,8.16E-01
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812),1,0,0.1,-, < 0.01,9.03E-01
"negative regulation of complement activation, classical pathway (GO:0045959)",4,0,0.41,-, < 0.01,6.66E-01
"negative regulation of complement activation, alternative pathway (GO:0045957)",3,0,0.3,-, < 0.01,7.37E-01
negative regulation of hair follicle placode formation (GO:0061170),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitotic recombination (GO:0045951),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of mitotic recombination (GO:0045950),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of antibacterial peptide production (GO:0002803),3,0,0.3,-, < 0.01,7.37E-01
regulation of hair follicle placode formation (GO:0061168),1,0,0.1,-, < 0.01,9.03E-01
response to 11-deoxycorticosterone (GO:1903496),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription by RNA polymerase III (GO:0045945),10,0,1.02,-, < 0.01,3.62E-01
response to dehydroepiandrosterone (GO:1903494),1,0,0.1,-, < 0.01,9.03E-01
response to acetylsalicylate (GO:1903492),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitotic cytokinesis (GO:1903490),2,0,0.2,-, < 0.01,8.16E-01
box H/ACA snoRNA metabolic process (GO:0033979),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of lactation (GO:1903489),2,0,0.2,-, < 0.01,8.16E-01
choline metabolic process (GO:0019695),9,0,0.91,-, < 0.01,4.00E-01
pulmonary artery morphogenesis (GO:0061156),7,0,0.71,-, < 0.01,4.91E-01
alkanesulfonate metabolic process (GO:0019694),7,0,0.71,-, < 0.01,4.91E-01
regulation of lactation (GO:1903487),3,0,0.3,-, < 0.01,7.37E-01
pulmonary artery endothelial tube morphogenesis (GO:0061155),1,0,0.1,-, < 0.01,9.03E-01
trachea gland development (GO:0061153),2,0,0.2,-, < 0.01,8.16E-01
trachea submucosa development (GO:0061152),2,0,0.2,-, < 0.01,8.16E-01
BMP signaling pathway involved in renal system segmentation (GO:0061151),1,0,0.1,-, < 0.01,9.03E-01
renal system segmentation (GO:0061150),1,0,0.1,-, < 0.01,9.03E-01
box C/D snoRNA metabolic process (GO:0033967),2,0,0.2,-, < 0.01,8.16E-01
neural plate anterior/posterior regionalization (GO:0021999),3,0,0.3,-, < 0.01,7.37E-01
neural plate mediolateral regionalization (GO:0021998),1,0,0.1,-, < 0.01,9.03E-01
neural plate axis specification (GO:0021997),2,0,0.2,-, < 0.01,8.16E-01
initiation of neural tube closure (GO:0021993),1,0,0.1,-, < 0.01,9.03E-01
BMP signaling pathway involved in ureter morphogenesis (GO:0061149),1,0,0.1,-, < 0.01,9.03E-01
Peyer's patch morphogenesis (GO:0061146),3,0,0.3,-, < 0.01,7.37E-01
lung smooth muscle development (GO:0061145),2,0,0.2,-, < 0.01,8.16E-01
alveolar secondary septum development (GO:0061144),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of female receptivity (GO:0045925),3,0,0.3,-, < 0.01,7.37E-01
alveolar primary septum development (GO:0061143),1,0,0.1,-, < 0.01,9.03E-01
lung ciliated cell differentiation (GO:0061141),1,0,0.1,-, < 0.01,9.03E-01
olfactory cortex development (GO:0021989),1,0,0.1,-, < 0.01,9.03E-01
habenula development (GO:0021986),3,0,0.3,-, < 0.01,7.37E-01
neurohypophysis development (GO:0021985),2,0,0.2,-, < 0.01,8.16E-01
NAD catabolic process (GO:0019677),1,0,0.1,-, < 0.01,9.03E-01
ammonia assimilation cycle (GO:0019676),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cytolysis (GO:0045919),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of cytolysis (GO:0045918),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of complement activation (GO:0045917),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of complement activation (GO:0045916),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of mitotic cell cycle DNA replication (GO:1903465),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of catecholamine metabolic process (GO:0045914),4,0,0.41,-, < 0.01,6.66E-01
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461),1,0,0.1,-, < 0.01,9.03E-01
corticospinal neuron axon guidance through spinal cord (GO:0021972),1,0,0.1,-, < 0.01,9.03E-01
lactate catabolic process (GO:1903457),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of translational termination (GO:0045905),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of G1 to G0 transition (GO:1903452),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of translational elongation (GO:0045901),3,0,0.3,-, < 0.01,7.37E-01
regulation of G1 to G0 transition (GO:1903450),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of translational elongation (GO:0045900),5,0,0.51,-, < 0.01,6.01E-01
spinal cord ventral commissure morphogenesis (GO:0021965),3,0,0.3,-, < 0.01,7.37E-01
branching involved in pancreas morphogenesis (GO:0061114),1,0,0.1,-, < 0.01,9.03E-01
protein transport from ciliary membrane to plasma membrane (GO:1903445),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of brown fat cell differentiation (GO:1903444),1,0,0.1,-, < 0.01,9.03E-01
central nervous system interneuron axonogenesis (GO:0021956),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of mitotic cytokinetic process (GO:1903438),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106),1,0,0.1,-, < 0.01,9.03E-01
regulation of mitotic cytokinetic process (GO:1903436),2,0,0.2,-, < 0.01,8.16E-01
regulation of stomach neuroendocrine cell differentiation (GO:0061105),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of constitutive secretory pathway (GO:1903435),1,0,0.1,-, < 0.01,9.03E-01
adrenal chromaffin cell differentiation (GO:0061104),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of constitutive secretory pathway (GO:1903434),1,0,0.1,-, < 0.01,9.03E-01
carotid body glomus cell differentiation (GO:0061103),1,0,0.1,-, < 0.01,9.03E-01
regulation of constitutive secretory pathway (GO:1903433),2,0,0.2,-, < 0.01,8.16E-01
stomach neuroendocrine cell differentiation (GO:0061102),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of cell maturation (GO:1903431),9,0,0.91,-, < 0.01,4.00E-01
lung neuroendocrine cell differentiation (GO:0061100),1,0,0.1,-, < 0.01,9.03E-01
neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944),1,0,0.1,-, < 0.01,9.03E-01
formation of radial glial scaffolds (GO:0021943),4,0,0.41,-, < 0.01,6.66E-01
radial glia guided migration of Purkinje cell (GO:0021942),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941),2,0,0.2,-, < 0.01,8.16E-01
protein localization to cell cortex (GO:0072697),2,0,0.2,-, < 0.01,8.16E-01
protein localization to endoplasmic reticulum tubular network (GO:1903420),1,0,0.1,-, < 0.01,9.03E-01
cerebellar granule cell precursor tangential migration (GO:0021935),2,0,0.2,-, < 0.01,8.16E-01
hindbrain tangential cell migration (GO:0021934),2,0,0.2,-, < 0.01,8.16E-01
radial glia guided migration of cerebellar granule cell (GO:0021933),1,0,0.1,-, < 0.01,9.03E-01
hindbrain radial glia guided cell migration (GO:0021932),10,0,1.02,-, < 0.01,3.62E-01
urate catabolic process (GO:0019628),1,0,0.1,-, < 0.01,9.03E-01
short-chain fatty acid catabolic process (GO:0019626),8,0,0.81,-, < 0.01,4.43E-01
"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)",1,0,0.1,-, < 0.01,9.03E-01
T cell extravasation (GO:0072683),8,0,0.81,-, < 0.01,4.43E-01
muscle hypertrophy in response to stress (GO:0003299),13,0,1.32,-, < 0.01,2.67E-01
atrial ventricular junction remodeling (GO:0003294),1,0,0.1,-, < 0.01,9.03E-01
cardiac septum cell differentiation (GO:0003292),2,0,0.2,-, < 0.01,8.16E-01
atrial septum secundum morphogenesis (GO:0003290),1,0,0.1,-, < 0.01,9.03E-01
thymocyte migration (GO:0072679),2,0,0.2,-, < 0.01,8.16E-01
regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification (GO:0021920),1,0,0.1,-, < 0.01,9.03E-01
catechol-containing compound catabolic process (GO:0019614),7,0,0.71,-, < 0.01,4.91E-01
lamellipodium morphogenesis (GO:0072673),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of renal phosphate excretion (GO:1903403),1,0,0.1,-, < 0.01,9.03E-01
regulation of renal phosphate excretion (GO:1903402),1,0,0.1,-, < 0.01,9.03E-01
L-lysine transmembrane transport (GO:1903401),4,0,0.41,-, < 0.01,6.66E-01
atrial septum primum morphogenesis (GO:0003289),4,0,0.41,-, < 0.01,6.66E-01
septum secundum development (GO:0003285),2,0,0.2,-, < 0.01,8.16E-01
septum primum development (GO:0003284),5,0,0.51,-, < 0.01,6.01E-01
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment (GO:0021918),1,0,0.1,-, < 0.01,9.03E-01
somatic motor neuron fate commitment (GO:0021917),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914),3,0,0.3,-, < 0.01,7.37E-01
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification (GO:0021913),3,0,0.3,-, < 0.01,7.37E-01
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification (GO:0021912),2,0,0.2,-, < 0.01,8.16E-01
2-oxobutyrate catabolic process (GO:0019606),1,0,0.1,-, < 0.01,9.03E-01
butyrate metabolic process (GO:0019605),2,0,0.2,-, < 0.01,8.16E-01
maintenance of protein location in plasma membrane (GO:0072660),2,0,0.2,-, < 0.01,8.16E-01
regulation of endoribonuclease activity (GO:0060699),4,0,0.41,-, < 0.01,6.66E-01
optokinetic behavior (GO:0007634),2,0,0.2,-, < 0.01,8.16E-01
epithelial cell maturation involved in salivary gland development (GO:0060691),1,0,0.1,-, < 0.01,9.03E-01
epithelial cell differentiation involved in salivary gland development (GO:0060690),1,0,0.1,-, < 0.01,9.03E-01
apoptotic process involved in heart morphogenesis (GO:0003278),2,0,0.2,-, < 0.01,8.16E-01
endocardial cushion fusion (GO:0003274),4,0,0.41,-, < 0.01,6.66E-01
cell migration involved in endocardial cushion formation (GO:0003273),4,0,0.41,-, < 0.01,6.66E-01
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271),1,0,0.1,-, < 0.01,9.03E-01
forebrain-midbrain boundary formation (GO:0021905),1,0,0.1,-, < 0.01,9.03E-01
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270),1,0,0.1,-, < 0.01,9.03E-01
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902),7,0,0.71,-, < 0.01,4.91E-01
maintenance of protein location in membrane (GO:0072658),2,0,0.2,-, < 0.01,8.16E-01
maintenance of protein location in mitochondrion (GO:0072656),5,0,0.51,-, < 0.01,6.01E-01
cell differentiation involved in salivary gland development (GO:0060689),3,0,0.3,-, < 0.01,7.37E-01
regulation of branching involved in prostate gland morphogenesis (GO:0060687),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of prostatic bud formation (GO:0060686),4,0,0.41,-, < 0.01,6.66E-01
ultradian rhythm (GO:0007624),2,0,0.2,-, < 0.01,8.16E-01
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683),1,0,0.1,-, < 0.01,9.03E-01
primary ureteric bud growth (GO:0060682),1,0,0.1,-, < 0.01,9.03E-01
branch elongation involved in ureteric bud branching (GO:0060681),1,0,0.1,-, < 0.01,9.03E-01
cardioblast migration (GO:0003260),1,0,0.1,-, < 0.01,9.03E-01
dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678),1,0,0.1,-, < 0.01,9.03E-01
ureteric bud formation (GO:0060676),4,0,0.41,-, < 0.01,6.66E-01
cardioblast anterior-lateral migration (GO:0003259),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003257),4,0,0.41,-, < 0.01,6.66E-01
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),7,0,0.71,-, < 0.01,4.91E-01
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251),1,0,0.1,-, < 0.01,9.03E-01
UDP-glucuronate metabolic process (GO:0046398),4,0,0.41,-, < 0.01,6.66E-01
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),6,0,0.61,-, < 0.01,5.43E-01
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of phospholipid efflux (GO:1902999),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of neurofibrillary tangle assembly (GO:1902998),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of neurofibrillary tangle assembly (GO:1902997),1,0,0.1,-, < 0.01,9.03E-01
regulation of neurofibrillary tangle assembly (GO:1902996),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of phospholipid efflux (GO:1902995),3,0,0.3,-, < 0.01,7.37E-01
regulation of phospholipid efflux (GO:1902994),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of amyloid precursor protein catabolic process (GO:1902992),14,0,1.42,-, < 0.01,2.41E-01
mitotic telomere maintenance via semi-conservative replication (GO:1902990),3,0,0.3,-, < 0.01,7.37E-01
deoxyribose phosphate biosynthetic process (GO:0046385),11,0,1.12,-, < 0.01,3.27E-01
N-acetylneuraminate biosynthetic process (GO:0046380),1,0,0.1,-, < 0.01,9.03E-01
nipple morphogenesis (GO:0060658),1,0,0.1,-, < 0.01,9.03E-01
neurofibrillary tangle assembly (GO:1902988),1,0,0.1,-, < 0.01,9.03E-01
DNA strand elongation involved in mitotic DNA replication (GO:1902983),1,0,0.1,-, < 0.01,9.03E-01
sinus venosus morphogenesis (GO:0003236),1,0,0.1,-, < 0.01,9.03E-01
sinus venosus development (GO:0003235),1,0,0.1,-, < 0.01,9.03E-01
fructose biosynthetic process (GO:0046370),2,0,0.2,-, < 0.01,8.16E-01
mitotic DNA replication termination (GO:1902979),1,0,0.1,-, < 0.01,9.03E-01
mitotic DNA replication preinitiation complex assembly (GO:1902977),1,0,0.1,-, < 0.01,9.03E-01
mitotic DNA replication initiation (GO:1902975),5,0,0.51,-, < 0.01,6.01E-01
atrial cardiac muscle tissue development (GO:0003228),7,0,0.71,-, < 0.01,4.91E-01
right ventricular compact myocardium morphogenesis (GO:0003226),1,0,0.1,-, < 0.01,9.03E-01
ventricular compact myocardium morphogenesis (GO:0003223),8,0,0.81,-, < 0.01,4.43E-01
right ventricular cardiac muscle tissue morphogenesis (GO:0003221),3,0,0.3,-, < 0.01,7.37E-01
GDP-L-fucose metabolic process (GO:0046368),3,0,0.3,-, < 0.01,7.37E-01
left ventricular cardiac muscle tissue morphogenesis (GO:0003220),2,0,0.2,-, < 0.01,8.16E-01
2-oxobutyrate metabolic process (GO:0046361),2,0,0.2,-, < 0.01,8.16E-01
2-oxobutyrate biosynthetic process (GO:0046360),1,0,0.1,-, < 0.01,9.03E-01
telomere tethering at nuclear periphery (GO:0034398),3,0,0.3,-, < 0.01,7.37E-01
telomere localization (GO:0034397),10,0,1.02,-, < 0.01,3.62E-01
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395),2,0,0.2,-, < 0.01,8.16E-01
mitotic DNA replication (GO:1902969),12,0,1.22,-, < 0.01,2.95E-01
positive regulation of protein localization to early endosome (GO:1902966),9,0,0.91,-, < 0.01,4.00E-01
regulation of protein localization to early endosome (GO:1902965),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963),2,0,0.2,-, < 0.01,8.16E-01
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962),2,0,0.2,-, < 0.01,8.16E-01
regulation of meiosis I (GO:0060631),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),8,0,0.81,-, < 0.01,4.43E-01
cardiac right ventricle formation (GO:0003219),4,0,0.41,-, < 0.01,6.66E-01
cardiac left ventricle formation (GO:0003218),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960),2,0,0.2,-, < 0.01,8.16E-01
cardiac right ventricle morphogenesis (GO:0003215),19,0,1.93,-, < 0.01,1.45E-01
cardiac left ventricle morphogenesis (GO:0003214),14,0,1.42,-, < 0.01,2.41E-01
cardiac right atrium morphogenesis (GO:0003213),2,0,0.2,-, < 0.01,8.16E-01
cardiac ventricle formation (GO:0003211),10,0,1.02,-, < 0.01,3.62E-01
butyrate catabolic process (GO:0046359),1,0,0.1,-, < 0.01,9.03E-01
acetyl-CoA catabolic process (GO:0046356),2,0,0.2,-, < 0.01,8.16E-01
disaccharide catabolic process (GO:0046352),1,0,0.1,-, < 0.01,9.03E-01
disaccharide biosynthetic process (GO:0046351),5,0,0.51,-, < 0.01,6.01E-01
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),10,0,1.02,-, < 0.01,3.62E-01
chylomicron remnant clearance (GO:0034382),7,0,0.71,-, < 0.01,4.91E-01
"negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)",2,0,0.2,-, < 0.01,8.16E-01
positive regulation of early endosome to recycling endosome transport (GO:1902955),1,0,0.1,-, < 0.01,9.03E-01
regulation of early endosome to recycling endosome transport (GO:1902954),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of dendritic spine maintenance (GO:1902952),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of dendritic spine maintenance (GO:1902951),4,0,0.41,-, < 0.01,6.66E-01
regulation of dendritic spine maintenance (GO:1902950),11,0,1.12,-, < 0.01,3.27E-01
amino sugar biosynthetic process (GO:0046349),13,0,1.32,-, < 0.01,2.67E-01
amino sugar catabolic process (GO:0046348),13,0,1.32,-, < 0.01,2.67E-01
positive regulation of tau-protein kinase activity (GO:1902949),7,0,0.71,-, < 0.01,4.91E-01
synaptic vesicle clustering (GO:0097091),6,0,0.61,-, < 0.01,5.43E-01
nipple development (GO:0060618),1,0,0.1,-, < 0.01,9.03E-01
very-low-density lipoprotein particle remodeling (GO:0034372),8,0,0.81,-, < 0.01,4.43E-01
protein localization to early endosome (GO:1902946),2,0,0.2,-, < 0.01,8.16E-01
fat pad development (GO:0060613),7,0,0.71,-, < 0.01,4.91E-01
positive regulation of voltage-gated chloride channel activity (GO:1902943),2,0,0.2,-, < 0.01,8.16E-01
mammary gland fat development (GO:0060611),1,0,0.1,-, < 0.01,9.03E-01
regulation of voltage-gated chloride channel activity (GO:1902941),2,0,0.2,-, < 0.01,8.16E-01
phosphatidylethanolamine catabolic process (GO:0046338),3,0,0.3,-, < 0.01,7.37E-01
octopamine metabolic process (GO:0046333),2,0,0.2,-, < 0.01,8.16E-01
methyl-branched fatty acid metabolic process (GO:0097089),3,0,0.3,-, < 0.01,7.37E-01
lateral inhibition (GO:0046331),3,0,0.3,-, < 0.01,7.37E-01
vascular associated smooth muscle cell development (GO:0097084),9,0,0.91,-, < 0.01,4.00E-01
negative regulation of intracellular calcium activated chloride channel activity (GO:1902939),1,0,0.1,-, < 0.01,9.03E-01
regulation of intracellular calcium activated chloride channel activity (GO:1902938),3,0,0.3,-, < 0.01,7.37E-01
glycerol biosynthetic process from pyruvate (GO:0046327),2,0,0.2,-, < 0.01,8.16E-01
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),11,0,1.12,-, < 0.01,3.27E-01
NAD salvage (GO:0034355),1,0,0.1,-, < 0.01,9.03E-01
'de novo' NAD biosynthetic process from tryptophan (GO:0034354),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of glial cell apoptotic process (GO:0034352),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of glucosylceramide biosynthetic process (GO:0046318),1,0,0.1,-, < 0.01,9.03E-01
regulation of glucosylceramide biosynthetic process (GO:0046317),1,0,0.1,-, < 0.01,9.03E-01
phosphocreatine biosynthetic process (GO:0046314),3,0,0.3,-, < 0.01,7.37E-01
cellular response to thyroxine stimulus (GO:0097069),2,0,0.2,-, < 0.01,8.16E-01
response to thyroxine (GO:0097068),4,0,0.41,-, < 0.01,6.66E-01
glial cell apoptotic process (GO:0034349),5,0,0.51,-, < 0.01,6.01E-01
anterior head development (GO:0097065),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of type III interferon production (GO:0034346),2,0,0.2,-, < 0.01,8.16E-01
dendritic spine maintenance (GO:0097062),10,0,1.02,-, < 0.01,3.62E-01
regulation of type III interferon production (GO:0034344),4,0,0.41,-, < 0.01,6.66E-01
response to type III interferon (GO:0034342),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of protein polyubiquitination (GO:1902915),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of neuroepithelial cell differentiation (GO:1902913),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of melanosome transport (GO:1902910),1,0,0.1,-, < 0.01,9.03E-01
alkanesulfonate biosynthetic process (GO:0046305),2,0,0.2,-, < 0.01,8.16E-01
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056),4,0,0.41,-, < 0.01,6.66E-01
agmatine biosynthetic process (GO:0097055),1,0,0.1,-, < 0.01,9.03E-01
type B pancreatic cell apoptotic process (GO:0097050),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of autophagosome assembly (GO:1902902),14,0,1.42,-, < 0.01,2.41E-01
negative regulation of antibacterial peptide production (GO:0002787),1,0,0.1,-, < 0.01,9.03E-01
regulation of antibacterial peptide production (GO:0002786),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of antimicrobial peptide production (GO:0002785),1,0,0.1,-, < 0.01,9.03E-01
regulation of antimicrobial peptide production (GO:0002784),6,0,0.61,-, < 0.01,5.43E-01
motor neuron apoptotic process (GO:0097049),3,0,0.3,-, < 0.01,7.37E-01
antibacterial peptide biosynthetic process (GO:0002780),1,0,0.1,-, < 0.01,9.03E-01
phosphatidylserine exposure on blood platelet (GO:0097045),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of muscle adaptation (GO:0014745),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of muscle adaptation (GO:0014744),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of muscle hypertrophy (GO:0014741),26,0,2.64,-, < 0.01,7.10E-02
negative regulation of muscle hyperplasia (GO:0014740),2,0,0.2,-, < 0.01,8.16E-01
COP9 signalosome assembly (GO:0010387),5,0,0.51,-, < 0.01,6.01E-01
antibacterial peptide production (GO:0002778),2,0,0.2,-, < 0.01,8.16E-01
antimicrobial peptide biosynthetic process (GO:0002777),1,0,0.1,-, < 0.01,9.03E-01
antimicrobial peptide production (GO:0002775),2,0,0.2,-, < 0.01,8.16E-01
cell wall polysaccharide metabolic process (GO:0010383),1,0,0.1,-, < 0.01,9.03E-01
mesodermal cell migration (GO:0008078),4,0,0.41,-, < 0.01,6.66E-01
heme export (GO:0097037),3,0,0.3,-, < 0.01,7.37E-01
regulation of plasma membrane sterol distribution (GO:0097036),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of muscle hyperplasia (GO:0014739),1,0,0.1,-, < 0.01,9.03E-01
regulation of muscle hyperplasia (GO:0014738),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of muscle atrophy (GO:0014737),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of muscle atrophy (GO:0014736),2,0,0.2,-, < 0.01,8.16E-01
regulation of muscle atrophy (GO:0014735),4,0,0.41,-, < 0.01,6.66E-01
skeletal muscle hypertrophy (GO:0014734),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle adaptation (GO:0014733),11,0,1.12,-, < 0.01,3.27E-01
skeletal muscle atrophy (GO:0014732),7,0,0.71,-, < 0.01,4.91E-01
natural killer cell inhibitory signaling pathway (GO:0002769),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of antimicrobial humoral response (GO:0002760),6,0,0.61,-, < 0.01,5.43E-01
Toll signaling pathway (GO:0008063),6,0,0.61,-, < 0.01,5.43E-01
regulation of the force of skeletal muscle contraction (GO:0014728),2,0,0.2,-, < 0.01,8.16E-01
regulation of twitch skeletal muscle contraction (GO:0014724),3,0,0.3,-, < 0.01,7.37E-01
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722),5,0,0.51,-, < 0.01,6.01E-01
twitch skeletal muscle contraction (GO:0014721),2,0,0.2,-, < 0.01,8.16E-01
regulation of antimicrobial humoral response (GO:0002759),8,0,0.81,-, < 0.01,4.43E-01
cell surface pattern recognition receptor signaling pathway (GO:0002752),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of anion channel activity (GO:0010360),2,0,0.2,-, < 0.01,8.16E-01
eye pigment granule organization (GO:0008057),1,0,0.1,-, < 0.01,9.03E-01
renal protein absorption (GO:0097017),1,0,0.1,-, < 0.01,9.03E-01
skeletal muscle satellite cell activation (GO:0014719),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718),2,0,0.2,-, < 0.01,8.16E-01
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717),3,0,0.3,-, < 0.01,7.37E-01
regulation of anion channel activity (GO:0010359),8,0,0.81,-, < 0.01,4.43E-01
male courtship behavior (GO:0008049),1,0,0.1,-, < 0.01,9.03E-01
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737),1,0,0.1,-, < 0.01,9.03E-01
regulation of plasmacytoid dendritic cell cytokine production (GO:0002736),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of myeloid dendritic cell cytokine production (GO:0002735),6,0,0.61,-, < 0.01,5.43E-01
synaptic target recognition (GO:0008039),1,0,0.1,-, < 0.01,9.03E-01
regulation of myeloid dendritic cell cytokine production (GO:0002733),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of dendritic cell cytokine production (GO:0002731),2,0,0.2,-, < 0.01,8.16E-01
positive regulation of sister chromatid cohesion (GO:0045876),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of sister chromatid cohesion (GO:0045875),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of rhodopsin gene expression (GO:0045872),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of sequestering of zinc ion (GO:0061090),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870),2,0,0.2,-, < 0.01,8.16E-01
protein K6-linked ubiquitination (GO:0085020),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of natural killer cell cytokine production (GO:0002728),2,0,0.2,-, < 0.01,8.16E-01
response to non-ionic osmotic stress (GO:0010335),1,0,0.1,-, < 0.01,9.03E-01
regulation of sequestering of zinc ion (GO:0061088),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of histone H3-K27 methylation (GO:0061087),6,0,0.61,-, < 0.01,5.43E-01
regulation of B cell cytokine production (GO:0002721),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of histone H3-K27 methylation (GO:0061086),3,0,0.3,-, < 0.01,7.37E-01
regulation of histone H3-K27 methylation (GO:0061085),8,0,0.81,-, < 0.01,4.43E-01
negative regulation of protein refolding (GO:0061084),4,0,0.41,-, < 0.01,6.66E-01
regulation of protein refolding (GO:0061083),4,0,0.41,-, < 0.01,6.66E-01
entry into host cell by a symbiont-containing vacuole (GO:0085017),1,0,0.1,-, < 0.01,9.03E-01
regulation of neural retina development (GO:0061074),3,0,0.3,-, < 0.01,7.37E-01
pH elevation (GO:0045852),7,0,0.71,-, < 0.01,4.91E-01
regulation of hydrogen peroxide metabolic process (GO:0010310),19,0,1.93,-, < 0.01,1.45E-01
positive regulation of nitrogen utilization (GO:0045848),1,0,0.1,-, < 0.01,9.03E-01
protein localization to kinetochore involved in kinetochore assembly (GO:1903394),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of adherens junction organization (GO:1903393),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of striated muscle tissue development (GO:0045843),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of adherens junction organization (GO:1903392),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),13,0,1.32,-, < 0.01,2.67E-01
regulation of adherens junction organization (GO:1903391),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of mitotic nuclear division (GO:0045840),35,0,3.56,-, < 0.01,2.84E-02
positive regulation of homophilic cell adhesion (GO:1903387),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of membrane potential (GO:0045837),14,0,1.42,-, < 0.01,2.41E-01
regulation of homophilic cell adhesion (GO:1903385),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of meiotic nuclear division (GO:0045835),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052),9,0,0.91,-, < 0.01,4.00E-01
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051),5,0,0.51,-, < 0.01,6.01E-01
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382),1,0,0.1,-, < 0.01,9.03E-01
regulation of cell growth involved in cardiac muscle cell development (GO:0061050),14,0,1.42,-, < 0.01,2.41E-01
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of NAD(P)H oxidase activity (GO:0033861),2,0,0.2,-, < 0.01,8.16E-01
commitment of multipotent stem cells to neuronal lineage in forebrain (GO:0021898),3,0,0.3,-, < 0.01,7.37E-01
cerebral cortex neuron differentiation (GO:0021895),25,0,2.54,-, < 0.01,7.86E-02
cerebral cortex GABAergic interneuron development (GO:0021894),7,0,0.71,-, < 0.01,4.91E-01
cerebral cortex GABAergic interneuron fate commitment (GO:0021893),2,0,0.2,-, < 0.01,8.16E-01
cerebral cortex GABAergic interneuron differentiation (GO:0021892),11,0,1.12,-, < 0.01,3.27E-01
olfactory bulb interneuron development (GO:0021891),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of branching involved in lung morphogenesis (GO:0061048),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of isotype switching (GO:0045829),5,0,0.51,-, < 0.01,6.01E-01
positive regulation of branching involved in lung morphogenesis (GO:0061047),1,0,0.1,-, < 0.01,9.03E-01
regulation of branching involved in lung morphogenesis (GO:0061046),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of isoprenoid metabolic process (GO:0045828),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of isoprenoid metabolic process (GO:0045827),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of vascular wound healing (GO:0061044),4,0,0.41,-, < 0.01,6.66E-01
regulation of vascular wound healing (GO:0061043),10,0,1.02,-, < 0.01,3.62E-01
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373),3,0,0.3,-, < 0.01,7.37E-01
regulation of endoplasmic reticulum tubular network organization (GO:1903371),5,0,0.51,-, < 0.01,6.01E-01
female gonad morphogenesis (GO:0061040),1,0,0.1,-, < 0.01,9.03E-01
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment (GO:0021882),3,0,0.3,-, < 0.01,7.37E-01
uterus morphogenesis (GO:0061038),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of glycogen catabolic process (GO:0045819),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of fear response (GO:1903366),1,0,0.1,-, < 0.01,9.03E-01
olfactory bulb mitral cell layer development (GO:0061034),2,0,0.2,-, < 0.01,8.16E-01
"positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)",1,0,0.1,-, < 0.01,9.03E-01
endodermal digestive tract morphogenesis (GO:0061031),2,0,0.2,-, < 0.01,8.16E-01
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030),4,0,0.41,-, < 0.01,6.66E-01
forebrain neuron fate commitment (GO:0021877),11,0,1.12,-, < 0.01,3.27E-01
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874),1,0,0.1,-, < 0.01,9.03E-01
forebrain neuroblast division (GO:0021873),6,0,0.61,-, < 0.01,5.43E-01
Cajal-Retzius cell differentiation (GO:0021870),1,0,0.1,-, < 0.01,9.03E-01
regulation of Golgi organization (GO:1903358),12,0,1.22,-, < 0.01,2.95E-01
umbilical cord development (GO:0061027),2,0,0.2,-, < 0.01,8.16E-01
cardiac muscle tissue regeneration (GO:0061026),3,0,0.3,-, < 0.01,7.37E-01
glycerol catabolic process (GO:0019563),5,0,0.51,-, < 0.01,6.01E-01
regulation of nucleus organization (GO:1903353),1,0,0.1,-, < 0.01,9.03E-01
"blood coagulation, extrinsic pathway (GO:0007598)",4,0,0.41,-, < 0.01,6.66E-01
forebrain ventricular zone progenitor cell division (GO:0021869),6,0,0.61,-, < 0.01,5.43E-01
histidine catabolic process to glutamate and formate (GO:0019557),3,0,0.3,-, < 0.01,7.37E-01
histidine catabolic process to glutamate and formamide (GO:0019556),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of bicellular tight junction assembly (GO:1903348),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of bicellular tight junction assembly (GO:1903347),4,0,0.41,-, < 0.01,6.66E-01
snRNA import into nucleus (GO:0061015),2,0,0.2,-, < 0.01,8.16E-01
gall bladder development (GO:0061010),2,0,0.2,-, < 0.01,8.16E-01
cerebral cortex GABAergic interneuron migration (GO:0021853),6,0,0.61,-, < 0.01,5.43E-01
pyramidal neuron migration (GO:0021852),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of vacuolar transport (GO:1903337),2,0,0.2,-, < 0.01,8.16E-01
arginine catabolic process to glutamate (GO:0019544),1,0,0.1,-, < 0.01,9.03E-01
propionate catabolic process (GO:0019543),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of vacuolar transport (GO:1903336),2,0,0.2,-, < 0.01,8.16E-01
regulation of vacuolar transport (GO:1903335),5,0,0.51,-, < 0.01,6.01E-01
propionate biosynthetic process (GO:0019542),2,0,0.2,-, < 0.01,8.16E-01
propionate metabolic process (GO:0019541),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of protein folding (GO:1903333),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of dendritic spine morphogenesis (GO:0061002),7,0,0.71,-, < 0.01,4.91E-01
negative regulation of dendritic spine development (GO:0061000),13,0,1.32,-, < 0.01,2.67E-01
neuroblast division in subventricular zone (GO:0021849),3,0,0.3,-, < 0.01,7.37E-01
ventricular zone neuroblast division (GO:0021847),3,0,0.3,-, < 0.01,7.37E-01
cell proliferation in forebrain (GO:0021846),27,0,2.74,-, < 0.01,6.41E-02
substrate-independent telencephalic tangential interneuron migration (GO:0021843),9,0,0.91,-, < 0.01,4.00E-01
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842),2,0,0.2,-, < 0.01,8.16E-01
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840),2,0,0.2,-, < 0.01,8.16E-01
oxygen metabolic process (GO:0072592),3,0,0.3,-, < 0.01,7.37E-01
taurine metabolic process (GO:0019530),7,0,0.71,-, < 0.01,4.91E-01
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836),2,0,0.2,-, < 0.01,8.16E-01
embryonic olfactory bulb interneuron precursor migration (GO:0021831),1,0,0.1,-, < 0.01,9.03E-01
interneuron migration from the subpallium to the cortex (GO:0021830),9,0,0.91,-, < 0.01,4.00E-01
pentitol catabolic process (GO:0019527),1,0,0.1,-, < 0.01,9.03E-01
caveolin-mediated endocytosis (GO:0072584),5,0,0.51,-, < 0.01,6.01E-01
D-gluconate metabolic process (GO:0019521),2,0,0.2,-, < 0.01,8.16E-01
regulation of nitrogen cycle metabolic process (GO:1903314),1,0,0.1,-, < 0.01,9.03E-01
aldonic acid metabolic process (GO:0019520),2,0,0.2,-, < 0.01,8.16E-01
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199),2,0,0.2,-, < 0.01,8.16E-01
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),12,0,1.22,-, < 0.01,2.95E-01
tricuspid valve formation (GO:0003195),2,0,0.2,-, < 0.01,8.16E-01
pulmonary valve formation (GO:0003193),2,0,0.2,-, < 0.01,8.16E-01
postnatal olfactory bulb interneuron migration (GO:0021827),2,0,0.2,-, < 0.01,8.16E-01
mitral valve formation (GO:0003192),3,0,0.3,-, < 0.01,7.37E-01
substrate-independent telencephalic tangential migration (GO:0021826),9,0,0.91,-, < 0.01,4.00E-01
substrate-dependent cerebral cortex tangential migration (GO:0021825),2,0,0.2,-, < 0.01,8.16E-01
atrioventricular valve formation (GO:0003190),8,0,0.81,-, < 0.01,4.43E-01
cerebral cortex tangential migration using cell-cell interactions (GO:0021823),2,0,0.2,-, < 0.01,8.16E-01
glycine receptor clustering (GO:0072579),1,0,0.1,-, < 0.01,9.03E-01
pentitol metabolic process (GO:0019519),1,0,0.1,-, < 0.01,9.03E-01
neurotransmitter-gated ion channel clustering (GO:0072578),10,0,1.02,-, < 0.01,3.62E-01
lactate oxidation (GO:0019516),1,0,0.1,-, < 0.01,9.03E-01
histone H3-K4 trimethylation (GO:0080182),16,0,1.63,-, < 0.01,1.96E-01
tolerance induction to lipopolysaccharide (GO:0072573),2,0,0.2,-, < 0.01,8.16E-01
peptidyl-proline hydroxylation (GO:0019511),13,0,1.32,-, < 0.01,2.67E-01
S-adenosylhomocysteine catabolic process (GO:0019510),1,0,0.1,-, < 0.01,9.03E-01
regulation of pyruvate kinase activity (GO:1903302),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of hexokinase activity (GO:1903301),6,0,0.61,-, < 0.01,5.43E-01
negative regulation of hexokinase activity (GO:1903300),4,0,0.41,-, < 0.01,6.66E-01
"primary sex determination, germ-line (GO:0007542)",2,0,0.2,-, < 0.01,8.16E-01
heart valve formation (GO:0003188),12,0,1.22,-, < 0.01,2.95E-01
sinoatrial valve morphogenesis (GO:0003185),1,0,0.1,-, < 0.01,9.03E-01
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817),3,0,0.3,-, < 0.01,7.37E-01
coronary sinus valve morphogenesis (GO:0003182),1,0,0.1,-, < 0.01,9.03E-01
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813),1,0,0.1,-, < 0.01,9.03E-01
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812),2,0,0.2,-, < 0.01,8.16E-01
hydrogen peroxide transmembrane transport (GO:0080170),1,0,0.1,-, < 0.01,9.03E-01
type B pancreatic cell maturation (GO:0072560),2,0,0.2,-, < 0.01,8.16E-01
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599),2,0,0.2,-, < 0.01,8.16E-01
primary sex determination (GO:0007538),3,0,0.3,-, < 0.01,7.37E-01
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598),1,0,0.1,-, < 0.01,9.03E-01
mammary placode formation (GO:0060596),3,0,0.3,-, < 0.01,7.37E-01
coronary sinus valve development (GO:0003178),1,0,0.1,-, < 0.01,9.03E-01
cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808),1,0,0.1,-, < 0.01,9.03E-01
sinoatrial valve development (GO:0003172),1,0,0.1,-, < 0.01,9.03E-01
initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806),1,0,0.1,-, < 0.01,9.03E-01
cerebral cortex tangential migration (GO:0021800),6,0,0.61,-, < 0.01,5.43E-01
regulation of nitric oxide metabolic process (GO:0080164),1,0,0.1,-, < 0.01,9.03E-01
blood vessel lumenization (GO:0072554),2,0,0.2,-, < 0.01,8.16E-01
regulation of protein serine/threonine phosphatase activity (GO:0080163),1,0,0.1,-, < 0.01,9.03E-01
terminal button organization (GO:0072553),2,0,0.2,-, < 0.01,8.16E-01
establishment of synaptic specificity at neuromuscular junction (GO:0007529),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of lipoprotein lipid oxidation (GO:0060588),1,0,0.1,-, < 0.01,9.03E-01
regulation of lipoprotein lipid oxidation (GO:0060587),2,0,0.2,-, < 0.01,8.16E-01
multicellular organismal iron ion homeostasis (GO:0060586),9,0,0.91,-, < 0.01,4.00E-01
somatic muscle development (GO:0007525),3,0,0.3,-, < 0.01,7.37E-01
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585),3,0,0.3,-, < 0.01,7.37E-01
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584),3,0,0.3,-, < 0.01,7.37E-01
cell fate determination involved in pattern specification (GO:0060582),1,0,0.1,-, < 0.01,9.03E-01
visceral muscle development (GO:0007522),1,0,0.1,-, < 0.01,9.03E-01
cell fate commitment involved in pattern specification (GO:0060581),12,0,1.22,-, < 0.01,2.95E-01
muscle cell fate determination (GO:0007521),2,0,0.2,-, < 0.01,8.16E-01
ventral spinal cord interneuron fate determination (GO:0060580),1,0,0.1,-, < 0.01,9.03E-01
coronary vein morphogenesis (GO:0003169),2,0,0.2,-, < 0.01,8.16E-01
Purkinje myocyte differentiation (GO:0003168),1,0,0.1,-, < 0.01,9.03E-01
atrioventricular bundle cell differentiation (GO:0003167),1,0,0.1,-, < 0.01,9.03E-01
bundle of His development (GO:0003166),4,0,0.41,-, < 0.01,6.66E-01
sinoatrial node development (GO:0003163),3,0,0.3,-, < 0.01,7.37E-01
atrioventricular node development (GO:0003162),3,0,0.3,-, < 0.01,7.37E-01
endocardium morphogenesis (GO:0003160),6,0,0.61,-, < 0.01,5.43E-01
ventral spinal cord interneuron fate commitment (GO:0060579),12,0,1.22,-, < 0.01,2.95E-01
myoblast fate determination (GO:0007518),2,0,0.2,-, < 0.01,8.16E-01
pulmonary vein morphogenesis (GO:0060577),1,0,0.1,-, < 0.01,9.03E-01
intestinal epithelial cell development (GO:0060576),13,0,1.32,-, < 0.01,2.67E-01
intestinal epithelial cell maturation (GO:0060574),4,0,0.41,-, < 0.01,6.66E-01
cell fate specification involved in pattern specification (GO:0060573),8,0,0.81,-, < 0.01,4.43E-01
adult heart development (GO:0007512),13,0,1.32,-, < 0.01,2.67E-01
endocardium development (GO:0003157),11,0,1.12,-, < 0.01,3.27E-01
muscular septum morphogenesis (GO:0003150),4,0,0.41,-, < 0.01,6.66E-01
glycolate catabolic process (GO:0046296),1,0,0.1,-, < 0.01,9.03E-01
fibroblast activation (GO:0072537),6,0,0.61,-, < 0.01,5.43E-01
formaldehyde biosynthetic process (GO:0046293),1,0,0.1,-, < 0.01,9.03E-01
amino acid homeostasis (GO:0080144),4,0,0.41,-, < 0.01,6.66E-01
pyrimidine-containing compound transmembrane transport (GO:0072531),12,0,1.22,-, < 0.01,2.95E-01
mesoderm migration involved in gastrulation (GO:0007509),2,0,0.2,-, < 0.01,8.16E-01
regulation of postsynaptic density protein 95 clustering (GO:1902897),3,0,0.3,-, < 0.01,7.37E-01
"positive regulation of DNA-templated transcription, termination (GO:0060566)",1,0,0.1,-, < 0.01,9.03E-01
terminal web assembly (GO:1902896),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),16,0,1.63,-, < 0.01,1.96E-01
apoptotic process involved in morphogenesis (GO:0060561),14,0,1.42,-, < 0.01,2.41E-01
membranous septum morphogenesis (GO:0003149),8,0,0.81,-, < 0.01,4.43E-01
mesodermal cell fate determination (GO:0007500),3,0,0.3,-, < 0.01,7.37E-01
neural crest cell migration involved in heart formation (GO:0003147),1,0,0.1,-, < 0.01,9.03E-01
embryonic heart tube formation (GO:0003144),1,0,0.1,-, < 0.01,9.03E-01
cardiogenic plate morphogenesis (GO:0003142),1,0,0.1,-, < 0.01,9.03E-01
pyridine-containing compound biosynthetic process (GO:0072525),32,0,3.25,-, < 0.01,3.85E-02
protein localization to spindle microtubule (GO:1902889),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of response to oxidative stress (GO:1902884),6,0,0.61,-, < 0.01,5.43E-01
secondary heart field specification (GO:0003139),11,0,1.12,-, < 0.01,3.27E-01
primary heart field specification (GO:0003138),3,0,0.3,-, < 0.01,7.37E-01
negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136),1,0,0.1,-, < 0.01,9.03E-01
mesodermal-endodermal cell signaling (GO:0003131),1,0,0.1,-, < 0.01,9.03E-01
proteasome core complex assembly (GO:0080129),1,0,0.1,-, < 0.01,9.03E-01
stilbene catabolic process (GO:0046272),1,0,0.1,-, < 0.01,9.03E-01
phenylpropanoid catabolic process (GO:0046271),2,0,0.2,-, < 0.01,8.16E-01
CAAX-box protein maturation (GO:0080120),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of necrotic cell death (GO:0060547),18,0,1.83,-, < 0.01,1.60E-01
negative regulation of necroptotic process (GO:0060546),14,0,1.42,-, < 0.01,2.41E-01
positive regulation of necroptotic process (GO:0060545),3,0,0.3,-, < 0.01,7.37E-01
regulation of strand invasion (GO:0060542),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of amacrine cell differentiation (GO:1902871),2,0,0.2,-, < 0.01,8.16E-01
heart field specification (GO:0003128),11,0,1.12,-, < 0.01,3.27E-01
negative regulation of amacrine cell differentiation (GO:1902870),1,0,0.1,-, < 0.01,9.03E-01
detection of nodal flow (GO:0003127),2,0,0.2,-, < 0.01,8.16E-01
regulation of amacrine cell differentiation (GO:1902869),3,0,0.3,-, < 0.01,7.37E-01
cartilage morphogenesis (GO:0060536),12,0,1.22,-, < 0.01,2.95E-01
regulation of retina development in camera-type eye (GO:1902866),1,0,0.1,-, < 0.01,9.03E-01
trachea cartilage morphogenesis (GO:0060535),4,0,0.41,-, < 0.01,6.66E-01
trachea cartilage development (GO:0060534),8,0,0.81,-, < 0.01,4.43E-01
bronchus cartilage development (GO:0060532),2,0,0.2,-, < 0.01,8.16E-01
propionyl-CoA biosynthetic process (GO:1902860),1,0,0.1,-, < 0.01,9.03E-01
detection of monosaccharide stimulus (GO:0034287),3,0,0.3,-, < 0.01,7.37E-01
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529),2,0,0.2,-, < 0.01,8.16E-01
propionyl-CoA catabolic process (GO:1902859),1,0,0.1,-, < 0.01,9.03E-01
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527),6,0,0.61,-, < 0.01,5.43E-01
propionyl-CoA metabolic process (GO:1902858),2,0,0.2,-, < 0.01,8.16E-01
prostate glandular acinus morphogenesis (GO:0060526),6,0,0.61,-, < 0.01,5.43E-01
positive regulation of non-motile cilium assembly (GO:1902857),5,0,0.51,-, < 0.01,6.01E-01
activation of prostate induction by androgen receptor signaling pathway (GO:0060520),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of the force of heart contraction by chemical signal (GO:0003108),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glomerular filtration by angiotensin (GO:0003106),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of glomerular filtration (GO:0003105),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of glomerular filtration (GO:0003104),4,0,0.41,-, < 0.01,6.66E-01
regulation of systemic arterial blood pressure by endothelin (GO:0003100),5,0,0.51,-, < 0.01,6.01E-01
kynurenic acid biosynthetic process (GO:0034276),2,0,0.2,-, < 0.01,8.16E-01
kynurenic acid metabolic process (GO:0034275),2,0,0.2,-, < 0.01,8.16E-01
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517),1,0,0.1,-, < 0.01,9.03E-01
regulation of neuronal signal transduction (GO:1902847),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of autophagy in response to ER overload (GO:0034263),1,0,0.1,-, < 0.01,9.03E-01
regulation of nuclear migration along microtubule (GO:1902838),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of proline import across plasma membrane (GO:1902836),1,0,0.1,-, < 0.01,9.03E-01
bud dilation involved in lung branching (GO:0060503),1,0,0.1,-, < 0.01,9.03E-01
regulation of proline import across plasma membrane (GO:1902834),1,0,0.1,-, < 0.01,9.03E-01
epithelial cell proliferation involved in lung morphogenesis (GO:0060502),2,0,0.2,-, < 0.01,8.16E-01
coumarin catabolic process (GO:0046226),2,0,0.2,-, < 0.01,8.16E-01
regulation of urea metabolic process (GO:0034255),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of late endosome to lysosome transport (GO:1902824),2,0,0.2,-, < 0.01,8.16E-01
negative regulation of late endosome to lysosome transport (GO:1902823),2,0,0.2,-, < 0.01,8.16E-01
regulation of late endosome to lysosome transport (GO:1902822),4,0,0.41,-, < 0.01,6.66E-01
nitric oxide catabolic process (GO:0046210),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of protein localization to microtubule (GO:1902817),4,0,0.41,-, < 0.01,6.66E-01
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242),3,0,0.3,-, < 0.01,7.37E-01
regulation of protein localization to microtubule (GO:1902816),4,0,0.41,-, < 0.01,6.66E-01
positive regulation of skeletal muscle fiber differentiation (GO:1902811),3,0,0.3,-, < 0.01,7.37E-01
spermine catabolic process (GO:0046208),2,0,0.2,-, < 0.01,8.16E-01
nor-spermidine metabolic process (GO:0046204),1,0,0.1,-, < 0.01,9.03E-01
macrophage fusion (GO:0034238),1,0,0.1,-, < 0.01,9.03E-01
regulation of skeletal muscle fiber differentiation (GO:1902809),4,0,0.41,-, < 0.01,6.66E-01
islet amyloid polypeptide processing (GO:0034231),1,0,0.1,-, < 0.01,9.03E-01
positive regulation of synaptic vesicle transport (GO:1902805),1,0,0.1,-, < 0.01,9.03E-01
negative regulation of synaptic vesicle transport (GO:1902804),1,0,0.1,-, < 0.01,9.03E-01
regulation of synaptic vesicle transport (GO:1902803),4,0,0.41,-, < 0.01,6.66E-01
somatic recombination of T cell receptor gene segments (GO:0002681),5,0,0.51,-, < 0.01,6.01E-01
cellular response to zinc ion starvation (GO:0034224),2,0,0.2,-, < 0.01,8.16E-01
